,Term,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes,cluster
1,cellular response to cytokine stimulus (GO:0071345),5.42E-09,2.77E-05,0,0,6.251953736,118.9926527,EGR1;OSM;TNF;CXCL2;AIF1;ZFP36L1;CXCL10;ZFP36;AXL;CCL5;UBC;CCL4;PIM1;CCL3;CCL17;NFE2L2,0
2,cellular response to tumor necrosis factor (GO:0071356),1.27E-08,3.24E-05,0,0,10.07326007,183.1439234,NFKBIA;ZFP36;TMSB4X;CCL5;UBC;CCL4;CCL3;TNF;CCL17;ZFP36L1;NFE2L2,0
3,positive regulation of lymphocyte migration (GO:2000403),2.95E-08,5.02E-05,0,0,52.5210084,910.6267937,CXCL10;CCL5;CCL4;CCL3;AIF1,0
4,cellular response to lipopolysaccharide (GO:0071222),4.73E-08,6.03E-05,0,0,15.52795031,261.9064437,CXCL10;ZFP36;AXL;CCL5;TNIP3;CCL3;TNFAIP3;TNF,0
5,response to tumor necrosis factor (GO:0034612),7.78E-08,7.94E-05,0,0,14.57725948,238.6214359,ZFP36;CCL5;CCL4;CCL3;CCL17;CXCL16;ZFP36L1;NFE2L2,0
6,response to interferon-gamma (GO:0034341),1.16E-07,9.85E-05,0,0,18.11594203,289.3356864,BST2;CCL5;CCL4;CCL3;AIF1;CCL17;CXCL16,0
7,negative regulation of viral transcription (GO:0032897),1.56E-07,0.000113916,0,0,38.81987578,608.3742146,JUN;ZFP36;CCL5;CCL4;CCL3,0
8,lymphocyte chemotaxis (GO:0048247),1.84E-07,0.000117173,0,0,23.80952381,369.2857902,CXCL10;CCL5;CCL4;CCL3;CCL17;CXCL16,0
9,negative regulation by host of viral transcription (GO:0043922),4.46E-07,0.000252625,0,0,59.52380952,870.4739718,JUN;CCL5;CCL4;CCL3,0
10,chemokine-mediated signaling pathway (GO:0070098),4.99E-07,0.00025478,0,0,20.21563342,293.3310751,CXCL10;CCL5;CCL4;CCL3;CXCL2;CCL17,0
11,mitochondrial ATP synthesis coupled electron transport (GO:0042775),5.33E-07,0.000247459,0,0,14.53488372,209.9411681,MT-ND4;MT-CO1;MT-CO2;MT-CO3;MT-ND2;MT-ND3;MT-ND1,0
12,respiratory electron transport chain (GO:0022904),1.05E-06,0.000447607,0,0,13.15789474,181.1088512,MT-ND4;MT-CO1;MT-CO2;MT-CO3;MT-ND2;MT-ND3;MT-ND1,0
13,positive regulation of leukocyte chemotaxis (GO:0002690),1.28E-06,0.000503784,0,0,17.28110599,234.4354387,CXCL10;CCL5;CCL4;CCL3;CXCL2;AIF1,0
14,cellular response to transforming growth factor beta stimulus (GO:0071560),1.59E-06,0.000580949,0,0,12.37623762,165.2150209,JUN;ITGB5;GDF15;UBC;FURIN;F11R;ZFP36L1,0
15,inflammatory response (GO:0006954),1.60E-06,0.000545986,0,0,7.058159232,94.17314887,CXCL10;CCL5;CCRL2;CCL4;CCL3;F11R;TNF;CXCL2;AIF1;CCL17,0
16,cytokine-mediated signaling pathway (GO:0019221),2.54E-06,0.000810764,0,0,4.22487607,54.42708787,EGR1;OSM;TNF;CXCL2;NFKBIA;BST2;CXCL10;TMSB4X;CCL5;UBC;CCL4;PIM1;CCL3;B2M;CCL17,0
17,response to lipopolysaccharide (GO:0032496),2.74E-06,0.000822355,0,0,9.157509158,117.2867062,CXCL10;ZFP36;JUN;AXL;TNIP3;TNFAIP3;TRIB1;CXCL2,0
18,positive regulation of mononuclear cell migration (GO:0071677),3.38E-06,0.000959606,0,0,37.59398496,473.5413636,CXCL10;CCL5;TNF;AIF1,0
19,regulation of inflammatory response (GO:0050727),4.55E-06,0.001220982,0,0,8.554319932,105.2287843,NFKBIA;TMSB4X;CCL5;CCL4;CCL3;TNFAIP3;APOE;TLR2,0
20,transforming growth factor beta receptor signaling pathway (GO:0007179),4.62E-06,0.001179835,0,0,13.91465677,170.9308765,JUN;ITGB5;GDF15;UBC;FURIN;F11R,0
21,regulation of smooth muscle cell proliferation (GO:0048660),5.14E-06,0.001249975,0,0,19.84126984,241.6208901,CCL5;TNFAIP3;TRIB1;TNF;AIF1,0
22,regulation of natural killer cell chemotaxis (GO:2000501),5.89E-06,0.001365324,0,0,76.53061224,921.6508913,CCL5;CCL4;CCL3,0
23,activation of MAPKKK activity (GO:0000185),5.89E-06,0.001305962,0,0,76.53061224,921.6508913,GADD45B;TNF;GADD45G,0
24,cellular response to molecule of bacterial origin (GO:0071219),8.23E-06,0.001749026,0,0,12.60504202,147.5826856,CXCL10;ZFP36;AXL;TNIP3;TNFAIP3;TLR2,0
25,modulation by host of viral transcription (GO:0043921),1.72E-05,0.003510697,0,0,25.51020408,279.8634884,JUN;CCL5;CCL4;CCL3,0
26,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1.83E-05,0.003583618,0,0,7.072135785,77.16315127,CD74;GPNMB;AXL;CCL5;CCL4;CCL3;TNF;CCL17,0
27,T cell chemotaxis (GO:0010818),1.99E-05,0.003767754,0,0,53.57142857,579.8048167,CXCL10;CCL3;CXCL16,0
28,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),2.03E-05,0.003700361,0,0,6.968641115,75.29410682,NFKBIA;BST2;CD74;TNIP3;UBC;TNFAIP3;TNF;MALT1,0
29,cellular response to interleukin-1 (GO:0071347),2.27E-05,0.003998206,0,0,8.278145695,88.51156944,NFKBIA;EGR1;CCL5;UBC;CCL4;CCL3;CCL17,0
30,cellular response to oxygen-containing compound (GO:1901701),2.46E-05,0.004189112,0,0,5.844155844,62.0161536,EGR1;CXCL10;ZFP36;JUN;AXL;TNIP3;TNFAIP3;ZFP36L1;TLR2,0
31,positive regulation of MAPK cascade (GO:0043410),3.73E-05,0.006141256,0,0,5.541871921,56.50671464,CD74;GPNMB;AXL;CCL5;CCL4;CCL3;OSM;TNF;CCL17,0
32,positive regulation of chemokine production (GO:0032722),4.27E-05,0.006805333,0,0,20.40816327,205.3448314,EGR1;CD74;TNF;TLR2,0
33,protein kinase B signaling (GO:0043491),4.78E-05,0.00739207,0,0,19.84126984,197.3893598,CCL5;CCL3;TNF;ZFP36L1,0
34,cellular response to interferon-gamma (GO:0071346),5.09E-05,0.007637555,0,0,9.157509158,90.53022976,CCL5;CCL4;CCL3;B2M;AIF1;CCL17,0
35,positive regulation of smooth muscle cell proliferation (GO:0048661),5.94E-05,0.008658877,0,0,18.79699248,182.9211661,JUN;CCL5;TNF;AIF1,0
36,positive regulation of inflammatory response (GO:0050729),5.96E-05,0.008450583,0,0,12.06563707,117.3695069,NFKBIA;CCL4;CCL3;OSM;TLR2,0
37,positive regulation of defense response (GO:0031349),6.36E-05,0.008770452,0,0,11.9047619,115.0361057,NFKBIA;CCL5;CCL4;CCL3;TLR2,0
38,regulation of transcription from RNA polymerase II promoter (GO:0006357),6.48E-05,0.008705025,0,0,2.535496957,24.45195891,EGR1;JUN;GDF15;OSM;TNF;NFKBIA;CXCL10;ZFP36;NFIC;TNIP3;UBC;BHLHE40;NFKBIZ;FOSB;APOE;CCNL1;IER5;SKIL;ATF3;NFE2L2;TLR2,0
39,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),7.41E-05,0.009690377,0,0,35.71428571,339.6658626,FURIN;APOE;TNF,0
40,regulation of ERK1 and ERK2 cascade (GO:0070372),7.83E-05,0.009983037,0,0,5.760368664,54.46758246,CD74;GPNMB;AXL;CCL5;CCL4;CCL3;TNF;CCL17,0
41,positive regulation of intracellular signal transduction (GO:1902533),8.05E-05,0.01001617,0,0,4.092261905,38.58007061,BST2;CXCL10;CD74;AXL;CCL5;UBC;CCL4;CCL3;OSM;TNF;MALT1,0
42,neutrophil degranulation (GO:0043312),8.05E-05,0.009777689,0,0,4.092261905,38.58007061,BST2;SYNGR1;GRN;FABP5;HEXB;IQGAP1;B2M;CTSD;CTSS;CTSB;TLR2,0
43,neutrophil activation involved in immune response (GO:0002283),8.66E-05,0.010279895,0,0,4.058441558,37.96245516,BST2;SYNGR1;GRN;FABP5;HEXB;IQGAP1;B2M;CTSD;CTSS;CTSB;TLR2,0
44,monocyte chemotaxis (GO:0002548),8.85E-05,0.01026588,0,0,17.00680272,158.7129887,CCL5;CCL4;CCL3;CCL17,0
45,T cell migration (GO:0072678),9.08E-05,0.010294284,0,0,33.48214286,311.6212466,CXCL10;CCL3;CXCL16,0
46,lipopolysaccharide-mediated signaling pathway (GO:0031663),9.08E-05,0.010070495,0,0,33.48214286,311.6212466,CCL5;CCL3;TNF,0
47,neutrophil mediated immunity (GO:0002446),9.32E-05,0.010115742,0,0,4.025175644,37.35805246,BST2;SYNGR1;GRN;FABP5;HEXB;IQGAP1;B2M;CTSD;CTSS;CTSB;TLR2,0
48,positive regulation of monocyte chemotaxis (GO:0090026),0.000109782,0.011671197,0,0,31.51260504,287.300867,CXCL10;CCL5;AIF1,0
49,regulation of T cell migration (GO:2000404),0.000109782,0.011433009,0,0,31.51260504,287.300867,CXCL10;CCL5;AIF1,0
50,toll-like receptor signaling pathway (GO:0002224),0.000129079,0.013173787,0,0,10.26272578,91.90360331,TNIP3;UBC;CTSS;CTSB;TLR2,0
51,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.000138051,0.013813205,0,0,15.19756839,135.0742931,MT-ND4;MT-ND2;MT-ND3;MT-ND1,0
52,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),0.000143032,0.014036367,0,0,7.598784195,67.26781021,NFKBIA;TMSB4X;BHLHE40;PIM1;TNFAIP3;TRIB1,0
53,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.000149954,0.014438054,0,0,14.88095238,131.0294624,NFKBIA;TMSB4X;TNIP3;TNFAIP3,0
54,positive regulation of response to external stimulus (GO:0032103),0.0001596,0.015082192,0,0,9.811616954,85.78140099,NFKBIA;CCL4;CCL3;LY86;TLR2,0
55,regulation of cytokine-mediated signaling pathway (GO:0001959),0.0001596,0.014807971,0,0,9.811616954,85.78140099,CD74;AXL;UBC;TNFAIP3;TNF,0
56,positive regulation of chemotaxis (GO:0050921),0.000162583,0.014815342,0,0,14.57725948,127.1767378,CXCL10;TMSB4X;CXCL2;AIF1,0
57,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.000166642,0.014918885,0,0,7.389162562,64.28320243,JUN;ITGB5;GDF15;UBC;FURIN;F11R,0
58,positive regulation of T cell migration (GO:2000406),0.000181807,0.015995876,0,0,26.78571429,230.6937105,CXCL10;CCL5;AIF1,0
59,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.000211245,0.018270877,0,0,25.51020408,215.8799321,MT-CO1;MT-CO2;MT-CO3,0
60,response to molecule of bacterial origin (GO:0002237),0.000236911,0.020149277,0,0,9.018759019,75.28703276,CXCL10;JUN;TNFAIP3;TRIB1;CXCL2,0
61,neutrophil chemotaxis (GO:0030593),0.000237512,0.019869278,0,0,13.22751323,110.3874413,CCL5;CCL4;CCL3;CCL17,0
62,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.000243604,0.020050157,0,0,24.35064935,202.5966182,FURIN;APOE;TNF,0
63,regulation of monocyte chemotaxis (GO:0090025),0.000243604,0.019731901,0,0,24.35064935,202.5966182,CXCL10;CCL5;AIF1,0
64,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),0.000280004,0.022325947,0,0,2.944640754,24.08924188,EGR1;JUN;OSM;TNF;NFKBIA;CXCL10;NFIC;TNIP3;UBC;CCNL1;IER5;ATF3;NFE2L2;TLR2,0
65,granulocyte chemotaxis (GO:0071621),0.000292862,0.022991922,0,0,12.53132832,101.9524929,CCL5;CCL4;CCL3;CCL17,0
66,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.000313207,0.024216591,0,0,12.31527094,99.36756707,NFKBIA;UBC;TNF;TLR2,0
67,cellular respiration (GO:0045333),0.000313207,0.023855149,0,0,12.31527094,99.36756707,MT-ND4;MT-CO1;MT-CO3;MT-ND1,0
68,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.000324132,0.024324195,0,0,6.533101045,52.48928513,BST2;CD74;UBC;TNF;MALT1;TLR2,0
69,neutrophil migration (GO:1990266),0.000334545,0.024741813,0,0,12.10653753,96.88544826,CCL5;CCL4;CCL3;CCL17,0
70,eosinophil migration (GO:0072677),0.000359402,0.026200397,0,0,21.42857143,169.9514864,CCL5;CCL4;CCL3,0
71,response to glucocorticoid (GO:0051384),0.000359402,0.025831377,0,0,21.42857143,169.9514864,ZFP36;TNF;ZFP36L1,0
72,eosinophil chemotaxis (GO:0048245),0.000359402,0.025472608,0,0,21.42857143,169.9514864,CCL5;CCL4;CCL3,0
73,negative regulation of cytokine production (GO:0001818),0.00040256,0.02814059,0,0,8.043758044,62.88341933,GPNMB;AXL;UBC;TNFAIP3;TNF,0
74,cellular response to epidermal growth factor stimulus (GO:0071364),0.000404628,0.02790296,0,0,20.6043956,160.9726912,ZFP36;IQGAP1;ZFP36L1,0
75,regulation of tumor necrosis factor production (GO:0032680),0.000404801,0.027542663,0,0,11.52073733,90.00132326,ZFP36;CCL3;TNFAIP3;TLR2,0
76,stress-activated MAPK cascade (GO:0051403),0.000430393,0.028898653,0,0,11.33786848,87.87767402,ZFP36;UBC;TRIB1;ZFP36L1,0
77,positive regulation of hydrolase activity (GO:0051345),0.000430943,0.028559739,0,0,6.193228737,47.99464737,RGS1;CCL5;CCL4;CCL3;F11R;CCL17,0
78,regulation of NF-kappaB import into nucleus (GO:0042345),0.000453357,0.029659984,0,0,19.84126984,152.7545941,NFKBIA;TNF;TLR2,0
79,regulation of keratinocyte apoptotic process (GO:1902172),0.000459413,0.029675778,0,0,59.52380952,457.4738188,ZFP36;ZFP36L1,0
80,negative regulation of erythrocyte differentiation (GO:0045647),0.000459413,0.029304831,0,0,59.52380952,457.4738188,ZFP36;ZFP36L1,0
81,positive regulation of endocytosis (GO:0045807),0.000485009,0.030555554,0,0,10.98901099,83.86091791,AXL;APOE;TNF;B2M,0
82,NADH dehydrogenase complex assembly (GO:0010257),0.000485009,0.030182925,0,0,10.98901099,83.86091791,MT-ND4;MT-ND2;MT-ND3;MT-ND1,0
83,mitochondrial respiratory chain complex I biogenesis (GO:0097031),0.000485009,0.029819276,0,0,10.98901099,83.86091791,MT-ND4;MT-ND2;MT-ND3;MT-ND1,0
84,mitochondrial respiratory chain complex I assembly (GO:0032981),0.000485009,0.029464284,0,0,10.98901099,83.86091791,MT-ND4;MT-ND2;MT-ND3;MT-ND1,0
85,negative regulation of smooth muscle cell proliferation (GO:0048662),0.000505696,0.030359597,0,0,19.13265306,145.2087094,TNFAIP3;TRIB1;AIF1,0
86,negative regulation of homeostatic process (GO:0032845),0.000561754,0.033332888,0,0,18.4729064,138.2594949,ZFP36;TNFAIP3;ZFP36L1,0
87,aerobic respiration (GO:0009060),0.000561754,0.032949751,0,0,18.4729064,138.2594949,MT-ND4;MT-CO1;MT-CO3,0
88,cytoplasmic sequestering of NF-kappaB (GO:0007253),0.000640826,0.037160606,0,0,51.02040816,375.1404661,NFKBIA;TMSB4X,0
89,negative regulation of synapse organization (GO:1905809),0.000640826,0.036743071,0,0,51.02040816,375.1404661,APOE;TLR2,0
90,regulation of chemokine biosynthetic process (GO:0045073),0.000640826,0.036334814,0,0,51.02040816,375.1404661,EGR1;TNF,0
91,regulation of apoptotic process (GO:0042981),0.000646113,0.036232008,0,0,2.844887955,20.89438405,CD74;JUN;GADD45B;GDF15;TNF;MALT1;GADD45G;NFKBIA;AXL;UBC;PIM1;SGK1;CTSB,0
92,regulation of GTPase activity (GO:0043087),0.00068684,0.038097199,0,0,5.66893424,41.28917138,RGS1;CCL5;CCL4;CCL3;F11R;CCL17,0
93,regulation of neuron death (GO:1901214),0.000753415,0.041340595,0,0,9.784735812,70.3610052,EGR1;GPNMB;CCL5;APOE,0
94,positive regulation of GTPase activity (GO:0043547),0.000766186,0.041594118,0,0,5.551443375,39.82653011,RGS1;CCL5;CCL4;CCL3;F11R;CCL17,0
95,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.000798367,0.042884902,0,0,6.9213732,49.36975669,NFKBIA;UBC;TNF;MALT1;TLR2,0
96,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.000825245,0.043866944,0,0,16.23376623,115.2569791,CD74;TNF;ZFP36L1,0
97,positive regulation of monocyte differentiation (GO:0045657),0.000851309,0.044785886,0,0,44.64285714,315.5685333,CD74;ZFP36L1,0
98,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.000851309,0.044328887,0,0,44.64285714,315.5685333,ZFP36;ZFP36L1,0
99,positive regulation of calcium ion transport (GO:0051928),0.000901434,0.04646485,0,0,15.75630252,110.4756805,CCL5;CCL4;CCL3,0
100,response to interleukin-1 (GO:0070555),0.000920822,0.046989542,0,0,9.276437848,64.84456309,CCL5;CCL4;CCL3;CCL17,0
101,positive regulation of leukocyte migration (GO:0002687),0.000981944,0.049612459,0,0,15.30612245,106.0098468,CXCL10;CXCL2;TNF,0
102,cellular response to organic cyclic compound (GO:0071407),0.001012274,0.050643465,0,0,6.56512605,45.27019532,EGR1;CCL5;CCL3;TNF;ZFP36L1,0
103,negative regulation of cell proliferation (GO:0008285),0.001024797,0.050772209,0,0,3.924646782,27.01436824,GPNMB;BHLHE40;OSM;TNFAIP3;TRIB1;CBFA2T3;AIF1;MTSS1,0
104,negative regulation of lipid localization (GO:1905953),0.001090539,0.053509795,0,0,39.68253968,270.6779184,NFKBIA;TNF,0
105,negative regulation of signal transduction (GO:0009968),0.001101042,0.053510641,0,0,4.401408451,29.98018609,RGS2;MMP14;AXL;CCL5;UBC;TNFAIP3;TRIB1,0
106,cellular response to hormone stimulus (GO:0032870),0.001112847,0.053574157,0,0,8.818342152,59.97207461,JUN;CTSS;CTSB;ZFP36L1,0
107,positive regulation of protein catabolic process (GO:0045732),0.001164919,0.055556842,0,0,8.710801394,58.84236621,TNFAIP3;FURIN;APOE;TNF,0
108,cellular response to thyroid hormone stimulus (GO:0097067),0.001358191,0.064174533,0,0,35.71428571,235.7714817,CTSS;CTSB,0
109,3'-UTR-mediated mRNA destabilization (GO:0061158),0.001358191,0.063585776,0,0,35.71428571,235.7714817,ZFP36;ZFP36L1,0
110,positive regulation of smooth muscle cell migration (GO:0014911),0.001358191,0.063007723,0,0,35.71428571,235.7714817,CCL5;AIF1,0
111,macrophage chemotaxis (GO:0048246),0.001358191,0.062440086,0,0,35.71428571,235.7714817,CCL5;CCL3,0
112,"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",0.001358191,0.061882585,0,0,35.71428571,235.7714817,MT-ND4;MT-CO1,0
113,macrophage migration (GO:1905517),0.001358191,0.061334952,0,0,35.71428571,235.7714817,CCL5;CCL3,0
114,regulation of T cell chemotaxis (GO:0010819),0.001358191,0.060796926,0,0,35.71428571,235.7714817,CXCL10;CCL5,0
115,"positive regulation of transcription, DNA-templated (GO:0045893)",0.001463508,0.064941596,0,0,2.389448197,15.5957341,EGR1;CD74;JUN;OSM;TNF;NFKBIA;CXCL10;NFIC;TNIP3;UBC;CCNL1;IER5;ATF3;NFE2L2;TLR2,0
116,regulation of MAP kinase activity (GO:0043405),0.001513737,0.066591383,0,0,8.116883117,52.70433261,RGS2;APOE;TRIB1;TNF,0
117,response to thyroid hormone (GO:0097066),0.001653947,0.072137522,0,0,32.46753247,207.9412629,CTSS;CTSB,0
118,regulation of interleukin-6 production (GO:0032675),0.001792327,0.07751053,0,0,12.45847176,78.7903746,TNFAIP3;TNF;TLR2,0
119,proteolysis involved in cellular protein catabolic process (GO:0051603),0.001929448,0.082739268,0,0,7.598784195,47.49636284,UBC;TNFAIP3;CTSS;CTSB,0
120,cellular response to fluid shear stress (GO:0071498),0.001977488,0.084092669,0,0,29.76190476,185.2954769,MTSS1;NFE2L2,0
121,regulation of mononuclear cell migration (GO:0071675),0.001977488,0.083397688,0,0,29.76190476,185.2954769,CCL5;TNF,0
122,PERK-mediated unfolded protein response (GO:0036499),0.001977488,0.082714101,0,0,29.76190476,185.2954769,ATF3;NFE2L2,0
123,positive regulation of T cell cytokine production (GO:0002726),0.001977488,0.082041628,0,0,29.76190476,185.2954769,B2M;MALT1,0
124,cellular response to fibroblast growth factor stimulus (GO:0044344),0.002005672,0.082539882,0,0,7.518796992,46.70508267,ZFP36;CCL5;UBC;ZFP36L1,0
125,positive regulation of transport (GO:0051050),0.002044212,0.083452915,0,0,11.9047619,73.72312901,APOE;SGK1;TNF,0
126,regulation of cell migration (GO:0030334),0.002061378,0.083485814,0,0,3.943217666,24.38635854,BST2;MMP14;GPNMB;CCL5;CCL3;SGK1;CXCL16,0
127,positive regulation of protein metabolic process (GO:0051247),0.002164325,0.08696495,0,0,7.36377025,45.18149417,NFKBIA;TNFAIP3;APOE;TNF,0
128,mitochondrial respiratory chain complex assembly (GO:0033108),0.002246809,0.089573965,0,0,7.288629738,44.44784397,MT-ND4;MT-ND2;MT-ND3;MT-ND1,0
129,positive regulation of protein phosphorylation (GO:0001934),0.00226851,0.089738033,0,0,3.459010723,21.06064364,CD74;GPNMB;GDF15;AXL;OSM;IQGAP1;CCNL1;TNF,0
130,positive regulation of ion transport (GO:0043270),0.002317069,0.09095388,0,0,11.39817629,69.15788913,CCL5;CCL4;CCL3,0
131,regulation of T cell cytokine production (GO:0002724),0.0023285,0.090704836,0,0,27.47252747,166.553054,B2M;MALT1,0
132,positive regulation of cholesterol efflux (GO:0010875),0.0023285,0.090017678,0,0,27.47252747,166.553054,NFKBIA;APOE,0
133,pattern recognition receptor signaling pathway (GO:0002221),0.002611477,0.100198255,0,0,10.93294461,65.02739719,CTSS;CTSB;TLR2,0
134,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.00270667,0.103075643,0,0,25.51020408,150.817251,ZFP36;ZFP36L1,0
135,positive regulation of response to cytokine stimulus (GO:0060760),0.00270667,0.10231212,0,0,25.51020408,150.817251,CD74;AXL,0
136,regulation of monocyte differentiation (GO:0045655),0.00270667,0.101559825,0,0,25.51020408,150.817251,CD74;ZFP36L1,0
137,negative regulation of smooth muscle cell migration (GO:0014912),0.00270667,0.100818512,0,0,25.51020408,150.817251,TRIB1;AIF1,0
138,negative regulation of viral genome replication (GO:0045071),0.002927988,0.108271906,0,0,10.50420168,61.27562777,BST2;CCL5;TNF,0
139,positive regulation of acute inflammatory response (GO:0002675),0.003111689,0.114237038,0,0,23.80952381,137.4426109,OSM;TNF,0
140,regulation of B cell differentiation (GO:0045577),0.003111689,0.113421059,0,0,23.80952381,137.4426109,MMP14;ZFP36L1,0
141,positive regulation of NF-kappaB import into nucleus (GO:0042346),0.003111689,0.112616654,0,0,23.80952381,137.4426109,TNF;TLR2,0
142,positive regulation of cytokine production involved in immune response (GO:0002720),0.003111689,0.111823579,0,0,23.80952381,137.4426109,B2M;MALT1,0
143,negative regulation of interleukin-2 production (GO:0032703),0.003111689,0.111041596,0,0,23.80952381,137.4426109,ZFP36;TNFAIP3,0
144,cellular response to corticosteroid stimulus (GO:0071384),0.003111689,0.110270474,0,0,23.80952381,137.4426109,ZFP36;ZFP36L1,0
145,viral life cycle (GO:0019058),0.003194099,0.112410263,0,0,6.613756614,38.00562286,AXL;UBC;FURIN;APOE,0
146,positive regulation of proteolysis (GO:0045862),0.003267128,0.114192841,0,0,10.10781671,57.85556531,FURIN;APOE;TNF,0
147,regulation of calcium ion transport (GO:0051924),0.003267128,0.113416019,0,0,10.10781671,57.85556531,CCL5;CCL4;CCL3,0
148,regulation of cytokine production (GO:0001817),0.003301676,0.113840899,0,0,6.553079948,37.4398757,CD83;GPNMB;UBC;TNF,0
149,cellular response to lipid (GO:0071396),0.003368639,0.115370248,0,0,4.988028731,28.39807637,CXCL10;ZFP36;AXL;TNIP3;TNFAIP3,0
150,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),0.003445342,0.117210519,0,0,9.920634921,56.25726432,UBC;PMEPA1;SKIL,0
151,positive regulation of cell motility (GO:2000147),0.003449698,0.116581532,0,0,4.96031746,28.12236336,MMP14;GPNMB;CCL5;CCL3;CXCL16,0
152,negative regulation of NF-kappaB import into nucleus (GO:0042347),0.00354325,0.118955279,0,0,22.32142857,125.953371,NFKBIA;TMSB4X,0
153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.00354325,0.118177794,0,0,22.32142857,125.953371,ZFP36;ZFP36L1,0
154,cytoplasmic sequestering of transcription factor (GO:0042994),0.00354325,0.117410405,0,0,22.32142857,125.953371,NFKBIA;TMSB4X,0
155,positive regulation of lymphocyte differentiation (GO:0045621),0.00354325,0.116652919,0,0,22.32142857,125.953371,MMP14;AXL,0
156,negative regulation of lipid storage (GO:0010888),0.00354325,0.115905144,0,0,22.32142857,125.953371,NFKBIA;TNF,0
157,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.003819356,0.124141238,0,0,9.566326531,53.26218192,UBC;PMEPA1;SKIL,0
158,positive regulation of kinase activity (GO:0033674),0.00387675,0.125209199,0,0,6.26566416,34.79171801,CD74;AXL;IQGAP1;TNF,0
159,positive regulation of cholesterol transport (GO:0032376),0.004001047,0.128410972,0,0,21.00840336,115.9915781,NFKBIA;APOE,0
160,response to interferon-alpha (GO:0035455),0.004001047,0.127608403,0,0,21.00840336,115.9915781,BST2;AXL,0
161,long-term memory (GO:0007616),0.004001047,0.126815805,0,0,21.00840336,115.9915781,APOE;SGK1,0
162,virion assembly (GO:0019068),0.004001047,0.126032991,0,0,21.00840336,115.9915781,UBC;APOE,0
163,positive regulation of cation transmembrane transport (GO:1904064),0.004001047,0.125259783,0,0,21.00840336,115.9915781,TMSB4X;CTSS,0
164,cellular response to glucocorticoid stimulus (GO:0071385),0.004001047,0.124496003,0,0,21.00840336,115.9915781,ZFP36;ZFP36L1,0
165,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.004001047,0.123741482,0,0,21.00840336,115.9915781,PPP1R15A;TNF,0
166,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.004015273,0.123433369,0,0,9.398496241,51.85761166,UBC;TNFAIP3;TNF,0
167,regulation of programmed cell death (GO:0043067),0.004083367,0.124774972,0,0,3.983005842,21.90985179,GDF15;UBC;SGK1;TNF;MALT1;CTSB,0
168,regulation of cholesterol efflux (GO:0010874),0.00448478,0.136225198,0,0,19.84126984,107.2830515,NFKBIA;APOE,0
169,regulation of keratinocyte proliferation (GO:0010837),0.00448478,0.135419132,0,0,19.84126984,107.2830515,ZFP36;ZFP36L1,0
170,positive regulation of p38MAPK cascade (GO:1900745),0.00448478,0.134622549,0,0,19.84126984,107.2830515,GADD45B;GADD45G,0
171,regulation of chemokine production (GO:0032642),0.00448478,0.133835282,0,0,19.84126984,107.2830515,TNF;TLR2,0
172,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.00448478,0.13305717,0,0,19.84126984,107.2830515,LY86;TRIB1,0
173,regulation of smooth muscle cell migration (GO:0014910),0.00448478,0.132288054,0,0,19.84126984,107.2830515,CCL5;TRIB1,0
174,mRNA destabilization (GO:0061157),0.00448478,0.131527778,0,0,19.84126984,107.2830515,ZFP36;ZFP36L1,0
175,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),0.00454892,0.132646506,0,0,2.839475013,15.31290667,ZFP36;JUN;NFIC;UBC;BHLHE40;FOSB;TNF;SKIL;ATF3,0
176,MAPK cascade (GO:0000165),0.004870559,0.141218525,0,0,3.840245776,20.44756778,ZFP36;CCL5;UBC;CCL3;TNF;ZFP36L1,0
177,regulation of acute inflammatory response (GO:0002673),0.00493209,0.142194652,0,0,5.854800937,31.10065878,C1QB;C1QA;OSM;C1QC,0
178,negative regulation of lymphocyte activation (GO:0051250),0.004994149,0.143174944,0,0,18.79699248,99.61444247,GPNMB;TNFAIP3,0
179,negative regulation of viral life cycle (GO:1903901),0.005086139,0.144997575,0,0,8.640552995,45.63280243,BST2;CCL5;TNF,0
180,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.005223194,0.148077546,0,0,5.760368664,30.26869937,NFKBIA;TMSB4X;UBC;TNF,0
181,regulation of T cell proliferation (GO:0042129),0.005318927,0.149958472,0,0,8.503401361,44.52792282,GPNMB;CCL5;AIF1,0
182,regulation of epidermal cell differentiation (GO:0045604),0.005528855,0.1550206,0,0,17.85714286,92.8174011,ZFP36;ZFP36L1,0
183,regulation of viral genome replication (GO:0045069),0.005558033,0.154987114,0,0,8.370535714,43.46409902,BST2;CCL5;TNF,0
184,regulation of MAPK cascade (GO:0043408),0.005844275,0.16208334,0,0,4.3767507,22.50653341,CD74;GDF15;AXL;OSM;TRIB1,0
185,proteolysis (GO:0006508),0.006054355,0.167002013,0,0,3.66927593,18.7389095,MMP14;FURIN;CTSD;CTSS;MALT1;CTSB,0
186,cellular response to reactive oxygen species (GO:0034614),0.00605538,0.166132289,0,0,8.116883117,41.4513644,JUN;TNFAIP3;NFE2L2,0
187,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.006088606,0.166150574,0,0,17.00680272,86.75741657,MT-ATP6;MT-ATP8,0
188,regulation of interleukin-2 production (GO:0032663),0.006088606,0.165266794,0,0,17.00680272,86.75741657,TNFAIP3;MALT1,0
189,positive regulation of T cell mediated immunity (GO:0002711),0.006088606,0.164392367,0,0,17.00680272,86.75741657,B2M;MALT1,0
190,positive regulation of translational initiation (GO:0045948),0.006088606,0.163527144,0,0,17.00680272,86.75741657,PPP1R15A;CCL5,0
191,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),0.006088606,0.162670981,0,0,17.00680272,86.75741657,RGS2;CCL5,0
192,positive regulation of phosphorylation (GO:0042327),0.006461281,0.171728724,0,0,4.272043746,21.53933587,CD74;GPNMB;AXL;CCL5;TNF,0
193,positive regulation of biosynthetic process (GO:0009891),0.006673109,0.176439761,0,0,16.23376623,81.32580281,CCL5;APOE,0
194,negative regulation of myeloid cell differentiation (GO:0045638),0.006673109,0.175530277,0,0,16.23376623,81.32580281,ZFP36;ZFP36L1,0
195,triglyceride catabolic process (GO:0019433),0.006673109,0.174630122,0,0,16.23376623,81.32580281,FABP5;APOE,0
196,cellular response to organic substance (GO:0071310),0.006852001,0.178396737,0,0,5.330490405,26.56297747,JUN;CCL5;CCL3;TNF,0
197,response to organic cyclic compound (GO:0014070),0.00712781,0.1846356,0,0,7.653061224,37.8348312,CCL5;CCL3;TNF,0
198,regulation of interleukin-8 secretion (GO:2000482),0.007282073,0.18767889,0,0,15.52795031,76.4338456,TMSB4X;TLR2,0
199,positive regulation of mRNA catabolic process (GO:0061014),0.007282073,0.18673578,0,0,15.52795031,76.4338456,ZFP36;ZFP36L1,0
200,positive regulation of ion transmembrane transporter activity (GO:0032414),0.007282073,0.185802102,0,0,15.52795031,76.4338456,TMSB4X;CTSS,0
201,positive regulation of monooxygenase activity (GO:0032770),0.007282073,0.184877713,0,0,15.52795031,76.4338456,APOE;TNF,0
202,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),0.007400061,0.186943114,0,0,4.133597884,20.28053528,NFKBIA;UBC;TNF;MALT1;TLR2,0
203,regulation of cell cycle (GO:0051726),0.007400061,0.186022212,0,0,4.133597884,20.28053528,JUN;GADD45B;PIM1;IQGAP1;GADD45G,0
204,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.007412345,0.185417635,0,0,7.54527163,37.00660261,TRIB1;CBFA2T3;NFE2L2,0
205,positive regulation of lymphocyte proliferation (GO:0050671),0.007703527,0.191761448,0,0,7.44047619,36.20593037,CD74;CCL5;AIF1,0
206,positive regulation of apoptotic process (GO:0043065),0.007784441,0.192834968,0,0,3.478664193,16.89110015,JUN;GADD45B;UBC;CCL3;TNF;GADD45G,0
207,cellular response to growth factor stimulus (GO:0071363),0.007974514,0.196589096,0,0,5.102040816,24.65053379,ZFP36;CCL5;IQGAP1;ZFP36L1,0
208,regulation of fat cell differentiation (GO:0045598),0.00800139,0.196303321,0,0,7.338551859,35.43155621,ZFP36;TNF;ZFP36L1,0
209,regulation of epithelial cell proliferation (GO:0050678),0.00800139,0.195364071,0,0,7.338551859,35.43155621,ZFP36;MTSS1;ZFP36L1,0
210,response to lipid (GO:0033993),0.008172624,0.198594761,0,0,5.06585613,24.35139441,CXCL10;JUN;TRIB1;CXCL2,0
211,positive regulation of cell migration (GO:0030335),0.008277288,0.200184834,0,0,4.021879022,19.28185294,MMP14;GPNMB;CCL5;CCL3;CXCL16,0
212,positive regulation of neutrophil chemotaxis (GO:0090023),0.008572242,0.206340339,0,0,14.28571429,67.98894209,CD74;CXCL2,0
213,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.008572242,0.205371605,0,0,14.28571429,67.98894209,TMSB4X;APOE,0
214,regulation of neuronal synaptic plasticity (GO:0048168),0.008572242,0.204411925,0,0,14.28571429,67.98894209,SYNGR1;APOE,0
215,negative regulation of interleukin-6 production (GO:0032715),0.008572242,0.203461172,0,0,14.28571429,67.98894209,TNFAIP3;TNF,0
216,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.008572242,0.202519222,0,0,14.28571429,67.98894209,UBC;TNFAIP3,0
217,negative regulation of endothelial cell apoptotic process (GO:2000352),0.008572242,0.201585954,0,0,14.28571429,67.98894209,TNFAIP3;NFE2L2,0
218,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),0.008617294,0.201715833,0,0,7.142857143,33.95702968,RGS2;CCL5;NMT1,0
219,regulation of cell proliferation (GO:0042127),0.008714386,0.203057136,0,0,2.409870831,11.42948726,CXCL10;JUN;GPNMB;BHLHE40;OSM;SGK1;IER5;CXCL2;CBFA2T3;ZFP36L1,0
220,regulation of defense response (GO:0031347),0.0089354,0.207260669,0,0,7.04887218,33.25470637,TMSB4X;TNFAIP3;APOE,0
221,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.009252879,0.213653583,0,0,13.73626374,64.32445777,UBC;TNFAIP3,0
222,positive regulation of neutrophil migration (GO:1902624),0.009252879,0.21269118,0,0,13.73626374,64.32445777,CD74;CXCL2,0
223,positive regulation of JNK cascade (GO:0046330),0.009260316,0.2119076,0,0,6.957328386,32.57433018,GADD45B;TNF;GADD45G,0
224,extracellular matrix organization (GO:0030198),0.00955592,0.217695791,0,0,3.881987578,18.05354997,MMP14;ITGB5;FURIN;F11R;CTSS,0
225,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.009592072,0.217548196,0,0,6.868131868,31.91496112,UBC;PMEPA1;SKIL,0
226,apoptotic process (GO:0006915),0.009895679,0.223440928,0,0,3.848522167,17.76345861,NFKBIA;PPP1R15A;LY86;HK2;TLR2,0
227,extracellular matrix disassembly (GO:0022617),0.009930695,0.223243782,0,0,6.78119349,31.2757105,MMP14;FURIN;CTSS,0
228,regulation of p38MAPK cascade (GO:1900744),0.009956843,0.222849874,0,0,13.22751323,60.97215872,GADD45B;GADD45G,0
229,positive regulation of granulocyte chemotaxis (GO:0071624),0.009956843,0.22187673,0,0,13.22751323,60.97215872,CD74;CXCL2,0
230,activation of protein kinase activity (GO:0032147),0.010243666,0.227275782,0,0,3.815628816,17.47976066,GADD45B;UBC;TNF;MALT1;GADD45G,0
231,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.010276213,0.22701089,0,0,6.696428571,30.65573745,GPNMB;UBC;ZFP36L1,0
232,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.010276213,0.226032395,0,0,6.696428571,30.65573745,UBC;PMEPA1;SKIL,0
233,ATP synthesis coupled proton transport (GO:0015986),0.010683857,0.233990225,0,0,12.75510204,57.8956807,MT-ATP6;MT-ATP8,0
234,cristae formation (GO:0042407),0.010683857,0.232990267,0,0,12.75510204,57.8956807,MT-ATP6;MT-ATP8,0
235,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),0.010683857,0.231998819,0,0,12.75510204,57.8956807,MT-ATP6;MT-ATP8,0
236,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.010683857,0.231015773,0,0,12.75510204,57.8956807,CCL3;C1QC,0
237,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.011354386,0.244478624,0,0,6.454388985,28.90372941,NFKBIA;TMSB4X;TNFAIP3,0
238,cellular response to hydrogen peroxide (GO:0070301),0.011433645,0.245150798,0,0,12.31527094,55.06397739,TNFAIP3;NFE2L2,0
239,regulation of NIK/NF-kappaB signaling (GO:1901222),0.011433645,0.244125062,0,0,12.31527094,55.06397739,TMSB4X;TNF,0
240,positive regulation of calcium-mediated signaling (GO:0050850),0.011433645,0.243107874,0,0,12.31527094,55.06397739,CCL4;CCL3,0
241,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.011433645,0.242099128,0,0,12.31527094,55.06397739,UBC;TNFAIP3,0
242,protein maturation (GO:0051604),0.01172773,0.247300019,0,0,6.37755102,28.35331112,MMP14;FURIN;CTSS,0
243,regulation of keratinocyte differentiation (GO:0045616),0.012205934,0.256324608,0,0,11.9047619,52.45039373,ZFP36;ZFP36L1,0
244,negative regulation of epithelial cell apoptotic process (GO:1904036),0.012205934,0.255274098,0,0,11.9047619,52.45039373,TNFAIP3;NFE2L2,0
245,negative regulation of Notch signaling pathway (GO:0045746),0.012205934,0.254232163,0,0,11.9047619,52.45039373,MMP14;UBC,0
246,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.012205934,0.253198699,0,0,11.9047619,52.45039373,UBC;TLR2,0
247,amino acid transmembrane transport (GO:0003333),0.012205934,0.252173603,0,0,11.9047619,52.45039373,SLC38A1;SLC38A2,0
248,regulation of neutrophil chemotaxis (GO:0090022),0.012205934,0.251156774,0,0,11.9047619,52.45039373,CD74;CXCL2,0
249,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.012205934,0.250148112,0,0,11.9047619,52.45039373,ATF3;NFE2L2,0
250,acylglycerol catabolic process (GO:0046464),0.013000453,0.265365241,0,0,11.52073733,50.03192508,FABP5;APOE,0
251,regulation of leukocyte chemotaxis (GO:0002688),0.013000453,0.264308009,0,0,11.52073733,50.03192508,CXCL10;CXCL2,0
252,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.013000453,0.263259168,0,0,11.52073733,50.03192508,TNIP3;UBC,0
253,positive regulation of interleukin-1 beta production (GO:0032731),0.013816933,0.278686999,0,0,11.16071429,47.78862039,EGR1;CCL3,0
254,endodermal cell differentiation (GO:0035987),0.014655109,0.294429221,0,0,10.82251082,45.70309798,MMP14;ITGB5,0
255,positive regulation of transcription factor import into nucleus (GO:0042993),0.014655109,0.293274597,0,0,10.82251082,45.70309798,TNF;TLR2,0
256,regulation of erythrocyte differentiation (GO:0045646),0.014655109,0.292128993,0,0,10.82251082,45.70309798,ZFP36;ZFP36L1,0
257,ATP biosynthetic process (GO:0006754),0.014655109,0.290992304,0,0,10.82251082,45.70309798,MT-ATP6;MT-ATP8,0
258,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.014655109,0.289864427,0,0,10.82251082,45.70309798,CCL3;TLR2,0
259,regulation of protein catabolic process (GO:0042176),0.014968528,0.294920456,0,0,5.822981366,24.46703467,TNFAIP3;FURIN;TNF,0
260,positive regulation of programmed cell death (GO:0043068),0.015093743,0.296243728,0,0,3.4606866,14.51230277,JUN;GADD45B;UBC;TNF;GADD45G,0
261,positive regulation of cellular metabolic process (GO:0031325),0.015405638,0.301206786,0,0,5.760368664,24.03814359,NFKBIA;CCL5;APOE,0
262,positive regulation of cell-cell adhesion (GO:0022409),0.015514716,0.30218167,0,0,10.50420168,43.76014984,CCL5;TNF,0
263,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.015514716,0.30103269,0,0,10.50420168,43.76014984,CD74;AXL,0
264,entry into host cell (GO:0030260),0.015514716,0.299892415,0,0,10.50420168,43.76014984,AXL;UBC,0
265,cellular glucose homeostasis (GO:0001678),0.015514716,0.298760745,0,0,10.50420168,43.76014984,TRA2B;HK2,0
266,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.015849909,0.304067994,0,0,5.699088146,23.62039235,UBC;ATF3;NFE2L2,0
267,"negative regulation of transcription, DNA-templated (GO:0045892)",0.016005403,0.305901019,0,0,2.193752194,9.070790016,ZFP36;JUN;NFIC;UBC;BHLHE40;FOSB;TNF;SKIL;CBFA2T3;ATF3,0
268,positive regulation of protein kinase activity (GO:0045860),0.016307597,0.310513694,0,0,4.128819158,16.99473235,EGR1;CCL5;IQGAP1;TNF,0
269,regulation of interleukin-8 production (GO:0032677),0.016395493,0.311026767,0,0,10.20408163,41.94641638,TNF;TLR2,0
270,negative regulation of DNA binding (GO:0043392),0.016395493,0.309874816,0,0,10.20408163,41.94641638,NFKBIA;JUN,0
271,interleukin-1-mediated signaling pathway (GO:0070498),0.016759979,0.315594742,0,0,5.580357143,22.81674894,NFKBIA;EGR1;UBC,0
272,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.017297179,0.32451289,0,0,9.920634921,40.25011743,TNF;MALT1,0
273,regulation of endothelial cell apoptotic process (GO:2000351),0.017297179,0.323324198,0,0,9.920634921,40.25011743,TNFAIP3;NFE2L2,0
274,carboxylic acid transmembrane transport (GO:1905039),0.017297179,0.322144182,0,0,9.920634921,40.25011743,SLC38A1;SLC38A2,0
275,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.017698821,0.328425759,0,0,5.466472303,22.05315552,CD74;CTSD;CTSS,0
276,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.017698821,0.327235811,0,0,5.466472303,22.05315552,CD74;CTSD;CTSS,0
277,positive regulation of MAP kinase activity (GO:0043406),0.017912858,0.32999752,0,0,4.012841091,16.14059596,GADD45B;UBC;TNF;GADD45G,0
278,regulation of angiogenesis (GO:0045765),0.017912858,0.328810479,0,0,4.012841091,16.14059596,GPNMB;STAB1;TNFAIP3;HK2,0
279,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.018179053,0.332500741,0,0,5.411255411,21.68552646,CD74;CTSD;CTSS,0
280,endoderm formation (GO:0001706),0.018219518,0.332050718,0,0,9.652509653,38.66082852,MMP14;ITGB5,0
281,inner mitochondrial membrane organization (GO:0007007),0.018219518,0.330869043,0,0,9.652509653,38.66082852,MT-ATP6;MT-ATP8,0
282,cellular response to metal ion (GO:0071248),0.019161174,0.34673572,0,0,5.304101839,20.97702906,JUN;IQGAP1;B2M,0
283,regulation of osteoclast differentiation (GO:0045670),0.019162254,0.345529976,0,0,9.398496241,37.16929382,CCL3;TNF,0
284,negative regulation of apoptotic process (GO:0043066),0.019557846,0.351421446,0,0,2.572016461,10.11928683,NFKBIA;CD74;AXL;UBC;PIM1;APOE;MALT1,0
285,Fc-epsilon receptor signaling pathway (GO:0038095),0.019613416,0.351183384,0,0,3.903200625,15.34559497,NFKBIA;JUN;UBC;MALT1,0
286,protein processing (GO:0016485),0.019663076,0.350841528,0,0,5.25210084,20.63557099,MMP14;FURIN;CTSS,0
287,positive regulation of macromolecule metabolic process (GO:0010604),0.019879334,0.353464249,0,0,3.223310985,12.62917289,EGR1;CCL3;TNF;NFE2L2;TLR2,0
288,Fc receptor signaling pathway (GO:0038093),0.019965093,0.353756486,0,0,3.881987578,15.19320611,NFKBIA;JUN;UBC;MALT1,0
289,positive regulation of neuron death (GO:1901216),0.020125134,0.355358342,0,0,9.157509158,35.76726903,EGR1;CCL3,0
290,positive regulation of innate immune response (GO:0045089),0.020125134,0.354132968,0,0,9.157509158,35.76726903,CCL5;TLR2,0
291,positive regulation of fat cell differentiation (GO:0045600),0.021107908,0.370150013,0,0,8.928571429,34.44738866,ZFP36;ZFP36L1,0
292,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.021107908,0.368882376,0,0,8.928571429,34.44738866,MT-ATP6;MT-ATP8,0
293,negative regulation of catabolic process (GO:0009895),0.022110326,0.385081885,0,0,8.710801394,33.20305357,TNF;CBFA2T3,0
294,positive regulation of cytokine biosynthetic process (GO:0042108),0.022110326,0.383772083,0,0,8.710801394,33.20305357,EGR1;TNF,0
295,response to cAMP (GO:0051591),0.022110326,0.382471161,0,0,8.710801394,33.20305357,JUN;ZFP36L1,0
296,negative regulation of cytokine secretion (GO:0050710),0.022110326,0.381179028,0,0,8.710801394,33.20305357,TMSB4X;TNF,0
297,protein complex assembly (GO:0006461),0.022156999,0.380697532,0,0,3.759398496,14.32181143,TRA2B;TNFAIP3;TNF;MALT1,0
298,response to endoplasmic reticulum stress (GO:0034976),0.022281154,0.381546075,0,0,5.006675567,19.04546424,PPP1R15A;JUN;ATF3,0
299,positive regulation of cellular component organization (GO:0051130),0.022281154,0.380270001,0,0,5.006675567,19.04546424,PPP1R15A;APOE;TNF,0
300,positive regulation of cellular catabolic process (GO:0031331),0.022281154,0.379002434,0,0,5.006675567,19.04546424,FURIN;APOE;TNF,0
301,negative regulation of response to external stimulus (GO:0032102),0.0228265,0.386988799,0,0,4.96031746,18.74917236,TNFAIP3;APOE;TRIB1,0
302,regulation of response to external stimulus (GO:0032101),0.0228265,0.385707379,0,0,4.96031746,18.74917236,TMSB4X;NMT1;TNFAIP3,0
303,regulation of phagocytosis (GO:0050764),0.023132142,0.389581908,0,0,8.503401361,32.02833521,TNF;TLR2,0
304,regulation of calcium-mediated signaling (GO:0050848),0.023132142,0.388300389,0,0,8.503401361,32.02833521,CCL4;CCL3,0
305,regulation of protein activation cascade (GO:2000257),0.02337909,0.391159008,0,0,4.914809961,18.45959979,C1QB;C1QA;C1QC,0
306,regulation of complement activation (GO:0030449),0.023938925,0.399216774,0,0,4.87012987,18.17653975,C1QB;C1QA;C1QC,0
307,response to hydrogen peroxide (GO:0042542),0.02523299,0.419426547,0,0,8.116883117,29.86690745,TNFAIP3;NFE2L2,0
308,positive regulation of developmental process (GO:0051094),0.026250662,0.434925742,0,0,4.69924812,17.10556424,JUN;DDHD1;TNF,0
309,regulation of humoral immune response (GO:0002920),0.026250662,0.433518215,0,0,4.69924812,17.10556424,C1QB;C1QA;C1QC,0
310,negative regulation of type I interferon production (GO:0032480),0.026311541,0.433121909,0,0,7.936507937,28.87101292,UBC;TNFAIP3,0
311,positive regulation of viral life cycle (GO:1903902),0.026311541,0.431729234,0,0,7.936507937,28.87101292,CD74;CCL5,0
312,positive regulation of interleukin-8 production (GO:0032757),0.026311541,0.430345487,0,0,7.936507937,28.87101292,TNF;TLR2,0
313,regulation of T cell activation (GO:0050863),0.026311541,0.428970581,0,0,7.936507937,28.87101292,GPNMB;CCL5,0
314,regulation of immune effector process (GO:0002697),0.026846679,0.436301291,0,0,4.658385093,16.8522351,C1QB;C1QA;C1QC,0
315,regulation of cell growth (GO:0001558),0.026968103,0.436883265,0,0,3.536067893,12.77616864,BST2;MMP14;SGK1;CXCL16,0
316,negative regulation of programmed cell death (GO:0043069),0.027591339,0.445565201,0,0,2.619629759,9.405134531,NFKBIA;CD74;AXL;UBC;PIM1;MALT1,0
317,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.028060381,0.451710169,0,0,4.578754579,16.36170619,CD74;CCL5;OSM,0
318,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.028523701,0.457724675,0,0,7.598784195,27.02902674,GPNMB;AIF1,0
319,positive regulation of signal transduction (GO:0009967),0.029143449,0.46620382,0,0,3.450655625,12.1998797,CD74;AXL;LY86;TLR2,0
320,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.029302929,0.467290152,0,0,4.50180072,15.89166172,CCNL1;TNF;MALT1,0
321,positive regulation of tumor necrosis factor production (GO:0032760),0.029656841,0.471460618,0,0,7.44047619,26.17605999,CCL3;TLR2,0
322,amino acid transport (GO:0006865),0.03080771,0.488235225,0,0,7.288629738,25.36436083,SLC38A1;SLC38A2,0
323,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.031220708,0.493248529,0,0,4.391100703,15.22251321,NFKBIA;UBC;MALT1,0
324,positive regulation of cell proliferation (GO:0008284),0.032411189,0.510476231,0,0,2.521008403,8.645172019,CD74;CCL5;PIM1;OSM;TNF;AIF1,0
325,"complement activation, classical pathway (GO:0006958)",0.032535094,0.510851029,0,0,4.320276498,14.79883046,C1QB;C1QA;C1QC,0
326,cellular response to lipoteichoic acid (GO:0071223),0.033136987,0.518705652,0,0,29.76190476,101.4019405,TLR2,0
327,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),0.033136987,0.517119396,0,0,29.76190476,101.4019405,CCL3,0
328,regulation of endothelial cell development (GO:1901550),0.033136987,0.515542812,0,0,29.76190476,101.4019405,TNF,0
329,response to heparin (GO:0071503),0.033136987,0.513975813,0,0,29.76190476,101.4019405,EGR1,0
330,response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.033136987,0.51241831,0,0,29.76190476,101.4019405,ZFP36,0
331,negative regulation of transforming growth factor beta production (GO:0071635),0.033136987,0.510870219,0,0,29.76190476,101.4019405,FURIN,0
332,positive regulation of hormone metabolic process (GO:0032352),0.033136987,0.509331453,0,0,29.76190476,101.4019405,EGR1,0
333,regulation of extent of cell growth (GO:0061387),0.033136987,0.507801929,0,0,29.76190476,101.4019405,APOE,0
334,regulation of translational initiation in response to stress (GO:0043558),0.033136987,0.506281564,0,0,29.76190476,101.4019405,PPP1R15A,0
335,cellular response to iron ion (GO:0071281),0.033136987,0.504770276,0,0,29.76190476,101.4019405,B2M,0
336,lipoprotein metabolic process (GO:0042157),0.033136987,0.503267983,0,0,29.76190476,101.4019405,APOE,0
337,positive regulation of cardiac muscle contraction (GO:0060452),0.033136987,0.501774607,0,0,29.76190476,101.4019405,RGS2,0
338,positive regulation of ATP biosynthetic process (GO:2001171),0.033136987,0.500290066,0,0,29.76190476,101.4019405,TMSB4X,0
339,negative regulation of glycolytic process (GO:0045820),0.033136987,0.498814284,0,0,29.76190476,101.4019405,CBFA2T3,0
340,establishment of endothelial intestinal barrier (GO:0090557),0.033136987,0.497347184,0,0,29.76190476,101.4019405,F11R,0
341,regulation of digestive system process (GO:0044058),0.033136987,0.495888687,0,0,29.76190476,101.4019405,SGK1,0
342,response to lipoteichoic acid (GO:0070391),0.033136987,0.494438721,0,0,29.76190476,101.4019405,TLR2,0
343,positive regulation of receptor binding (GO:1900122),0.033136987,0.492997208,0,0,29.76190476,101.4019405,B2M,0
344,negative regulation of bone resorption (GO:0045779),0.033136987,0.491564077,0,0,29.76190476,101.4019405,TNFAIP3,0
345,positive regulation of podosome assembly (GO:0071803),0.033136987,0.490139253,0,0,29.76190476,101.4019405,TNF,0
346,cellular response to bacterial lipopeptide (GO:0071221),0.033136987,0.488722666,0,0,29.76190476,101.4019405,TLR2,0
347,positive regulation of activation of Janus kinase activity (GO:0010536),0.033136987,0.487314243,0,0,29.76190476,101.4019405,CCL5,0
348,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.033136987,0.485913915,0,0,29.76190476,101.4019405,ATF3,0
349,protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.033136987,0.484521612,0,0,29.76190476,101.4019405,TNFAIP3,0
350,positive regulation of phospholipid transport (GO:2001140),0.033136987,0.483137264,0,0,29.76190476,101.4019405,APOE,0
351,negative regulation of phospholipase activity (GO:0010519),0.033136987,0.481760805,0,0,29.76190476,101.4019405,RGS2,0
352,lipoprotein catabolic process (GO:0042159),0.033136987,0.480392166,0,0,29.76190476,101.4019405,APOE,0
353,positive regulation of cGMP biosynthetic process (GO:0030828),0.033136987,0.479031282,0,0,29.76190476,101.4019405,APOE,0
354,positive regulation of fever generation (GO:0031622),0.033136987,0.477678086,0,0,29.76190476,101.4019405,TNF,0
355,negative regulation of coenzyme metabolic process (GO:0051198),0.033136987,0.476332514,0,0,29.76190476,101.4019405,CBFA2T3,0
356,cellular response to cold (GO:0070417),0.033136987,0.474994501,0,0,29.76190476,101.4019405,NFKBIA,0
357,negative regulation of cell cycle phase transition (GO:1901988),0.033136987,0.473663984,0,0,29.76190476,101.4019405,ZFP36L1,0
358,cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.033136987,0.472340901,0,0,29.76190476,101.4019405,ZFP36,0
359,antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.033136987,0.471025188,0,0,29.76190476,101.4019405,B2M,0
360,regulation of NFAT protein import into nucleus (GO:0051532),0.033136987,0.469716784,0,0,29.76190476,101.4019405,TNF,0
361,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.033136987,0.46841563,0,0,29.76190476,101.4019405,CD74,0
362,regulation of cellular protein metabolic process (GO:0032268),0.033161716,0.467470271,0,0,7.00280112,23.85405597,NFKBIA;APOE,0
363,regulation of blood vessel endothelial cell migration (GO:0043535),0.033161716,0.466182475,0,0,7.00280112,23.85405597,TMSB4X;APOE,0
364,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.033203016,0.465480745,0,0,4.285714286,14.59334812,NFKBIA;UBC;MALT1,0
365,humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.033878076,0.473643349,0,0,4.25170068,14.39195236,C1QB;C1QA;C1QC,0
366,protein oligomerization (GO:0051259),0.034287595,0.478059015,0,0,3.276539974,11.05167641,TRA2B;CCL5;TNFAIP3;MALT1,0
367,carboxylic acid transport (GO:0046942),0.034364399,0.477824333,0,0,6.868131868,23.15064665,SLC38A1;SLC38A2,0
368,regulation of DNA binding (GO:0051101),0.035583903,0.493436562,0,0,6.738544474,22.4788539,NFKBIA;JUN,0
369,triglyceride metabolic process (GO:0006641),0.035583903,0.492099336,0,0,6.738544474,22.4788539,FABP5;APOE,0
370,viral process (GO:0016032),0.035776632,0.493427439,0,0,3.232062056,10.76425449,UBC;FURIN;APOE;B2M,0
371,regulation of mRNA stability (GO:0043488),0.035945962,0.494426528,0,0,4.15282392,13.81120655,ZFP36;UBC;ZFP36L1,0
372,regulation of protein processing (GO:0070613),0.035945962,0.493097424,0,0,4.15282392,13.81120655,C1QB;C1QA;C1QC,0
373,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.036820003,0.503733183,0,0,6.613756614,21.83673288,CCL5;OSM,0
374,regulation of vitamin D biosynthetic process (GO:0060556),0.038553028,0.526032361,0,0,25.51020408,83.05409767,TNF,0
375,negative regulation of muscle hypertrophy (GO:0014741),0.038553028,0.524629608,0,0,25.51020408,83.05409767,RGS2,0
376,regulation of hormone biosynthetic process (GO:0046885),0.038553028,0.523234317,0,0,25.51020408,83.05409767,EGR1,0
377,granulocyte migration (GO:0097530),0.038553028,0.521846427,0,0,25.51020408,83.05409767,CCL3,0
378,positive regulation of lipid transport (GO:0032370),0.038553028,0.520465881,0,0,25.51020408,83.05409767,APOE,0
379,regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.038553028,0.51909262,0,0,25.51020408,83.05409767,TNF,0
380,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.038553028,0.517726587,0,0,25.51020408,83.05409767,TNF,0
381,cellular response to interferon-alpha (GO:0035457),0.038553028,0.516367725,0,0,25.51020408,83.05409767,AXL,0
382,regulation of pinocytosis (GO:0048548),0.038553028,0.515015977,0,0,25.51020408,83.05409767,AXL,0
383,regulation of dendritic spine maintenance (GO:1902950),0.038553028,0.513671287,0,0,25.51020408,83.05409767,APOE,0
384,negative regulation of interleukin-8 secretion (GO:2000483),0.038553028,0.512333602,0,0,25.51020408,83.05409767,TMSB4X,0
385,positive regulation of striated muscle contraction (GO:0045989),0.038553028,0.511002865,0,0,25.51020408,83.05409767,RGS2,0
386,cellular response to laminar fluid shear stress (GO:0071499),0.038553028,0.509679023,0,0,25.51020408,83.05409767,NFE2L2,0
387,regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.038553028,0.508362023,0,0,25.51020408,83.05409767,TNFAIP3,0
388,death-inducing signaling complex assembly (GO:0071550),0.038553028,0.507051812,0,0,25.51020408,83.05409767,TNF,0
389,negative regulation of dendritic cell apoptotic process (GO:2000669),0.038553028,0.505748337,0,0,25.51020408,83.05409767,AXL,0
390,release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),0.038553028,0.504451546,0,0,25.51020408,83.05409767,CCL3,0
391,positive regulation of ceramide biosynthetic process (GO:2000304),0.038553028,0.503161389,0,0,25.51020408,83.05409767,TNF,0
392,positive regulation of autophagy of mitochondrion (GO:1903599),0.038553028,0.501877814,0,0,25.51020408,83.05409767,HK2,0
393,epithelial cell differentiation involved in kidney development (GO:0035850),0.038553028,0.500600771,0,0,25.51020408,83.05409767,MTSS1,0
394,regulation of sterol transport (GO:0032371),0.038553028,0.499330211,0,0,25.51020408,83.05409767,APOE,0
395,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.038553028,0.498066084,0,0,25.51020408,83.05409767,CCL5,0
396,regulation of activation of Janus kinase activity (GO:0010533),0.038553028,0.496808341,0,0,25.51020408,83.05409767,CCL5,0
397,regulation of calcidiol 1-monooxygenase activity (GO:0060558),0.038553028,0.495556935,0,0,25.51020408,83.05409767,TNF,0
398,lens fiber cell differentiation (GO:0070306),0.038553028,0.494311817,0,0,25.51020408,83.05409767,MAF,0
399,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.038553028,0.49307294,0,0,25.51020408,83.05409767,TMSB4X,0
400,positive regulation of macrophage chemotaxis (GO:0010759),0.038553028,0.491840258,0,0,25.51020408,83.05409767,CCL5,0
401,positive regulation of B cell differentiation (GO:0045579),0.038553028,0.490613723,0,0,25.51020408,83.05409767,MMP14,0
402,regulation of interleukin-18 production (GO:0032661),0.038553028,0.489393291,0,0,25.51020408,83.05409767,TLR2,0
403,chylomicron remnant clearance (GO:0034382),0.038553028,0.488178916,0,0,25.51020408,83.05409767,APOE,0
404,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.038553028,0.486970552,0,0,25.51020408,83.05409767,NFE2L2,0
405,positive regulation of lymphocyte apoptotic process (GO:0070230),0.038553028,0.485768156,0,0,25.51020408,83.05409767,CCL5,0
406,microglial cell activation (GO:0001774),0.038553028,0.484571682,0,0,25.51020408,83.05409767,AIF1,0
407,positive regulation of macrophage migration (GO:1905523),0.038553028,0.483381089,0,0,25.51020408,83.05409767,CCL5,0
408,regulation of Cdc42 protein signal transduction (GO:0032489),0.038553028,0.482196331,0,0,25.51020408,83.05409767,APOE,0
409,cellular defense response (GO:0006968),0.040625696,0.506877576,0,0,6.26566416,20.07114346,LGALS3BP;CX3CR1,0
410,ATP metabolic process (GO:0046034),0.040625696,0.50564129,0,0,6.26566416,20.07114346,MT-ATP6;MT-ATP8,0
411,positive regulation of cell death (GO:0010942),0.041926002,0.520555688,0,0,6.157635468,19.53109035,EGR1;TNF,0
412,response to cytokine (GO:0034097),0.043297226,0.536276083,0,0,3.854059609,12.10046262,BST2;JUN;CXCL16,0
413,regulation of nitrogen compound metabolic process (GO:0051171),0.043939002,0.542907326,0,0,22.32142857,69.75341365,APOE,0
414,cGMP-mediated signaling (GO:0019934),0.043939002,0.541595956,0,0,22.32142857,69.75341365,APOE,0
415,mRNA cleavage (GO:0006379),0.043939002,0.540290906,0,0,22.32142857,69.75341365,RNASE4,0
416,glomerular visceral epithelial cell development (GO:0072015),0.043939002,0.538992129,0,0,22.32142857,69.75341365,IQGAP1,0
417,negative regulation of lipase activity (GO:0060192),0.043939002,0.537699582,0,0,22.32142857,69.75341365,RGS2,0
418,positive regulation of interleukin-8 biosynthetic process (GO:0045416),0.043939002,0.53641322,0,0,22.32142857,69.75341365,TNF,0
419,regulation of sensory perception (GO:0051931),0.043939002,0.535132997,0,0,22.32142857,69.75341365,CCL3,0
420,positive regulation of steroid biosynthetic process (GO:0010893),0.043939002,0.533858871,0,0,22.32142857,69.75341365,TNF,0
421,glomerular epithelial cell development (GO:0072310),0.043939002,0.532590798,0,0,22.32142857,69.75341365,IQGAP1,0
422,granulocyte differentiation (GO:0030851),0.043939002,0.531328734,0,0,22.32142857,69.75341365,CBFA2T3,0
423,regulation of PERK-mediated unfolded protein response (GO:1903897),0.043939002,0.530072638,0,0,22.32142857,69.75341365,PPP1R15A,0
424,negative regulation of bone remodeling (GO:0046851),0.043939002,0.528822467,0,0,22.32142857,69.75341365,TNFAIP3,0
425,negative regulation of protein complex disassembly (GO:0043242),0.043939002,0.527578178,0,0,22.32142857,69.75341365,TNF,0
426,regulation of ATP biosynthetic process (GO:2001169),0.043939002,0.526339732,0,0,22.32142857,69.75341365,TMSB4X,0
427,regulation of amyloid fibril formation (GO:1905906),0.043939002,0.525107086,0,0,22.32142857,69.75341365,APOE,0
428,positive regulation of cAMP-mediated signaling (GO:0043950),0.043939002,0.5238802,0,0,22.32142857,69.75341365,CXCL10,0
429,positive regulation of viral entry into host cell (GO:0046598),0.043939002,0.522659035,0,0,22.32142857,69.75341365,CD74,0
430,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.043939002,0.521443548,0,0,22.32142857,69.75341365,TNFAIP3,0
431,immunoglobulin mediated immune response (GO:0016064),0.043939002,0.520233703,0,0,22.32142857,69.75341365,CD74,0
432,positive regulation of protein localization to cell surface (GO:2000010),0.043939002,0.519029458,0,0,22.32142857,69.75341365,TNF,0
433,regulation of receptor binding (GO:1900120),0.043939002,0.517830776,0,0,22.32142857,69.75341365,B2M,0
434,B cell mediated immunity (GO:0019724),0.043939002,0.516637617,0,0,22.32142857,69.75341365,CD74,0
435,regulation of protein metabolic process (GO:0051246),0.044572944,0.522886747,0,0,5.952380952,18.51564425,FURIN;APOE,0
436,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.044572944,0.521687465,0,0,5.952380952,18.51564425,GDF15;PMEPA1,0
437,response to reactive oxygen species (GO:0000302),0.045919161,0.536213908,0,0,5.854800937,18.03789696,JUN;APOE,0
438,positive regulation of protein binding (GO:0032092),0.045919161,0.534989676,0,0,5.854800937,18.03789696,APOE;B2M,0
439,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.047280264,0.549592679,0,0,5.760368664,17.57870003,CCL5;OSM,0
440,negative regulation of MAP kinase activity (GO:0043407),0.047280264,0.548343605,0,0,5.760368664,17.57870003,RGS2;APOE,0
441,positive regulation of T cell proliferation (GO:0042102),0.047280264,0.547100196,0,0,5.760368664,17.57870003,CCL5;AIF1,0
442,positive regulation of catabolic process (GO:0009896),0.048656048,0.561746178,0,0,5.66893424,17.13707013,TNFAIP3;TNF,0
443,diterpenoid metabolic process (GO:0016101),0.048656048,0.560478128,0,0,5.66893424,17.13707013,APOE;DHRS3,0
444,second-messenger-mediated signaling (GO:0019932),0.048656048,0.55921579,0,0,5.66893424,17.13707013,CCL3;APOE,0
445,cellular protein catabolic process (GO:0044257),0.048656048,0.557959125,0,0,5.66893424,17.13707013,CTSS;CTSB,0
446,very-low-density lipoprotein particle remodeling (GO:0034372),0.049295072,0.564019627,0,0,19.84126984,59.72085631,APOE,0
447,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.049295072,0.562757838,0,0,19.84126984,59.72085631,TMSB4X,0
448,negative regulation of phagocytosis (GO:0050765),0.049295072,0.561501682,0,0,19.84126984,59.72085631,TLR2,0
449,negative regulation of alcohol biosynthetic process (GO:1902931),0.049295072,0.560251121,0,0,19.84126984,59.72085631,APOE,0
450,regulation of macrophage cytokine production (GO:0010935),0.049295072,0.559006119,0,0,19.84126984,59.72085631,CD74,0
451,negative regulation of response to reactive oxygen species (GO:1901032),0.049295072,0.557766637,0,0,19.84126984,59.72085631,NFE2L2,0
452,basement membrane organization (GO:0071711),0.049295072,0.55653264,0,0,19.84126984,59.72085631,CTSS,0
453,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.049295072,0.555304092,0,0,19.84126984,59.72085631,TNFAIP3,0
454,negative regulation of lymphocyte apoptotic process (GO:0070229),0.049295072,0.554080955,0,0,19.84126984,59.72085631,CCL5,0
455,sarcoplasmic reticulum calcium ion transport (GO:0070296),0.049295072,0.552863194,0,0,19.84126984,59.72085631,CCL3,0
456,negative regulation of T cell apoptotic process (GO:0070233),0.049295072,0.551650775,0,0,19.84126984,59.72085631,CCL5,0
457,sterol catabolic process (GO:0016127),0.049295072,0.550443662,0,0,19.84126984,59.72085631,APOE,0
458,regulation of leukocyte activation (GO:0002694),0.049295072,0.54924182,0,0,19.84126984,59.72085631,CD74,0
459,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.049295072,0.548045215,0,0,19.84126984,59.72085631,NFE2L2,0
460,regulation of morphogenesis of an epithelium (GO:1905330),0.049295072,0.546853812,0,0,19.84126984,59.72085631,CXCL10,0
461,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.049295072,0.545667578,0,0,19.84126984,59.72085631,TLR2,0
462,positive regulation of cholesterol esterification (GO:0010873),0.049295072,0.544486479,0,0,19.84126984,59.72085631,APOE,0
463,cholesterol catabolic process (GO:0006707),0.049295072,0.543310483,0,0,19.84126984,59.72085631,APOE,0
464,granulocyte activation (GO:0036230),0.049295072,0.542139555,0,0,19.84126984,59.72085631,CCL5,0
465,B cell homeostasis (GO:0001782),0.049295072,0.540973663,0,0,19.84126984,59.72085631,TNFAIP3,0
466,ATP synthesis coupled electron transport (GO:0042773),0.049295072,0.539812776,0,0,19.84126984,59.72085631,MT-CO2,0
467,chylomicron remodeling (GO:0034371),0.049295072,0.53865686,0,0,19.84126984,59.72085631,APOE,0
468,regulation of homotypic cell-cell adhesion (GO:0034110),0.049295072,0.537505884,0,0,19.84126984,59.72085631,CCL5,0
469,regulation of sensory perception of pain (GO:0051930),0.049295072,0.536359816,0,0,19.84126984,59.72085631,CCL3,0
470,negative regulation of amyloid-beta formation (GO:1902430),0.049295072,0.535218624,0,0,19.84126984,59.72085631,APOE,0
471,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.049295072,0.534082279,0,0,19.84126984,59.72085631,B2M,0
472,positive regulation of T cell chemotaxis (GO:0010820),0.049295072,0.532950749,0,0,19.84126984,59.72085631,CCL5,0
473,fatty acid homeostasis (GO:0055089),0.049295072,0.531824003,0,0,19.84126984,59.72085631,APOE,0
474,positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),0.049295072,0.530702012,0,0,19.84126984,59.72085631,CCNL1,0
475,regulation of cytokine secretion involved in immune response (GO:0002739),0.049295072,0.529584744,0,0,19.84126984,59.72085631,TNF,0
476,iron ion homeostasis (GO:0055072),0.050046308,0.536525863,0,0,5.580357143,16.71209005,UBC;B2M,0
477,regulation of protein kinase activity (GO:0045859),0.05050547,0.54031323,0,0,3.61969112,10.80721637,IQGAP1;TRIB1;TNF,0
478,regulated exocytosis (GO:0045055),0.051340351,0.54809584,0,0,3.595397891,10.67573681,LGALS3BP;SYNGR1;TMSB4X,0
479,positive regulation of JAK-STAT cascade (GO:0046427),0.051450844,0.548128719,0,0,5.494505495,16.30290338,CCL5;OSM,0
480,positive regulation of cell adhesion (GO:0045785),0.051450844,0.546986784,0,0,5.494505495,16.30290338,CCL5;TNF,0
481,cellular response to type I interferon (GO:0071357),0.052869454,0.560899844,0,0,5.411255411,15.90870958,BST2;EGR1,0
482,type I interferon signaling pathway (GO:0060337),0.052869454,0.559736152,0,0,5.411255411,15.90870958,BST2;EGR1,0
483,negative regulation of cell differentiation (GO:0045596),0.053030228,0.560275888,0,0,3.547776727,10.4194413,NFKBIA;TNF;SKIL,0
484,negative regulation of epithelial cell proliferation (GO:0050680),0.054301941,0.572526455,0,0,5.330490405,15.52875965,APOE;MTSS1,0
485,JNK cascade (GO:0007254),0.054301941,0.571345988,0,0,5.330490405,15.52875965,UBC;TRIB1,0
486,negative regulation of cellular protein catabolic process (GO:1903363),0.054621404,0.573524742,0,0,17.85714286,51.91659746,FURIN,0
487,positive regulation of calcium ion import (GO:0090280),0.054621404,0.572347073,0,0,17.85714286,51.91659746,CCL3,0
488,cytochrome complex assembly (GO:0017004),0.054621404,0.571174231,0,0,17.85714286,51.91659746,MT-CO3,0
489,regulation of cellular respiration (GO:0043457),0.054621404,0.570006186,0,0,17.85714286,51.91659746,CBFA2T3,0
490,neuron projection regeneration (GO:0031102),0.054621404,0.568842908,0,0,17.85714286,51.91659746,APOE,0
491,positive regulation of steroid metabolic process (GO:0045940),0.054621404,0.567684368,0,0,17.85714286,51.91659746,APOE,0
492,regulation of podosome assembly (GO:0071801),0.054621404,0.566530538,0,0,17.85714286,51.91659746,TNF,0
493,protein K11-linked deubiquitination (GO:0035871),0.054621404,0.565381389,0,0,17.85714286,51.91659746,TNFAIP3,0
494,positive regulation of alcohol biosynthetic process (GO:1902932),0.054621404,0.564236892,0,0,17.85714286,51.91659746,TNF,0
495,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.054621404,0.56309702,0,0,17.85714286,51.91659746,JUN,0
496,response to acidic pH (GO:0010447),0.054621404,0.561961743,0,0,17.85714286,51.91659746,CTSS,0
497,contractile actin filament bundle assembly (GO:0030038),0.054621404,0.560831036,0,0,17.85714286,51.91659746,ITGB5,0
498,regulation of phospholipase activity (GO:0010517),0.054621404,0.559704869,0,0,17.85714286,51.91659746,RGS2,0
499,response to laminar fluid shear stress (GO:0034616),0.054621404,0.558583216,0,0,17.85714286,51.91659746,NFE2L2,0
500,regulation of amyloid-beta clearance (GO:1900221),0.054621404,0.55746605,0,0,17.85714286,51.91659746,APOE,0
501,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.054621404,0.556353343,0,0,17.85714286,51.91659746,JUN,0
502,stress fiber assembly (GO:0043149),0.054621404,0.555245069,0,0,17.85714286,51.91659746,ITGB5,0
503,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.054621404,0.554141202,0,0,17.85714286,51.91659746,PMEPA1,0
504,regulation of mRNA 3'-end processing (GO:0031440),0.054621404,0.553041716,0,0,17.85714286,51.91659746,ZFP36L1,0
505,chylomicron assembly (GO:0034378),0.054621404,0.551946584,0,0,17.85714286,51.91659746,APOE,0
506,regulation of granulocyte differentiation (GO:0030852),0.054621404,0.55085578,0,0,17.85714286,51.91659746,C1QC,0
507,positive regulation of natural killer cell activation (GO:0032816),0.054621404,0.54976928,0,0,17.85714286,51.91659746,AXL,0
508,positive regulation of T cell apoptotic process (GO:0070234),0.054621404,0.548687057,0,0,17.85714286,51.91659746,CCL5,0
509,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.054621404,0.547609086,0,0,17.85714286,51.91659746,PPP1R15A,0
510,negative regulation of cell activation (GO:0050866),0.054621404,0.546535343,0,0,17.85714286,51.91659746,APOE,0
511,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.054621404,0.545465802,0,0,17.85714286,51.91659746,TRA2B,0
512,sequestering of actin monomers (GO:0042989),0.054621404,0.544400439,0,0,17.85714286,51.91659746,TMSB4X,0
513,regulation of dendritic cell apoptotic process (GO:2000668),0.054621404,0.54333923,0,0,17.85714286,51.91659746,AXL,0
514,negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),0.054621404,0.542282149,0,0,17.85714286,51.91659746,TRIB1,0
515,regulation of T cell apoptotic process (GO:0070232),0.054621404,0.541229174,0,0,17.85714286,51.91659746,CCL5,0
516,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.055748107,0.551322848,0,0,5.25210084,15.16235203,RGS2;APOE,0
517,protein deubiquitination (GO:0016579),0.057191196,0.564500336,0,0,2.76854928,7.921803177,NFKBIA;TNIP3;UBC;TNFAIP3,0
518,positive regulation of T cell activation (GO:0050870),0.057207757,0.563573718,0,0,5.175983437,14.80882904,CCL5;AIF1,0
519,regulation of innate immune response (GO:0045088),0.058680699,0.576970342,0,0,5.102040816,14.46757353,CCL5;TNFAIP3,0
520,regulation of protein phosphorylation (GO:0001932),0.059842504,0.587262113,0,0,2.726281352,7.677314881,CD74;GPNMB;GDF15;TNF,0
521,protein modification by small protein removal (GO:0070646),0.059842504,0.586134931,0,0,2.726281352,7.677314881,NFKBIA;TNIP3;UBC;TNFAIP3,0
522,positive regulation of posttranscriptional gene silencing (GO:0060148),0.059918161,0.585751674,0,0,16.23376623,45.69440968,ZFP36,0
523,negative regulation of morphogenesis of an epithelium (GO:1905331),0.059918161,0.58463169,0,0,16.23376623,45.69440968,TNF,0
524,regulation of cholesterol esterification (GO:0010872),0.059918161,0.583515981,0,0,16.23376623,45.69440968,APOE,0
525,positive regulation by host of viral process (GO:0044794),0.059918161,0.582404522,0,0,16.23376623,45.69440968,APOE,0
526,protein localization to mitochondrion (GO:0070585),0.059918161,0.581297289,0,0,16.23376623,45.69440968,HK2,0
527,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.059918161,0.580194258,0,0,16.23376623,45.69440968,CD74,0
528,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.059918161,0.579095405,0,0,16.23376623,45.69440968,NFE2L2,0
529,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.059918161,0.578000707,0,0,16.23376623,45.69440968,GPNMB,0
530,negative regulation of bone mineralization (GO:0030502),0.059918161,0.57691014,0,0,16.23376623,45.69440968,CCL3,0
531,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.059918161,0.57582368,0,0,16.23376623,45.69440968,ZFP36,0
532,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.059918161,0.574741304,0,0,16.23376623,45.69440968,RGS2,0
533,T cell differentiation in thymus (GO:0033077),0.059918161,0.573662991,0,0,16.23376623,45.69440968,ZFP36L1,0
534,negative regulation of chemotaxis (GO:0050922),0.059918161,0.572588715,0,0,16.23376623,45.69440968,AIF1,0
535,I-kappaB phosphorylation (GO:0007252),0.059918161,0.571518456,0,0,16.23376623,45.69440968,TLR2,0
536,modulation by host of viral process (GO:0044788),0.059918161,0.57045219,0,0,16.23376623,45.69440968,APOE,0
537,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.059918161,0.569389896,0,0,16.23376623,45.69440968,ATF3,0
538,relaxation of cardiac muscle (GO:0055119),0.059918161,0.56833155,0,0,16.23376623,45.69440968,RGS2,0
539,epithelial cell-cell adhesion (GO:0090136),0.059918161,0.567277132,0,0,16.23376623,45.69440968,ITGB5,0
540,oxidative phosphorylation (GO:0006119),0.059918161,0.566226618,0,0,16.23376623,45.69440968,MT-CO2,0
541,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.059918161,0.565179989,0,0,16.23376623,45.69440968,ZFP36,0
542,negative regulation of peptide secretion (GO:0002792),0.059918161,0.564137221,0,0,16.23376623,45.69440968,CD74,0
543,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.059918161,0.563098295,0,0,16.23376623,45.69440968,APOE,0
544,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),0.059918161,0.562063187,0,0,16.23376623,45.69440968,CCNL1,0
545,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.059918161,0.561031879,0,0,16.23376623,45.69440968,SYNGR1,0
546,regulation of ceramide biosynthetic process (GO:2000303),0.059918161,0.560004348,0,0,16.23376623,45.69440968,TNF,0
547,miRNA mediated inhibition of translation (GO:0035278),0.059918161,0.558980574,0,0,16.23376623,45.69440968,ZFP36,0
548,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.059918161,0.557960536,0,0,16.23376623,45.69440968,ZFP36,0
549,response to corticosteroid (GO:0031960),0.059918161,0.556944215,0,0,16.23376623,45.69440968,TNF,0
550,alcohol catabolic process (GO:0046164),0.059918161,0.555931589,0,0,16.23376623,45.69440968,APOE,0
551,response to sterol (GO:0036314),0.059918161,0.554922639,0,0,16.23376623,45.69440968,CCL3,0
552,relaxation of muscle (GO:0090075),0.059918161,0.553917344,0,0,16.23376623,45.69440968,RGS2,0
553,negative regulation of receptor binding (GO:1900121),0.059918161,0.552915685,0,0,16.23376623,45.69440968,B2M,0
554,regulation of Notch signaling pathway (GO:0008593),0.06016674,0.554207358,0,0,5.030181087,14.13800586,MMP14;UBC,0
555,positive regulation of cellular biosynthetic process (GO:0031328),0.060961777,0.560518825,0,0,3.348214286,9.366656979,EGR1;CCL5;TNF,0
556,endocytosis (GO:0006897),0.061192452,0.56162785,0,0,2.705627706,7.558797143,AXL;STAB1;APOE;CXCL16,0
557,actomyosin structure organization (GO:0031032),0.061665691,0.564955158,0,0,4.96031746,13.81958114,ITGB5;F11R,0
558,positive regulation of growth (GO:0045927),0.061665691,0.563942694,0,0,4.96031746,13.81958114,MMP14;CXCL16,0
559,negative regulation of intracellular signal transduction (GO:1902532),0.062795826,0.573250625,0,0,3.306878307,9.152998264,TMSB4X;TNIP3;TNFAIP3,0
560,positive regulation of protein modification process (GO:0031401),0.064655408,0.589172409,0,0,3.266550523,8.946048088,CD74;GPNMB;TNF,0
561,T cell receptor signaling pathway (GO:0050852),0.064655408,0.58812219,0,0,3.266550523,8.946048088,NFKBIA;UBC;MALT1,0
562,regulation of peptide hormone secretion (GO:0090276),0.064701571,0.587494872,0,0,4.826254826,13.21413993,CCL5;TNF,0
563,positive regulation of cytokine secretion (GO:0050715),0.064701571,0.586451364,0,0,4.826254826,13.21413993,TNF;TLR2,0
564,positive regulation of proteasomal protein catabolic process (GO:1901800),0.064701571,0.585411557,0,0,4.826254826,13.21413993,TRIB1;CBFA2T3,0
565,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.065185505,0.58874625,0,0,14.88095238,40.63271062,TNF,0
566,regulation of leukocyte cell-cell adhesion (GO:1903037),0.065185505,0.587706062,0,0,14.88095238,40.63271062,CCL5,0
567,retinol metabolic process (GO:0042572),0.065185505,0.586669543,0,0,14.88095238,40.63271062,DHRS3,0
568,positive regulation of establishment of protein localization (GO:1904951),0.065185505,0.585636674,0,0,14.88095238,40.63271062,TNF,0
569,modification-dependent macromolecule catabolic process (GO:0043632),0.065185505,0.584607436,0,0,14.88095238,40.63271062,UBC,0
570,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.065185505,0.583581809,0,0,14.88095238,40.63271062,CD74,0
571,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.065185505,0.582559774,0,0,14.88095238,40.63271062,SYNGR1,0
572,entry of bacterium into host cell (GO:0035635),0.065185505,0.581541313,0,0,14.88095238,40.63271062,UBC,0
573,cellular response to arsenic-containing substance (GO:0071243),0.065185505,0.580526407,0,0,14.88095238,40.63271062,ATF3,0
574,negative regulation of ATP metabolic process (GO:1903579),0.065185505,0.579515037,0,0,14.88095238,40.63271062,CBFA2T3,0
575,phospholipid efflux (GO:0033700),0.065185505,0.578507184,0,0,14.88095238,40.63271062,APOE,0
576,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.065185505,0.577502832,0,0,14.88095238,40.63271062,CD74,0
577,regulation of hormone secretion (GO:0046883),0.065185505,0.57650196,0,0,14.88095238,40.63271062,OSM,0
578,regulation of interleukin-2 biosynthetic process (GO:0045076),0.065185505,0.575504552,0,0,14.88095238,40.63271062,ZFP36,0
579,keratan sulfate catabolic process (GO:0042340),0.065185505,0.574510589,0,0,14.88095238,40.63271062,HEXB,0
580,regulation of interleukin-8 biosynthetic process (GO:0045414),0.065185505,0.573520053,0,0,14.88095238,40.63271062,TNF,0
581,negative regulation of leukocyte apoptotic process (GO:2000107),0.065185505,0.572532928,0,0,14.88095238,40.63271062,AXL,0
582,regulation of catabolic process (GO:0009894),0.065185505,0.571549194,0,0,14.88095238,40.63271062,FURIN,0
583,regulation of establishment of endothelial barrier (GO:1903140),0.065185505,0.570568835,0,0,14.88095238,40.63271062,TNF,0
584,nitrogen compound transport (GO:0071705),0.066238129,0.578789676,0,0,4.761904762,12.92618581,SLC38A1;SLC38A2,0
585,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.067786853,0.591309934,0,0,4.69924812,12.64749535,ITGB5;B2M,0
586,retinoid metabolic process (GO:0001523),0.067786853,0.590300872,0,0,4.69924812,12.64749535,APOE;DHRS3,0
587,purine ribonucleotide biosynthetic process (GO:0009152),0.067786853,0.589295249,0,0,4.69924812,12.64749535,MT-ATP6;MT-ATP8,0
588,regulation of actin cytoskeleton organization (GO:0032956),0.067786853,0.588293046,0,0,4.69924812,12.64749535,BST2;F11R,0
589,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.069347563,0.60081598,0,0,4.638218924,12.37766363,TNFAIP3;TNF,0
590,response to iron ion (GO:0010039),0.070423598,0.609104443,0,0,13.73626374,36.44542405,B2M,0
591,protein localization to endoplasmic reticulum (GO:0070972),0.070423598,0.608073809,0,0,13.73626374,36.44542405,PPP1R15A,0
592,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.070423598,0.607046658,0,0,13.73626374,36.44542405,NFKBIA,0
593,regulation of endothelial cell chemotaxis (GO:2001026),0.070423598,0.60602297,0,0,13.73626374,36.44542405,TMSB4X,0
594,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.070423598,0.60500273,0,0,13.73626374,36.44542405,TLR2,0
595,regulation of necrotic cell death (GO:0010939),0.070423598,0.603985918,0,0,13.73626374,36.44542405,UBC,0
596,regulation of granulocyte chemotaxis (GO:0071622),0.070423598,0.602972519,0,0,13.73626374,36.44542405,CCL5,0
597,negative regulation of hemostasis (GO:1900047),0.070423598,0.601962515,0,0,13.73626374,36.44542405,APOE,0
598,prostanoid biosynthetic process (GO:0046457),0.070423598,0.600955889,0,0,13.73626374,36.44542405,CD74,0
599,regulation of lymphocyte activation (GO:0051249),0.070423598,0.599952623,0,0,13.73626374,36.44542405,CCL5,0
600,intestinal absorption (GO:0050892),0.070423598,0.598952702,0,0,13.73626374,36.44542405,F11R,0
601,negative regulation of hormone secretion (GO:0046888),0.070423598,0.597956109,0,0,13.73626374,36.44542405,OSM,0
602,positive regulation of ERAD pathway (GO:1904294),0.070423598,0.596962826,0,0,13.73626374,36.44542405,NFE2L2,0
603,triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.070423598,0.595972838,0,0,13.73626374,36.44542405,APOE,0
604,renal absorption (GO:0070293),0.070423598,0.594986128,0,0,13.73626374,36.44542405,SGK1,0
605,chondroitin sulfate catabolic process (GO:0030207),0.070423598,0.59400268,0,0,13.73626374,36.44542405,HEXB,0
606,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.070423598,0.593022477,0,0,13.73626374,36.44542405,DHRS3,0
607,positive regulation of endothelial cell chemotaxis (GO:2001028),0.070423598,0.592045505,0,0,13.73626374,36.44542405,TMSB4X,0
608,positive regulation of protein complex disassembly (GO:0043243),0.070423598,0.591071746,0,0,13.73626374,36.44542405,TNF,0
609,glomerular visceral epithelial cell differentiation (GO:0072112),0.070423598,0.590101184,0,0,13.73626374,36.44542405,IQGAP1,0
610,regulation of macrophage differentiation (GO:0045649),0.070423598,0.589133805,0,0,13.73626374,36.44542405,C1QC,0
611,regulation of cAMP metabolic process (GO:0030814),0.070423598,0.588169593,0,0,13.73626374,36.44542405,CXCL10,0
612,high-density lipoprotein particle assembly (GO:0034380),0.070423598,0.587208532,0,0,13.73626374,36.44542405,APOE,0
613,amyloid precursor protein metabolic process (GO:0042982),0.070423598,0.586250606,0,0,13.73626374,36.44542405,APOE,0
614,leukocyte differentiation (GO:0002521),0.070423598,0.5852958,0,0,13.73626374,36.44542405,AXL,0
615,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.072504219,0.601608179,0,0,4.52079566,11.86306747,ITGB5;B2M,0
616,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.072504219,0.600631542,0,0,4.52079566,11.86306747,UBC;NFE2L2,0
617,negative regulation of cell communication (GO:0010648),0.072504219,0.599658071,0,0,4.52079566,11.86306747,AXL;OSM,0
618,negative regulation of inflammatory response (GO:0050728),0.072504219,0.598687751,0,0,4.52079566,11.86306747,TNFAIP3;APOE,0
619,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.074099811,0.610874531,0,0,4.464285714,11.61759955,HSPE1;TNF,0
620,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.075632602,0.622505107,0,0,12.75510204,32.93198788,NFE2L2,0
621,cellular response to osmotic stress (GO:0071470),0.075632602,0.621502683,0,0,12.75510204,32.93198788,ZFP36L1,0
622,neutrophil activation (GO:0042119),0.075632602,0.620503483,0,0,12.75510204,32.93198788,CCL5,0
623,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.075632602,0.61950749,0,0,12.75510204,32.93198788,PIM1,0
624,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.075632602,0.618514689,0,0,12.75510204,32.93198788,CCL5,0
625,positive regulation of osteoclast differentiation (GO:0045672),0.075632602,0.617525066,0,0,12.75510204,32.93198788,TNF,0
626,regulation of lipase activity (GO:0060191),0.075632602,0.616538604,0,0,12.75510204,32.93198788,FURIN,0
627,positive regulation of vascular smooth muscle cell proliferation (GO:1904707),0.075632602,0.615555289,0,0,12.75510204,32.93198788,JUN,0
628,fatty acid transport (GO:0015908),0.075632602,0.614575105,0,0,12.75510204,32.93198788,APOE,0
629,regulation of secretion (GO:0051046),0.075632602,0.613598039,0,0,12.75510204,32.93198788,SGK1,0
630,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.075632602,0.612624073,0,0,12.75510204,32.93198788,CD74,0
631,positive regulation of purine nucleotide metabolic process (GO:1900544),0.075632602,0.611653195,0,0,12.75510204,32.93198788,CXCL10,0
632,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.075632602,0.61068539,0,0,12.75510204,32.93198788,EGR1,0
633,negative regulation of secretion (GO:0051048),0.075632602,0.609720642,0,0,12.75510204,32.93198788,CD74,0
634,positive regulation of transporter activity (GO:0032411),0.075632602,0.608758937,0,0,12.75510204,32.93198788,SGK1,0
635,regulation of lymphocyte differentiation (GO:0045619),0.075632602,0.607800262,0,0,12.75510204,32.93198788,ZFP36L1,0
636,positive regulation of mitochondrial fission (GO:0090141),0.075632602,0.606844601,0,0,12.75510204,32.93198788,DDHD1,0
637,regulation of defense response to virus (GO:0050688),0.075632602,0.605891941,0,0,12.75510204,32.93198788,TNFAIP3,0
638,negative regulation of biomineral tissue development (GO:0070168),0.075632602,0.604942267,0,0,12.75510204,32.93198788,CCL3,0
639,positive regulation of interleukin-8 secretion (GO:2000484),0.075632602,0.603995565,0,0,12.75510204,32.93198788,TLR2,0
640,RNA transport (GO:0050658),0.075706677,0.603642461,0,0,4.409171076,11.37958074,ZFP36;ZFP36L1,0
641,positive regulation of stress-activated MAPK cascade (GO:0032874),0.075706677,0.602700741,0,0,4.409171076,11.37958074,GADD45B;GADD45G,0
642,ERBB signaling pathway (GO:0038127),0.075706677,0.601761955,0,0,4.409171076,11.37958074,UBC;IQGAP1,0
643,NIK/NF-kappaB signaling (GO:0038061),0.075706677,0.600826089,0,0,4.409171076,11.37958074,UBC;MALT1,0
644,negative regulation of MAPK cascade (GO:0043409),0.075706677,0.599893129,0,0,4.409171076,11.37958074,RGS2;APOE,0
645,negative regulation of defense response (GO:0031348),0.075706677,0.598963062,0,0,4.409171076,11.37958074,TNFAIP3;APOE,0
646,positive regulation of binding (GO:0051099),0.077324645,0.610816819,0,0,4.355400697,11.14870447,APOE;B2M,0
647,protein catabolic process (GO:0030163),0.077324645,0.609872744,0,0,4.355400697,11.14870447,APOE;CTSD,0
648,negative regulation of cell death (GO:0060548),0.077324645,0.608931582,0,0,4.355400697,11.14870447,GPNMB;APOE,0
649,regulation of anatomical structure morphogenesis (GO:0022603),0.078953542,0.62080112,0,0,4.30292599,10.92468016,GPNMB;TNFAIP3,0
650,negative regulation of binding (GO:0051100),0.078953542,0.619846042,0,0,4.30292599,10.92468016,NFKBIA;JUN,0
651,negative regulation of cellular process (GO:0048523),0.08020966,0.628740237,0,0,2.002670227,5.052959929,BST2;GPNMB;BHLHE40;OSM;SKIL;CBFA2T3,0
652,negative regulation of signaling (GO:0023057),0.080593198,0.630777746,0,0,4.25170068,10.70723224,AXL;OSM,0
653,negative regulation of neuron death (GO:1901215),0.080593198,0.629811777,0,0,4.25170068,10.70723224,GPNMB;APOE,0
654,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.080593198,0.628848762,0,0,4.25170068,10.70723224,OSM;TNF,0
655,response to cholesterol (GO:0070723),0.080812675,0.629598599,0,0,11.9047619,29.94787444,CCL3,0
656,myeloid cell development (GO:0061515),0.080812675,0.628638845,0,0,11.9047619,29.94787444,TLR2,0
657,regulation of protein homooligomerization (GO:0032462),0.080812675,0.627682013,0,0,11.9047619,29.94787444,APOE,0
658,regulation of macrophage chemotaxis (GO:0010758),0.080812675,0.626728089,0,0,11.9047619,29.94787444,CCL5,0
659,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.080812675,0.62577706,0,0,11.9047619,29.94787444,CD74,0
660,negative regulation of platelet activation (GO:0010544),0.080812675,0.624828913,0,0,11.9047619,29.94787444,APOE,0
661,negative regulation of cytokine production involved in immune response (GO:0002719),0.080812675,0.623883634,0,0,11.9047619,29.94787444,TNF,0
662,negative regulation of coagulation (GO:0050819),0.080812675,0.622941212,0,0,11.9047619,29.94787444,APOE,0
663,regulation of protein complex disassembly (GO:0043244),0.080812675,0.622001632,0,0,11.9047619,29.94787444,TNF,0
664,toll-like receptor 4 signaling pathway (GO:0034142),0.080812675,0.621064883,0,0,11.9047619,29.94787444,TNIP3,0
665,cytoplasmic sequestering of protein (GO:0051220),0.080812675,0.620130951,0,0,11.9047619,29.94787444,NFKBIA,0
666,regulation of peptide secretion (GO:0002791),0.080812675,0.619199823,0,0,11.9047619,29.94787444,CD74,0
667,nitric oxide mediated signal transduction (GO:0007263),0.080812675,0.618271488,0,0,11.9047619,29.94787444,APOE,0
668,negative regulation of lipid catabolic process (GO:0050995),0.080812675,0.617345932,0,0,11.9047619,29.94787444,TNF,0
669,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.080812675,0.616423142,0,0,11.9047619,29.94787444,PPP1R15A,0
670,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.083904111,0.639048776,0,0,4.15282392,10.29103266,CD74;OSM,0
671,regulation of type I interferon production (GO:0032479),0.083904111,0.638096393,0,0,4.15282392,10.29103266,UBC;TNFAIP3,0
672,regulation of peptidyl-serine phosphorylation (GO:0033135),0.085575035,0.649835423,0,0,4.105090312,10.09179673,OSM;TNF,0
673,postsynaptic membrane organization (GO:0001941),0.085963978,0.651818992,0,0,11.16071429,27.38646123,APOE,0
674,regulation of steroid metabolic process (GO:0019218),0.085963978,0.650851902,0,0,11.16071429,27.38646123,APOE,0
675,dendritic cell chemotaxis (GO:0002407),0.085963978,0.649887677,0,0,11.16071429,27.38646123,CCL5,0
676,positive regulation of cyclic nucleotide metabolic process (GO:0030801),0.085963978,0.648926304,0,0,11.16071429,27.38646123,CXCL10,0
677,positive regulation of cardiac muscle tissue growth (GO:0055023),0.085963978,0.647967772,0,0,11.16071429,27.38646123,PIM1,0
678,positive regulation of nitric-oxide synthase activity (GO:0051000),0.085963978,0.647012068,0,0,11.16071429,27.38646123,APOE,0
679,leukocyte tethering or rolling (GO:0050901),0.085963978,0.646059178,0,0,11.16071429,27.38646123,TNF,0
680,hyaluronan catabolic process (GO:0030214),0.085963978,0.645109091,0,0,11.16071429,27.38646123,HEXB,0
681,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.085963978,0.644161794,0,0,11.16071429,27.38646123,MALT1,0
682,regulation of stem cell proliferation (GO:0072091),0.085963978,0.643217275,0,0,11.16071429,27.38646123,ZFP36L1,0
683,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.085963978,0.642275522,0,0,11.16071429,27.38646123,AIF1,0
684,negative regulation of steroid biosynthetic process (GO:0010894),0.085963978,0.641336523,0,0,11.16071429,27.38646123,APOE,0
685,regulation of necroptotic process (GO:0060544),0.085963978,0.640400265,0,0,11.16071429,27.38646123,UBC,0
686,positive regulation of mRNA processing (GO:0050685),0.085963978,0.639466737,0,0,11.16071429,27.38646123,TRA2B,0
687,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.085963978,0.638535927,0,0,11.16071429,27.38646123,TNF,0
688,regulation of bicellular tight junction assembly (GO:2000810),0.085963978,0.637607822,0,0,11.16071429,27.38646123,TNF,0
689,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.085963978,0.636682412,0,0,11.16071429,27.38646123,TMSB4X,0
690,ruffle organization (GO:0031529),0.085963978,0.635759684,0,0,11.16071429,27.38646123,AIF1,0
691,neurotransmitter transport (GO:0006836),0.085963978,0.634839626,0,0,11.16071429,27.38646123,SLC38A1,0
692,positive regulation of myotube differentiation (GO:0010831),0.085963978,0.633922228,0,0,11.16071429,27.38646123,MMP14,0
693,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.085963978,0.633007477,0,0,11.16071429,27.38646123,PPP1R15A,0
694,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.085963978,0.632095363,0,0,11.16071429,27.38646123,JUN,0
695,calcium ion homeostasis (GO:0055074),0.087256051,0.640672846,0,0,4.058441558,9.898167081,CCL5;CCL3,0
696,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.088946996,0.65215017,0,0,4.012841091,9.709930345,TRIB1;CBFA2T3,0
697,divalent metal ion transport (GO:0070838),0.088946996,0.651214517,0,0,4.012841091,9.709930345,CCL5;CCL3,0
698,positive regulation of protein complex assembly (GO:0031334),0.088946996,0.650281545,0,0,4.012841091,9.709930345,JUN;TNF,0
699,receptor-mediated endocytosis (GO:0006898),0.089959518,0.656743088,0,0,2.83446712,6.826517895,STAB1;APOE;CXCL16,0
700,regulation of neuron apoptotic process (GO:0043523),0.090647708,0.660821788,0,0,3.968253968,9.526883455,CCL3;APOE,0
701,regulation of protein sumoylation (GO:0033233),0.091086669,0.663074569,0,0,10.50420168,25.16747707,EGR1,0
702,3'-UTR-mediated mRNA stabilization (GO:0070935),0.091086669,0.662130018,0,0,10.50420168,25.16747707,ZFP36,0
703,high-density lipoprotein particle remodeling (GO:0034375),0.091086669,0.661188155,0,0,10.50420168,25.16747707,APOE,0
704,regulation of tissue remodeling (GO:0034103),0.091086669,0.660248967,0,0,10.50420168,25.16747707,GPNMB,0
705,reverse cholesterol transport (GO:0043691),0.091086669,0.659312444,0,0,10.50420168,25.16747707,APOE,0
706,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.091086669,0.658378573,0,0,10.50420168,25.16747707,TNFAIP3,0
707,response to purine-containing compound (GO:0014074),0.091086669,0.657447345,0,0,10.50420168,25.16747707,JUN,0
708,macrophage activation (GO:0042116),0.091086669,0.656518747,0,0,10.50420168,25.16747707,AIF1,0
709,negative regulation of B cell activation (GO:0050869),0.091086669,0.655592768,0,0,10.50420168,25.16747707,TNFAIP3,0
710,positive regulation of striated muscle cell differentiation (GO:0051155),0.091086669,0.654669398,0,0,10.50420168,25.16747707,MMP14,0
711,positive regulation of response to biotic stimulus (GO:0002833),0.091086669,0.653748626,0,0,10.50420168,25.16747707,LY86,0
712,positive regulation by host of viral transcription (GO:0043923),0.091086669,0.652830439,0,0,10.50420168,25.16747707,JUN,0
713,negative regulation of interleukin-8 production (GO:0032717),0.091086669,0.651914829,0,0,10.50420168,25.16747707,TMSB4X,0
714,positive chemotaxis (GO:0050918),0.091086669,0.651001783,0,0,10.50420168,25.16747707,GPNMB,0
715,viral entry into host cell (GO:0046718),0.091086669,0.650091291,0,0,10.50420168,25.16747707,AXL,0
716,positive regulation of cellular protein catabolic process (GO:1903364),0.091086669,0.649183342,0,0,10.50420168,25.16747707,APOE,0
717,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.091086669,0.648277926,0,0,10.50420168,25.16747707,CBFA2T3,0
718,protein tetramerization (GO:0051262),0.092358027,0.65641088,0,0,3.924646782,9.348833032,CD74;CCL5,0
719,regulation of JNK cascade (GO:0046328),0.092358027,0.65549793,0,0,3.924646782,9.348833032,GADD45B;GADD45G,0
720,regulation of cardiac muscle cell proliferation (GO:0060043),0.096180905,0.681682165,0,0,9.920634921,23.22940905,PIM1,0
721,regulation of amyloid-beta formation (GO:1902003),0.096180905,0.680736697,0,0,9.920634921,23.22940905,APOE,0
722,actin filament polymerization (GO:0030041),0.096180905,0.679793849,0,0,9.920634921,23.22940905,AIF1,0
723,regulation of lipid catabolic process (GO:0050994),0.096180905,0.678853608,0,0,9.920634921,23.22940905,TNF,0
724,negative regulation of osteoclast differentiation (GO:0045671),0.096180905,0.677915965,0,0,9.920634921,23.22940905,CCL3,0
725,glucan biosynthetic process (GO:0009250),0.096180905,0.676980909,0,0,9.920634921,23.22940905,UBC,0
726,maintenance of protein localization in organelle (GO:0072595),0.096180905,0.676048428,0,0,9.920634921,23.22940905,HK2,0
727,glycogen biosynthetic process (GO:0005978),0.096180905,0.675118513,0,0,9.920634921,23.22940905,UBC,0
728,regulation of cAMP-mediated signaling (GO:0043949),0.096180905,0.674191152,0,0,9.920634921,23.22940905,CXCL10,0
729,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.096180905,0.673266336,0,0,9.920634921,23.22940905,NFE2L2,0
730,positive regulation of cyclic nucleotide biosynthetic process (GO:0030804),0.096180905,0.672344053,0,0,9.920634921,23.22940905,APOE,0
731,regulation of peptidase activity (GO:0052547),0.096180905,0.671424294,0,0,9.920634921,23.22940905,FURIN,0
732,anion homeostasis (GO:0055081),0.096180905,0.670507047,0,0,9.920634921,23.22940905,APOE,0
733,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.096180905,0.669592304,0,0,9.920634921,23.22940905,NFE2L2,0
734,response to organophosphorus (GO:0046683),0.096180905,0.668680053,0,0,9.920634921,23.22940905,JUN,0
735,negative regulation of protein dephosphorylation (GO:0035308),0.096180905,0.667770284,0,0,9.920634921,23.22940905,PPP1R15A,0
736,prostaglandin biosynthetic process (GO:0001516),0.096180905,0.666862987,0,0,9.920634921,23.22940905,CD74,0
737,positive regulation of cell differentiation (GO:0045597),0.096568142,0.66863939,0,0,2.747252747,6.421720828,ZFP36;JUN;ZFP36L1,0
738,regulation of B cell activation (GO:0050864),0.101048236,0.698711583,0,0,3.720238095,8.527370878,TNFAIP3;ZFP36L1,0
739,regulation of mitotic spindle assembly (GO:1901673),0.101246843,0.699137536,0,0,9.398496241,21.5243774,PMEPA1,0
740,primary alcohol metabolic process (GO:0034308),0.101246843,0.698192755,0,0,9.398496241,21.5243774,DHRS3,0
741,error-free translesion synthesis (GO:0070987),0.101246843,0.697250525,0,0,9.398496241,21.5243774,UBC,0
742,negative regulation of cell junction assembly (GO:1901889),0.101246843,0.696310834,0,0,9.398496241,21.5243774,TNF,0
743,macromolecule biosynthetic process (GO:0009059),0.101246843,0.695373673,0,0,9.398496241,21.5243774,TNF,0
744,positive regulation of heart contraction (GO:0045823),0.101246843,0.694439031,0,0,9.398496241,21.5243774,RGS2,0
745,regulation of platelet activation (GO:0010543),0.101246843,0.693506898,0,0,9.398496241,21.5243774,APOE,0
746,regulation of long-term synaptic potentiation (GO:1900271),0.101246843,0.692577264,0,0,9.398496241,21.5243774,APOE,0
747,positive regulation of phospholipase activity (GO:0010518),0.101246843,0.691650119,0,0,9.398496241,21.5243774,CCL5,0
748,positive regulation of STAT cascade (GO:1904894),0.101246843,0.690725453,0,0,9.398496241,21.5243774,CCL5,0
749,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),0.101246843,0.689803256,0,0,9.398496241,21.5243774,JUN,0
750,regulation of myotube differentiation (GO:0010830),0.101246843,0.688883518,0,0,9.398496241,21.5243774,MMP14,0
751,regulation of heterotypic cell-cell adhesion (GO:0034114),0.101246843,0.68796623,0,0,9.398496241,21.5243774,TNF,0
752,Rac protein signal transduction (GO:0016601),0.101246843,0.687051381,0,0,9.398496241,21.5243774,AIF1,0
753,positive regulation of oxidoreductase activity (GO:0051353),0.101246843,0.686138963,0,0,9.398496241,21.5243774,TNF,0
754,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.101246843,0.685228964,0,0,9.398496241,21.5243774,TLR2,0
755,negative regulation of lipid metabolic process (GO:0045833),0.101246843,0.684321376,0,0,9.398496241,21.5243774,TNF,0
756,regulation of mitochondrial fission (GO:0090140),0.101246843,0.683416189,0,0,9.398496241,21.5243774,DDHD1,0
757,protein heterotetramerization (GO:0051290),0.101246843,0.682513393,0,0,9.398496241,21.5243774,CD74,0
758,regulation of transcription factor import into nucleus (GO:0042990),0.101246843,0.68161298,0,0,9.398496241,21.5243774,NFKBIA,0
759,response to interferon-beta (GO:0035456),0.101246843,0.680714939,0,0,9.398496241,21.5243774,BST2,0
760,positive regulation of neuron apoptotic process (GO:0043525),0.101246843,0.679819262,0,0,9.398496241,21.5243774,CCL3,0
761,regulation of cell death (GO:0010941),0.10281292,0.689427507,0,0,3.681885125,8.375715203,JUN;CCL5,0
762,epithelial cell differentiation (GO:0030855),0.10281292,0.688522746,0,0,3.681885125,8.375715203,MAF;CTSB,0
763,cellular metal ion homeostasis (GO:0006875),0.10281292,0.687620357,0,0,3.681885125,8.375715203,CCL5;CCL3,0
764,mRNA metabolic process (GO:0016071),0.104586132,0.698564179,0,0,3.644314869,8.227931176,ZFP36;RNASE4,0
765,cellular response to organonitrogen compound (GO:0071417),0.104586132,0.697651024,0,0,3.644314869,8.227931176,EGR1;ZFP36L1,0
766,negative regulation of innate immune response (GO:0045824),0.106284638,0.708055493,0,0,8.928571429,20.01459392,TNFAIP3,0
767,positive regulation of interleukin-2 production (GO:0032743),0.106284638,0.707132344,0,0,8.928571429,20.01459392,MALT1,0
768,regulation of toll-like receptor signaling pathway (GO:0034121),0.106284638,0.706211599,0,0,8.928571429,20.01459392,TLR2,0
769,positive regulation of dendritic spine development (GO:0060999),0.106284638,0.705293248,0,0,8.928571429,20.01459392,APOE,0
770,regulation of lipoprotein lipase activity (GO:0051004),0.106284638,0.704377283,0,0,8.928571429,20.01459392,FURIN,0
771,endoplasmic reticulum mannose trimming (GO:1904380),0.106284638,0.703463694,0,0,8.928571429,20.01459392,UBC,0
772,embryonic digestive tract development (GO:0048566),0.106284638,0.702552471,0,0,8.928571429,20.01459392,TNF,0
773,error-prone translesion synthesis (GO:0042276),0.106284638,0.701643606,0,0,8.928571429,20.01459392,UBC,0
774,regulation of cholesterol transport (GO:0032374),0.106284638,0.70073709,0,0,8.928571429,20.01459392,APOE,0
775,negative regulation of response to biotic stimulus (GO:0002832),0.106284638,0.699832913,0,0,8.928571429,20.01459392,TRIB1,0
776,negative regulation of interferon-gamma production (GO:0032689),0.106284638,0.698931067,0,0,8.928571429,20.01459392,AXL,0
777,entrainment of circadian clock by photoperiod (GO:0043153),0.106284638,0.698031542,0,0,8.928571429,20.01459392,BHLHE40,0
778,positive regulation of gene silencing by miRNA (GO:2000637),0.106284638,0.697134329,0,0,8.928571429,20.01459392,ZFP36,0
779,glial cell development (GO:0021782),0.106284638,0.69623942,0,0,8.928571429,20.01459392,TLR2,0
780,positive regulation of cell growth (GO:0030307),0.106367723,0.695890372,0,0,3.607503608,8.083885654,MMP14;CXCL16,0
781,regulation of insulin secretion (GO:0050796),0.106367723,0.694999348,0,0,3.607503608,8.083885654,CCL5;TNF,0
782,hyaluronan metabolic process (GO:0030212),0.111294446,0.726260302,0,0,8.503401361,18.66986331,HEXB,0
783,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.111294446,0.725332767,0,0,8.503401361,18.66986331,NFE2L2,0
784,dendritic cell differentiation (GO:0097028),0.111294446,0.724407598,0,0,8.503401361,18.66986331,AXL,0
785,response to nicotine (GO:0035094),0.111294446,0.723484785,0,0,8.503401361,18.66986331,TNF,0
786,negative regulation of viral process (GO:0048525),0.111294446,0.722564321,0,0,8.503401361,18.66986331,ZFP36,0
787,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.111294446,0.721646196,0,0,8.503401361,18.66986331,TNF,0
788,cortical actin cytoskeleton organization (GO:0030866),0.111294446,0.720730402,0,0,8.503401361,18.66986331,TNF,0
789,cellular response to alkaloid (GO:0071312),0.111294446,0.719816928,0,0,8.503401361,18.66986331,TNF,0
790,positive regulation of lipid metabolic process (GO:0045834),0.111294446,0.718905768,0,0,8.503401361,18.66986331,APOE,0
791,regulation of cardiac muscle hypertrophy (GO:0010611),0.111294446,0.717996911,0,0,8.503401361,18.66986331,RGS2,0
792,photoperiodism (GO:0009648),0.111294446,0.717090349,0,0,8.503401361,18.66986331,BHLHE40,0
793,negative regulation of cytokine biosynthetic process (GO:0042036),0.111294446,0.716186074,0,0,8.503401361,18.66986331,ZFP36,0
794,ERK1 and ERK2 cascade (GO:0070371),0.111294446,0.715284076,0,0,8.503401361,18.66986331,ZFP36L1,0
795,regulation of macrophage activation (GO:0043030),0.111294446,0.714384348,0,0,8.503401361,18.66986331,CD74,0
796,establishment of endothelial barrier (GO:0061028),0.111294446,0.71348688,0,0,8.503401361,18.66986331,F11R,0
797,cellular divalent inorganic cation homeostasis (GO:0072503),0.111761302,0.715580834,0,0,3.50140056,7.672933868,CCL5;CCL3,0
798,regulation of protein ubiquitination (GO:0031396),0.111761302,0.714684117,0,0,3.50140056,7.672933868,TNFAIP3;MALT1,0
799,regulation of kinase activity (GO:0043549),0.111761302,0.713789643,0,0,3.50140056,7.672933868,CD74;AXL,0
800,regulation of calcium ion import (GO:0090279),0.11627642,0.741698214,0,0,8.116883117,17.46578727,CCL3,0
801,positive regulation of protein autophosphorylation (GO:0031954),0.11627642,0.740772248,0,0,8.116883117,17.46578727,GPNMB,0
802,acylglycerol homeostasis (GO:0055090),0.11627642,0.739848592,0,0,8.116883117,17.46578727,APOE,0
803,cellular response to hexose stimulus (GO:0071331),0.11627642,0.738927236,0,0,8.116883117,17.46578727,TRA2B,0
804,negative regulation of nervous system development (GO:0051961),0.11627642,0.738008173,0,0,8.116883117,17.46578727,TLR2,0
805,negative regulation of GTPase activity (GO:0034260),0.11627642,0.737091392,0,0,8.116883117,17.46578727,F11R,0
806,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.11627642,0.736176887,0,0,8.116883117,17.46578727,GPNMB,0
807,positive regulation of RNA splicing (GO:0033120),0.11627642,0.735264648,0,0,8.116883117,17.46578727,TRA2B,0
808,regulation of bone resorption (GO:0045124),0.11627642,0.734354667,0,0,8.116883117,17.46578727,TNFAIP3,0
809,negative regulation of actin filament polymerization (GO:0030837),0.11627642,0.733446936,0,0,8.116883117,17.46578727,TMSB4X,0
810,positive regulation of phosphatase activity (GO:0010922),0.11627642,0.732541445,0,0,8.116883117,17.46578727,PPP1R15A,0
811,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.11627642,0.731638188,0,0,8.116883117,17.46578727,UBC,0
812,mRNA transport (GO:0051028),0.117225069,0.736698928,0,0,3.401360544,7.291358916,ZFP36;ZFP36L1,0
813,positive regulation of ATP metabolic process (GO:1903580),0.121230714,0.760935219,0,0,7.763975155,16.38245204,TMSB4X,0
814,regulation of protein oligomerization (GO:0032459),0.121230714,0.760000409,0,0,7.763975155,16.38245204,APOE,0
815,cholesterol efflux (GO:0033344),0.121230714,0.759067893,0,0,7.763975155,16.38245204,APOE,0
816,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.121230714,0.758137663,0,0,7.763975155,16.38245204,UBC,0
817,negative regulation of signal transduction in absence of ligand (GO:1901099),0.121230714,0.75720971,0,0,7.763975155,16.38245204,TNF,0
818,positive regulation of ERBB signaling pathway (GO:1901186),0.121230714,0.756284026,0,0,7.763975155,16.38245204,UBC,0
819,glycolytic process (GO:0006096),0.121230714,0.755360602,0,0,7.763975155,16.38245204,HK2,0
820,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.121230714,0.75443943,0,0,7.763975155,16.38245204,TNF,0
821,protein K48-linked deubiquitination (GO:0071108),0.121230714,0.753520503,0,0,7.763975155,16.38245204,TNFAIP3,0
822,negative regulation of transcription factor import into nucleus (GO:0042992),0.121230714,0.752603811,0,0,7.763975155,16.38245204,NFKBIA,0
823,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.121230714,0.751689347,0,0,7.763975155,16.38245204,UBC,0
824,regulation of protein secretion (GO:0050708),0.122755229,0.760218364,0,0,3.306878307,6.936385308,CCL5;TNF,0
825,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.12615748,0.780341358,0,0,7.44047619,15.4034547,AIF1,0
826,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.126477059,0.781370982,0,0,3.246753247,6.713293314,HSPE1;TNF,0
827,positive regulation of cytokine production (GO:0001819),0.127336496,0.785729309,0,0,2.424046542,4.995771144,TNF;MALT1;TLR2,0
828,chaperone mediated protein folding requiring cofactor (GO:0051085),0.13105687,0.807709187,0,0,7.142857143,14.51517092,HSPE1,0
829,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.13105687,0.80673487,0,0,7.142857143,14.51517092,GPNMB,0
830,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.13105687,0.8057629,0,0,7.142857143,14.51517092,NFE2L2,0
831,ATP generation from ADP (GO:0006757),0.13105687,0.804793269,0,0,7.142857143,14.51517092,HK2,0
832,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.13105687,0.80382597,0,0,7.142857143,14.51517092,PPP1R15A,0
833,"protein alpha-1,2-demannosylation (GO:0036508)",0.13105687,0.802860993,0,0,7.142857143,14.51517092,UBC,0
834,transition metal ion homeostasis (GO:0055076),0.13105687,0.80189833,0,0,7.142857143,14.51517092,B2M,0
835,negative regulation of T cell proliferation (GO:0042130),0.13105687,0.800937972,0,0,7.142857143,14.51517092,GPNMB,0
836,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.13105687,0.799979913,0,0,7.142857143,14.51517092,CD74,0
837,negative regulation of oxidative stress-induced cell death (GO:1903202),0.13105687,0.799024142,0,0,7.142857143,14.51517092,NFE2L2,0
838,negative regulation of gene expression (GO:0010629),0.134238551,0.817445497,0,0,1.730902377,3.475888812,ZFP36;JUN;BHLHE40;CCL3;TNF;CBFA2T3,0
839,glycolytic process through glucose-6-phosphate (GO:0061620),0.135929034,0.826753113,0,0,6.868131868,13.70619737,HK2,0
840,negative regulation of wound healing (GO:0061045),0.135929034,0.825768883,0,0,6.868131868,13.70619737,APOE,0
841,signal peptide processing (GO:0006465),0.135929034,0.824786993,0,0,6.868131868,13.70619737,FURIN,0
842,canonical glycolysis (GO:0061621),0.135929034,0.823807436,0,0,6.868131868,13.70619737,HK2,0
843,long-chain fatty acid transport (GO:0015909),0.135929034,0.822830203,0,0,6.868131868,13.70619737,APOE,0
844,glucose catabolic process to pyruvate (GO:0061718),0.135929034,0.821855286,0,0,6.868131868,13.70619737,HK2,0
845,regulation of spindle assembly (GO:0090169),0.135929034,0.820882676,0,0,6.868131868,13.70619737,PMEPA1,0
846,"protein import into nucleus, translocation (GO:0000060)",0.135929034,0.819912366,0,0,6.868131868,13.70619737,TNF,0
847,respiratory chain complex IV assembly (GO:0008535),0.135929034,0.818944346,0,0,6.868131868,13.70619737,MT-CO3,0
848,neutral amino acid transport (GO:0015804),0.135929034,0.81797861,0,0,6.868131868,13.70619737,SLC38A1,0
849,positive regulation of interleukin-12 production (GO:0032735),0.135929034,0.817015149,0,0,6.868131868,13.70619737,TLR2,0
850,prostaglandin metabolic process (GO:0006693),0.135929034,0.816053955,0,0,6.868131868,13.70619737,CD74,0
851,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.135929034,0.815095019,0,0,6.868131868,13.70619737,CD74,0
852,regulation of vascular smooth muscle cell proliferation (GO:1904705),0.135929034,0.814138335,0,0,6.868131868,13.70619737,JUN,0
853,"RNA splicing, via transesterification reactions (GO:0000375)",0.135929034,0.813183894,0,0,6.868131868,13.70619737,TRA2B,0
854,positive regulation of calcium ion transmembrane transport (GO:1904427),0.135929034,0.812231688,0,0,6.868131868,13.70619737,CXCL10,0
855,response to alcohol (GO:0097305),0.135929034,0.811281709,0,0,6.868131868,13.70619737,CCL3,0
856,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.135929034,0.81033395,0,0,6.868131868,13.70619737,TNF,0
857,positive regulation of interleukin-1 beta secretion (GO:0050718),0.135929034,0.809388403,0,0,6.868131868,13.70619737,CCL3,0
858,positive regulation of nitric oxide metabolic process (GO:1904407),0.135929034,0.80844506,0,0,6.868131868,13.70619737,TNF,0
859,cellular protein metabolic process (GO:0044267),0.136548178,0.811182015,0,0,1.840942563,3.665459823,UBC;RRBP1;FURIN;APOE;B2M,0
860,cellular response to oxidative stress (GO:0034599),0.137799156,0.817661738,0,0,3.078817734,6.102087572,JUN;NFE2L2,0
861,"transcription, DNA-templated (GO:0006351)",0.14057674,0.833174337,0,0,2.00080032,3.925573725,EGR1;MAF;NFIC;NFE2L2,0
862,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.140774123,0.833376275,0,0,6.613756614,12.96692221,CCNL1,0
863,regulation of viral entry into host cell (GO:0046596),0.140774123,0.832410602,0,0,6.613756614,12.96692221,CD74,0
864,positive regulation of interferon-beta production (GO:0032728),0.140774123,0.831447163,0,0,6.613756614,12.96692221,TLR2,0
865,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),0.140774123,0.830485953,0,0,6.613756614,12.96692221,JUN,0
866,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.140774123,0.829526962,0,0,6.613756614,12.96692221,NMT1,0
867,regulation of supramolecular fiber organization (GO:1902903),0.140774123,0.828570184,0,0,6.613756614,12.96692221,APOE,0
868,positive regulation of cAMP metabolic process (GO:0030816),0.140774123,0.82761561,0,0,6.613756614,12.96692221,CXCL10,0
869,activation of MAPK activity (GO:0000187),0.141621962,0.831641973,0,0,3.026634383,5.915841428,UBC;TNF,0
870,protein localization to cell periphery (GO:1990778),0.141621962,0.830686062,0,0,3.026634383,5.915841428,F11R;TNF,0
871,positive regulation of gene expression (GO:0010628),0.142399255,0.834286333,0,0,1.619170984,3.155959382,EGR1;CD74;JUN;CCL3;TNF;NFE2L2;TLR2,0
872,calcium ion transport (GO:0006816),0.143541947,0.840016692,0,0,3.00120048,5.825714205,CCL5;CCL3,0
873,regulation of signal transduction (GO:0009966),0.143884921,0.84105928,0,0,2.289377289,4.438510667,RGS2;AXL;DHRS3,0
874,positive regulation of B cell activation (GO:0050871),0.145467489,0.849337069,0,0,2.976190476,5.737507909,CD74;MMP14,0
875,leukocyte cell-cell adhesion (GO:0007159),0.145592285,0.849094207,0,0,6.37755102,12.28919089,CCL5,0
876,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.145592285,0.848124921,0,0,6.37755102,12.28919089,TNF,0
877,regulation of protein transport (GO:0051223),0.145592285,0.847157846,0,0,6.37755102,12.28919089,TNF,0
878,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.145592285,0.846192974,0,0,6.37755102,12.28919089,TNF,0
879,regulation of protein localization to cell surface (GO:2000008),0.145592285,0.845230297,0,0,6.37755102,12.28919089,TNF,0
880,cellular response to glucose stimulus (GO:0071333),0.145592285,0.844269808,0,0,6.37755102,12.28919089,TRA2B,0
881,negative regulation of cell migration (GO:0030336),0.149334766,0.864989003,0,0,2.927400468,5.566641513,BST2;TRIB1,0
882,regulation of cell differentiation (GO:0045595),0.149334766,0.864008289,0,0,2.927400468,5.566641513,JUN;SKIL,0
883,regulation of vasculature development (GO:1901342),0.150383669,0.869091579,0,0,6.157635468,11.66604345,GPNMB,0
884,negative regulation of endocytosis (GO:0045806),0.150383669,0.868108443,0,0,6.157635468,11.66604345,TLR2,0
885,neuron projection extension (GO:1990138),0.150383669,0.86712753,0,0,6.157635468,11.66604345,IQGAP1,0
886,carboxylic acid catabolic process (GO:0046395),0.150383669,0.866148831,0,0,6.157635468,11.66604345,HEXB,0
887,RNA phosphodiester bond hydrolysis (GO:0090501),0.150383669,0.865172338,0,0,6.157635468,11.66604345,RNASE4,0
888,"synaptic transmission, cholinergic (GO:0007271)",0.150383669,0.864198045,0,0,6.157635468,11.66604345,APOE,0
889,regulation of lipid biosynthetic process (GO:0046890),0.150383669,0.863225944,0,0,6.157635468,11.66604345,APOE,0
890,triglyceride homeostasis (GO:0070328),0.150383669,0.862256027,0,0,6.157635468,11.66604345,APOE,0
891,negative regulation of response to DNA damage stimulus (GO:2001021),0.150383669,0.861288287,0,0,6.157635468,11.66604345,CD74,0
892,regulation of mRNA processing (GO:0050684),0.150383669,0.860322717,0,0,6.157635468,11.66604345,ZFP36L1,0
893,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.150383669,0.85935931,0,0,6.157635468,11.66604345,B2M,0
894,positive regulation of phosphate metabolic process (GO:0045937),0.150383669,0.858398058,0,0,6.157635468,11.66604345,CCL5,0
895,regulation of defense response to virus by virus (GO:0050690),0.150383669,0.857438954,0,0,6.157635468,11.66604345,B2M,0
896,positive regulation of lipid biosynthetic process (GO:0046889),0.150383669,0.856481991,0,0,6.157635468,11.66604345,APOE,0
897,protein K63-linked deubiquitination (GO:0070536),0.150383669,0.855527162,0,0,6.157635468,11.66604345,TNFAIP3,0
898,positive regulation of fibroblast proliferation (GO:0048146),0.150383669,0.854574459,0,0,6.157635468,11.66604345,CD74,0
899,bicellular tight junction assembly (GO:0070830),0.150383669,0.853623875,0,0,6.157635468,11.66604345,F11R,0
900,positive regulation of nucleic acid-templated transcription (GO:1903508),0.152030095,0.862010637,0,0,1.775063902,3.343646666,EGR1;CD74;JUN;TNF;NFE2L2,0
901,cellular calcium ion homeostasis (GO:0006874),0.15322284,0.867809268,0,0,2.880184332,5.402828196,CCL5;CCL3,0
902,cellular response to cadmium ion (GO:0071276),0.155148423,0.87774102,0,0,5.952380952,11.09150628,JUN,0
903,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.155148423,0.876768992,0,0,5.952380952,11.09150628,UBC,0
904,regulation of macrophage derived foam cell differentiation (GO:0010743),0.155148423,0.875799115,0,0,5.952380952,11.09150628,NFKBIA,0
905,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.155148423,0.874831381,0,0,5.952380952,11.09150628,UBC,0
906,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.155148423,0.873865784,0,0,5.952380952,11.09150628,ZFP36,0
907,cortical cytoskeleton organization (GO:0030865),0.155148423,0.872902316,0,0,5.952380952,11.09150628,TNF,0
908,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.155148423,0.871940969,0,0,5.952380952,11.09150628,UBC,0
909,regulation of cellular biosynthetic process (GO:0031326),0.155148423,0.870981738,0,0,5.952380952,11.09150628,CCL5,0
910,positive regulation of interleukin-1 secretion (GO:0050716),0.155148423,0.870024616,0,0,5.952380952,11.09150628,CCL3,0
911,negative regulation of lymphocyte proliferation (GO:0050672),0.155148423,0.869069594,0,0,5.952380952,11.09150628,GPNMB,0
912,regulation of myoblast differentiation (GO:0045661),0.155148423,0.868116667,0,0,5.952380952,11.09150628,ZFP36L1,0
913,platelet degranulation (GO:0002576),0.155174382,0.867310924,0,0,2.857142857,5.323444991,LGALS3BP;TMSB4X,0
914,negative regulation of macromolecule metabolic process (GO:0010605),0.155174382,0.866362006,0,0,2.857142857,5.323444991,CCL3;TNF,0
915,negative regulation of multicellular organismal process (GO:0051241),0.157130775,0.876326062,0,0,2.83446712,5.2456827,GPNMB;TNF,0
916,G2/M transition of mitotic cell cycle (GO:0000086),0.159091904,0.886294747,0,0,2.812148481,5.169497267,UBC;PHLDA1,0
917,cytoskeleton organization (GO:0007010),0.159091904,0.885328232,0,0,2.812148481,5.169497267,CCL3;APOE,0
918,regulation of actin cytoskeleton reorganization (GO:2000249),0.159886692,0.888781905,0,0,5.760368664,10.56042564,F11R,0
919,positive regulation of cation channel activity (GO:2001259),0.159886692,0.887814786,0,0,5.760368664,10.56042564,CTSS,0
920,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.159886692,0.88684977,0,0,5.760368664,10.56042564,NMT1,0
921,regulation of developmental growth (GO:0048638),0.159886692,0.88588685,0,0,5.760368664,10.56042564,APOE,0
922,regulation of defense response to virus by host (GO:0050691),0.159886692,0.884926018,0,0,5.760368664,10.56042564,TNFAIP3,0
923,negative regulation of endothelial cell proliferation (GO:0001937),0.159886692,0.883967268,0,0,5.760368664,10.56042564,APOE,0
924,replication fork processing (GO:0031297),0.159886692,0.883010594,0,0,5.760368664,10.56042564,BHLHE40,0
925,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.159886692,0.882055987,0,0,5.760368664,10.56042564,CCNL1,0
926,cellular response to cAMP (GO:0071320),0.159886692,0.881103443,0,0,5.760368664,10.56042564,ZFP36L1,0
927,phosphatidylinositol 3-kinase signaling (GO:0014065),0.159886692,0.880152954,0,0,5.760368664,10.56042564,ZFP36L1,0
928,negative regulation of transferase activity (GO:0051348),0.159886692,0.879204513,0,0,5.760368664,10.56042564,ZFP36,0
929,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.159886692,0.878258115,0,0,5.760368664,10.56042564,NMT1,0
930,regulation of blood coagulation (GO:0030193),0.159886692,0.877313751,0,0,5.760368664,10.56042564,APOE,0
931,positive regulation of B cell proliferation (GO:0030890),0.159886692,0.876371416,0,0,5.760368664,10.56042564,CD74,0
932,negative regulation of secretion by cell (GO:1903531),0.159886692,0.875431103,0,0,5.760368664,10.56042564,OSM,0
933,chondroitin sulfate metabolic process (GO:0030204),0.159886692,0.874492806,0,0,5.760368664,10.56042564,HEXB,0
934,'de novo' posttranslational protein folding (GO:0051084),0.159886692,0.873556519,0,0,5.760368664,10.56042564,HSPE1,0
935,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.159886692,0.872622234,0,0,5.760368664,10.56042564,TNF,0
936,cell cycle G2/M phase transition (GO:0044839),0.161057657,0.878073956,0,0,2.790178571,5.094846152,UBC;PHLDA1,0
937,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.164598623,0.896421316,0,0,5.580357143,10.06833346,TNFAIP3,0
938,regulation of dendritic spine development (GO:0060998),0.164598623,0.895465643,0,0,5.580357143,10.06833346,APOE,0
939,response to cadmium ion (GO:0046686),0.164598623,0.894512006,0,0,5.580357143,10.06833346,JUN,0
940,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.164598623,0.893560397,0,0,5.580357143,10.06833346,APOE,0
941,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.164598623,0.892610811,0,0,5.580357143,10.06833346,TNFAIP3,0
942,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.164598623,0.891663241,0,0,5.580357143,10.06833346,CXCL10,0
943,positive regulation of protein dephosphorylation (GO:0035307),0.164598623,0.890717681,0,0,5.580357143,10.06833346,PPP1R15A,0
944,secondary alcohol metabolic process (GO:1902652),0.164598623,0.889774124,0,0,5.580357143,10.06833346,APOE,0
945,regulation of cytokine secretion (GO:0050707),0.164598623,0.888832564,0,0,5.580357143,10.06833346,TNF,0
946,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.164598623,0.887892995,0,0,5.580357143,10.06833346,TNFAIP3,0
947,gene silencing by miRNA (GO:0035195),0.164598623,0.88695541,0,0,5.580357143,10.06833346,ZFP36,0
948,positive regulation of viral genome replication (GO:0045070),0.164598623,0.886019803,0,0,5.580357143,10.06833346,CCL5,0
949,regulation of protein autophosphorylation (GO:0031952),0.164598623,0.885086168,0,0,5.580357143,10.06833346,GPNMB,0
950,regulation of macromolecule metabolic process (GO:0060255),0.165002585,0.886324413,0,0,2.747252747,4.949983894,APOE;ZFP36L1,0
951,protein localization to plasma membrane (GO:0072659),0.166981541,0.896011359,0,0,2.726281352,4.879694676,F11R;TNF,0
952,positive regulation of cellular process (GO:0048522),0.167302182,0.896788903,0,0,1.717032967,3.069975323,JUN;MMP14;OSM;IER5;CXCL16,0
953,positive regulation of calcium ion transport into cytosol (GO:0010524),0.169284361,0.906461799,0,0,5.411255411,9.611338572,CXCL10,0
954,positive regulation of dendrite development (GO:1900006),0.169284361,0.90551163,0,0,5.411255411,9.611338572,APOE,0
955,negative regulation of fat cell differentiation (GO:0045599),0.169284361,0.90456345,0,0,5.411255411,9.611338572,TNF,0
956,regulation of nitric oxide biosynthetic process (GO:0045428),0.169284361,0.903617254,0,0,5.411255411,9.611338572,TNF,0
957,negative regulation of BMP signaling pathway (GO:0030514),0.169284361,0.902673035,0,0,5.411255411,9.611338572,SKIL,0
958,cyclic-nucleotide-mediated signaling (GO:0019935),0.169284361,0.901730788,0,0,5.411255411,9.611338572,APOE,0
959,global genome nucleotide-excision repair (GO:0070911),0.169284361,0.900790505,0,0,5.411255411,9.611338572,UBC,0
960,cellular response to hypoxia (GO:0071456),0.170951892,0.908716149,0,0,2.68528464,4.743214546,UBC;ZFP36L1,0
961,glycogen metabolic process (GO:0005977),0.17394405,0.923659198,0,0,5.25210084,9.186037714,UBC,0
962,negative regulation of multi-organism process (GO:0043901),0.17394405,0.922699053,0,0,5.25210084,9.186037714,TRIB1,0
963,mRNA stabilization (GO:0048255),0.17394405,0.921740903,0,0,5.25210084,9.186037714,ZFP36,0
964,regulation of interleukin-12 production (GO:0032655),0.17394405,0.92078474,0,0,5.25210084,9.186037714,TLR2,0
965,antigen receptor-mediated signaling pathway (GO:0050851),0.176139722,0.93144145,0,0,2.07641196,3.605643119,NFKBIA;UBC;MALT1,0
966,phagocytosis (GO:0006909),0.176936921,0.934688516,0,0,2.62605042,4.548219512,AXL;AIF1,0
967,mitochondrial transport (GO:0006839),0.176936921,0.93372193,0,0,2.62605042,4.548219512,MT-ATP6;MT-ATP8,0
968,epithelial tube morphogenesis (GO:0060562),0.178577834,0.941407737,0,0,5.102040816,8.789442476,MTSS1,0
969,apoptotic mitochondrial changes (GO:0008637),0.178577834,0.940436212,0,0,5.102040816,8.789442476,HK2,0
970,negative regulation of cellular metabolic process (GO:0031324),0.178577834,0.93946669,0,0,5.102040816,8.789442476,APOE,0
971,keratan sulfate metabolic process (GO:0042339),0.178577834,0.938499165,0,0,5.102040816,8.789442476,HEXB,0
972,negative regulation of T cell activation (GO:0050868),0.178577834,0.937533631,0,0,5.102040816,8.789442476,GPNMB,0
973,regulation of axon extension (GO:0030516),0.178577834,0.936570081,0,0,5.102040816,8.789442476,APOE,0
974,negative regulation of endothelial cell migration (GO:0010596),0.178577834,0.935608511,0,0,5.102040816,8.789442476,APOE,0
975,regulation of interleukin-1 beta secretion (GO:0050706),0.178577834,0.934648912,0,0,5.102040816,8.789442476,CCL3,0
976,regulation of wound healing (GO:0061041),0.178577834,0.93369128,0,0,5.102040816,8.789442476,TNFAIP3,0
977,regulation of JUN kinase activity (GO:0043506),0.178577834,0.932735608,0,0,5.102040816,8.789442476,TNF,0
978,regulation of interferon-beta production (GO:0032648),0.178577834,0.931781891,0,0,5.102040816,8.789442476,TLR2,0
979,macromolecule catabolic process (GO:0009057),0.178577834,0.930830122,0,0,5.102040816,8.789442476,CTSD,0
980,positive regulation of transferase activity (GO:0051347),0.18094539,0.942208497,0,0,2.587991718,4.424327131,CD74;AXL,0
981,regulation of synapse assembly (GO:0051963),0.183185856,0.952902572,0,0,4.96031746,8.418918824,TLR2,0
982,negative regulation of protein complex assembly (GO:0031333),0.183185856,0.951932203,0,0,4.96031746,8.418918824,PMEPA1,0
983,apical junction assembly (GO:0043297),0.183185856,0.950963808,0,0,4.96031746,8.418918824,F11R,0
984,positive regulation of ATPase activity (GO:0032781),0.183185856,0.949997381,0,0,4.96031746,8.418918824,TMSB4X,0
985,regulation of phosphoprotein phosphatase activity (GO:0043666),0.183185856,0.949032917,0,0,4.96031746,8.418918824,PPP1R15A,0
986,negative regulation of tumor necrosis factor production (GO:0032720),0.183185856,0.948070409,0,0,4.96031746,8.418918824,TNFAIP3,0
987,regulation of mitotic spindle organization (GO:0060236),0.183185856,0.947109851,0,0,4.96031746,8.418918824,PMEPA1,0
988,regulation of cardiac muscle contraction (GO:0055117),0.183185856,0.946151238,0,0,4.96031746,8.418918824,RGS2,0
989,carbohydrate catabolic process (GO:0016052),0.183185856,0.945194563,0,0,4.96031746,8.418918824,HK2,0
990,actin filament bundle organization (GO:0061572),0.183185856,0.944239821,0,0,4.96031746,8.418918824,AIF1,0
991,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.183185856,0.943287006,0,0,4.96031746,8.418918824,BHLHE40,0
992,sulfur compound catabolic process (GO:0044273),0.183185856,0.942336112,0,0,4.96031746,8.418918824,HEXB,0
993,cholesterol biosynthetic process (GO:0006695),0.183185856,0.941387133,0,0,4.96031746,8.418918824,APOE,0
994,positive regulation of Wnt signaling pathway (GO:0030177),0.186983734,0.95993762,0,0,2.532928065,4.24704572,UBC;TLR2,0
995,actin polymerization or depolymerization (GO:0008154),0.187768257,0.962996397,0,0,4.826254826,8.072136835,AIF1,0
996,regulation of receptor-mediated endocytosis (GO:0048259),0.187768257,0.962029533,0,0,4.826254826,8.072136835,B2M,0
997,acylglycerol metabolic process (GO:0006639),0.187768257,0.961064609,0,0,4.826254826,8.072136835,APOE,0
998,regulation of muscle cell differentiation (GO:0051147),0.187768257,0.960101619,0,0,4.826254826,8.072136835,ZFP36L1,0
999,regulation of nitric-oxide synthase activity (GO:0050999),0.187768257,0.959140556,0,0,4.826254826,8.072136835,APOE,0
1000,negative regulation of blood coagulation (GO:0030195),0.187768257,0.958181415,0,0,4.826254826,8.072136835,APOE,0
1001,mRNA catabolic process (GO:0006402),0.187768257,0.957224191,0,0,4.826254826,8.072136835,ZFP36,0
1002,secondary alcohol biosynthetic process (GO:1902653),0.187768257,0.956268878,0,0,4.826254826,8.072136835,APOE,0
1003,zymogen activation (GO:0031638),0.187768257,0.955315469,0,0,4.826254826,8.072136835,FURIN,0
1004,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.192325178,0.977525285,0,0,4.69924812,7.747028673,NMT1,0
1005,actin filament bundle assembly (GO:0051017),0.192325178,0.976552623,0,0,4.69924812,7.747028673,AIF1,0
1006,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.192325178,0.975581894,0,0,4.69924812,7.747028673,UBC,0
1007,positive regulation of multi-organism process (GO:0043902),0.192325178,0.974613094,0,0,4.69924812,7.747028673,LY86,0
1008,T cell differentiation (GO:0030217),0.196856761,0.996587352,0,0,4.578754579,7.44175328,ZFP36L1,0
1009,retina homeostasis (GO:0001895),0.196856761,0.995599654,0,0,4.578754579,7.44175328,B2M,0
1010,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.201363144,1,0,0,4.464285714,7.15466658,TNFAIP3,0
1011,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.201363144,1,0,0,4.464285714,7.15466658,TRA2B,0
1012,regulation of RNA metabolic process (GO:0051252),0.201363144,1,0,0,4.464285714,7.15466658,TRA2B,0
1013,positive regulation of phagocytosis (GO:0050766),0.201363144,1,0,0,4.464285714,7.15466658,TNF,0
1014,ERBB2 signaling pathway (GO:0038128),0.201363144,1,0,0,4.464285714,7.15466658,UBC,0
1015,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.203217738,1,0,0,2.396931927,3.819456552,UBC;APOE,0
1016,negative regulation of transport (GO:0051051),0.205844467,1,0,0,4.355400697,6.884296217,BST2,0
1017,androgen receptor signaling pathway (GO:0030521),0.205844467,1,0,0,4.355400697,6.884296217,PMEPA1,0
1018,response to peptide hormone (GO:0043434),0.205844467,1,0,0,4.355400697,6.884296217,ZFP36L1,0
1019,"nucleotide-excision repair, DNA incision (GO:0033683)",0.205844467,1,0,0,4.355400697,6.884296217,UBC,0
1020,phosphatidic acid biosynthetic process (GO:0006654),0.205844467,1,0,0,4.355400697,6.884296217,DDHD1,0
1021,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.205844467,1,0,0,4.355400697,6.884296217,UBC,0
1022,regulation of protein dephosphorylation (GO:0035304),0.205844467,1,0,0,4.355400697,6.884296217,PPP1R15A,0
1023,regulation of cholesterol biosynthetic process (GO:0045540),0.205844467,1,0,0,4.355400697,6.884296217,APOE,0
1024,regulation of viral transcription (GO:0046782),0.205844467,1,0,0,4.355400697,6.884296217,ZFP36,0
1025,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.205844467,1,0,0,4.355400697,6.884296217,AIF1,0
1026,sterol biosynthetic process (GO:0016126),0.205844467,1,0,0,4.355400697,6.884296217,APOE,0
1027,regulation of cholesterol metabolic process (GO:0090181),0.210300867,1,0,0,4.25170068,6.629320043,APOE,0
1028,phosphatidic acid metabolic process (GO:0046473),0.210300867,1,0,0,4.25170068,6.629320043,DDHD1,0
1029,cellular response to peptide (GO:1901653),0.210300867,1,0,0,4.25170068,6.629320043,ZFP36L1,0
1030,DNA duplex unwinding (GO:0032508),0.210300867,1,0,0,4.25170068,6.629320043,UBC,0
1031,positive regulation of viral transcription (GO:0050434),0.210300867,1,0,0,4.25170068,6.629320043,JUN,0
1032,positive regulation of receptor-mediated endocytosis (GO:0048260),0.210300867,1,0,0,4.25170068,6.629320043,B2M,0
1033,negative regulation of cell projection organization (GO:0031345),0.210300867,1,0,0,4.25170068,6.629320043,APOE,0
1034,regulation of intracellular signal transduction (GO:1902531),0.212982072,1,0,0,1.68861871,2.611528686,GDF15;TMSB4X;UBC;TNF,0
1035,cellular response to calcium ion (GO:0071277),0.214732482,1,0,0,4.15282392,6.388547737,IQGAP1,0
1036,translesion synthesis (GO:0019985),0.214732482,1,0,0,4.15282392,6.388547737,UBC,0
1037,regulation of B cell proliferation (GO:0030888),0.219139449,1,0,0,4.058441558,6.16090503,CD74,0
1038,negative regulation of ERBB signaling pathway (GO:1901185),0.219139449,1,0,0,4.058441558,6.16090503,UBC,0
1039,negative regulation of protein metabolic process (GO:0051248),0.219139449,1,0,0,4.058441558,6.16090503,APOE,0
1040,RNA catabolic process (GO:0006401),0.219139449,1,0,0,4.058441558,6.16090503,ZFP36,0
1041,response to unfolded protein (GO:0006986),0.219139449,1,0,0,4.058441558,6.16090503,HSPE1,0
1042,positive regulation of interleukin-6 production (GO:0032755),0.219139449,1,0,0,4.058441558,6.16090503,TLR2,0
1043,digestive tract development (GO:0048565),0.219139449,1,0,0,4.058441558,6.16090503,TNF,0
1044,regulation of multicellular organismal development (GO:2000026),0.219139449,1,0,0,4.058441558,6.16090503,CXCL10,0
1045,regulation of interferon-gamma production (GO:0032649),0.219139449,1,0,0,4.058441558,6.16090503,AXL,0
1046,cholesterol transport (GO:0030301),0.223521903,1,0,0,3.968253968,5.945420119,APOE,0
1047,amide biosynthetic process (GO:0043604),0.223521903,1,0,0,3.968253968,5.945420119,FURIN,0
1048,regulation of steroid biosynthetic process (GO:0050810),0.223521903,1,0,0,3.968253968,5.945420119,EGR1,0
1049,negative regulation of immune response (GO:0050777),0.223521903,1,0,0,3.968253968,5.945420119,TNFAIP3,0
1050,positive regulation of viral process (GO:0048524),0.223521903,1,0,0,3.968253968,5.945420119,APOE,0
1051,regulation of gene expression (GO:0010468),0.225911331,1,0,0,1.376273053,2.047361267,EGR1;TRA2B;BHLHE40;CCL3;TNF;ZFP36L1;NFE2L2;TLR2,0
1052,protein localization to membrane (GO:0072657),0.227843504,1,0,0,2.218278616,3.281047629,F11R;TNF,0
1053,protein polymerization (GO:0051258),0.22787998,1,0,0,3.881987578,5.741211932,AIF1,0
1054,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.22787998,1,0,0,3.881987578,5.741211932,TMSB4X,0
1055,nicotinamide nucleotide metabolic process (GO:0046496),0.22787998,1,0,0,3.881987578,5.741211932,HK2,0
1056,negative regulation of ossification (GO:0030279),0.22787998,1,0,0,3.881987578,5.741211932,CCL3,0
1057,nucleocytoplasmic transport (GO:0006913),0.232213813,1,0,0,3.799392097,5.547479949,MALT1,0
1058,regulation of fibroblast proliferation (GO:0048145),0.232213813,1,0,0,3.799392097,5.547479949,CD74,0
1059,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.232213813,1,0,0,3.799392097,5.547479949,TNFAIP3,0
1060,pyruvate metabolic process (GO:0006090),0.232213813,1,0,0,3.799392097,5.547479949,HK2,0
1061,neuron projection morphogenesis (GO:0048812),0.234036625,1,0,0,2.177700348,3.162625561,IQGAP1;SGK1,0
1062,response to glucose (GO:0009749),0.236523538,1,0,0,3.720238095,5.363495356,TRA2B,0
1063,positive regulation of organelle assembly (GO:1902117),0.236523538,1,0,0,3.720238095,5.363495356,TNF,0
1064,cellular response to heat (GO:0034605),0.236523538,1,0,0,3.720238095,5.363495356,IER5,0
1065,postreplication repair (GO:0006301),0.236523538,1,0,0,3.720238095,5.363495356,UBC,0
1066,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.236523538,1,0,0,3.720238095,5.363495356,GDF15,0
1067,regulation of mitotic cell cycle (GO:0007346),0.238171241,1,0,0,2.151462995,3.086844591,PIM1;IQGAP1,0
1068,negative regulation of nucleic acid-templated transcription (GO:1903507),0.239155778,1,0,0,1.605136437,2.296372628,JUN;BHLHE40;TNF;CBFA2T3,0
1069,negative regulation of mitotic cell cycle (GO:0045930),0.240809285,1,0,0,3.644314869,5.188593317,ZFP36L1,0
1070,protein K48-linked ubiquitination (GO:0070936),0.240809285,1,0,0,3.644314869,5.188593317,TNFAIP3,0
1071,interstrand cross-link repair (GO:0036297),0.240809285,1,0,0,3.644314869,5.188593317,UBC,0
1072,neuron projection development (GO:0031175),0.242309835,1,0,0,2.12585034,3.013473772,APOE;SGK1,0
1073,protein heterooligomerization (GO:0051291),0.245071189,1,0,0,3.571428571,5.02216623,CD74,0
1074,establishment of protein localization to mitochondrion (GO:0072655),0.245071189,1,0,0,3.571428571,5.02216623,HK2,0
1075,lipid homeostasis (GO:0055088),0.245071189,1,0,0,3.571428571,5.02216623,APOE,0
1076,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.245071189,1,0,0,3.571428571,5.02216623,CXCL10,0
1077,regulation of bone mineralization (GO:0030500),0.249309379,1,0,0,3.50140056,4.863657796,CCL3,0
1078,myeloid leukocyte differentiation (GO:0002573),0.249309379,1,0,0,3.50140056,4.863657796,CBFA2T3,0
1079,positive regulation of JUN kinase activity (GO:0043507),0.249309379,1,0,0,3.50140056,4.863657796,TNF,0
1080,blood circulation (GO:0008015),0.249309379,1,0,0,3.50140056,4.863657796,CXCL10,0
1081,negative regulation of protein ubiquitination (GO:0031397),0.249309379,1,0,0,3.50140056,4.863657796,TNFAIP3,0
1082,negative regulation of neuron projection development (GO:0010977),0.253523988,1,0,0,3.434065934,4.712557809,APOE,0
1083,negative regulation of Wnt signaling pathway (GO:0030178),0.256817722,1,0,0,2.040816327,2.774262652,UBC;APOE,0
1084,peptide biosynthetic process (GO:0043043),0.256817722,1,0,0,2.040816327,2.774262652,RRBP1;FURIN,0
1085,nuclear-transcribed mRNA catabolic process (GO:0000956),0.256817722,1,0,0,2.040816327,2.774262652,ZFP36;ZFP36L1,0
1086,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.257715144,1,0,0,3.369272237,4.568397561,SGK1,0
1087,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.261882978,1,0,0,3.306878307,4.430745779,CCL5,0
1088,embryonic organ development (GO:0048568),0.261882978,1,0,0,3.306878307,4.430745779,TNF,0
1089,negative regulation of protein phosphorylation (GO:0001933),0.265117109,1,0,0,1.995211492,2.648810114,PMEPA1;TRIB1,0
1090,intracellular transport of virus (GO:0075733),0.266027618,1,0,0,3.246753247,4.299205031,UBC,0
1091,transport of virus (GO:0046794),0.266027618,1,0,0,3.246753247,4.299205031,UBC,0
1092,negative regulation of cellular component organization (GO:0051129),0.266027618,1,0,0,3.246753247,4.299205031,TNF,0
1093,glycosphingolipid metabolic process (GO:0006687),0.266027618,1,0,0,3.246753247,4.299205031,HEXB,0
1094,positive regulation of immune response (GO:0050778),0.266027618,1,0,0,3.246753247,4.299205031,CCL5,0
1095,positive regulation of response to stimulus (GO:0048584),0.266027618,1,0,0,3.246753247,4.299205031,IER5,0
1096,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.270149191,1,0,0,3.18877551,4.173408522,TNF,0
1097,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.270149191,1,0,0,3.18877551,4.173408522,SKIL,0
1098,regulation of axonogenesis (GO:0050770),0.270149191,1,0,0,3.18877551,4.173408522,APOE,0
1099,regulation of RNA splicing (GO:0043484),0.270149191,1,0,0,3.18877551,4.173408522,TRA2B,0
1100,Notch signaling pathway (GO:0007219),0.270149191,1,0,0,3.18877551,4.173408522,UBC,0
1101,chromosome organization (GO:0051276),0.274247826,1,0,0,3.13283208,4.053017255,UBC,0
1102,protein import (GO:0017038),0.274247826,1,0,0,3.13283208,4.053017255,APOE,0
1103,phosphatidylinositol-mediated signaling (GO:0048015),0.274247826,1,0,0,3.13283208,4.053017255,ZFP36L1,0
1104,regulation of BMP signaling pathway (GO:0030510),0.274247826,1,0,0,3.13283208,4.053017255,SKIL,0
1105,organonitrogen compound catabolic process (GO:1901565),0.274247826,1,0,0,3.13283208,4.053017255,CTSD,0
1106,cellular iron ion homeostasis (GO:0006879),0.274247826,1,0,0,3.13283208,4.053017255,UBC,0
1107,positive regulation of protein transport (GO:0051222),0.274247826,1,0,0,3.13283208,4.053017255,TNF,0
1108,glycosaminoglycan catabolic process (GO:0006027),0.274247826,1,0,0,3.13283208,4.053017255,HEXB,0
1109,regulation of mitotic cell cycle phase transition (GO:1901990),0.277567236,1,0,0,1.930501931,2.47430904,UBC;ZFP36L1,0
1110,regulation of glycolytic process (GO:0006110),0.278323648,1,0,0,3.078817734,3.937717492,CBFA2T3,0
1111,regulation of Rho protein signal transduction (GO:0035023),0.278323648,1,0,0,3.078817734,3.937717492,APOE,0
1112,epidermal growth factor receptor signaling pathway (GO:0007173),0.278323648,1,0,0,3.078817734,3.937717492,IQGAP1,0
1113,phospholipid transport (GO:0015914),0.282376783,1,0,0,3.026634383,3.827218489,APOE,0
1114,sterol homeostasis (GO:0055092),0.282376783,1,0,0,3.026634383,3.827218489,APOE,0
1115,receptor metabolic process (GO:0043112),0.282376783,1,0,0,3.026634383,3.827218489,TNF,0
1116,sodium ion transport (GO:0006814),0.282376783,1,0,0,3.026634383,3.827218489,SGK1,0
1117,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.282376783,1,0,0,3.026634383,3.827218489,UBC,0
1118,cholesterol homeostasis (GO:0042632),0.282376783,1,0,0,3.026634383,3.827218489,APOE,0
1119,integrin-mediated signaling pathway (GO:0007229),0.282376783,1,0,0,3.026634383,3.827218489,ITGB5,0
1120,"regulation of transcription, DNA-templated (GO:0006355)",0.282917227,1,0,0,1.22844635,1.551037478,EGR1;CD74;JUN;BHLHE40;NFKBIZ;FOSB;APOE;TNF;CBFA2T3;ATF3;NFE2L2,0
1121,sterol metabolic process (GO:0016125),0.286407357,1,0,0,2.976190476,3.721250461,APOE,0
1122,transcription from RNA polymerase II promoter (GO:0006366),0.28971018,1,0,0,1.469723692,1.820802815,EGR1;MAF;NFIC;NFE2L2,0
1123,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.290415494,1,0,0,2.927400468,3.619562769,TRA2B,0
1124,muscle organ development (GO:0007517),0.290415494,1,0,0,2.927400468,3.619562769,CXCL10,0
1125,positive regulation of cellular amide metabolic process (GO:0034250),0.294401318,1,0,0,2.880184332,3.521922276,TNF,0
1126,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.298364952,1,0,0,2.83446712,3.428111877,UBC,0
1127,positive regulation of type I interferon production (GO:0032481),0.298364952,1,0,0,2.83446712,3.428111877,TLR2,0
1128,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.298364952,1,0,0,2.83446712,3.428111877,UBC,0
1129,establishment of protein localization to organelle (GO:0072594),0.298364952,1,0,0,2.83446712,3.428111877,HK2,0
1130,regulation of actin filament-based process (GO:0032970),0.298364952,1,0,0,2.83446712,3.428111877,BST2,0
1131,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.298364952,1,0,0,2.83446712,3.428111877,NFE2L2,0
1132,regulation of translational initiation (GO:0006446),0.298364952,1,0,0,2.83446712,3.428111877,CCL5,0
1133,ubiquitin-dependent protein catabolic process (GO:0006511),0.300099721,1,0,0,1.56641604,1.885401718,UBC;TNFAIP3;NFE2L2,0
1134,negative regulation of protein modification process (GO:0031400),0.302306518,1,0,0,2.790178571,3.337929173,PPP1R15A,0
1135,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),0.302306518,1,0,0,2.790178571,3.337929173,RGS1,0
1136,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),0.302306518,1,0,0,2.790178571,3.337929173,UBC,0
1137,negative regulation of dephosphorylation (GO:0035305),0.302306518,1,0,0,2.790178571,3.337929173,PPP1R15A,0
1138,negative regulation of neuron apoptotic process (GO:0043524),0.302306518,1,0,0,2.790178571,3.337929173,APOE,0
1139,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.302306518,1,0,0,2.790178571,3.337929173,ZFP36,0
1140,positive regulation of cell projection organization (GO:0031346),0.302306518,1,0,0,2.790178571,3.337929173,APOE,0
1141,cellular response to decreased oxygen levels (GO:0036294),0.306226138,1,0,0,2.747252747,3.251185264,ZFP36L1,0
1142,negative regulation of neuron differentiation (GO:0045665),0.306226138,1,0,0,2.747252747,3.251185264,APOE,0
1143,glycolipid metabolic process (GO:0006664),0.310123934,1,0,0,2.705627706,3.167703668,HEXB,0
1144,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.310123934,1,0,0,2.705627706,3.167703668,MALT1,0
1145,DNA synthesis involved in DNA repair (GO:0000731),0.310123934,1,0,0,2.705627706,3.167703668,UBC,0
1146,regulation of JAK-STAT cascade (GO:0046425),0.310123934,1,0,0,2.705627706,3.167703668,CCL5,0
1147,defense response to Gram-positive bacterium (GO:0050830),0.310123934,1,0,0,2.705627706,3.167703668,TLR2,0
1148,negative regulation of blood vessel morphogenesis (GO:2000181),0.310123934,1,0,0,2.705627706,3.167703668,STAB1,0
1149,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.314000024,1,0,0,2.665245203,3.087319337,PMEPA1,0
1150,positive regulation of cellular protein localization (GO:1903829),0.314000024,1,0,0,2.665245203,3.087319337,TNF,0
1151,extrinsic apoptotic signaling pathway (GO:0097191),0.317854531,1,0,0,2.62605042,3.00987776,TNF,0
1152,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.317854531,1,0,0,2.62605042,3.00987776,CCNL1,0
1153,regulation of gene silencing by miRNA (GO:0060964),0.317854531,1,0,0,2.62605042,3.00987776,ZFP36,0
1154,negative regulation of protein binding (GO:0032091),0.317854531,1,0,0,2.62605042,3.00987776,B2M,0
1155,negative regulation of phosphatase activity (GO:0010923),0.321687572,1,0,0,2.587991718,2.935234159,PPP1R15A,0
1156,regulation of endopeptidase activity (GO:0052548),0.321687572,1,0,0,2.587991718,2.935234159,FURIN,0
1157,cholesterol metabolic process (GO:0008203),0.321687572,1,0,0,2.587991718,2.935234159,APOE,0
1158,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.323812575,1,0,0,1.392369813,1.570022837,JUN;BHLHE40;TNF;CBFA2T3,0
1159,regulation of endocytosis (GO:0030100),0.325499265,1,0,0,2.551020408,2.86325274,APOE,0
1160,negative regulation of angiogenesis (GO:0016525),0.325499265,1,0,0,2.551020408,2.86325274,STAB1,0
1161,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.325499265,1,0,0,2.551020408,2.86325274,UBC,0
1162,positive regulation of endothelial cell migration (GO:0010595),0.32928973,1,0,0,2.515090543,2.79380603,TMSB4X,0
1163,stress-activated protein kinase signaling cascade (GO:0031098),0.32928973,1,0,0,2.515090543,2.79380603,UBC,0
1164,interferon-gamma-mediated signaling pathway (GO:0060333),0.32928973,1,0,0,2.515090543,2.79380603,B2M,0
1165,negative regulation of developmental process (GO:0051093),0.32928973,1,0,0,2.515090543,2.79380603,SKIL,0
1166,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.32928973,1,0,0,2.515090543,2.79380603,AXL,0
1167,calcium-mediated signaling (GO:0019722),0.32928973,1,0,0,2.515090543,2.79380603,CCL3,0
1168,regulation of cation channel activity (GO:2001257),0.333059083,1,0,0,2.48015873,2.726774255,CTSS,0
1169,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),0.333059083,1,0,0,2.48015873,2.726774255,UBC,0
1170,response to insulin (GO:0032868),0.333059083,1,0,0,2.48015873,2.726774255,ZFP36L1,0
1171,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.33680744,1,0,0,2.446183953,2.662044784,UBC,0
1172,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),0.33680744,1,0,0,2.446183953,2.662044784,UBC,0
1173,regulation of canonical Wnt signaling pathway (GO:0060828),0.337368624,1,0,0,1.668891856,1.813383022,UBC;APOE,0
1174,B cell activation (GO:0042113),0.340534917,1,0,0,2.413127413,2.599511612,MALT1,0
1175,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.340534917,1,0,0,2.413127413,2.599511612,UBC,0
1176,transcription-coupled nucleotide-excision repair (GO:0006283),0.340534917,1,0,0,2.413127413,2.599511612,UBC,0
1177,regulation of protein complex assembly (GO:0043254),0.340534917,1,0,0,2.413127413,2.599511612,TNF,0
1178,glucose homeostasis (GO:0042593),0.34424163,1,0,0,2.380952381,2.539074893,HK2,0
1179,negative regulation of phosphorylation (GO:0042326),0.347927694,1,0,0,2.34962406,2.480640502,CBFA2T3,0
1180,negative regulation of cellular amide metabolic process (GO:0034249),0.347927694,1,0,0,2.34962406,2.480640502,APOE,0
1181,ion transmembrane transport (GO:0034220),0.349588925,1,0,0,1.623376623,1.706164473,UBC;SGK1,0
1182,regulation of hematopoietic stem cell differentiation (GO:1902036),0.351593221,1,0,0,2.319109462,2.424119649,UBC,0
1183,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),0.351593221,1,0,0,2.319109462,2.424119649,UBC,0
1184,mitotic cell cycle phase transition (GO:0044772),0.353646216,1,0,0,1.608751609,1.672230141,UBC;PHLDA1,0
1185,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.355238327,1,0,0,2.289377289,2.369428507,UBC,0
1186,negative regulation of ubiquitin protein ligase activity (GO:1904667),0.355238327,1,0,0,2.289377289,2.369428507,UBC,0
1187,Ras protein signal transduction (GO:0007265),0.357694894,1,0,0,1.594387755,1.639150043,JUN;AIF1,0
1188,fibroblast growth factor receptor signaling pathway (GO:0008543),0.358863123,1,0,0,2.26039783,2.316487877,UBC,0
1189,positive regulation of translation (GO:0045727),0.358863123,1,0,0,2.26039783,2.316487877,CCL5,0
1190,visual perception (GO:0007601),0.358863123,1,0,0,2.26039783,2.316487877,DHRS3,0
1191,regulation of cellular response to heat (GO:1900034),0.358863123,1,0,0,2.26039783,2.316487877,IER5,0
1192,regulation of endothelial cell proliferation (GO:0001936),0.362467721,1,0,0,2.232142857,2.265222888,APOE,0
1193,response to calcium ion (GO:0051592),0.362467721,1,0,0,2.232142857,2.265222888,IQGAP1,0
1194,cell-cell junction assembly (GO:0007043),0.362467721,1,0,0,2.232142857,2.265222888,F11R,0
1195,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.362467721,1,0,0,2.232142857,2.265222888,UBC,0
1196,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.366052234,1,0,0,2.204585538,2.215562699,CCL5,0
1197,regulation of protein serine/threonine kinase activity (GO:0071900),0.366052234,1,0,0,2.204585538,2.215562699,TRIB1,0
1198,epidermis development (GO:0008544),0.369616771,1,0,0,2.177700348,2.16744025,FABP5,0
1199,BMP signaling pathway (GO:0030509),0.369616771,1,0,0,2.177700348,2.16744025,GDF15,0
1200,sensory perception of light stimulus (GO:0050953),0.369616771,1,0,0,2.177700348,2.16744025,DHRS3,0
1201,positive regulation of protein secretion (GO:0050714),0.373161445,1,0,0,2.151462995,2.120792009,TNF,0
1202,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.373161445,1,0,0,2.151462995,2.120792009,UBC,0
1203,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.373161445,1,0,0,2.151462995,2.120792009,GDF15,0
1204,positive regulation of cell cycle (GO:0045787),0.373161445,1,0,0,2.151462995,2.120792009,CCNL1,0
1205,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.373161445,1,0,0,2.151462995,2.120792009,UBC,0
1206,positive regulation of cell cycle arrest (GO:0071158),0.373161445,1,0,0,2.151462995,2.120792009,UBC,0
1207,positive regulation of protein ubiquitination (GO:0031398),0.376686363,1,0,0,2.12585034,2.075557753,MALT1,0
1208,positive regulation of supramolecular fiber organization (GO:1902905),0.380191635,1,0,0,2.100840336,2.031680359,APOE,0
1209,regulation of mitotic nuclear division (GO:0007088),0.380191635,1,0,0,2.100840336,2.031680359,PMEPA1,0
1210,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.384246891,1,0,0,1.349406261,1.290666592,AXL;UBC;MTSS1,0
1211,proteasomal protein catabolic process (GO:0010498),0.385769196,1,0,0,1.50060024,1.429345777,UBC;NFE2L2,0
1212,cellular response to BMP stimulus (GO:0071773),0.390590659,1,0,0,2.029220779,1.907660664,GDF15,0
1213,positive regulation of cellular component biogenesis (GO:0044089),0.390590659,1,0,0,2.029220779,1.907660664,TNF,0
1214,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),0.390590659,1,0,0,2.029220779,1.907660664,UBC,0
1215,plasma membrane bounded cell projection assembly (GO:0120031),0.393696377,1,0,0,1.47579693,1.375701423,AIF1;MTSS1,0
1216,defense response to bacterium (GO:0042742),0.393696377,1,0,0,1.47579693,1.375701423,STAB1;TLR2,0
1217,regulation of stem cell differentiation (GO:2000736),0.394018427,1,0,0,2.006420546,1.868695026,UBC,0
1218,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.394018427,1,0,0,2.006420546,1.868695026,UBC,0
1219,negative regulation of cellular protein metabolic process (GO:0032269),0.397427086,1,0,0,1.984126984,1.830840858,APOE,0
1220,regulation of establishment of planar polarity (GO:0090175),0.397427086,1,0,0,1.984126984,1.830840858,UBC,0
1221,cell-matrix adhesion (GO:0007160),0.400816742,1,0,0,1.962323391,1.794056042,ITGB5,0
1222,lipid transport (GO:0006869),0.404187499,1,0,0,1.940993789,1.758300471,APOE,0
1223,positive regulation of cellular protein metabolic process (GO:0032270),0.404187499,1,0,0,1.940993789,1.758300471,NFKBIA,0
1224,protein-DNA complex assembly (GO:0065004),0.404187499,1,0,0,1.940993789,1.758300471,UBC,0
1225,cellular response to acid chemical (GO:0071229),0.404187499,1,0,0,1.940993789,1.758300471,EGR1,0
1226,negative regulation of kinase activity (GO:0033673),0.404187499,1,0,0,1.940993789,1.758300471,TRIB1,0
1227,nuclear export (GO:0051168),0.407539461,1,0,0,1.920122888,1.723535931,MALT1,0
1228,cellular transition metal ion homeostasis (GO:0046916),0.410872734,1,0,0,1.899696049,1.689725992,UBC,0
1229,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.410872734,1,0,0,1.899696049,1.689725992,TNF,0
1230,positive regulation of protein localization to membrane (GO:1905477),0.41748362,1,0,0,1.860119048,1.62483253,NMT1,0
1231,regulation of cytoskeleton organization (GO:0051493),0.41748362,1,0,0,1.860119048,1.62483253,BST2,0
1232,positive regulation of neuron projection development (GO:0010976),0.424020978,1,0,0,1.822157434,1.563360694,APOE,0
1233,negative regulation of cell motility (GO:2000146),0.424020978,1,0,0,1.822157434,1.563360694,BST2,0
1234,protein localization to organelle (GO:0033365),0.424020978,1,0,0,1.822157434,1.563360694,PPP1R15A,0
1235,positive regulation of neuron differentiation (GO:0045666),0.427262337,1,0,0,1.803751804,1.533833122,APOE,0
1236,small GTPase mediated signal transduction (GO:0007264),0.430485616,1,0,0,1.785714286,1.50507387,JUN,0
1237,metal ion transport (GO:0030001),0.436878338,1,0,0,1.75070028,1.449755821,SGK1,0
1238,intrinsic apoptotic signaling pathway (GO:0097193),0.436878338,1,0,0,1.75070028,1.449755821,PPP1R15A,0
1239,positive regulation of angiogenesis (GO:0045766),0.443199936,1,0,0,1.717032967,1.3972086,HK2,0
1240,plasma membrane invagination (GO:0099024),0.443199936,1,0,0,1.717032967,1.3972086,AIF1,0
1241,protein import into nucleus (GO:0006606),0.443199936,1,0,0,1.717032967,1.3972086,TNF,0
1242,monovalent inorganic cation transport (GO:0015672),0.446334308,1,0,0,1.700680272,1.37191673,SGK1,0
1243,positive regulation of vasculature development (GO:1904018),0.446334308,1,0,0,1.700680272,1.37191673,HK2,0
1244,peptide metabolic process (GO:0006518),0.446334308,1,0,0,1.700680272,1.37191673,FURIN,0
1245,"phagocytosis, engulfment (GO:0006911)",0.446334308,1,0,0,1.700680272,1.37191673,AIF1,0
1246,RNA splicing (GO:0008380),0.452550688,1,0,0,1.668891856,1.323190095,TRA2B,0
1247,nucleotide-excision repair (GO:0006289),0.458697888,1,0,0,1.638269987,1.276807802,UBC,0
1248,negative regulation of hydrolase activity (GO:0051346),0.458697888,1,0,0,1.638269987,1.276807802,F11R,0
1249,regulation of cell motility (GO:2000145),0.461745784,1,0,0,1.623376623,1.254449335,SGK1,0
1250,Wnt signaling pathway (GO:0016055),0.461745784,1,0,0,1.623376623,1.254449335,UBC,0
1251,regulation of Wnt signaling pathway (GO:0030111),0.461745784,1,0,0,1.623376623,1.254449335,TLR2,0
1252,negative regulation of protein kinase activity (GO:0006469),0.461745784,1,0,0,1.623376623,1.254449335,TRIB1,0
1253,viral gene expression (GO:0019080),0.464776671,1,0,0,1.608751609,1.232622693,FURIN,0
1254,macroautophagy (GO:0016236),0.464776671,1,0,0,1.608751609,1.232622693,UBC,0
1255,cellular response to insulin stimulus (GO:0032869),0.464776671,1,0,0,1.608751609,1.232622693,ZFP36L1,0
1256,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.464776671,1,0,0,1.608751609,1.232622693,NMT1,0
1257,cellular response to peptide hormone stimulus (GO:0071375),0.464776671,1,0,0,1.608751609,1.232622693,ZFP36L1,0
1258,regulation of protein binding (GO:0043393),0.467790643,1,0,0,1.594387755,1.211311269,B2M,0
1259,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.473768214,1,0,0,1.56641604,1.17017086,UBC,0
1260,protein polyubiquitination (GO:0000209),0.4738587,1,0,0,1.257545272,0.939192785,UBC;TNFAIP3,0
1261,negative regulation of cell growth (GO:0030308),0.47967924,1,0,0,1.539408867,1.13090771,BST2,0
1262,epithelium development (GO:0060429),0.47967924,1,0,0,1.539408867,1.13090771,CTSB,0
1263,sphingolipid metabolic process (GO:0006665),0.482610028,1,0,0,1.526251526,1.111944973,HEXB,0
1264,ion transport (GO:0006811),0.484796905,1,0,0,1.231527094,0.891656685,UBC;SGK1,0
1265,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.488412079,1,0,0,1.223091977,0.876462579,UBC;NFE2L2,0
1266,regulation of neuron projection development (GO:0010975),0.491304585,1,0,0,1.488095238,1.057575904,APOE,0
1267,regulation of phosphorylation (GO:0042325),0.491304585,1,0,0,1.488095238,1.057575904,CCL5,0
1268,protein phosphorylation (GO:0006468),0.493291889,1,0,0,1.137397634,0.803746829,PIM1;SGK1;TLR2,0
1269,enzyme linked receptor protein signaling pathway (GO:0007167),0.494170468,1,0,0,1.47579693,1.040251984,MTSS1,0
1270,DNA replication (GO:0006260),0.494170468,1,0,0,1.47579693,1.040251984,PTMS,0
1271,negative regulation of growth (GO:0045926),0.494170468,1,0,0,1.47579693,1.040251984,BST2,0
1272,macromolecular complex assembly (GO:0065003),0.494170468,1,0,0,1.47579693,1.040251984,CD74,0
1273,protein dephosphorylation (GO:0006470),0.50826161,1,0,0,1.41723356,0.959125544,PPP1R15A,0
1274,positive regulation of protein kinase B signaling (GO:0051897),0.513788505,1,0,0,1.395089286,0.929050735,CCL3,0
1275,negative regulation of response to stimulus (GO:0048585),0.513788505,1,0,0,1.395089286,0.929050735,AXL,0
1276,non-canonical Wnt signaling pathway (GO:0035567),0.513788505,1,0,0,1.395089286,0.929050735,UBC,0
1277,positive regulation of mitochondrion organization (GO:0010822),0.516528821,1,0,0,1.38427464,0.914485315,DDHD1,0
1278,DNA metabolic process (GO:0006259),0.52883936,1,0,0,1.133786848,0.722302222,UBC;PTMS,0
1279,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),0.532652208,1,0,0,1.322751323,0.833183315,RGS1,0
1280,muscle contraction (GO:0006936),0.540512897,1,0,0,1.293995859,0.796113847,ITGB5,0
1281,regulation of signal transduction by p53 class mediator (GO:1901796),0.543103896,1,0,0,1.284686536,0.784242858,UBC,0
1282,regulation of primary metabolic process (GO:0080090),0.545680414,1,0,0,1.275510204,0.772604332,APOE,0
1283,neuron differentiation (GO:0030182),0.545680414,1,0,0,1.275510204,0.772604332,SKIL,0
1284,regulation of cellular component organization (GO:0051128),0.548242532,1,0,0,1.266464032,0.761192393,SGK1,0
1285,protein transport (GO:0015031),0.549068472,1,0,0,1.092179991,0.654796989,CD74;APOE,0
1286,modification-dependent protein catabolic process (GO:0019941),0.550790329,1,0,0,1.257545272,0.750001347,UBC,0
1287,positive regulation of macromolecule biosynthetic process (GO:0010557),0.553323884,1,0,0,1.248751249,0.739025678,TLR2,0
1288,neuron development (GO:0048666),0.558348586,1,0,0,1.231527094,0.717699267,SKIL,0
1289,peptidyl-serine phosphorylation (GO:0018105),0.560839889,1,0,0,1.223091977,0.707338327,SGK1,0
1290,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.570666587,1,0,0,1.19047619,0.667797799,UBC,0
1291,intracellular protein transport (GO:0006886),0.583001723,1,0,0,1.026272578,0.553740904,CD74;TNF,0
1292,regulation of protein kinase B signaling (GO:0051896),0.603374748,1,0,0,1.088850174,0.550105404,CCL3,0
1293,glycerophospholipid biosynthetic process (GO:0046474),0.605614206,1,0,0,1.082251082,0.542762034,DDHD1,0
1294,mitochondrion organization (GO:0007005),0.612257663,1,0,0,1.06292517,0.521473286,HK2,0
1295,cellular macromolecule biosynthetic process (GO:0034645),0.613559708,1,0,0,0.970496894,0.474066087,RRBP1;PTMS,0
1296,peptidyl-serine modification (GO:0018209),0.618790192,1,0,0,1.04427736,0.501241657,SGK1,0
1297,protein autophosphorylation (GO:0046777),0.629436207,1,0,0,1.01461039,0.469694368,PIM1,0
1298,transmembrane transport (GO:0055085),0.629632991,1,0,0,0.942329438,0.435938733,UBC;SGK1,0
1299,phosphorylation (GO:0016310),0.640996952,1,0,0,0.92284976,0.410419506,PIM1;SGK1,0
1300,organonitrogen compound biosynthetic process (GO:1901566),0.641823097,1,0,0,0.981161695,0.435088857,FURIN,0
1301,protein modification by small protein conjugation (GO:0032446),0.657532046,1,0,0,0.89509488,0.37527907,UBC;NFE2L2,0
1302,positive regulation of multicellular organismal process (GO:0051240),0.682032047,1,0,0,0.87966221,0.336627932,TNF,0
1303,endosomal transport (GO:0016197),0.727219831,1,0,0,0.776397516,0.247303157,UBC,0
1304,translation (GO:0006412),0.731829845,1,0,0,0.766400981,0.239275938,RRBP1,0
1305,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.737856624,1,0,0,0.753465943,0.229057979,TRA2B,0
1306,regulation of immune response (GO:0050776),0.759285238,1,0,0,0.70861678,0.195137305,B2M,0
1307,"mRNA splicing, via spliceosome (GO:0000398)",0.772596949,1,0,0,0.681570338,0.175843633,TRA2B,0
1308,protein ubiquitination (GO:0016567),0.780267466,1,0,0,0.704423781,0.174780581,UBC;NFE2L2,0
1309,mRNA processing (GO:0006397),0.799369039,1,0,0,0.628772636,0.140802669,TRA2B,0
1310,DNA repair (GO:0006281),0.805003769,1,0,0,0.617894217,0.134026396,UBC,0
1311,chemical synaptic transmission (GO:0007268),0.806111749,1,0,0,0.615763547,0.132717302,APOE,0
1312,cellular protein localization (GO:0034613),0.843894339,1,0,0,0.544425087,0.092404172,CD74,0
1313,cellular response to DNA damage stimulus (GO:0006974),0.845666839,1,0,0,0.541125541,0.090708768,PPP1R15A,0
1314,post-translational protein modification (GO:0043687),0.868485223,1,0,0,0.498802873,0.070333553,APOE,0
1315,gene expression (GO:0010467),0.903464301,1,0,0,0.433425798,0.044000815,RRBP1,0
1316,cellular protein modification process (GO:0006464),0.924052591,1,0,0,0.534644996,0.042229626,PIM1;APOE;SGK1,0
1317,regulation of nucleic acid-templated transcription (GO:1903506),0.96880029,1,0,0,0.293703008,0.009309442,BHLHE40,0
1318,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.972851512,1,0,0,0.282549729,0.007776847,BHLHE40,0
1319,neutrophil degranulation (GO:0043312),2.98E-22,1.52E-18,0,0,6.505576208,322.4547956,CD63;CSTB;HVCN1;CTSZ;ITGB2;CXCL1;TCIRG1;GNS;CTSS;LGALS3;HK3;SYNGR1;CYB5R3;GM2A;ANPEP;FTH1;CREG1;LAMP2;PSAP;TIMP2;ITGAX;OLR1;SIRPA;CD36;CTSD;CTSB;VAT1;ANXA3;SLC11A1;CYBB;TNFRSF1B;IGF2R;BST1;CLEC4D;FABP5;TMBIM1;ADAM8;DEGS1;MAN2B1;CD68;S100A9;CD44,1
1320,neutrophil activation involved in immune response (GO:0002283),4.09E-22,1.04E-18,0,0,6.451811116,317.7332474,CD63;CSTB;HVCN1;CTSZ;ITGB2;CXCL1;TCIRG1;GNS;CTSS;LGALS3;HK3;SYNGR1;CYB5R3;GM2A;ANPEP;FTH1;CREG1;LAMP2;PSAP;TIMP2;ITGAX;OLR1;SIRPA;CD36;CTSD;CTSB;VAT1;ANXA3;SLC11A1;CYBB;TNFRSF1B;IGF2R;BST1;CLEC4D;FABP5;TMBIM1;ADAM8;DEGS1;MAN2B1;CD68;S100A9;CD44,1
1321,neutrophil mediated immunity (GO:0002446),5.61E-22,9.55E-19,0,0,6.398927418,313.1092099,CD63;CSTB;HVCN1;CTSZ;ITGB2;CXCL1;TCIRG1;GNS;CTSS;LGALS3;HK3;SYNGR1;CYB5R3;GM2A;ANPEP;FTH1;CREG1;LAMP2;PSAP;TIMP2;ITGAX;OLR1;SIRPA;CD36;CTSD;CTSB;VAT1;ANXA3;SLC11A1;CYBB;TNFRSF1B;IGF2R;BST1;CLEC4D;FABP5;TMBIM1;ADAM8;DEGS1;MAN2B1;CD68;S100A9;CD44,1
1322,extracellular matrix disassembly (GO:0022617),6.31E-10,8.05E-07,0,0,11.29358618,239.2368902,MMP12;MMP13;CTSL;CTSK;SH3PXD2B;TIMP2;SPP1;FN1;MMP19;ADAM8;CTSS;CD44,1
1323,cellular response to low-density lipoprotein particle stimulus (GO:0071404),8.88E-09,9.06E-06,0,0,34.31512725,636.1953326,ABCA1;CD81;ITGB2;LPL;CD9;CD36,1
1324,regulated exocytosis (GO:0045055),1.16E-07,9.87E-05,0,0,6.4868641,103.5922291,CD63;TEX264;APLP2;ACTN1;FN1;ACTN4;IGF1;LHFPL2;SYNGR1;LAMP2;PSAP;CD9;CD36,1
1325,platelet degranulation (GO:0002576),1.26E-07,9.15E-05,0,0,7.137546468,113.418568,CD63;TEX264;APLP2;ACTN1;LAMP2;PSAP;FN1;CD9;ACTN4;IGF1;CD36;LHFPL2,1
1326,proton transport (GO:0015992),1.86E-07,0.000118608,0,0,16.26394052,252.0558309,SLC36A2;HVCN1;UCP2;ATP6V1B2;TCIRG1;ATP6V1E1;ATP6V1C1,1
1327,pattern recognition receptor signaling pathway (GO:0002221),2.70E-07,0.000153125,0,0,12.13868447,183.5929449,CTSL;S100A1;CTSK;CD36;S100A9;CTSS;CTSB;HSP90B1,1
1328,intracellular pH reduction (GO:0051452),2.90E-07,0.000148211,0,0,15.30723814,230.4025827,ATP6V1A;SLC11A1;ATP6V1B2;TCIRG1;ATP6V1E1;ATP6V0D2;ATP6V1C1,1
1329,transferrin transport (GO:0033572),5.37E-07,0.000249128,0,0,14.06611072,203.0757117,ATP6V1A;CLTC;ATP6V1B2;TCIRG1;ATP6V1E1;ATP6V0D2;ATP6V1C1,1
1330,ferric iron transport (GO:0015682),5.37E-07,0.000228367,0,0,14.06611072,203.0757117,ATP6V1A;CLTC;ATP6V1B2;TCIRG1;ATP6V1E1;ATP6V0D2;ATP6V1C1,1
1331,phagosome acidification (GO:0090383),1.65E-06,0.00064573,0,0,15.93202337,212.1789232,ATP6V1A;ATP6V1B2;TCIRG1;ATP6V1E1;ATP6V0D2;ATP6V1C1,1
1332,cellular protein catabolic process (GO:0044257),1.97E-06,0.000718542,0,0,9.441199032,124.027269,BNIP3L;CTSL;CTSK;CTSZ;CLTC;TCIRG1;CTSS;CTSB,1
1333,hydrogen ion transmembrane transport (GO:1902600),2.05E-06,0.000697705,0,0,15.38264325,201.4702957,HVCN1;UCP2;ATP6V1B2;TCIRG1;ATP6V1E1;ATP6V1C1,1
1334,toll-like receptor signaling pathway (GO:0002224),2.59E-06,0.00082536,0,0,7.691321625,98.94643787,CTSL;S100A1;CTSK;ITGB2;CD36;S100A9;CTSS;CTSB;HSP90B1,1
1335,extracellular matrix organization (GO:0030198),3.03E-06,0.000908454,0,0,4.525618232,57.51217449,ITGB2;FN1;CTSS;MMP12;MMP13;CTSL;CTSK;SH3PXD2B;TIMP2;SPP1;ITGAX;MMP19;ADAM8;CD44,1
1336,inorganic cation transmembrane transport (GO:0098662),3.34E-06,0.000946512,0,0,5.800311108,73.14156687,FKBP1A;P2RX4;SLC11A1;HVCN1;UCP2;ATP6V1B2;CACNA1D;TCIRG1;ATP6V1E1;SLC39A1;ATP6V1C1,1
1337,insulin receptor signaling pathway (GO:0008286),3.55E-06,0.00095361,0,0,8.746993221,109.7607757,ATP6V1A;CAV2;ATP6V1B2;TCIRG1;ATP6V1E1;BAIAP2;ATP6V0D2;ATP6V1C1,1
1338,phagosome maturation (GO:0090382),4.57E-06,0.00116626,0,0,13.51808043,166.2156805,ATP6V1A;ATP6V1B2;TCIRG1;ATP6V1E1;ATP6V0D2;ATP6V1C1,1
1339,cellular response to thyroid hormone stimulus (GO:0097067),6.31E-06,0.001532286,0,0,29.73977695,356.1057488,CTSL;KLF9;CTSS;CTSB,1
1340,response to thyroid hormone (GO:0097066),9.80E-06,0.002274132,0,0,27.03616087,311.7998876,CTSL;KLF9;CTSS;CTSB,1
1341,cellular response to insulin stimulus (GO:0032869),1.93E-05,0.004273368,0,0,6.028333166,65.45228204,ATP6V1A;CAV2;ATP6V1B2;MYO5A;TCIRG1;ATP6V1E1;BAIAP2;ATP6V0D2;ATP6V1C1,1
1342,positive regulation of intracellular signal transduction (GO:1902533),2.94E-05,0.0062535,0,0,2.942998761,30.70767297,TCF7L2;PRKCB;CAV2;PLK2;CAV1;TREM2;ACTN4;IGF1;RHOC;TNFRSF1B;RTN4;FKBP1A;F7;P2RX4;HMOX1;ADAM8;IL7R;S100A9;MET,1
1343,negative regulation of apoptotic process (GO:0043066),3.48E-05,0.007105687,0,0,2.906665443,29.8385715,BNIP3L;ANXA1;WFS1;PLK2;ANXA4;SPHK1;CAV1;IGF1;TNFRSF1B;FAM129B;HSP90B1;SOCS2;GCLC;PDPN;CTNNB1;ADAM8;SQSTM1;MET;CD44,1
1344,receptor-mediated endocytosis (GO:0006898),5.27E-05,0.010349216,0,0,4.327216223,42.62451593,CD81;CAV2;CAV1;CLTC;ITGB2;MRC1;M6PR;CD9;CD36;IGF2R;HSP90B1,1
1345,acylglycerol catabolic process (GO:0046464),5.41E-05,0.010227494,0,0,11.99184555,117.8129595,ABHD12;FABP4;FABP5;LPL;DAGLB,1
1346,receptor internalization (GO:0031623),6.07E-05,0.011061528,0,0,8.746993221,84.93034371,CD81;CAV1;CLTC;ITGB2;CD9;CD36,1
1347,regulation of lipid metabolic process (GO:0019216),6.63E-05,0.011660216,0,0,5.889064743,56.66376005,ABCA1;SLC27A1;ALAS1;CAV1;TXNRD1;PSAP;PLIN2;CD36,1
1348,positive regulation of cellular protein catabolic process (GO:1903364),6.63E-05,0.011285553,0,0,17.49398644,168.3029678,RNF128;CD81;ATPIF1;PTTG1IP,1
1349,positive chemotaxis (GO:0050918),6.63E-05,0.010921503,0,0,17.49398644,168.3029678,NRP1;LGALS3;GPNMB;MET,1
1350,positive regulation of calcium ion transport (GO:0051928),8.57E-05,0.013674289,0,0,10.93374153,102.3844946,LGALS3;P2RX4;WFS1;CAV1;CACNA1D,1
1351,positive regulation of leukocyte migration (GO:0002687),9.89E-05,0.015301123,0,0,10.62134891,97.93845334,LGALS3;F7;CXCL1;ADAM8;CXCL3,1
1352,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.000102186,0.015336954,0,0,2.996451078,27.53353028,ATP6V1A;NUS1;NRP1;SORT1;CAV2;MATK;CYBB;IGF1;TCIRG1;BAIAP2;SOCS2;BLNK;ATP6V1B2;ATP6V1E1;ATP6V0D2;ATP6V1C1,1
1353,cellular response to hormone stimulus (GO:0032870),0.000109634,0.015984672,0,0,6.425260453,58.5878433,SOCS2;CTSL;CAV1;KLF9;ATP1A1;CTSS;CTSB,1
1354,glycosaminoglycan catabolic process (GO:0006027),0.00011433,0.016206321,0,0,7.826257093,71.03438768,GPC1;HEXA;SDC3;SDC1;GNS;CD44,1
1355,response to lipid (GO:0033993),0.000125705,0.017337105,0,0,4.745709088,42.623929,SOCS2;SLC11A1;SPP1;CTNNB1;CXCL1;CD36;CXCL3;TNFRSF1B;ABCG1,1
1356,"wound healing, spreading of cells (GO:0044319)",0.000130837,0.017570064,0,0,14.86988848,132.959947,MMP12;PDPN;RHOC;CD44,1
1357,receptor metabolic process (GO:0043112),0.00013881,0.018162737,0,0,7.560960242,67.15951425,CD81;CAV1;CLTC;ITGB2;CD9;CD36,1
1358,protein transport (GO:0015031),0.000148304,0.018919835,0,0,3.183156554,28.06350032,ATP6V1A;PRKCB;CLTC;TCIRG1;HSP90B1;LAMP2;ATP6V1B2;MYH9;CD36;ATP6V1E1;RAB7B;ATP6V0D2;ATP6V1C1;ABCG1,1
1359,regulation of angiogenesis (GO:0045765),0.000153997,0.01916694,0,0,4.176934965,36.66755843,RGCC;GPNMB;PRKCB;ANXA3;TNFSF12;SPHK1;HMOX1;CTNNB1;RHOB;FAM129B,1
1360,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.000160031,0.019443769,0,0,6.051698798,52.89271231,NRP1;BST1;CD81;ITGB2;TREM2;IGF1;CD44,1
1361,ion transport (GO:0006811),0.000162642,0.019301423,0,0,3.332906038,29.0761397,ATP6V1A;SLC36A2;ATP1B3;TCIRG1;ATP1A1;LASP1;P2RX4;ATP6V1B2;ATP6V1E1;SGK1;ATP6V0D2;SLC39A1;ATP6V1C1,1
1362,myelin assembly (GO:0032288),0.00019035,0.02207622,0,0,24.78314746,212.3085136,GPC1;AHNAK2;CD9,1
1363,L-ascorbic acid metabolic process (GO:0019852),0.00019035,0.021585637,0,0,24.78314746,212.3085136,CYB5A;CYB5R3;AKR1A1,1
1364,endocytosis (GO:0006897),0.000254691,0.028254092,0,0,3.379520108,27.96708172,MYO1E;ANXA1;ANXA3;SORT1;SLC11A1;CAV1;CLTC;MRC1;M6PR;CD36;IGF2R;HSP90B1,1
1365,positive regulation of bone remodeling (GO:0046852),0.000269226,0.02923108,0,0,22.30483271,183.3448111,DCSTAMP;SPP1;ADAM8,1
1366,positive regulation of bone resorption (GO:0045780),0.000269226,0.028622099,0,0,22.30483271,183.3448111,DCSTAMP;SPP1;ADAM8,1
1367,cellular modified amino acid biosynthetic process (GO:0042398),0.000324011,0.033743428,0,0,11.89591078,95.58046905,SLC27A1;GCLC;ATPIF1;GCLM,1
1368,cholesterol transport (GO:0030301),0.000333766,0.034064129,0,0,8.261049153,66.13028718,ABCA1;SOAT1;CAV1;CD36;ABCG1,1
1369,negative regulation of cellular process (GO:0048523),0.000358677,0.035888766,0,0,2.501476566,19.84443676,LRPAP1;BNIP3L;ACTN1;CAV1;CXCL1;INHBA;RTN4;RHOB;FAM129B;DCSTAMP;RGCC;GPNMB;FTH1;PDPN;CTNNB1;MYH9;CD9;APBB2,1
1370,positive regulation of extracellular matrix organization (GO:1903055),0.00036651,0.035967321,0,0,20.27712065,160.4221293,RGCC;PDPN;COLGALT1,1
1371,positive regulation of endothelial cell migration (GO:0010595),0.000385742,0.037140379,0,0,6.283051469,49.38693647,NRP1;NUS1;P2RX4;ANXA3;MET;RHOB,1
1372,regulation of fibroblast proliferation (GO:0048145),0.000409986,0.038743664,0,0,7.909515147,61.68937663,FTH1;SPHK1;FN1;CTNNB1;IGF1,1
1373,negative regulation of programmed cell death (GO:0043069),0.000457448,0.042442818,0,0,2.726752165,20.96831038,BNIP3L;ANXA1;WFS1;PLK2;ANXA4;SPHK1;IGF1;FAM129B;HSP90B1;SOCS2;GCLC;PDPN;SQSTM1;MET;CD44,1
1374,regulation of autophagy (GO:0010506),0.000459269,0.041850854,0,0,3.644580509,28.01179117,ATP6V1A;DAP;PLK2;CTSK;PSAP;ATP6V1B2;ATP6V1E1;ATP6V0D2;MET;ATP6V1C1,1
1375,regulation of cholesterol storage (GO:0010885),0.000483831,0.043315567,0,0,18.58736059,141.8917436,ABCA1;LPL;ABCG1,1
1376,positive regulation of chemotaxis (GO:0050921),0.00049865,0.043872578,0,0,7.586677794,57.68611385,F7;P2RX4;CXCL1;CXCL3;MET,1
1377,amino acid transport (GO:0006865),0.00049865,0.043128975,0,0,7.586677794,57.68611385,SLC6A6;SLC36A2;SLC6A8;SLC7A11;SLC7A2,1
1378,positive regulation of angiogenesis (GO:0045766),0.000515585,0.043850546,0,0,5.004289391,37.88350873,S100A1;PRKCB;ANXA3;TNFSF12;SPHK1;HMOX1;RHOB,1
1379,nitrogen compound transport (GO:0071705),0.000518623,0.043385808,0,0,5.94795539,44.99231471,SLC48A1;SLC6A6;SLC36A2;SLC11A1;SLC7A11;SLC7A2,1
1380,blood circulation (GO:0008015),0.00060101,0.049467021,0,0,7.289161018,54.06296791,GCLC;CYB5R3;MYOF;OLR1;GCLM,1
1381,regulation of leukocyte migration (GO:0002685),0.000622742,0.05044209,0,0,17.15756363,126.6464711,BST1;ANXA1;HMOX1,1
1382,proteolysis (GO:0006508),0.000628923,0.050146748,0,0,3.055456536,22.5233052,MMP12;F7;CTSL;ANPEP;CTSK;CTSZ;OLR1;MMP19;TPP1;CTSD;CTSS;CTSB,1
1383,transmembrane transport (GO:0055085),0.000656364,0.051529597,0,0,2.746417397,20.12793159,ATP6V1A;SLC44A1;ABCC5;ATP1B3;TCIRG1;ATP1A1;P2RX4;UCP2;ATP6V1B2;ATP6V1E1;SGK1;ATP6V0D2;ATP6V1C1;ABCG1,1
1384,carboxylic acid transport (GO:0046942),0.00065773,0.050854509,0,0,7.148984844,52.37857892,SLC6A6;SLC36A2;PSAP;SLC7A11;SLC7A2,1
1385,regulation of macrophage derived foam cell differentiation (GO:0010743),0.000665855,0.050714274,0,0,9.913258984,72.50992939,ABCA1;LPL;CD36;ABCG1,1
1386,regulation of apoptotic process (GO:0042981),0.000700634,0.052578486,0,0,2.095633793,15.22168726,BNIP3L;ANXA1;ACTN1;PLK2;ANXA4;SPHK1;ACTN4;IGF1;INHBA;TNFRSF1B;RTN4;RHOB;FAM129B;HSP90B1;SOCS2;GCLC;PDPN;CTNNB1;SGK1;SQSTM1;MET;CD44;CTSB,1
1387,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),0.000716095,0.052959912,0,0,3.442103814,24.92667424,MTPN;RGCC;PRKCB;ANXA3;SPHK1;CTNNB1;ADAM8;CD36;RAB7B;S100A9,1
1388,regulation of calcium ion transport (GO:0051924),0.000718364,0.052368721,0,0,7.014098338,50.77179232,CD84;P2RX4;WFS1;CTNNB1;CACNA1D,1
1389,regulation of endothelial cell proliferation (GO:0001936),0.000731948,0.052607466,0,0,5.576208178,40.25911468,NRP1;RGCC;CAV2;CAV1;TNFSF12;ATPIF1,1
1390,negative regulation of endothelial cell proliferation (GO:0001937),0.000756483,0.053615764,0,0,9.593476436,68.94668349,RGCC;CAV2;CAV1;ATPIF1,1
1391,epiboly involved in wound healing (GO:0090505),0.000784725,0.054855511,0,0,15.93202337,113.9167882,PDPN;RHOC;CD44,1
1392,ion transmembrane transport (GO:0034220),0.000824324,0.056844904,0,0,3.379520108,23.99779484,ATP6V1A;P2RX4;ATP6V1B2;ATP1B3;TCIRG1;ATP1A1;ATP6V1E1;SGK1;ATP6V0D2;ATP6V1C1,1
1393,organonitrogen compound biosynthetic process (GO:1901566),0.000824719,0.056113884,0,0,3.676620777,26.10572733,SLC27A1;SGPL1;GSTM1;SLC44A1;SPHK1;ESD;AKR1A1;DEGS1;INHBA,1
1394,positive regulation of homeostatic process (GO:0032846),0.000946895,0.063579018,0,0,5.310674456,36.97462727,DCSTAMP;P2RX4;CAV1;SPP1;ADAM8;INHBA,1
1395,aminoglycan catabolic process (GO:0006026),0.000963291,0.063839909,0,0,9.012053622,62.5901112,GPC1;SDC3;SDC1;GNS,1
1396,granulocyte chemotaxis (GO:0071621),0.00100343,0.065647487,0,0,6.52188091,45.02922467,LGALS3;ANXA1;ITGB2;CXCL3;S100A9,1
1397,sphingolipid metabolic process (GO:0006665),0.001038716,0.067095814,0,0,4.448257236,30.55850258,SGPL1;GM2A;SPHK1;PSAP;HEXA;DEGS1;SERINC1,1
1398,calcium ion transport (GO:0006816),0.001146966,0.073162069,0,0,4.373496611,29.61135104,FKBP1A;P2RX4;CAV1;NPY;CACNA1D;KCNN4;TMEM165,1
1399,cholesterol homeostasis (GO:0042632),0.001173919,0.073956894,0,0,6.300800202,42.51406715,ABCA1;SOAT1;CAV1;LPL;ABCG1,1
1400,sterol homeostasis (GO:0055092),0.001173919,0.07305498,0,0,6.300800202,42.51406715,ABCA1;SOAT1;CAV1;LPL;ABCG1,1
1401,myoblast differentiation (GO:0045445),0.00118348,0.072762613,0,0,13.94052045,93.94929759,TCF7L2;SDC1;IGF1,1
1402,negative regulation of T cell activation (GO:0050868),0.001206923,0.073320577,0,0,8.497079129,57.09766176,CD274;LGALS3;DUSP3;GPNMB,1
1403,regulation of insulin receptor signaling pathway (GO:0046626),0.001206923,0.072457982,0,0,8.497079129,57.09766176,SOCS2;PTPRE;PRKCB;IGF1,1
1404,actin filament organization (GO:0007015),0.001263872,0.074994629,0,0,4.30120741,28.70443184,ACTN1;DSTN;EVL;RHOC;BAIAP2;ARHGAP25;RHOB,1
1405,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.001266774,0.074302869,0,0,6.195786865,41.33383814,LGALS3;TCF7L2;CAV1;TNFSF12;IGF1,1
1406,glycosaminoglycan metabolic process (GO:0030203),0.001468614,0.085162932,0,0,5.995922773,39.11401894,GPC1;HEXA;SDC3;SDC1;GNS,1
1407,diterpenoid metabolic process (GO:0016101),0.001577965,0.090475926,0,0,5.900749395,38.0693868,GPC1;SDC3;LPL;SDC1;DHRS3,1
1408,actin filament bundle assembly (GO:0051017),0.001648645,0.093478151,0,0,7.826257093,50.14910394,BAIAP2;RHOC;HSP90B1;RHOB,1
1409,regulation of cell growth (GO:0001558),0.001706782,0.09571111,0,0,3.312598918,21.11167414,SOCS2;DCSTAMP;MTPN;SPHK1;APBB2;INHBA;SGK1;S100A9;RTN4,1
1410,positive regulation of multicellular organismal process (GO:0051240),0.001765463,0.09792565,0,0,3.296280697,20.89625087,LRPAP1;RGCC;SLC11A1;HILPDA;PDPN;CTNNB1;INHBA;RTN4;FAM129B,1
1411,cellular response to decreased oxygen levels (GO:0036294),0.001814457,0.099560998,0,0,5.719187875,36.09933751,BNIP3L;RGCC;HILPDA;HMOX1;ADAM8,1
1412,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.001827648,0.099217959,0,0,4.034465866,25.43619918,MTPN;PRKCB;SPHK1;ADAM8;CD36;RAB7B;S100A9,1
1413,regulation of cytoskeleton organization (GO:0051493),0.001889534,0.101497832,0,0,4.646840149,29.14230867,BST1;CLIC4;RHOC;BAIAP2;S100A9;RHOB,1
1414,positive regulation of cellular process (GO:0048522),0.001903646,0.101190709,0,0,2.28767515,14.3299606,MTPN;CD81;SPHK1;CAV1;HILPDA;FN1;MATK;ACTN4;IGF1;TCIRG1;BST1;P2RX4;PDPN;CD36;IL7R;S100A9,1
1415,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.00194197,0.102163657,0,0,5.632533514,35.16983315,FKBP1A;WFS1;SPHK1;CAV1;PTTG1IP,1
1416,primary alcohol metabolic process (GO:0034308),0.001987708,0.103502779,0,0,11.73938564,73.02805577,GDE1;IGF1;DHRS3,1
1417,negative regulation of lymphocyte activation (GO:0051250),0.001987708,0.102457297,0,0,11.73938564,73.02805577,LGALS3;DUSP3;GPNMB,1
1418,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.001987708,0.101432724,0,0,11.73938564,73.02805577,CTNNB1;IGF1;FAM129B,1
1419,negative regulation of epithelial cell proliferation (GO:0050680),0.002075913,0.104884989,0,0,5.548465849,34.27483903,RGCC;CAV2;CAV1;ATPIF1;KLF9,1
1420,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.002191715,0.10965023,0,0,7.253604135,44.4143315,TCF7L2;RGCC;PDPN;CTNNB1,1
1421,negative regulation of cytokine secretion (GO:0050710),0.002191715,0.108585664,0,0,7.253604135,44.4143315,ANXA1;RGCC;ANXA4;FN1,1
1422,vacuolar acidification (GO:0007035),0.002315392,0.113610063,0,0,11.15241636,67.6748272,SLC11A1;TCIRG1;ATP6V0D2,1
1423,glycosaminoglycan biosynthetic process (GO:0006024),0.002324077,0.112950144,0,0,4.460966543,27.05322956,CHST11;ABCC5;GPC1;SDC3;HEXA;SDC1,1
1424,inflammatory response (GO:0006954),0.002334519,0.112387273,0,0,2.938713138,17.80845281,ANXA1;SLC11A1;ITGB2;BLNK;CYBB;ADAM8;CXCL1;CXCL3;TNFRSF1B;S100A9,1
1425,regulation of calcium-mediated signaling (GO:0050848),0.002397145,0.114323644,0,0,7.080899274,42.7224423,FKBP1A;BST1;P2RX4;TREM2,1
1426,regulation of cell proliferation (GO:0042127),0.002566816,0.121282046,0,0,2.006732588,11.97033877,TCF7L2;CD81;HILPDA;FN1;MATK;CXCL1;IGF1;INHBA;TCIRG1;CXCL3;TNFRSF1B;FAM129B;BST1;RGCC;GPNMB;FTH1;PDPN;CTNNB1;SGK1;IL7R,1
1427,negative regulation of cholesterol storage (GO:0010887),0.002608712,0.122130824,0,0,24.78314746,147.4324282,ABCA1;ABCG1,1
1428,retinal ganglion cell axon guidance (GO:0031290),0.002608712,0.121020544,0,0,24.78314746,147.4324282,NRP1;ALCAM,1
1429,morphogenesis of an endothelium (GO:0003159),0.002608712,0.119930269,0,0,24.78314746,147.4324282,CTNNB1;RHOB,1
1430,hyaluronan metabolic process (GO:0030212),0.002674639,0.121863245,0,0,10.62134891,62.92024231,ABCC5;HEXA;CD44,1
1431,regulation of cardiac muscle hypertrophy (GO:0010611),0.002674639,0.120784809,0,0,10.62134891,62.92024231,MTPN;P2RX4;IGF1,1
1432,membrane depolarization (GO:0051899),0.00284699,0.127440245,0,0,6.759040216,39.61806777,P2RX4;CAV1;ATPIF1;CACNA1D,1
1433,regulation of primary metabolic process (GO:0080090),0.002900612,0.128711497,0,0,3.717472119,21.72057095,ABCA1;SLC27A1;ALAS1;TXNRD1;PSAP;PLIN2;CD36,1
1434,positive regulation of vasculature development (GO:1904018),0.002968318,0.130580395,0,0,4.248539565,24.7254801,PRKCB;ANXA3;TNFSF12;SPHK1;HMOX1;RHOB,1
1435,lysosomal transport (GO:0007041),0.003025178,0.131944323,0,0,5.09242756,29.54007837,SORT1;NCOA4;M6PR;RAB7B;RHOB,1
1436,glutathione derivative biosynthetic process (GO:1901687),0.003066415,0.132609466,0,0,10.13856032,58.67434342,GSTM1;ESD;AKR1A1,1
1437,sterol transport (GO:0015918),0.003066415,0.131495101,0,0,10.13856032,58.67434342,CAV1;CD36;ABCG1,1
1438,triglyceride catabolic process (GO:0019433),0.003066415,0.130399308,0,0,10.13856032,58.67434342,FABP4;FABP5;LPL,1
1439,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.003066415,0.129321628,0,0,10.13856032,58.67434342,TIMP2;ADAM8;TNFRSF1B,1
1440,regulation of bone resorption (GO:0045124),0.003066415,0.128261615,0,0,10.13856032,58.67434342,DCSTAMP;SPP1;ADAM8,1
1441,glutathione derivative metabolic process (GO:1901685),0.003066415,0.127218837,0,0,10.13856032,58.67434342,GSTM1;ESD;AKR1A1,1
1442,regulation of T cell activation (GO:0050863),0.003092183,0.127253308,0,0,6.608839323,38.19167579,LGALS3;DUSP3;GPNMB;SIRPA,1
1443,regulation of smooth muscle cell proliferation (GO:0048660),0.003092183,0.126235281,0,0,6.608839323,38.19167579,TCF7L2;HMOX1;CTNNB1;IGF1,1
1444,positive regulation of cell migration (GO:0030335),0.003222647,0.130517195,0,0,3.014166583,17.29393832,NRP1;F7;GPNMB;SPHK1;PDPN;FN1;ACTN4;IGF1;RTN4,1
1445,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.003351402,0.134663016,0,0,6.465168903,36.84096714,NUS1;ANXA1;P2RX4;HMOX1,1
1446,cholesterol efflux (GO:0033344),0.003491631,0.139201517,0,0,9.697753354,54.8639365,ABCA1;SOAT1;ABCG1,1
1447,retinoid metabolic process (GO:0001523),0.003601972,0.142487318,0,0,4.891410683,27.52041554,GPC1;SDC3;LPL;SDC1;DHRS3,1
1448,intracellular sterol transport (GO:0032366),0.003619837,0.142092543,0,0,21.24269782,119.4121329,ABCA1;ABCG1,1
1449,negative regulation of interleukin-8 secretion (GO:2000483),0.003619837,0.141007867,0,0,21.24269782,119.4121329,ANXA1;ANXA4,1
1450,vesicle transport along actin filament (GO:0030050),0.003619837,0.139939625,0,0,21.24269782,119.4121329,MYO5A;ACTN4,1
1451,leukocyte aggregation (GO:0070486),0.003619837,0.138887448,0,0,21.24269782,119.4121329,S100A9;CD44,1
1452,heme catabolic process (GO:0042167),0.003619837,0.137850974,0,0,21.24269782,119.4121329,HMOX1;BLVRB,1
1453,vascular endothelial growth factor signaling pathway (GO:0038084),0.003619837,0.136829856,0,0,21.24269782,119.4121329,NRP1;NUS1,1
1454,porphyrin-containing compound catabolic process (GO:0006787),0.003619837,0.135823754,0,0,21.24269782,119.4121329,HMOX1;BLVRB,1
1455,granulocyte migration (GO:0097530),0.003619837,0.13483234,0,0,21.24269782,119.4121329,ANXA1;ITGB2,1
1456,regulation of RNA biosynthetic process (GO:2001141),0.003619837,0.133855294,0,0,21.24269782,119.4121329,MITF;ACTN4,1
1457,regulation of Cdc42 protein signal transduction (GO:0032489),0.003619837,0.132892306,0,0,21.24269782,119.4121329,ABCA1;NRP1,1
1458,protein complex disassembly (GO:0043241),0.003625023,0.13213208,0,0,6.327612117,35.56051385,GABARAPL1;CAV1;LAMP2;CTNNB1,1
1459,regulation of cellular component movement (GO:0051270),0.003625023,0.131194973,0,0,6.327612117,35.56051385,ACTN1;PDPN;CD9;ACTN4,1
1460,aminoglycan biosynthetic process (GO:0006023),0.003625023,0.130271065,0,0,6.327612117,35.56051385,GPC1;HEXA;SDC3;SDC1,1
1461,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.00381064,0.135983873,0,0,4.827885869,26.89112264,LGALS3;TCF7L2;TMBIM1;HMOX1;IGF1,1
1462,regulation of cell migration (GO:0030334),0.003918878,0.138875234,0,0,2.579949105,14.29794876,F7;CLIC4;ANXA1;GPNMB;SPHK1;PDPN;ACTN4;IGF1;RHOC;SGK1;RHOB,1
1463,regulation of protein binding (GO:0043393),0.004083367,0.143706347,0,0,3.983005842,21.90985179,FKBP1A;LRPAP1;TCF7L2;CAV1;CTSZ;CD36,1
1464,endosome to lysosome transport (GO:0008333),0.004216954,0.14739121,0,0,6.069342235,33.19106103,SORT1;M6PR;RAB7B;RHOB,1
1465,positive regulation of macromolecule metabolic process (GO:0010604),0.004443667,0.154258734,0,0,2.684095393,14.53779955,CD63;MTPN;RGCC;WFS1;SLC11A1;FN1;MITF;IGF1;CD36;INHBA,1
1466,neuron projection extension involved in neuron projection guidance (GO:1902284),0.004783731,0.164941749,0,0,18.58736059,99.30361547,NRP1;ALCAM,1
1467,lipoprotein transport (GO:0042953),0.004783731,0.163834757,0,0,18.58736059,99.30361547,PRKCB;CD36,1
1468,amyloid fibril formation (GO:1990000),0.004783731,0.162742525,0,0,18.58736059,99.30361547,FKBP1A;CD36,1
1469,axon extension involved in axon guidance (GO:0048846),0.004783731,0.16166476,0,0,18.58736059,99.30361547,NRP1;ALCAM,1
1470,phospholipid homeostasis (GO:0055091),0.004783731,0.160601176,0,0,18.58736059,99.30361547,ABCA1;ABCG1,1
1471,lipoprotein localization (GO:0044872),0.004783731,0.159551496,0,0,18.58736059,99.30361547,PRKCB;CD36,1
1472,interleukin-1 beta secretion (GO:0050702),0.004783731,0.158515447,0,0,18.58736059,99.30361547,ABCA1;CD36,1
1473,wound healing (GO:0042060),0.004870884,0.160362084,0,0,5.831328814,31.04879223,MMP12;SLC11A1;MYOF;HMOX1,1
1474,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.004976215,0.162779659,0,0,8.578781813,45.49401476,NRP1;NUS1;ANXA1,1
1475,negative regulation of insulin receptor signaling pathway (GO:0046627),0.004976215,0.161742845,0,0,8.578781813,45.49401476,SOCS2;PTPRE;PRKCB,1
1476,positive regulation of neutrophil migration (GO:1902624),0.004976215,0.160719157,0,0,8.578781813,45.49401476,CXCL1;ADAM8;CXCL3,1
1477,negative regulation of cell death (GO:0060548),0.004985503,0.160006417,0,0,4.533502584,24.03309928,BNIP3L;LRPAP1;GPNMB;WFS1;CTNNB1,1
1478,positive regulation of binding (GO:0051099),0.004985503,0.159006376,0,0,4.533502584,24.03309928,FKBP1A;TCF7L2;CAV1;IGF1;MET,1
1479,positive regulation of protein catabolic process (GO:0045732),0.004985503,0.158018759,0,0,4.533502584,24.03309928,PLK2;TNFSF12;ADAM8;PTTG1IP;TNFRSF1B,1
1480,regulation of macroautophagy (GO:0016241),0.005050985,0.159106018,0,0,3.812791917,20.1626997,ATP6V1A;BNIP3L;ATP6V1B2;ATP6V1E1;ATP6V0D2;ATP6V1C1,1
1481,positive regulation of protein ubiquitination (GO:0031398),0.005520321,0.17282329,0,0,4.425562046,23.00991029,FKBP1A;WFS1;SPHK1;CAV1;PTTG1IP,1
1482,negative regulation of cellular response to insulin stimulus (GO:1900077),0.005543229,0.172482304,0,0,8.261049153,42.91762153,SOCS2;PTPRE;PRKCB,1
1483,regulation of T cell receptor signaling pathway (GO:0050856),0.005543229,0.171436957,0,0,8.261049153,42.91762153,LGALS3;DUSP3;KCNN4,1
1484,positive regulation of mitotic cell cycle (GO:0045931),0.005589625,0.171830462,0,0,5.61127867,29.10482186,DUSP3;RGCC;SPHK1;IGF1,1
1485,triglyceride metabolic process (GO:0006641),0.005589625,0.170801537,0,0,5.61127867,29.10482186,FABP4;FABP5;CAV1;LPL,1
1486,cytokine-mediated signaling pathway (GO:0019221),0.005626526,0.17090572,0,0,1.993597035,10.3273572,IL1RN;ANXA1;TNFSF12;ITGB2;FN1;CXCL1;CXCL3;TNFRSF1B;HSP90B1;SOCS2;ITGAX;HMOX1;SDC1;CD36;IL7R;SQSTM1;CD44,1
1487,neutrophil chemotaxis (GO:0030593),0.00597415,0.180391047,0,0,5.507366102,28.19944083,LGALS3;ITGB2;CXCL3;S100A9,1
1488,positive regulation of MAPK cascade (GO:0043410),0.006092787,0.182891139,0,0,2.563773875,13.07691223,NRP1;GPNMB;CAV2;ADAM8;TREM2;IGF1;CD36;TNFRSF1B;MET;CD44,1
1489,interleukin-1 beta production (GO:0032611),0.006096131,0.181921394,0,0,16.52209831,84.26436861,ABCA1;CD36,1
1490,interleukin-1 secretion (GO:0050701),0.006096131,0.180863712,0,0,16.52209831,84.26436861,ABCA1;CD36,1
1491,protein localization to vacuole (GO:0072665),0.006096131,0.179818257,0,0,16.52209831,84.26436861,RNF128;CD81,1
1492,response to hexose (GO:0009746),0.006147449,0.180289827,0,0,7.966011683,40.5606863,TCF7L2;LPL;IGF1,1
1493,cell morphogenesis involved in differentiation (GO:0000904),0.006375885,0.185920797,0,0,5.407232173,27.33481541,NRP1;RILPL2;ACTN1;FN1,1
1494,sulfur compound biosynthetic process (GO:0044272),0.006422665,0.18622079,0,0,3.626802067,18.30781449,GCLC;GSTM1;CHST11;ESD;AKR1A1;GCLM,1
1495,regulation of MAPK cascade (GO:0043408),0.006522399,0.188044093,0,0,2.915664407,14.67311891,DUSP3;CAV2;CAV1;FN1;IGF1;INHBA;TNFRSF1B;MET,1
1496,organic substance transport (GO:0071702),0.006709277,0.192345166,0,0,4.224400135,21.140014,SLC48A1;ABCA1;CAV2;CAV1;PSAP,1
1497,regulation of vasculature development (GO:1901342),0.00678948,0.193557083,0,0,7.691321625,38.39800703,GPNMB;HMOX1;CTNNB1,1
1498,neuron projection extension (GO:1990138),0.00678948,0.192481766,0,0,7.691321625,38.39800703,NRP1;ALCAM;CTNNB1,1
1499,positive regulation of sprouting angiogenesis (GO:1903672),0.00678948,0.191418331,0,0,7.691321625,38.39800703,ANXA1;S100A1;HMOX1,1
1500,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.00678948,0.190366582,0,0,7.691321625,38.39800703,CAV1;TNFSF12;INHBA,1
1501,positive regulation of calcium-mediated signaling (GO:0050850),0.00678948,0.189326327,0,0,7.691321625,38.39800703,P2RX4;TREM2;IGF1,1
1502,positive regulation of fibroblast proliferation (GO:0048146),0.00678948,0.18829738,0,0,7.691321625,38.39800703,SPHK1;FN1;IGF1,1
1503,divalent metal ion transport (GO:0070838),0.007032429,0.193980988,0,0,4.176934965,20.70599884,SLC11A1;NPY;CAV1;CACNA1D;KCNN4,1
1504,organonitrogen compound catabolic process (GO:1901565),0.007232263,0.19842064,0,0,5.217504728,25.71814134,SGPL1;ANPEP;TPP1;CTSD,1
1505,cellular iron ion homeostasis (GO:0006879),0.007232263,0.197359567,0,0,5.217504728,25.71814134,ATP6V1A;FTH1;SLC11A1;HMOX1,1
1506,regulation of neutrophil chemotaxis (GO:0090022),0.007469885,0.202759706,0,0,7.434944238,36.40799727,BST1;CXCL1;CXCL3,1
1507,amino acid transmembrane transport (GO:0003333),0.007469885,0.201686904,0,0,7.434944238,36.40799727,SLC6A6;SLC36A2;SLC7A11,1
1508,ganglion development (GO:0061548),0.007552864,0.202854016,0,0,14.86988848,72.65172492,NRP1;CTNNB1,1
1509,regulation of coagulation (GO:0050818),0.007552864,0.201791953,0,0,14.86988848,72.65172492,PROCR;CAV1,1
1510,"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",0.007552864,0.200740953,0,0,14.86988848,72.65172492,MT-CO1;ATP1A1,1
1511,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.007552864,0.199700845,0,0,14.86988848,72.65172492,CTNNB1;MITF,1
1512,epithelial cell morphogenesis (GO:0003382),0.007552864,0.198671459,0,0,14.86988848,72.65172492,RILPL2;MET,1
1513,positive regulation of T cell apoptotic process (GO:0070234),0.007552864,0.197652631,0,0,14.86988848,72.65172492,CD274;ADAM8,1
1514,actin filament depolymerization (GO:0030042),0.007552864,0.196644199,0,0,14.86988848,72.65172492,MICAL2;DSTN,1
1515,cellular response to ATP (GO:0071318),0.007552864,0.195646005,0,0,14.86988848,72.65172492,P2RX4;HSP90B1,1
1516,positive regulation of reproductive process (GO:2000243),0.007552864,0.194657894,0,0,14.86988848,72.65172492,INHBA;LHFPL2,1
1517,sympathetic ganglion development (GO:0061549),0.007552864,0.193679714,0,0,14.86988848,72.65172492,NRP1;CTNNB1,1
1518,positive regulation of smooth muscle cell migration (GO:0014911),0.007552864,0.192711315,0,0,14.86988848,72.65172492,NRP1;IGF1,1
1519,actin filament-based transport (GO:0099515),0.007552864,0.191752552,0,0,14.86988848,72.65172492,MYO5A;ACTN4,1
1520,endothelial tube morphogenesis (GO:0061154),0.007552864,0.190803282,0,0,14.86988848,72.65172492,CTNNB1;RHOB,1
1521,intracellular cholesterol transport (GO:0032367),0.007552864,0.189863365,0,0,14.86988848,72.65172492,ABCA1;ABCG1,1
1522,neutrophil migration (GO:1990266),0.008161247,0.204151191,0,0,5.040640161,24.23720404,LGALS3;ITGB2;CXCL3;S100A9,1
1523,regulation of leukocyte chemotaxis (GO:0002688),0.008189181,0.203850676,0,0,7.195107327,34.57206932,F7;CXCL1;CXCL3,1
1524,protein localization to lysosome (GO:0061462),0.008189181,0.20286111,0,0,7.195107327,34.57206932,RNF128;CD81;NCOA4,1
1525,aminoglycan metabolic process (GO:0006022),0.008189181,0.201881105,0,0,7.195107327,34.57206932,GPC1;SDC3;SDC1,1
1526,proteolysis involved in cellular protein catabolic process (GO:0051603),0.008812478,0.216202292,0,0,3.954757573,18.71227784,CTSL;CTSK;CTSZ;CTSS;CTSB,1
1527,secondary alcohol metabolic process (GO:1902652),0.00894784,0.21847287,0,0,6.970260223,32.87413848,ABCA1;SOAT1;ABCG1,1
1528,lysosome organization (GO:0007040),0.00894784,0.217432523,0,0,6.970260223,32.87413848,ABCA1;TPP1;TMEM165,1
1529,regulation of lamellipodium morphogenesis (GO:2000392),0.009149837,0.221287292,0,0,13.51808043,63.45412915,PDPN;CD44,1
1530,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.009149837,0.220243484,0,0,13.51808043,63.45412915,DUSP3;GPNMB,1
1531,low-density lipoprotein particle remodeling (GO:0034374),0.009149837,0.219209477,0,0,13.51808043,63.45412915,PLA2G7;ABCG1,1
1532,relaxation of cardiac muscle (GO:0055119),0.009149837,0.218185134,0,0,13.51808043,63.45412915,P2RX4;ATP1A1,1
1533,regulation of integrin-mediated signaling pathway (GO:2001044),0.009149837,0.21717032,0,0,13.51808043,63.45412915,BST1;CD63,1
1534,regulation of hemopoiesis (GO:1903706),0.009149837,0.216164901,0,0,13.51808043,63.45412915,LGALS3;PRKCB,1
1535,sphingolipid catabolic process (GO:0030149),0.009149837,0.21516875,0,0,13.51808043,63.45412915,SGPL1;SPHK1,1
1536,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.009149837,0.214181737,0,0,13.51808043,63.45412915,SOAT1;IGF1,1
1537,transcytosis (GO:0045056),0.009149837,0.213203738,0,0,13.51808043,63.45412915,LRPAP1;CLTC,1
1538,relaxation of muscle (GO:0090075),0.009149837,0.21223463,0,0,13.51808043,63.45412915,P2RX4;ATP1A1,1
1539,cellular response to increased oxygen levels (GO:0036295),0.009149837,0.211274293,0,0,13.51808043,63.45412915,ATP6V1A;CAV1,1
1540,oxidative phosphorylation (GO:0006119),0.009149837,0.210322607,0,0,13.51808043,63.45412915,CHCHD10;MT-CO2,1
1541,glutathione biosynthetic process (GO:0006750),0.009149837,0.209379456,0,0,13.51808043,63.45412915,GCLC;GCLM,1
1542,regulation of stress fiber assembly (GO:0051492),0.009165204,0.208794806,0,0,4.875373271,22.8769145,NRP1;RGCC;EVL;MET,1
1543,cellular response to cytokine stimulus (GO:0071345),0.009268123,0.210201034,0,0,2.114973197,9.900558339,IL1RN;ANXA1;ITGB2;FN1;CXCL1;TNFRSF1B;HSP90B1;SOCS2;DCSTAMP;ITGAX;HMOX1;SDC1;CD36,1
1544,positive regulation of leukocyte chemotaxis (GO:0002690),0.009696005,0.218932355,0,0,4.796738218,22.23787676,F7;CXCL1;CXCL3;PLA2G7,1
1545,regulation of potassium ion transmembrane transport (GO:1901379),0.009746298,0.21909849,0,0,6.759040216,31.30022161,CD63;CAV1;CACNA1D,1
1546,endodermal cell differentiation (GO:0035987),0.009746298,0.218137532,0,0,6.759040216,31.30022161,ITGB2;FN1;INHBA,1
1547,regulation of nitric oxide biosynthetic process (GO:0045428),0.009746298,0.217184966,0,0,6.759040216,31.30022161,P2RX4;CAV1;CD36,1
1548,positive regulation of protein metabolic process (GO:0051247),0.010018087,0.222270855,0,0,3.832445483,17.64213829,MTPN;WFS1;PLK2;TNFSF12;INHBA,1
1549,epithelial cell differentiation (GO:0030855),0.010018087,0.221308644,0,0,3.832445483,17.64213829,LGALS3;BASP1;ANXA4;TPP1;CTSB,1
1550,regulation of cell death (GO:0010941),0.010018087,0.220354727,0,0,3.832445483,17.64213829,BNIP3L;LRPAP1;CTSZ;CTNNB1;CD36,1
1551,regulation of actin filament-based process (GO:0032970),0.010246382,0.224408951,0,0,4.720599516,21.62426692,BST1;RHOC;BAIAP2;RHOB,1
1552,regulation of T cell proliferation (GO:0042129),0.010246382,0.223449939,0,0,4.720599516,21.62426692,LGALS3;CD274;ANXA1;GPNMB,1
1553,phagocytosis (GO:0006909),0.01029295,0.223510307,0,0,3.280122458,15.01081167,ANXA1;ANXA3;SLC11A1;ITGB2;MYH9;ARHGAP25,1
1554,positive regulation of protein phosphorylation (GO:0001934),0.010433827,0.225609395,0,0,2.160274355,9.856688532,NRP1;GPNMB;CD81;CAV2;SPHK1;CAV1;TREM2;IGF1;INHBA;TNFRSF1B;MET;CD44,1
1555,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.010443881,0.224873954,0,0,3.793338897,17.30422191,DYNC1I2;CTSL;CLTC;CTSD;CTSS,1
1556,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.010443881,0.223929105,0,0,3.793338897,17.30422191,DYNC1I2;CTSL;CLTC;CTSD;CTSS,1
1557,entry into host cell (GO:0030260),0.010584945,0.226004083,0,0,6.560244916,29.83810982,CD81;CTNNB1;MET,1
1558,iron ion homeostasis (GO:0055072),0.010816596,0.229987877,0,0,4.646840149,21.0347288,ATP6V1A;FTH1;SLC11A1;HMOX1,1
1559,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.010881907,0.230416471,0,0,3.755022342,16.97515607,DYNC1I2;CTSL;CLTC;CTSD;CTSS,1
1560,entry of bacterium into host cell (GO:0035635),0.010883044,0.229488331,0,0,12.39157373,56.01671936,CTNNB1;MET,1
1561,phospholipid efflux (GO:0033700),0.010883044,0.228543934,0,0,12.39157373,56.01671936,ABCA1;ABCG1,1
1562,positive regulation of T-helper 1 type immune response (GO:0002827),0.010883044,0.227607279,0,0,12.39157373,56.01671936,ANXA1;SLC11A1,1
1563,nonribosomal peptide biosynthetic process (GO:0019184),0.010883044,0.22667827,0,0,12.39157373,56.01671936,GCLC;GCLM,1
1564,regulation of blood vessel size (GO:0050880),0.010883044,0.225756813,0,0,12.39157373,56.01671936,GCLC;GCLM,1
1565,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.010883044,0.224842818,0,0,12.39157373,56.01671936,PTTG1IP;CD44,1
1566,keratan sulfate catabolic process (GO:0042340),0.010883044,0.223936194,0,0,12.39157373,56.01671936,HEXA;GNS,1
1567,regulation of programmed cell death (GO:0043067),0.010894482,0.223271253,0,0,2.487527812,11.24237908,BNIP3L;WFS1;ACTN1;ACTN4;INHBA;SGK1;TNFRSF1B;RTN4;CTSB,1
1568,glycerophospholipid metabolic process (GO:0006650),0.011406902,0.23283768,0,0,4.5753503,20.46799741,ABHD12;GDE1;SERINC1;PLA2G7,1
1569,epithelial tube morphogenesis (GO:0060562),0.011464137,0.233073676,0,0,6.372809347,28.47710003,CTNNB1;MET;RHOB,1
1570,regulation of protein ubiquitination (GO:0031396),0.012270927,0.248486279,0,0,3.644580509,16.03805832,FKBP1A;WFS1;CAV1;SPHK1;PTTG1IP,1
1571,endothelial cell migration (GO:0043542),0.01238419,0.249788627,0,0,6.195786865,27.20777326,NRP1;TNFSF12;MYH9,1
1572,carboxylic acid transmembrane transport (GO:1905039),0.01238419,0.248805207,0,0,6.195786865,27.20777326,SLC6A6;SLC36A2;SLC7A11,1
1573,actin filament bundle organization (GO:0061572),0.01238419,0.2478295,0,0,6.195786865,27.20777326,BAIAP2;RHOC;RHOB,1
1574,sulfur compound catabolic process (GO:0044273),0.01238419,0.246861416,0,0,6.195786865,27.20777326,GPC1;HEXA;GNS,1
1575,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.01274856,0.253135808,0,0,11.43837575,49.89804906,ABCA1;ABCG1,1
1576,sodium ion export from cell (GO:0036376),0.01274856,0.252154662,0,0,11.43837575,49.89804906,ATP1B3;ATP1A1,1
1577,glycerolipid catabolic process (GO:0046503),0.01274856,0.251181091,0,0,11.43837575,49.89804906,ABHD12;GDE1,1
1578,regulation of macromolecule biosynthetic process (GO:0010556),0.01274856,0.25021501,0,0,11.43837575,49.89804906,MTPN;MITF,1
1579,positive regulation of skeletal muscle tissue development (GO:0048643),0.01274856,0.249256332,0,0,11.43837575,49.89804906,GPC1;FAM129B,1
1580,sodium ion export (GO:0071436),0.01274856,0.248304972,0,0,11.43837575,49.89804906,ATP1B3;ATP1A1,1
1581,positive regulation of endothelial cell chemotaxis (GO:2001028),0.01274856,0.247360847,0,0,11.43837575,49.89804906,P2RX4;MET,1
1582,regulation of macrophage differentiation (GO:0045649),0.01274856,0.246423874,0,0,11.43837575,49.89804906,INHBA;C1QC,1
1583,cellular potassium ion homeostasis (GO:0030007),0.01274856,0.245493972,0,0,11.43837575,49.89804906,ATP1B3;ATP1A1,1
1584,membrane repolarization (GO:0086009),0.01274856,0.244571063,0,0,11.43837575,49.89804906,ATP1B3;ATP1A1,1
1585,regulation of endothelial cell chemotaxis (GO:2001026),0.01274856,0.243655066,0,0,11.43837575,49.89804906,P2RX4;MET,1
1586,glomerular visceral epithelial cell differentiation (GO:0072112),0.01274856,0.242745906,0,0,11.43837575,49.89804906,MYO1E;BASP1,1
1587,regulation of protein localization to plasma membrane (GO:1903076),0.013300779,0.252319247,0,0,4.373496611,18.89321077,CLTC;TMBIM1;TREM2;SQSTM1,1
1588,actin polymerization or depolymerization (GO:0008154),0.013345384,0.252227761,0,0,6.028333166,26.02181075,DSTN;MICAL2;EVL,1
1589,regulation of nitric-oxide synthase activity (GO:0050999),0.013345384,0.251297032,0,0,6.028333166,26.02181075,NUS1;S100A1;CAV1,1
1590,endoderm formation (GO:0001706),0.013345384,0.250373145,0,0,6.028333166,26.02181075,ITGB2;FN1;INHBA,1
1591,acylglycerol metabolic process (GO:0006639),0.013345384,0.249456028,0,0,6.028333166,26.02181075,ABHD12;CAV1;LPL,1
1592,peptide metabolic process (GO:0006518),0.013775548,0.256557009,0,0,3.540449637,15.17033159,F7;GSTM1;ANPEP;LAMP2;TPP1,1
1593,positive regulation of stress fiber assembly (GO:0051496),0.014347964,0.266246044,0,0,5.869692819,24.91184036,NRP1;RGCC;EVL,1
1594,response to organic cyclic compound (GO:0014070),0.014668105,0.271200501,0,0,4.248539565,17.93767347,SOCS2;SPP1;HMOX1;CTNNB1,1
1595,branching involved in blood vessel morphogenesis (GO:0001569),0.014742539,0.271592692,0,0,10.62134891,44.79042129,NRP1;CTNNB1,1
1596,regulation of lipase activity (GO:0060191),0.014742539,0.27061574,0,0,10.62134891,44.79042129,LPL;RHOC,1
1597,myotube cell development (GO:0014904),0.014742539,0.269645791,0,0,10.62134891,44.79042129,CAV2;IGF1,1
1598,establishment or maintenance of actin cytoskeleton polarity (GO:0030950),0.014742539,0.268682771,0,0,10.62134891,44.79042129,RHOC;RHOB,1
1599,regulation of platelet aggregation (GO:0090330),0.014742539,0.267726604,0,0,10.62134891,44.79042129,PDPN;CD9,1
1600,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.014742539,0.266777219,0,0,10.62134891,44.79042129,PTTG1IP;CD44,1
1601,positive regulation of muscle hypertrophy (GO:0014742),0.014742539,0.265834544,0,0,10.62134891,44.79042129,MTPN;IGF1,1
1602,negative regulation of T cell receptor signaling pathway (GO:0050860),0.014742539,0.264898506,0,0,10.62134891,44.79042129,LGALS3;DUSP3,1
1603,response to ATP (GO:0033198),0.014742539,0.263969038,0,0,10.62134891,44.79042129,P2RX4;HSP90B1,1
1604,positive regulation of cellular catabolic process (GO:0031331),0.014844796,0.264870609,0,0,3.474273008,14.62705732,PLK2;ADAM8;PTTG1IP;IGF1;TNFRSF1B,1
1605,positive regulation of epithelial cell proliferation (GO:0050679),0.015399691,0.273814019,0,0,3.442103814,14.36530302,MMP12;NRP1;TNFSF12;IGF1;RTN4,1
1606,positive regulation of lymphocyte proliferation (GO:0050671),0.016121192,0.285647362,0,0,4.130524577,17.04923846,CD274;BST1;ANXA1;CD81,1
1607,positive regulation of growth (GO:0045927),0.016121192,0.284658963,0,0,4.130524577,17.04923846,MTPN;WFS1;SPHK1;S100A9,1
1608,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.016478095,0.289957643,0,0,5.576208178,22.89436831,LGALS3;TMBIM1;HMOX1,1
1609,positive regulation of cell differentiation (GO:0045597),0.016636815,0.291744559,0,0,2.668954342,10.93240335,RGCC;GPC1;PDPN;CTNNB1;LPL;IGF1;CD36,1
1610,myotube differentiation (GO:0014902),0.016861214,0.294667037,0,0,9.913258984,40.4732523,SORT1;IGF1,1
1611,glycerophospholipid catabolic process (GO:0046475),0.016861214,0.293661348,0,0,9.913258984,40.4732523,ABHD12;GDE1,1
1612,negative regulation of cellular component movement (GO:0051271),0.016861214,0.2926625,0,0,9.913258984,40.4732523,ACTN1;CD9,1
1613,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.016861214,0.291670423,0,0,9.913258984,40.4732523,ADAM8;TNFRSF1B,1
1614,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.016861214,0.29068505,0,0,9.913258984,40.4732523,PTTG1IP;CD44,1
1615,cellular sodium ion homeostasis (GO:0006883),0.016861214,0.289706313,0,0,9.913258984,40.4732523,ATP1B3;ATP1A1,1
1616,negative regulation of cytokine production (GO:0001818),0.017147069,0.293629168,0,0,3.349073981,13.6170938,CD274;CD84;RGCC;GPNMB;SLC11A1,1
1617,response to peptide hormone (GO:0043434),0.017605969,0.300479132,0,0,5.440203101,21.97579443,SORT1;CAV1;IGF1,1
1618,positive regulation of inflammatory response (GO:0050729),0.017661581,0.300423491,0,0,4.018888777,16.22169625,LPL;ADAM8;S100A9;PLA2G7,1
1619,positive regulation of epithelial cell migration (GO:0010634),0.01846496,0.313045481,0,0,3.965303594,15.82901773,NRP1;ANXA3;RTN4;RHOB,1
1620,positive regulation of defense response (GO:0031349),0.01846496,0.312008907,0,0,3.965303594,15.82901773,LPL;ADAM8;S100A9;PLA2G7,1
1621,glucose homeostasis (GO:0042593),0.01846496,0.310979174,0,0,3.965303594,15.82901773,HK3;TCF7L2;WFS1;IGF1,1
1622,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.018775881,0.315175402,0,0,5.310674456,21.11089827,NRP1;PDPN;ACTN4,1
1623,cellular response to peptide (GO:1901653),0.018775881,0.31414204,0,0,5.310674456,21.11089827,CAV1;CD36;IGF1,1
1624,hyaluronan catabolic process (GO:0030214),0.019100896,0.318535538,0,0,9.293680297,36.78457259,HEXA;CD44,1
1625,sympathetic nervous system development (GO:0048485),0.019100896,0.317497963,0,0,9.293680297,36.78457259,NRP1;CTNNB1,1
1626,heme biosynthetic process (GO:0006783),0.019100896,0.316467125,0,0,9.293680297,36.78457259,ALAS1;ATPIF1,1
1627,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.019100896,0.31544296,0,0,9.293680297,36.78457259,MTPN;IGF1,1
1628,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.019100896,0.314425402,0,0,9.293680297,36.78457259,LPL;CD36,1
1629,positive regulation of nitric-oxide synthase activity (GO:0051000),0.019100896,0.313414388,0,0,9.293680297,36.78457259,NUS1;S100A1,1
1630,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.019100896,0.312409854,0,0,9.293680297,36.78457259,ANXA1;HMOX1,1
1631,negative regulation of lipid storage (GO:0010888),0.019100896,0.31141174,0,0,9.293680297,36.78457259,ABCA1;ABCG1,1
1632,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.019100896,0.310419983,0,0,9.293680297,36.78457259,CTNNB1;MITF,1
1633,regulation of actin cytoskeleton organization (GO:0032956),0.019290683,0.312509063,0,0,3.913128546,15.44955215,BST1;RHOC;BAIAP2;RHOB,1
1634,regulation of ERK1 and ERK2 cascade (GO:0070372),0.019392516,0.313164594,0,0,2.398369109,9.456452897,NRP1;DUSP3;GPNMB;FN1;TREM2;CD36;MET;CD44,1
1635,cellular response to oxidative stress (GO:0034599),0.020342593,0.327470833,0,0,3.204717344,12.4824971,SRXN1;PRDX1;TXNRD1;CYBB;HMOX1,1
1636,axon guidance (GO:0007411),0.020765331,0.333224787,0,0,2.805639335,10.87036678,NRP1;ALCAM;PTPRA;GPC1;EVL;FAM129B,1
1637,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.021025256,0.33633818,0,0,3.177326597,12.27093355,NRP1;CD81;TREM2;IGF1;CD44,1
1638,development of primary male sexual characteristics (GO:0046546),0.021242134,0.338745653,0,0,5.069280162,19.52569428,NCOA4;INHBA;LHFPL2,1
1639,branching morphogenesis of an epithelial tube (GO:0048754),0.021242134,0.337690371,0,0,5.069280162,19.52569428,NRP1;CTNNB1;MET,1
1640,positive regulation of protein processing (GO:0010954),0.021457973,0.340062227,0,0,8.746993221,33.60296516,MYH9;ADAM8,1
1641,reverse cholesterol transport (GO:0043691),0.021457973,0.339009403,0,0,8.746993221,33.60296516,ABCA1;ABCG1,1
1642,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.021457973,0.337963078,0,0,8.746993221,33.60296516,LGALS3;DUSP3,1
1643,positive regulation of nitrogen compound metabolic process (GO:0051173),0.021457973,0.336923191,0,0,8.746993221,33.60296516,MTPN;WFS1,1
1644,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.021457973,0.335889685,0,0,8.746993221,33.60296516,PRKCB;KCNN4,1
1645,negative regulation of interleukin-8 production (GO:0032717),0.021457973,0.334862499,0,0,8.746993221,33.60296516,ANXA1;ANXA4,1
1646,phospholipid catabolic process (GO:0009395),0.021457973,0.333841577,0,0,8.746993221,33.60296516,ABHD12;GDE1,1
1647,regulation of lamellipodium organization (GO:1902743),0.021457973,0.332826861,0,0,8.746993221,33.60296516,PDPN;CD44,1
1648,cellular response to glucocorticoid stimulus (GO:0071385),0.021457973,0.331818295,0,0,8.746993221,33.60296516,ANXA1;KLF9,1
1649,cellular monovalent inorganic cation homeostasis (GO:0030004),0.021457973,0.330815822,0,0,8.746993221,33.60296516,ATP1B3;ATP1A1,1
1650,positive regulation of transport (GO:0051050),0.022538562,0.346428552,0,0,4.956629492,18.79815411,CD63;ANXA1;SGK1,1
1651,carboxylic acid biosynthetic process (GO:0046394),0.022538562,0.345388226,0,0,4.956629492,18.79815411,ABCC5;ATPIF1;AKR1A1,1
1652,positive regulation of actin filament bundle assembly (GO:0032233),0.022538562,0.34435413,0,0,4.956629492,18.79815411,NRP1;RGCC;EVL,1
1653,post-translational protein modification (GO:0043687),0.023593382,0.35939412,0,0,2.076800066,7.781331677,SOCS2;WSB2;WFS1;APLP2;FN1;SPP1;FAM20C;MFGE8;FBXO32;HSP90B1,1
1654,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.023746634,0.360652008,0,0,2.72010155,10.1740352,FKBP1A;PRKCB;PLK2;SPHK1;HMOX1;RHOC,1
1655,porphyrin-containing compound biosynthetic process (GO:0006779),0.023928906,0.362341859,0,0,8.261049153,30.83575467,ALAS1;ATPIF1,1
1656,membrane lipid metabolic process (GO:0006643),0.023928906,0.361269841,0,0,8.261049153,30.83575467,SGPL1;SERINC1,1
1657,cardiac muscle cell contraction (GO:0086003),0.023928906,0.360204149,0,0,8.261049153,30.83575467,CACNA1D;ATP1A1,1
1658,anion homeostasis (GO:0055081),0.023928906,0.359144725,0,0,8.261049153,30.83575467,ABCA1;ABCG1,1
1659,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.023928906,0.358091514,0,0,8.261049153,30.83575467,NRP1;BAIAP2,1
1660,blood vessel endothelial cell migration (GO:0043534),0.023928906,0.357044463,0,0,8.261049153,30.83575467,NRP1;MYH9,1
1661,regulation of peptidase activity (GO:0052547),0.023928906,0.356003517,0,0,8.261049153,30.83575467,CSTB;CAV1,1
1662,regulation of smooth muscle cell migration (GO:0014910),0.023928906,0.354968623,0,0,8.261049153,30.83575467,NRP1;IGF1,1
1663,positive regulation of ion transport (GO:0043270),0.025258036,0.373599302,0,0,4.745709088,17.4576172,P2RX4;WFS1;CACNA1D,1
1664,positive regulation of protein secretion (GO:0050714),0.025708452,0.379162517,0,0,3.583105657,13.11751858,TCF7L2;RGCC;ADAM8;IGF1,1
1665,negative regulation of protein localization to plasma membrane (GO:1903077),0.026510229,0.389860807,0,0,7.826257093,28.41107111,CLTC;TMBIM1,1
1666,protein targeting to lysosome (GO:0006622),0.026510229,0.388740517,0,0,7.826257093,28.41107111,NCOA4;LAMP2,1
1667,regulation of heterotypic cell-cell adhesion (GO:0034114),0.026510229,0.387626647,0,0,7.826257093,28.41107111,IL1RN;CD44,1
1668,positive regulation of mononuclear cell migration (GO:0071677),0.026510229,0.386519142,0,0,7.826257093,28.41107111,LGALS3;PLA2G7,1
1669,positive regulation of lipid storage (GO:0010884),0.026510229,0.385417948,0,0,7.826257093,28.41107111,HILPDA;LPL,1
1670,striated muscle cell differentiation (GO:0051146),0.026510229,0.384323011,0,0,7.826257093,28.41107111,SORT1;SDC1,1
1671,cellular response to interleukin-7 (GO:0098761),0.026510229,0.383234277,0,0,7.826257093,28.41107111,SOCS2;IL7R,1
1672,negative regulation of protein localization to cell periphery (GO:1904376),0.026510229,0.382151695,0,0,7.826257093,28.41107111,CLTC;TMBIM1,1
1673,interleukin-7-mediated signaling pathway (GO:0038111),0.026510229,0.381075211,0,0,7.826257093,28.41107111,SOCS2;IL7R,1
1674,response to glucose (GO:0009749),0.026681013,0.382452842,0,0,4.646840149,16.8392336,TCF7L2;LPL;IGF1,1
1675,negative regulation of cellular biosynthetic process (GO:0031327),0.026681013,0.381381546,0,0,4.646840149,16.8392336,SLC27A1;CAV1;CLTC,1
1676,negative regulation of multicellular organismal process (GO:0051241),0.027846372,0.396927469,0,0,2.950374698,10.56544701,PROCR;LRPAP1;GPNMB;SLC11A1;EVL,1
1677,regulation of mitochondrion organization (GO:0010821),0.028146063,0.400081788,0,0,4.552006676,16.25224691,CTSK;ATPIF1;SQSTM1,1
1678,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.028807132,0.408341095,0,0,3.458113599,12.2663864,MT-ND5;MT-CO1;MT-CO2;MT-ND3,1
1679,regulation of epidermal cell differentiation (GO:0045604),0.02919855,0.412742944,0,0,7.434944238,26.27238821,CTSL;CTSK,1
1680,regulation of lipoprotein lipase activity (GO:0051004),0.02919855,0.41160277,0,0,7.434944238,26.27238821,SORT1;LPL,1
1681,axon extension (GO:0048675),0.02919855,0.410468878,0,0,7.434944238,26.27238821,NRP1;ALCAM,1
1682,striated muscle cell development (GO:0055002),0.02919855,0.409341216,0,0,7.434944238,26.27238821,SDC1;IGF1,1
1683,inactivation of MAPK activity (GO:0000188),0.02919855,0.408219734,0,0,7.434944238,26.27238821,DUSP3;CAV1,1
1684,vesicle cytoskeletal trafficking (GO:0099518),0.02919855,0.407104379,0,0,7.434944238,26.27238821,MYO5A;ACTN4,1
1685,negative regulation of interferon-gamma production (GO:0032689),0.02919855,0.405995103,0,0,7.434944238,26.27238821,CD274;INHBA,1
1686,vesicle organization (GO:0016050),0.029531779,0.409512687,0,0,2.904275093,10.22969429,CAV2;SORT1;CAV1;SQSTM1;PI4K2A,1
1687,positive regulation of protein kinase B signaling (GO:0051897),0.029531779,0.408402896,0,0,2.904275093,10.22969429,F7;TCF7L2;ADAM8;MET;RTN4,1
1688,glutathione metabolic process (GO:0006749),0.029653092,0.408972239,0,0,4.460966543,15.69452286,GCLC;GSTM1;GCLM,1
1689,gonad development (GO:0008406),0.029653092,0.407869888,0,0,4.460966543,15.69452286,BASP1;NCOA4;INHBA,1
1690,regulation of blood vessel endothelial cell migration (GO:0043535),0.031201983,0.428020746,0,0,4.373496611,15.16410951,NUS1;RGCC;P2RX4,1
1691,positive regulation of cellular component movement (GO:0051272),0.031990547,0.437661558,0,0,7.080899274,24.37468457,PDPN;ACTN4,1
1692,dendritic cell differentiation (GO:0097028),0.031990547,0.43649134,0,0,7.080899274,24.37468457,DCSTAMP;TREM2,1
1693,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.031990547,0.435327363,0,0,7.080899274,24.37468457,SIRPA;CD44,1
1694,regulation of ruffle assembly (GO:1900027),0.031990547,0.434169577,0,0,7.080899274,24.37468457,CAV1;EVL,1
1695,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.031990547,0.433017934,0,0,7.080899274,24.37468457,MT-CO1;MT-CO2,1
1696,glutamate metabolic process (GO:0006536),0.031990547,0.431872384,0,0,7.080899274,24.37468457,GCLC;GCLM,1
1697,axonogenesis (GO:0007409),0.032286863,0.434722589,0,0,2.323420074,7.976521501,NRP1;PTPRA;GPC1;EVL;BAIAP2;RTN4;FAM129B,1
1698,cellular response to hypoxia (GO:0071456),0.03402252,0.456886628,0,0,2.795091819,9.449458103,BNIP3L;RGCC;HILPDA;HMOX1;ADAM8,1
1699,positive regulation of proteolysis (GO:0045862),0.034424779,0.461075184,0,0,4.208459003,14.1782086,ATPIF1;ADAM8;TNFRSF1B,1
1700,positive regulation of cell-substrate adhesion (GO:0010811),0.034424779,0.459868181,0,0,4.208459003,14.1782086,NRP1;FN1;CD36,1
1701,positive regulation of secretion by cell (GO:1903532),0.034424779,0.45866748,0,0,4.208459003,14.1782086,RGCC;ADAM8;IGF1,1
1702,cell-matrix adhesion (GO:0007160),0.034444688,0.457737607,0,0,3.268107357,11.00829445,CD63;ACTN1;ITGB2;CD44,1
1703,regulation of calcium ion transport into cytosol (GO:0010522),0.034882966,0.462357857,0,0,6.759040216,22.68169417,P2RX4;CAV1,1
1704,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.034882966,0.461160039,0,0,6.759040216,22.68169417,PRKCB;FAM129B,1
1705,regulation of calcium ion import (GO:0090279),0.034882966,0.459968411,0,0,6.759040216,22.68169417,LGALS3;CTNNB1,1
1706,regulation of DNA biosynthetic process (GO:2000278),0.034882966,0.458782925,0,0,6.759040216,22.68169417,RGCC;FAM129B,1
1707,peripheral nervous system development (GO:0007422),0.034882966,0.457603535,0,0,6.759040216,22.68169417,EGR2;GPC1,1
1708,beta-catenin destruction complex disassembly (GO:1904886),0.034882966,0.456430192,0,0,6.759040216,22.68169417,CAV1;CTNNB1,1
1709,positive regulation of biosynthetic process (GO:0009891),0.034882966,0.455262852,0,0,6.759040216,22.68169417,MTPN;CD36,1
1710,positive regulation of cell motility (GO:2000147),0.035172685,0.457872986,0,0,2.478314746,8.296122671,F7;GPNMB;SPHK1;PDPN;ACTN4;IGF1,1
1711,lipid transport (GO:0006869),0.035643679,0.462823652,0,0,3.232584451,10.77802957,ABCA1;CAV2;CAV1;PSAP,1
1712,endosomal transport (GO:0016197),0.036449328,0.472083557,0,0,2.262809116,7.494044213,ABCA1;SORT1;CLTC;M6PR;RAB7B;SQSTM1;RHOB,1
1713,cellular response to organic cyclic compound (GO:0071407),0.036909623,0.476834952,0,0,2.733435382,9.018376825,P2RX4;SPP1;CTNNB1;ATP1A1;HSP90B1,1
1714,glycosphingolipid metabolic process (GO:0006687),0.037813108,0.487273455,0,0,4.05542413,13.28191743,GM2A;HEXA;PSAP,1
1715,glutamine family amino acid metabolic process (GO:0009064),0.037872623,0.486811065,0,0,6.465168903,21.1639036,GCLC;GCLM,1
1716,regulation of smooth muscle contraction (GO:0006940),0.037872623,0.485587921,0,0,6.465168903,21.1639036,CAV1;SPHK1,1
1717,regulation of interleukin-8 secretion (GO:2000482),0.037872623,0.484370909,0,0,6.465168903,21.1639036,ANXA1;ANXA4,1
1718,autophagosome maturation (GO:0097352),0.037872623,0.483159982,0,0,6.465168903,21.1639036,GABARAPL1;LAMP2,1
1719,divalent inorganic cation homeostasis (GO:0072507),0.037872623,0.481955094,0,0,6.465168903,21.1639036,WFS1;CAV1,1
1720,positive regulation of ion transmembrane transporter activity (GO:0032414),0.037872623,0.480756201,0,0,6.465168903,21.1639036,ATP1B3;CTSS,1
1721,cellular response to amyloid-beta (GO:1904646),0.037872623,0.479563257,0,0,6.465168903,21.1639036,IGF1;CD36,1
1722,positive regulation of monooxygenase activity (GO:0032770),0.037872623,0.47837622,0,0,6.465168903,21.1639036,NUS1;S100A1,1
1723,positive regulation of cell junction assembly (GO:1901890),0.037872623,0.477195044,0,0,6.465168903,21.1639036,NRP1;CAV1,1
1724,cellular transition metal ion homeostasis (GO:0046916),0.038113439,0.479046505,0,0,3.163806059,10.3367502,ATP6V1A;FTH1;SLC11A1;HMOX1,1
1725,negative regulation of signal transduction (GO:0009968),0.038858191,0.487207239,0,0,2.09435049,6.802107755,SOCS2;LRPAP1;PTPRE;PRKCB;GPC1;TMBIM1;MET;FAM129B,1
1726,respiratory electron transport chain (GO:0022904),0.039384249,0.492592708,0,0,3.130502837,10.12526489,MT-ND5;MT-CO1;MT-CO2;MT-ND3,1
1727,regulation of signal transduction (GO:0009966),0.039412753,0.491743959,0,0,2.224128618,7.19208872,SOCS2;BST1;CD63;CD36;MET;DHRS3;YWHAG,1
1728,regulation of heart contraction (GO:0008016),0.040679029,0.506305082,0,0,3.097893432,9.919586693,P2RX4;S100A1;ATP1B3;ATP1A1,1
1729,protein import (GO:0017038),0.041365323,0.513594265,0,0,3.913128546,12.46453672,MMP12;LAMP2;PTTG1IP,1
1730,negative regulation of cellular catabolic process (GO:0031330),0.041365323,0.512347677,0,0,3.913128546,12.46453672,DAP;TIMP2;MET,1
1731,cellular metal ion homeostasis (GO:0006875),0.041997781,0.518921729,0,0,3.065956387,9.719506402,CAV1;ATP1B3;ATP1A1;TMEM165,1
1732,regulation of Rho protein signal transduction (GO:0035023),0.043202296,0.532515259,0,0,3.845660813,12.08253417,ABCA1;NRP1;MET,1
1733,positive regulation of neutrophil chemotaxis (GO:0090023),0.044131243,0.54265478,0,0,5.94795539,18.56111397,CXCL1;CXCL3,1
1734,negative regulation of protein localization to membrane (GO:1905476),0.044131243,0.541350322,0,0,5.94795539,18.56111397,CLTC;TMBIM1,1
1735,response to glucocorticoid (GO:0051384),0.044131243,0.54005212,0,0,5.94795539,18.56111397,IL1RN;ANXA1,1
1736,transition metal ion homeostasis (GO:0055076),0.044131243,0.538760129,0,0,5.94795539,18.56111397,SLC11A1;HMOX1,1
1737,negative regulation of T cell proliferation (GO:0042130),0.044131243,0.537474305,0,0,5.94795539,18.56111397,CD274;GPNMB,1
1738,positive regulation of cell growth (GO:0030307),0.044707181,0.543192244,0,0,3.004017874,9.335349485,MTPN;SPHK1;IGF1;S100A9,1
1739,response to molecule of bacterial origin (GO:0002237),0.044707181,0.541902001,0,0,3.004017874,9.335349485,SLC11A1;CXCL1;CXCL3;TNFRSF1B,1
1740,integrin-mediated signaling pathway (GO:0007229),0.045079498,0.545120088,0,0,3.780480121,11.71694688,NRP1;ITGB2;MYH9,1
1741,regulation of protein metabolic process (GO:0051246),0.046996647,0.56695955,0,0,3.717472119,11.36683651,FKBP1A;MTPN;WFS1,1
1742,sterol metabolic process (GO:0016125),0.046996647,0.565622381,0,0,3.717472119,11.36683651,ABCA1;SOAT1;ABCG1,1
1743,heterotypic cell-cell adhesion (GO:0034113),0.047394168,0.569064558,0,0,5.719187875,17.43926855,ITGB2;ITGAX,1
1744,potassium ion homeostasis (GO:0055075),0.047394168,0.567728725,0,0,5.719187875,17.43926855,ATP1B3;ATP1A1,1
1745,peptide catabolic process (GO:0043171),0.047394168,0.56639915,0,0,5.719187875,17.43926855,ANPEP;TPP1,1
1746,response to amyloid-beta (GO:1904645),0.047394168,0.565075787,0,0,5.719187875,17.43926855,CD36;IGF1,1
1747,positive regulation of nuclear division (GO:0051785),0.047394168,0.563758594,0,0,5.719187875,17.43926855,RGCC;IGF1,1
1748,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.047394168,0.562447528,0,0,5.719187875,17.43926855,PTTG1IP;CD44,1
1749,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.047394168,0.561142545,0,0,5.719187875,17.43926855,CACNA1D;ATP1B3,1
1750,long-chain fatty acid transport (GO:0015909),0.047394168,0.559843604,0,0,5.719187875,17.43926855,SLC27A1;CD36,1
1751,protein depolymerization (GO:0051261),0.047394168,0.558550663,0,0,5.719187875,17.43926855,DSTN;MICAL2,1
1752,regulation of nervous system development (GO:0051960),0.047394168,0.55726368,0,0,5.719187875,17.43926855,CTNNB1;RTN4,1
1753,positive regulation of embryonic development (GO:0040019),0.047394168,0.555982614,0,0,5.719187875,17.43926855,IGF1;FAM129B,1
1754,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.047394168,0.554707424,0,0,5.719187875,17.43926855,P2RX4;CD36,1
1755,positive regulation of nitric oxide metabolic process (GO:1904407),0.047394168,0.553438071,0,0,5.719187875,17.43926855,P2RX4;CD36,1
1756,positive regulation of protein binding (GO:0032092),0.048953448,0.570341202,0,0,3.656529953,11.03133208,FKBP1A;TCF7L2;CAV1,1
1757,membrane lipid biosynthetic process (GO:0046467),0.048953448,0.56904202,0,0,3.656529953,11.03133208,SGPL1;SPHK1;DEGS1,1
1758,sodium ion homeostasis (GO:0055078),0.050742248,0.588494752,0,0,5.507366102,16.41743865,ATP1B3;ATP1A1,1
1759,regulation of transcription regulatory region DNA binding (GO:2000677),0.050742248,0.587160297,0,0,5.507366102,16.41743865,IGF1;FAM129B,1
1760,positive regulation of granulocyte chemotaxis (GO:0071624),0.050742248,0.58583188,0,0,5.507366102,16.41743865,CXCL1;CXCL3,1
1761,negative regulation of catalytic activity (GO:0043086),0.050742248,0.584509461,0,0,5.507366102,16.41743865,ATPIF1;TMBIM1,1
1762,cation transmembrane transport (GO:0098655),0.050742248,0.583192998,0,0,5.507366102,16.41743865,SLC36A2;SLC7A2,1
1763,actin cytoskeleton reorganization (GO:0031532),0.050949592,0.584260153,0,0,3.597553664,10.70962415,NRP1;ANXA1;MYH9,1
1764,positive regulation of T cell proliferation (GO:0042102),0.050949592,0.582950152,0,0,3.597553664,10.70962415,CD274;ANXA1;IGF1,1
1765,vesicle-mediated transport (GO:0016192),0.052121968,0.595029983,0,0,1.808988866,5.344058412,LRPAP1;MYO1E;SORT1;CAV2;APLP2;CLTC;M6PR;MYO5A;RAB7B;RHOB,1
1766,second-messenger-mediated signaling (GO:0019932),0.052984755,0.603529475,0,0,3.540449637,10.40095963,LAT2;SPHK1;CD36,1
1767,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.054172622,0.615685727,0,0,5.310674456,15.48369423,INHBA;C1QC,1
1768,phosphatidylserine metabolic process (GO:0006658),0.054172622,0.614317536,0,0,5.310674456,15.48369423,SLC27A1;SERINC1,1
1769,regulation of immune response (GO:0050776),0.054677057,0.618663019,0,0,2.065262288,6.002294695,FKBP1A;CD200R1;CD81;ITGB2;CD300LD;TREM2;CD200,1
1770,carbohydrate homeostasis (GO:0033500),0.055058601,0.621601864,0,0,3.485130112,10.10463702,TCF7L2;WFS1;IGF1,1
1771,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.055901191,0.629721359,0,0,2.208399279,6.369398064,NRP1;GPNMB;TREM2;CD36;MET;CD44,1
1772,protein stabilization (GO:0050821),0.056059415,0.630112769,0,0,2.429720339,7.000858082,WFS1;LAMP2;ATP1B3;IGF1;RTN4,1
1773,positive regulation of endocytosis (GO:0045807),0.057170783,0.641192318,0,0,3.431512725,9.820002178,CD63;SLC11A1;SIRPA,1
1774,negative regulation of endocytosis (GO:0045806),0.05768249,0.645512598,0,0,5.12754775,14.62787655,LGALS3;CAV1,1
1775,cellular response to ketone (GO:1901655),0.05768249,0.644100098,0,0,5.12754775,14.62787655,KLF9;SPP1,1
1776,carboxylic acid catabolic process (GO:0046395),0.05768249,0.642693766,0,0,5.12754775,14.62787655,HEXA;CD44,1
1777,negative regulation of response to DNA damage stimulus (GO:2001021),0.05768249,0.641293562,0,0,5.12754775,14.62787655,PTTG1IP;CD44,1
1778,regulation of receptor internalization (GO:0002090),0.05768249,0.639899445,0,0,5.12754775,14.62787655,CD63;LRPAP1,1
1779,lytic vacuole organization (GO:0080171),0.05768249,0.638511377,0,0,5.12754775,14.62787655,ABCA1;TPP1,1
1780,cardiac muscle cell action potential involved in contraction (GO:0086002),0.05768249,0.637129318,0,0,5.12754775,14.62787655,CACNA1D;ATP1A1,1
1781,regulation of cell morphogenesis (GO:0022604),0.05768249,0.635753228,0,0,5.12754775,14.62787655,PDPN;CD44,1
1782,negative regulation of cell proliferation (GO:0008285),0.058488922,0.64325209,0,0,1.838310388,5.218812281,RGCC;GPNMB;FTH1;PDPN;HMOX1;CTNNB1;CXCL1;INHBA;FAM129B,1
1783,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.059196073,0.64962916,0,0,2.17608124,6.151564226,FKBP1A;PRKCB;PLK2;HMOX1;RHOC;SQSTM1,1
1784,glycolipid metabolic process (GO:0006664),0.059320939,0.649602476,0,0,3.379520108,9.546444491,GM2A;HEXA;PSAP,1
1785,negative regulation of blood vessel morphogenesis (GO:2000181),0.059320939,0.648211465,0,0,3.379520108,9.546444491,RGCC;CTNNB1;FAM129B,1
1786,negative regulation of apoptotic signaling pathway (GO:2001234),0.059320939,0.646826397,0,0,3.379520108,9.546444491,LGALS3;TCF7L2;IGF1,1
1787,regulation of cytokine production (GO:0001817),0.059684773,0.649405961,0,0,2.728419904,7.690538121,ANXA1;GPNMB;SLC11A1;HILPDA,1
1788,response to lipopolysaccharide (GO:0032496),0.059935757,0.650749292,0,0,2.382994948,6.706896409,CD274;SLC11A1;CXCL1;CXCL3;TNFRSF1B,1
1789,superoxide metabolic process (GO:0006801),0.061269109,0.663813724,0,0,4.956629492,13.8412862,SH3PXD2B;CYBB,1
1790,cardiac muscle cell action potential (GO:0086001),0.061269109,0.662407339,0,0,4.956629492,13.8412862,CACNA1D;ATP1A1,1
1791,positive regulation of myeloid cell differentiation (GO:0045639),0.061269109,0.661006901,0,0,4.956629492,13.8412862,INHBA;RAB7B,1
1792,negative regulation of lymphocyte proliferation (GO:0050672),0.061269109,0.659612372,0,0,4.956629492,13.8412862,CD274;GPNMB,1
1793,regulation of keratinocyte differentiation (GO:0045616),0.061269109,0.658223714,0,0,4.956629492,13.8412862,CTSL;CTSK,1
1794,negative regulation of epithelial cell apoptotic process (GO:1904036),0.061269109,0.656840891,0,0,4.956629492,13.8412862,TCF7L2;WFS1,1
1795,regulation of activated T cell proliferation (GO:0046006),0.061269109,0.655463866,0,0,4.956629492,13.8412862,CD274;IGF1,1
1796,semaphorin-plexin signaling pathway (GO:0071526),0.061269109,0.654092603,0,0,4.956629492,13.8412862,NRP1;MET,1
1797,skeletal muscle organ development (GO:0060538),0.061269109,0.652727065,0,0,4.956629492,13.8412862,BASP1;CAV1,1
1798,respiratory system development (GO:0060541),0.061269109,0.651367217,0,0,4.956629492,13.8412862,BASP1;PDPN,1
1799,sphingolipid biosynthetic process (GO:0030148),0.0615087,0.65255488,0,0,3.32907951,9.283393375,SGPL1;SPHK1;DEGS1,1
1800,positive regulation of cell proliferation (GO:0008284),0.062393168,0.660565015,0,0,1.749398644,4.853355773,BST1;CD81;SPHK1;HILPDA;FN1;MATK;HMOX1;IGF1;TCIRG1;IL7R,1
1801,macroautophagy (GO:0016236),0.06296352,0.665223278,0,0,2.679259185,7.408686872,GABARAPL1;LAMP2;TCIRG1;SQSTM1,1
1802,epidermal cell differentiation (GO:0009913),0.063733684,0.671968982,0,0,3.280122458,9.030315126,CLIC4;ANXA1;CTNNB1,1
1803,positive regulation of endothelial cell proliferation (GO:0001938),0.063733684,0.670583479,0,0,3.280122458,9.030315126,NRP1;TNFSF12;HMOX1,1
1804,negative regulation of protein binding (GO:0032091),0.063733684,0.669203678,0,0,3.280122458,9.030315126,LRPAP1;CAV1;CTSZ,1
1805,regulation of cardiac conduction (GO:1903779),0.063733684,0.667829543,0,0,3.280122458,9.030315126,CAV1;ATP1B3;ATP1A1,1
1806,regulation of actin cytoskeleton reorganization (GO:2000249),0.064929799,0.678968777,0,0,4.796738218,13.11643416,NRP1;BAIAP2,1
1807,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.064929799,0.677580292,0,0,4.796738218,13.11643416,ANXA1;HMOX1,1
1808,beta-catenin-TCF complex assembly (GO:1904837),0.064929799,0.676197475,0,0,4.796738218,13.11643416,TCF7L2;CTNNB1,1
1809,connective tissue development (GO:0061448),0.064929799,0.674820291,0,0,4.796738218,13.11643416,SH3PXD2B;CD44,1
1810,regulation of cation transmembrane transport (GO:1904062),0.064929799,0.673448705,0,0,4.796738218,13.11643416,CD63;CACNA1D,1
1811,response to estradiol (GO:0032355),0.064929799,0.672082684,0,0,4.796738218,13.11643416,SOCS2;CTNNB1,1
1812,positive regulation of B cell proliferation (GO:0030890),0.064929799,0.670722192,0,0,4.796738218,13.11643416,BST1;CD81,1
1813,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.064929799,0.669367198,0,0,4.796738218,13.11643416,ACTN4;RTN4,1
1814,chondroitin sulfate metabolic process (GO:0030204),0.064929799,0.668017667,0,0,4.796738218,13.11643416,CHST11;HEXA,1
1815,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.064929799,0.666673567,0,0,4.796738218,13.11643416,P2RX4;CD36,1
1816,regulation of epithelial to mesenchymal transition (GO:0010717),0.065995498,0.67625507,0,0,3.232584451,8.786710054,RGCC;PDPN;CTNNB1,1
1817,cholesterol metabolic process (GO:0008203),0.065995498,0.67489985,0,0,3.232584451,8.786710054,ABCA1;SOAT1;ABCG1,1
1818,positive regulation of T cell activation (GO:0050870),0.065995498,0.67355005,0,0,3.232584451,8.786710054,CD274;ANXA1;SIRPA,1
1819,protein localization to membrane (GO:0072657),0.06672746,0.679661131,0,0,2.308988894,6.250753244,CAV1;ITGB2;SH3PXD2B;MYO5A;ATP1B3,1
1820,regulation of endothelial cell migration (GO:0010594),0.068293742,0.69422901,0,0,3.186404673,8.552109873,NRP1;ANXA3;RHOB,1
1821,regulation of endocytosis (GO:0030100),0.068293742,0.692848833,0,0,3.186404673,8.552109873,LGALS3;CD63;LRPAP1,1
1822,negative regulation of angiogenesis (GO:0016525),0.068293742,0.691474133,0,0,3.186404673,8.552109873,RGCC;CTNNB1;FAM129B,1
1823,negative regulation of cell-cell adhesion (GO:0022408),0.068661934,0.693825444,0,0,4.646840149,12.44684165,IL1RN;RGCC,1
1824,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.068661934,0.692454247,0,0,4.646840149,12.44684165,TMBIM1;HMOX1,1
1825,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.070628005,0.710877136,0,0,3.141525734,8.326075331,NRP1;CYBB;BAIAP2,1
1826,neuron projection morphogenesis (GO:0048812),0.071000206,0.713216637,0,0,2.266751292,5.995721507,ALCAM;CTNNB1;SGK1;BAIAP2;RTN4,1
1827,regulation of protein kinase B signaling (GO:0051896),0.071000206,0.711815425,0,0,2.266751292,5.995721507,F7;TCF7L2;ADAM8;MET;RTN4,1
1828,epithelium development (GO:0060429),0.071565567,0.71607664,0,0,2.563773875,6.761033802,LGALS3;ANXA4;TPP1;CTSB,1
1829,negative regulation of cell growth (GO:0030308),0.071565567,0.714675316,0,0,2.563773875,6.761033802,DCSTAMP;APBB2;INHBA;RTN4,1
1830,positive regulation of calcium ion transport into cytosol (GO:0010524),0.072462947,0.722223477,0,0,4.506026811,11.82687808,P2RX4;CAV1,1
1831,phosphatidylcholine biosynthetic process (GO:0006656),0.072462947,0.720815634,0,0,4.506026811,11.82687808,SLC27A1;SLC44A1,1
1832,central nervous system neuron differentiation (GO:0021953),0.072462947,0.719413269,0,0,4.506026811,11.82687808,NPY;CTNNB1,1
1833,ATP biosynthetic process (GO:0006754),0.072462947,0.71801635,0,0,4.506026811,11.82687808,CHCHD10;TCIRG1,1
1834,regulation of cell-cell adhesion (GO:0022407),0.072462947,0.716624846,0,0,4.506026811,11.82687808,SIRPA;ADAM8,1
1835,substrate adhesion-dependent cell spreading (GO:0034446),0.072462947,0.715238724,0,0,4.506026811,11.82687808,NRP1;FN1,1
1836,regulation of cell communication (GO:0010646),0.072997868,0.71912765,0,0,3.097893432,8.108194046,SOCS2;ANXA1;YWHAG,1
1837,response to insulin (GO:0032868),0.072997868,0.717742047,0,0,3.097893432,8.108194046,SORT1;MYO5A;IGF1,1
1838,Rho protein signal transduction (GO:0007266),0.075402906,0.739963516,0,0,3.055456536,7.898078526,PDPN;RHOC;RHOB,1
1839,regulation of inflammatory response (GO:0050727),0.075420206,0.738712685,0,0,2.226031209,5.753578483,BST1;ANXA1;LPL;S100A9;PLA2G7,1
1840,positive regulation of cell-cell adhesion (GO:0022409),0.076330327,0.746194748,0,0,4.373496611,11.25162891,SIRPA;CD44,1
1841,negative regulation of mitochondrion organization (GO:0010823),0.076330327,0.744767989,0,0,4.373496611,11.25162891,VAT1;IGF1,1
1842,regulation of cell-substrate adhesion (GO:0010810),0.076330327,0.743346676,0,0,4.373496611,11.25162891,BST1;PDPN,1
1843,positive regulation of cell-matrix adhesion (GO:0001954),0.076330327,0.741930778,0,0,4.373496611,11.25162891,NRP1;CD36,1
1844,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.076330327,0.740520263,0,0,4.373496611,11.25162891,CAV1;S100A9,1
1845,carboxylic acid metabolic process (GO:0019752),0.076330327,0.739115101,0,0,4.373496611,11.25162891,CYB5A;CYB5R3,1
1846,regulation of DNA recombination (GO:0000018),0.076330327,0.737715262,0,0,4.373496611,11.25162891,ZRANB3;IL7R,1
1847,B cell activation (GO:0042113),0.077842682,0.750909655,0,0,3.014166583,7.695364362,LAT2;PRKCB;BLNK,1
1848,positive regulation of cytokine secretion (GO:0050715),0.077842682,0.749492844,0,0,3.014166583,7.695364362,CD274;RGCC;LPL,1
1849,canonical Wnt signaling pathway (GO:0060070),0.077842682,0.74808137,0,0,3.014166583,7.695364362,TCF7L2;CAV1;CTNNB1,1
1850,positive regulation of skeletal muscle fiber development (GO:0048743),0.07804378,0.748604151,0,0,12.39157373,31.60452701,FAM129B,1
1851,positive regulation of cellular extravasation (GO:0002693),0.07804378,0.747199641,0,0,12.39157373,31.60452701,ADAM8,1
1852,regulation of lymphocyte apoptotic process (GO:0070228),0.07804378,0.74580039,0,0,12.39157373,31.60452701,LGALS3,1
1853,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.07804378,0.744406371,0,0,12.39157373,31.60452701,PTTG1IP,1
1854,positive regulation of icosanoid secretion (GO:0032305),0.07804378,0.743017553,0,0,12.39157373,31.60452701,P2RX4,1
1855,regulation of superoxide metabolic process (GO:0090322),0.07804378,0.741633908,0,0,12.39157373,31.60452701,BST1,1
1856,aldehyde catabolic process (GO:0046185),0.07804378,0.740255406,0,0,12.39157373,31.60452701,AKR1A1,1
1857,positive regulation of amyloid-beta clearance (GO:1900223),0.07804378,0.738882019,0,0,12.39157373,31.60452701,LRPAP1,1
1858,negative regulation of lymphocyte differentiation (GO:0045620),0.07804378,0.737513719,0,0,12.39157373,31.60452701,INHBA,1
1859,regulation of digestive system process (GO:0044058),0.07804378,0.736150478,0,0,12.39157373,31.60452701,SGK1,1
1860,regulation of thymocyte apoptotic process (GO:0070243),0.07804378,0.734792267,0,0,12.39157373,31.60452701,ADAM8,1
1861,positive regulation of receptor binding (GO:1900122),0.07804378,0.733439058,0,0,12.39157373,31.60452701,NRP1,1
1862,ceramide transport (GO:0035627),0.07804378,0.732090824,0,0,12.39157373,31.60452701,PSAP,1
1863,negative regulation of muscle cell apoptotic process (GO:0010656),0.07804378,0.730747538,0,0,12.39157373,31.60452701,IGF1,1
1864,phagosome-lysosome fusion (GO:0090385),0.07804378,0.729409173,0,0,12.39157373,31.60452701,RAB7B,1
1865,regulation of protein targeting (GO:1903533),0.07804378,0.728075701,0,0,12.39157373,31.60452701,ATPIF1,1
1866,choline catabolic process (GO:0042426),0.07804378,0.726747096,0,0,12.39157373,31.60452701,SLC44A1,1
1867,positive regulation of vesicle fusion (GO:0031340),0.07804378,0.725423331,0,0,12.39157373,31.60452701,ANXA1,1
1868,glomerular epithelial cell differentiation (GO:0072311),0.07804378,0.724104379,0,0,12.39157373,31.60452701,BASP1,1
1869,negative regulation of phospholipid metabolic process (GO:1903726),0.07804378,0.722790215,0,0,12.39157373,31.60452701,SLC27A1,1
1870,renal filtration cell differentiation (GO:0061318),0.07804378,0.721480812,0,0,12.39157373,31.60452701,BASP1,1
1871,platelet dense granule organization (GO:0060155),0.07804378,0.720176145,0,0,12.39157373,31.60452701,ABCA1,1
1872,embryonic skeletal joint morphogenesis (GO:0060272),0.07804378,0.718876189,0,0,12.39157373,31.60452701,CTNNB1,1
1873,regulation of blood vessel remodeling (GO:0060312),0.07804378,0.717580916,0,0,12.39157373,31.60452701,TMBIM1,1
1874,negative regulation of leukocyte degranulation (GO:0043301),0.07804378,0.716290303,0,0,12.39157373,31.60452701,CD84,1
1875,alpha-beta T cell activation (GO:0046631),0.07804378,0.715004324,0,0,12.39157373,31.60452701,ANXA1,1
1876,regulation of hyaluronan biosynthetic process (GO:1900125),0.07804378,0.713722954,0,0,12.39157373,31.60452701,CLTC,1
1877,positive regulation of microtubule motor activity (GO:2000576),0.07804378,0.712446169,0,0,12.39157373,31.60452701,DYNC1I2,1
1878,macrophage derived foam cell differentiation (GO:0010742),0.07804378,0.711173944,0,0,12.39157373,31.60452701,SOAT1,1
1879,positive regulation of axon guidance (GO:1902669),0.07804378,0.709906254,0,0,12.39157373,31.60452701,NRP1,1
1880,"positive regulation of protein import into nucleus, translocation (GO:0033160)",0.07804378,0.708643076,0,0,12.39157373,31.60452701,IGF1,1
1881,positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),0.07804378,0.707384384,0,0,12.39157373,31.60452701,CAV1,1
1882,positive regulation of T cell differentiation in thymus (GO:0033089),0.07804378,0.706130157,0,0,12.39157373,31.60452701,ADAM8,1
1883,folic acid-containing compound biosynthetic process (GO:0009396),0.07804378,0.704880369,0,0,12.39157373,31.60452701,ATPIF1,1
1884,positive regulation of cholesterol storage (GO:0010886),0.07804378,0.703634997,0,0,12.39157373,31.60452701,LPL,1
1885,regulation of interleukin-10 secretion (GO:2001179),0.07804378,0.702394018,0,0,12.39157373,31.60452701,CD274,1
1886,cellular response to bacterial lipopeptide (GO:0071221),0.07804378,0.701157409,0,0,12.39157373,31.60452701,CD36,1
1887,aggrephagy (GO:0035973),0.07804378,0.699925147,0,0,12.39157373,31.60452701,SQSTM1,1
1888,heart trabecula formation (GO:0060347),0.07804378,0.698697208,0,0,12.39157373,31.60452701,FKBP1A,1
1889,positive regulation of antigen processing and presentation (GO:0002579),0.07804378,0.69747357,0,0,12.39157373,31.60452701,SLC11A1,1
1890,positive regulation of megakaryocyte differentiation (GO:0045654),0.07804378,0.696254211,0,0,12.39157373,31.60452701,RAB7B,1
1891,regulation of extracellular exosome assembly (GO:1903551),0.07804378,0.695039107,0,0,12.39157373,31.60452701,SDC1,1
1892,negative regulation of cell cycle phase transition (GO:1901988),0.07804378,0.693828238,0,0,12.39157373,31.60452701,RGCC,1
1893,sterol import (GO:0035376),0.07804378,0.69262158,0,0,12.39157373,31.60452701,CD36,1
1894,positive regulation of dendritic cell antigen processing and presentation (GO:0002606),0.07804378,0.691419112,0,0,12.39157373,31.60452701,SLC11A1,1
1895,endoplasmic reticulum membrane organization (GO:0090158),0.07804378,0.690220812,0,0,12.39157373,31.60452701,RTN4,1
1896,cholesterol import (GO:0070508),0.07804378,0.689026658,0,0,12.39157373,31.60452701,CD36,1
1897,foam cell differentiation (GO:0090077),0.07804378,0.687836629,0,0,12.39157373,31.60452701,SOAT1,1
1898,positive regulation of cytokine production (GO:0001819),0.07869015,0.692337649,0,0,2.018536897,5.131599767,ANXA1;RGCC;SLC11A1;HILPDA;CTNNB1;RAB7B,1
1899,keratan sulfate metabolic process (GO:0042339),0.080261615,0.704948406,0,0,4.248539565,10.7167872,HEXA;GNS,1
1900,regulation of wound healing (GO:0061041),0.080261615,0.703737154,0,0,4.248539565,10.7167872,ANXA1;CAV1,1
1901,positive regulation of DNA binding (GO:0043388),0.080261615,0.702530058,0,0,4.248539565,10.7167872,IGF1;FAM129B,1
1902,bone development (GO:0060348),0.080261615,0.701327096,0,0,4.248539565,10.7167872,MMP13;SH3PXD2B,1
1903,endoplasmic reticulum organization (GO:0007029),0.080261615,0.700128246,0,0,4.248539565,10.7167872,CAV2;RTN4,1
1904,positive regulation of cell development (GO:0010720),0.080261615,0.698933488,0,0,4.248539565,10.7167872,IGF1;FAM129B,1
1905,positive regulation of chemokine production (GO:0032722),0.080261615,0.6977428,0,0,4.248539565,10.7167872,LPL;HMOX1,1
1906,macromolecule catabolic process (GO:0009057),0.080261615,0.696556163,0,0,4.248539565,10.7167872,TPP1;CTSD,1
1907,negative regulation of growth (GO:0045926),0.080735576,0.699479872,0,0,2.457832806,6.185322948,DCSTAMP;APBB2;INHBA;RTN4,1
1908,negative regulation of cell migration (GO:0030336),0.082636365,0.714734527,0,0,2.437686635,6.077897348,CLIC4;HMOX1;EVL;RHOB,1
1909,Ras protein signal transduction (GO:0007265),0.082704051,0.7141096,0,0,1.991502921,4.963794523,PLK2;PDPN;IGF1;RHOC;RAB7B;RHOB,1
1910,regulation of heart rate by cardiac conduction (GO:0086091),0.084254409,0.726267316,0,0,4.130524577,10.21856412,CAV1;CACNA1D,1
1911,positive regulation of peptide secretion (GO:0002793),0.084254409,0.725042582,0,0,4.130524577,10.21856412,ADAM8;IGF1,1
1912,erythrocyte differentiation (GO:0030218),0.084254409,0.723821972,0,0,4.130524577,10.21856412,ATPIF1;INHBA,1
1913,regulation of sodium ion transport (GO:0002028),0.084254409,0.722605464,0,0,4.130524577,10.21856412,P2RX4;ATP1A1,1
1914,positive regulation of ATPase activity (GO:0032781),0.084254409,0.721393039,0,0,4.130524577,10.21856412,DYNC1I2;ATP1B3,1
1915,regulation of phosphoprotein phosphatase activity (GO:0043666),0.084254409,0.720184676,0,0,4.130524577,10.21856412,FKBP1A;HSP90B1,1
1916,carbohydrate catabolic process (GO:0016052),0.084254409,0.718980353,0,0,4.130524577,10.21856412,HK3;MAN2B1,1
1917,positive regulation of apoptotic signaling pathway (GO:2001235),0.085365996,0.727249882,0,0,2.896731521,7.12829844,CAV1;TNFSF12;S100A9,1
1918,water-soluble vitamin metabolic process (GO:0006767),0.087940247,0.747931803,0,0,2.859593938,6.951952257,CYB5A;CYB5R3;ACP5,1
1919,regulation of potassium ion transport (GO:0043266),0.088306358,0.749795913,0,0,4.018888777,9.753614675,CD63;CACNA1D,1
1920,endosome organization (GO:0007032),0.088306358,0.748550405,0,0,4.018888777,9.753614675,SQSTM1;PI4K2A,1
1921,epithelial cell migration (GO:0010631),0.088306358,0.747309028,0,0,4.018888777,9.753614675,NRP1;TNFSF12,1
1922,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.088306358,0.746071761,0,0,4.018888777,9.753614675,TCF7L2;CTNNB1,1
1923,angiotensin-activated signaling pathway (GO:0038166),0.09044779,0.762900945,0,0,10.62134891,25.52291559,CAV1,1
1924,adherens junction assembly (GO:0034333),0.09044779,0.761642032,0,0,10.62134891,25.52291559,CTNNB1,1
1925,positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.09044779,0.760387268,0,0,10.62134891,25.52291559,IGF1,1
1926,"substrate-dependent cell migration, cell extension (GO:0006930)",0.09044779,0.759136631,0,0,10.62134891,25.52291559,NRP1,1
1927,ATP hydrolysis coupled proton transport (GO:0015991),0.09044779,0.757890101,0,0,10.62134891,25.52291559,ATP1A1,1
1928,protein localization to basolateral plasma membrane (GO:1903361),0.09044779,0.756647658,0,0,10.62134891,25.52291559,CAV1,1
1929,regulation of entry of bacterium into host cell (GO:2000535),0.09044779,0.755409282,0,0,10.62134891,25.52291559,CAV1,1
1930,negative regulation of muscle hypertrophy (GO:0014741),0.09044779,0.754174954,0,0,10.62134891,25.52291559,P2RX4,1
1931,replication fork protection (GO:0048478),0.09044779,0.752944652,0,0,10.62134891,25.52291559,ZRANB3,1
1932,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),0.09044779,0.751718358,0,0,10.62134891,25.52291559,MMP12,1
1933,bleb assembly (GO:0032060),0.09044779,0.750496051,0,0,10.62134891,25.52291559,EMP1,1
1934,ATP hydrolysis coupled cation transmembrane transport (GO:0099132),0.09044779,0.749277714,0,0,10.62134891,25.52291559,ATP1A1,1
1935,negative regulation of leukocyte migration (GO:0002686),0.09044779,0.748063325,0,0,10.62134891,25.52291559,HMOX1,1
1936,negative regulation of keratinocyte proliferation (GO:0010839),0.09044779,0.746852867,0,0,10.62134891,25.52291559,KLF9,1
1937,positive regulation of lipid transport (GO:0032370),0.09044779,0.745646319,0,0,10.62134891,25.52291559,SPP1,1
1938,dolichyl diphosphate biosynthetic process (GO:0006489),0.09044779,0.744443664,0,0,10.62134891,25.52291559,NUS1,1
1939,flavin-containing compound metabolic process (GO:0042726),0.09044779,0.743244882,0,0,10.62134891,25.52291559,ACP5,1
1940,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.09044779,0.742049954,0,0,10.62134891,25.52291559,IGF1,1
1941,regulation of mitochondrial fusion (GO:0010635),0.09044779,0.740858863,0,0,10.62134891,25.52291559,VAT1,1
1942,ornithine transport (GO:0015822),0.09044779,0.739671589,0,0,10.62134891,25.52291559,SLC7A2,1
1943,positive regulation of extracellular matrix disassembly (GO:0090091),0.09044779,0.738488115,0,0,10.62134891,25.52291559,PDPN,1
1944,melanocyte differentiation (GO:0030318),0.09044779,0.737308421,0,0,10.62134891,25.52291559,MITF,1
1945,riboflavin metabolic process (GO:0006771),0.09044779,0.736132491,0,0,10.62134891,25.52291559,ACP5,1
1946,negative regulation of type 2 immune response (GO:0002829),0.09044779,0.734960305,0,0,10.62134891,25.52291559,ANXA1,1
1947,dolichyl diphosphate metabolic process (GO:0046465),0.09044779,0.733791847,0,0,10.62134891,25.52291559,NUS1,1
1948,pteridine-containing compound biosynthetic process (GO:0042559),0.09044779,0.732627098,0,0,10.62134891,25.52291559,ATPIF1,1
1949,positive regulation of autophagy of mitochondrion (GO:1903599),0.09044779,0.731466041,0,0,10.62134891,25.52291559,ATPIF1,1
1950,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),0.09044779,0.730308658,0,0,10.62134891,25.52291559,HMOX1,1
1951,L-alanine transport (GO:0015808),0.09044779,0.729154931,0,0,10.62134891,25.52291559,SLC36A2,1
1952,lymphatic endothelial cell differentiation (GO:0060836),0.09044779,0.728004845,0,0,10.62134891,25.52291559,PDPN,1
1953,regulation of T-helper 1 cell differentiation (GO:0045625),0.09044779,0.72685838,0,0,10.62134891,25.52291559,ANXA1,1
1954,regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.09044779,0.725715521,0,0,10.62134891,25.52291559,RAB7B,1
1955,regulation of chemokine biosynthetic process (GO:0045073),0.09044779,0.724576251,0,0,10.62134891,25.52291559,HMOX1,1
1956,gas homeostasis (GO:0033483),0.09044779,0.723440551,0,0,10.62134891,25.52291559,CAV1,1
1957,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659),0.09044779,0.722308406,0,0,10.62134891,25.52291559,RGCC,1
1958,retinoic acid receptor signaling pathway (GO:0048384),0.09044779,0.721179799,0,0,10.62134891,25.52291559,ACTN4,1
1959,regulation of interleukin-18 production (GO:0032661),0.09044779,0.720054714,0,0,10.62134891,25.52291559,CD84,1
1960,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.09044779,0.718933133,0,0,10.62134891,25.52291559,CAV1,1
1961,negative regulation of nitrogen compound metabolic process (GO:0051172),0.09044779,0.717815041,0,0,10.62134891,25.52291559,CLTC,1
1962,regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),0.09044779,0.716700422,0,0,10.62134891,25.52291559,CACNA1D,1
1963,peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.09044779,0.715589258,0,0,10.62134891,25.52291559,ACTN4,1
1964,negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.09044779,0.714481535,0,0,10.62134891,25.52291559,TIMP2,1
1965,negative regulation of nitric oxide metabolic process (GO:1904406),0.09044779,0.713377236,0,0,10.62134891,25.52291559,CAV1,1
1966,negative regulation of receptor internalization (GO:0002091),0.09044779,0.712276345,0,0,10.62134891,25.52291559,LRPAP1,1
1967,regulation of pinocytosis (GO:0048548),0.09044779,0.711178847,0,0,10.62134891,25.52291559,CAV1,1
1968,positive regulation of neuroblast proliferation (GO:0002052),0.09044779,0.710084726,0,0,10.62134891,25.52291559,CTNNB1,1
1969,regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.09044779,0.708993966,0,0,10.62134891,25.52291559,CAV1,1
1970,positive regulation of sequestering of triglyceride (GO:0010890),0.09044779,0.707906552,0,0,10.62134891,25.52291559,LPL,1
1971,"wound healing, spreading of epidermal cells (GO:0035313)",0.09044779,0.706822468,0,0,10.62134891,25.52291559,MMP12,1
1972,mannose metabolic process (GO:0006013),0.09044779,0.7057417,0,0,10.62134891,25.52291559,MAN2B1,1
1973,hyaluronan biosynthetic process (GO:0030213),0.09044779,0.704664231,0,0,10.62134891,25.52291559,ABCC5,1
1974,positive regulation of insulin receptor signaling pathway (GO:0046628),0.09044779,0.703590048,0,0,10.62134891,25.52291559,IGF1,1
1975,forebrain neuron differentiation (GO:0021879),0.09044779,0.702519135,0,0,10.62134891,25.52291559,INHBA,1
1976,tetrahydrofolate interconversion (GO:0035999),0.09044779,0.701451477,0,0,10.62134891,25.52291559,ATPIF1,1
1977,negative regulation of nitric oxide biosynthetic process (GO:0045019),0.09044779,0.700387059,0,0,10.62134891,25.52291559,CAV1,1
1978,xenobiotic catabolic process (GO:0042178),0.09044779,0.699325866,0,0,10.62134891,25.52291559,GSTM1,1
1979,SA node cell action potential (GO:0086015),0.09044779,0.698267884,0,0,10.62134891,25.52291559,CACNA1D,1
1980,tooth mineralization (GO:0034505),0.09044779,0.697213099,0,0,10.62134891,25.52291559,FAM20C,1
1981,regulation of skeletal muscle fiber development (GO:0048742),0.09044779,0.696161496,0,0,10.62134891,25.52291559,FAM129B,1
1982,response to increased oxygen levels (GO:0036296),0.09044779,0.69511306,0,0,10.62134891,25.52291559,ATP6V1A,1
1983,amino acid import across plasma membrane (GO:0089718),0.09044779,0.694067777,0,0,10.62134891,25.52291559,SLC7A2,1
1984,regulation of protein heterodimerization activity (GO:0043497),0.09044779,0.693025633,0,0,10.62134891,25.52291559,CD36,1
1985,long term synaptic depression (GO:0060292),0.09044779,0.691986614,0,0,10.62134891,25.52291559,PLK2,1
1986,ER overload response (GO:0006983),0.09044779,0.690950706,0,0,10.62134891,25.52291559,WFS1,1
1987,long-chain fatty acid import (GO:0044539),0.09044779,0.689917895,0,0,10.62134891,25.52291559,CD36,1
1988,positive regulation of smooth muscle cell proliferation (GO:0048661),0.092415161,0.70387249,0,0,3.913128546,9.318975658,HMOX1;IGF1,1
1989,regulation of metal ion transport (GO:0010959),0.092415161,0.7028235,0,0,3.913128546,9.318975658,P2RX4;ATP1A1,1
1990,response to steroid hormone (GO:0048545),0.092415161,0.701777632,0,0,3.913128546,9.318975658,CAV1;ATP1A1,1
1991,positive regulation of multi-organism process (GO:0043902),0.092415161,0.700734872,0,0,3.913128546,9.318975658,INHBA;LHFPL2,1
1992,cation transport (GO:0006812),0.09318568,0.705528969,0,0,2.788104089,6.616620494,SLC36A2;P2RX4;SLC39A1,1
1993,potassium ion import (GO:0010107),0.096578572,0.730134002,0,0,3.812791917,8.912013678,ATP1B3;ATP1A1,1
1994,mitochondrion disassembly (GO:0061726),0.096578572,0.729053922,0,0,3.812791917,8.912013678,GABARAPL1;SQSTM1,1
1995,protein catabolic process (GO:0030163),0.098557189,0.742891189,0,0,2.72010155,6.302797085,LAMP2;TPP1;CTSD,1
1996,skeletal muscle tissue development (GO:0007519),0.10079439,0.758633882,0,0,3.717472119,8.530381337,CAV2;CAV1,1
1997,positive regulation of phagocytosis (GO:0050766),0.10079439,0.757516601,0,0,3.717472119,8.530381337,SLC11A1;SIRPA,1
1998,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.10079439,0.756402606,0,0,3.717472119,8.530381337,ITGB2;CD36,1
1999,regulation of RNA metabolic process (GO:0051252),0.10079439,0.755291883,0,0,3.717472119,8.530381337,AHNAK2;MITF,1
2000,regulation of anatomical structure morphogenesis (GO:0022603),0.101289018,0.757885426,0,0,2.687329243,6.153385445,GPNMB;HMOX1;CTNNB1,1
2001,negative regulation of binding (GO:0051100),0.101289018,0.756775785,0,0,2.687329243,6.153385445,LRPAP1;CAV1;CTSZ,1
2002,biomineral tissue development (GO:0031214),0.10268553,0.766088096,0,0,9.293680297,21.15319769,FAM20C,1
2003,phosphate ion transmembrane transport (GO:0035435),0.10268553,0.764969719,0,0,9.293680297,21.15319769,SLC37A2,1
2004,positive regulation of extracellular matrix assembly (GO:1901203),0.10268553,0.763854603,0,0,9.293680297,21.15319769,RGCC,1
2005,regulation of establishment of protein localization to mitochondrion (GO:1903747),0.10268553,0.762742733,0,0,9.293680297,21.15319769,ATPIF1,1
2006,positive regulation of tissue remodeling (GO:0034105),0.10268553,0.761634095,0,0,9.293680297,21.15319769,TMBIM1,1
2007,defense response to protozoan (GO:0042832),0.10268553,0.760528676,0,0,9.293680297,21.15319769,SLC11A1,1
2008,regulation of amyloid precursor protein catabolic process (GO:1902991),0.10268553,0.75942646,0,0,9.293680297,21.15319769,FKBP1A,1
2009,myelin maintenance (GO:0043217),0.10268553,0.758327435,0,0,9.293680297,21.15319769,AHNAK2,1
2010,glomerular visceral epithelial cell development (GO:0072015),0.10268553,0.757231586,0,0,9.293680297,21.15319769,MYO1E,1
2011,development of primary female sexual characteristics (GO:0046545),0.10268553,0.7561389,0,0,9.293680297,21.15319769,LHFPL2,1
2012,negative regulation of platelet aggregation (GO:0090331),0.10268553,0.755049362,0,0,9.293680297,21.15319769,CD9,1
2013,negative regulation of lipase activity (GO:0060192),0.10268553,0.75396296,0,0,9.293680297,21.15319769,SORT1,1
2014,positive regulation of steroid biosynthetic process (GO:0010893),0.10268553,0.75287968,0,0,9.293680297,21.15319769,ABCG1,1
2015,intestinal cholesterol absorption (GO:0030299),0.10268553,0.751799509,0,0,9.293680297,21.15319769,CD36,1
2016,cardiolipin biosynthetic process (GO:0032049),0.10268553,0.750722432,0,0,9.293680297,21.15319769,SLC27A1,1
2017,negative regulation of activated T cell proliferation (GO:0046007),0.10268553,0.749648437,0,0,9.293680297,21.15319769,CD274,1
2018,SMAD protein complex assembly (GO:0007183),0.10268553,0.748577511,0,0,9.293680297,21.15319769,FKBP1A,1
2019,coronary vasculature morphogenesis (GO:0060977),0.10268553,0.74750964,0,0,9.293680297,21.15319769,NRP1,1
2020,negative regulation of T-helper cell differentiation (GO:0045623),0.10268553,0.746444811,0,0,9.293680297,21.15319769,ANXA1,1
2021,regulation of muscle organ development (GO:0048634),0.10268553,0.745383012,0,0,9.293680297,21.15319769,MTPN,1
2022,plasma membrane to endosome transport (GO:0048227),0.10268553,0.744324229,0,0,9.293680297,21.15319769,SORT1,1
2023,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.10268553,0.74326845,0,0,9.293680297,21.15319769,HMOX1,1
2024,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.10268553,0.742215662,0,0,9.293680297,21.15319769,CAV1,1
2025,regulation of positive chemotaxis (GO:0050926),0.10268553,0.741165852,0,0,9.293680297,21.15319769,F7,1
2026,regulation of store-operated calcium entry (GO:2001256),0.10268553,0.740119008,0,0,9.293680297,21.15319769,CD84,1
2027,positive regulation of metanephros development (GO:0072216),0.10268553,0.739075116,0,0,9.293680297,21.15319769,BASP1,1
2028,genetic imprinting (GO:0071514),0.10268553,0.738034165,0,0,9.293680297,21.15319769,DNMT3A,1
2029,regulation of chemokine secretion (GO:0090196),0.10268553,0.736996143,0,0,9.293680297,21.15319769,LPL,1
2030,diol biosynthetic process (GO:0034312),0.10268553,0.735961036,0,0,9.293680297,21.15319769,SPHK1,1
2031,protein localization to endosome (GO:0036010),0.10268553,0.734928832,0,0,9.293680297,21.15319769,NRP1,1
2032,amyloid precursor protein catabolic process (GO:0042987),0.10268553,0.73389952,0,0,9.293680297,21.15319769,ABCG1,1
2033,sphingosine biosynthetic process (GO:0046512),0.10268553,0.732873087,0,0,9.293680297,21.15319769,SPHK1,1
2034,positive regulation of monocyte differentiation (GO:0045657),0.10268553,0.731849522,0,0,9.293680297,21.15319769,DCSTAMP,1
2035,cGMP-mediated signaling (GO:0019934),0.10268553,0.730828811,0,0,9.293680297,21.15319769,CD36,1
2036,cellular biogenic amine catabolic process (GO:0042402),0.10268553,0.729810944,0,0,9.293680297,21.15319769,SLC44A1,1
2037,negative regulation of exocytosis (GO:0045920),0.10268553,0.728795907,0,0,9.293680297,21.15319769,ANXA1,1
2038,membrane lipid catabolic process (GO:0046466),0.10268553,0.727783691,0,0,9.293680297,21.15319769,SGPL1,1
2039,glomerular epithelial cell development (GO:0072310),0.10268553,0.726774282,0,0,9.293680297,21.15319769,MYO1E,1
2040,positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.10268553,0.72576767,0,0,9.293680297,21.15319769,BNIP3L,1
2041,actin filament network formation (GO:0051639),0.10268553,0.724763842,0,0,9.293680297,21.15319769,ACTN1,1
2042,regulation of smooth muscle cell apoptotic process (GO:0034391),0.10268553,0.723762787,0,0,9.293680297,21.15319769,IGF1,1
2043,regulation of dendritic cell antigen processing and presentation (GO:0002604),0.10268553,0.722764493,0,0,9.293680297,21.15319769,SLC11A1,1
2044,bone resorption (GO:0045453),0.10268553,0.72176895,0,0,9.293680297,21.15319769,TPP1,1
2045,regulation of T-helper 2 cell differentiation (GO:0045628),0.10268553,0.720776145,0,0,9.293680297,21.15319769,ANXA1,1
2046,positive regulation of chemokine secretion (GO:0090197),0.10268553,0.719786068,0,0,9.293680297,21.15319769,LPL,1
2047,regulation of dopamine receptor signaling pathway (GO:0060159),0.10268553,0.718798707,0,0,9.293680297,21.15319769,CAV2,1
2048,response to vitamin D (GO:0033280),0.10268553,0.717814051,0,0,9.293680297,21.15319769,SPP1,1
2049,kidney mesenchyme development (GO:0072074),0.10268553,0.71683209,0,0,9.293680297,21.15319769,BASP1,1
2050,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.10268553,0.715852811,0,0,9.293680297,21.15319769,CAV1,1
2051,negative regulation of neuron death (GO:1901215),0.104050915,0.724381745,0,0,2.655337228,6.00869605,GPNMB;WFS1;ADAM8,1
2052,negative regulation of transport (GO:0051051),0.105060466,0.73041357,0,0,3.626802067,8.171980138,LGALS3;PRKCB,1
2053,regulation of protein dephosphorylation (GO:0035304),0.105060466,0.72941981,0,0,3.626802067,8.171980138,PPP1R14B;HSP90B1,1
2054,autophagy of mitochondrion (GO:0000422),0.105060466,0.72842875,0,0,3.626802067,8.171980138,GABARAPL1;SQSTM1,1
2055,positive regulation of mitotic nuclear division (GO:0045840),0.105060466,0.72744038,0,0,3.626802067,8.171980138,RGCC;IGF1,1
2056,androgen receptor signaling pathway (GO:0030521),0.105060466,0.726454689,0,0,3.626802067,8.171980138,NCOA4;CTNNB1,1
2057,regulation of ATPase activity (GO:0043462),0.105060466,0.725471665,0,0,3.626802067,8.171980138,ATPIF1;ATP1B3,1
2058,positive regulation of supramolecular fiber organization (GO:1902905),0.106842387,0.736779327,0,0,2.624097966,5.868534129,BAIAP2;COLGALT1;MET,1
2059,regulation of mitotic nuclear division (GO:0007088),0.106842387,0.735785022,0,0,2.624097966,5.868534129,RGCC;CAV2;IGF1,1
2060,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),0.109285925,0.751598482,0,0,2.202946441,4.876855666,ABCA1;RGS1;PSAP;CACNA1D,1
2061,regulation of phagocytosis (GO:0050764),0.109374699,0.751196622,0,0,3.540449637,7.834928959,SLC11A1;SIRPA,1
2062,peptide transport (GO:0015833),0.109374699,0.750186949,0,0,3.540449637,7.834928959,MYH9;HSP90B1,1
2063,negative regulation of STAT cascade (GO:1904893),0.109374699,0.749179987,0,0,3.540449637,7.834928959,SOCS2;CAV1,1
2064,monocyte chemotaxis (GO:0002548),0.109374699,0.748175724,0,0,3.540449637,7.834928959,LGALS3;ANXA1,1
2065,regulation of protein localization (GO:0032880),0.109374699,0.74717415,0,0,3.540449637,7.834928959,FKBP1A;PLEKHM2,1
2066,negative regulation of proteolysis (GO:0045861),0.109374699,0.746175254,0,0,3.540449637,7.834928959,CSTB;TIMP2,1
2067,calcium ion transmembrane transport (GO:0070588),0.112512077,0.766554246,0,0,2.563773875,5.601063222,FKBP1A;P2RX4;CACNA1D,1
2068,regulation of protein modification process (GO:0031399),0.113735033,0.773853167,0,0,3.458113599,7.517537147,PPP1R14B;FN1,1
2069,ceramide metabolic process (GO:0006672),0.113735033,0.772822737,0,0,3.458113599,7.517537147,SGPL1;DEGS1,1
2070,protein complex assembly (GO:0006461),0.114044124,0.773892506,0,0,1.956564273,4.248033365,TCF7L2;CTSZ;SH3PXD2B;FN1;CTNNB1,1
2071,very-low-density lipoprotein particle remodeling (GO:0034372),0.114759219,0.777710884,0,0,8.261049153,17.88450303,LPL,1
2072,secretory granule organization (GO:0033363),0.114759219,0.776679437,0,0,8.261049153,17.88450303,ABCA1,1
2073,alanine transport (GO:0032328),0.114759219,0.775650723,0,0,8.261049153,17.88450303,SLC36A2,1
2074,manganese ion transport (GO:0006828),0.114759219,0.77462473,0,0,8.261049153,17.88450303,SLC11A1,1
2075,integrin activation (GO:0033622),0.114759219,0.773601448,0,0,8.261049153,17.88450303,FN1,1
2076,positive regulation of protein maturation (GO:1903319),0.114759219,0.772580865,0,0,8.261049153,17.88450303,ADAM8,1
2077,ATF6-mediated unfolded protein response (GO:0036500),0.114759219,0.771562972,0,0,8.261049153,17.88450303,HSP90B1,1
2078,actin crosslink formation (GO:0051764),0.114759219,0.770547758,0,0,8.261049153,17.88450303,BAIAP2,1
2079,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.114759219,0.769535211,0,0,8.261049153,17.88450303,SOAT1,1
2080,cellular response to interleukin-4 (GO:0071353),0.114759219,0.768525323,0,0,8.261049153,17.88450303,DCSTAMP,1
2081,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.114759219,0.767518081,0,0,8.261049153,17.88450303,RAB7B,1
2082,regulation of T-helper 1 type immune response (GO:0002825),0.114759219,0.766513476,0,0,8.261049153,17.88450303,SLC11A1,1
2083,oligosaccharide catabolic process (GO:0009313),0.114759219,0.765511498,0,0,8.261049153,17.88450303,MAN2B1,1
2084,negative regulation of mitotic nuclear division (GO:0045839),0.114759219,0.764512135,0,0,8.261049153,17.88450303,RGCC,1
2085,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.114759219,0.763515379,0,0,8.261049153,17.88450303,CAV1,1
2086,neurotrophin TRK receptor signaling pathway (GO:0048011),0.114759219,0.762521218,0,0,8.261049153,17.88450303,SORT1,1
2087,positive regulation of long-term synaptic potentiation (GO:1900273),0.114759219,0.761529643,0,0,8.261049153,17.88450303,SQSTM1,1
2088,phagolysosome assembly (GO:0001845),0.114759219,0.760540644,0,0,8.261049153,17.88450303,RAB7B,1
2089,adipose tissue development (GO:0060612),0.114759219,0.75955421,0,0,8.261049153,17.88450303,SH3PXD2B,1
2090,regulation of integrin activation (GO:0033623),0.114759219,0.758570331,0,0,8.261049153,17.88450303,FBLIM1,1
2091,ATP synthesis coupled electron transport (GO:0042773),0.114759219,0.757588998,0,0,8.261049153,17.88450303,MT-CO2,1
2092,central nervous system neuron development (GO:0021954),0.114759219,0.756610201,0,0,8.261049153,17.88450303,NPY,1
2093,chylomicron remodeling (GO:0034371),0.114759219,0.75563393,0,0,8.261049153,17.88450303,LPL,1
2094,sphingoid biosynthetic process (GO:0046520),0.114759219,0.754660175,0,0,8.261049153,17.88450303,SPHK1,1
2095,endosome to pigment granule transport (GO:0043485),0.114759219,0.753688926,0,0,8.261049153,17.88450303,CD63,1
2096,regulation of skeletal muscle cell differentiation (GO:2001014),0.114759219,0.752720175,0,0,8.261049153,17.88450303,GPC1,1
2097,cellular response to oxygen levels (GO:0071453),0.114759219,0.75175391,0,0,8.261049153,17.88450303,ATP6V1A,1
2098,regulation of striated muscle tissue development (GO:0016202),0.114759219,0.750790123,0,0,8.261049153,17.88450303,MTPN,1
2099,podosome assembly (GO:0071800),0.114759219,0.749828804,0,0,8.261049153,17.88450303,SH3PXD2B,1
2100,glycine transport (GO:0015816),0.114759219,0.748869943,0,0,8.261049153,17.88450303,SLC36A2,1
2101,intestinal lipid absorption (GO:0098856),0.114759219,0.747913532,0,0,8.261049153,17.88450303,CD36,1
2102,negative regulation of protein sumoylation (GO:0033234),0.114759219,0.746959561,0,0,8.261049153,17.88450303,CTNNB1,1
2103,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.114759219,0.74600802,0,0,8.261049153,17.88450303,IL1RN,1
2104,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.114759219,0.7450589,0,0,8.261049153,17.88450303,IL1RN,1
2105,basement membrane organization (GO:0071711),0.114759219,0.744112193,0,0,8.261049153,17.88450303,CTSS,1
2106,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.114759219,0.743167888,0,0,8.261049153,17.88450303,FAM129B,1
2107,endothelial cell chemotaxis (GO:0035767),0.114759219,0.742225977,0,0,8.261049153,17.88450303,NRP1,1
2108,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.114759219,0.74128645,0,0,8.261049153,17.88450303,ITGB2,1
2109,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.114759219,0.740349299,0,0,8.261049153,17.88450303,RGCC,1
2110,response to interleukin-4 (GO:0070670),0.114759219,0.739414515,0,0,8.261049153,17.88450303,DCSTAMP,1
2111,glucose import (GO:0046323),0.114759219,0.738482088,0,0,8.261049153,17.88450303,SORT1,1
2112,potassium ion import across plasma membrane (GO:1990573),0.114759219,0.73755201,0,0,8.261049153,17.88450303,ATP1A1,1
2113,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.114759219,0.736624271,0,0,8.261049153,17.88450303,CAV1,1
2114,endosome to melanosome transport (GO:0035646),0.114759219,0.735698864,0,0,8.261049153,17.88450303,CD63,1
2115,T cell mediated immunity (GO:0002456),0.114759219,0.734775779,0,0,8.261049153,17.88450303,SLC11A1,1
2116,proline transport (GO:0015824),0.114759219,0.733855007,0,0,8.261049153,17.88450303,SLC36A2,1
2117,positive regulation of protein homooligomerization (GO:0032464),0.114759219,0.73293654,0,0,8.261049153,17.88450303,RHOC,1
2118,negative regulation of transcription by competitive promoter binding (GO:0010944),0.114759219,0.73202037,0,0,8.261049153,17.88450303,BHLHE41,1
2119,negative regulation of potassium ion transmembrane transport (GO:1901380),0.114759219,0.731106487,0,0,8.261049153,17.88450303,CAV1,1
2120,proton-transporting V-type ATPase complex assembly (GO:0070070),0.114759219,0.730194882,0,0,8.261049153,17.88450303,TCIRG1,1
2121,sphingosine metabolic process (GO:0006670),0.114759219,0.729285549,0,0,8.261049153,17.88450303,SPHK1,1
2122,regulation of nephron tubule epithelial cell differentiation (GO:0072182),0.114759219,0.728378477,0,0,8.261049153,17.88450303,CTNNB1,1
2123,regulation of glycoprotein biosynthetic process (GO:0010559),0.114759219,0.727473659,0,0,8.261049153,17.88450303,IGF1,1
2124,response to vitamin (GO:0033273),0.114759219,0.726571087,0,0,8.261049153,17.88450303,SPP1,1
2125,calcium ion homeostasis (GO:0055074),0.115389298,0.729655004,0,0,2.534640081,5.473412469,WFS1;CAV1;TMEM165,1
2126,regulation of B cell proliferation (GO:0030888),0.11813946,0.746120874,0,0,3.379520108,7.218281462,BST1;CD81,1
2127,male gonad development (GO:0008584),0.11813946,0.745198599,0,0,3.379520108,7.218281462,NCOA4;INHBA,1
2128,negative regulation of DNA metabolic process (GO:0051053),0.11813946,0.744278601,0,0,3.379520108,7.218281462,ZRANB3;FAM129B,1
2129,response to hydrogen peroxide (GO:0042542),0.11813946,0.743360871,0,0,3.379520108,7.218281462,HMOX1;RHOB,1
2130,positive regulation of protein localization to plasma membrane (GO:1903078),0.11813946,0.742445402,0,0,3.379520108,7.218281462,TREM2;SQSTM1,1
2131,substantia nigra development (GO:0021762),0.11813946,0.741532185,0,0,3.379520108,7.218281462,BASP1;S100A1,1
2132,regulation of interferon-gamma production (GO:0032649),0.11813946,0.740621212,0,0,3.379520108,7.218281462,CD274;SLC11A1,1
2133,regulation of protein targeting to mitochondrion (GO:1903214),0.118294101,0.740680735,0,0,2.506160979,5.34960454,CTSK;ATPIF1;ITGAX,1
2134,positive regulation of protein complex assembly (GO:0031334),0.118294101,0.739773038,0,0,2.506160979,5.34960454,CTNNB1;MITF;CD36,1
2135,cellular response to growth factor stimulus (GO:0071363),0.120445597,0.752305854,0,0,2.124269782,4.496138298,NRP1;ANXA1;CTNNB1;CD44,1
2136,cellular protein metabolic process (GO:0044267),0.120516103,0.751826009,0,0,1.532978193,3.243738776,F7;WFS1;APLP2;FN1;SPP1;FAM20C;MAN2B1;IGF1;MFGE8;HSP90B1,1
2137,regulation of neuron apoptotic process (GO:0043523),0.121225983,0.755331124,0,0,2.478314746,5.22948909,WFS1;CTNNB1;ADAM8,1
2138,amide biosynthetic process (GO:0043604),0.122586017,0.762873713,0,0,3.304419661,6.935786258,ATPIF1;DEGS1,1
2139,unsaturated fatty acid metabolic process (GO:0033559),0.122586017,0.761944512,0,0,3.304419661,6.935786258,DEGS1;DAGLB,1
2140,inorganic anion transport (GO:0015698),0.122586017,0.761017572,0,0,3.304419661,6.935786258,CLIC4;SLC11A1,1
2141,myeloid cell differentiation (GO:0030099),0.122586017,0.760092885,0,0,3.304419661,6.935786258,ATPIF1;INHBA,1
2142,regulation of small GTPase mediated signal transduction (GO:0051056),0.122734606,0.76009065,0,0,2.109204039,4.424542544,RHOC;SQSTM1;ARHGAP25;RHOB,1
2143,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),0.122734606,0.759169328,0,0,2.109204039,4.424542544,TCF7L2;DAP;WFS1;ANXA4,1
2144,positive regulation of response to external stimulus (GO:0032103),0.124184438,0.767207247,0,0,2.451080518,5.112923119,LPL;S100A9;PLA2G7,1
2145,regulation of Ras protein signal transduction (GO:0046578),0.124184438,0.766279548,0,0,2.451080518,5.112923119,APLP2;IGF1;SQSTM1,1
2146,glomerular filtration (GO:0003094),0.12667105,0.780679186,0,0,7.434944238,15.36179713,MYO1E,1
2147,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.12667105,0.779737474,0,0,7.434944238,15.36179713,CLTC,1
2148,protein deglycosylation (GO:0006517),0.12667105,0.778798031,0,0,7.434944238,15.36179713,MAN2B1,1
2149,vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),0.12667105,0.77786085,0,0,7.434944238,15.36179713,TCIRG1,1
2150,positive regulation of calcium ion import (GO:0090280),0.12667105,0.776925921,0,0,7.434944238,15.36179713,LGALS3,1
2151,cellular response to growth hormone stimulus (GO:0071378),0.12667105,0.775993236,0,0,7.434944238,15.36179713,SOCS2,1
2152,superoxide anion generation (GO:0042554),0.12667105,0.775062789,0,0,7.434944238,15.36179713,CYBB,1
2153,macrophage chemotaxis (GO:0048246),0.12667105,0.77413457,0,0,7.434944238,15.36179713,LGALS3,1
2154,regulation of mammary gland epithelial cell proliferation (GO:0033599),0.12667105,0.773208572,0,0,7.434944238,15.36179713,RTN4,1
2155,phosphatidylglycerol biosynthetic process (GO:0006655),0.12667105,0.772284786,0,0,7.434944238,15.36179713,SLC27A1,1
2156,positive regulation of alcohol biosynthetic process (GO:1902932),0.12667105,0.771363205,0,0,7.434944238,15.36179713,ABCG1,1
2157,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.12667105,0.770443821,0,0,7.434944238,15.36179713,F7,1
2158,response to acidic pH (GO:0010447),0.12667105,0.769526626,0,0,7.434944238,15.36179713,CTSS,1
2159,response to laminar fluid shear stress (GO:0034616),0.12667105,0.768611612,0,0,7.434944238,15.36179713,ABCA1,1
2160,regulation of mast cell activation (GO:0033003),0.12667105,0.767698772,0,0,7.434944238,15.36179713,CD84,1
2161,hair cell differentiation (GO:0035315),0.12667105,0.766788097,0,0,7.434944238,15.36179713,CTNNB1,1
2162,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.12667105,0.765879581,0,0,7.434944238,15.36179713,CD36,1
2163,regulation of actin filament-based movement (GO:1903115),0.12667105,0.764973214,0,0,7.434944238,15.36179713,PDPN,1
2164,mesenchymal to epithelial transition (GO:0060231),0.12667105,0.764068991,0,0,7.434944238,15.36179713,BASP1,1
2165,regulation of amyloid-beta clearance (GO:1900221),0.12667105,0.763166902,0,0,7.434944238,15.36179713,LRPAP1,1
2166,positive regulation of cardiac muscle cell differentiation (GO:2000727),0.12667105,0.762266941,0,0,7.434944238,15.36179713,IGF1,1
2167,positive regulation of lipase activity (GO:0060193),0.12667105,0.7613691,0,0,7.434944238,15.36179713,RHOC,1
2168,creatine metabolic process (GO:0006600),0.12667105,0.760473372,0,0,7.434944238,15.36179713,SLC6A8,1
2169,nuclear pore complex assembly (GO:0051292),0.12667105,0.759579749,0,0,7.434944238,15.36179713,RTN4,1
2170,positive regulation of fertilization (GO:1905516),0.12667105,0.758688223,0,0,7.434944238,15.36179713,LHFPL2,1
2171,regulation of granulocyte differentiation (GO:0030852),0.12667105,0.757798788,0,0,7.434944238,15.36179713,C1QC,1
2172,macrophage migration (GO:1905517),0.12667105,0.756911436,0,0,7.434944238,15.36179713,LGALS3,1
2173,virion attachment to host cell (GO:0019062),0.12667105,0.756026159,0,0,7.434944238,15.36179713,CD81,1
2174,Rap protein signal transduction (GO:0032486),0.12667105,0.755142951,0,0,7.434944238,15.36179713,PLK2,1
2175,myeloid dendritic cell differentiation (GO:0043011),0.12667105,0.754261804,0,0,7.434944238,15.36179713,DCSTAMP,1
2176,insulin-like growth factor receptor signaling pathway (GO:0048009),0.12667105,0.753382711,0,0,7.434944238,15.36179713,IGF1,1
2177,regulation of gene expression by genetic imprinting (GO:0006349),0.12667105,0.752505665,0,0,7.434944238,15.36179713,DNMT3A,1
2178,neuron projection fasciculation (GO:0106030),0.12667105,0.751630658,0,0,7.434944238,15.36179713,RTN4,1
2179,negative regulation of embryonic development (GO:0045992),0.12667105,0.750757684,0,0,7.434944238,15.36179713,CTNNB1,1
2180,negative regulation of protein autophosphorylation (GO:0031953),0.12667105,0.749886735,0,0,7.434944238,15.36179713,CAV1,1
2181,positive regulation of lipid localization (GO:1905954),0.12667105,0.749017805,0,0,7.434944238,15.36179713,HILPDA,1
2182,very-low-density lipoprotein particle assembly (GO:0034379),0.12667105,0.748150887,0,0,7.434944238,15.36179713,SOAT1,1
2183,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.12667105,0.747285972,0,0,7.434944238,15.36179713,CD9,1
2184,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.12667105,0.746423055,0,0,7.434944238,15.36179713,CTNNB1,1
2185,regulation of neuroblast proliferation (GO:1902692),0.12667105,0.745562129,0,0,7.434944238,15.36179713,CTNNB1,1
2186,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.12667105,0.744703187,0,0,7.434944238,15.36179713,WFS1,1
2187,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.12667105,0.743846221,0,0,7.434944238,15.36179713,SLC11A1,1
2188,regulation of lysosomal lumen pH (GO:0035751),0.12667105,0.742991225,0,0,7.434944238,15.36179713,TMEM165,1
2189,regulation of plasminogen activation (GO:0010755),0.12667105,0.742138193,0,0,7.434944238,15.36179713,CTSZ,1
2190,regulation of T cell apoptotic process (GO:0070232),0.12667105,0.741287117,0,0,7.434944238,15.36179713,LGALS3,1
2191,negative regulation of glucose transport (GO:0010829),0.12667105,0.740437991,0,0,7.434944238,15.36179713,PRKCB,1
2192,hexose metabolic process (GO:0019318),0.127072784,0.741936405,0,0,3.232584451,6.668806377,AKR1A1;MAN2B1,1
2193,nicotinamide nucleotide metabolic process (GO:0046496),0.127072784,0.741088478,0,0,3.232584451,6.668806377,HK3;BST1,1
2194,metal ion homeostasis (GO:0055065),0.127072784,0.740242486,0,0,3.232584451,6.668806377,WFS1;CAV1,1
2195,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.127368074,0.741116629,0,0,2.079704682,4.285593699,CD84;ALCAM;ITGB2;CD200,1
2196,positive regulation of protein localization to cell periphery (GO:1904377),0.131597887,0.764856512,0,0,3.163806059,6.416212343,TREM2;SQSTM1,1
2197,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.131597887,0.763986368,0,0,3.163806059,6.416212343,CAV1;CTNNB1,1
2198,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.131597887,0.763118202,0,0,3.163806059,6.416212343,MT-ND5;MT-ND3,1
2199,negative regulation of autophagy (GO:0010507),0.131597887,0.762252006,0,0,3.163806059,6.416212343,DAP;MET,1
2200,peptide cross-linking (GO:0018149),0.136159493,0.787779924,0,0,3.097893432,6.176977503,ANXA1;FN1,1
2201,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.136159493,0.786887761,0,0,3.097893432,6.176977503,CAV1;S100A9,1
2202,negative regulation of JAK-STAT cascade (GO:0046426),0.136159493,0.785997616,0,0,3.097893432,6.176977503,SOCS2;CAV1,1
2203,fatty acid biosynthetic process (GO:0006633),0.136159493,0.785109483,0,0,3.097893432,6.176977503,LPL;DEGS1,1
2204,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.136159493,0.784223355,0,0,3.097893432,6.176977503,ALCAM;CD200,1
2205,skin development (GO:0043588),0.136273844,0.783997097,0,0,2.347877128,4.67952775,CLIC4;ANXA1;MET,1
2206,skeletal system development (GO:0001501),0.13685093,0.786430511,0,0,2.023114078,4.023696838,PRDX1;SH3PXD2B;IGF1;CD44,1
2207,positive regulation of endothelial cell apoptotic process (GO:2000353),0.138423182,0.794570865,0,0,6.759040216,13.36559478,RGCC,1
2208,negative regulation of leukocyte activation (GO:0002695),0.138423182,0.793678089,0,0,6.759040216,13.36559478,CD84,1
2209,mononuclear cell differentiation (GO:1903131),0.138423182,0.792787317,0,0,6.759040216,13.36559478,MYH9,1
2210,positive regulation by host of viral process (GO:0044794),0.138423182,0.791898542,0,0,6.759040216,13.36559478,CAV2,1
2211,positive regulation of superoxide anion generation (GO:0032930),0.138423182,0.791011757,0,0,6.759040216,13.36559478,ITGB2,1
2212,positive regulation of leukocyte degranulation (GO:0043302),0.138423182,0.790126957,0,0,6.759040216,13.36559478,ITGB2,1
2213,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.138423182,0.789244133,0,0,6.759040216,13.36559478,CD63,1
2214,modulation by host of viral process (GO:0044788),0.138423182,0.78836328,0,0,6.759040216,13.36559478,CAV2,1
2215,regulation of actin filament depolymerization (GO:0030834),0.138423182,0.787484392,0,0,6.759040216,13.36559478,MTPN,1
2216,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.138423182,0.78660746,0,0,6.759040216,13.36559478,CAV1,1
2217,negative regulation of myotube differentiation (GO:0010832),0.138423182,0.78573248,0,0,6.759040216,13.36559478,BHLHE41,1
2218,monocyte differentiation (GO:0030224),0.138423182,0.784859444,0,0,6.759040216,13.36559478,MYH9,1
2219,T cell proliferation (GO:0042098),0.138423182,0.783988345,0,0,6.759040216,13.36559478,SLC11A1,1
2220,renal filtration (GO:0097205),0.138423182,0.783119179,0,0,6.759040216,13.36559478,MYO1E,1
2221,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.138423182,0.782251937,0,0,6.759040216,13.36559478,SYNGR1,1
2222,positive regulation of T cell receptor signaling pathway (GO:0050862),0.138423182,0.781386614,0,0,6.759040216,13.36559478,KCNN4,1
2223,regulation of cholesterol esterification (GO:0010872),0.138423182,0.780523204,0,0,6.759040216,13.36559478,ABCG1,1
2224,negative regulation of potassium ion transport (GO:0043267),0.138423182,0.779661699,0,0,6.759040216,13.36559478,CAV1,1
2225,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.138423182,0.778802094,0,0,6.759040216,13.36559478,CD44,1
2226,metanephric mesenchyme development (GO:0072075),0.138423182,0.777944382,0,0,6.759040216,13.36559478,BASP1,1
2227,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.138423182,0.777088558,0,0,6.759040216,13.36559478,P2RX4,1
2228,angiotensin maturation (GO:0002003),0.138423182,0.776234615,0,0,6.759040216,13.36559478,CTSZ,1
2229,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.138423182,0.775382546,0,0,6.759040216,13.36559478,ACTN4,1
2230,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.138423182,0.774532346,0,0,6.759040216,13.36559478,CLTC,1
2231,protein carboxylation (GO:0018214),0.138423182,0.773684008,0,0,6.759040216,13.36559478,F7,1
2232,midbrain dopaminergic neuron differentiation (GO:1904948),0.138423182,0.772837527,0,0,6.759040216,13.36559478,CTNNB1,1
2233,"regulation of symbiosis, encompassing mutualism through parasitism (GO:0043903)",0.138423182,0.771992895,0,0,6.759040216,13.36559478,CAV1,1
2234,response to corticosteroid (GO:0031960),0.138423182,0.771150108,0,0,6.759040216,13.36559478,IL1RN,1
2235,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.138423182,0.770309159,0,0,6.759040216,13.36559478,HMOX1,1
2236,peptidyl-glutamic acid carboxylation (GO:0017187),0.138423182,0.769470043,0,0,6.759040216,13.36559478,F7,1
2237,positive regulation of T-helper cell differentiation (GO:0045624),0.138423182,0.768632752,0,0,6.759040216,13.36559478,ANXA1,1
2238,cardiac muscle cell membrane repolarization (GO:0099622),0.138423182,0.767797282,0,0,6.759040216,13.36559478,ATP1A1,1
2239,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.138423182,0.766963626,0,0,6.759040216,13.36559478,NRP1,1
2240,positive regulation of protein localization to membrane (GO:1905477),0.139357549,0.771303223,0,0,2.323420074,4.578792645,TREM2;SQSTM1;YWHAG,1
2241,negative regulation of mitotic cell cycle (GO:0045930),0.140755812,0.778198166,0,0,3.034671118,5.95016682,RGCC;CTNNB1,1
2242,regulation of epithelial cell migration (GO:0010632),0.140755812,0.77735596,0,0,3.034671118,5.95016682,EVL;RTN4,1
2243,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.145385094,0.802054201,0,0,2.973977695,5.734927091,S100A9;HIST1H2BC,1
2244,lipid homeostasis (GO:0055088),0.145385094,0.801188052,0,0,2.973977695,5.734927091,ABCA1;ABCG1,1
2245,cellular response to organonitrogen compound (GO:0071417),0.145595019,0.801479374,0,0,2.276003338,4.385690822,P2RX4;CTNNB1;HSP90B1,1
2246,positive regulation of signal transduction (GO:0009967),0.147591172,0.811592404,0,0,1.795880251,3.436074168,F7;CD63;PRKCB;TREM2;IGF1,1
2247,phosphatidylinositol biosynthetic process (GO:0006661),0.148747765,0.817071952,0,0,2.253013405,4.293124392,SLC27A1;PGAP2;PI4K2A,1
2248,axonal fasciculation (GO:0007413),0.15001775,0.823161914,0,0,6.195786865,11.75341794,RTN4,1
2249,negative regulation of ATPase activity (GO:0032780),0.15001775,0.822277745,0,0,6.195786865,11.75341794,ATPIF1,1
2250,import across plasma membrane (GO:0098739),0.15001775,0.821395472,0,0,6.195786865,11.75341794,ATP1A1,1
2251,ribose phosphate metabolic process (GO:0019693),0.15001775,0.820515091,0,0,6.195786865,11.75341794,PGD,1
2252,retinol metabolic process (GO:0042572),0.15001775,0.819636596,0,0,6.195786865,11.75341794,DHRS3,1
2253,pentose-phosphate shunt (GO:0006098),0.15001775,0.818759979,0,0,6.195786865,11.75341794,PGD,1
2254,iron ion transport (GO:0006826),0.15001775,0.817885235,0,0,6.195786865,11.75341794,SLC11A1,1
2255,mitochondrial outer membrane permeabilization (GO:0097345),0.15001775,0.817012359,0,0,6.195786865,11.75341794,BNIP3L,1
2256,carbohydrate derivative transport (GO:1901264),0.15001775,0.816141344,0,0,6.195786865,11.75341794,ABCG1,1
2257,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.15001775,0.815272183,0,0,6.195786865,11.75341794,CD44,1
2258,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.15001775,0.814404873,0,0,6.195786865,11.75341794,SYNGR1,1
2259,skeletal muscle fiber development (GO:0048741),0.15001775,0.813539405,0,0,6.195786865,11.75341794,CAV2,1
2260,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.15001775,0.812675775,0,0,6.195786865,11.75341794,ATP1B3,1
2261,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.15001775,0.811813977,0,0,6.195786865,11.75341794,ACTN4,1
2262,regulation of cell communication by electrical coupling (GO:0010649),0.15001775,0.810954004,0,0,6.195786865,11.75341794,CAV1,1
2263,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.15001775,0.810095852,0,0,6.195786865,11.75341794,CD44,1
2264,regulation of mononuclear cell migration (GO:0071675),0.15001775,0.809239514,0,0,6.195786865,11.75341794,LGALS3,1
2265,"regulation of protein import into nucleus, translocation (GO:0033158)",0.15001775,0.808384984,0,0,6.195786865,11.75341794,IGF1,1
2266,regulation of sequestering of triglyceride (GO:0010889),0.15001775,0.807532258,0,0,6.195786865,11.75341794,LPL,1
2267,negative regulation of epithelial cell differentiation (GO:0030857),0.15001775,0.806681328,0,0,6.195786865,11.75341794,CAV1,1
2268,regulation of angiotensin levels in blood (GO:0002002),0.15001775,0.80583219,0,0,6.195786865,11.75341794,CTSZ,1
2269,regulation of hormone secretion (GO:0046883),0.15001775,0.804984837,0,0,6.195786865,11.75341794,ANXA1,1
2270,regulation of T cell differentiation in thymus (GO:0033081),0.15001775,0.804139265,0,0,6.195786865,11.75341794,ADAM8,1
2271,endosome transport via multivesicular body sorting pathway (GO:0032509),0.15001775,0.803295467,0,0,6.195786865,11.75341794,SORT1,1
2272,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.15001775,0.802453438,0,0,6.195786865,11.75341794,GPC1,1
2273,regulation of sister chromatid cohesion (GO:0007063),0.15001775,0.801613173,0,0,6.195786865,11.75341794,CTNNB1,1
2274,membrane repolarization during action potential (GO:0086011),0.15001775,0.800774666,0,0,6.195786865,11.75341794,ATP1A1,1
2275,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.15001775,0.79993791,0,0,6.195786865,11.75341794,PRKCB,1
2276,regulation of cellular protein metabolic process (GO:0032268),0.150045632,0.799251419,0,0,2.915664407,5.530478368,MTPN;INHBA,1
2277,myeloid leukocyte differentiation (GO:0002573),0.150045632,0.798417998,0,0,2.915664407,5.530478368,DCSTAMP;MYH9,1
2278,cellular divalent inorganic cation homeostasis (GO:0072503),0.15833595,0.841654536,0,0,2.186748305,4.030256364,SLC11A1;CAV1;TMEM165,1
2279,chemokine-mediated signaling pathway (GO:0070098),0.159453835,0.846714799,0,0,2.805639335,5.151156154,CXCL1;CXCL3,1
2280,regulation of cell-matrix adhesion (GO:0001952),0.159453835,0.845834638,0,0,2.805639335,5.151156154,BST1;CD36,1
2281,positive regulation of histone H3-K4 methylation (GO:0051571),0.161456858,0.855570456,0,0,5.719187875,10.42903804,CTNNB1,1
2282,regulation of granulocyte chemotaxis (GO:0071622),0.161456858,0.854682934,0,0,5.719187875,10.42903804,BST1,1
2283,cellular response to exogenous dsRNA (GO:0071360),0.161456858,0.853797253,0,0,5.719187875,10.42903804,CAV1,1
2284,intestinal absorption (GO:0050892),0.161456858,0.852913405,0,0,5.719187875,10.42903804,CD36,1
2285,regulation of superoxide anion generation (GO:0032928),0.161456858,0.852031385,0,0,5.719187875,10.42903804,ITGB2,1
2286,cellular response to nitrogen starvation (GO:0006995),0.161456858,0.851151187,0,0,5.719187875,10.42903804,GABARAPL1,1
2287,renal absorption (GO:0070293),0.161456858,0.850272806,0,0,5.719187875,10.42903804,SGK1,1
2288,steroid catabolic process (GO:0006706),0.161456858,0.849396236,0,0,5.719187875,10.42903804,SPP1,1
2289,muscle cell development (GO:0055001),0.161456858,0.848521471,0,0,5.719187875,10.42903804,SDC1,1
2290,positive regulation of glycogen biosynthetic process (GO:0045725),0.161456858,0.847648507,0,0,5.719187875,10.42903804,IGF1,1
2291,myelination in peripheral nervous system (GO:0022011),0.161456858,0.846777337,0,0,5.719187875,10.42903804,AHNAK2,1
2292,multivesicular body sorting pathway (GO:0071985),0.161456858,0.845907956,0,0,5.719187875,10.42903804,SORT1,1
2293,positive regulation of cholesterol efflux (GO:0010875),0.161456858,0.845040358,0,0,5.719187875,10.42903804,ABCA1,1
2294,regulation of axon guidance (GO:1902667),0.161456858,0.844174538,0,0,5.719187875,10.42903804,NRP1,1
2295,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.161456858,0.84331049,0,0,5.719187875,10.42903804,CD84,1
2296,cardiolipin metabolic process (GO:0032048),0.161456858,0.842448209,0,0,5.719187875,10.42903804,SLC27A1,1
2297,phosphate ion transport (GO:0006817),0.161456858,0.84158769,0,0,5.719187875,10.42903804,SLC37A2,1
2298,tetrahydrofolate metabolic process (GO:0046653),0.161456858,0.840728927,0,0,5.719187875,10.42903804,ATPIF1,1
2299,leukocyte differentiation (GO:0002521),0.161456858,0.839871915,0,0,5.719187875,10.42903804,TREM2,1
2300,sensory perception of taste (GO:0050909),0.161456858,0.839016648,0,0,5.719187875,10.42903804,CD36,1
2301,positive regulation of muscle contraction (GO:0045933),0.161456858,0.838163122,0,0,5.719187875,10.42903804,SPHK1,1
2302,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.161456858,0.83731133,0,0,5.719187875,10.42903804,CAV1,1
2303,positive regulation of ERAD pathway (GO:1904294),0.161456858,0.836461268,0,0,5.719187875,10.42903804,CAV1,1
2304,triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.161456858,0.83561293,0,0,5.719187875,10.42903804,LPL,1
2305,diacylglycerol metabolic process (GO:0046339),0.161456858,0.834766311,0,0,5.719187875,10.42903804,DAGLB,1
2306,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.161456858,0.833921406,0,0,5.719187875,10.42903804,NRP1,1
2307,chondroitin sulfate catabolic process (GO:0030207),0.161456858,0.833078209,0,0,5.719187875,10.42903804,HEXA,1
2308,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.161456858,0.832236716,0,0,5.719187875,10.42903804,DHRS3,1
2309,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.161456858,0.831396921,0,0,5.719187875,10.42903804,TCIRG1,1
2310,high-density lipoprotein particle assembly (GO:0034380),0.161456858,0.830558819,0,0,5.719187875,10.42903804,ABCA1,1
2311,amyloid precursor protein metabolic process (GO:0042982),0.161456858,0.829722406,0,0,5.719187875,10.42903804,ABCG1,1
2312,response to fatty acid (GO:0070542),0.161456858,0.828887675,0,0,5.719187875,10.42903804,CD36,1
2313,negative regulation of interleukin-10 production (GO:0032693),0.161456858,0.828054622,0,0,5.719187875,10.42903804,CD274,1
2314,cellular response to nitrogen levels (GO:0043562),0.161456858,0.827223242,0,0,5.719187875,10.42903804,GABARAPL1,1
2315,plasma membrane invagination (GO:0099024),0.164831298,0.843665111,0,0,2.144695453,3.866527228,ITGB2;MYH9;ARHGAP25,1
2316,protein import into nucleus (GO:0006606),0.164831298,0.842819755,0,0,2.144695453,3.866527228,MMP12;CTNNB1;PTTG1IP,1
2317,monovalent inorganic cation transport (GO:0015672),0.168108427,0.858716017,0,0,2.124269782,3.787883402,SLC36A2;KCNN4;SGK1,1
2318,"phagocytosis, engulfment (GO:0006911)",0.168108427,0.857857301,0,0,2.124269782,3.787883402,ITGB2;MYH9;ARHGAP25,1
2319,positive regulation of immune response (GO:0050778),0.168967533,0.861379941,0,0,2.703616087,4.807161053,ITGB2;ADAM8,1
2320,positive regulation of cellular biosynthetic process (GO:0031328),0.169504912,0.86325705,0,0,1.858736059,3.299021144,RGCC;P2RX4;IGF1;CD36,1
2321,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.172742583,0.878868796,0,0,5.310674456,9.325293419,MET,1
2322,mitotic cell cycle arrest (GO:0071850),0.172742583,0.877993428,0,0,5.310674456,9.325293419,RGCC,1
2323,positive regulation of neural precursor cell proliferation (GO:2000179),0.172742583,0.877119803,0,0,5.310674456,9.325293419,CTNNB1,1
2324,clathrin coat assembly (GO:0048268),0.172742583,0.876247915,0,0,5.310674456,9.325293419,CLTC,1
2325,negative regulation of receptor-mediated endocytosis (GO:0048261),0.172742583,0.875377758,0,0,5.310674456,9.325293419,LRPAP1,1
2326,myeloid dendritic cell activation (GO:0001773),0.172742583,0.874509328,0,0,5.310674456,9.325293419,DCSTAMP,1
2327,lipid particle organization (GO:0034389),0.172742583,0.873642619,0,0,5.310674456,9.325293419,HILPDA,1
2328,regulation of activin receptor signaling pathway (GO:0032925),0.172742583,0.872777626,0,0,5.310674456,9.325293419,FKBP1A,1
2329,pore complex assembly (GO:0046931),0.172742583,0.871914344,0,0,5.310674456,9.325293419,RTN4,1
2330,endoplasmic reticulum tubular network organization (GO:0071786),0.172742583,0.871052769,0,0,5.310674456,9.325293419,RTN4,1
2331,neurotransmitter biosynthetic process (GO:0042136),0.172742583,0.870192895,0,0,5.310674456,9.325293419,DAGLB,1
2332,regulation of extracellular matrix disassembly (GO:0010715),0.172742583,0.869334716,0,0,5.310674456,9.325293419,PDPN,1
2333,regulation of secretion (GO:0051046),0.172742583,0.868478229,0,0,5.310674456,9.325293419,SGK1,1
2334,negative regulation of Rho protein signal transduction (GO:0035024),0.172742583,0.867623427,0,0,5.310674456,9.325293419,MET,1
2335,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.172742583,0.866770307,0,0,5.310674456,9.325293419,IGF1,1
2336,regulation of monocyte differentiation (GO:0045655),0.172742583,0.865918863,0,0,5.310674456,9.325293419,DCSTAMP,1
2337,modified amino acid transport (GO:0072337),0.172742583,0.865069089,0,0,5.310674456,9.325293419,SLC6A8,1
2338,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.172742583,0.864220983,0,0,5.310674456,9.325293419,ATP1A1,1
2339,pancreas development (GO:0031016),0.172742583,0.863374537,0,0,5.310674456,9.325293419,TCF7L2,1
2340,hydrogen peroxide catabolic process (GO:0042744),0.172742583,0.862529748,0,0,5.310674456,9.325293419,PRDX1,1
2341,positive regulation of glycogen metabolic process (GO:0070875),0.172742583,0.86168661,0,0,5.310674456,9.325293419,IGF1,1
2342,cell migration involved in sprouting angiogenesis (GO:0002042),0.172742583,0.860845119,0,0,5.310674456,9.325293419,NRP1,1
2343,neuromuscular process controlling balance (GO:0050885),0.172742583,0.86000527,0,0,5.310674456,9.325293419,TPP1,1
2344,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),0.172742583,0.859167059,0,0,5.310674456,9.325293419,RGCC,1
2345,regulation of fatty acid metabolic process (GO:0019217),0.172742583,0.858330479,0,0,5.310674456,9.325293419,CAV1,1
2346,positive regulation of vascular smooth muscle cell proliferation (GO:1904707),0.172742583,0.857495527,0,0,5.310674456,9.325293419,IGF1,1
2347,fatty acid transport (GO:0015908),0.172742583,0.856662198,0,0,5.310674456,9.325293419,SLC27A1,1
2348,regulation of interferon-gamma biosynthetic process (GO:0045072),0.172742583,0.855830488,0,0,5.310674456,9.325293419,INHBA,1
2349,positive regulation of transporter activity (GO:0032411),0.172742583,0.85500039,0,0,5.310674456,9.325293419,SGK1,1
2350,positive regulation of smooth muscle contraction (GO:0045987),0.172742583,0.854171901,0,0,5.310674456,9.325293419,SPHK1,1
2351,negative regulation of cation transmembrane transport (GO:1904063),0.172742583,0.853345017,0,0,5.310674456,9.325293419,CAV1,1
2352,positive regulation of blood vessel diameter (GO:0097755),0.172742583,0.852519731,0,0,5.310674456,9.325293419,HMOX1,1
2353,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.173760079,0.856712738,0,0,2.655337228,4.647052011,GPC1;FAM129B,1
2354,fat cell differentiation (GO:0045444),0.173760079,0.855885795,0,0,2.655337228,4.647052011,TCF7L2;EGR2,1
2355,regulation of response to external stimulus (GO:0032101),0.178051616,0.876178782,0,0,2.065262288,3.563985527,BST1;ANXA1;CAV1,1
2356,cellular response to starvation (GO:0009267),0.178051616,0.875334679,0,0,2.065262288,3.563985527,GABARAPL1;DAP;LAMP2,1
2357,regulation of protein secretion (GO:0050708),0.178051616,0.874492201,0,0,2.065262288,3.563985527,ADAM8;CACNA1D;IGF1,1
2358,positive regulation of protein transport (GO:0051222),0.178574436,0.876216678,0,0,2.608752364,4.494227505,ADAM8;IGF1,1
2359,IRE1-mediated unfolded protein response (GO:0036498),0.183409157,0.899074857,0,0,2.563773875,4.348252258,WFS1;TPP1,1
2360,regulation of neurogenesis (GO:0050767),0.183409157,0.898212021,0,0,2.563773875,4.348252258,CTNNB1;YWHAG,1
2361,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.183876974,0.89963969,0,0,4.956629492,8.393994382,ATP1A1,1
2362,regulation of mast cell degranulation (GO:0043304),0.183876974,0.898777966,0,0,4.956629492,8.393994382,CD84,1
2363,nuclear pore organization (GO:0006999),0.183876974,0.897917891,0,0,4.956629492,8.393994382,RTN4,1
2364,selective autophagy (GO:0061912),0.183876974,0.897059461,0,0,4.956629492,8.393994382,SQSTM1,1
2365,phosphatidylethanolamine biosynthetic process (GO:0006646),0.183876974,0.896202671,0,0,4.956629492,8.393994382,SLC27A1,1
2366,positive regulation of response to wounding (GO:1903036),0.183876974,0.895347516,0,0,4.956629492,8.393994382,ANXA1,1
2367,regulation of protein homooligomerization (GO:0032462),0.183876974,0.894493991,0,0,4.956629492,8.393994382,RHOC,1
2368,regulation of B cell differentiation (GO:0045577),0.183876974,0.893642092,0,0,4.956629492,8.393994382,INHBA,1
2369,autonomic nervous system development (GO:0048483),0.183876974,0.892791814,0,0,4.956629492,8.393994382,NRP1,1
2370,positive regulation of vasoconstriction (GO:0045907),0.183876974,0.891943153,0,0,4.956629492,8.393994382,CAV1,1
2371,positive regulation of glycolytic process (GO:0045821),0.183876974,0.891096103,0,0,4.956629492,8.393994382,IGF1,1
2372,positive regulation of mesonephros development (GO:0061213),0.183876974,0.890250661,0,0,4.956629492,8.393994382,BASP1,1
2373,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.183876974,0.889406821,0,0,4.956629492,8.393994382,IGF1,1
2374,substrate-dependent cell migration (GO:0006929),0.183876974,0.88856458,0,0,4.956629492,8.393994382,NRP1,1
2375,transport along microtubule (GO:0010970),0.183876974,0.887723932,0,0,4.956629492,8.393994382,DYNC1I2,1
2376,positive regulation of coenzyme metabolic process (GO:0051197),0.183876974,0.886884874,0,0,4.956629492,8.393994382,IGF1,1
2377,L-alpha-amino acid transmembrane transport (GO:1902475),0.183876974,0.8860474,0,0,4.956629492,8.393994382,SLC7A2,1
2378,G-protein coupled glutamate receptor signaling pathway (GO:0007216),0.183876974,0.885211506,0,0,4.956629492,8.393994382,DAGLB,1
2379,positive regulation of potassium ion transmembrane transport (GO:1901381),0.183876974,0.884377188,0,0,4.956629492,8.393994382,ATP1B3,1
2380,unsaturated fatty acid biosynthetic process (GO:0006636),0.183876974,0.883544441,0,0,4.956629492,8.393994382,DEGS1,1
2381,negative regulation of coagulation (GO:0050819),0.183876974,0.882713261,0,0,4.956629492,8.393994382,PROCR,1
2382,regulation of centriole replication (GO:0046599),0.183876974,0.881883643,0,0,4.956629492,8.393994382,PLK2,1
2383,nitric oxide mediated signal transduction (GO:0007263),0.183876974,0.881055584,0,0,4.956629492,8.393994382,CD36,1
2384,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.183876974,0.880229077,0,0,4.956629492,8.393994382,IGF1,1
2385,positive regulation of acute inflammatory response (GO:0002675),0.183876974,0.87940412,0,0,4.956629492,8.393994382,ADAM8,1
2386,regulation of exit from mitosis (GO:0007096),0.183876974,0.878580708,0,0,4.956629492,8.393994382,RGCC,1
2387,positive regulation of viral release from host cell (GO:1902188),0.183876974,0.877758837,0,0,4.956629492,8.393994382,CAV2,1
2388,positive regulation of cellular response to insulin stimulus (GO:1900078),0.183876974,0.876938501,0,0,4.956629492,8.393994382,IGF1,1
2389,cofactor transport (GO:0051181),0.183876974,0.876119698,0,0,4.956629492,8.393994382,SLC48A1,1
2390,negative regulation of platelet activation (GO:0010544),0.183876974,0.875302422,0,0,4.956629492,8.393994382,CD9,1
2391,negative regulation of DNA-dependent DNA replication (GO:2000104),0.183876974,0.87448667,0,0,4.956629492,8.393994382,ZRANB3,1
2392,positive regulation of collagen metabolic process (GO:0010714),0.183876974,0.873672436,0,0,4.956629492,8.393994382,RGCC,1
2393,positive regulation of NF-kappaB import into nucleus (GO:0042346),0.183876974,0.872859718,0,0,4.956629492,8.393994382,SPHK1,1
2394,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.183876974,0.87204851,0,0,4.956629492,8.393994382,DCSTAMP,1
2395,positive regulation of exosomal secretion (GO:1903543),0.183876974,0.871238808,0,0,4.956629492,8.393994382,SDC1,1
2396,positive regulation of collagen biosynthetic process (GO:0032967),0.183876974,0.870430609,0,0,4.956629492,8.393994382,RGCC,1
2397,negative regulation of protein processing (GO:0010955),0.183876974,0.869623908,0,0,4.956629492,8.393994382,CTSZ,1
2398,regulation of lymphocyte proliferation (GO:0050670),0.183876974,0.8688187,0,0,4.956629492,8.393994382,LGALS3,1
2399,toll-like receptor 4 signaling pathway (GO:0034142),0.183876974,0.868014983,0,0,4.956629492,8.393994382,ITGB2,1
2400,regulation of fertilization (GO:0080154),0.183876974,0.867212751,0,0,4.956629492,8.393994382,LHFPL2,1
2401,positive regulation of protein export from nucleus (GO:0046827),0.183876974,0.866412,0,0,4.956629492,8.393994382,TCF7L2,1
2402,negative regulation of anoikis (GO:2000811),0.183876974,0.865612727,0,0,4.956629492,8.393994382,CAV1,1
2403,cellular response to corticosteroid stimulus (GO:0071384),0.183876974,0.864814928,0,0,4.956629492,8.393994382,ANXA1,1
2404,regulation of cell motility (GO:2000145),0.184768608,0.868208295,0,0,2.027712065,3.424098011,RHOC;SGK1;RHOB,1
2405,negative regulation of protein kinase activity (GO:0006469),0.184768608,0.867409575,0,0,2.027712065,3.424098011,SOCS2;CAV1;YWHAG,1
2406,regulation of mitotic cell cycle (GO:0007346),0.18542255,0.869679478,0,0,1.791552828,3.018977929,DUSP3;CAV2;SPHK1;CLTC,1
2407,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.188152084,0.881671335,0,0,2.009444389,3.356786269,CTSK;ITGAX;YWHAG,1
2408,cellular response to peptide hormone stimulus (GO:0071375),0.188152084,0.880862462,0,0,2.009444389,3.356786269,CAV1;MYO5A;GNG12,1
2409,phospholipid transport (GO:0015914),0.18826283,0.880573074,0,0,2.520320081,4.208723478,ABCA1;ABCG1,1
2410,ubiquitin-dependent ERAD pathway (GO:0030433),0.18826283,0.879766689,0,0,2.520320081,4.208723478,WFS1;HSP90B1,1
2411,post-Golgi vesicle-mediated transport (GO:0006892),0.18826283,0.878961778,0,0,2.520320081,4.208723478,SORT1;MYO5A,1
2412,mitochondrion organization (GO:0007005),0.19083409,0.890152069,0,0,1.770224819,2.932113409,BNIP3L;ALAS1;CAV2;CHCHD10,1
2413,mitotic cytokinesis (GO:0000281),0.19313408,0.900057725,0,0,2.478314746,4.07526795,RHOC;RHOB,1
2414,cell junction assembly (GO:0034329),0.19313408,0.899236504,0,0,2.478314746,4.07526795,FBLIM1;CTNNB1,1
2415,keratinocyte differentiation (GO:0030216),0.19313408,0.898416781,0,0,2.478314746,4.07526795,CLIC4;ANXA1,1
2416,cell morphogenesis (GO:0000902),0.19313408,0.897598551,0,0,2.478314746,4.07526795,PDPN;ADAM8,1
2417,dicarboxylic acid metabolic process (GO:0043648),0.19313408,0.89678181,0,0,2.478314746,4.07526795,GCLC;GCLM,1
2418,cellular protein modification process (GO:0006464),0.194007805,0.900019846,0,0,1.261417685,2.068544478,ANXA1;WSB2;PRKCB;WFS1;PLK2;APLP2;FN1;MATK;FBXO32;HSP90B1;SOCS2;PTPRE;SPP1;FAM20C;MAN2B1;MFGE8;SGK1,1
2419,positive regulation of epithelial cell apoptotic process (GO:1904037),0.194862051,0.903161715,0,0,4.646840149,7.599736985,RGCC,1
2420,positive regulation of secretion (GO:0051047),0.194862051,0.902342149,0,0,4.646840149,7.599736985,SPP1,1
2421,positive regulation of cardiac muscle tissue growth (GO:0055023),0.194862051,0.90152407,0,0,4.646840149,7.599736985,IGF1,1
2422,cellular response to dsRNA (GO:0071359),0.194862051,0.900707472,0,0,4.646840149,7.599736985,CAV1,1
2423,DNA alkylation (GO:0006305),0.194862051,0.899892352,0,0,4.646840149,7.599736985,DNMT3A,1
2424,establishment of skin barrier (GO:0061436),0.194862051,0.899078706,0,0,4.646840149,7.599736985,MET,1
2425,glucose 6-phosphate metabolic process (GO:0051156),0.194862051,0.89826653,0,0,4.646840149,7.599736985,PGD,1
2426,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.194862051,0.89745582,0,0,4.646840149,7.599736985,CD36,1
2427,regulation of exosomal secretion (GO:1903541),0.194862051,0.896646572,0,0,4.646840149,7.599736985,SDC1,1
2428,epithelial cell development (GO:0002064),0.194862051,0.895838783,0,0,4.646840149,7.599736985,RILPL2,1
2429,regulation of water loss via skin (GO:0033561),0.194862051,0.895032447,0,0,4.646840149,7.599736985,MET,1
2430,stabilization of membrane potential (GO:0030322),0.194862051,0.894227562,0,0,4.646840149,7.599736985,KCNN4,1
2431,neuromuscular process (GO:0050905),0.194862051,0.893424123,0,0,4.646840149,7.599736985,TPP1,1
2432,negative regulation of striated muscle cell differentiation (GO:0051154),0.194862051,0.892622126,0,0,4.646840149,7.599736985,BHLHE41,1
2433,regulation of histone H3-K4 methylation (GO:0051569),0.194862051,0.891821568,0,0,4.646840149,7.599736985,CTNNB1,1
2434,regulation of energy homeostasis (GO:2000505),0.194862051,0.891022445,0,0,4.646840149,7.599736985,CD36,1
2435,DNA methylation or demethylation (GO:0044728),0.194862051,0.890224753,0,0,4.646840149,7.599736985,DNMT3A,1
2436,cellular response to pH (GO:0071467),0.194862051,0.889428487,0,0,4.646840149,7.599736985,HVCN1,1
2437,positive regulation of myotube differentiation (GO:0010831),0.194862051,0.888633645,0,0,4.646840149,7.599736985,FAM129B,1
2438,negative regulation of DNA recombination (GO:0045910),0.194862051,0.887840222,0,0,4.646840149,7.599736985,ZRANB3,1
2439,regulation of steroid metabolic process (GO:0019218),0.194862051,0.887048215,0,0,4.646840149,7.599736985,ABCG1,1
2440,bone morphogenesis (GO:0060349),0.194862051,0.886257619,0,0,4.646840149,7.599736985,MMP13,1
2441,artery development (GO:0060840),0.194862051,0.885468432,0,0,4.646840149,7.599736985,NRP1,1
2442,regulation of membrane repolarization (GO:0060306),0.194862051,0.884680648,0,0,4.646840149,7.599736985,CAV1,1
2443,endoplasmic reticulum to cytosol transport (GO:1903513),0.194862051,0.883894266,0,0,4.646840149,7.599736985,HSP90B1,1
2444,regulation of glucose transport (GO:0010827),0.194862051,0.883109279,0,0,4.646840149,7.599736985,PRKCB,1
2445,positive regulation of positive chemotaxis (GO:0050927),0.194862051,0.882325687,0,0,4.646840149,7.599736985,F7,1
2446,cell chemotaxis (GO:0060326),0.19802156,0.895836899,0,0,2.437686635,3.947539434,NRP1;CXCL14,1
2447,response to reactive oxygen species (GO:0000302),0.19802156,0.89504342,0,0,2.437686635,3.947539434,TXNRD1;HMOX1,1
2448,regulation of organelle organization (GO:0033043),0.198396572,0.895944871,0,0,1.956564273,3.16471799,CLIC4;SQSTM1;S100A9,1
2449,negative regulation of MAP kinase activity (GO:0043407),0.20292396,0.915579991,0,0,2.398369109,3.825216331,DUSP3;CAV1,1
2450,apoptotic process (GO:0006915),0.203395654,0.916897548,0,0,1.602358672,2.551919882,DAP;TNFSF12;ITGB2;RTN4;RHOB,1
2451,positive regulation of hydrolase activity (GO:0051345),0.204575963,0.921404358,0,0,1.719062252,2.727835343,RGS1;CAV2;ATP1B3;RHOC,1
2452,regulation of protein sumoylation (GO:0033233),0.205699812,0.925649152,0,0,4.373496611,6.91597375,CTNNB1,1
2453,regulation of cellular protein catabolic process (GO:1903362),0.205699812,0.924833603,0,0,4.373496611,6.91597375,PTTG1IP,1
2454,high-density lipoprotein particle remodeling (GO:0034375),0.205699812,0.924019488,0,0,4.373496611,6.91597375,ABCG1,1
2455,positive regulation of cholesterol transport (GO:0032376),0.205699812,0.923206806,0,0,4.373496611,6.91597375,ABCA1,1
2456,regulation of tissue remodeling (GO:0034103),0.205699812,0.922395553,0,0,4.373496611,6.91597375,GPNMB,1
2457,positive regulation of focal adhesion assembly (GO:0051894),0.205699812,0.921585723,0,0,4.373496611,6.91597375,NRP1,1
2458,negative regulation of immune effector process (GO:0002698),0.205699812,0.920777315,0,0,4.373496611,6.91597375,LGALS3,1
2459,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.205699812,0.919970323,0,0,4.373496611,6.91597375,RAB7B,1
2460,positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),0.205699812,0.919164745,0,0,4.373496611,6.91597375,CAV2,1
2461,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.205699812,0.918360576,0,0,4.373496611,6.91597375,IGF1,1
2462,RNA stabilization (GO:0043489),0.205699812,0.917557814,0,0,4.373496611,6.91597375,SLC11A1,1
2463,positive regulation of monocyte chemotaxis (GO:0090026),0.205699812,0.916756453,0,0,4.373496611,6.91597375,PLA2G7,1
2464,negative regulation of B cell activation (GO:0050869),0.205699812,0.915956491,0,0,4.373496611,6.91597375,INHBA,1
2465,negative regulation of lipid biosynthetic process (GO:0051055),0.205699812,0.915157924,0,0,4.373496611,6.91597375,SLC27A1,1
2466,pigment granule transport (GO:0051904),0.205699812,0.914360748,0,0,4.373496611,6.91597375,MYO5A,1
2467,positive regulation of stem cell proliferation (GO:2000648),0.205699812,0.91356496,0,0,4.373496611,6.91597375,CTNNB1,1
2468,negative regulation of intracellular transport (GO:0032387),0.205699812,0.912770556,0,0,4.373496611,6.91597375,CD84,1
2469,negative regulation of stress fiber assembly (GO:0051497),0.205699812,0.911977532,0,0,4.373496611,6.91597375,MET,1
2470,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.205699812,0.911185884,0,0,4.373496611,6.91597375,FKBP1A,1
2471,regulation of collagen biosynthetic process (GO:0032965),0.205699812,0.91039561,0,0,4.373496611,6.91597375,RGCC,1
2472,response to purine-containing compound (GO:0014074),0.205699812,0.909606706,0,0,4.373496611,6.91597375,P2RX4,1
2473,long-term memory (GO:0007616),0.205699812,0.908819168,0,0,4.373496611,6.91597375,SGK1,1
2474,macrophage activation (GO:0042116),0.205699812,0.908032992,0,0,4.373496611,6.91597375,SLC11A1,1
2475,defense response to fungus (GO:0050832),0.205699812,0.907248175,0,0,4.373496611,6.91597375,S100A9,1
2476,neurotrophin signaling pathway (GO:0038179),0.205699812,0.906464714,0,0,4.373496611,6.91597375,SORT1,1
2477,serine family amino acid metabolic process (GO:0009069),0.205699812,0.905682605,0,0,4.373496611,6.91597375,GCLC,1
2478,regulation of B cell receptor signaling pathway (GO:0050855),0.205699812,0.904901844,0,0,4.373496611,6.91597375,PRKCB,1
2479,melanosome transport (GO:0032402),0.205699812,0.904122428,0,0,4.373496611,6.91597375,MYO5A,1
2480,positive regulation of cation transmembrane transport (GO:1904064),0.205699812,0.903344354,0,0,4.373496611,6.91597375,CTSS,1
2481,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.205699812,0.902567617,0,0,4.373496611,6.91597375,NRP1,1
2482,viral entry into host cell (GO:0046718),0.205699812,0.901792216,0,0,4.373496611,6.91597375,CD81,1
2483,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.205699812,0.901018145,0,0,4.373496611,6.91597375,CACNA1D,1
2484,positive regulation of catabolic process (GO:0009896),0.207840001,0.909611944,0,0,2.360299758,3.707999576,PLK2;TNFSF12,1
2485,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.207840001,0.908832499,0,0,2.360299758,3.707999576,RGCC;PLK2,1
2486,negative regulation of peptidase activity (GO:0010466),0.207840001,0.908054389,0,0,2.360299758,3.707999576,CSTB;TIMP2,1
2487,establishment of protein localization to organelle (GO:0072594),0.207840001,0.90727761,0,0,2.360299758,3.707999576,MMP12;PTTG1IP,1
2488,protein localization to cell periphery (GO:1990778),0.212257398,0.925768807,0,0,1.89024006,2.929788162,CAV1;MYO5A;ATP1B3,1
2489,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),0.212768435,0.927205228,0,0,2.323420074,3.595610748,RGS1;PSAP,1
2490,regulation of proteolysis (GO:0030162),0.212768435,0.926414097,0,0,2.323420074,3.595610748,CSTB;CAV1,1
2491,negative regulation of neuron apoptotic process (GO:0043524),0.212768435,0.925624315,0,0,2.323420074,3.595610748,WFS1;ADAM8,1
2492,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),0.212768435,0.924835879,0,0,2.323420074,3.595610748,RGCC;PLK2,1
2493,regulation of multicellular organism growth (GO:0040014),0.216392222,0.939786818,0,0,4.130524577,6.32243979,IGF1,1
2494,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.216392222,0.93898768,0,0,4.130524577,6.32243979,ACSL4,1
2495,establishment of melanosome localization (GO:0032401),0.216392222,0.938189899,0,0,4.130524577,6.32243979,MYO5A,1
2496,membrane protein ectodomain proteolysis (GO:0006509),0.216392222,0.937393473,0,0,4.130524577,6.32243979,MYH9,1
2497,regulation of spindle organization (GO:0090224),0.216392222,0.936598398,0,0,4.130524577,6.32243979,CLTC,1
2498,response to nutrient levels (GO:0031667),0.216392222,0.935804671,0,0,4.130524577,6.32243979,IGF1,1
2499,regulation of keratinocyte proliferation (GO:0010837),0.216392222,0.935012287,0,0,4.130524577,6.32243979,KLF9,1
2500,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.216392222,0.934221245,0,0,4.130524577,6.32243979,WFS1,1
2501,negative regulation of fibroblast proliferation (GO:0048147),0.216392222,0.93343154,0,0,4.130524577,6.32243979,FTH1,1
2502,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.216392222,0.932643168,0,0,4.130524577,6.32243979,CLIC4,1
2503,regulation of dephosphorylation (GO:0035303),0.216392222,0.931856128,0,0,4.130524577,6.32243979,PPP1R14B,1
2504,negative regulation of protein dephosphorylation (GO:0035308),0.216392222,0.931070414,0,0,4.130524577,6.32243979,FKBP1A,1
2505,"retrograde protein transport, ER to cytosol (GO:0030970)",0.216392222,0.930286025,0,0,4.130524577,6.32243979,HSP90B1,1
2506,regulation of cholesterol efflux (GO:0010874),0.216392222,0.929502956,0,0,4.130524577,6.32243979,ABCA1,1
2507,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.216392222,0.928721204,0,0,4.130524577,6.32243979,CACNA1D,1
2508,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.216392222,0.927940766,0,0,4.130524577,6.32243979,CAV1,1
2509,heart trabecula morphogenesis (GO:0061384),0.216392222,0.927161638,0,0,4.130524577,6.32243979,FKBP1A,1
2510,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.216392222,0.926383818,0,0,4.130524577,6.32243979,NUS1,1
2511,acute-phase response (GO:0006953),0.216392222,0.925607302,0,0,4.130524577,6.32243979,IL1RN,1
2512,regulation of epithelial cell differentiation (GO:0030856),0.216392222,0.924832086,0,0,4.130524577,6.32243979,CAV1,1
2513,DNA methylation (GO:0006306),0.216392222,0.924058168,0,0,4.130524577,6.32243979,DNMT3A,1
2514,positive regulation of carbohydrate metabolic process (GO:0045913),0.216392222,0.923285545,0,0,4.130524577,6.32243979,IGF1,1
2515,glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.216392222,0.922514212,0,0,4.130524577,6.32243979,PGD,1
2516,cell-substrate adherens junction assembly (GO:0007045),0.216392222,0.921744166,0,0,4.130524577,6.32243979,ACTN1,1
2517,response to organophosphorus (GO:0046683),0.216392222,0.920975406,0,0,4.130524577,6.32243979,P2RX4,1
2518,focal adhesion assembly (GO:0048041),0.216392222,0.920207926,0,0,4.130524577,6.32243979,ACTN1,1
2519,positive regulation of protein polymerization (GO:0032273),0.217708044,0.925032595,0,0,2.28767515,3.487790364,BAIAP2;MET,1
2520,inorganic anion transmembrane transport (GO:0098661),0.217708044,0.924263017,0,0,2.28767515,3.487790364,CLIC4;SLC37A2,1
2521,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.217708044,0.923494719,0,0,2.28767515,3.487790364,CD84;CD200,1
2522,NADH dehydrogenase complex assembly (GO:0010257),0.217708044,0.922727697,0,0,2.28767515,3.487790364,MT-ND5;MT-ND3,1
2523,mitochondrial respiratory chain complex I biogenesis (GO:0097031),0.217708044,0.921961948,0,0,2.28767515,3.487790364,MT-ND5;MT-ND3,1
2524,mitochondrial respiratory chain complex I assembly (GO:0032981),0.217708044,0.921197468,0,0,2.28767515,3.487790364,MT-ND5;MT-ND3,1
2525,positive regulation of cell adhesion (GO:0045785),0.217708044,0.920434256,0,0,2.28767515,3.487790364,SIRPA;ADAM8,1
2526,regulation of phosphorylation (GO:0042325),0.219265645,0.926252141,0,0,1.858736059,2.820578612,NRP1;FN1;INHBA,1
2527,cellular response to lipid (GO:0071396),0.221433617,0.934636683,0,0,1.661440053,2.504840905,CD274;SPP1;ATP1A1;TNFRSF1B,1
2528,negative regulation of protein phosphorylation (GO:0001933),0.221433617,0.933864256,0,0,1.661440053,2.504840905,SOCS2;DUSP3;CAV1;YWHAG,1
2529,regulation of myeloid cell differentiation (GO:0045637),0.222657642,0.938250987,0,0,2.253013405,3.384296331,LGALS3;PRKCB,1
2530,regulation of JAK-STAT cascade (GO:0046425),0.222657642,0.937476853,0,0,2.253013405,3.384296331,SOCS2;CAV1,1
2531,regulation of acute inflammatory response (GO:0002673),0.226320821,0.952114716,0,0,1.828264977,2.716439254,CD81;ADAM8;C1QC,1
2532,regulation of sprouting angiogenesis (GO:1903670),0.226941226,0.953938284,0,0,3.913128546,5.803420901,S100A1,1
2533,NADP metabolic process (GO:0006739),0.226941226,0.953153149,0,0,3.913128546,5.803420901,PGD,1
2534,regulation of long-term synaptic potentiation (GO:1900271),0.226941226,0.952369306,0,0,3.913128546,5.803420901,SQSTM1,1
2535,positive regulation of STAT cascade (GO:1904894),0.226941226,0.951586751,0,0,3.913128546,5.803420901,IL7R,1
2536,protein exit from endoplasmic reticulum (GO:0032527),0.226941226,0.950805482,0,0,3.913128546,5.803420901,HSP90B1,1
2537,positive regulation of activated T cell proliferation (GO:0042104),0.226941226,0.950025493,0,0,3.913128546,5.803420901,IGF1,1
2538,sulfur compound transport (GO:0072348),0.226941226,0.949246784,0,0,3.913128546,5.803420901,SLC6A6,1
2539,endothelial cell development (GO:0001885),0.226941226,0.94846935,0,0,3.913128546,5.803420901,MET,1
2540,acylglycerol biosynthetic process (GO:0046463),0.226941226,0.947693189,0,0,3.913128546,5.803420901,LPL,1
2541,regulation of myotube differentiation (GO:0010830),0.226941226,0.946918296,0,0,3.913128546,5.803420901,BHLHE41,1
2542,cellular response to zinc ion (GO:0071294),0.226941226,0.94614467,0,0,3.913128546,5.803420901,HVCN1,1
2543,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.226941226,0.945372307,0,0,3.913128546,5.803420901,CAV1,1
2544,osteoclast differentiation (GO:0030316),0.226941226,0.944601204,0,0,3.913128546,5.803420901,DCSTAMP,1
2545,macromolecule biosynthetic process (GO:0009059),0.226941226,0.943831358,0,0,3.913128546,5.803420901,SLC11A1,1
2546,positive regulation of adherens junction organization (GO:1903393),0.226941226,0.943062766,0,0,3.913128546,5.803420901,NRP1,1
2547,innate immune response in mucosa (GO:0002227),0.226941226,0.942295424,0,0,3.913128546,5.803420901,HIST1H2BC,1
2548,triglyceride biosynthetic process (GO:0019432),0.226941226,0.94152933,0,0,3.913128546,5.803420901,LPL,1
2549,activin receptor signaling pathway (GO:0032924),0.226941226,0.940764481,0,0,3.913128546,5.803420901,INHBA,1
2550,positive regulation of neuron apoptotic process (GO:0043525),0.226941226,0.940000874,0,0,3.913128546,5.803420901,CTNNB1,1
2551,positive regulation of axon extension (GO:0045773),0.226941226,0.939238505,0,0,3.913128546,5.803420901,NRP1,1
2552,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.227616072,0.941268082,0,0,2.21938634,3.284902549,NCOA4;CTNNB1,1
2553,positive regulation of synaptic transmission (GO:0050806),0.232582205,0.961025906,0,0,2.186748305,3.18939765,PLK2;SQSTM1,1
2554,extrinsic apoptotic signaling pathway (GO:0097191),0.232582205,0.960248377,0,0,2.186748305,3.18939765,SORT1;INHBA,1
2555,positive regulation of autophagy (GO:0010508),0.232582205,0.959472105,0,0,2.186748305,3.18939765,BNIP3L;PLK2,1
2556,cellular calcium ion homeostasis (GO:0006874),0.233419276,0.962147469,0,0,1.798776832,2.617074543,WFS1;CAV1;TMEM165,1
2557,phosphate-containing compound metabolic process (GO:0006796),0.235752725,0.970981561,0,0,1.616292226,2.335496687,DUSP3;GDE1;LPL;FAM20C,1
2558,positive regulation of interleukin-2 production (GO:0032743),0.237348739,0.976766624,0,0,3.717472119,5.346560402,ANXA1,1
2559,Golgi to endosome transport (GO:0006895),0.237348739,0.975979544,0,0,3.717472119,5.346560402,SORT1,1
2560,hydrogen peroxide metabolic process (GO:0042743),0.237348739,0.975193731,0,0,3.717472119,5.346560402,PRDX1,1
2561,proteoglycan metabolic process (GO:0006029),0.237348739,0.974409182,0,0,3.717472119,5.346560402,IGF1,1
2562,negative regulation of phosphate metabolic process (GO:0045936),0.237348739,0.973625895,0,0,3.717472119,5.346560402,INHBA,1
2563,negative regulation of macromolecule biosynthetic process (GO:0010558),0.237348739,0.972843866,0,0,3.717472119,5.346560402,CLTC,1
2564,negative regulation of actin filament bundle assembly (GO:0032232),0.237348739,0.972063093,0,0,3.717472119,5.346560402,MET,1
2565,response to progesterone (GO:0032570),0.237348739,0.971283571,0,0,3.717472119,5.346560402,CAV1,1
2566,regulation of cholesterol transport (GO:0032374),0.237348739,0.970505299,0,0,3.717472119,5.346560402,NUS1,1
2567,phosphatidylethanolamine metabolic process (GO:0046337),0.237348739,0.969728273,0,0,3.717472119,5.346560402,SLC27A1,1
2568,androgen metabolic process (GO:0008209),0.237348739,0.968952491,0,0,3.717472119,5.346560402,SPP1,1
2569,regulation of anoikis (GO:2000209),0.237348739,0.968177948,0,0,3.717472119,5.346560402,CAV1,1
2570,regulation of cell development (GO:0060284),0.237348739,0.967404643,0,0,3.717472119,5.346560402,CTNNB1,1
2571,growth hormone receptor signaling pathway (GO:0060396),0.237348739,0.966632573,0,0,3.717472119,5.346560402,SOCS2,1
2572,regulation of glycogen biosynthetic process (GO:0005979),0.237348739,0.965861733,0,0,3.717472119,5.346560402,IGF1,1
2573,regulation of toll-like receptor signaling pathway (GO:0034121),0.237348739,0.965092122,0,0,3.717472119,5.346560402,CD36,1
2574,melanosome localization (GO:0032400),0.237348739,0.964323737,0,0,3.717472119,5.346560402,MYO5A,1
2575,heparan sulfate proteoglycan metabolic process (GO:0030201),0.237348739,0.963556574,0,0,3.717472119,5.346560402,GPC1,1
2576,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.237348739,0.962790631,0,0,3.717472119,5.346560402,GPC1,1
2577,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.237348739,0.962025904,0,0,3.717472119,5.346560402,EVL,1
2578,chondroitin sulfate biosynthetic process (GO:0030206),0.237348739,0.961262392,0,0,3.717472119,5.346560402,CHST11,1
2579,cellular response to steroid hormone stimulus (GO:0071383),0.237348739,0.96050009,0,0,3.717472119,5.346560402,ATP1A1,1
2580,dopaminergic neuron differentiation (GO:0071542),0.237348739,0.959738996,0,0,3.717472119,5.346560402,CTNNB1,1
2581,regulation of transport (GO:0051049),0.237348739,0.958979108,0,0,3.717472119,5.346560402,NRP1,1
2582,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.237554944,0.959052909,0,0,2.155056301,3.097583839,TNFRSF1B;CD44,1
2583,regulation of actin filament polymerization (GO:0030833),0.237554944,0.958294765,0,0,2.155056301,3.097583839,MTPN;BAIAP2,1
2584,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.240557418,0.969640207,0,0,1.770224819,2.522210082,ANXA1;NPY;CACNA1D,1
2585,regulation of innate immune response (GO:0045088),0.242533215,0.976832672,0,0,2.124269782,3.009275857,ADAM8;CD36,1
2586,cytoskeleton-dependent cytokinesis (GO:0061640),0.247515975,0.996115159,0,0,2.09435049,2.924300022,RHOC;RHOB,1
2587,phospholipid metabolic process (GO:0006644),0.247515975,0.995330198,0,0,2.09435049,2.924300022,GDE1;LPL,1
2588,neuropeptide signaling pathway (GO:0007218),0.247515975,0.994546473,0,0,2.09435049,2.924300022,SORT1;NPY,1
2589,calcium-mediated signaling (GO:0019722),0.247515975,0.993763982,0,0,2.09435049,2.924300022,LAT2;SPHK1,1
2590,mesoderm development (GO:0007498),0.247616651,0.993386612,0,0,3.540449637,4.942019792,MATK,1
2591,ventricular cardiac muscle tissue development (GO:0003229),0.247616651,0.992606261,0,0,3.540449637,4.942019792,FKBP1A,1
2592,phospholipid translocation (GO:0045332),0.247616651,0.991827136,0,0,3.540449637,4.942019792,ABCA1,1
2593,zinc II ion transport (GO:0006829),0.247616651,0.991049232,0,0,3.540449637,4.942019792,SLC39A1,1
2594,negative regulation of cytokine biosynthetic process (GO:0042036),0.247616651,0.990272548,0,0,3.540449637,4.942019792,INHBA,1
2595,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),0.247616651,0.98949708,0,0,3.540449637,4.942019792,MET,1
2596,vesicle docking (GO:0048278),0.247616651,0.988722825,0,0,3.540449637,4.942019792,CAV2,1
2597,negative regulation of protein tyrosine kinase activity (GO:0061099),0.247616651,0.987949782,0,0,3.540449637,4.942019792,CAV1,1
2598,regulation of nuclear division (GO:0051783),0.247616651,0.987177946,0,0,3.540449637,4.942019792,CAV2,1
2599,regulation of interleukin-2 production (GO:0032663),0.247616651,0.986407315,0,0,3.540449637,4.942019792,ANXA1,1
2600,response to nicotine (GO:0035094),0.247616651,0.985637887,0,0,3.540449637,4.942019792,HMOX1,1
2601,long-term synaptic potentiation (GO:0060291),0.247616651,0.984869658,0,0,3.540449637,4.942019792,PLK2,1
2602,positive regulation of receptor internalization (GO:0002092),0.247616651,0.984102625,0,0,3.540449637,4.942019792,CD63,1
2603,ERK1 and ERK2 cascade (GO:0070371),0.247616651,0.983336786,0,0,3.540449637,4.942019792,IGF1,1
2604,hepaticobiliary system development (GO:0061008),0.247616651,0.982572139,0,0,3.540449637,4.942019792,MET,1
2605,protein lipidation (GO:0006497),0.247731713,0.982264905,0,0,1.742565056,2.431590821,BST1;ZDHHC18;PGAP2,1
2606,non-canonical Wnt signaling pathway (GO:0035567),0.247731713,0.981502277,0,0,1.742565056,2.431590821,TCF7L2;CLTC;CTNNB1,1
2607,regulation of protein processing (GO:0070613),0.251331332,0.994991303,0,0,1.7290568,2.387798325,CD81;ADAM8;C1QC,1
2608,phosphatidylcholine metabolic process (GO:0046470),0.252502207,0.998851755,0,0,2.065262288,2.842493368,SLC27A1;SLC44A1,1
2609,nuclear import (GO:0051170),0.252502207,0.998078051,0,0,2.065262288,2.842493368,MMP12;PTTG1IP,1
2610,regulation of cation channel activity (GO:2001257),0.252502207,0.997305545,0,0,2.065262288,2.842493368,FKBP1A;CTSS,1
2611,regulation of neuron death (GO:1901214),0.25749092,1,0,0,2.036971024,2.763702847,GPNMB;CTSZ,1
2612,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.25749092,1,0,0,2.036971024,2.763702847,TNFRSF1B;CD44,1
2613,response to metal ion (GO:0010038),0.25749092,1,0,0,2.036971024,2.763702847,HVCN1;CAV1,1
2614,negative regulation of cell cycle (GO:0045786),0.25749092,1,0,0,2.036971024,2.763702847,INHBA;RHOB,1
2615,positive regulation of protein autophosphorylation (GO:0031954),0.257746829,1,0,0,3.379520108,4.581877184,GPNMB,1
2616,acylglycerol homeostasis (GO:0055090),0.257746829,1,0,0,3.379520108,4.581877184,LPL,1
2617,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.257746829,1,0,0,3.379520108,4.581877184,ZDHHC18,1
2618,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.257746829,1,0,0,3.379520108,4.581877184,ZDHHC18,1
2619,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.257746829,1,0,0,3.379520108,4.581877184,ATPIF1,1
2620,lipid translocation (GO:0034204),0.257746829,1,0,0,3.379520108,4.581877184,ABCA1,1
2621,outflow tract septum morphogenesis (GO:0003148),0.257746829,1,0,0,3.379520108,4.581877184,NRP1,1
2622,hematopoietic progenitor cell differentiation (GO:0002244),0.257746829,1,0,0,3.379520108,4.581877184,INHBA,1
2623,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.257746829,1,0,0,3.379520108,4.581877184,GPNMB,1
2624,sulfur amino acid metabolic process (GO:0000096),0.257746829,1,0,0,3.379520108,4.581877184,GCLC,1
2625,positive regulation of interleukin-10 production (GO:0032733),0.257746829,1,0,0,3.379520108,4.581877184,CD274,1
2626,positive regulation of erythrocyte differentiation (GO:0045648),0.257746829,1,0,0,3.379520108,4.581877184,INHBA,1
2627,protein localization to cell surface (GO:0034394),0.257746829,1,0,0,3.379520108,4.581877184,CTNNB1,1
2628,phosphatidylglycerol metabolic process (GO:0046471),0.257746829,1,0,0,3.379520108,4.581877184,SLC27A1,1
2629,STAT cascade (GO:0097696),0.257746829,1,0,0,3.379520108,4.581877184,SOCS2,1
2630,regulation of monocyte chemotaxis (GO:0090025),0.257746829,1,0,0,3.379520108,4.581877184,PLA2G7,1
2631,glucose transport (GO:0015758),0.257746829,1,0,0,3.379520108,4.581877184,SORT1,1
2632,generation of neurons (GO:0048699),0.258553374,1,0,0,1.702658986,2.303107009,NRP1;MTPN;CTNNB1,1
2633,protein localization to plasma membrane (GO:0072659),0.258553374,1,0,0,1.702658986,2.303107009,RILPL2;MYO5A;ATP1B3,1
2634,regulation of axon extension involved in axon guidance (GO:0048841),0.267741113,1,0,0,3.232584451,4.259688901,NRP1,1
2635,positive regulation of ERBB signaling pathway (GO:1901186),0.267741113,1,0,0,3.232584451,4.259688901,RTN4,1
2636,glycolytic process (GO:0006096),0.267741113,1,0,0,3.232584451,4.259688901,HK3,1
2637,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.267741113,1,0,0,3.232584451,4.259688901,ATPIF1,1
2638,positive regulation of protein oligomerization (GO:0032461),0.267741113,1,0,0,3.232584451,4.259688901,RHOC,1
2639,zinc II ion transmembrane transport (GO:0071577),0.267741113,1,0,0,3.232584451,4.259688901,SLC39A1,1
2640,protein K48-linked deubiquitination (GO:0071108),0.267741113,1,0,0,3.232584451,4.259688901,MINDY1,1
2641,metanephros development (GO:0001656),0.267741113,1,0,0,3.232584451,4.259688901,BASP1,1
2642,positive regulation of ATP metabolic process (GO:1903580),0.267741113,1,0,0,3.232584451,4.259688901,IGF1,1
2643,cellular nitrogen compound biosynthetic process (GO:0044271),0.267741113,1,0,0,3.232584451,4.259688901,SPHK1,1
2644,positive regulation of blood circulation (GO:1903524),0.267741113,1,0,0,3.232584451,4.259688901,CAV1,1
2645,folic acid-containing compound metabolic process (GO:0006760),0.267741113,1,0,0,3.232584451,4.259688901,ATPIF1,1
2646,response to alkaloid (GO:0043279),0.267741113,1,0,0,3.232584451,4.259688901,HMOX1,1
2647,negative regulation of axonogenesis (GO:0050771),0.267741113,1,0,0,3.232584451,4.259688901,RTN4,1
2648,regulation of monooxygenase activity (GO:0032768),0.267741113,1,0,0,3.232584451,4.259688901,CAV1,1
2649,regulation of cell size (GO:0008361),0.267741113,1,0,0,3.232584451,4.259688901,MTPN,1
2650,NAD metabolic process (GO:0019674),0.267741113,1,0,0,3.232584451,4.259688901,BST1,1
2651,negative regulation of axon extension (GO:0030517),0.267741113,1,0,0,3.232584451,4.259688901,RTN4,1
2652,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.269437151,1,0,0,1.664539755,2.182910929,P2RX4;CAV1;CD36,1
2653,regulation of defense response (GO:0031347),0.272462422,1,0,0,1.956564273,2.544031646,BST1;ANXA1,1
2654,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.272462422,1,0,0,1.956564273,2.544031646,CYBB;CD36,1
2655,gland development (GO:0048732),0.272462422,1,0,0,1.956564273,2.544031646,CAV1;MET,1
2656,ammonium transport (GO:0015696),0.27760132,1,0,0,3.097893432,3.970165108,SLC44A1,1
2657,regulation of protein phosphorylation (GO:0001932),0.277838482,1,0,0,1.418882488,1.817184558,BST1;GPNMB;ITGB2;FN1;INHBA,1
2658,ERAD pathway (GO:0036503),0.282438803,1,0,0,1.906395958,2.410243787,WFS1;HSP90B1,1
2659,positive regulation of cytoskeleton organization (GO:0051495),0.282438803,1,0,0,1.906395958,2.410243787,NRP1;BAIAP2,1
2660,positive regulation of histone methylation (GO:0031062),0.287329241,1,0,0,2.973977695,3.708926516,CTNNB1,1
2661,positive regulation of microtubule polymerization (GO:0031116),0.287329241,1,0,0,2.973977695,3.708926516,MET,1
2662,receptor clustering (GO:0043113),0.287329241,1,0,0,2.973977695,3.708926516,ITGB2,1
2663,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.287329241,1,0,0,2.973977695,3.708926516,GPNMB,1
2664,negative regulation of developmental growth (GO:0048640),0.287329241,1,0,0,2.973977695,3.708926516,RTN4,1
2665,ATP generation from ADP (GO:0006757),0.287329241,1,0,0,2.973977695,3.708926516,HK3,1
2666,receptor catabolic process (GO:0032801),0.287329241,1,0,0,2.973977695,3.708926516,CLTC,1
2667,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.287329241,1,0,0,2.973977695,3.708926516,MET,1
2668,sensory perception of pain (GO:0019233),0.287329241,1,0,0,2.973977695,3.708926516,P2RX4,1
2669,eosinophil chemotaxis (GO:0048245),0.287329241,1,0,0,2.973977695,3.708926516,LGALS3,1
2670,DNA geometric change (GO:0032392),0.287329241,1,0,0,2.973977695,3.708926516,ZRANB3,1
2671,eosinophil migration (GO:0072677),0.287329241,1,0,0,2.973977695,3.708926516,LGALS3,1
2672,mucosal immune response (GO:0002385),0.287329241,1,0,0,2.973977695,3.708926516,HIST1H2BC,1
2673,regulation of neuronal synaptic plasticity (GO:0048168),0.287329241,1,0,0,2.973977695,3.708926516,SYNGR1,1
2674,mammary gland development (GO:0030879),0.287329241,1,0,0,2.973977695,3.708926516,CAV1,1
2675,regulation of cardiac muscle cell action potential (GO:0098901),0.287329241,1,0,0,2.973977695,3.708926516,CAV1,1
2676,proteoglycan biosynthetic process (GO:0030166),0.287329241,1,0,0,2.973977695,3.708926516,IGF1,1
2677,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.287329241,1,0,0,2.973977695,3.708926516,CD44,1
2678,organic cation transport (GO:0015695),0.287329241,1,0,0,2.973977695,3.708926516,SLC44A1,1
2679,sensory perception of mechanical stimulus (GO:0050954),0.287423007,1,0,0,1.882264364,2.346807695,WFS1;CACNA1D,1
2680,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.287423007,1,0,0,1.882264364,2.346807695,CYBB;CD36,1
2681,visual perception (GO:0007601),0.287423007,1,0,0,1.882264364,2.346807695,WFS1;DHRS3,1
2682,response to cytokine (GO:0034097),0.287684817,1,0,0,1.604664224,1.999234762,CD274;SLC11A1;TIMP2,1
2683,neuron differentiation (GO:0030182),0.29134699,1,0,0,1.593202337,1.964801356,MTPN;CTNNB1;INHBA,1
2684,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.292403451,1,0,0,1.858736059,2.285540427,RGCC;GPNMB,1
2685,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.292403451,1,0,0,1.858736059,2.285540427,DAP;S100A9,1
2686,response to calcium ion (GO:0051592),0.292403451,1,0,0,1.858736059,2.285540427,CLIC4;CAV1,1
2687,cell-cell junction assembly (GO:0007043),0.292403451,1,0,0,1.858736059,2.285540427,CD9;RHOC,1
2688,regulation of cellular component organization (GO:0051128),0.295012476,1,0,0,1.581903029,1.931088558,SOCS2;ABCA1;SGK1,1
2689,glycolytic process through glucose-6-phosphate (GO:0061620),0.296926644,1,0,0,2.859593938,3.472319587,HK3,1
2690,signal peptide processing (GO:0006465),0.296926644,1,0,0,2.859593938,3.472319587,F7,1
2691,regulation of centrosome duplication (GO:0010824),0.296926644,1,0,0,2.859593938,3.472319587,PLK2,1
2692,canonical glycolysis (GO:0061621),0.296926644,1,0,0,2.859593938,3.472319587,HK3,1
2693,glucose catabolic process to pyruvate (GO:0061718),0.296926644,1,0,0,2.859593938,3.472319587,HK3,1
2694,glial cell differentiation (GO:0010001),0.296926644,1,0,0,2.859593938,3.472319587,GPC1,1
2695,"negative regulation of gene expression, epigenetic (GO:0045814)",0.296926644,1,0,0,2.859593938,3.472319587,DNMT3A,1
2696,neutral amino acid transport (GO:0015804),0.296926644,1,0,0,2.859593938,3.472319587,SLC36A2,1
2697,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.296926644,1,0,0,2.859593938,3.472319587,FKBP1A,1
2698,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.296926644,1,0,0,2.859593938,3.472319587,CHST11,1
2699,regulation of interleukin-10 production (GO:0032653),0.296926644,1,0,0,2.859593938,3.472319587,CD274,1
2700,positive regulation of filopodium assembly (GO:0051491),0.296926644,1,0,0,2.859593938,3.472319587,NRP1,1
2701,positive regulation of glucose transport (GO:0010828),0.296926644,1,0,0,2.859593938,3.472319587,IGF1,1
2702,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.296926644,1,0,0,2.859593938,3.472319587,ACSL4,1
2703,respiratory tube development (GO:0030323),0.296926644,1,0,0,2.859593938,3.472319587,PDPN,1
2704,peptidyl-tyrosine dephosphorylation (GO:0035335),0.296926644,1,0,0,2.859593938,3.472319587,DUSP3,1
2705,regulation of vascular smooth muscle cell proliferation (GO:1904705),0.296926644,1,0,0,2.859593938,3.472319587,IGF1,1
2706,regulation of cellular protein localization (GO:1903827),0.296926644,1,0,0,2.859593938,3.472319587,CTNNB1,1
2707,L-amino acid transport (GO:0015807),0.296926644,1,0,0,2.859593938,3.472319587,SLC36A2,1
2708,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.296926644,1,0,0,2.859593938,3.472319587,SPHK1,1
2709,regulation of hydrolase activity (GO:0051336),0.297379338,1,0,0,1.835788701,2.226346733,CAV1;ATPIF1,1
2710,negative regulation of MAPK cascade (GO:0043409),0.297379338,1,0,0,1.835788701,2.226346733,DUSP3;CAV1,1
2711,positive regulation of protein targeting to mitochondrion (GO:1903955),0.302349891,1,0,0,1.813401034,2.169136554,CTSK;ITGAX,1
2712,epidermis development (GO:0008544),0.302349891,1,0,0,1.813401034,2.169136554,FABP5;EMP1,1
2713,sensory perception of light stimulus (GO:0050953),0.302349891,1,0,0,1.813401034,2.169136554,WFS1;DHRS3,1
2714,sensory perception of sound (GO:0007605),0.302349891,1,0,0,1.813401034,2.169136554,WFS1;CACNA1D,1
2715,positive regulation of macromolecule biosynthetic process (GO:0010557),0.302351889,1,0,0,1.559778511,1.865750507,MTPN;RGCC;IGF1,1
2716,Golgi vesicle transport (GO:0048193),0.303837416,1,0,0,1.366717691,1.628119581,F7;DYNC1I2;CTSZ;MYO5A;RAB7B,1
2717,positive regulation of glucose import (GO:0046326),0.306395275,1,0,0,2.753683051,3.257274572,IGF1,1
2718,cytoskeleton-dependent intracellular transport (GO:0030705),0.306395275,1,0,0,2.753683051,3.257274572,DYNC1I2,1
2719,response to growth factor (GO:0070848),0.306395275,1,0,0,2.753683051,3.257274572,CTNNB1,1
2720,regulation of centrosome cycle (GO:0046605),0.306395275,1,0,0,2.753683051,3.257274572,CTNNB1,1
2721,regulation of NF-kappaB import into nucleus (GO:0042345),0.306395275,1,0,0,2.753683051,3.257274572,SPHK1,1
2722,positive regulation of wound healing (GO:0090303),0.306395275,1,0,0,2.753683051,3.257274572,ANXA1,1
2723,response to ketone (GO:1901654),0.306395275,1,0,0,2.753683051,3.257274572,CAV1,1
2724,regulation of cardiac muscle cell contraction (GO:0086004),0.306395275,1,0,0,2.753683051,3.257274572,CAV1,1
2725,regulation of muscle contraction (GO:0006937),0.306395275,1,0,0,2.753683051,3.257274572,CAV1,1
2726,T cell activation involved in immune response (GO:0002286),0.306395275,1,0,0,2.753683051,3.257274572,SLC11A1,1
2727,GPI anchor metabolic process (GO:0006505),0.306395275,1,0,0,2.753683051,3.257274572,PGAP2,1
2728,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.307314357,1,0,0,1.791552828,2.113824682,RGCC;PLK2,1
2729,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.307314357,1,0,0,1.791552828,2.113824682,DAP;ANXA4,1
2730,positive regulation of cell cycle (GO:0045787),0.307314357,1,0,0,1.791552828,2.113824682,DUSP3;SPHK1,1
2731,"retrograde transport, endosome to Golgi (GO:0042147)",0.307314357,1,0,0,1.791552828,2.113824682,CLTC;RAB7B,1
2732,positive regulation of DNA metabolic process (GO:0051054),0.307314357,1,0,0,1.791552828,2.113824682,RGCC;IGF1,1
2733,positive regulation of cell cycle arrest (GO:0071158),0.307314357,1,0,0,1.791552828,2.113824682,RGCC;PLK2,1
2734,cellular protein complex assembly (GO:0043623),0.309700096,1,0,0,1.538264325,1.803077888,FKBP1A;CLTC;RTN4,1
2735,positive regulation of phosphorylation (GO:0042327),0.309990611,1,0,0,1.422955835,1.666584756,NRP1;GPNMB;IGF1;MET,1
2736,establishment of protein localization to membrane (GO:0090150),0.312272001,1,0,0,1.770224819,2.060330451,ZDHHC18;RILPL2,1
2737,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.312272001,1,0,0,1.770224819,2.060330451,CAV1;CD44,1
2738,protein maturation (GO:0051604),0.312272001,1,0,0,1.770224819,2.060330451,F7;CTSS,1
2739,peptidyl-serine phosphorylation (GO:0018105),0.313376592,1,0,0,1.527728268,1.77269895,PRKCB;PLK2;SGK1,1
2740,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.315736855,1,0,0,2.655337228,3.061195296,FKBP1A,1
2741,ATP synthesis coupled proton transport (GO:0015986),0.315736855,1,0,0,2.655337228,3.061195296,TCIRG1,1
2742,phosphatidylinositol phosphorylation (GO:0046854),0.315736855,1,0,0,2.655337228,3.061195296,PI4K2A,1
2743,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.315736855,1,0,0,2.655337228,3.061195296,CAV1,1
2744,positive regulation of lipid kinase activity (GO:0090218),0.315736855,1,0,0,2.655337228,3.061195296,CD81,1
2745,negative regulation of smooth muscle cell proliferation (GO:0048662),0.315736855,1,0,0,2.655337228,3.061195296,HMOX1,1
2746,negative regulation of synaptic transmission (GO:0050805),0.315736855,1,0,0,2.655337228,3.061195296,PLK2,1
2747,leukocyte cell-cell adhesion (GO:0007159),0.315736855,1,0,0,2.655337228,3.061195296,ITGB2,1
2748,peptidyl-glutamic acid modification (GO:0018200),0.315736855,1,0,0,2.655337228,3.061195296,F7,1
2749,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.315736855,1,0,0,2.655337228,3.061195296,ARHGAP25,1
2750,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.315736855,1,0,0,2.655337228,3.061195296,INHBA,1
2751,transition metal ion transport (GO:0000041),0.315736855,1,0,0,2.655337228,3.061195296,SLC11A1,1
2752,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.315736855,1,0,0,2.655337228,3.061195296,SORT1,1
2753,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),0.315736855,1,0,0,2.655337228,3.061195296,CHCHD10,1
2754,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.315736855,1,0,0,2.655337228,3.061195296,NRP1,1
2755,protein targeting to vacuole (GO:0006623),0.315736855,1,0,0,2.655337228,3.061195296,NCOA4,1
2756,regulation of blood vessel diameter (GO:0097746),0.315736855,1,0,0,2.655337228,3.061195296,HMOX1,1
2757,muscle fiber development (GO:0048747),0.315736855,1,0,0,2.655337228,3.061195296,CAV2,1
2758,regulation of autophagy of mitochondrion (GO:1903146),0.315736855,1,0,0,2.655337228,3.061195296,CTSK,1
2759,regulation of protein localization to cell surface (GO:2000008),0.315736855,1,0,0,2.655337228,3.061195296,CTNNB1,1
2760,regulation of cell cycle G2/M phase transition (GO:1902749),0.317222112,1,0,0,1.749398644,2.008577443,DYNC1I2;YWHAG,1
2761,cellular response to molecule of bacterial origin (GO:0071219),0.317222112,1,0,0,1.749398644,2.008577443,CD274;TNFRSF1B,1
2762,cellular response to hydrogen peroxide (GO:0070301),0.324953083,1,0,0,2.563773875,2.881872755,RHOB,1
2763,cellular response to alcohol (GO:0097306),0.324953083,1,0,0,2.563773875,2.881872755,CTNNB1,1
2764,aerobic respiration (GO:0009060),0.324953083,1,0,0,2.563773875,2.881872755,MT-CO1,1
2765,positive regulation of phosphate metabolic process (GO:0045937),0.324953083,1,0,0,2.563773875,2.881872755,NRP1,1
2766,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.324953083,1,0,0,2.563773875,2.881872755,FKBP1A,1
2767,positive regulation of phospholipid metabolic process (GO:1903727),0.324953083,1,0,0,2.563773875,2.881872755,CD81,1
2768,regulation of NIK/NF-kappaB signaling (GO:1901222),0.324953083,1,0,0,2.563773875,2.881872755,ACTN4,1
2769,negative regulation of JNK cascade (GO:0046329),0.324953083,1,0,0,2.563773875,2.881872755,DUSP3,1
2770,neural crest cell migration (GO:0001755),0.324953083,1,0,0,2.563773875,2.881872755,NRP1,1
2771,triglyceride homeostasis (GO:0070328),0.324953083,1,0,0,2.563773875,2.881872755,LPL,1
2772,calcium ion import (GO:0070509),0.324953083,1,0,0,2.563773875,2.881872755,CACNA1D,1
2773,protein export from nucleus (GO:0006611),0.324953083,1,0,0,2.563773875,2.881872755,EGR2,1
2774,regulation of peptidyl-serine phosphorylation (GO:0033135),0.327096983,1,0,0,1.709182583,1.910009091,CAV1;CD44,1
2775,intracellular protein transport (GO:0006886),0.327293493,1,0,0,1.281886938,1.431736927,MMP12;EGR2;CLTC;LAMP2;PTTG1IP;RAB7B,1
2776,heart development (GO:0007507),0.328090316,1,0,0,1.486988848,1.657199042,FKBP1A;SH3PXD2B;MICAL2,1
2777,negative regulation of cell differentiation (GO:0045596),0.331768967,1,0,0,1.477141239,1.629754208,ABCA1;CAV1;ABCG1,1
2778,positive regulation of cellular component biogenesis (GO:0044089),0.332020417,1,0,0,1.689760054,1.863059845,RGCC;SDC1,1
2779,regulation of striated muscle contraction (GO:0006942),0.334045633,1,0,0,2.478314746,2.717416776,P2RX4,1
2780,lung development (GO:0030324),0.334045633,1,0,0,2.478314746,2.717416776,PDPN,1
2781,regulation of vasoconstriction (GO:0019229),0.334045633,1,0,0,2.478314746,2.717416776,CAV1,1
2782,vacuolar transport (GO:0007034),0.334045633,1,0,0,2.478314746,2.717416776,ATP6V0D2,1
2783,negative regulation of Notch signaling pathway (GO:0045746),0.334045633,1,0,0,2.478314746,2.717416776,FAM129B,1
2784,regulation of embryonic development (GO:0045995),0.334045633,1,0,0,2.478314746,2.717416776,FAM129B,1
2785,lysosome localization (GO:0032418),0.334045633,1,0,0,2.478314746,2.717416776,PLEKHM2,1
2786,coenzyme biosynthetic process (GO:0009108),0.334045633,1,0,0,2.478314746,2.717416776,ATPIF1,1
2787,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.334045633,1,0,0,2.478314746,2.717416776,CD36,1
2788,regulation of cellular biosynthetic process (GO:0031326),0.334045633,1,0,0,2.478314746,2.717416776,MITF,1
2789,striated muscle tissue development (GO:0014706),0.334045633,1,0,0,2.478314746,2.717416776,CAV1,1
2790,positive regulation of intracellular protein transport (GO:0090316),0.339124195,1,0,0,1.457832204,1.576483536,TCF7L2;CTSK;ITGAX,1
2791,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.34301616,1,0,0,2.398369109,2.566201506,YWHAG,1
2792,negative regulation of stress-activated MAPK cascade (GO:0032873),0.34301616,1,0,0,2.398369109,2.566201506,DUSP3,1
2793,replication fork processing (GO:0031297),0.34301616,1,0,0,2.398369109,2.566201506,ZRANB3,1
2794,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.34301616,1,0,0,2.398369109,2.566201506,RGCC,1
2795,negative regulation of transferase activity (GO:0051348),0.34301616,1,0,0,2.398369109,2.566201506,CHCHD10,1
2796,negative regulation of secretion by cell (GO:1903531),0.34301616,1,0,0,2.398369109,2.566201506,ANXA1,1
2797,activation of protein kinase B activity (GO:0032148),0.34301616,1,0,0,2.398369109,2.566201506,IGF1,1
2798,negative regulation of DNA biosynthetic process (GO:2000279),0.34301616,1,0,0,2.398369109,2.566201506,FAM129B,1
2799,protein palmitoylation (GO:0018345),0.34301616,1,0,0,2.398369109,2.566201506,ZDHHC18,1
2800,fatty-acyl-CoA biosynthetic process (GO:0046949),0.34301616,1,0,0,2.398369109,2.566201506,ACSL4,1
2801,regulation of ARF protein signal transduction (GO:0032012),0.34301616,1,0,0,2.398369109,2.566201506,APLP2,1
2802,positive regulation of cation channel activity (GO:2001259),0.34301616,1,0,0,2.398369109,2.566201506,CTSS,1
2803,regulation of developmental growth (GO:0048638),0.34301616,1,0,0,2.398369109,2.566201506,IGF1,1
2804,phosphatidylinositol 3-kinase signaling (GO:0014065),0.34301616,1,0,0,2.398369109,2.566201506,IGF1,1
2805,artery morphogenesis (GO:0048844),0.34301616,1,0,0,2.398369109,2.566201506,NRP1,1
2806,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.34301616,1,0,0,2.398369109,2.566201506,YWHAG,1
2807,regulation of blood coagulation (GO:0030193),0.34301616,1,0,0,2.398369109,2.566201506,CAV1,1
2808,positive regulation of gene expression (GO:0010628),0.345571353,1,0,0,1.155690814,1.227986367,EGR2;RGCC;SLC11A1;NCOA4;FN1;SPP1;CTNNB1;MITF;IGF1;CD36;INHBA;FAM129B,1
2809,mitotic cell cycle phase transition (GO:0044772),0.349546172,1,0,0,1.339629592,1.408110944,DYNC1I2;PLK2;INHBA;YWHAG,1
2810,positive regulation of cellular protein metabolic process (GO:0032270),0.35160623,1,0,0,1.616292226,1.689418773,PTTG1IP;INHBA,1
2811,regulation of protein catabolic process (GO:0042176),0.35160623,1,0,0,1.616292226,1.689418773,PLK2;TNFSF12,1
2812,cellular response to lipopolysaccharide (GO:0071222),0.35160623,1,0,0,1.616292226,1.689418773,CD274;TNFRSF1B,1
2813,negative regulation of kinase activity (GO:0033673),0.35160623,1,0,0,1.616292226,1.689418773,SOCS2;YWHAG,1
2814,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.351866296,1,0,0,2.323420074,2.4268216,RAB7B,1
2815,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.351866296,1,0,0,2.323420074,2.4268216,RGCC,1
2816,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.351866296,1,0,0,2.323420074,2.4268216,CD274,1
2817,alpha-amino acid metabolic process (GO:1901605),0.351866296,1,0,0,2.323420074,2.4268216,SLC6A8,1
2818,regulation of glucose import (GO:0046324),0.351866296,1,0,0,2.323420074,2.4268216,IGF1,1
2819,regulation of protein tyrosine kinase activity (GO:0061097),0.351866296,1,0,0,2.323420074,2.4268216,CAV1,1
2820,renal water homeostasis (GO:0003091),0.351866296,1,0,0,2.323420074,2.4268216,WFS1,1
2821,skeletal system morphogenesis (GO:0048705),0.351866296,1,0,0,2.323420074,2.4268216,MMP13,1
2822,regulation of protein export from nucleus (GO:0046825),0.351866296,1,0,0,2.323420074,2.4268216,TCF7L2,1
2823,regulation of protein autophosphorylation (GO:0031952),0.351866296,1,0,0,2.323420074,2.4268216,GPNMB,1
2824,cellular zinc ion homeostasis (GO:0006882),0.351866296,1,0,0,2.323420074,2.4268216,S100A9,1
2825,positive regulation of insulin secretion (GO:0032024),0.351866296,1,0,0,2.323420074,2.4268216,TCF7L2,1
2826,nucleobase-containing small molecule interconversion (GO:0015949),0.351866296,1,0,0,2.323420074,2.4268216,TXNRD1,1
2827,regulation of cytokine secretion (GO:0050707),0.351866296,1,0,0,2.323420074,2.4268216,RGCC,1
2828,liver development (GO:0001889),0.351866296,1,0,0,2.323420074,2.4268216,MET,1
2829,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),0.355966256,1,0,0,1.13844847,1.17592544,TCF7L2;EGR2;CD81;SLC11A1;MICAL2;MITF;IGF1;INHBA;MMP12;RGCC;CTNNB1;SQSTM1;MET,1
2830,positive regulation of cellular metabolic process (GO:0031325),0.356472761,1,0,0,1.598912739,1.649274413,CD63;INHBA,1
2831,cell cycle G1/S phase transition (GO:0044843),0.356472761,1,0,0,1.598912739,1.649274413,PLK2;INHBA,1
2832,response to zinc ion (GO:0010043),0.36059765,1,0,0,2.253013405,2.298056745,HVCN1,1
2833,cellular response to glucagon stimulus (GO:0071377),0.36059765,1,0,0,2.253013405,2.298056745,GNG12,1
2834,ceramide biosynthetic process (GO:0046513),0.36059765,1,0,0,2.253013405,2.298056745,DEGS1,1
2835,cyclic-nucleotide-mediated signaling (GO:0019935),0.36059765,1,0,0,2.253013405,2.298056745,CD36,1
2836,negative regulation of receptor activity (GO:2000272),0.36059765,1,0,0,2.253013405,2.298056745,CAV1,1
2837,GPI anchor biosynthetic process (GO:0006506),0.36059765,1,0,0,2.253013405,2.298056745,PGAP2,1
2838,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.36059765,1,0,0,2.253013405,2.298056745,ADAM8,1
2839,mitochondrial transmembrane transport (GO:1990542),0.36059765,1,0,0,2.253013405,2.298056745,UCP2,1
2840,positive regulation of T cell differentiation (GO:0045582),0.36059765,1,0,0,2.253013405,2.298056745,ADAM8,1
2841,positive regulation of transcription factor import into nucleus (GO:0042993),0.36059765,1,0,0,2.253013405,2.298056745,SPHK1,1
2842,regulation of erythrocyte differentiation (GO:0045646),0.36059765,1,0,0,2.253013405,2.298056745,INHBA,1
2843,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.36059765,1,0,0,2.253013405,2.298056745,DCSTAMP,1
2844,vasculogenesis (GO:0001570),0.36059765,1,0,0,2.253013405,2.298056745,CAV1,1
2845,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.361326207,1,0,0,1.581903029,1.610336324,TNFRSF1B;CD44,1
2846,positive regulation of nucleic acid-templated transcription (GO:1903508),0.365645849,1,0,0,1.182496101,1.189697549,EGR2;NCOA4;SPP1;CTNNB1;MITF;IGF1;INHBA;FAM129B,1
2847,vesicle fusion (GO:0006906),0.366166042,1,0,0,1.565251419,1.572558609,CAV2;RAB7B,1
2848,axon development (GO:0061564),0.366166042,1,0,0,1.565251419,1.572558609,BAIAP2;RTN4,1
2849,response to exogenous dsRNA (GO:0043330),0.36921181,1,0,0,2.186748305,2.17884275,CAV1,1
2850,platelet aggregation (GO:0070527),0.36921181,1,0,0,2.186748305,2.17884275,MYH9,1
2851,mRNA stabilization (GO:0048255),0.36921181,1,0,0,2.186748305,2.17884275,SLC11A1,1
2852,positive regulation of catalytic activity (GO:0043085),0.36921181,1,0,0,2.186748305,2.17884275,CAV1,1
2853,positive regulation of nucleocytoplasmic transport (GO:0046824),0.36921181,1,0,0,2.186748305,2.17884275,TCF7L2,1
2854,cellular glucose homeostasis (GO:0001678),0.36921181,1,0,0,2.186748305,2.17884275,HK3,1
2855,positive regulation of organelle organization (GO:0010638),0.36921181,1,0,0,2.186748305,2.17884275,ANXA1,1
2856,interleukin-1-mediated signaling pathway (GO:0070498),0.370991754,1,0,0,1.548946716,1.535897527,IL1RN;SQSTM1,1
2857,negative regulation of intracellular signal transduction (GO:1902532),0.372125966,1,0,0,1.376841526,1.361039329,DUSP3;CAV1;ARHGAP25,1
2858,protein localization to nucleus (GO:0034504),0.375802847,1,0,0,1.532978193,1.500311373,MMP12;PTTG1IP,1
2859,ciliary basal body-plasma membrane docking (GO:0097711),0.375802847,1,0,0,1.532978193,1.500311373,DYNC1I2;YWHAG,1
2860,embryonic limb morphogenesis (GO:0030326),0.377710344,1,0,0,2.124269782,2.068247826,CTNNB1,1
2861,negative regulation of cellular metabolic process (GO:0031324),0.377710344,1,0,0,2.124269782,2.068247826,LRPAP1,1
2862,positive regulation of exocytosis (GO:0045921),0.377710344,1,0,0,2.124269782,2.068247826,SDC1,1
2863,positive regulation of muscle cell differentiation (GO:0051149),0.377710344,1,0,0,2.124269782,2.068247826,CTNNB1,1
2864,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.377710344,1,0,0,2.124269782,2.068247826,FKBP1A,1
2865,regulation of axon extension (GO:0030516),0.377710344,1,0,0,2.124269782,2.068247826,RTN4,1
2866,negative regulation of endothelial cell migration (GO:0010596),0.377710344,1,0,0,2.124269782,2.068247826,RGCC,1
2867,response to glucagon (GO:0033762),0.377710344,1,0,0,2.124269782,2.068247826,GNG12,1
2868,anterior/posterior pattern specification (GO:0009952),0.377710344,1,0,0,2.124269782,2.068247826,BASP1,1
2869,cell morphogenesis involved in neuron differentiation (GO:0048667),0.380598842,1,0,0,1.517335559,1.465760361,BAIAP2;RTN4,1
2870,negative regulation of cell motility (GO:2000146),0.380598842,1,0,0,1.517335559,1.465760361,CLIC4;RHOB,1
2871,mitochondrial respiratory chain complex assembly (GO:0033108),0.380598842,1,0,0,1.517335559,1.465760361,MT-ND5;MT-ND3,1
2872,glycerophospholipid biosynthetic process (GO:0046474),0.383066249,1,0,0,1.351808043,1.297123798,SLC27A1;SLC44A1;PI4K2A,1
2873,regulation of insulin secretion (GO:0050796),0.385379276,1,0,0,1.502008937,1.432206522,TCF7L2;CACNA1D,1
2874,lipid phosphorylation (GO:0046834),0.386094797,1,0,0,2.065262288,1.965453017,PI4K2A,1
2875,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.386094797,1,0,0,2.065262288,1.965453017,ACTN4,1
2876,antibacterial humoral response (GO:0019731),0.386094797,1,0,0,2.065262288,1.965453017,HIST1H2BC,1
2877,negative regulation of cell-substrate adhesion (GO:0010812),0.386094797,1,0,0,2.065262288,1.965453017,ACTN4,1
2878,regulation of microtubule polymerization (GO:0031113),0.386094797,1,0,0,2.065262288,1.965453017,MET,1
2879,regulation of endothelial cell apoptotic process (GO:2000351),0.386094797,1,0,0,2.065262288,1.965453017,RGCC,1
2880,positive regulation of DNA replication (GO:0045740),0.386094797,1,0,0,2.065262288,1.965453017,IGF1,1
2881,negative regulation of epithelial cell migration (GO:0010633),0.386094797,1,0,0,2.065262288,1.965453017,EVL,1
2882,apical junction assembly (GO:0043297),0.386094797,1,0,0,2.065262288,1.965453017,RHOC,1
2883,regulation of mitotic spindle organization (GO:0060236),0.386094797,1,0,0,2.065262288,1.965453017,CLTC,1
2884,regulation of mitochondrial membrane potential (GO:0051881),0.386094797,1,0,0,2.065262288,1.965453017,ATPIF1,1
2885,membrane protein proteolysis (GO:0033619),0.386094797,1,0,0,2.065262288,1.965453017,MYH9,1
2886,regulation of cardiac muscle contraction (GO:0055117),0.386094797,1,0,0,2.065262288,1.965453017,P2RX4,1
2887,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.386094797,1,0,0,2.065262288,1.965453017,ZRANB3,1
2888,positive regulation of osteoblast differentiation (GO:0045669),0.386094797,1,0,0,2.065262288,1.965453017,IGF1,1
2889,protein kinase B signaling (GO:0043491),0.386094797,1,0,0,2.065262288,1.965453017,IGF1,1
2890,small GTPase mediated signal transduction (GO:0007264),0.390143699,1,0,0,1.486988848,1.399613606,PLK2;IGF1,1
2891,negative regulation of nucleic acid-templated transcription (GO:1903507),0.391249908,1,0,0,1.16954179,1.097508277,TCF7L2;DAP;GCLC;BASP1;BHLHE41;CTNNB1;FAM129B,1
2892,protein acylation (GO:0043543),0.394366697,1,0,0,2.009444389,1.86973596,ZDHHC18,1
2893,regulation of receptor-mediated endocytosis (GO:0048259),0.394366697,1,0,0,2.009444389,1.86973596,LRPAP1,1
2894,muscle cell differentiation (GO:0042692),0.394366697,1,0,0,2.009444389,1.86973596,IGF1,1
2895,regulation of muscle cell differentiation (GO:0051147),0.394366697,1,0,0,2.009444389,1.86973596,CTNNB1,1
2896,natural killer cell activation (GO:0030101),0.394366697,1,0,0,2.009444389,1.86973596,PRDX1,1
2897,regulation of filopodium assembly (GO:0051489),0.394366697,1,0,0,2.009444389,1.86973596,NRP1,1
2898,heart looping (GO:0001947),0.394366697,1,0,0,2.009444389,1.86973596,MICAL2,1
2899,regulation of blood circulation (GO:1903522),0.394366697,1,0,0,2.009444389,1.86973596,S100A1,1
2900,plasma membrane organization (GO:0007009),0.394366697,1,0,0,2.009444389,1.86973596,MYOF,1
2901,regulation of cell morphogenesis involved in differentiation (GO:0010769),0.394366697,1,0,0,2.009444389,1.86973596,PDPN,1
2902,cardiac muscle tissue morphogenesis (GO:0055008),0.394366697,1,0,0,2.009444389,1.86973596,FKBP1A,1
2903,glutamate receptor signaling pathway (GO:0007215),0.394366697,1,0,0,2.009444389,1.86973596,DAGLB,1
2904,cellular response to metal ion (GO:0071248),0.394891676,1,0,0,1.472266186,1.367946982,CLIC4;HVCN1,1
2905,protein processing (GO:0016485),0.39962279,1,0,0,1.457832204,1.337173559,F7;CTSS,1
2906,metal ion transport (GO:0030001),0.39962279,1,0,0,1.457832204,1.337173559,KCNN4;SGK1,1
2907,epithelial to mesenchymal transition (GO:0001837),0.402527547,1,0,0,1.956564273,1.780457336,CTNNB1,1
2908,myelination (GO:0042552),0.402527547,1,0,0,1.956564273,1.780457336,GPC1,1
2909,protein peptidyl-prolyl isomerization (GO:0000413),0.402527547,1,0,0,1.956564273,1.780457336,FKBP1A,1
2910,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.402527547,1,0,0,1.956564273,1.780457336,YWHAG,1
2911,phospholipid biosynthetic process (GO:0008654),0.402527547,1,0,0,1.956564273,1.780457336,NUS1,1
2912,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.402527547,1,0,0,1.956564273,1.780457336,SPHK1,1
2913,negative regulation of Ras protein signal transduction (GO:0046580),0.402527547,1,0,0,1.956564273,1.780457336,MET,1
2914,peptidyl-serine modification (GO:0018209),0.4048115,1,0,0,1.304376182,1.179591408,PRKCB;PLK2;SGK1,1
2915,defense response to bacterium (GO:0042742),0.410385617,1,0,0,1.228916403,1.094544265,ANXA3;SLC11A1;S100A9;HIST1H2BC,1
2916,T cell differentiation (GO:0030217),0.410578834,1,0,0,1.906395958,1.697049518,ANXA1,1
2917,positive regulation of neuron death (GO:1901216),0.410578834,1,0,0,1.906395958,1.697049518,CTNNB1,1
2918,regulation of cellular amide metabolic process (GO:0034248),0.410578834,1,0,0,1.906395958,1.697049518,MTPN,1
2919,membrane depolarization during action potential (GO:0086010),0.410578834,1,0,0,1.906395958,1.697049518,CACNA1D,1
2920,homotypic cell-cell adhesion (GO:0034109),0.410578834,1,0,0,1.906395958,1.697049518,MYH9,1
2921,positive regulation of innate immune response (GO:0045089),0.410578834,1,0,0,1.906395958,1.697049518,ADAM8,1
2922,retina homeostasis (GO:0001895),0.410578834,1,0,0,1.906395958,1.697049518,PRDX1,1
2923,B cell receptor signaling pathway (GO:0050853),0.413710957,1,0,0,1.416179855,1.249902951,LAT2;PRKCB,1
2924,G1/S transition of mitotic cell cycle (GO:0000082),0.418370694,1,0,0,1.402819668,1.222399398,PLK2;INHBA,1
2925,negative regulation of protein catabolic process (GO:0042177),0.418522023,1,0,0,1.858736059,1.619007003,TIMP2,1
2926,clathrin-dependent endocytosis (GO:0072583),0.418522023,1,0,0,1.858736059,1.619007003,CLTC,1
2927,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.418522023,1,0,0,1.858736059,1.619007003,CHCHD10,1
2928,ERBB2 signaling pathway (GO:0038128),0.418522023,1,0,0,1.858736059,1.619007003,MATK,1
2929,positive regulation of peptide hormone secretion (GO:0090277),0.418522023,1,0,0,1.858736059,1.619007003,TCF7L2,1
2930,inositol lipid-mediated signaling (GO:0048017),0.418522023,1,0,0,1.858736059,1.619007003,IGF1,1
2931,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.418522023,1,0,0,1.858736059,1.619007003,CAV1,1
2932,cellular response to amino acid starvation (GO:0034198),0.418522023,1,0,0,1.858736059,1.619007003,DAP,1
2933,phosphorylation (GO:0016310),0.420552624,1,0,0,1.152704533,0.998456138,PRKCB;PLK2;MATK;FAM20C;CHCHD10;SGK1,1
2934,response to endoplasmic reticulum stress (GO:0034976),0.423011676,1,0,0,1.389709203,1.195643953,WFS1;HSP90B1,1
2935,fatty acid metabolic process (GO:0006631),0.423011676,1,0,0,1.389709203,1.195643953,SGPL1;LPL,1
2936,positive regulation of cellular component organization (GO:0051130),0.423011676,1,0,0,1.389709203,1.195643953,CD63;PLEKHM2,1
2937,embryonic heart tube morphogenesis (GO:0003143),0.426358559,1,0,0,1.813401034,1.545878317,MICAL2,1
2938,cognition (GO:0050890),0.426358559,1,0,0,1.813401034,1.545878317,CBR3,1
2939,sensory organ development (GO:0007423),0.426358559,1,0,0,1.813401034,1.545878317,SH3PXD2B,1
2940,ameboidal-type cell migration (GO:0001667),0.426358559,1,0,0,1.813401034,1.545878317,SGPL1,1
2941,positive regulation of Ras protein signal transduction (GO:0046579),0.426358559,1,0,0,1.813401034,1.545878317,IGF1,1
2942,peptidyl-proline modification (GO:0018208),0.426358559,1,0,0,1.813401034,1.545878317,FKBP1A,1
2943,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.426358559,1,0,0,1.813401034,1.545878317,DUSP3,1
2944,phosphatidic acid biosynthetic process (GO:0006654),0.426358559,1,0,0,1.813401034,1.545878317,SLC27A1,1
2945,regulation of release of cytochrome c from mitochondria (GO:0090199),0.426358559,1,0,0,1.813401034,1.545878317,IGF1,1
2946,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.426358559,1,0,0,1.813401034,1.545878317,IL1RN,1
2947,neuron migration (GO:0001764),0.426358559,1,0,0,1.813401034,1.545878317,NRP1,1
2948,regulation of cholesterol biosynthetic process (GO:0045540),0.426358559,1,0,0,1.813401034,1.545878317,ABCG1,1
2949,positive regulation of cytokine biosynthetic process (GO:0042108),0.426358559,1,0,0,1.813401034,1.545878317,HMOX1,1
2950,determination of heart left/right asymmetry (GO:0061371),0.426358559,1,0,0,1.813401034,1.545878317,MICAL2,1
2951,JAK-STAT cascade (GO:0007259),0.426358559,1,0,0,1.813401034,1.545878317,SOCS2,1
2952,positive regulation of cell cycle process (GO:0090068),0.427633563,1,0,0,1.376841526,1.169611197,RGCC;IGF1,1
2953,positive regulation of MAP kinase activity (GO:0043406),0.429892316,1,0,0,1.25308049,1.057876274,CD81;ADAM8;IGF1,1
2954,regulation of protein activation cascade (GO:2000257),0.432236027,1,0,0,1.364209952,1.144276772,CD81;C1QC,1
2955,monocarboxylic acid metabolic process (GO:0032787),0.432236027,1,0,0,1.364209952,1.144276772,SGPL1;IGF1,1
2956,negative regulation of hydrolase activity (GO:0051346),0.432236027,1,0,0,1.364209952,1.144276772,CSTB;ATPIF1,1
2957,odontogenesis (GO:0042476),0.434089871,1,0,0,1.770224819,1.477259145,INHBA,1
2958,mesenchymal cell differentiation (GO:0048762),0.434089871,1,0,0,1.770224819,1.477259145,CTNNB1,1
2959,phosphatidic acid metabolic process (GO:0046473),0.434089871,1,0,0,1.770224819,1.477259145,SLC27A1,1
2960,positive regulation of receptor-mediated endocytosis (GO:0048260),0.434089871,1,0,0,1.770224819,1.477259145,CD63,1
2961,regulation of cellular metabolic process (GO:0031323),0.434089871,1,0,0,1.770224819,1.477259145,ABCG1,1
2962,circulatory system development (GO:0072359),0.436818756,1,0,0,1.351808043,1.119617326,SH3PXD2B;MICAL2,1
2963,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.436818756,1,0,0,1.351808043,1.119617326,DAP;S100A9,1
2964,regulation of complement activation (GO:0030449),0.436818756,1,0,0,1.351808043,1.119617326,CD81;C1QC,1
2965,Wnt signaling pathway (GO:0016055),0.436818756,1,0,0,1.351808043,1.119617326,TCF7L2;CTNNB1,1
2966,ER to Golgi vesicle-mediated transport (GO:0006888),0.440527704,1,0,0,1.2323112,1.01022647,F7;DYNC1I2;CTSZ,1
2967,regulation of interleukin-6 production (GO:0032675),0.441717364,1,0,0,1.7290568,1.412786459,RAB7B,1
2968,cellular response to calcium ion (GO:0071277),0.441717364,1,0,0,1.7290568,1.412786459,CLIC4,1
2969,cellular response to radiation (GO:0071478),0.441717364,1,0,0,1.7290568,1.412786459,RHOB,1
2970,negative regulation of protein secretion (GO:0050709),0.441717364,1,0,0,1.7290568,1.412786459,RGCC,1
2971,glycolipid biosynthetic process (GO:0009247),0.441717364,1,0,0,1.7290568,1.412786459,PGAP2,1
2972,regulation of ion transmembrane transporter activity (GO:0032412),0.441717364,1,0,0,1.7290568,1.412786459,CACNA1D,1
2973,positive regulation of interferon-gamma production (GO:0032729),0.449242429,1,0,0,1.689760054,1.3521335,SLC11A1,1
2974,cardiac ventricle morphogenesis (GO:0003208),0.449242429,1,0,0,1.689760054,1.3521335,FKBP1A,1
2975,eye development (GO:0001654),0.449242429,1,0,0,1.689760054,1.3521335,SH3PXD2B,1
2976,positive regulation of interleukin-6 production (GO:0032755),0.449242429,1,0,0,1.689760054,1.3521335,RAB7B,1
2977,regulation of ATP metabolic process (GO:1903578),0.449242429,1,0,0,1.689760054,1.3521335,ATPIF1,1
2978,phosphatidylinositol metabolic process (GO:0046488),0.450445556,1,0,0,1.315919334,1.049469437,SLC27A1;PI4K2A,1
2979,cellular protein localization (GO:0034613),0.452204236,1,0,0,1.133375646,0.899471113,CD63;CLTC;SH3PXD2B;CTNNB1;RAB7B,1
2980,regulation of mitotic cell cycle phase transition (GO:1901990),0.454588589,1,0,0,1.205666633,0.950502324,DYNC1I2;RGCC;YWHAG,1
2981,positive regulation of developmental process (GO:0051094),0.454946429,1,0,0,1.304376182,1.027294862,RTN4;FAM129B,1
2982,regulation of humoral immune response (GO:0002920),0.454946429,1,0,0,1.304376182,1.027294862,CD81;C1QC,1
2983,regulation of focal adhesion assembly (GO:0051893),0.456666436,1,0,0,1.652209831,1.295005458,NRP1,1
2984,sprouting angiogenesis (GO:0002040),0.456666436,1,0,0,1.652209831,1.295005458,NRP1,1
2985,adherens junction organization (GO:0034332),0.456666436,1,0,0,1.652209831,1.295005458,CTNNB1,1
2986,lymphocyte chemotaxis (GO:0048247),0.456666436,1,0,0,1.652209831,1.295005458,ADAM8,1
2987,negative regulation of immune system process (GO:0002683),0.456666436,1,0,0,1.652209831,1.295005458,HMOX1,1
2988,positive regulation of macroautophagy (GO:0016239),0.456666436,1,0,0,1.652209831,1.295005458,BNIP3L,1
2989,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.456666436,1,0,0,1.652209831,1.295005458,PLK2,1
2990,regulation of intracellular pH (GO:0051453),0.456666436,1,0,0,1.652209831,1.295005458,TMEM165,1
2991,mitotic nuclear envelope disassembly (GO:0007077),0.456666436,1,0,0,1.652209831,1.295005458,PRKCB,1
2992,posttranscriptional regulation of gene expression (GO:0010608),0.456666436,1,0,0,1.652209831,1.295005458,MTPN,1
2993,negative regulation of immune response (GO:0050777),0.456666436,1,0,0,1.652209831,1.295005458,LGALS3,1
2994,positive regulation of viral process (GO:0048524),0.456666436,1,0,0,1.652209831,1.295005458,CAV2,1
2995,positive regulation of programmed cell death (GO:0043068),0.45823584,1,0,0,1.152704533,0.899537527,BNIP3L;CTNNB1;SQSTM1;RHOB,1
2996,regulation of immune effector process (GO:0002697),0.459426167,1,0,0,1.293033781,1.005691976,CD81;C1QC,1
2997,peptidyl-tyrosine autophosphorylation (GO:0038083),0.463990737,1,0,0,1.616292226,1.241135754,MATK,1
2998,cellular response to ionizing radiation (GO:0071479),0.471216665,1,0,0,1.581903029,1.190282811,RHOB,1
2999,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.471216665,1,0,0,1.581903029,1.190282811,GPNMB,1
3000,nuclear envelope disassembly (GO:0051081),0.471216665,1,0,0,1.581903029,1.190282811,PRKCB,1
3001,cartilage development (GO:0051216),0.471216665,1,0,0,1.581903029,1.190282811,CD44,1
3002,pyruvate metabolic process (GO:0006090),0.471216665,1,0,0,1.581903029,1.190282811,HK3,1
3003,icosanoid metabolic process (GO:0006690),0.471216665,1,0,0,1.581903029,1.190282811,DAGLB,1
3004,regulation of DNA metabolic process (GO:0051052),0.471216665,1,0,0,1.581903029,1.190282811,IL7R,1
3005,activation of MAPK activity (GO:0000187),0.472736152,1,0,0,1.26016004,0.944134414,CD81;IGF1,1
3006,protein homooligomerization (GO:0051260),0.475398937,1,0,0,1.167792289,0.868371467,CAV1;ATPIF1;HMOX1,1
3007,plasma membrane bounded cell projection organization (GO:0120036),0.477128983,1,0,0,1.24957046,0.924642679,NPY;PDPN,1
3008,cytosolic transport (GO:0016482),0.477128983,1,0,0,1.24957046,0.924642679,SORT1;CLTC,1
3009,regulation of organelle assembly (GO:1902115),0.478345538,1,0,0,1.548946716,1.142227267,PLK2,1
3010,positive regulation of organelle assembly (GO:1902117),0.478345538,1,0,0,1.548946716,1.142227267,SDC1,1
3011,cellular response to heat (GO:0034605),0.478345538,1,0,0,1.548946716,1.142227267,HMOX1,1
3012,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.478345538,1,0,0,1.548946716,1.142227267,INHBA,1
3013,positive regulation of B cell activation (GO:0050871),0.481499546,1,0,0,1.239157373,0.905638154,BST1;CD81,1
3014,regulation of cell cycle arrest (GO:0071156),0.485378655,1,0,0,1.517335559,1.096769534,RGCC,1
3015,glycoprotein metabolic process (GO:0009100),0.485378655,1,0,0,1.517335559,1.096769534,MAN2B1,1
3016,enzyme linked receptor protein signaling pathway (GO:0007167),0.485847644,1,0,0,1.228916403,0.887105832,MATK;BLNK,1
3017,macromolecular complex assembly (GO:0065003),0.485847644,1,0,0,1.228916403,0.887105832,MITF;CAPG,1
3018,cellular response to tumor necrosis factor (GO:0071356),0.489069014,1,0,0,1.143837575,0.818131732,DCSTAMP;TNFSF12;TNFRSF1B,1
3019,Golgi organization (GO:0007030),0.490173089,1,0,0,1.218843318,0.869031272,PLEKHM2;PI4K2A,1
3020,regulation of cell differentiation (GO:0045595),0.490173089,1,0,0,1.218843318,0.869031272,LGALS3;PRKCB,1
3021,regulation of reactive oxygen species metabolic process (GO:2000377),0.492317296,1,0,0,1.486988848,1.053727673,BST1,1
3022,regulation of megakaryocyte differentiation (GO:0045652),0.492317296,1,0,0,1.486988848,1.053727673,RAB7B,1
3023,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.492317296,1,0,0,1.486988848,1.053727673,FKBP1A,1
3024,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.498755314,1,0,0,1.199184555,0.834200331,TNFSF12;TNFRSF1B,1
3025,negative regulation of protein ubiquitination (GO:0031397),0.499162726,1,0,0,1.457832204,1.012935538,CAV1,1
3026,heart morphogenesis (GO:0003007),0.499162726,1,0,0,1.457832204,1.012935538,FKBP1A,1
3027,neurogenesis (GO:0022008),0.499162726,1,0,0,1.457832204,1.012935538,DAGLB,1
3028,dephosphorylation (GO:0016311),0.503011763,1,0,0,1.189591078,0.817417664,PTPRE;DUSP3,1
3029,regulation of intracellular signal transduction (GO:1902531),0.505232249,1,0,0,1.05460202,0.720015878,BST1;INHBA;RHOC;SQSTM1;ARHGAP25;RHOB,1
3030,negative regulation of neuron projection development (GO:0010977),0.505916193,1,0,0,1.429796969,0.974241136,RTN4,1
3031,regulation of exocytosis (GO:0017157),0.505916193,1,0,0,1.429796969,0.974241136,ANXA1,1
3032,positive regulation of actin filament polymerization (GO:0030838),0.505916193,1,0,0,1.429796969,0.974241136,BAIAP2,1
3033,arachidonic acid metabolic process (GO:0019369),0.505916193,1,0,0,1.429796969,0.974241136,DAGLB,1
3034,positive regulation of developmental growth (GO:0048639),0.505916193,1,0,0,1.429796969,0.974241136,IGF1,1
3035,protein dephosphorylation (GO:0006470),0.507244895,1,0,0,1.180149879,0.801040142,PTPRE;DUSP3,1
3036,cellular response to oxygen-containing compound (GO:1901701),0.507570012,1,0,0,1.081446435,0.73335113,CD274;P2RX4;TNFRSF1B;HSP90B1,1
3037,G2/M transition of mitotic cell cycle (GO:0000086),0.511454567,1,0,0,1.17085736,0.785055786,DYNC1I2;YWHAG,1
3038,positive regulation of ossification (GO:0045778),0.512578927,1,0,0,1.402819668,0.937505191,IGF1,1
3039,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.512578927,1,0,0,1.402819668,0.937505191,SGK1,1
3040,B cell differentiation (GO:0030183),0.512578927,1,0,0,1.402819668,0.937505191,BLNK,1
3041,regulation of DNA binding (GO:0051101),0.512578927,1,0,0,1.402819668,0.937505191,IGF1,1
3042,cell cycle G2/M phase transition (GO:0044839),0.515640642,1,0,0,1.161710037,0.769453051,DYNC1I2;YWHAG,1
3043,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.519152144,1,0,0,1.376841526,0.902599878,IGF1,1
3044,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),0.519152144,1,0,0,1.376841526,0.902599878,CAV1,1
3045,positive regulation of protein import into nucleus (GO:0042307),0.519152144,1,0,0,1.376841526,0.902599878,IGF1,1
3046,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.519152144,1,0,0,1.376841526,0.902599878,IGF1,1
3047,positive regulation of mitochondrion organization (GO:0010822),0.519802991,1,0,0,1.152704533,0.754220803,CTSK;ITGAX,1
3048,regulation of macromolecule metabolic process (GO:0060255),0.523941494,1,0,0,1.143837575,0.739348303,SORT1;IGF1,1
3049,sensory perception (GO:0007600),0.52563704,1,0,0,1.351808043,0.869407694,P2RX4,1
3050,cellular response to nutrient levels (GO:0031669),0.52563704,1,0,0,1.351808043,0.869407694,LAMP2,1
3051,action potential (GO:0001508),0.52563704,1,0,0,1.351808043,0.869407694,CACNA1D,1
3052,negative regulation of cellular component organization (GO:0051129),0.52563704,1,0,0,1.351808043,0.869407694,LGALS3,1
3053,membrane fusion (GO:0061025),0.52563704,1,0,0,1.351808043,0.869407694,DCSTAMP,1
3054,regulation of cellular catabolic process (GO:0031329),0.5320348,1,0,0,1.327668614,0.837820471,PSAP,1
3055,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5320348,1,0,0,1.327668614,0.837820471,CAV1,1
3056,long-chain fatty acid metabolic process (GO:0001676),0.5320348,1,0,0,1.327668614,0.837820471,DAGLB,1
3057,regulation of axonogenesis (GO:0050770),0.5320348,1,0,0,1.327668614,0.837820471,RTN4,1
3058,regulation of RNA splicing (GO:0043484),0.5320348,1,0,0,1.327668614,0.837820471,AHNAK2,1
3059,positive regulation of DNA biosynthetic process (GO:2000573),0.5320348,1,0,0,1.327668614,0.837820471,RGCC,1
3060,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.537935404,1,0,0,1.014514808,0.629016217,TCF7L2;DAP;GCLC;BASP1;BHLHE41;CTNNB1;FAM129B,1
3061,chromosome organization (GO:0051276),0.538346588,1,0,0,1.304376182,0.807738485,TCF7L2,1
3062,regulation of secretion by cell (GO:1903530),0.538346588,1,0,0,1.304376182,0.807738485,ANXA1,1
3063,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.538346588,1,0,0,1.304376182,0.807738485,SPHK1,1
3064,cellular defense response (GO:0006968),0.538346588,1,0,0,1.304376182,0.807738485,TCIRG1,1
3065,phosphatidylinositol-mediated signaling (GO:0048015),0.538346588,1,0,0,1.304376182,0.807738485,IGF1,1
3066,autophagosome organization (GO:1905037),0.538346588,1,0,0,1.304376182,0.807738485,GABARAPL1,1
3067,ATP metabolic process (GO:0046034),0.538346588,1,0,0,1.304376182,0.807738485,CHCHD10,1
3068,protein targeting (GO:0006605),0.540254876,1,0,0,1.10969317,0.683253907,ZDHHC18;LAMP2,1
3069,cellular response to organic substance (GO:0071310),0.540254876,1,0,0,1.10969317,0.683253907,SOCS2;CTNNB1,1
3070,regulation of glycolytic process (GO:0006110),0.544573557,1,0,0,1.281886938,0.779069676,IGF1,1
3071,positive regulation of cell death (GO:0010942),0.544573557,1,0,0,1.281886938,0.779069676,CD36,1
3072,chloride transmembrane transport (GO:1902476),0.544573557,1,0,0,1.281886938,0.779069676,CLIC4,1
3073,cellular respiration (GO:0045333),0.544573557,1,0,0,1.281886938,0.779069676,MT-CO1,1
3074,protein homotetramerization (GO:0051289),0.544573557,1,0,0,1.281886938,0.779069676,ATPIF1,1
3075,"positive regulation of transcription, DNA-templated (GO:0045893)",0.546164274,1,0,0,0.99486319,0.601728555,TCF7L2;EGR2;CD81;SLC11A1;NCOA4;MITF;IGF1;INHBA;FAM129B;MMP12;RGCC;SPP1;CTNNB1;SQSTM1;MET,1
3076,response to light stimulus (GO:0009416),0.550716842,1,0,0,1.26016004,0.75172894,ZRANB3,1
3077,autophagosome assembly (GO:0000045),0.550716842,1,0,0,1.26016004,0.75172894,GABARAPL1,1
3078,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.550716842,1,0,0,1.26016004,0.75172894,NRP1,1
3079,sodium ion transport (GO:0006814),0.550716842,1,0,0,1.26016004,0.75172894,SGK1,1
3080,positive regulation of transferase activity (GO:0051347),0.556178911,1,0,0,1.07752815,0.632148326,SERINC1;MET,1
3081,muscle contraction (GO:0006936),0.556178911,1,0,0,1.07752815,0.632148326,SLC6A8;MYOF,1
3082,regulation of cytosolic calcium ion concentration (GO:0051480),0.556178911,1,0,0,1.07752815,0.632148326,CAV1;CD36,1
3083,renal system development (GO:0072001),0.556777563,1,0,0,1.239157373,0.725637505,WFS1,1
3084,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.556777563,1,0,0,1.239157373,0.725637505,INHBA,1
3085,nucleosome assembly (GO:0006334),0.562756826,1,0,0,1.218843318,0.70072237,HIST1H2BC,1
3086,muscle organ development (GO:0007517),0.562756826,1,0,0,1.218843318,0.70072237,IGF1,1
3087,protein oligomerization (GO:0051259),0.564032963,1,0,0,1.023157464,0.585903534,CAV1;ATPIF1;HMOX1,1
3088,potassium ion transport (GO:0006813),0.568655722,1,0,0,1.199184555,0.6769158,KCNN4,1
3089,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.568655722,1,0,0,1.199184555,0.6769158,IGF1,1
3090,regulation of vesicle fusion (GO:0031338),0.568655722,1,0,0,1.199184555,0.6769158,ANXA1,1
3091,regulation of cellular ketone metabolic process (GO:0010565),0.568655722,1,0,0,1.199184555,0.6769158,CAV1,1
3092,protein targeting to membrane (GO:0006612),0.568655722,1,0,0,1.199184555,0.6769158,ZDHHC18,1
3093,regulation of DNA replication (GO:0006275),0.568655722,1,0,0,1.199184555,0.6769158,IGF1,1
3094,modification-dependent protein catabolic process (GO:0019941),0.571709172,1,0,0,1.047175245,0.585501709,RNF128;SQSTM1,1
3095,positive regulation of type I interferon production (GO:0032481),0.574475327,1,0,0,1.180149879,0.654154871,CTNNB1,1
3096,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.574475327,1,0,0,1.180149879,0.654154871,PTTG1IP,1
3097,cellular amide metabolic process (GO:0043603),0.574475327,1,0,0,1.180149879,0.654154871,SGPL1,1
3098,nervous system development (GO:0007399),0.578716901,1,0,0,0.978282137,0.535063456,EGR2;TPP1;CXCL1;EVL;INHBA;DAGLB,1
3099,kidney development (GO:0001822),0.580216702,1,0,0,1.161710037,0.632381065,WFS1,1
3100,vesicle coating (GO:0006901),0.580216702,1,0,0,1.161710037,0.632381065,CTSZ,1
3101,COPII vesicle coating (GO:0048208),0.580216702,1,0,0,1.161710037,0.632381065,CTSZ,1
3102,oligosaccharide metabolic process (GO:0009311),0.580216702,1,0,0,1.161710037,0.632381065,MAN2B1,1
3103,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.580216702,1,0,0,1.161710037,0.632381065,CTSZ,1
3104,positive regulation of cell projection organization (GO:0031346),0.580216702,1,0,0,1.161710037,0.632381065,S100A9,1
3105,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.583096664,1,0,0,1.02550955,0.553162211,FKBP1A;INHBA,1
3106,positive regulation of JAK-STAT cascade (GO:0046427),0.585880896,1,0,0,1.143837575,0.611539902,IGF1,1
3107,glucose metabolic process (GO:0006006),0.585880896,1,0,0,1.143837575,0.611539902,AKR1A1,1
3108,chromatin assembly (GO:0031497),0.591468942,1,0,0,1.126506703,0.591580606,HIST1H2BC,1
3109,cellular response to reactive oxygen species (GO:0034614),0.591468942,1,0,0,1.126506703,0.591580606,RHOB,1
3110,defense response to Gram-positive bacterium (GO:0050830),0.591468942,1,0,0,1.126506703,0.591580606,HIST1H2BC,1
3111,regulation of protein kinase activity (GO:0045859),0.594260311,1,0,0,1.004722194,0.522895431,SOCS2;YWHAG,1
3112,negative regulation of gene expression (GO:0010629),0.595454926,1,0,0,0.960897478,0.49815768,TCF7L2;DAP;GCLC;BASP1;DNMT3A;BHLHE41;CTNNB1;FAM129B,1
3113,positive regulation of cellular protein localization (GO:1903829),0.596981861,1,0,0,1.10969317,0.572455807,RTN4,1
3114,positive regulation of apoptotic process (GO:0043065),0.596997347,1,0,0,0.965577174,0.49808585,BNIP3L;CTNNB1;SQSTM1;RHOB,1
3115,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.597931722,1,0,0,0.997979092,0.513239399,TCF7L2;CAV1,1
3116,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.601578225,1,0,0,0.991325898,0.503790536,DYNC1I2;YWHAG,1
3117,cellular response to interleukin-1 (GO:0071347),0.605199823,1,0,0,0.984760826,0.494543529,IL1RN;SQSTM1,1
3118,protein sumoylation (GO:0016925),0.607786326,1,0,0,1.07752815,0.536535636,MITF,1
3119,negative regulation of phosphatase activity (GO:0010923),0.607786326,1,0,0,1.07752815,0.536535636,FKBP1A,1
3120,monocarboxylic acid biosynthetic process (GO:0072330),0.607786326,1,0,0,1.07752815,0.536535636,LPL,1
3121,response to interferon-gamma (GO:0034341),0.607786326,1,0,0,1.07752815,0.536535636,SLC11A1,1
3122,regulation of endopeptidase activity (GO:0052548),0.607786326,1,0,0,1.07752815,0.536535636,TIMP2,1
3123,COPII-coated vesicle budding (GO:0090114),0.607786326,1,0,0,1.07752815,0.536535636,CTSZ,1
3124,activation of protein kinase activity (GO:0032147),0.612070961,1,0,0,0.953197979,0.467931612,CD81;SLC11A1;IGF1,1
3125,positive regulation of neurogenesis (GO:0050769),0.613079845,1,0,0,1.062134891,0.519660222,CTNNB1,1
3126,regulation of osteoblast differentiation (GO:0045667),0.613079845,1,0,0,1.062134891,0.519660222,IGF1,1
3127,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.613079845,1,0,0,1.062134891,0.519660222,NRP1,1
3128,regulation of transcription from RNA polymerase II promoter (GO:0006357),0.616805333,1,0,0,0.955131444,0.461521243,TCF7L2;EGR2;PRKCB;CD81;WFS1;SLC11A1;ANXA4;CAV1;BHLHE41;MITF;IGF1;INHBA;MMP12;RGCC;CREG1;KLF9;CTNNB1;SQSTM1;MET,1
3129,regulation of Notch signaling pathway (GO:0008593),0.618302182,1,0,0,1.047175245,0.503458792,FAM129B,1
3130,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.618302182,1,0,0,1.047175245,0.503458792,CAV1,1
3131,Rab protein signal transduction (GO:0032482),0.618302182,1,0,0,1.047175245,0.503458792,RAB7B,1
3132,interferon-gamma-mediated signaling pathway (GO:0060333),0.618302182,1,0,0,1.047175245,0.503458792,CD44,1
3133,negative regulation of developmental process (GO:0051093),0.618302182,1,0,0,1.047175245,0.503458792,VAT1,1
3134,actomyosin structure organization (GO:0031032),0.62345429,1,0,0,1.032631144,0.487897386,MYH9,1
3135,defense response to Gram-negative bacterium (GO:0050829),0.62345429,1,0,0,1.032631144,0.487897386,SLC11A1,1
3136,organelle membrane fusion (GO:0090174),0.62345429,1,0,0,1.032631144,0.487897386,CAV2,1
3137,lipid biosynthetic process (GO:0008610),0.62853711,1,0,0,1.018485512,0.472944143,LPL,1
3138,glycoprotein biosynthetic process (GO:0009101),0.62853711,1,0,0,1.018485512,0.472944143,IGF1,1
3139,regulation of phosphatase activity (GO:0010921),0.62853711,1,0,0,1.018485512,0.472944143,HSP90B1,1
3140,regulation of epithelial cell proliferation (GO:0050678),0.62853711,1,0,0,1.018485512,0.472944143,IGF1,1
3141,protein N-linked glycosylation (GO:0006487),0.633551572,1,0,0,1.004722194,0.45856915,TMEM165,1
3142,lymphocyte differentiation (GO:0030098),0.633551572,1,0,0,1.004722194,0.45856915,BLNK,1
3143,regulation of peptide hormone secretion (GO:0090276),0.633551572,1,0,0,1.004722194,0.45856915,CACNA1D,1
3144,regulation of protein complex assembly (GO:0043254),0.633551572,1,0,0,1.004722194,0.45856915,FBLIM1,1
3145,chloride transport (GO:0006821),0.633551572,1,0,0,1.004722194,0.45856915,CLIC4,1
3146,plasma membrane bounded cell projection assembly (GO:0120031),0.634725637,1,0,0,0.921687302,0.41896443,NRP1;RILPL2;EMP1,1
3147,mitotic spindle organization (GO:0007052),0.638498589,1,0,0,0.991325898,0.4447443,PLK2,1
3148,"regulation of gene expression, epigenetic (GO:0040029)",0.638498589,1,0,0,0.991325898,0.4447443,DNMT3A,1
3149,negative regulation of phosphorylation (GO:0042326),0.643379067,1,0,0,0.978282137,0.431443161,INHBA,1
3150,C-terminal protein lipidation (GO:0006501),0.643379067,1,0,0,0.978282137,0.431443161,BST1,1
3151,purine ribonucleotide biosynthetic process (GO:0009152),0.643379067,1,0,0,0.978282137,0.431443161,CHCHD10,1
3152,cAMP-mediated signaling (GO:0019933),0.643379067,1,0,0,0.978282137,0.431443161,ABCA1,1
3153,transforming growth factor beta receptor signaling pathway (GO:0007179),0.648193897,1,0,0,0.965577174,0.418640856,FKBP1A,1
3154,hemopoiesis (GO:0030097),0.648193897,1,0,0,0.965577174,0.418640856,INHBA,1
3155,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.652943959,1,0,0,0.953197979,0.406313958,CAV1,1
3156,response to ionizing radiation (GO:0010212),0.652943959,1,0,0,0.953197979,0.406313958,RHOB,1
3157,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),0.657630121,1,0,0,0.941132182,0.394440386,ABCA1,1
3158,negative regulation of cell communication (GO:0010648),0.657630121,1,0,0,0.941132182,0.394440386,MET,1
3159,"negative regulation of transcription, DNA-templated (GO:0045892)",0.659739332,1,0,0,0.913383813,0.379885894,TCF7L2;DAP;GCLC;BASP1;WFS1;CAV1;BHLHE41;CTNNB1;MITF;FAM129B,1
3160,nucleosome organization (GO:0034728),0.662253239,1,0,0,0.92936803,0.382999312,HIST1H2BC,1
3161,peptidyl-tyrosine phosphorylation (GO:0018108),0.662253239,1,0,0,0.92936803,0.382999312,MATK,1
3162,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.662253239,1,0,0,0.92936803,0.382999312,CAV1,1
3163,neuron projection development (GO:0031175),0.6629794,1,0,0,0.885112409,0.363791255,NPY;SGK1,1
3164,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.666814159,1,0,0,0.91789435,0.371971081,IGF1,1
3165,ERBB signaling pathway (GO:0038127),0.666814159,1,0,0,0.91789435,0.371971081,MATK,1
3166,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.675752725,1,0,0,0.895776414,0.351079913,INHBA,1
3167,C-terminal protein amino acid modification (GO:0018410),0.675752725,1,0,0,0.895776414,0.351079913,BST1,1
3168,negative regulation of signaling (GO:0023057),0.680132007,1,0,0,0.885112409,0.341182839,MET,1
3169,negative regulation of endopeptidase activity (GO:0010951),0.680132007,1,0,0,0.885112409,0.341182839,TIMP2,1
3170,protein modification process (GO:0036211),0.684452358,1,0,0,0.874699322,0.33163021,MAN2B1,1
3171,regulation of neuron differentiation (GO:0045664),0.684452358,1,0,0,0.874699322,0.33163021,YWHAG,1
3172,negative regulation of Wnt signaling pathway (GO:0030178),0.684723846,1,0,0,0.849707913,0.321818091,TCF7L2;CAV1,1
3173,regulation of type I interferon production (GO:0032479),0.68871457,1,0,0,0.8645284,0.322407159,CTNNB1,1
3174,regulation of MAP kinase activity (GO:0043405),0.697067681,1,0,0,0.844880027,0.304894195,ADAM8,1
3175,T cell activation (GO:0042110),0.701160109,1,0,0,0.835386993,0.29657827,FKBP1A,1
3176,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.701160109,1,0,0,0.835386993,0.29657827,CLTC,1
3177,negative regulation of cellular protein metabolic process (GO:0032269),0.705197452,1,0,0,0.826104915,0.288539811,CSTB,1
3178,regulation of establishment of planar polarity (GO:0090175),0.705197452,1,0,0,0.826104915,0.288539811,CLTC,1
3179,regulation of cell cycle process (GO:0010564),0.709180451,1,0,0,0.817026839,0.280767409,CAV2,1
3180,regulation of cytokine-mediated signaling pathway (GO:0001959),0.709180451,1,0,0,0.817026839,0.280767409,SPHK1,1
3181,protein tetramerization (GO:0051262),0.709180451,1,0,0,0.817026839,0.280767409,ATPIF1,1
3182,regulation of JNK cascade (GO:0046328),0.709180451,1,0,0,0.817026839,0.280767409,DUSP3,1
3183,protein-DNA complex assembly (GO:0065004),0.713109834,1,0,0,0.808146113,0.273250223,HIST1H2BC,1
3184,nuclear export (GO:0051168),0.716986319,1,0,0,0.79945637,0.26597795,EGR2,1
3185,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.720810617,1,0,0,0.790951515,0.258940792,HMOX1,1
3186,cellular response to fibroblast growth factor stimulus (GO:0044344),0.724583427,1,0,0,0.782625709,0.252129425,CD44,1
3187,regulation of GTPase activity (GO:0043087),0.724766169,1,0,0,0.786766586,0.253265043,RGS1;CAV2,1
3188,MAPK cascade (GO:0000165),0.727335191,1,0,0,0.79945637,0.254521203,PTPRA;IGF1;MET,1
3189,positive regulation of GTPase activity (GO:0043547),0.735391237,1,0,0,0.770460543,0.236803072,RGS1;CAV2,1
3190,positive regulation of neuron projection development (GO:0010976),0.735599792,1,0,0,0.758667779,0.232963409,S100A9,1
3191,response to tumor necrosis factor (GO:0034612),0.735599792,1,0,0,0.758667779,0.232963409,DCSTAMP,1
3192,response to UV (GO:0009411),0.739173466,1,0,0,0.751004468,0.226970565,ZRANB3,1
3193,positive regulation of neuron differentiation (GO:0045666),0.739173466,1,0,0,0.751004468,0.226970565,S100A9,1
3194,regulation of gene expression (GO:0010468),0.74508661,1,0,0,0.859531126,0.252921171,TCF7L2;RGCC;SORT1;SLC11A1;AHNAK2;FN1;APBB2;MITF;IGF1;CD36;INHBA;ABCG1,1
3195,cellular response to transforming growth factor beta stimulus (GO:0071560),0.746177083,1,0,0,0.736133093,0.215534124,FKBP1A,1
3196,"regulation of transcription, DNA-templated (GO:0006355)",0.746555114,1,0,0,0.883451786,0.258220443,TCF7L2;EGR2;PRKCB;ANXA4;NCOA4;BHLHE41;MITF;IGF1;INHBA;FAM129B;DAP;GCLC;BASP1;CREG1;KLF9;SPP1;CTNNB1;APBB2;ABCG1,1
3197,cilium assembly (GO:0060271),0.748969394,1,0,0,0.77179352,0.223092442,DYNC1I2;RILPL2;YWHAG,1
3198,regulation of kinase activity (GO:0043549),0.749608309,1,0,0,0.728916102,0.210076874,MET,1
3199,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.755186784,1,0,0,0.763864134,0.214485536,WFS1;CTNNB1;HSP90B1,1
3200,positive regulation of lymphocyte activation (GO:0051251),0.759627174,1,0,0,0.708089927,0.194673412,SIRPA,1
3201,protein phosphorylation (GO:0006468),0.762459834,1,0,0,0.789272212,0.214054924,PRKCB;PLK2;MATK;FAM20C;SGK1,1
3202,viral life cycle (GO:0019058),0.769246584,1,0,0,0.688420763,0.180602854,CD81,1
3203,regulation of canonical Wnt signaling pathway (GO:0060828),0.785600598,1,0,0,0.694854602,0.167673113,TCF7L2;CAV1,1
3204,positive regulation of kinase activity (GO:0033674),0.787349888,1,0,0,0.652188091,0.155926788,MET,1
3205,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.787349888,1,0,0,0.652188091,0.155926788,CAV1,1
3206,regulation of cell cycle (GO:0051726),0.789918715,1,0,0,0.688420763,0.162346985,INHBA;RHOB,1
3207,peptidyl-lysine modification (GO:0018205),0.793064158,1,0,0,0.640943469,0.148603484,MITF,1
3208,central nervous system development (GO:0007417),0.79416025,1,0,0,0.682104976,0.157204742,EGR2;TPP1,1
3209,cellular response to interferon-gamma (GO:0071346),0.795863661,1,0,0,0.635465319,0.145094137,CD44,1
3210,DNA metabolic process (GO:0006259),0.7988258,1,0,0,0.708089927,0.159045763,ZRANB3;TCF7L2;IGF1,1
3211,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.801349971,1,0,0,0.62478523,0.138363381,ADAM8,1
3212,regulation of neuron projection development (GO:0010975),0.804037785,1,0,0,0.619578686,0.135135697,S100A9,1
3213,brain development (GO:0007420),0.804037785,1,0,0,0.619578686,0.135135697,EGR2,1
3214,DNA replication (GO:0006260),0.806689365,1,0,0,0.614458201,0.131995828,IGF1,1
3215,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.809305197,1,0,0,0.609421659,0.128940935,CLEC4D,1
3216,"complement activation, classical pathway (GO:0006958)",0.814431533,1,0,0,0.599592277,0.123075258,C1QC,1
3217,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.816942978,1,0,0,0.594795539,0.12025932,CLEC4D,1
3218,organic anion transport (GO:0015711),0.816942978,1,0,0,0.594795539,0.12025932,SLC6A6,1
3219,negative regulation of macromolecule metabolic process (GO:0010605),0.816942978,1,0,0,0.594795539,0.12025932,LRPAP1,1
3220,humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.819420558,1,0,0,0.59007494,0.117518042,C1QC,1
3221,cytoskeleton organization (GO:0007010),0.821864728,1,0,0,0.58542868,0.114849084,MICAL2,1
3222,negative regulation of response to stimulus (GO:0048585),0.824275936,1,0,0,0.580855019,0.112250193,MET,1
3223,regulation of mRNA stability (GO:0043488),0.826654626,1,0,0,0.576352267,0.109719198,SLC11A1,1
3224,protein glycosylation (GO:0006486),0.831316193,1,0,0,0.567552995,0.104852612,TMEM165,1
3225,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.83807539,1,0,0,0.554846585,0.098012106,BAIAP2,1
3226,Fc-gamma receptor signaling pathway (GO:0038094),0.840267943,1,0,0,0.55073661,0.095847147,BAIAP2,1
3227,ubiquitin-dependent protein catabolic process (GO:0006511),0.841581854,1,0,0,0.652188091,0.112484184,RNF128;CTNNB1;SQSTM1,1
3228,mitochondrial transport (GO:0006839),0.842430917,1,0,0,0.546687076,0.093736944,UCP2,1
3229,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.842430917,1,0,0,0.546687076,0.093736944,BAIAP2,1
3230,regulation of vesicle-mediated transport (GO:0060627),0.848746307,1,0,0,0.534888075,0.087718944,NRP1,1
3231,positive regulation of Wnt signaling pathway (GO:0030177),0.852815816,1,0,0,0.52730101,0.08395248,CAV1,1
3232,neuron development (GO:0048666),0.860630458,1,0,0,0.512754775,0.076959399,NPY,1
3233,protein deubiquitination (GO:0016579),0.864430385,1,0,0,0.576352267,0.083965594,RNF128;MINDY1,1
3234,antigen receptor-mediated signaling pathway (GO:0050851),0.864430385,1,0,0,0.576352267,0.083965594,LAT2;PRKCB,1
3235,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),0.881167139,1,0,0,0.656797194,0.083090071,TCF7L2;WFS1;CAV1;BHLHE41;MITF,1
3236,organelle assembly (GO:0070925),0.885173994,1,0,0,0.591640125,0.072162967,GABARAPL1;RILPL2;SH3PXD2B,1
3237,positive regulation of protein modification process (GO:0031401),0.892462619,1,0,0,0.453350258,0.051577954,GPNMB,1
3238,positive regulation of protein kinase activity (GO:0045860),0.904899911,1,0,0,0.429765563,0.042946875,SLC11A1,1
3239,protein modification by small protein conjugation (GO:0032446),0.906788054,1,0,0,0.559018364,0.054698009,MITF;FBXO32;HIST1H2BC,1
3240,protein autophosphorylation (GO:0046777),0.908718516,1,0,0,0.422440014,0.040435914,MATK,1
3241,regulation of nucleic acid-templated transcription (GO:1903506),0.914878468,1,0,0,0.611426335,0.054394959,TCF7L2;APBB2;MITF;ACTN4;ABCG1,1
3242,Fc-epsilon receptor signaling pathway (GO:0038095),0.917044915,1,0,0,0.406281106,0.035183467,LAT2,1
3243,Fc receptor signaling pathway (GO:0038093),0.918170937,1,0,0,0.404073056,0.034496403,LAT2,1
3244,cilium organization (GO:0044782),0.927643896,1,0,0,0.385230271,0.028933626,RILPL2,1
3245,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.930118725,1,0,0,0.588207614,0.042611548,MTPN;TCF7L2;APBB2;MITF;ABCG1,1
3246,regulation of translation (GO:0006417),0.94571181,1,0,0,0.347427301,0.019392487,MTPN,1
3247,cellular macromolecule biosynthetic process (GO:0034645),0.960023267,1,0,0,0.404073056,0.016485275,IGF1;INHBA,1
3248,proteasomal protein catabolic process (GO:0010498),0.960920413,1,0,0,0.312392615,0.012453123,CTNNB1,1
3249,anterograde trans-synaptic signaling (GO:0098916),0.962494629,1,0,0,0.30850391,0.011793115,NPY,1
3250,protein modification by small protein removal (GO:0070646),0.971879502,1,0,0,0.283776498,0.008094285,RNF128,1
3251,protein polyubiquitination (GO:0000209),0.979209894,1,0,0,0.261793811,0.005500095,FBXO32,1
3252,DNA repair (GO:0006281),0.980589967,1,0,0,0.257264507,0.005042611,ZRANB3,1
3253,chemical synaptic transmission (GO:0007268),0.980854826,1,0,0,0.256377388,0.004955984,NPY,1
3254,sensory perception of chemical stimulus (GO:0007606),0.988647308,1,0,0,0.226675129,0.002588092,CD36,1
3255,cellular response to DNA damage stimulus (GO:0006974),0.988955602,1,0,0,0.225301341,0.002502161,ZRANB3,1
3256,protein ubiquitination (GO:0016567),0.992271904,1,0,0,0.293291686,0.00227539,FBXO32;HIST1H2BC,1
3257,"transcription, DNA-templated (GO:0006351)",0.992385976,1,0,0,0.208261743,0.001591778,EGR2,1
3258,transcription from RNA polymerase II promoter (GO:0006366),0.998719562,1,0,0,0.152982392,0.00019601,EGR2,1
3259,neutrophil degranulation (GO:0043312),2.55E-09,1.30E-05,0,0,5.385487528,106.5687193,GSN;ANXA2;ARG1;C5AR1;GDI2;PLAUR;MIF;PA2G4;HMGB1;CFP;TUBB4B;PKM;CLEC5A;COTL1;CD14;ALDOA;PPIA;S100A11;CTSC,2
3260,neutrophil activation involved in immune response (GO:0002283),2.92E-09,7.45E-06,0,0,5.340979367,104.9619164,GSN;ANXA2;ARG1;C5AR1;GDI2;PLAUR;MIF;PA2G4;HMGB1;CFP;TUBB4B;PKM;CLEC5A;COTL1;CD14;ALDOA;PPIA;S100A11;CTSC,2
3261,neutrophil mediated immunity (GO:0002446),3.34E-09,5.68E-06,0,0,5.297200848,103.3886092,GSN;ANXA2;ARG1;C5AR1;GDI2;PLAUR;MIF;PA2G4;HMGB1;CFP;TUBB4B;PKM;CLEC5A;COTL1;CD14;ALDOA;PPIA;S100A11;CTSC,2
3262,regulation of humoral immune response (GO:0002920),1.65E-07,0.000210093,0,0,10.74113856,167.7685092,C4B;C1QB;C1QA;IGKC;CD81;C1QBP;C5AR1;CFP;FCGR2B,2
3263,regulation of immune effector process (GO:0002697),1.78E-07,0.000181215,0,0,10.64773736,165.5081325,C4B;C1QB;C1QA;IGKC;CD81;C1QBP;C5AR1;CFP;FCGR2B,2
3264,glycolytic process through glucose-6-phosphate (GO:0061620),1.16E-06,0.000989618,0,0,26.16431188,357.5095698,TPI1;PKM;ENO1;ALDOA;GAPDH,2
3265,canonical glycolysis (GO:0061621),1.16E-06,0.000848244,0,0,26.16431188,357.5095698,TPI1;PKM;ENO1;ALDOA;GAPDH,2
3266,glucose catabolic process to pyruvate (GO:0061718),1.16E-06,0.000742214,0,0,26.16431188,357.5095698,TPI1;PKM;ENO1;ALDOA;GAPDH,2
3267,regulation of protein activation cascade (GO:2000257),1.43E-06,0.000810071,0,0,9.985645634,134.3942931,C4B;C1QB;C1QA;IGKC;CD81;C1QBP;C5AR1;CFP,2
3268,regulation of complement activation (GO:0030449),1.53E-06,0.000781405,0,0,9.894867038,132.4864901,C4B;C1QB;C1QA;IGKC;CD81;C1QBP;C5AR1;CFP,2
3269,regulation of acute inflammatory response (GO:0002673),3.34E-06,0.0015503,0,0,8.921601427,112.492432,C4B;C1QB;C1QA;IGKC;CD81;C1QBP;C5AR1;CFP,2
3270,regulation of cytokine secretion (GO:0050707),3.44E-06,0.001461967,0,0,21.2585034,267.4457847,SRGN;RGCC;MIF;FCGR2B;GAPDH,2
3271,regulation of protein processing (GO:0070613),5.07E-06,0.001988744,0,0,8.437483521,102.8772793,C4B;C1QB;C1QA;IGKC;CD81;C1QBP;C5AR1;CFP,2
3272,regulation of apoptotic cell clearance (GO:2000425),2.12E-05,0.00772899,0,0,51.02040816,549.046101,C4B;CCL2;HMGB1,2
3273,glycolytic process (GO:0006096),2.22E-05,0.007569215,0,0,23.66163857,253.4918572,LDHA;TPI1;PKM;ALDOA,2
3274,interleukin-12-mediated signaling pathway (GO:0035722),2.40E-05,0.007643877,0,0,14.47387466,153.9853156,ANXA2;RPLP0;PITPNA;MIF;PPIA,2
3275,cellular response to interleukin-12 (GO:0071349),2.40E-05,0.007194238,0,0,14.47387466,153.9853156,ANXA2;RPLP0;PITPNA;MIF;PPIA,2
3276,ATP generation from ADP (GO:0006757),3.14E-05,0.008908592,0,0,21.76870748,225.6968978,LDHA;TPI1;PKM;ALDOA,2
3277,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),3.16E-05,0.00849654,0,0,45.35147392,469.8975597,GSN;PLAUR;PARK7,2
3278,viral process (GO:0016032),3.84E-05,0.009803124,0,0,5.54067781,56.33154906,RANBP1;RPL3;UBB;RPLP0;RPL14;CCL2;RPS2;PPIA;RAN,2
3279,negative regulation of apoptotic process (GO:0043066),6.34E-05,0.015405991,0,0,3.639315809,35.17784598,CD74;PRELID1;ANXA5;PLAUR;PARK7;MIF;PA2G4;DAB2;HNRNPK;UBB;CLEC5A;CCL2;LGMN,2
3280,phagocytosis (GO:0006909),6.65E-05,0.015418336,0,0,7.00280112,67.35811804,MSR1;IGHM;GSN;IGKC;CD14;HMGB1;FCGR2B,2
3281,positive regulation of DNA binding (GO:0043388),0.000122852,0.027257072,0,0,15.54907677,140.0121583,PLAUR;PARK7;HMGB1;NME1,2
3282,regulation of mitochondrial membrane potential (GO:0051881),0.000137423,0.029219493,0,0,15.11715797,134.4285603,PRELID1;PID1;UBB;PARK7,2
3283,carbohydrate catabolic process (GO:0016052),0.000137423,0.028050714,0,0,15.11715797,134.4285603,LDHA;TPI1;PKM;ALDOA,2
3284,negative regulation of cytokine production (GO:0001818),0.000170954,0.033553107,0,0,7.354293069,63.79197015,SRGN;RGCC;UBB;C1QBP;HMGB1;FCGR2B,2
3285,positive regulation of cytokine secretion (GO:0050715),0.000214676,0.040573716,0,0,9.192866336,77.64645926,RGCC;HMGB1;MIF;CD14;GAPDH,2
3286,negative regulation of programmed cell death (GO:0043069),0.000225025,0.041010893,0,0,3.659165378,30.73441655,CD74;PRELID1;DAB2;HNRNPK;UBB;CLEC5A;ANXA5;PLAUR;PARK7;MIF;PA2G4,2
3287,positive regulation of intracellular signal transduction (GO:1902533),0.00022853,0.040213312,0,0,3.401360544,28.51648041,CD74;ECM1;LGALS1;UBB;EEF1D;C1QBP;UBE2N;PARK7;MIF;CD14;HMGB1;PF4,2
3288,negative regulation of cytokine secretion (GO:0050710),0.000229624,0.039058965,0,0,13.27360212,111.2204328,SRGN;RGCC;FCGR2B;EZR,2
3289,positive regulation of cellular protein catabolic process (GO:1903364),0.000245273,0.040375165,0,0,24.00960384,199.5951284,CD81;EZR;CTSC,2
3290,cytokine-mediated signaling pathway (GO:0019221),0.000247722,0.03950387,0,0,3.004356317,24.94578527,ANXA2;IFNGR1;PITPNA;RPLP0;MIF;UBB;CCL7;PSMB2;UBE2N;CCL2;PLP2;VIM;PPIA;PF4,2
3291,cellular protein metabolic process (GO:0044267),0.000251188,0.038842762,0,0,3.366294972,27.90426202,RPL3;LGALS1;GSN;SPCS1;UBB;RPLP0;UBE2N;RPL14;TGFBI;RPS2;MRPL23;LGMN,2
3292,gluconeogenesis (GO:0006094),0.000252354,0.037875308,0,0,12.95756398,107.3492611,TPI1;ENO1;ALDOA;GAPDH,2
3293,positive regulation of translation (GO:0045727),0.000291651,0.042522689,0,0,8.611039352,70.09345832,RBM3;EIF5A;C1QBP;CIRBP;VIM,2
3294,regulation of B cell proliferation (GO:0030888),0.000302595,0.04289291,0,0,12.3685838,100.2240405,CD74;CD81;MIF;FCGR2B,2
3295,platelet degranulation (GO:0002576),0.000325618,0.044908934,0,0,6.530612245,52.43940895,SRGN;ECM1;ANXA5;TAGLN2;ALDOA;PF4,2
3296,hexose biosynthetic process (GO:0019319),0.000330233,0.044346775,0,0,12.09372638,96.93983987,TPI1;ENO1;ALDOA;GAPDH,2
3297,protein heterotetramerization (GO:0051290),0.000345768,0.045242422,0,0,21.48227712,171.2082134,CD74;ANXA2;S100A10,2
3298,nicotinamide nucleotide metabolic process (GO:0046496),0.000359632,0.045880029,0,0,11.83081928,93.82348171,LDHA;TPI1;PKM;ALDOA,2
3299,positive regulation of protein secretion (GO:0050714),0.000367,0.045678042,0,0,8.196049504,64.831976,RGCC;MIF;EZR;PPIA;GAPDH,2
3300,pyruvate metabolic process (GO:0006090),0.000390857,0.047489084,0,0,11.57909972,90.86316012,LDHA;TPI1;PKM;ALDOA,2
3301,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.000404601,0.048015777,0,0,20.40816327,159.441008,ACTR3;ARPC2;ARPC1B,2
3302,regulation of macrophage activation (GO:0043030),0.0004695,0.05445129,0,0,19.43634597,148.9571038,CD74;MIF;FCGR2B,2
3303,protein targeting to ER (GO:0045047),0.000786105,0.089144256,0,0,6.941552131,49.62113538,RPL3;SPCS1;RPLP0;RPL14;RPS2,2
3304,positive regulation of ATP biosynthetic process (GO:2001171),0.000789409,0.087572912,0,0,45.35147392,324.0011809,PID1;ENO1,2
3305,membrane raft assembly (GO:0001765),0.000789409,0.085709658,0,0,45.35147392,324.0011809,ANXA2;S100A10,2
3306,positive regulation of neutrophil chemotaxis (GO:0090023),0.000794631,0.084479217,0,0,16.32653061,116.5327772,CD74;C1QBP;PF4,2
3307,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.000794631,0.082755151,0,0,16.32653061,116.5327772,PID1;ENO1;CALM2,2
3308,actin nucleation (GO:0045010),0.000794631,0.081100048,0,0,16.32653061,116.5327772,ACTR3;ARPC2;ARPC1B,2
3309,regulated exocytosis (GO:0045055),0.000825247,0.082573248,0,0,5.478701548,38.8978374,SRGN;ECM1;ANXA5;TAGLN2;ALDOA;PF4,2
3310,organophosphate ester transport (GO:0015748),0.000893463,0.087679629,0,0,15.69858713,110.210453,PRELID1;PITPNA;PLTP,2
3311,positive regulation of neutrophil migration (GO:1902624),0.000893463,0.086025296,0,0,15.69858713,110.210453,CD74;C1QBP;PF4,2
3312,regulation of viral entry into host cell (GO:0046596),0.000999759,0.094477196,0,0,15.11715797,104.4292763,CD74;LGALS1;GSN,2
3313,positive regulation of granulocyte chemotaxis (GO:0071624),0.000999759,0.092759428,0,0,15.11715797,104.4292763,CD74;C1QBP;PF4,2
3314,regulation of apoptotic process (GO:0042981),0.001007568,0.091814593,0,0,2.5010004,17.25744352,CD74;PRELID1;ANXA5;PLAUR;PARK7;MIF;PA2G4;HMGB1;NME1;DAB2;LGALS1;HNRNPK;UBB;C1QBP;CLEC5A,2
3315,plasma membrane invagination (GO:0099024),0.001027759,0.092011486,0,0,6.54107797,45.00506593,MSR1;IGHM;GSN;IGKC;FCGR2B,2
3316,"phagocytosis, engulfment (GO:0006911)",0.001072849,0.094392206,0,0,6.478781989,44.29826785,MSR1;IGHM;GSN;IGKC;FCGR2B,2
3317,bleb assembly (GO:0032060),0.001099845,0.095127263,0,0,38.87269193,264.8235612,EMP1;EMP3,2
3318,regulation of dendritic cell differentiation (GO:2001198),0.001099845,0.093541808,0,0,38.87269193,264.8235612,HMGB1;FCGR2B,2
3319,regulation of low-density lipoprotein particle clearance (GO:0010988),0.001099845,0.092008336,0,0,38.87269193,264.8235612,HNRNPK;ANXA2,2
3320,regulation of natural killer cell chemotaxis (GO:2000501),0.001099845,0.090524331,0,0,38.87269193,264.8235612,CCL7;CCL2,2
3321,positive regulation of apoptotic cell clearance (GO:2000427),0.001099845,0.089087437,0,0,38.87269193,264.8235612,C4B;CCL2,2
3322,positive regulation of leukocyte chemotaxis (GO:0002690),0.001122626,0.089511872,0,0,8.77770463,59.61891431,CCL7;C1QBP;HMGB1;PF4,2
3323,viral life cycle (GO:0019058),0.00121694,0.095539188,0,0,6.298815823,42.27396938,UBB;CD81;CCL2;PPIA;RAN,2
3324,glucose metabolic process (GO:0006006),0.001339532,0.103570164,0,0,8.372579801,55.38825846,TPI1;ENO1;ALDOA;GAPDH,2
3325,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.001354259,0.103146031,0,0,4.977600796,32.87456835,CD74;ECM1;LGALS1;UBB;EEF1D;UBE2N,2
3326,regulation of neutrophil chemotaxis (GO:0090022),0.001365521,0.102474354,0,0,13.60544218,89.74447477,CD74;C1QBP;PF4,2
3327,negative regulation of lymphocyte proliferation (GO:0050672),0.001365521,0.100989218,0,0,13.60544218,89.74447477,SDC4;ARG1;FCGR2B,2
3328,microvillus organization (GO:0032528),0.001459394,0.106389826,0,0,34.01360544,222.0997948,FXYD5;EZR,2
3329,microvillus assembly (GO:0030033),0.001459394,0.104891378,0,0,34.01360544,222.0997948,FXYD5;EZR,2
3330,regulation of ATP biosynthetic process (GO:2001169),0.001459394,0.103434553,0,0,34.01360544,222.0997948,PID1;ENO1,2
3331,positive regulation of early endosome to late endosome transport (GO:2000643),0.001459394,0.102017641,0,0,34.01360544,222.0997948,DAB2;EZR,2
3332,positive regulation of viral entry into host cell (GO:0046598),0.001459394,0.100639024,0,0,34.01360544,222.0997948,CD74;LGALS1,2
3333,immunoglobulin mediated immune response (GO:0016064),0.001459394,0.099297171,0,0,34.01360544,222.0997948,CD74;FCGR2B,2
3334,B cell mediated immunity (GO:0019724),0.001459394,0.097990629,0,0,34.01360544,222.0997948,CD74;FCGR2B,2
3335,positive regulation of B cell proliferation (GO:0030890),0.001503736,0.099656658,0,0,13.16655695,85.58002481,CD74;CD81;MIF,2
3336,regulation of ubiquitin-protein transferase activity (GO:0051438),0.001650416,0.107975315,0,0,12.75510204,81.71846556,UBE2N;PARK7;RPS2,2
3337,positive regulation of gene expression (GO:0010628),0.001686634,0.108948025,0,0,2.467308167,15.75381292,CD74;PID1;GSN;CNBP;CIRBP;PARK7;RBM3;DAB2;RGCC;VIM;EZR;RAN;YWHAH;PF4,2
3338,translation (GO:0006412),0.001706505,0.10885371,0,0,4.087471899,26.05071596,EEF1G;RPL3;EEF1D;RPLP0;RPL14;RPS2;MRPL23,2
3339,positive regulation of hydrolase activity (GO:0051345),0.001777075,0.111955748,0,0,4.718650466,29.88220514,CCL7;RGS10;CCL2;PFN1;CALM2;S100A10,2
3340,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.001805748,0.112374754,0,0,12.3685838,78.12963028,CD14;MIF;PF4,2
3341,global genome nucleotide-excision repair (GO:0070911),0.001805748,0.111020841,0,0,12.3685838,78.12963028,UBB;SUMO2;UBE2N,2
3342,negative regulation of phagocytosis (GO:0050765),0.001867328,0.113440151,0,0,30.23431595,189.9696741,HMGB1;FCGR2B,2
3343,regulation of leukocyte activation (GO:0002694),0.001867328,0.112105561,0,0,30.23431595,189.9696741,CD74;MIF,2
3344,positive regulation of B cell activation (GO:0050871),0.001939669,0.115094528,0,0,5.66893424,35.40384406,IGHM;CD74;IGKC;CD81;MIF,2
3345,entry into host cell (GO:0030260),0.001969908,0.115545278,0,0,12.00480192,74.78713772,UBB;CD81;PPIA,2
3346,negative regulation of T cell activation (GO:0050868),0.00214307,0.124273708,0,0,11.66180758,71.66782378,SDC4;ARG1;FCGR2B,2
3347,membrane raft organization (GO:0031579),0.002322925,0.133189711,0,0,27.21088435,165.032062,ANXA2;S100A10,2
3348,positive regulation of cytoplasmic transport (GO:1903651),0.002322925,0.131709825,0,0,27.21088435,165.032062,DAB2;EZR,2
3349,regulation of ERK1 and ERK2 cascade (GO:0070372),0.002425495,0.136014307,0,0,3.840245776,23.12488317,CD74;CCL7;C5AR1;CCL2;MIF;HMGB1;EZR,2
3350,regulation of mitotic cell cycle phase transition (GO:1901990),0.002488257,0.138017133,0,0,4.412575841,26.45856704,PID1;RGCC;TUBA1A;UBB;PSMB2;TUBB4B,2
3351,positive regulation of receptor activity (GO:2000273),0.002718224,0.149151581,0,0,10.74113856,63.45624659,ANXA2;PARK7;CALM2,2
3352,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.002718224,0.147564862,0,0,10.74113856,63.45624659,GLRX;FXYD5;YWHAH,2
3353,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.002825472,0.151772463,0,0,24.73716759,145.1844111,CD74;MIF,2
3354,negative regulation of bone mineralization (GO:0030502),0.002825472,0.1501915,0,0,24.73716759,145.1844111,SRGN;ECM1,2
3355,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.003131521,0.164743846,0,0,5.076657529,29.27320724,ACTR3;ARPC2;IGKC;ARPC1B;FCGR2B,2
3356,positive regulation of binding (GO:0051099),0.003143409,0.163681789,0,0,6.636801062,38.24421737,PLAUR;HMGB1;RAN;NME1,2
3357,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.003149616,0.162348366,0,0,10.20408163,58.78035588,ATP5B;ADSSL1;ALDOA,2
3358,positive regulation of phagocytosis (GO:0050766),0.003149616,0.160724882,0,0,10.20408163,58.78035588,C4B;CCL2;FCGR2B,2
3359,positive regulation of cell differentiation (GO:0045597),0.003228985,0.163143643,0,0,4.186289901,24.01083238,MSR1;DAB2;RGCC;TMEM119;PA2G4;PF4,2
3360,Fc-gamma receptor signaling pathway (GO:0038094),0.003233075,0.161748837,0,0,5.039052658,28.89554851,ACTR3;ARPC2;IGKC;ARPC1B;FCGR2B,2
3361,ephrin receptor signaling pathway (GO:0048013),0.003283987,0.162700832,0,0,6.556839603,37.49657926,ACTR3;ARPC2;ARPC1B;MYL12A,2
3362,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.003336981,0.163736693,0,0,5.0020008,28.52485322,ACTR3;ARPC2;IGKC;ARPC1B;FCGR2B,2
3363,vesicle budding from membrane (GO:0006900),0.003374265,0.163989266,0,0,22.67573696,129.0607219,ANXA2;S100A10,2
3364,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.003374265,0.162442197,0,0,22.67573696,129.0607219,CD74;MIF,2
3365,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.003374265,0.160924046,0,0,22.67573696,129.0607219,CD74;MIF,2
3366,gene expression (GO:0010467),0.003471266,0.164017328,0,0,2.972062611,16.83149153,RBM3;EIF5A;RPL3;HNRNPK;ALYREF;RPLP0;RPL14;RPS2;MRPL23,2
3367,positive regulation of receptor-mediated endocytosis (GO:0048260),0.003620742,0.169510529,0,0,9.718172983,54.62659119,DAB2;HNRNPK;ANXA2,2
3368,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.0038377,0.178034373,0,0,4.041220449,22.48083312,CD74;CCL7;C5AR1;CCL2;MIF;HMGB1,2
3369,negative regulation of protein secretion (GO:0050709),0.00387155,0.177986646,0,0,9.492168961,52.72045973,SRGN;RGCC;FCGR2B,2
3370,toll-like receptor signaling pathway (GO:0002224),0.003889146,0.177199222,0,0,6.255375714,34.71461812,UBB;HMGB1;CD14;LGMN,2
3371,positive regulation of multicellular organismal process (GO:0051240),0.003931153,0.177528067,0,0,4.021312959,22.27333917,DAB2;RGCC;C1QBP;TMEM119;ENO1;PFN1,2
3372,prostanoid biosynthetic process (GO:0046457),0.003968605,0.177647291,0,0,20.9314495,115.7371143,CD74;MIF,2
3373,regulation of cell aging (GO:0090342),0.003968605,0.176102532,0,0,20.9314495,115.7371143,LMNA;MIF,2
3374,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.004123109,0.181381261,0,0,3.982080637,21.86619308,CD74;ECM1;LGALS1;UBB;EEF1D;UBE2N,2
3375,regulation of interferon-gamma production (GO:0032649),0.004132694,0.180249021,0,0,9.276437848,50.91675214,C1QBP;HMGB1;CD14,2
3376,positive regulation of macromolecule biosynthetic process (GO:0010557),0.004132773,0.178724901,0,0,4.757147614,26.11106407,RBM3;RGCC;CIRBP;CCL2;VIM,2
3377,positive regulation of cell proliferation (GO:0008284),0.004250196,0.182258425,0,0,2.881152461,15.73336874,EIF5A;CD74;PID1;CD81;CNBP;C5AR1;TMEM119;MIF;NME1,2
3378,cellular response to oxygen-containing compound (GO:1901701),0.004284243,0.18218745,0,0,3.463203463,18.88419502,PID1;GNB1;CAPN2;CCL2;PARK7;CD14;EZR,2
3379,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.004389668,0.185127882,0,0,6.04686319,32.82540754,RPL3;RPLP0;RPL14;RPS2,2
3380,positive regulation of viral life cycle (GO:1903902),0.004404299,0.184222439,0,0,9.070294785,49.20792906,CD74;LGALS1;PPIA,2
3381,positive regulation of actin filament bundle assembly (GO:0032233),0.004404299,0.182724696,0,0,9.070294785,49.20792906,RGCC;PFN1;S100A10,2
3382,regulation of T cell activation (GO:0050863),0.004404299,0.18125111,0,0,9.070294785,49.20792906,PRELID1;GSN;CCL2,2
3383,positive regulation of macromolecule metabolic process (GO:0010604),0.004455661,0.181897908,0,0,3.438198384,18.61296145,PID1;RGCC;GSN;ANXA2;PARK7;EZR;PF4,2
3384,protein tetramerization (GO:0051262),0.004565705,0.184911058,0,0,5.980414144,32.22954212,CD74;ANXA2;ALDOA;S100A10,2
3385,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.004607803,0.1851466,0,0,19.43634597,104.5676215,CD74;MIF,2
3386,negative regulation of biomineral tissue development (GO:0070168),0.004607803,0.183700143,0,0,19.43634597,104.5676215,SRGN;ECM1,2
3387,positive regulation of cellular protein metabolic process (GO:0032270),0.004746436,0.187760195,0,0,5.915409642,31.64957802,RBM3;CIRBP;VIM;EZR,2
3388,nuclear export (GO:0051168),0.004931918,0.193596746,0,0,5.851803087,31.08493799,EIF5A;RANBP1;ALYREF;RAN,2
3389,proteolysis involved in cellular protein catabolic process (GO:0051603),0.005122205,0.199531402,0,0,5.789549862,30.53507142,PSMB2;CAPN2;CTSC;LGMN,2
3390,cotranslational protein targeting to membrane (GO:0006613),0.005122205,0.1980198,0,0,5.789549862,30.53507142,RPL3;RPLP0;RPL14;RPS2,2
3391,cellular response to interleukin-1 (GO:0071347),0.005198647,0.199463887,0,0,4.505113304,23.69399842,UBB;CCL7;PSMB2;UBE2N;CCL2,2
3392,positive regulation of tumor necrosis factor production (GO:0032760),0.005283065,0.201190166,0,0,8.503401361,44.58544898,CD14;MIF;PF4,2
3393,apoptotic DNA fragmentation (GO:0006309),0.005291176,0.200006458,0,0,18.14058957,95.08779548,H1F0;HMGB1,2
3394,vitamin D metabolic process (GO:0042359),0.005291176,0.198535822,0,0,18.14058957,95.08779548,SUMO2;LGMN,2
3395,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.005291176,0.197086656,0,0,18.14058957,95.08779548,CD74;MIF,2
3396,positive regulation of collagen metabolic process (GO:0010714),0.005291176,0.195658492,0,0,18.14058957,95.08779548,RGCC;VIM,2
3397,positive regulation of collagen biosynthetic process (GO:0032967),0.005291176,0.194250876,0,0,18.14058957,95.08779548,RGCC;VIM,2
3398,pattern recognition receptor signaling pathway (GO:0002221),0.005597677,0.204035315,0,0,8.329862557,43.19369967,HMGB1;CD14;LGMN,2
3399,positive regulation of cytokine production (GO:0001819),0.005917742,0.214171906,0,0,3.693785206,18.94838038,RGCC;PARK7;MIF;CD14;HMGB1;GAPDH,2
3400,protein heterooligomerization (GO:0051291),0.005923308,0.212863683,0,0,8.163265306,41.86824592,CD74;ANXA2;S100A10,2
3401,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.005932511,0.211703515,0,0,5.553241705,28.47317922,CD74;CAPZA2;FCGR2B;LGMN,2
3402,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.005932511,0.210233352,0,0,5.553241705,28.47317922,CD74;CAPZA2;FCGR2B;LGMN,2
3403,positive regulation of epithelial cell apoptotic process (GO:1904037),0.00601805,0.211793848,0,0,17.00680272,86.95564677,GSN;RGCC,2
3404,positive regulation of cyclic nucleotide metabolic process (GO:0030801),0.00601805,0.210343205,0,0,17.00680272,86.95564677,CALM2;PF4,2
3405,G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),0.00601805,0.208912299,0,0,17.00680272,86.95564677,GNB1;RGS10,2
3406,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.00601805,0.20750073,0,0,17.00680272,86.95564677,MSR1;PF4,2
3407,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.006147645,0.210546536,0,0,5.497148354,27.98975416,CD74;CAPZA2;FCGR2B;LGMN,2
3408,response to molecule of bacterial origin (GO:0002237),0.006147645,0.209142892,0,0,5.497148354,27.98975416,C4B;CD14;FCGR2B;PF4,2
3409,regulation of bone mineralization (GO:0030500),0.00626006,0.21155686,0,0,8.003201281,40.60476606,SRGN;ECM1;TMEM119,2
3410,regulation of blood vessel endothelial cell migration (GO:0043535),0.00626006,0.210165038,0,0,8.003201281,40.60476606,ATP5B;RGCC;HMGB1,2
3411,negative regulation of cellular process (GO:0048523),0.006260537,0.208807316,0,0,2.543073304,12.90225531,RGCC;LMNA;ENO1;PARK7;MIF;TGFBI;EMP3;S100A11;NME1;PF4,2
3412,positive regulation of cellular biosynthetic process (GO:0031328),0.00661553,0.21921461,0,0,4.25170068,21.33645984,RBM3;RGCC;CIRBP;PARK7;VIM,2
3413,cellular response to cytokine stimulus (GO:0071345),0.006753151,0.222331167,0,0,2.679408744,13.39100441,PID1;UBB;CCL7;IFNGR1;CCL2;PLP2;VIM;GAPDH;PF4,2
3414,positive regulation of protein processing (GO:0010954),0.006787756,0.222037953,0,0,16.00640256,79.91412288,GSN;ENO1,2
3415,regulation of collagen biosynthetic process (GO:0032965),0.006787756,0.220623698,0,0,16.00640256,79.91412288,RGCC;VIM,2
3416,virion assembly (GO:0019068),0.006787756,0.219227346,0,0,16.00640256,79.91412288,UBB;PPIA,2
3417,regulation of early endosome to late endosome transport (GO:2000641),0.006787756,0.217848558,0,0,16.00640256,79.91412288,DAB2;EZR,2
3418,chemokine-mediated signaling pathway (GO:0070098),0.006967299,0.222213301,0,0,7.701193685,38.24819106,CCL7;CCL2;PF4,2
3419,regulation of DNA binding (GO:0051101),0.006967299,0.220833094,0,0,7.701193685,38.24819106,PLAUR;HMGB1;NME1,2
3420,positive regulation of secretion by cell (GO:1903532),0.006967299,0.219469927,0,0,7.701193685,38.24819106,RGCC;EZR;PPIA,2
3421,positive regulation of protein modification process (GO:0031401),0.007324618,0.22930998,0,0,4.148000664,20.39370436,CD74;DAB2;UBE2N;PLAUR;CALM2,2
3422,neutrophil chemotaxis (GO:0030593),0.007337966,0.228327075,0,0,7.558578987,37.14809971,JAML;CCL7;CCL2,2
3423,prostaglandin biosynthetic process (GO:0001516),0.007599636,0.235036007,0,0,15.11715797,73.76651494,CD74;MIF,2
3424,translational elongation (GO:0006414),0.007800047,0.239780968,0,0,5.134129123,24.91914002,EEF1G;MRPL20;EEF1D;MRPL23,2
3425,positive regulation of epithelial cell proliferation (GO:0050679),0.00832073,0.254255598,0,0,5.039052658,24.13204986,ECM1;JAML;C5AR1;NME1,2
3426,negative regulation of protein localization to plasma membrane (GO:1903077),0.008453035,0.25676094,0,0,14.32151808,68.35989579,DAB2;PID1,2
3427,negative regulation of protein localization to cell periphery (GO:1904376),0.008453035,0.255241644,0,0,14.32151808,68.35989579,DAB2;PID1,2
3428,acetylcholine receptor signaling pathway (GO:0095500),0.008453035,0.253740223,0,0,14.32151808,68.35989579,GNB1;RGS10,2
3429,ribosome assembly (GO:0042255),0.008519147,0.254229291,0,0,7.16075904,34.12416058,MRPL20;RPL3;C1QBP,2
3430,granulocyte chemotaxis (GO:0071621),0.008519147,0.252751213,0,0,7.16075904,34.12416058,JAML;CCL7;CCL2,2
3431,plasma membrane bounded cell projection assembly (GO:0120031),0.00906345,0.267345592,0,0,3.373250126,15.86610016,ACTR3;GSN;EMP1;FXYD5;EMP3;EZR,2
3432,viral gene expression (GO:0019080),0.009143656,0.268161367,0,0,4.902862046,23.01744167,RPL3;RPLP0;RPL14;RPS2,2
3433,negative regulation of interferon-gamma production (GO:0032689),0.009347309,0.272567521,0,0,13.60544218,63.57369821,C1QBP;HMGB1,2
3434,phospholipid transport (GO:0015914),0.009365006,0.271531972,0,0,6.918021446,32.3125235,PRELID1;PITPNA;PLTP,2
3435,neutrophil migration (GO:1990266),0.009365006,0.269997893,0,0,6.918021446,32.3125235,JAML;CCL7;CCL2,2
3436,regulation of protein binding (GO:0043393),0.009429321,0.270324857,0,0,4.859086492,22.66244509,DAB2;PARK7;RAN;PPP1CA,2
3437,peptide biosynthetic process (GO:0043043),0.009545186,0.272117778,0,0,3.887269193,18.08248153,RPL3;RPLP0;RPL14;RPS2;MRPL23,2
3438,nuclear-transcribed mRNA catabolic process (GO:0000956),0.009545186,0.270606013,0,0,3.887269193,18.08248153,EIF4A1;RPL3;RPLP0;RPL14;RPS2,2
3439,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.009720737,0.274060347,0,0,4.816085726,22.31530336,RPL3;RPLP0;RPL14;RPS2,2
3440,viral transcription (GO:0019083),0.010017949,0.280887878,0,0,4.77383936,21.97578181,RPL3;RPLP0;RPL14;RPS2,2
3441,positive regulation of developmental process (GO:0051094),0.010017949,0.279352971,0,0,4.77383936,21.97578181,C1QBP;LMNA;TMEM119;PA2G4,2
3442,regulation of stress fiber assembly (GO:0051492),0.010258226,0.284498515,0,0,6.691201071,30.64352874,RGCC;PFN1;S100A10,2
3443,regulation of tumor necrosis factor production (GO:0032680),0.010722749,0.295773995,0,0,6.583278473,29.85772022,MIF;CD14;PF4,2
3444,positive regulation of cellular amide metabolic process (GO:0034250),0.010722749,0.294183813,0,0,6.583278473,29.85772022,RBM3;CIRBP;VIM,2
3445,cellular response to interferon-gamma (GO:0071346),0.010944778,0.298669519,0,0,4.651433223,21.00072269,CCL7;IFNGR1;CCL2;GAPDH,2
3446,inflammatory response (GO:0006954),0.011119523,0.30182407,0,0,3.226587078,14.51658595,CCL7;C5AR1;CCL2;HMGB1;FCGR2B;PF4,2
3447,negative regulation of peptidase activity (GO:0010466),0.01119929,0.302380827,0,0,6.478781989,29.1020726,ECM1;PARK7;GAPDH,2
3448,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.01119929,0.300789349,0,0,6.478781989,29.1020726,PLAUR;PARK7;ENO1,2
3449,cellular protein catabolic process (GO:0044257),0.01119929,0.299214535,0,0,6.478781989,29.1020726,CAPN2;CTSC;LGMN,2
3450,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.011255932,0.299161563,0,0,12.3685838,55.49610409,ARG1;IFNGR1,2
3451,"DNA catabolic process, endonucleolytic (GO:0000737)",0.011255932,0.297611503,0,0,12.3685838,55.49610409,H1F0;HMGB1,2
3452,negative regulation of actin filament polymerization (GO:0030837),0.011255932,0.296077423,0,0,12.3685838,55.49610409,GSN;PFN1,2
3453,activation of MAPK activity (GO:0000187),0.011265589,0.294811804,0,0,4.612014297,20.68950722,UBB;CD81;C5AR1;UBE2N,2
3454,positive regulation of protein phosphorylation (GO:0001934),0.011458939,0.298341652,0,0,2.635436741,11.77772776,CD74;DAB2;CD81;PLAUR;PARK7;MIF;HMGB1;CALM2,2
3455,ribosomal large subunit biogenesis (GO:0042273),0.0116879,0.302758144,0,0,6.37755102,28.37500733,MRPL20;RPL3;RPL14,2
3456,negative regulation of neuron apoptotic process (GO:0043524),0.0116879,0.301229062,0,0,6.37755102,28.37500733,CCL2;PARK7;LGMN,2
3457,RNA export from nucleus (GO:0006405),0.011925256,0.305801914,0,0,4.535147392,20.08660673,EIF5A;RANBP1;ALYREF;RAN,2
3458,positive regulation of endocytosis (GO:0045807),0.012188629,0.310992867,0,0,6.279434851,27.67505065,DAB2;HNRNPK;FCGR2B,2
3459,positive regulation of ATP metabolic process (GO:1903580),0.012269025,0.31148675,0,0,11.83081928,52.06361965,PID1;ENO1,2
3460,apoptotic nuclear changes (GO:0030262),0.012269025,0.309944736,0,0,11.83081928,52.06361965,H1F0;HMGB1,2
3461,positive regulation of ERBB signaling pathway (GO:1901186),0.012269025,0.308417915,0,0,11.83081928,52.06361965,UBB;PLAUR,2
3462,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.012269025,0.306906063,0,0,11.83081928,52.06361965,UBB;CTSC,2
3463,membrane assembly (GO:0071709),0.012269025,0.30540896,0,0,11.83081928,52.06361965,ANXA2;S100A10,2
3464,negative regulation of apoptotic signaling pathway (GO:2001234),0.012701522,0.314640133,0,0,6.184291899,27.00082523,PRELID1;PLAUR;PARK7,2
3465,"complement activation, classical pathway (GO:0006958)",0.013317836,0.328313598,0,0,4.388852315,18.95392198,C1QB;IGHM;C1QA;IGKC,2
3466,regulation of androgen receptor signaling pathway (GO:0060765),0.013320481,0.326800079,0,0,11.33786848,48.96204621,DAB2;PARK7,2
3467,negative regulation of protein binding (GO:0032091),0.01376397,0.336064771,0,0,6.00240096,25.72449578,DAB2;PARK7;PPP1CA,2
3468,humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.014051336,0.341447467,0,0,4.319187993,18.42150002,C1QB;IGHM;C1QA;IGKC,2
3469,response to interferon-gamma (GO:0034341),0.0143136,0.346172051,0,0,5.915409642,25.12005393,CCL7;CCL2;GAPDH,2
3470,eosinophil migration (GO:0072677),0.014409689,0.346852089,0,0,10.88435374,46.14807566,CCL7;CCL2,2
3471,negative regulation of protein localization to membrane (GO:1905476),0.014409689,0.345223676,0,0,10.88435374,46.14807566,DAB2;PID1,2
3472,eosinophil chemotaxis (GO:0048245),0.014409689,0.343610481,0,0,10.88435374,46.14807566,CCL7;CCL2,2
3473,negative regulation of T cell proliferation (GO:0042130),0.014409689,0.342012293,0,0,10.88435374,46.14807566,SDC4;ARG1,2
3474,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.014409689,0.340428903,0,0,10.88435374,46.14807566,CD74;MIF,2
3475,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.014409689,0.338860106,0,0,10.88435374,46.14807566,UBB;UBE2N,2
3476,cellular response to tumor necrosis factor (GO:0071356),0.0146957,0.344000724,0,0,3.488574917,14.72248503,PID1;UBB;CCL7;PSMB2;CCL2,2
3477,vesicle organization (GO:0016050),0.014810017,0.345093676,0,0,4.25170068,17.91008302,SRGN;SNX2;ANXA2;S100A10,2
3478,non-canonical Wnt signaling pathway (GO:0035567),0.014810017,0.343525068,0,0,4.25170068,17.91008302,UBB;PSMB2;GNB1;PFN1,2
3479,regulation of mRNA stability (GO:0043488),0.015198883,0.35094977,0,0,4.21874176,17.66190307,UBB;PSMB2;CIRBP;VIM,2
3480,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.015536044,0.357119076,0,0,10.46572475,43.58547888,UBB;UBE2N,2
3481,prostaglandin metabolic process (GO:0006693),0.015536044,0.355517645,0,0,10.46572475,43.58547888,CD74;MIF,2
3482,regulation of interleukin-10 production (GO:0032653),0.015536044,0.353930513,0,0,10.46572475,43.58547888,HMGB1;FCGR2B,2
3483,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.015536044,0.352357488,0,0,10.46572475,43.58547888,CD74;MIF,2
3484,positive regulation of lymphocyte proliferation (GO:0050671),0.016036518,0.362098894,0,0,5.66893424,23.42906348,CD74;CD81;MIF,2
3485,response to metal ion (GO:0010038),0.016635592,0.373971046,0,0,5.591277607,22.90305152,CRIP1;CALM2;PPP1CA,2
3486,regulation of neuron death (GO:1901214),0.016635592,0.372330822,0,0,5.591277607,22.90305152,UBB;PARK7;FCGR2B,2
3487,cytoskeleton-dependent intracellular transport (GO:0030705),0.016698951,0.372116789,0,0,10.07810532,41.24373295,TUBA1B;TUBA1A,2
3488,fat-soluble vitamin metabolic process (GO:0006775),0.016698951,0.37049889,0,0,10.07810532,41.24373295,SUMO2;LGMN,2
3489,positive regulation of cAMP metabolic process (GO:0030816),0.016698951,0.368894999,0,0,10.07810532,41.24373295,CALM2;PF4,2
3490,cellular response to hypoxia (GO:0071456),0.016818595,0.369936596,0,0,4.091862309,16.71636299,RGCC;UBB;PSMB2;LMNA,2
3491,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),0.017897817,0.391985235,0,0,9.718172983,39.09695368,ATP5B;ALDOA,2
3492,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.017897817,0.390310084,0,0,9.718172983,39.09695368,C1QBP;S100A10,2
3493,"positive regulation of transcription, DNA-templated (GO:0045893)",0.018084209,0.392696682,0,0,1.820531959,7.305277966,CD74;PID1;CD81;ALYREF;CNBP;PARK7;YBX1;HMGB1;DAB2;HNRNPK;RGCC;UBB;RAN;YWHAH;PF4,2
3494,purine ribonucleotide biosynthetic process (GO:0009152),0.018507439,0.400184155,0,0,5.37056928,21.42632936,ATP5B;ADSSL1;ALDOA,2
3495,negative regulation of response to DNA damage stimulus (GO:2001021),0.01913206,0.411944726,0,0,9.38306357,37.12305737,CD74;MIF,2
3496,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.01913206,0.410213866,0,0,9.38306357,37.12305737,UBB;UBE2N,2
3497,protein export from nucleus (GO:0006611),0.01913206,0.40849749,0,0,9.38306357,37.12305737,EIF5A;RAN,2
3498,positive regulation of fibroblast proliferation (GO:0048146),0.01913206,0.406795417,0,0,9.38306357,37.12305737,CD74;MIF,2
3499,cellular macromolecule biosynthetic process (GO:0034645),0.019216385,0.406892995,0,0,2.587991718,10.22772253,EEF1G;RPL3;EEF1D;RPLP0;RPL14;RPS2;MRPL23,2
3500,regulation of macrophage derived foam cell differentiation (GO:0010743),0.020401101,0.43019347,0,0,9.070294785,35.30309656,MSR1;PF4,2
3501,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.020401101,0.428423127,0,0,9.070294785,35.30309656,UBB;CD14,2
3502,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.020401101,0.426667294,0,0,9.070294785,35.30309656,UBB;PLAUR,2
3503,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.020401101,0.424925795,0,0,9.070294785,35.30309656,UBB;CD14,2
3504,positive regulation of MAPK cascade (GO:0043410),0.020438571,0.423975726,0,0,2.814919071,10.95096811,CD74;CCL7;C5AR1;CCL2;MIF;HMGB1,2
3505,regulation of gene expression (GO:0010468),0.020797651,0.42967778,0,0,1.835030737,7.106918513,EIF4A1;MSR1;PID1;GSN;TSC22D3;CNBP;PARK7;MIF;YBX1;HMGB1;CRIP1;RGCC;EZR;PF4,2
3506,proteolysis (GO:0006508),0.021057868,0.433299606,0,0,2.795638803,10.79251047,SRGN;SPCS1;CAPN2;UBE2N;CTSC;LGMN,2
3507,regulation of translation (GO:0006417),0.021067173,0.431750143,0,0,3.17884163,12.27045335,RBM3;CIRBP;VIM;GAPDH;RAN,2
3508,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.02117793,0.432283907,0,0,5.102040816,19.66732489,RGCC;UBB;PSMB2,2
3509,ribosomal large subunit assembly (GO:0000027),0.021704371,0.441264565,0,0,8.77770463,33.62072946,MRPL20;RPL3,2
3510,regulation of protein polymerization (GO:0032271),0.021704371,0.439513515,0,0,8.77770463,33.62072946,TPPP3;PFN1,2
3511,regulation of sodium ion transmembrane transport (GO:1902305),0.021704371,0.437776308,0,0,8.77770463,33.62072946,FXYD5;YWHAH,2
3512,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.021704371,0.436052779,0,0,8.77770463,33.62072946,UBB;CD14,2
3513,negative regulation of cell-cell adhesion (GO:0022408),0.023041305,0.461097168,0,0,8.503401361,32.06179267,RGCC;FXYD5,2
3514,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.023041305,0.459296007,0,0,8.503401361,32.06179267,UBE2N;RPS2,2
3515,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.023041305,0.457508863,0,0,8.503401361,32.06179267,RGCC;HMGB1,2
3516,nucleobase-containing small molecule interconversion (GO:0015949),0.023041305,0.455735573,0,0,8.503401361,32.06179267,GLRX;NME1,2
3517,positive regulation of DNA metabolic process (GO:0051054),0.02331212,0.459311767,0,0,4.917629702,18.48429746,RGCC;UBE2N;HMGB1,2
3518,negative regulation of binding (GO:0051100),0.02331212,0.457545183,0,0,4.917629702,18.48429746,DAB2;PARK7;PPP1CA,2
3519,negative regulation of neuron death (GO:1901215),0.024048541,0.470190437,0,0,4.859086492,18.11312417,CCL2;PARK7;LGMN,2
3520,positive regulation of protein ubiquitination (GO:0031398),0.024048541,0.468395817,0,0,4.859086492,18.11312417,UBB;UBE2N;RPS2,2
3521,mitotic cell cycle phase transition (GO:0044772),0.024215869,0.469861521,0,0,3.064288779,11.40144363,RANBP1;TUBA1A;UBB;EIF4EBP1;TUBB4B,2
3522,ATP biosynthetic process (GO:0006754),0.024411344,0.471860181,0,0,8.245722531,30.61395459,ATP5B;ALDOA,2
3523,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.024411344,0.470079576,0,0,8.245722531,30.61395459,CD74;PF4,2
3524,cellular response to molecule of bacterial origin (GO:0071219),0.024797469,0.475719866,0,0,4.801920768,17.7527668,CCL2;CD14;FCGR2B,2
3525,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.024885181,0.475614523,0,0,3.628117914,13.40039112,TUBA1A;UBB;PSMB2;TUBB4B,2
3526,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.025558898,0.486668119,0,0,4.74608448,17.40279909,CD74;CD81;MIF,2
3527,negative regulation of multi-organism process (GO:0043901),0.025813937,0.489697099,0,0,8.003201281,29.26643254,ANXA2;C1QBP,2
3528,platelet aggregation (GO:0070527),0.025813937,0.487883406,0,0,8.003201281,29.26643254,CLIC1;MYL12A,2
3529,positive regulation of organelle organization (GO:0010638),0.025813937,0.486083098,0,0,8.003201281,29.26643254,TMED9;ANXA2,2
3530,mRNA stabilization (GO:0048255),0.025813937,0.484296028,0,0,8.003201281,29.26643254,CIRBP;YBX1,2
3531,regulation of interleukin-12 production (GO:0032655),0.025813937,0.48252205,0,0,8.003201281,29.26643254,C1QBP;HMGB1,2
3532,ribosome biogenesis (GO:0042254),0.026330062,0.49037338,0,0,2.996793431,10.89946943,RPL3;RPLP0;RPL14;RPS2;RAN,2
3533,protein stabilization (GO:0050821),0.026513026,0.49198536,0,0,3.556978347,12.91225504,CCT3;PARK7;PFN1;GAPDH,2
3534,positive regulation of cellular component biogenesis (GO:0044089),0.027119222,0.50141083,0,0,4.638218924,16.73243279,RGCC;SDC4;PFN1,2
3535,negative regulation of endothelial cell migration (GO:0010596),0.027248538,0.501982994,0,0,7.774538387,28.00976024,RGCC;HMGB1,2
3536,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.027918094,0.512467744,0,0,4.586104105,16.41128308,DAB2;SUMO2;PARK7,2
3537,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.027918094,0.510630942,0,0,4.586104105,16.41128308,UBB;PSMB2;PFN1,2
3538,positive regulation of peptide secretion (GO:0002793),0.028714608,0.523323731,0,0,7.558578987,26.83559559,EZR;PPIA,2
3539,regulation of establishment of planar polarity (GO:0090175),0.02872942,0.521730362,0,0,4.535147392,16.09901852,UBB;PSMB2;PFN1,2
3540,regulation of neuron apoptotic process (GO:0043523),0.02872942,0.519880254,0,0,4.535147392,16.09901852,CCL2;PARK7;LGMN,2
3541,activation of protein kinase activity (GO:0032147),0.029483087,0.531633187,0,0,2.907145764,10.24460291,UBB;CD81;C5AR1;UBE2N;PARK7,2
3542,regulation of cytokine-mediated signaling pathway (GO:0001959),0.029553185,0.53102078,0,0,4.485310608,15.79530732,CD74;UBB;IFNGR1,2
3543,lipid transport (GO:0006869),0.030389369,0.544129643,0,0,4.436557232,15.49983339,PRELID1;PITPNA;PLTP,2
3544,positive regulation of cellular metabolic process (GO:0031325),0.031237952,0.55736807,0,0,4.388852315,15.21229546,PRELID1;PID1;ANXA2,2
3545,positive regulation of stress fiber assembly (GO:0051496),0.031739027,0.564335385,0,0,7.16075904,24.70610968,RGCC;S100A10,2
3546,homotypic cell-cell adhesion (GO:0034109),0.033296328,0.589969307,0,0,6.977149834,23.73841387,CLIC1;MYL12A,2
3547,positive regulation of DNA repair (GO:0045739),0.033296328,0.58792789,0,0,6.977149834,23.73841387,UBE2N;HMGB1,2
3548,regulation of B cell activation (GO:0050864),0.033857865,0.595781679,0,0,4.25170068,14.39448957,IGHM;IGKC;FCGR2B,2
3549,interleukin-1-mediated signaling pathway (GO:0070498),0.033857865,0.593734319,0,0,4.25170068,14.39448957,UBB;PSMB2;UBE2N,2
3550,protein localization to nucleus (GO:0034504),0.034755805,0.607393409,0,0,4.207868714,14.13595059,RANBP1;LMNA;RAN,2
3551,response to tumor necrosis factor (GO:0034612),0.035666016,0.621172972,0,0,4.164931279,13.8840357,PID1;CCL7;CCL2,2
3552,regulation of release of cytochrome c from mitochondria (GO:0090199),0.036498534,0.63351027,0,0,6.636801062,21.97101829,PRELID1;PLAUR,2
3553,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.036498534,0.631362778,0,0,6.636801062,21.97101829,DAB2;RGCC,2
3554,positive regulation of mitotic nuclear division (GO:0045840),0.036498534,0.629229796,0,0,6.636801062,21.97101829,RANBP1;RGCC,2
3555,monocyte chemotaxis (GO:0002548),0.038142427,0.655356241,0,0,6.478781989,21.16247524,CCL7;CCL2,2
3556,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.038142427,0.653157059,0,0,6.478781989,21.16247524,C1QBP;S100A10,2
3557,positive regulation of cellular process (GO:0048522),0.038493806,0.656969544,0,0,2.09314495,6.817912979,EIF5A;DAB2;CD81;CNBP;LMNA;PA2G4;EZR;FCGR2B,2
3558,protein processing (GO:0016485),0.039428925,0.670686009,0,0,4.00160064,12.93819769,SRGN;SPCS1;LGMN,2
3559,regulation of protein ubiquitination (GO:0031396),0.039428925,0.668457816,0,0,4.00160064,12.93819769,UBB;UBE2N;PARK7,2
3560,regulation of ion transmembrane transporter activity (GO:0032412),0.03981418,0.672754171,0,0,6.32811264,20.39887456,FXYD5;YWHAH,2
3561,positive regulation of protein localization to nucleus (GO:1900182),0.03981418,0.670533861,0,0,6.32811264,20.39887456,CCT3;PARK7,2
3562,negative regulation of ERBB signaling pathway (GO:1901185),0.041513301,0.696849922,0,0,6.184291899,19.67681751,UBB;LGMN,2
3563,substantia nigra development (GO:0021762),0.041513301,0.694565168,0,0,6.184291899,19.67681751,CALM2;YWHAH,2
3564,antigen receptor-mediated signaling pathway (GO:0050851),0.042056741,0.701358008,0,0,2.6367136,8.355048228,IGHM;UBB;PSMB2;IGKC;UBE2N,2
3565,positive regulation of lymphocyte activation (GO:0051251),0.04237828,0.704418114,0,0,3.887269193,12.28812175,IGHM;IGKC;CCL2,2
3566,positive regulation of MAP kinase activity (GO:0043406),0.042539113,0.704795758,0,0,3.057402736,9.65323342,UBB;CD81;C5AR1;UBE2N,2
3567,positive regulation of transport (GO:0051050),0.043239304,0.71407822,0,0,6.04686319,18.99322978,DAB2;ANXA2,2
3568,lymphocyte chemotaxis (GO:0048247),0.043239304,0.711774741,0,0,6.04686319,18.99322978,CCL7;CCL2,2
3569,negative regulation of immune system process (GO:0002683),0.043239304,0.709486077,0,0,6.04686319,18.99322978,TSC22D3;FCGR2B,2
3570,positive regulation of interleukin-8 production (GO:0032757),0.043239304,0.707212083,0,0,6.04686319,18.99322978,PARK7;CD14,2
3571,sphingosine-1-phosphate signaling pathway (GO:0003376),0.043302652,0.705985413,0,0,22.67573696,71.19141481,EZR,2
3572,regulation of protein localization to early endosome (GO:1902965),0.043302652,0.703737052,0,0,22.67573696,71.19141481,EZR,2
3573,response to lead ion (GO:0010288),0.043302652,0.701502966,0,0,22.67573696,71.19141481,PPP1CA,2
3574,cellular response to lipoteichoic acid (GO:0071223),0.043302652,0.69928302,0,0,22.67573696,71.19141481,CD14,2
3575,negative regulation of membrane potential (GO:0045837),0.043302652,0.69707708,0,0,22.67573696,71.19141481,PRELID1,2
3576,regulation of fat cell proliferation (GO:0070344),0.043302652,0.694885014,0,0,22.67573696,71.19141481,PID1,2
3577,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.043302652,0.692706691,0,0,22.67573696,71.19141481,PARK7,2
3578,granzyme-mediated apoptotic signaling pathway (GO:0008626),0.043302652,0.690541983,0,0,22.67573696,71.19141481,SRGN,2
3579,corticosteroid receptor signaling pathway (GO:0031958),0.043302652,0.688390761,0,0,22.67573696,71.19141481,YWHAH,2
3580,ribosomal small subunit export from nucleus (GO:0000056),0.043302652,0.686252902,0,0,22.67573696,71.19141481,RAN,2
3581,regulation of keratinocyte apoptotic process (GO:1902172),0.043302652,0.68412828,0,0,22.67573696,71.19141481,GSN,2
3582,positive regulation of protein localization to endosome (GO:1905668),0.043302652,0.682016773,0,0,22.67573696,71.19141481,EZR,2
3583,COPI coating of Golgi vesicle (GO:0048205),0.043302652,0.67991826,0,0,22.67573696,71.19141481,TMED9,2
3584,regulation of translational initiation in response to stress (GO:0043558),0.043302652,0.677832621,0,0,22.67573696,71.19141481,PPP1CA,2
3585,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.043302652,0.675759738,0,0,22.67573696,71.19141481,UBB,2
3586,viral release from host cell (GO:0019076),0.043302652,0.673699495,0,0,22.67573696,71.19141481,PPIA,2
3587,positive regulation of cholesterol storage (GO:0010886),0.043302652,0.671651776,0,0,22.67573696,71.19141481,MSR1,2
3588,positive regulation of protein localization to early endosome (GO:1902966),0.043302652,0.669616468,0,0,22.67573696,71.19141481,EZR,2
3589,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.043302652,0.667593457,0,0,22.67573696,71.19141481,UBB,2
3590,negative regulation of cellular response to hypoxia (GO:1900038),0.043302652,0.665582634,0,0,22.67573696,71.19141481,ENO1,2
3591,negative regulation of acute inflammatory response (GO:0002674),0.043302652,0.663583887,0,0,22.67573696,71.19141481,FCGR2B,2
3592,astral microtubule organization (GO:0030953),0.043302652,0.661597109,0,0,22.67573696,71.19141481,EZR,2
3593,cellular response to monoamine stimulus (GO:0071868),0.043302652,0.659622192,0,0,22.67573696,71.19141481,GNB1,2
3594,response to lipoteichoic acid (GO:0070391),0.043302652,0.657659031,0,0,22.67573696,71.19141481,CD14,2
3595,positive regulation of receptor binding (GO:1900122),0.043302652,0.655707521,0,0,22.67573696,71.19141481,ANXA2,2
3596,positive regulation of humoral immune response (GO:0002922),0.043302652,0.653767557,0,0,22.67573696,71.19141481,FCGR2B,2
3597,regulation of NAD(P)H oxidase activity (GO:0033860),0.043302652,0.65183904,0,0,22.67573696,71.19141481,PARK7,2
3598,cellular response to bacterial lipopeptide (GO:0071221),0.043302652,0.649921866,0,0,22.67573696,71.19141481,CD14,2
3599,ceramide transport (GO:0035627),0.043302652,0.648015937,0,0,22.67573696,71.19141481,PLTP,2
3600,positive regulation of phospholipid transport (GO:2001140),0.043302652,0.646121153,0,0,22.67573696,71.19141481,PRELID1,2
3601,positive regulation of sodium ion transmembrane transport (GO:1902307),0.043302652,0.644237418,0,0,22.67573696,71.19141481,GLRX,2
3602,Golgi transport vesicle coating (GO:0048200),0.043302652,0.642364635,0,0,22.67573696,71.19141481,TMED9,2
3603,positive regulation of clathrin-dependent endocytosis (GO:2000370),0.043302652,0.640502708,0,0,22.67573696,71.19141481,DAB2,2
3604,regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.043302652,0.638651545,0,0,22.67573696,71.19141481,LMNA,2
3605,regulation of dendritic cell chemotaxis (GO:2000508),0.043302652,0.63681105,0,0,22.67573696,71.19141481,C1QBP,2
3606,positive regulation of vesicle fusion (GO:0031340),0.043302652,0.634981133,0,0,22.67573696,71.19141481,ANXA2,2
3607,positive regulation of centrosome cycle (GO:0046607),0.043302652,0.633161703,0,0,22.67573696,71.19141481,RANBP1,2
3608,response to catecholamine (GO:0071869),0.043302652,0.63135267,0,0,22.67573696,71.19141481,GNB1,2
3609,positive regulation of osteoblast proliferation (GO:0033690),0.043302652,0.629553944,0,0,22.67573696,71.19141481,TMEM119,2
3610,COPI-coated vesicle budding (GO:0035964),0.043302652,0.627765439,0,0,22.67573696,71.19141481,TMED9,2
3611,positive regulation of trophoblast cell migration (GO:1901165),0.043302652,0.625987066,0,0,22.67573696,71.19141481,C1QBP,2
3612,regulation of extracellular exosome assembly (GO:1903551),0.043302652,0.624218741,0,0,22.67573696,71.19141481,SDC4,2
3613,protein localization to nucleolus (GO:1902570),0.043302652,0.622460379,0,0,22.67573696,71.19141481,RAN,2
3614,negative regulation of cell cycle phase transition (GO:1901988),0.043302652,0.620711894,0,0,22.67573696,71.19141481,RGCC,2
3615,negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.043302652,0.618973206,0,0,22.67573696,71.19141481,ARG1,2
3616,negative regulation of response to interferon-gamma (GO:0060331),0.043302652,0.61724423,0,0,22.67573696,71.19141481,ARG1,2
3617,regulation of glial cell apoptotic process (GO:0034350),0.043302652,0.615524887,0,0,22.67573696,71.19141481,CCL2,2
3618,neutrophil extravasation (GO:0072672),0.043302652,0.613815096,0,0,22.67573696,71.19141481,JAML,2
3619,negative regulation of leukocyte degranulation (GO:0043301),0.043302652,0.612114777,0,0,22.67573696,71.19141481,FCGR2B,2
3620,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.043302652,0.610423852,0,0,22.67573696,71.19141481,CD74,2
3621,glucocorticoid receptor signaling pathway (GO:0042921),0.043302652,0.608742244,0,0,22.67573696,71.19141481,YWHAH,2
3622,intracellular protein transport (GO:0006886),0.043854531,0.614806785,0,0,2.345765893,7.33492199,EIF5A;CD74;RANBP1;TMED9;RAN;YWHAH,2
3623,regulation of protein phosphorylation (GO:0001932),0.044423644,0.621079057,0,0,2.596458431,8.085328522,CD74;DAB2;PID1;PLAUR;PARK7,2
3624,protein polymerization (GO:0051258),0.044991708,0.627302422,0,0,5.915409642,18.34532429,TPPP3;GSN,2
3625,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.044991708,0.625593151,0,0,5.915409642,18.34532429,ATP5B;HMGB1,2
3626,negative regulation of ossification (GO:0030279),0.044991708,0.623893169,0,0,5.915409642,18.34532429,SRGN;ECM1,2
3627,endocytosis (GO:0006897),0.045636545,0.631120024,0,0,2.576788291,7.954665172,MSR1;SNX2;IGKC;CD14;FCGR2B,2
3628,Fc-epsilon receptor signaling pathway (GO:0038095),0.046276898,0.638245972,0,0,2.973867142,9.139028022,UBB;PSMB2;IGKC;UBE2N,2
3629,nucleotide-excision repair (GO:0006289),0.046478266,0.639295396,0,0,3.744617113,11.49137042,UBB;SUMO2;UBE2N,2
3630,regulation of fibroblast proliferation (GO:0048145),0.046770037,0.641579299,0,0,5.789549862,17.73056891,CD74;MIF,2
3631,regulation of DNA metabolic process (GO:0051052),0.046770037,0.639859247,0,0,5.789549862,17.73056891,ALYREF;UBE2N,2
3632,Fc receptor signaling pathway (GO:0038093),0.047045791,0.641910888,0,0,2.957704821,9.040620742,UBB;PSMB2;IGKC;UBE2N,2
3633,regulation of organelle assembly (GO:1902115),0.048573821,0.660992561,0,0,5.66893424,17.14665844,GSN;EZR,2
3634,postreplication repair (GO:0006301),0.048573821,0.659234602,0,0,5.66893424,17.14665844,UBB;UBE2N,2
3635,regulation of cyclic nucleotide metabolic process (GO:0030799),0.05033647,0.681344847,0,0,19.43634597,58.09573199,CALM2,2
3636,regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),0.05033647,0.679542348,0,0,19.43634597,58.09573199,CALM2,2
3637,protein localization to cytoplasmic stress granule (GO:1903608),0.05033647,0.67774936,0,0,19.43634597,58.09573199,YBX1,2
3638,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),0.05033647,0.675965809,0,0,19.43634597,58.09573199,JAML,2
3639,positive regulation of protein kinase A signaling (GO:0010739),0.05033647,0.674191621,0,0,19.43634597,58.09573199,MIF,2
3640,positive regulation of lipid transport (GO:0032370),0.05033647,0.672426721,0,0,19.43634597,58.09573199,PRELID1,2
3641,negative regulation of macrophage activation (GO:0043031),0.05033647,0.670671038,0,0,19.43634597,58.09573199,FCGR2B,2
3642,rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.05033647,0.668924499,0,0,19.43634597,58.09573199,RAN,2
3643,negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),0.05033647,0.667187032,0,0,19.43634597,58.09573199,CD14,2
3644,negative regulation of glial cell apoptotic process (GO:0034351),0.05033647,0.665458569,0,0,19.43634597,58.09573199,CCL2,2
3645,positive regulation of dendritic cell chemotaxis (GO:2000510),0.05033647,0.663739037,0,0,19.43634597,58.09573199,C1QBP,2
3646,regulation of dendritic spine maintenance (GO:1902950),0.05033647,0.66202837,0,0,19.43634597,58.09573199,FCGR2B,2
3647,regulation of mitochondrial fusion (GO:0010635),0.05033647,0.660326497,0,0,19.43634597,58.09573199,PID1,2
3648,regulation of MDA-5 signaling pathway (GO:0039533),0.05033647,0.658633353,0,0,19.43634597,58.09573199,C1QBP,2
3649,bone cell development (GO:0098751),0.05033647,0.656948868,0,0,19.43634597,58.09573199,ANXA2,2
3650,V(D)J recombination (GO:0033151),0.05033647,0.655272978,0,0,19.43634597,58.09573199,HMGB1,2
3651,positive regulation of autophagy of mitochondrion (GO:1903599),0.05033647,0.653605617,0,0,19.43634597,58.09573199,PARK7,2
3652,adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.05033647,0.651946719,0,0,19.43634597,58.09573199,GNB1,2
3653,exit from host cell (GO:0035891),0.05033647,0.650296221,0,0,19.43634597,58.09573199,PPIA,2
3654,AMP metabolic process (GO:0046033),0.05033647,0.648654059,0,0,19.43634597,58.09573199,ADSSL1,2
3655,regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.05033647,0.64702017,0,0,19.43634597,58.09573199,HMGB1,2
3656,negative regulation of dendrite morphogenesis (GO:0050774),0.05033647,0.645394491,0,0,19.43634597,58.09573199,YWHAH,2
3657,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659),0.05033647,0.643776961,0,0,19.43634597,58.09573199,RGCC,2
3658,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.05033647,0.642167519,0,0,19.43634597,58.09573199,ALDOA,2
3659,negative regulation of RIG-I signaling pathway (GO:0039536),0.05033647,0.640566103,0,0,19.43634597,58.09573199,C1QBP,2
3660,"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.05033647,0.638972655,0,0,19.43634597,58.09573199,DAB2,2
3661,T-helper 1 type immune response (GO:0042088),0.05033647,0.637387115,0,0,19.43634597,58.09573199,HMGB1,2
3662,negative regulation of dendrite development (GO:2000171),0.05033647,0.635809424,0,0,19.43634597,58.09573199,YWHAH,2
3663,detection of molecule of bacterial origin (GO:0032490),0.05033647,0.634239525,0,0,19.43634597,58.09573199,C4B,2
3664,fructose metabolic process (GO:0006000),0.05033647,0.632677358,0,0,19.43634597,58.09573199,ALDOA,2
3665,positive regulation of lymphocyte apoptotic process (GO:0070230),0.05033647,0.631122869,0,0,19.43634597,58.09573199,PRELID1,2
3666,regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714),0.05033647,0.629575999,0,0,19.43634597,58.09573199,HNRNPK,2
3667,attachment of GPI anchor to protein (GO:0016255),0.05033647,0.628036693,0,0,19.43634597,58.09573199,PLAUR,2
3668,regulation of cell cycle arrest (GO:0071156),0.050402596,0.627327924,0,0,5.553241705,16.59149017,RGCC;MIF,2
3669,receptor-mediated endocytosis (GO:0006898),0.050996706,0.633178074,0,0,2.879458662,8.569252408,MSR1;IGKC;CD81;FCGR2B,2
3670,regulation of GTPase activity (GO:0043087),0.050996706,0.631641234,0,0,2.879458662,8.569252408,CCL7;RGS10;CCL2;S100A10,2
3671,regulation of organelle organization (GO:0033043),0.051868378,0.640882161,0,0,3.58037952,10.59450757,TMED9;CAPN2;EZR,2
3672,glutathione metabolic process (GO:0006749),0.052255903,0.644110801,0,0,5.442176871,16.06314244,EEF1G;PARK7,2
3673,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.052255903,0.642558727,0,0,5.442176871,16.06314244,GAPDH;PF4,2
3674,positive regulation of GTPase activity (GO:0043547),0.054284794,0.665902174,0,0,2.819780762,8.215462622,CCL7;RGS10;CCL2;S100A10,2
3675,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.055241442,0.676012174,0,0,3.488574917,10.10305897,CD74;CD81;MIF,2
3676,positive regulation of actin filament polymerization (GO:0030838),0.0560343,0.684074242,0,0,5.232862376,15.08001714,GSN;PFN1,2
3677,positive regulation of monocyte differentiation (GO:0045657),0.057318925,0.698087049,0,0,17.00680272,48.62456519,CD74,2
3678,membrane fusion involved in viral entry into host cell (GO:0039663),0.057318925,0.696424937,0,0,17.00680272,48.62456519,PPIA,2
3679,peptidyl-cysteine modification (GO:0018198),0.057318925,0.694770721,0,0,17.00680272,48.62456519,PARK7,2
3680,positive regulation of macrophage differentiation (GO:0045651),0.057318925,0.693124345,0,0,17.00680272,48.62456519,PF4,2
3681,positive regulation of extracellular matrix assembly (GO:1901203),0.057318925,0.691485753,0,0,17.00680272,48.62456519,RGCC,2
3682,positive regulation of cell aging (GO:0090343),0.057318925,0.68985489,0,0,17.00680272,48.62456519,LMNA,2
3683,ribosomal large subunit export from nucleus (GO:0000055),0.057318925,0.688231702,0,0,17.00680272,48.62456519,RAN,2
3684,defense response to protozoan (GO:0042832),0.057318925,0.686616135,0,0,17.00680272,48.62456519,PF4,2
3685,cellular response to prostaglandin E stimulus (GO:0071380),0.057318925,0.685008135,0,0,17.00680272,48.62456519,GNB1,2
3686,positive regulation of membrane potential (GO:0045838),0.057318925,0.683407648,0,0,17.00680272,48.62456519,GLRX,2
3687,positive regulation of protein localization to Cajal body (GO:1904871),0.057318925,0.681814623,0,0,17.00680272,48.62456519,CCT3,2
3688,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.057318925,0.680229008,0,0,17.00680272,48.62456519,FCGR2B,2
3689,establishment of integrated proviral latency (GO:0075713),0.057318925,0.678650751,0,0,17.00680272,48.62456519,PPIA,2
3690,amyloid fibril formation (GO:1990000),0.057318925,0.6770798,0,0,17.00680272,48.62456519,GSN,2
3691,translocation of molecules into host (GO:0044417),0.057318925,0.675516105,0,0,17.00680272,48.62456519,ALYREF,2
3692,regulation of MHC class II biosynthetic process (GO:0045346),0.057318925,0.673959616,0,0,17.00680272,48.62456519,PF4,2
3693,negative regulation of glucose import (GO:0046325),0.057318925,0.672410284,0,0,17.00680272,48.62456519,PID1,2
3694,regulation of T cell mediated immunity (GO:0002709),0.057318925,0.670868058,0,0,17.00680272,48.62456519,HMGB1,2
3695,fusion of virus membrane with host plasma membrane (GO:0019064),0.057318925,0.669332891,0,0,17.00680272,48.62456519,PPIA,2
3696,regulation of endodeoxyribonuclease activity (GO:0032071),0.057318925,0.667804734,0,0,17.00680272,48.62456519,HMGB1,2
3697,regulation of protein localization to Cajal body (GO:1904869),0.057318925,0.666283539,0,0,17.00680272,48.62456519,CCT3,2
3698,cellular response to UV-B (GO:0071493),0.057318925,0.664769258,0,0,17.00680272,48.62456519,CRIP1,2
3699,regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.057318925,0.663261845,0,0,17.00680272,48.62456519,CD14,2
3700,regulation of dendritic cell antigen processing and presentation (GO:0002604),0.057318925,0.661761252,0,0,17.00680272,48.62456519,FCGR2B,2
3701,positive regulation of cAMP-mediated signaling (GO:0043950),0.057318925,0.660267434,0,0,17.00680272,48.62456519,PF4,2
3702,positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.057318925,0.658780346,0,0,17.00680272,48.62456519,CALM2,2
3703,osteoblast development (GO:0002076),0.057318925,0.65729994,0,0,17.00680272,48.62456519,CLEC5A,2
3704,positive regulation of protein homodimerization activity (GO:0090073),0.057318925,0.655826174,0,0,17.00680272,48.62456519,PARK7,2
3705,aldehyde biosynthetic process (GO:0046184),0.057318925,0.654359001,0,0,17.00680272,48.62456519,TPI1,2
3706,viral mRNA export from host cell nucleus (GO:0046784),0.057318925,0.652898378,0,0,17.00680272,48.62456519,ALYREF,2
3707,arginine catabolic process (GO:0006527),0.057318925,0.651444262,0,0,17.00680272,48.62456519,ARG1,2
3708,negative regulation of biosynthetic process (GO:0009890),0.057318925,0.649996608,0,0,17.00680272,48.62456519,PARK7,2
3709,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.057318925,0.648555374,0,0,17.00680272,48.62456519,DAB2,2
3710,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.057958499,0.654341194,0,0,5.134129123,14.62214381,SNX2;UBB,2
3711,positive regulation of cell-substrate adhesion (GO:0010811),0.057958499,0.652896732,0,0,5.134129123,14.62214381,C1QBP;S100A10,2
3712,positive regulation of mitotic cell cycle (GO:0045931),0.057958499,0.651458634,0,0,5.134129123,14.62214381,RGCC;EIF4EBP1,2
3713,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.061090115,0.685149141,0,0,3.345600535,9.35230914,UBB;PSMB2;UBE2N,2
3714,rRNA metabolic process (GO:0016072),0.061198209,0.684856272,0,0,2.707550682,7.56391473,RPL3;RPLP0;RPL14;RPS2,2
3715,intracellular transport of virus (GO:0075733),0.061874706,0.690911648,0,0,4.947433519,13.76694528,UBB;RAN,2
3716,transport of virus (GO:0046794),0.061874706,0.689403107,0,0,4.947433519,13.76694528,UBB;RAN,2
3717,rRNA processing (GO:0006364),0.062996297,0.700370598,0,0,2.680875306,7.411760542,RPL3;RPLP0;RPL14;RPS2,2
3718,Notch signaling pathway (GO:0007219),0.063865853,0.708494446,0,0,4.859086492,13.36720335,UBB;YBX1,2
3719,positive regulation of DNA biosynthetic process (GO:2000573),0.063865853,0.706957582,0,0,4.859086492,13.36720335,CCT3;RGCC,2
3720,secretory granule organization (GO:0033363),0.064250388,0.709674744,0,0,15.11715797,41.49610749,SRGN,2
3721,negative regulation of leukocyte chemotaxis (GO:0002689),0.064250388,0.708141969,0,0,15.11715797,41.49610749,MIF,2
3722,negative regulation of protein sumoylation (GO:0033234),0.064250388,0.706615801,0,0,15.11715797,41.49610749,PARK7,2
3723,regulation of protein acetylation (GO:1901983),0.064250388,0.705096197,0,0,15.11715797,41.49610749,PARK7,2
3724,ornithine metabolic process (GO:0006591),0.064250388,0.703583115,0,0,15.11715797,41.49610749,ARG1,2
3725,regulation of macrophage cytokine production (GO:0010935),0.064250388,0.702076513,0,0,15.11715797,41.49610749,CD74,2
3726,negative regulation of response to reactive oxygen species (GO:1901032),0.064250388,0.70057635,0,0,15.11715797,41.49610749,PARK7,2
3727,actin filament reorganization (GO:0090527),0.064250388,0.699082584,0,0,15.11715797,41.49610749,GSN,2
3728,regulation of interleukin-1 secretion (GO:0050704),0.064250388,0.697595174,0,0,15.11715797,41.49610749,HMGB1,2
3729,negative regulation of T cell apoptotic process (GO:0070233),0.064250388,0.69611408,0,0,15.11715797,41.49610749,TSC22D3,2
3730,negative regulation of mitotic nuclear division (GO:0045839),0.064250388,0.694639262,0,0,15.11715797,41.49610749,RGCC,2
3731,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.064250388,0.69317068,0,0,15.11715797,41.49610749,RGCC,2
3732,positive regulation of mitochondrial translation (GO:0070131),0.064250388,0.691708295,0,0,15.11715797,41.49610749,C1QBP,2
3733,mature B cell differentiation involved in immune response (GO:0002313),0.064250388,0.690252067,0,0,15.11715797,41.49610749,FCGR2B,2
3734,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.064250388,0.688801958,0,0,15.11715797,41.49610749,CCL2,2
3735,mitochondrion morphogenesis (GO:0070584),0.064250388,0.687357928,0,0,15.11715797,41.49610749,PID1,2
3736,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.064250388,0.685919941,0,0,15.11715797,41.49610749,CALM2,2
3737,establishment of viral latency (GO:0019043),0.064250388,0.684487958,0,0,15.11715797,41.49610749,PPIA,2
3738,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.064250388,0.683061941,0,0,15.11715797,41.49610749,HMGB1,2
3739,regulation of oxidative stress-induced cell death (GO:1903201),0.064250388,0.681641854,0,0,15.11715797,41.49610749,PARK7,2
3740,cytoskeletal anchoring at plasma membrane (GO:0007016),0.064250388,0.680227659,0,0,15.11715797,41.49610749,EZR,2
3741,early endosome to Golgi transport (GO:0034498),0.064250388,0.67881932,0,0,15.11715797,41.49610749,SNX2,2
3742,DNA topological change (GO:0006265),0.064250388,0.677416801,0,0,15.11715797,41.49610749,HMGB1,2
3743,protein localization to vacuole (GO:0072665),0.064250388,0.676020066,0,0,15.11715797,41.49610749,CD81,2
3744,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.064732864,0.679695074,0,0,3.265306122,8.938730644,UBB;PSMB2;UBE2N,2
3745,organic anion transport (GO:0015711),0.064732864,0.678299396,0,0,3.265306122,8.938730644,PRELID1;PITPNA;PLTP,2
3746,negative regulation of macromolecule metabolic process (GO:0010605),0.064732864,0.676909438,0,0,3.265306122,8.938730644,MSR1;PARK7;MIF,2
3747,protein import (GO:0017038),0.065878463,0.687480152,0,0,4.77383936,12.98457435,RANBP1;RAN,2
3748,cellular defense response (GO:0006968),0.065878463,0.686077131,0,0,4.77383936,12.98457435,CLEC5A;C5AR1,2
3749,phosphatidylinositol-mediated signaling (GO:0048015),0.065878463,0.684679826,0,0,4.77383936,12.98457435,C1QBP;EZR,2
3750,positive regulation of protein transport (GO:0051222),0.065878463,0.6832882,0,0,4.77383936,12.98457435,EZR;PPIA,2
3751,ATP metabolic process (GO:0046034),0.065878463,0.68190222,0,0,4.77383936,12.98457435,ATP5B;ALDOA,2
3752,G2/M transition of mitotic cell cycle (GO:0000086),0.067215973,0.69433828,0,0,3.213883979,8.676986553,TUBA1A;UBB;TUBB4B,2
3753,cytoskeleton organization (GO:0007010),0.067215973,0.692935576,0,0,3.213883979,8.676986553,CCL7;CCL2;EZR,2
3754,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.067912118,0.698700679,0,0,4.691531785,12.61806613,UBB;CD14,2
3755,cell cycle G2/M phase transition (GO:0044839),0.068473717,0.703061125,0,0,3.18877551,8.550080668,TUBA1A;UBB;TUBB4B,2
3756,positive regulation of phosphorylation (GO:0042327),0.068556175,0.702494296,0,0,2.603912378,6.978750257,CD74;DAB2;PLAUR;MIF,2
3757,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.069966405,0.715508144,0,0,4.612014297,12.26675929,C1QBP;S100A10,2
3758,receptor metabolic process (GO:0043112),0.069966405,0.714077128,0,0,4.612014297,12.26675929,CD81;LGMN,2
3759,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.069966405,0.712651824,0,0,4.612014297,12.26675929,UBB;PLAUR,2
3760,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.07113123,0.723073045,0,0,13.60544218,35.9622965,C1QBP,2
3761,actin filament capping (GO:0051693),0.07113123,0.721635524,0,0,13.60544218,35.9622965,GSN,2
3762,complement receptor mediated signaling pathway (GO:0002430),0.07113123,0.720203708,0,0,13.60544218,35.9622965,C5AR1,2
3763,protein deglycosylation (GO:0006517),0.07113123,0.718777562,0,0,13.60544218,35.9622965,PARK7,2
3764,peptidyl-serine dephosphorylation (GO:0070262),0.07113123,0.717357053,0,0,13.60544218,35.9622965,PPP1CA,2
3765,negative regulation of cellular protein catabolic process (GO:1903363),0.07113123,0.715942147,0,0,13.60544218,35.9622965,ANXA2,2
3766,positive regulation of calcium ion import (GO:0090280),0.07113123,0.714532812,0,0,13.60544218,35.9622965,CCL2,2
3767,regulation of cellular respiration (GO:0043457),0.07113123,0.713129015,0,0,13.60544218,35.9622965,PRELID1,2
3768,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.07113123,0.711730723,0,0,13.60544218,35.9622965,PARK7,2
3769,macrophage chemotaxis (GO:0048246),0.07113123,0.710337903,0,0,13.60544218,35.9622965,CCL2,2
3770,epithelial cell apoptotic process (GO:1904019),0.07113123,0.708950525,0,0,13.60544218,35.9622965,GSN,2
3771,regulation of podosome assembly (GO:0071801),0.07113123,0.707568555,0,0,13.60544218,35.9622965,GSN,2
3772,mitotic nuclear envelope reassembly (GO:0007084),0.07113123,0.706191962,0,0,13.60544218,35.9622965,LMNA,2
3773,positive regulation of receptor recycling (GO:0001921),0.07113123,0.704820716,0,0,13.60544218,35.9622965,ANXA2,2
3774,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.07113123,0.703454784,0,0,13.60544218,35.9622965,PARK7,2
3775,glucocorticoid metabolic process (GO:0008211),0.07113123,0.702094137,0,0,13.60544218,35.9622965,YWHAH,2
3776,protein kinase A signaling (GO:0010737),0.07113123,0.700738742,0,0,13.60544218,35.9622965,EZR,2
3777,regulation of immunoglobulin production (GO:0002637),0.07113123,0.699388571,0,0,13.60544218,35.9622965,FCGR2B,2
3778,positive regulation of T cell apoptotic process (GO:0070234),0.07113123,0.698043593,0,0,13.60544218,35.9622965,PRELID1,2
3779,negative regulation of B cell proliferation (GO:0030889),0.07113123,0.696703778,0,0,13.60544218,35.9622965,FCGR2B,2
3780,positive regulation of vacuole organization (GO:0044090),0.07113123,0.695369097,0,0,13.60544218,35.9622965,ANXA2,2
3781,macrophage migration (GO:1905517),0.07113123,0.694039519,0,0,13.60544218,35.9622965,CCL2,2
3782,sequestering of actin monomers (GO:0042989),0.07113123,0.692715016,0,0,13.60544218,35.9622965,GSN,2
3783,virion attachment to host cell (GO:0019062),0.07113123,0.691395559,0,0,13.60544218,35.9622965,CD81,2
3784,regulation of plasminogen activation (GO:0010755),0.07113123,0.690081119,0,0,13.60544218,35.9622965,ENO1,2
3785,positive regulation of reproductive process (GO:2000243),0.07113123,0.688771667,0,0,13.60544218,35.9622965,C1QBP,2
3786,regulation of T cell apoptotic process (GO:0070232),0.07113123,0.687467175,0,0,13.60544218,35.9622965,PRELID1,2
3787,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.073151299,0.705654217,0,0,2.056238112,5.377526116,ACTR3;UBB;ARPC2;ARPC1B;NCF4;MYL12A,2
3788,regulation of canonical Wnt signaling pathway (GO:0060828),0.073377247,0.706498289,0,0,2.543073304,6.642866994,DAB2;UBB;PSMB2;PPP1CA,2
3789,positive regulation of protein binding (GO:0032092),0.074135247,0.712452284,0,0,4.460800714,11.60639767,PARK7;RAN,2
3790,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),0.07535295,0.722793432,0,0,2.519526329,6.514417231,RGCC;UBB;UBE2N;PARK7,2
3791,cellular response to organic substance (GO:0071310),0.076242636,0.729955297,0,0,3.045994517,7.839885593,PID1;CCL2;PARK7,2
3792,actin cytoskeleton reorganization (GO:0031532),0.076248999,0.728649141,0,0,4.388852315,11.29581301,GSN;EZR,2
3793,positive regulation of endothelial cell apoptotic process (GO:2000353),0.077961818,0.743624592,0,0,12.3685838,31.55888789,RGCC,2
3794,negative regulation of defense response to virus (GO:0050687),0.077961818,0.742237233,0,0,12.3685838,31.55888789,C1QBP,2
3795,cell part morphogenesis (GO:0032990),0.077961818,0.740855041,0,0,12.3685838,31.55888789,PID1,2
3796,negative regulation of leukocyte activation (GO:0002695),0.077961818,0.739477987,0,0,12.3685838,31.55888789,FCGR2B,2
3797,cellular response to prostaglandin stimulus (GO:0071379),0.077961818,0.738106042,0,0,12.3685838,31.55888789,GNB1,2
3798,regulation of trophoblast cell migration (GO:1901163),0.077961818,0.736739179,0,0,12.3685838,31.55888789,C1QBP,2
3799,arginine metabolic process (GO:0006525),0.077961818,0.735377369,0,0,12.3685838,31.55888789,ARG1,2
3800,positive regulation of extracellular matrix organization (GO:1903055),0.077961818,0.734020585,0,0,12.3685838,31.55888789,RGCC,2
3801,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.077961818,0.732668797,0,0,12.3685838,31.55888789,PARK7,2
3802,T-helper cell differentiation (GO:0042093),0.077961818,0.73132198,0,0,12.3685838,31.55888789,HMGB1,2
3803,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.077961818,0.729980104,0,0,12.3685838,31.55888789,LMNA,2
3804,positive regulation of receptor biosynthetic process (GO:0010870),0.077961818,0.728643144,0,0,12.3685838,31.55888789,HNRNPK,2
3805,glycerol metabolic process (GO:0006071),0.077961818,0.727311073,0,0,12.3685838,31.55888789,TPI1,2
3806,urea cycle (GO:0000050),0.077961818,0.725983863,0,0,12.3685838,31.55888789,ARG1,2
3807,regulation of mitotic centrosome separation (GO:0046602),0.077961818,0.724661488,0,0,12.3685838,31.55888789,RANBP1,2
3808,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.077961818,0.723343922,0,0,12.3685838,31.55888789,GLRX,2
3809,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.077961818,0.722031138,0,0,12.3685838,31.55888789,CALM2,2
3810,negative regulation of peptide secretion (GO:0002792),0.077961818,0.72072311,0,0,12.3685838,31.55888789,CD74,2
3811,stress granule assembly (GO:0034063),0.077961818,0.719419813,0,0,12.3685838,31.55888789,CIRBP,2
3812,rhodopsin mediated signaling pathway (GO:0016056),0.077961818,0.718121222,0,0,12.3685838,31.55888789,GNB1,2
3813,negative regulation of nucleocytoplasmic transport (GO:0046823),0.077961818,0.71682731,0,0,12.3685838,31.55888789,PARK7,2
3814,regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898),0.077961818,0.715538052,0,0,12.3685838,31.55888789,HMGB1,2
3815,stress-activated MAPK cascade (GO:0051403),0.078381779,0.718100926,0,0,4.319187993,10.99736009,UBB;UBE2N,2
3816,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.078381779,0.716814007,0,0,4.319187993,10.99736009,RGCC;UBB,2
3817,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.078381779,0.715531692,0,0,4.319187993,10.99736009,UBB;PSMB2,2
3818,establishment of protein localization to organelle (GO:0072594),0.078381779,0.714253957,0,0,4.319187993,10.99736009,RANBP1;RAN,2
3819,regulation of T cell proliferation (GO:0042129),0.078381779,0.712980777,0,0,4.319187993,10.99736009,SDC4;ARG1,2
3820,cellular response to organic cyclic compound (GO:0071407),0.078915372,0.716557196,0,0,3.00120048,7.621186191,GNB1;CCL2;EZR,2
3821,negative regulation of protein modification process (GO:0031400),0.080533196,0.729948314,0,0,4.25170068,10.71039882,PID1;PARK7,2
3822,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),0.080533196,0.728654079,0,0,4.25170068,10.71039882,RGCC;UBB,2
3823,positive regulation of cell migration (GO:0030335),0.08144008,0.735555271,0,0,2.451431023,6.147913817,DAB2;CCL7;C1QBP;PFN1,2
3824,muscle contraction (GO:0006936),0.081628716,0.735956428,0,0,2.957704821,7.410748788,VIM;ALDOA;MYL12A,2
3825,positive regulation of transferase activity (GO:0051347),0.081628716,0.734658445,0,0,2.957704821,7.410748788,CD74;UBE2N;RPS2,2
3826,positive regulation of protein polymerization (GO:0032273),0.082702867,0.743015374,0,0,4.186289901,10.43433179,TPPP3;PFN1,2
3827,cellular response to decreased oxygen levels (GO:0036294),0.082702867,0.741709547,0,0,4.186289901,10.43433179,RGCC;LMNA,2
3828,DNA metabolic process (GO:0006259),0.083221169,0.745048464,0,0,2.159593996,5.369298199,UBB;UBE2N;PARK7;HMGB1;RAN,2
3829,positive regulation of lyase activity (GO:0051349),0.084742515,0.757339853,0,0,11.33786848,27.98342234,PARK7,2
3830,peptidyl-arginine modification (GO:0018195),0.084742515,0.756015832,0,0,11.33786848,27.98342234,PARK7,2
3831,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.084742515,0.754696433,0,0,11.33786848,27.98342234,CALM2,2
3832,positive regulation of interleukin-1 production (GO:0032732),0.084742515,0.753381631,0,0,11.33786848,27.98342234,HMGB1,2
3833,positive regulation of peptidase activity (GO:0010952),0.084742515,0.752071402,0,0,11.33786848,27.98342234,PRELID1,2
3834,response to interleukin-6 (GO:0070741),0.084742515,0.750765722,0,0,11.33786848,27.98342234,PID1,2
3835,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.084742515,0.749464569,0,0,11.33786848,27.98342234,ADSSL1,2
3836,ribosomal subunit export from nucleus (GO:0000054),0.084742515,0.748167917,0,0,11.33786848,27.98342234,RAN,2
3837,entry of bacterium into host cell (GO:0035635),0.084742515,0.746875745,0,0,11.33786848,27.98342234,UBB,2
3838,regulation of cholesterol storage (GO:0010885),0.084742515,0.745588028,0,0,11.33786848,27.98342234,MSR1,2
3839,negative regulation of ATP metabolic process (GO:1903579),0.084742515,0.744304744,0,0,11.33786848,27.98342234,PID1,2
3840,mitochondrion transport along microtubule (GO:0047497),0.084742515,0.74302587,0,0,11.33786848,27.98342234,UBB,2
3841,L-serine metabolic process (GO:0006563),0.084742515,0.741751383,0,0,11.33786848,27.98342234,SERINC3,2
3842,PERK-mediated unfolded protein response (GO:0036499),0.084742515,0.74048126,0,0,11.33786848,27.98342234,CCL2,2
3843,cellular response to fatty acid (GO:0071398),0.084742515,0.739215481,0,0,11.33786848,27.98342234,PID1,2
3844,regulation of vascular endothelial cell proliferation (GO:1905562),0.084742515,0.737954021,0,0,11.33786848,27.98342234,HMGB1,2
3845,DNA ligation involved in DNA repair (GO:0051103),0.084742515,0.736696859,0,0,11.33786848,27.98342234,HMGB1,2
3846,regulation of cell communication by electrical coupling (GO:0010649),0.084742515,0.735443973,0,0,11.33786848,27.98342234,CALM2,2
3847,negative regulation of interleukin-12 production (GO:0032695),0.084742515,0.734195341,0,0,11.33786848,27.98342234,C1QBP,2
3848,response to prostaglandin E (GO:0034695),0.084742515,0.732950943,0,0,11.33786848,27.98342234,GNB1,2
3849,positive regulation of ruffle assembly (GO:1900029),0.084742515,0.731710755,0,0,11.33786848,27.98342234,PFN1,2
3850,negative regulation of androgen receptor signaling pathway (GO:0060766),0.084742515,0.730474757,0,0,11.33786848,27.98342234,DAB2,2
3851,positive regulation of SMAD protein import into nucleus (GO:0060391),0.084742515,0.729242928,0,0,11.33786848,27.98342234,DAB2,2
3852,negative regulation of blood vessel morphogenesis (GO:2000181),0.084890412,0.72928581,0,0,4.122861266,10.16860082,RGCC;PF4,2
3853,negative regulation of gene expression (GO:0010629),0.086701181,0.743590127,0,0,1.758377018,4.299737828,EID1;MSR1;DAB2;ENO1;PARK7;MIF;PA2G4;GAPDH,2
3854,purine ribonucleotide metabolic process (GO:0009150),0.087095454,0.745718288,0,0,4.061326023,9.912683903,ADSSL1;RAN,2
3855,JNK cascade (GO:0007254),0.087095454,0.744469179,0,0,4.061326023,9.912683903,UBB;UBE2N,2
3856,ncRNA processing (GO:0034470),0.08776359,0.748925753,0,0,2.38691968,5.807634695,RPL3;RPLP0;RPL14;RPS2,2
3857,positive regulation of endothelial cell proliferation (GO:0001938),0.089317622,0.760914566,0,0,4.00160064,9.666092341,ECM1;HMGB1,2
3858,regulation of protein localization to plasma membrane (GO:1903076),0.089317622,0.759646375,0,0,4.00160064,9.666092341,DAB2;PID1,2
3859,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.091473685,0.776689206,0,0,10.46572475,25.0309152,PARK7,2
3860,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.091473685,0.775399024,0,0,10.46572475,25.0309152,CD81,2
3861,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.091473685,0.774113122,0,0,10.46572475,25.0309152,CCL2,2
3862,regulation of necrotic cell death (GO:0010939),0.091473685,0.772831478,0,0,10.46572475,25.0309152,UBB,2
3863,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.091473685,0.771554071,0,0,10.46572475,25.0309152,FCGR2B,2
3864,positive regulation of lamellipodium assembly (GO:0010592),0.091473685,0.770280879,0,0,10.46572475,25.0309152,ARPC2,2
3865,regulation of viral life cycle (GO:1903900),0.091473685,0.769011883,0,0,10.46572475,25.0309152,PPIA,2
3866,"Notch receptor processing, ligand-dependent (GO:0035333)",0.091473685,0.76774706,0,0,10.46572475,25.0309152,YBX1,2
3867,renal absorption (GO:0070293),0.091473685,0.766486392,0,0,10.46572475,25.0309152,GSN,2
3868,steroid catabolic process (GO:0006706),0.091473685,0.765229857,0,0,10.46572475,25.0309152,YWHAH,2
3869,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.091473685,0.763977435,0,0,10.46572475,25.0309152,C1QBP,2
3870,nucleotide metabolic process (GO:0009117),0.091473685,0.762729106,0,0,10.46572475,25.0309152,PARK7,2
3871,regulation of glucose import in response to insulin stimulus (GO:2001273),0.091473685,0.76148485,0,0,10.46572475,25.0309152,PID1,2
3872,regulation of cytolysis (GO:0042268),0.091473685,0.760244646,0,0,10.46572475,25.0309152,PF4,2
3873,serine family amino acid biosynthetic process (GO:0009070),0.091473685,0.759008476,0,0,10.46572475,25.0309152,SERINC3,2
3874,positive regulation of cholesterol efflux (GO:0010875),0.091473685,0.757776319,0,0,10.46572475,25.0309152,PLTP,2
3875,positive regulation of actin nucleation (GO:0051127),0.091473685,0.756548157,0,0,10.46572475,25.0309152,GSN,2
3876,regulation of macrophage differentiation (GO:0045649),0.091473685,0.755323969,0,0,10.46572475,25.0309152,PF4,2
3877,regulation of cAMP metabolic process (GO:0030814),0.091473685,0.754103736,0,0,10.46572475,25.0309152,PF4,2
3878,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.091473685,0.75288744,0,0,10.46572475,25.0309152,PARK7,2
3879,response to UV-B (GO:0010224),0.091473685,0.751675061,0,0,10.46572475,25.0309152,CRIP1,2
3880,response to fatty acid (GO:0070542),0.091473685,0.75046658,0,0,10.46572475,25.0309152,PID1,2
3881,B cell activation involved in immune response (GO:0002312),0.091473685,0.749261979,0,0,10.46572475,25.0309152,FCGR2B,2
3882,negative regulation of interleukin-10 production (GO:0032693),0.091473685,0.748061238,0,0,10.46572475,25.0309152,FCGR2B,2
3883,detection of calcium ion (GO:0005513),0.091473685,0.74686434,0,0,10.46572475,25.0309152,CALM2,2
3884,positive regulation of muscle contraction (GO:0045933),0.091473685,0.745671266,0,0,10.46572475,25.0309152,ENO1,2
3885,regulation of epithelial to mesenchymal transition (GO:0010717),0.09155655,0.74515642,0,0,3.943606428,9.428368187,DAB2;RGCC,2
3886,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.09155655,0.743969865,0,0,3.943606428,9.428368187,PLAUR;PARK7,2
3887,regulation of endopeptidase activity (GO:0052548),0.09155655,0.742787083,0,0,3.943606428,9.428368187,PRELID1;GAPDH,2
3888,negative regulation of angiogenesis (GO:0016525),0.093811876,0.759876194,0,0,3.887269193,9.199081916,RGCC;PF4,2
3889,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.093811876,0.758671953,0,0,3.887269193,9.199081916,ARPC2;PFN1,2
3890,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.093811876,0.757471523,0,0,3.887269193,9.199081916,UBB;PSMB2,2
3891,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),0.096034923,0.774196229,0,0,1.60252558,3.754786937,PID1;HNRNPK;RGCC;UBB;CD81;CNBP;PARK7;YBX1;HMGB1;PF4,2
3892,positive regulation of endothelial cell migration (GO:0010595),0.096083241,0.773364006,0,0,3.832518923,8.977830288,ATP5B;HMGB1,2
3893,negative regulation of developmental process (GO:0051093),0.096083241,0.77214611,0,0,3.832518923,8.977830288,ANXA2;MIF,2
3894,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.096083241,0.770932043,0,0,3.832518923,8.977830288,DAB2;SUMO2,2
3895,regulation of cell proliferation (GO:0042127),0.096360779,0.771945141,0,0,1.652482855,3.866241457,EIF5A;RGCC;CD81;CNBP;LMNA;EMP3;S100A11;NME1;PF4,2
3896,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.097251713,0.77786127,0,0,2.739350774,6.383927366,DAB2;UBB;PSMB2,2
3897,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.098155685,0.783863005,0,0,9.718172983,22.5578274,PARK7,2
3898,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.098155685,0.782638219,0,0,9.718172983,22.5578274,ADSSL1,2
3899,mitotic cell cycle arrest (GO:0071850),0.098155685,0.781417254,0,0,9.718172983,22.5578274,RGCC,2
3900,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.098155685,0.780200093,0,0,9.718172983,22.5578274,PARK7,2
3901,necroptotic process (GO:0070266),0.098155685,0.778986718,0,0,9.718172983,22.5578274,CD14,2
3902,myeloid dendritic cell activation (GO:0001773),0.098155685,0.777777112,0,0,9.718172983,22.5578274,HMGB1,2
3903,lipid particle organization (GO:0034389),0.098155685,0.776571256,0,0,9.718172983,22.5578274,PPIA,2
3904,positive regulation of response to cytokine stimulus (GO:0060760),0.098155685,0.775369133,0,0,9.718172983,22.5578274,CD74,2
3905,regulation of histone modification (GO:0031056),0.098155685,0.774170726,0,0,9.718172983,22.5578274,UBE2N,2
3906,regulation of monocyte differentiation (GO:0045655),0.098155685,0.772976018,0,0,9.718172983,22.5578274,CD74,2
3907,positive regulation of purine nucleotide metabolic process (GO:1900544),0.098155685,0.771784992,0,0,9.718172983,22.5578274,PF4,2
3908,negative regulation of secretion (GO:0051048),0.098155685,0.770597631,0,0,9.718172983,22.5578274,CD74,2
3909,regulation of lymphocyte differentiation (GO:0045619),0.098155685,0.769413917,0,0,9.718172983,22.5578274,PRELID1,2
3910,regulation of response to interferon-gamma (GO:0060330),0.098155685,0.768233834,0,0,9.718172983,22.5578274,IFNGR1,2
3911,regulation of adaptive immune response (GO:0002819),0.098155685,0.767057366,0,0,9.718172983,22.5578274,FCGR2B,2
3912,regulation of defense response to virus (GO:0050688),0.098155685,0.765884495,0,0,9.718172983,22.5578274,C1QBP,2
3913,negative regulation of T cell receptor signaling pathway (GO:0050860),0.098155685,0.764715206,0,0,9.718172983,22.5578274,EZR,2
3914,positive regulation of interleukin-8 secretion (GO:2000484),0.098155685,0.763549482,0,0,9.718172983,22.5578274,CD14,2
3915,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),0.098155685,0.762387306,0,0,9.718172983,22.5578274,RGCC,2
3916,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),0.098370292,0.762893013,0,0,3.779289494,8.764234417,UBB;PSMB2,2
3917,nuclear import (GO:0051170),0.098370292,0.76173536,0,0,3.779289494,8.764234417,RANBP1;RAN,2
3918,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.10067268,0.77838286,0,0,3.727518405,8.557937987,UBB;PSMB2,2
3919,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),0.10067268,0.777205277,0,0,3.727518405,8.557937987,UBB;PSMB2,2
3920,regulation of epithelial cell proliferation (GO:0050678),0.10067268,0.776031251,0,0,3.727518405,8.557937987,C5AR1;NME1,2
3921,positive regulation of proteasomal protein catabolic process (GO:1901800),0.10299006,0.792697248,0,0,3.677146534,8.358605634,DAB2;SUMO2,2
3922,positive regulation of acute inflammatory response (GO:0002675),0.104788873,0.805327737,0,0,9.070294785,20.46084072,PARK7,2
3923,myeloid cell development (GO:0061515),0.104788873,0.804116718,0,0,9.070294785,20.46084072,ANXA2,2
3924,regulation of exit from mitosis (GO:0007096),0.104788873,0.802909336,0,0,9.070294785,20.46084072,RGCC,2
3925,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.104788873,0.801705574,0,0,9.070294785,20.46084072,CALM2,2
3926,regulation of mitochondrial translation (GO:0070129),0.104788873,0.800505416,0,0,9.070294785,20.46084072,C1QBP,2
3927,regulation of macrophage chemotaxis (GO:0010758),0.104788873,0.799308845,0,0,9.070294785,20.46084072,MIF,2
3928,negative regulation of viral entry into host cell (GO:0046597),0.104788873,0.798115847,0,0,9.070294785,20.46084072,GSN,2
3929,amide transport (GO:0042886),0.104788873,0.796926405,0,0,9.070294785,20.46084072,PLTP,2
3930,negative regulation of DNA-dependent DNA replication (GO:2000104),0.104788873,0.795740502,0,0,9.070294785,20.46084072,PID1,2
3931,"phototransduction, visible light (GO:0007603)",0.104788873,0.794558124,0,0,9.070294785,20.46084072,GNB1,2
3932,filopodium assembly (GO:0046847),0.104788873,0.793379255,0,0,9.070294785,20.46084072,EZR,2
3933,regulation of establishment of cell polarity (GO:2000114),0.104788873,0.792203878,0,0,9.070294785,20.46084072,GSN,2
3934,protein O-linked fucosylation (GO:0036066),0.104788873,0.791031979,0,0,9.070294785,20.46084072,CFP,2
3935,positive regulation of exosomal secretion (GO:1903543),0.104788873,0.789863541,0,0,9.070294785,20.46084072,SDC4,2
3936,negative regulation of mRNA processing (GO:0050686),0.104788873,0.788698551,0,0,9.070294785,20.46084072,C1QBP,2
3937,toll-like receptor 4 signaling pathway (GO:0034142),0.104788873,0.787536992,0,0,9.070294785,20.46084072,CD14,2
3938,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.104788873,0.786378849,0,0,9.070294785,20.46084072,CCT3,2
3939,negative regulation of cell aging (GO:0090344),0.104788873,0.785224108,0,0,9.070294785,20.46084072,MIF,2
3940,negative regulation of interleukin-2 production (GO:0032703),0.104788873,0.784072753,0,0,9.070294785,20.46084072,EZR,2
3941,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.104788873,0.78292477,0,0,9.070294785,20.46084072,GSN,2
3942,regulation of clathrin-dependent endocytosis (GO:2000369),0.104788873,0.781780143,0,0,9.070294785,20.46084072,DAB2,2
3943,regulation of peptide secretion (GO:0002791),0.104788873,0.780638858,0,0,9.070294785,20.46084072,CD74,2
3944,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.104788873,0.7795009,0,0,9.070294785,20.46084072,PRELID1,2
3945,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.104788873,0.778366256,0,0,9.070294785,20.46084072,CALM2,2
3946,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.104788873,0.777234909,0,0,9.070294785,20.46084072,SPCS1,2
3947,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.107668434,0.797433987,0,0,3.58037952,7.979587657,PSMB2;NCF4,2
3948,negative regulation of phosphorylation (GO:0042326),0.107668434,0.796278286,0,0,3.58037952,7.979587657,PID1;PARK7,2
3949,regulation of defense response (GO:0031347),0.107668434,0.795125929,0,0,3.58037952,7.979587657,PARK7;FCGR2B,2
3950,response to lipopolysaccharide (GO:0032496),0.107778127,0.794785813,0,0,2.616431188,5.828572851,CCL2;CD14;PF4,2
3951,ribonucleoprotein complex assembly (GO:0022618),0.109317036,0.804970898,0,0,2.599766021,5.75458998,MRPL20;RPL3;CIRBP,2
3952,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.110028759,0.809044316,0,0,3.533881085,7.799323281,PARK7;PF4,2
3953,regulation of hematopoietic stem cell differentiation (GO:1902036),0.110028759,0.807880223,0,0,3.533881085,7.799323281,UBB;PSMB2,2
3954,positive regulation of JNK cascade (GO:0046330),0.110028759,0.806719476,0,0,3.533881085,7.799323281,HMGB1;FCGR2B,2
3955,positive regulation of apoptotic signaling pathway (GO:2001235),0.110028759,0.805562059,0,0,3.533881085,7.799323281,GSN;PLAUR,2
3956,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),0.110028759,0.804407959,0,0,3.533881085,7.799323281,UBB;PSMB2,2
3957,response to interleukin-1 (GO:0070555),0.110028759,0.80325716,0,0,3.533881085,7.799323281,CCL7;CCL2,2
3958,miRNA metabolic process (GO:0010586),0.111373602,0.811913561,0,0,8.503401361,18.66381754,RAN,2
3959,peptidyl-threonine dephosphorylation (GO:0035970),0.111373602,0.810755339,0,0,8.503401361,18.66381754,PPP1CA,2
3960,regulation of actin nucleation (GO:0051125),0.111373602,0.809600417,0,0,8.503401361,18.66381754,GSN,2
3961,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.111373602,0.808448781,0,0,8.503401361,18.66381754,CCL2,2
3962,regulation of osteoblast proliferation (GO:0033688),0.111373602,0.807300416,0,0,8.503401361,18.66381754,TMEM119,2
3963,dendritic cell chemotaxis (GO:0002407),0.111373602,0.806155309,0,0,8.503401361,18.66381754,HMGB1,2
3964,regulation of SMAD protein import into nucleus (GO:0060390),0.111373602,0.805013446,0,0,8.503401361,18.66381754,DAB2,2
3965,Notch receptor processing (GO:0007220),0.111373602,0.803874813,0,0,8.503401361,18.66381754,YBX1,2
3966,fibrinolysis (GO:0042730),0.111373602,0.802739397,0,0,8.503401361,18.66381754,PLAUR,2
3967,regulation of protein homodimerization activity (GO:0043496),0.111373602,0.801607183,0,0,8.503401361,18.66381754,PARK7,2
3968,mRNA transcription from RNA polymerase II promoter (GO:0042789),0.111373602,0.800478159,0,0,8.503401361,18.66381754,C5AR1,2
3969,regulation of RIG-I signaling pathway (GO:0039535),0.111373602,0.79935231,0,0,8.503401361,18.66381754,C1QBP,2
3970,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.111373602,0.798229625,0,0,8.503401361,18.66381754,PARK7,2
3971,regulation of exosomal secretion (GO:1903541),0.111373602,0.797110088,0,0,8.503401361,18.66381754,SDC4,2
3972,regulation of necroptotic process (GO:0060544),0.111373602,0.795993687,0,0,8.503401361,18.66381754,UBB,2
3973,guanosine-containing compound metabolic process (GO:1901068),0.111373602,0.794880409,0,0,8.503401361,18.66381754,RAN,2
3974,negative regulation of translational initiation (GO:0045947),0.111373602,0.793770241,0,0,8.503401361,18.66381754,EIF4EBP1,2
3975,glutamine family amino acid catabolic process (GO:0009065),0.111373602,0.79266317,0,0,8.503401361,18.66381754,ARG1,2
3976,neuron apoptotic process (GO:0051402),0.111373602,0.791559182,0,0,8.503401361,18.66381754,GAPDH,2
3977,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.111373602,0.790458265,0,0,8.503401361,18.66381754,FCGR2B,2
3978,programmed necrotic cell death (GO:0097300),0.111373602,0.789360407,0,0,8.503401361,18.66381754,CD14,2
3979,negative regulation of DNA replication (GO:0008156),0.111373602,0.788265593,0,0,8.503401361,18.66381754,S100A11,2
3980,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.112402736,0.794447592,0,0,3.488574917,7.624863076,UBB;PSMB2,2
3981,negative regulation of ubiquitin protein ligase activity (GO:1904667),0.112402736,0.793348771,0,0,3.488574917,7.624863076,UBB;PSMB2,2
3982,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.114790041,0.80907953,0,0,3.444415741,7.455956424,PSMB2;NCF4,2
3983,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.114790041,0.807963558,0,0,3.444415741,7.455956424,UBB;PSMB2,2
3984,regulation of immune response (GO:0050776),0.115312889,0.81052572,0,0,2.159593996,4.664952102,JAML;IGKC;CD81;FCGR2B,2
3985,regulation of endothelial cell proliferation (GO:0001936),0.117190353,0.822589234,0,0,3.401360544,7.292366374,ECM1;RGCC,2
3986,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.117190353,0.821459304,0,0,3.401360544,7.292366374,UBB;PSMB2,2
3987,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.117190353,0.820332474,0,0,3.401360544,7.292366374,DAB2;UBB,2
3988,regulation of protein sumoylation (GO:0033233),0.117910225,0.824240931,0,0,8.003201281,17.10949777,PARK7,2
3989,regulation of cellular protein catabolic process (GO:1903362),0.117910225,0.823113378,0,0,8.003201281,17.10949777,EZR,2
3990,high-density lipoprotein particle remodeling (GO:0034375),0.117910225,0.821988906,0,0,8.003201281,17.10949777,PLTP,2
3991,positive regulation of cholesterol transport (GO:0032376),0.117910225,0.820867503,0,0,8.003201281,17.10949777,PLTP,2
3992,regulation of receptor recycling (GO:0001919),0.117910225,0.819749155,0,0,8.003201281,17.10949777,ANXA2,2
3993,positive regulation of focal adhesion assembly (GO:0051894),0.117910225,0.81863385,0,0,8.003201281,17.10949777,S100A10,2
3994,regulation of protein localization to membrane (GO:1905475),0.117910225,0.817521575,0,0,8.003201281,17.10949777,GSN,2
3995,negative regulation of immune effector process (GO:0002698),0.117910225,0.81641232,0,0,8.003201281,17.10949777,C1QBP,2
3996,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.117910225,0.81530607,0,0,8.003201281,17.10949777,EZR,2
3997,positive regulation of lymphocyte migration (GO:2000403),0.117910225,0.814202814,0,0,8.003201281,17.10949777,CCL7,2
3998,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.117910225,0.81310254,0,0,8.003201281,17.10949777,CALM2,2
3999,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.117910225,0.812005236,0,0,8.003201281,17.10949777,UBB,2
4000,positive regulation of interleukin-6 secretion (GO:2000778),0.117910225,0.810910889,0,0,8.003201281,17.10949777,HMGB1,2
4001,RNA stabilization (GO:0043489),0.117910225,0.809819488,0,0,8.003201281,17.10949777,CIRBP,2
4002,positive regulation of monocyte chemotaxis (GO:0090026),0.117910225,0.808731021,0,0,8.003201281,17.10949777,HMGB1,2
4003,negative regulation of B cell activation (GO:0050869),0.117910225,0.807645476,0,0,8.003201281,17.10949777,FCGR2B,2
4004,defense response to fungus (GO:0050832),0.117910225,0.806562841,0,0,8.003201281,17.10949777,GAPDH,2
4005,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.117910225,0.805483105,0,0,8.003201281,17.10949777,CALM2,2
4006,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.117910225,0.804406256,0,0,8.003201281,17.10949777,PARK7,2
4007,viral entry into host cell (GO:0046718),0.117910225,0.803332282,0,0,8.003201281,17.10949777,CD81,2
4008,negative regulation of stress fiber assembly (GO:0051497),0.117910225,0.802261173,0,0,8.003201281,17.10949777,PFN1,2
4009,RNA transport (GO:0050658),0.119603356,0.812697638,0,0,3.359368439,7.133868737,RANBP1;ALYREF,2
4010,positive regulation of stress-activated MAPK cascade (GO:0032874),0.119603356,0.811616924,0,0,3.359368439,7.133868737,HMGB1;FCGR2B,2
4011,nucleic acid metabolic process (GO:0090304),0.119603356,0.810539079,0,0,3.359368439,7.133868737,HNRNPK;RAN,2
4012,NIK/NF-kappaB signaling (GO:0038061),0.119603356,0.809464093,0,0,3.359368439,7.133868737,UBB;PSMB2,2
4013,T cell receptor signaling pathway (GO:0050852),0.12032415,0.813263755,0,0,2.488800398,5.270198934,UBB;PSMB2;UBE2N,2
4014,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),0.124255656,0.838725681,0,0,1.682651859,3.509025896,EID1;UBB;C1QBP;CNBP;ENO1;HMGB1;EZR,2
4015,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.12439909,0.838584622,0,0,7.558578987,15.75404694,HSD17B12,2
4016,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.12439909,0.83747831,0,0,7.558578987,15.75404694,CCT3,2
4017,regulation of cholesterol efflux (GO:0010874),0.12439909,0.836374913,0,0,7.558578987,15.75404694,PLTP,2
4018,nuclear envelope reassembly (GO:0031468),0.12439909,0.835274419,0,0,7.558578987,15.75404694,LMNA,2
4019,actin filament polymerization (GO:0030041),0.12439909,0.834176818,0,0,7.558578987,15.75404694,GSN,2
4020,glucan biosynthetic process (GO:0009250),0.12439909,0.833082098,0,0,7.558578987,15.75404694,UBB,2
4021,glycogen biosynthetic process (GO:0005978),0.12439909,0.831990247,0,0,7.558578987,15.75404694,UBB,2
4022,regulation of cAMP-mediated signaling (GO:0043949),0.12439909,0.830901255,0,0,7.558578987,15.75404694,PF4,2
4023,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.12439909,0.82981511,0,0,7.558578987,15.75404694,PARK7,2
4024,DNA conformation change (GO:0071103),0.12439909,0.8287318,0,0,7.558578987,15.75404694,HMGB1,2
4025,positive regulation of cyclic nucleotide biosynthetic process (GO:0030804),0.12439909,0.827651315,0,0,7.558578987,15.75404694,CALM2,2
4026,regulation of peptidase activity (GO:0052547),0.12439909,0.826573644,0,0,7.558578987,15.75404694,ECM1,2
4027,glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.12439909,0.825498776,0,0,7.558578987,15.75404694,TPI1,2
4028,negative regulation of RNA splicing (GO:0033119),0.12439909,0.8244267,0,0,7.558578987,15.75404694,C1QBP,2
4029,DNA ligation (GO:0006266),0.12439909,0.823357404,0,0,7.558578987,15.75404694,HMGB1,2
4030,negative regulation of calcium-mediated signaling (GO:0050849),0.12439909,0.822290879,0,0,7.558578987,15.75404694,CALM2,2
4031,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.124466186,0.821670045,0,0,3.278419802,6.831312851,RGCC;UBB,2
4032,positive regulation of cell cycle (GO:0045787),0.124466186,0.820608456,0,0,3.278419802,6.831312851,EIF4EBP1;MIF,2
4033,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.124466186,0.819549606,0,0,3.278419802,6.831312851,UBB;PSMB2,2
4034,positive regulation of cell cycle arrest (GO:0071158),0.124466186,0.818493485,0,0,3.278419802,6.831312851,RGCC;UBB,2
4035,mitochondrion organization (GO:0007005),0.126791261,0.832710173,0,0,2.429543246,5.017524684,ATP5B;PID1;PARK7,2
4036,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.126915398,0.832454082,0,0,3.239390994,6.686862884,PARK7;MIF,2
4037,regulation of cell cycle G2/M phase transition (GO:1902749),0.129376073,0.847504619,0,0,3.201280512,6.546720527,TUBA1A;TUBB4B,2
4038,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.130840545,0.855999101,0,0,7.16075904,14.56337926,DAB2,2
4039,regulation of protein kinase A signaling (GO:0010738),0.130840545,0.854903072,0,0,7.16075904,14.56337926,MIF,2
4040,negative regulation of lymphocyte activation (GO:0051250),0.130840545,0.853809845,0,0,7.16075904,14.56337926,FCGR2B,2
4041,insulin secretion (GO:0030073),0.130840545,0.852719411,0,0,7.16075904,14.56337926,PARK7,2
4042,error-free translesion synthesis (GO:0070987),0.130840545,0.851631759,0,0,7.16075904,14.56337926,UBB,2
4043,positive regulation of activated T cell proliferation (GO:0042104),0.130840545,0.850546878,0,0,7.16075904,14.56337926,HMGB1,2
4044,endothelial cell development (GO:0001885),0.130840545,0.849464757,0,0,7.16075904,14.56337926,EZR,2
4045,DNA double-strand break processing (GO:0000729),0.130840545,0.848385386,0,0,7.16075904,14.56337926,UBE2N,2
4046,positive regulation of mononuclear cell migration (GO:0071677),0.130840545,0.847308755,0,0,7.16075904,14.56337926,HMGB1,2
4047,positive regulation of oxidoreductase activity (GO:0051353),0.130840545,0.846234853,0,0,7.16075904,14.56337926,PARK7,2
4048,positive regulation of adherens junction organization (GO:1903393),0.130840545,0.84516367,0,0,7.16075904,14.56337926,S100A10,2
4049,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.130840545,0.844095195,0,0,7.16075904,14.56337926,HMGB1,2
4050,positive regulation of lipid storage (GO:0010884),0.130840545,0.843029418,0,0,7.16075904,14.56337926,MSR1,2
4051,osteoclast differentiation (GO:0030316),0.130840545,0.841966329,0,0,7.16075904,14.56337926,ANXA2,2
4052,regulation of cAMP biosynthetic process (GO:0030817),0.130840545,0.840905918,0,0,7.16075904,14.56337926,CALM2,2
4053,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.130840545,0.839848175,0,0,7.16075904,14.56337926,PARK7,2
4054,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.130840545,0.838793089,0,0,7.16075904,14.56337926,DAB2,2
4055,negative regulation of cell proliferation (GO:0008285),0.130924628,0.838279017,0,0,1.86887942,3.799681319,RGCC;LMNA;EMP3;S100A11;NME1,2
4056,regulation of peptidyl-serine phosphorylation (GO:0033135),0.134330621,0.859008972,0,0,3.127687857,6.278680727,PARK7;MIF,2
4057,mitochondrial translational elongation (GO:0070125),0.136823911,0.873857845,0,0,3.092145949,6.15046537,MRPL20;MRPL23,2
4058,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),0.136823911,0.872765523,0,0,3.092145949,6.15046537,UBB;PSMB2,2
4059,regulation of programmed cell death (GO:0043067),0.13685093,0.871848057,0,0,2.023114078,4.023696838,PRELID1;LGALS1;UBB;NME1,2
4060,regulation of vacuole organization (GO:0044088),0.137234932,0.873204309,0,0,6.802721088,13.510619,ANXA2,2
4061,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.137234932,0.872116881,0,0,6.802721088,13.510619,PARK7,2
4062,hydrogen peroxide metabolic process (GO:0042743),0.137234932,0.871032159,0,0,6.802721088,13.510619,PARK7,2
4063,negative regulation of intracellular protein transport (GO:0090317),0.137234932,0.869950131,0,0,6.802721088,13.510619,PARK7,2
4064,negative regulation of macromolecule biosynthetic process (GO:0010558),0.137234932,0.868870789,0,0,6.802721088,13.510619,PF4,2
4065,negative regulation of actin filament bundle assembly (GO:0032232),0.137234932,0.867794121,0,0,6.802721088,13.510619,PFN1,2
4066,endoplasmic reticulum mannose trimming (GO:1904380),0.137234932,0.866720119,0,0,6.802721088,13.510619,UBB,2
4067,error-prone translesion synthesis (GO:0042276),0.137234932,0.865648771,0,0,6.802721088,13.510619,UBB,2
4068,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.137234932,0.864580069,0,0,6.802721088,13.510619,ALYREF,2
4069,negative regulation of response to biotic stimulus (GO:0002832),0.137234932,0.863514002,0,0,6.802721088,13.510619,C1QBP,2
4070,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.137234932,0.862450561,0,0,6.802721088,13.510619,C5AR1,2
4071,entrainment of circadian clock by photoperiod (GO:0043153),0.137234932,0.861389737,0,0,6.802721088,13.510619,PPP1CA,2
4072,positive regulation of cAMP biosynthetic process (GO:0030819),0.137234932,0.860331518,0,0,6.802721088,13.510619,CALM2,2
4073,negative regulation of Wnt signaling pathway (GO:0030178),0.138400202,0.866572065,0,0,2.332361516,4.6124916,DAB2;UBB;PSMB2,2
4074,regulation of stem cell differentiation (GO:2000736),0.139327495,0.871309074,0,0,3.057402736,6.025920787,UBB;PSMB2,2
4075,negative regulation of translation (GO:0017148),0.139327495,0.8702426,0,0,3.057402736,6.025920787,EIF4EBP1;GAPDH,2
4076,Golgi vesicle transport (GO:0048193),0.140811761,0.878438162,0,0,2.00080032,3.922231509,TMED9;SNX2;CAPZA2;CTSC,2
4077,mitochondrial translational termination (GO:0070126),0.141841089,0.88377909,0,0,3.023431595,5.904906856,MRPL20;MRPL23,2
4078,regulation of angiogenesis (GO:0045765),0.143483296,0.892921048,0,0,2.293052052,4.452044611,ECM1;RGCC;PF4,2
4079,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.143582593,0.892450636,0,0,6.478781989,12.57431065,ATP5B,2
4080,mRNA transcription (GO:0009299),0.143582593,0.891364929,0,0,6.478781989,12.57431065,C5AR1,2
4081,RNA-dependent DNA biosynthetic process (GO:0006278),0.143582593,0.890281861,0,0,6.478781989,12.57431065,PPIA,2
4082,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.143582593,0.889201422,0,0,6.478781989,12.57431065,CCL2,2
4083,regulation of ruffle assembly (GO:1900027),0.143582593,0.888123602,0,0,6.478781989,12.57431065,PFN1,2
4084,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.143582593,0.887048392,0,0,6.478781989,12.57431065,NDUFA4,2
4085,energy reserve metabolic process (GO:0006112),0.143582593,0.885975782,0,0,6.478781989,12.57431065,PID1,2
4086,cellular protein complex localization (GO:0034629),0.143582593,0.884905763,0,0,6.478781989,12.57431065,EZR,2
4087,histone ubiquitination (GO:0016574),0.143582593,0.883838326,0,0,6.478781989,12.57431065,UBE2N,2
4088,photoperiodism (GO:0009648),0.143582593,0.88277346,0,0,6.478781989,12.57431065,PPP1CA,2
4089,positive regulation of lamellipodium organization (GO:1902745),0.143582593,0.881711158,0,0,6.478781989,12.57431065,ARPC2,2
4090,negative regulation of cell cycle arrest (GO:0071157),0.143582593,0.880651409,0,0,6.478781989,12.57431065,MIF,2
4091,establishment of endothelial barrier (GO:0061028),0.143582593,0.879594204,0,0,6.478781989,12.57431065,EZR,2
4092,regulation of JNK cascade (GO:0046328),0.144364414,0.883323265,0,0,2.990207072,5.787290202,HMGB1;FCGR2B,2
4093,cellular response to lipid (GO:0071396),0.145191436,0.887319641,0,0,2.280241706,4.400187336,PID1;CCL2;CD14,2
4094,negative regulation of protein phosphorylation (GO:0001933),0.145191436,0.886258253,0,0,2.280241706,4.400187336,PID1;PARK7;CALM2,2
4095,"negative regulation of transcription, DNA-templated (GO:0045892)",0.14588032,0.889399368,0,0,1.504287219,2.895705845,EID1;DAB2;UBB;C1QBP;CNBP;ENO1;PA2G4;HMGB1;EZR,2
4096,cellular response to acid chemical (GO:0071229),0.146897194,0.894530286,0,0,2.957704821,5.672943801,PID1;CAPN2,2
4097,cellular response to lipopolysaccharide (GO:0071222),0.146897194,0.8934641,0,0,2.957704821,5.672943801,CCL2;CD14,2
4098,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),0.146897194,0.892400452,0,0,2.957704821,5.672943801,P2RY6;C5AR1,2
4099,ER to Golgi vesicle-mediated transport (GO:0006888),0.148627889,0.901840803,0,0,2.255045665,4.298814948,TMED9;CAPZA2;CTSC,2
4100,cell cycle G1/S phase transition (GO:0044843),0.149439156,0.905686479,0,0,2.925901543,5.561746614,RANBP1;EIF4EBP1,2
4101,STAT cascade (GO:0097696),0.149883868,0.907304126,0,0,6.184291899,11.73713357,CCL2,2
4102,regulation of calcium ion import (GO:0090279),0.149883868,0.906229121,0,0,6.184291899,11.73713357,CCL2,2
4103,positive regulation of protein autophosphorylation (GO:0031954),0.149883868,0.90515666,0,0,6.184291899,11.73713357,CALM2,2
4104,beta-catenin destruction complex disassembly (GO:1904886),0.149883868,0.904086735,0,0,6.184291899,11.73713357,PPP1CA,2
4105,GTP metabolic process (GO:0046039),0.149883868,0.903019336,0,0,6.184291899,11.73713357,RAN,2
4106,negative regulation of protein polymerization (GO:0032272),0.149883868,0.901954455,0,0,6.184291899,11.73713357,PFN1,2
4107,protein homotrimerization (GO:0070207),0.149883868,0.900892082,0,0,6.184291899,11.73713357,MIF,2
4108,regulation of ERBB signaling pathway (GO:1901184),0.149883868,0.899832209,0,0,6.184291899,11.73713357,LGMN,2
4109,protein complex localization (GO:0031503),0.149883868,0.898774827,0,0,6.184291899,11.73713357,EZR,2
4110,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.149883868,0.897719927,0,0,6.184291899,11.73713357,CTSC,2
4111,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.149883868,0.896667501,0,0,6.184291899,11.73713357,CALM2,2
4112,sterol transport (GO:0015918),0.149883868,0.895617539,0,0,6.184291899,11.73713357,MSR1,2
4113,activation of phospholipase C activity (GO:0007202),0.149883868,0.894570033,0,0,6.184291899,11.73713357,C5AR1,2
4114,viral genome replication (GO:0019079),0.149883868,0.893524974,0,0,6.184291899,11.73713357,CCL2,2
4115,nuclear transport (GO:0051169),0.149883868,0.892482355,0,0,6.184291899,11.73713357,EIF5A,2
4116,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.149883868,0.891442165,0,0,6.184291899,11.73713357,PARK7,2
4117,regulation of DNA biosynthetic process (GO:2000278),0.149883868,0.890404398,0,0,6.184291899,11.73713357,RGCC,2
4118,negative regulation of myeloid cell differentiation (GO:0045638),0.149883868,0.889369044,0,0,6.184291899,11.73713357,PF4,2
4119,regulation of monocyte chemotaxis (GO:0090025),0.149883868,0.888336095,0,0,6.184291899,11.73713357,HMGB1,2
4120,positive regulation of interleukin-10 production (GO:0032733),0.149883868,0.887305543,0,0,6.184291899,11.73713357,HMGB1,2
4121,positive regulation of phosphatase activity (GO:0010922),0.149883868,0.886277379,0,0,6.184291899,11.73713357,CALM2,2
4122,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.149883868,0.885251595,0,0,6.184291899,11.73713357,UBB,2
4123,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.151990033,0.896653337,0,0,2.894774931,5.453583253,UBB;PSMB2,2
4124,cellular response to fibroblast growth factor stimulus (GO:0044344),0.154549557,0.910700217,0,0,2.864303616,5.348343656,UBB;CCL2,2
4125,cellular response to catecholamine stimulus (GO:0071870),0.156139093,0.919005527,0,0,5.915409642,10.98496331,GNB1,2
4126,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.156139093,0.917946765,0,0,5.915409642,10.98496331,UBB,2
4127,negative regulation of signal transduction in absence of ligand (GO:1901099),0.156139093,0.916890439,0,0,5.915409642,10.98496331,PF4,2
4128,microtubule polymerization or depolymerization (GO:0031109),0.156139093,0.915836542,0,0,5.915409642,10.98496331,TPPP3,2
4129,regulation of interleukin-8 secretion (GO:2000482),0.156139093,0.914785065,0,0,5.915409642,10.98496331,CD14,2
4130,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.156139093,0.913736,0,0,5.915409642,10.98496331,PF4,2
4131,cellular response to interleukin-6 (GO:0071354),0.156139093,0.912689338,0,0,5.915409642,10.98496331,PID1,2
4132,TOR signaling (GO:0031929),0.156139093,0.911645071,0,0,5.915409642,10.98496331,EIF4EBP1,2
4133,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.156139093,0.910603191,0,0,5.915409642,10.98496331,CALM2,2
4134,positive regulation of ion transmembrane transporter activity (GO:0032414),0.156139093,0.909563689,0,0,5.915409642,10.98496331,GLRX,2
4135,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.156139093,0.908526559,0,0,5.915409642,10.98496331,UBB,2
4136,cellular response to amyloid-beta (GO:1904646),0.156139093,0.90749179,0,0,5.915409642,10.98496331,FCGR2B,2
4137,positive regulation of monooxygenase activity (GO:0032770),0.156139093,0.906459376,0,0,5.915409642,10.98496331,PARK7,2
4138,positive regulation of cell junction assembly (GO:1901890),0.156139093,0.905429309,0,0,5.915409642,10.98496331,S100A10,2
4139,regulation of cell death (GO:0010941),0.159693502,0.924989719,0,0,2.80524581,5.146220382,UBB;PARK7,2
4140,ciliary basal body-plasma membrane docking (GO:0097711),0.159693502,0.923940978,0,0,2.80524581,5.146220382,TUBA1A;TUBB4B,2
4141,translational termination (GO:0006415),0.159693502,0.922894613,0,0,2.80524581,5.146220382,MRPL20;MRPL23,2
4142,epithelial cell differentiation (GO:0030855),0.159693502,0.921850614,0,0,2.80524581,5.146220382,DAB2;TAGLN2,2
4143,cellular response to organonitrogen compound (GO:0071417),0.16227741,0.935708046,0,0,2.776620852,5.049140646,CAPN2;EZR,2
4144,protein localization to organelle (GO:0033365),0.16227741,0.934651942,0,0,2.776620852,5.049140646,LMNA;YBX1,2
4145,DNA repair (GO:0006281),0.164089128,0.944021219,0,0,1.883106184,3.403423551,UBB;UBE2N;PARK7;HMGB1,2
4146,cilium assembly (GO:0060271),0.164089128,0.942958132,0,0,1.883106184,3.403423551,ACTR3;TUBA1A;GSN;TUBB4B,2
4147,steroid metabolic process (GO:0008202),0.167467831,0.96129172,0,0,2.721088435,4.862487082,SUMO2;LGMN,2
4148,small GTPase mediated signal transduction (GO:0007264),0.167467831,0.960211617,0,0,2.721088435,4.862487082,GNB1;PARK7,2
4149,RNA metabolic process (GO:0016070),0.16798182,0.962077695,0,0,2.12585034,3.792303404,RBM3;EIF4A1;HNRNPK,2
4150,positive regulation of dephosphorylation (GO:0035306),0.168512728,0.964036382,0,0,5.442176871,9.691123771,CALM2,2
4151,membrane protein intracellular domain proteolysis (GO:0031293),0.168512728,0.962956834,0,0,5.442176871,9.691123771,YBX1,2
4152,negative regulation of cytoskeleton organization (GO:0051494),0.168512728,0.961879701,0,0,5.442176871,9.691123771,PFN1,2
4153,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.168512728,0.960804975,0,0,5.442176871,9.691123771,PSMB2,2
4154,regulation of actin filament bundle assembly (GO:0032231),0.168512728,0.959732648,0,0,5.442176871,9.691123771,PFN1,2
4155,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.168512728,0.958662712,0,0,5.442176871,9.691123771,ALYREF,2
4156,receptor catabolic process (GO:0032801),0.168512728,0.957595159,0,0,5.442176871,9.691123771,LGMN,2
4157,positive regulation of endopeptidase activity (GO:0010950),0.168512728,0.956529981,0,0,5.442176871,9.691123771,PRELID1,2
4158,"protein alpha-1,2-demannosylation (GO:0036508)",0.168512728,0.95546717,0,0,5.442176871,9.691123771,UBB,2
4159,DNA geometric change (GO:0032392),0.168512728,0.954406718,0,0,5.442176871,9.691123771,HMGB1,2
4160,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.168512728,0.953348617,0,0,5.442176871,9.691123771,PARK7,2
4161,negative regulation of oxidative stress-induced cell death (GO:1903202),0.168512728,0.95229286,0,0,5.442176871,9.691123771,PARK7,2
4162,regulation of cell cycle G1/S phase transition (GO:1902806),0.168512728,0.951239439,0,0,5.442176871,9.691123771,PID1,2
4163,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.170073849,0.958990998,0,0,2.694146966,4.772742045,EIF5A;ALYREF,2
4164,signal peptide processing (GO:0006465),0.1746318,0.983604939,0,0,5.232862376,9.131740046,SPCS1,2
4165,negative regulation of insulin receptor signaling pathway (GO:0046627),0.1746318,0.982520479,0,0,5.232862376,9.131740046,PID1,2
4166,"protein import into nucleus, translocation (GO:0000060)",0.1746318,0.981438408,0,0,5.232862376,9.131740046,RAN,2
4167,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.1746318,0.980358718,0,0,5.232862376,9.131740046,HSD17B12,2
4168,lamellipodium organization (GO:0097581),0.1746318,0.9792814,0,0,5.232862376,9.131740046,SNX2,2
4169,peptide hormone secretion (GO:0030072),0.1746318,0.978206448,0,0,5.232862376,9.131740046,PARK7,2
4170,positive regulation of interleukin-12 production (GO:0032735),0.1746318,0.977133854,0,0,5.232862376,9.131740046,HMGB1,2
4171,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.1746318,0.976063608,0,0,5.232862376,9.131740046,CALM2,2
4172,response to amyloid-beta (GO:1904645),0.1746318,0.974995705,0,0,5.232862376,9.131740046,FCGR2B,2
4173,positive regulation of nuclear division (GO:0051785),0.1746318,0.973930136,0,0,5.232862376,9.131740046,RGCC,2
4174,regulation of lamellipodium assembly (GO:0010591),0.1746318,0.972866893,0,0,5.232862376,9.131740046,ARPC2,2
4175,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.1746318,0.97180597,0,0,5.232862376,9.131740046,CALM2,2
4176,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.177072878,0.984316879,0,0,1.591279787,2.754813849,EID1;DAB2;ENO1;PA2G4;GAPDH;S100A11,2
4177,protein import into nucleus (GO:0006606),0.177932235,0.988017622,0,0,2.616431188,4.516882532,RANBP1;RAN,2
4178,B cell receptor signaling pathway (GO:0050853),0.180564352,1,0,0,2.591512796,4.435809645,IGHM;IGKC,2
4179,peptide metabolic process (GO:0006518),0.180564352,1,0,0,2.591512796,4.435809645,EEF1G;SPCS1,2
4180,mRNA transport (GO:0051028),0.180564352,0.999370809,0,0,2.591512796,4.435809645,EIF5A;ALYREF,2
4181,negative regulation of cellular response to insulin stimulus (GO:1900077),0.180706144,0.999071996,0,0,5.039052658,8.621229937,PID1,2
4182,apoptotic cell clearance (GO:0043277),0.180706144,0.99799075,0,0,5.039052658,8.621229937,HMGB1,2
4183,regulation of muscle contraction (GO:0006937),0.180706144,0.996911841,0,0,5.039052658,8.621229937,ENO1,2
4184,regulation of transcription regulatory region DNA binding (GO:2000677),0.180706144,0.995835262,0,0,5.039052658,8.621229937,PARK7,2
4185,regulation of p38MAPK cascade (GO:1900744),0.180706144,0.994761006,0,0,5.039052658,8.621229937,EZR,2
4186,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.180706144,0.993689065,0,0,5.039052658,8.621229937,PLAUR,2
4187,regulation of T cell receptor signaling pathway (GO:0050856),0.180706144,0.992619432,0,0,5.039052658,8.621229937,EZR,2
4188,regulation of supramolecular fiber organization (GO:1902903),0.180706144,0.9915521,0,0,5.039052658,8.621229937,PARK7,2
4189,G1/S transition of mitotic cell cycle (GO:0000082),0.183202409,1,0,0,2.567064562,4.356728732,RANBP1;EIF4EBP1,2
4190,mRNA export from nucleus (GO:0006406),0.183202409,1,0,0,2.567064562,4.356728732,EIF5A;ALYREF,2
4191,positive regulation of cellular component organization (GO:0051130),0.18584618,1,0,0,2.543073304,4.279575148,DAB2;TMED9,2
4192,ATP synthesis coupled proton transport (GO:0015986),0.186736086,1,0,0,4.859086492,8.153833655,ATP5B,2
4193,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.186736086,1,0,0,4.859086492,8.153833655,PARK7,2
4194,positive regulation of lipid kinase activity (GO:0090218),0.186736086,1,0,0,4.859086492,8.153833655,CD81,2
4195,microtubule polymerization (GO:0046785),0.186736086,1,0,0,4.859086492,8.153833655,TPPP3,2
4196,leukocyte cell-cell adhesion (GO:0007159),0.186736086,1,0,0,4.859086492,8.153833655,EZR,2
4197,cristae formation (GO:0042407),0.186736086,1,0,0,4.859086492,8.153833655,ATP5B,2
4198,regulation of protein localization to nucleus (GO:1900180),0.186736086,1,0,0,4.859086492,8.153833655,PARK7,2
4199,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.186736086,1,0,0,4.859086492,8.153833655,PF4,2
4200,regulation of autophagy of mitochondrion (GO:1903146),0.186736086,1,0,0,4.859086492,8.153833655,PARK7,2
4201,regulation of protein secretion (GO:0050708),0.18849544,1,0,0,2.519526329,4.204286885,EZR;PPIA,2
4202,mitochondrial translation (GO:0032543),0.18849544,1,0,0,2.519526329,4.204286885,MRPL20;MRPL23,2
4203,negative regulation of endocytosis (GO:0045806),0.192721947,1,0,0,4.691531785,7.724639072,FCGR2B,2
4204,positive regulation of phospholipid metabolic process (GO:1903727),0.192721947,1,0,0,4.691531785,7.724639072,CD81,2
4205,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.192721947,1,0,0,4.691531785,7.724639072,DAB2,2
4206,cellular response to ketone (GO:1901655),0.192721947,1,0,0,4.691531785,7.724639072,GNB1,2
4207,cellular response to hydrogen peroxide (GO:0070301),0.192721947,1,0,0,4.691531785,7.724639072,PARK7,2
4208,hydrogen ion transmembrane transport (GO:1902600),0.192721947,1,0,0,4.691531785,7.724639072,ATP5B,2
4209,regulation of NIK/NF-kappaB signaling (GO:1901222),0.192721947,1,0,0,4.691531785,7.724639072,CD14,2
4210,cellular response to alcohol (GO:0097306),0.192721947,1,0,0,4.691531785,7.724639072,GNB1,2
4211,negative regulation of homeostatic process (GO:0032845),0.192721947,1,0,0,4.691531785,7.724639072,TSC22D3,2
4212,negative regulation of proteasomal protein catabolic process (GO:1901799),0.192721947,1,0,0,4.691531785,7.724639072,PARK7,2
4213,positive regulation of calcium-mediated signaling (GO:0050850),0.192721947,1,0,0,4.691531785,7.724639072,CALM2,2
4214,positive regulation of phosphate metabolic process (GO:0045937),0.192721947,1,0,0,4.691531785,7.724639072,MIF,2
4215,dopamine receptor signaling pathway (GO:0007212),0.192721947,1,0,0,4.691531785,7.724639072,GNB1,2
4216,regulation of actin polymerization or depolymerization (GO:0008064),0.192721947,1,0,0,4.691531785,7.724639072,PFN1,2
4217,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.193809544,1,0,0,2.473716759,4.059070713,GSN;HMGB1,2
4218,cellular response to peptide hormone stimulus (GO:0071375),0.196473954,1,0,0,2.451431023,3.989030847,PKM;GNB1,2
4219,regulation of transcription from RNA polymerase II promoter (GO:0006357),0.198592861,1,0,0,1.28787147,2.081842269,PID1;CD81;CNBP;ENO1;PARK7;YBX1;HMGB1;EID1;HNRNPK;RGCC;UBB;C1QBP;EZR;PF4,2
4220,regulation of striated muscle contraction (GO:0006942),0.198664048,1,0,0,4.535147392,7.329433474,CALM2,2
4221,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.198664048,1,0,0,4.535147392,7.329433474,UBB,2
4222,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.198664048,1,0,0,4.535147392,7.329433474,EIF4A1,2
4223,cortical cytoskeleton organization (GO:0030865),0.198664048,1,0,0,4.535147392,7.329433474,EZR,2
4224,protein alkylation (GO:0008213),0.198664048,1,0,0,4.535147392,7.329433474,RPS2,2
4225,positive regulation of histone modification (GO:0031058),0.198664048,1,0,0,4.535147392,7.329433474,UBE2N,2
4226,regulation of activated T cell proliferation (GO:0046006),0.198664048,1,0,0,4.535147392,7.329433474,HMGB1,2
4227,negative regulation of Notch signaling pathway (GO:0045746),0.198664048,1,0,0,4.535147392,7.329433474,UBB,2
4228,positive regulation of interleukin-1 secretion (GO:0050716),0.198664048,1,0,0,4.535147392,7.329433474,HMGB1,2
4229,carbohydrate derivative biosynthetic process (GO:1901137),0.198664048,1,0,0,4.535147392,7.329433474,TPI1,2
4230,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.204494069,1,0,0,2.38691968,3.788557834,UBB;PSMB2,2
4231,positive regulation of cation channel activity (GO:2001259),0.204562707,1,0,0,4.388852315,6.9645851,CALM2,2
4232,protein localization to lysosome (GO:0061462),0.204562707,1,0,0,4.388852315,6.9645851,CD81,2
4233,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.204562707,1,0,0,4.388852315,6.9645851,YWHAH,2
4234,negative regulation of stress-activated MAPK cascade (GO:0032873),0.204562707,1,0,0,4.388852315,6.9645851,EZR,2
4235,negative regulation of cation channel activity (GO:2001258),0.204562707,1,0,0,4.388852315,6.9645851,CALM2,2
4236,negative regulation of endothelial cell proliferation (GO:0001937),0.204562707,1,0,0,4.388852315,6.9645851,RGCC,2
4237,positive regulation of phospholipase C activity (GO:0010863),0.204562707,1,0,0,4.388852315,6.9645851,C5AR1,2
4238,replication fork processing (GO:0031297),0.204562707,1,0,0,4.388852315,6.9645851,ALYREF,2
4239,aminoglycan metabolic process (GO:0006022),0.204562707,1,0,0,4.388852315,6.9645851,SDC4,2
4240,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.204562707,1,0,0,4.388852315,6.9645851,RGCC,2
4241,cellular response to cAMP (GO:0071320),0.204562707,1,0,0,4.388852315,6.9645851,EZR,2
4242,phosphatidylinositol 3-kinase signaling (GO:0014065),0.204562707,1,0,0,4.388852315,6.9645851,C1QBP,2
4243,negative regulation of transferase activity (GO:0051348),0.204562707,1,0,0,4.388852315,6.9645851,PARK7,2
4244,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.204562707,1,0,0,4.388852315,6.9645851,YWHAH,2
4245,regulation of leukocyte chemotaxis (GO:0002688),0.204562707,1,0,0,4.388852315,6.9645851,PF4,2
4246,activation of protein kinase B activity (GO:0032148),0.204562707,1,0,0,4.388852315,6.9645851,PARK7,2
4247,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.204562707,1,0,0,4.388852315,6.9645851,YWHAH,2
4248,fatty-acyl-CoA biosynthetic process (GO:0046949),0.204562707,1,0,0,4.388852315,6.9645851,HSD17B12,2
4249,'de novo' posttranslational protein folding (GO:0051084),0.204562707,1,0,0,4.388852315,6.9645851,SELENOF,2
4250,peptidyl-lysine modification (GO:0018205),0.209861154,1,0,0,2.345765893,3.66246573,SUMO2;PARK7,2
4251,cellular response to oxidative stress (GO:0034599),0.209861154,1,0,0,2.345765893,3.66246573,NCF4;PARK7,2
4252,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.210418239,1,0,0,4.25170068,6.626947772,CD14,2
4253,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.210418239,1,0,0,4.25170068,6.626947772,CALM2,2
4254,organelle transport along microtubule (GO:0072384),0.210418239,1,0,0,4.25170068,6.626947772,UBB,2
4255,positive regulation of protein dephosphorylation (GO:0035307),0.210418239,1,0,0,4.25170068,6.626947772,CALM2,2
4256,regulation of protein export from nucleus (GO:0046825),0.210418239,1,0,0,4.25170068,6.626947772,PARK7,2
4257,positive regulation of bone mineralization (GO:0030501),0.210418239,1,0,0,4.25170068,6.626947772,TMEM119,2
4258,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.210418239,1,0,0,4.25170068,6.626947772,PARK7,2
4259,protein destabilization (GO:0031648),0.210418239,1,0,0,4.25170068,6.626947772,GSN,2
4260,gene silencing by miRNA (GO:0035195),0.210418239,1,0,0,4.25170068,6.626947772,RAN,2
4261,proton transport (GO:0015992),0.210418239,1,0,0,4.25170068,6.626947772,ATP5B,2
4262,positive regulation of viral genome replication (GO:0045070),0.210418239,1,0,0,4.25170068,6.626947772,PPIA,2
4263,regulation of protein autophosphorylation (GO:0031952),0.210418239,1,0,0,4.25170068,6.626947772,CALM2,2
4264,protein localization to cell periphery (GO:1990778),0.215242634,1,0,0,2.306007149,3.542002439,EZR;S100A10,2
4265,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.216230957,1,0,0,4.122861266,6.313783545,CALM2,2
4266,cellular response to amino acid stimulus (GO:0071230),0.216230957,1,0,0,4.122861266,6.313783545,CAPN2,2
4267,response to zinc ion (GO:0010043),0.216230957,1,0,0,4.122861266,6.313783545,CRIP1,2
4268,cellular response to glucagon stimulus (GO:0071377),0.216230957,1,0,0,4.122861266,6.313783545,GNB1,2
4269,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.216230957,1,0,0,4.122861266,6.313783545,RAN,2
4270,oxoacid metabolic process (GO:0043436),0.216230957,1,0,0,4.122861266,6.313783545,MIF,2
4271,positive regulation of telomere maintenance via telomerase (GO:0032212),0.216230957,1,0,0,4.122861266,6.313783545,CCT3,2
4272,sister chromatid segregation (GO:0000819),0.216230957,1,0,0,4.122861266,6.313783545,RAN,2
4273,protein trimerization (GO:0070206),0.216230957,1,0,0,4.122861266,6.313783545,MIF,2
4274,microtubule bundle formation (GO:0001578),0.216230957,1,0,0,4.122861266,6.313783545,TPPP3,2
4275,negative regulation of receptor activity (GO:2000272),0.216230957,1,0,0,4.122861266,6.313783545,CALM2,2
4276,aminoglycan catabolic process (GO:0006026),0.216230957,1,0,0,4.122861266,6.313783545,SDC4,2
4277,GPI anchor biosynthetic process (GO:0006506),0.216230957,1,0,0,4.122861266,6.313783545,PLAUR,2
4278,regulation of DNA recombination (GO:0000018),0.222001172,1,0,0,4.00160064,6.022699558,ALYREF,2
4279,positive regulation of biomineral tissue development (GO:0070169),0.222001172,1,0,0,4.00160064,6.022699558,TMEM119,2
4280,glycogen metabolic process (GO:0005977),0.222001172,1,0,0,4.00160064,6.022699558,UBB,2
4281,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.222001172,1,0,0,4.00160064,6.022699558,CD74,2
4282,regulation of T cell differentiation (GO:0045580),0.222001172,1,0,0,4.00160064,6.022699558,PRELID1,2
4283,negative regulation of mitochondrion organization (GO:0010823),0.222001172,1,0,0,4.00160064,6.022699558,PRELID1,2
4284,positive regulation of calcium ion transport (GO:0051928),0.222001172,1,0,0,4.00160064,6.022699558,CCL2,2
4285,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.222001172,1,0,0,4.00160064,6.022699558,RAN,2
4286,tRNA export from nucleus (GO:0006409),0.222001172,1,0,0,4.00160064,6.022699558,RAN,2
4287,positive regulation of cell-matrix adhesion (GO:0001954),0.222001172,1,0,0,4.00160064,6.022699558,S100A10,2
4288,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.222001172,1,0,0,4.00160064,6.022699558,UBB,2
4289,carboxylic acid metabolic process (GO:0019752),0.222001172,1,0,0,4.00160064,6.022699558,MIF,2
4290,cellular protein localization (GO:0034613),0.222033386,1,0,0,1.659200265,2.496976145,CD74;TMED9;EZR;YWHAH,2
4291,actin filament organization (GO:0007015),0.223338447,1,0,0,2.248833418,3.371151874,GSN;ALDOA,2
4292,macromolecular complex assembly (GO:0065003),0.223338447,1,0,0,2.248833418,3.371151874,CD74;CAPZA2,2
4293,regulation of interleukin-8 production (GO:0032677),0.227729192,1,0,0,3.887269193,5.751596146,PARK7,2
4294,positive regulation of leukocyte migration (GO:0002687),0.227729192,1,0,0,3.887269193,5.751596146,PF4,2
4295,ncRNA metabolic process (GO:0034660),0.227729192,1,0,0,3.887269193,5.751596146,RAN,2
4296,regulation of alcohol biosynthetic process (GO:1902930),0.227729192,1,0,0,3.887269193,5.751596146,RAN,2
4297,response to amino acid (GO:0043200),0.227729192,1,0,0,3.887269193,5.751596146,CAPN2,2
4298,positive regulation of exocytosis (GO:0045921),0.227729192,1,0,0,3.887269193,5.751596146,SDC4,2
4299,regulation of insulin receptor signaling pathway (GO:0046626),0.227729192,1,0,0,3.887269193,5.751596146,PID1,2
4300,positive regulation of chemokine production (GO:0032722),0.227729192,1,0,0,3.887269193,5.751596146,CD74,2
4301,response to glucagon (GO:0033762),0.227729192,1,0,0,3.887269193,5.751596146,GNB1,2
4302,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.227729192,1,0,0,3.887269193,5.751596146,CCT3,2
4303,macromolecule catabolic process (GO:0009057),0.227729192,1,0,0,3.887269193,5.751596146,LGMN,2
4304,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.231458064,1,0,0,2.194426158,3.211227938,UBB;PSMB2,2
4305,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.233415325,1,0,0,3.779289494,5.498623961,CD14,2
4306,antibacterial humoral response (GO:0019731),0.233415325,1,0,0,3.779289494,5.498623961,IGHM,2
4307,regulation of endothelial cell apoptotic process (GO:2000351),0.233415325,1,0,0,3.779289494,5.498623961,RGCC,2
4308,negative regulation of protein complex assembly (GO:0031333),0.233415325,1,0,0,3.779289494,5.498623961,PARK7,2
4309,positive regulation of ATPase activity (GO:0032781),0.233415325,1,0,0,3.779289494,5.498623961,PFN1,2
4310,regulation of phosphoprotein phosphatase activity (GO:0043666),0.233415325,1,0,0,3.779289494,5.498623961,CALM2,2
4311,regulation of cardiac muscle contraction (GO:0055117),0.233415325,1,0,0,3.779289494,5.498623961,CALM2,2
4312,tRNA transport (GO:0051031),0.233415325,1,0,0,3.779289494,5.498623961,RAN,2
4313,actin filament bundle organization (GO:0061572),0.233415325,1,0,0,3.779289494,5.498623961,EZR,2
4314,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.233415325,1,0,0,3.779289494,5.498623961,ALYREF,2
4315,positive regulation of osteoblast differentiation (GO:0045669),0.233415325,1,0,0,3.779289494,5.498623961,TMEM119,2
4316,protein kinase B signaling (GO:0043491),0.233415325,1,0,0,3.779289494,5.498623961,CCL2,2
4317,cholesterol biosynthetic process (GO:0006695),0.233415325,1,0,0,3.779289494,5.498623961,CNBP,2
4318,regulation of sodium ion transport (GO:0002028),0.233415325,1,0,0,3.779289494,5.498623961,YWHAH,2
4319,actin polymerization or depolymerization (GO:0008154),0.239059875,1,0,0,3.677146534,5.262148325,GSN,2
4320,regulation of receptor-mediated endocytosis (GO:0048259),0.239059875,1,0,0,3.677146534,5.262148325,HNRNPK,2
4321,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.239059875,1,0,0,3.677146534,5.262148325,GNB1,2
4322,positive regulation of signaling (GO:0023056),0.239059875,1,0,0,3.677146534,5.262148325,ANXA2,2
4323,negative regulation of blood coagulation (GO:0030195),0.239059875,1,0,0,3.677146534,5.262148325,PLAUR,2
4324,regulation of response to DNA damage stimulus (GO:2001020),0.239059875,1,0,0,3.677146534,5.262148325,UBE2N,2
4325,organophosphate biosynthetic process (GO:0090407),0.239059875,1,0,0,3.677146534,5.262148325,TPI1,2
4326,inner mitochondrial membrane organization (GO:0007007),0.239059875,1,0,0,3.677146534,5.262148325,ATP5B,2
4327,secondary alcohol biosynthetic process (GO:1902653),0.239059875,1,0,0,3.677146534,5.262148325,CNBP,2
4328,positive regulation of protein kinase B signaling (GO:0051897),0.24231284,1,0,0,2.12585034,3.013447406,C1QBP;PARK7,2
4329,apoptotic process (GO:0006915),0.243388194,1,0,0,1.759324419,2.486097122,EIF5A;CD14;GAPDH,2
4330,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.244663142,1,0,0,3.58037952,5.040719454,CALM2,2
4331,protein peptidyl-prolyl isomerization (GO:0000413),0.244663142,1,0,0,3.58037952,5.040719454,PPIA,2
4332,regulation of DNA repair (GO:0006282),0.244663142,1,0,0,3.58037952,5.040719454,UBE2N,2
4333,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.244663142,1,0,0,3.58037952,5.040719454,YWHAH,2
4334,actin filament bundle assembly (GO:0051017),0.244663142,1,0,0,3.58037952,5.040719454,EZR,2
4335,regulation of metal ion transport (GO:0010959),0.244663142,1,0,0,3.58037952,5.040719454,YWHAH,2
4336,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.244663142,1,0,0,3.58037952,5.040719454,UBB,2
4337,protein K63-linked ubiquitination (GO:0070534),0.244663142,1,0,0,3.58037952,5.040719454,UBE2N,2
4338,positive regulation of multi-organism process (GO:0043902),0.244663142,1,0,0,3.58037952,5.040719454,C1QBP,2
4339,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.245030489,1,0,0,2.10937088,2.966561476,UBB;UBE2N,2
4340,positive regulation of mitochondrion organization (GO:0010822),0.245030489,1,0,0,2.10937088,2.966561476,PLAUR;PARK7,2
4341,regulation of macromolecule metabolic process (GO:0060255),0.247749383,1,0,0,2.09314495,2.920643839,EIF4A1;CRIP1,2
4342,actin-myosin filament sliding (GO:0033275),0.250225428,1,0,0,3.488574917,4.833047457,VIM,2
4343,membrane depolarization during action potential (GO:0086010),0.250225428,1,0,0,3.488574917,4.833047457,YWHAH,2
4344,positive regulation of neuron death (GO:1901216),0.250225428,1,0,0,3.488574917,4.833047457,FCGR2B,2
4345,muscle filament sliding (GO:0030049),0.250225428,1,0,0,3.488574917,4.833047457,VIM,2
4346,regulation of cellular amide metabolic process (GO:0034248),0.250225428,1,0,0,3.488574917,4.833047457,RBM3,2
4347,regulation of cellular pH (GO:0030641),0.250225428,1,0,0,3.488574917,4.833047457,ATP5B,2
4348,retina homeostasis (GO:0001895),0.250225428,1,0,0,3.488574917,4.833047457,IGKC,2
4349,protein localization to plasma membrane (GO:0072659),0.25046936,1,0,0,2.077166745,2.875668445,EZR;S100A10,2
4350,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.253207383,1,0,0,1.72220787,2.365532473,HNRNPK;ALYREF;YBX1,2
4351,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.255747031,1,0,0,3.401360544,4.637981241,PID1,2
4352,inositol lipid-mediated signaling (GO:0048017),0.255747031,1,0,0,3.401360544,4.637981241,EZR,2
4353,regulation of proteasomal protein catabolic process (GO:0061136),0.255747031,1,0,0,3.401360544,4.637981241,UBB,2
4354,ERBB2 signaling pathway (GO:0038128),0.255747031,1,0,0,3.401360544,4.637981241,UBB,2
4355,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.255747031,1,0,0,3.401360544,4.637981241,ADSSL1,2
4356,DNA biosynthetic process (GO:0071897),0.255747031,1,0,0,3.401360544,4.637981241,PPIA,2
4357,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.258634177,1,0,0,2.030663011,2.746148157,C5AR1;HMGB1,2
4358,peptidyl-proline modification (GO:0018208),0.261228244,1,0,0,3.318400531,4.454490642,PPIA,2
4359,androgen receptor signaling pathway (GO:0030521),0.261228244,1,0,0,3.318400531,4.454490642,RAN,2
4360,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.261228244,1,0,0,3.318400531,4.454490642,EZR,2
4361,"nucleotide-excision repair, DNA incision (GO:0033683)",0.261228244,1,0,0,3.318400531,4.454490642,UBB,2
4362,regulation of cellular localization (GO:0060341),0.261228244,1,0,0,3.318400531,4.454490642,GSN,2
4363,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.261228244,1,0,0,3.318400531,4.454490642,ARG1,2
4364,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.261228244,1,0,0,3.318400531,4.454490642,UBB,2
4365,regulation of protein dephosphorylation (GO:0035304),0.261228244,1,0,0,3.318400531,4.454490642,CALM2,2
4366,regulation of cholesterol biosynthetic process (GO:0045540),0.261228244,1,0,0,3.318400531,4.454490642,RAN,2
4367,regulation of ATPase activity (GO:0043462),0.261228244,1,0,0,3.318400531,4.454490642,PFN1,2
4368,response to cAMP (GO:0051591),0.261228244,1,0,0,3.318400531,4.454490642,EZR,2
4369,sterol biosynthetic process (GO:0016126),0.261228244,1,0,0,3.318400531,4.454490642,CNBP,2
4370,JAK-STAT cascade (GO:0007259),0.261228244,1,0,0,3.318400531,4.454490642,CCL2,2
4371,defense response to bacterium (GO:0042742),0.263083794,1,0,0,1.686625063,2.252121249,IGHM;IGKC;CFP,2
4372,regulation of phagocytosis (GO:0050764),0.266669363,1,0,0,3.239390994,4.281651214,FCGR2B,2
4373,regulation of cholesterol metabolic process (GO:0090181),0.266669363,1,0,0,3.239390994,4.281651214,RAN,2
4374,cellular response to peptide (GO:1901653),0.266669363,1,0,0,3.239390994,4.281651214,FCGR2B,2
4375,DNA duplex unwinding (GO:0032508),0.266669363,1,0,0,3.239390994,4.281651214,UBB,2
4376,regulation of cellular metabolic process (GO:0031323),0.266669363,1,0,0,3.239390994,4.281651214,PID1,2
4377,negative regulation of proteolysis (GO:0045861),0.266669363,1,0,0,3.239390994,4.281651214,ECM1,2
4378,regulation of cytosolic calcium ion concentration (GO:0051480),0.269526202,1,0,0,1.971803214,2.58521082,C5AR1;HMGB1,2
4379,cellular response to radiation (GO:0071478),0.272070678,1,0,0,3.16405632,4.118631236,EEF1D,2
4380,translesion synthesis (GO:0019985),0.272070678,1,0,0,3.16405632,4.118631236,UBB,2
4381,positive regulation of interferon-gamma production (GO:0032729),0.277432478,1,0,0,3.092145949,3.964680576,CD14,2
4382,membrane depolarization (GO:0051899),0.277432478,1,0,0,3.092145949,3.964680576,YWHAH,2
4383,negative regulation of DNA metabolic process (GO:0051053),0.277432478,1,0,0,3.092145949,3.964680576,S100A11,2
4384,response to hydrogen peroxide (GO:0042542),0.277432478,1,0,0,3.092145949,3.964680576,PARK7,2
4385,positive regulation of interleukin-6 production (GO:0032755),0.277432478,1,0,0,3.092145949,3.964680576,HMGB1,2
4386,regulation of multicellular organismal development (GO:2000026),0.277432478,1,0,0,3.092145949,3.964680576,HMGB1,2
4387,regulation of cellular component organization (GO:0051128),0.277694196,1,0,0,1.929849954,2.472590889,GSN;PARK7,2
4388,positive regulation of Wnt signaling pathway (GO:0030177),0.277694196,1,0,0,1.929849954,2.472590889,UBB;PSMB2,2
4389,negative regulation of type I interferon production (GO:0032480),0.282755051,1,0,0,3.023431595,3.819121092,UBB,2
4390,regulation of focal adhesion assembly (GO:0051893),0.282755051,1,0,0,3.023431595,3.819121092,S100A10,2
4391,cholesterol transport (GO:0030301),0.282755051,1,0,0,3.023431595,3.819121092,MSR1,2
4392,amide biosynthetic process (GO:0043604),0.282755051,1,0,0,3.023431595,3.819121092,ARG1,2
4393,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.282755051,1,0,0,3.023431595,3.819121092,RAN,2
4394,regulation of intracellular pH (GO:0051453),0.282755051,1,0,0,3.023431595,3.819121092,ATP5B,2
4395,mitotic nuclear envelope disassembly (GO:0007077),0.282755051,1,0,0,3.023431595,3.819121092,LMNA,2
4396,inorganic anion transport (GO:0015698),0.282755051,1,0,0,3.023431595,3.819121092,CLIC1,2
4397,regulation of steroid biosynthetic process (GO:0050810),0.282755051,1,0,0,3.023431595,3.819121092,RAN,2
4398,regulation of dendrite morphogenesis (GO:0048814),0.282755051,1,0,0,3.023431595,3.819121092,YWHAH,2
4399,posttranscriptional regulation of gene expression (GO:0010608),0.282755051,1,0,0,3.023431595,3.819121092,RBM3,2
4400,negative regulation of immune response (GO:0050777),0.282755051,1,0,0,3.023431595,3.819121092,FCGR2B,2
4401,hexose metabolic process (GO:0019318),0.288038681,1,0,0,2.957704821,3.681338355,ALDOA,2
4402,mitochondrial gene expression (GO:0140053),0.288038681,1,0,0,2.957704821,3.681338355,MRPL23,2
4403,protein complex disassembly (GO:0043241),0.293283652,1,0,0,2.894774931,3.550774473,PPP1CA,2
4404,nucleocytoplasmic transport (GO:0006913),0.293283652,1,0,0,2.894774931,3.550774473,EIF5A,2
4405,cellular response to ionizing radiation (GO:0071479),0.293283652,1,0,0,2.894774931,3.550774473,EEF1D,2
4406,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.293283652,1,0,0,2.894774931,3.550774473,PID1,2
4407,protein methylation (GO:0006479),0.293283652,1,0,0,2.894774931,3.550774473,RPS2,2
4408,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.293283652,1,0,0,2.894774931,3.550774473,PARK7,2
4409,nuclear envelope disassembly (GO:0051081),0.293283652,1,0,0,2.894774931,3.550774473,LMNA,2
4410,RNA secondary structure unwinding (GO:0010501),0.293283652,1,0,0,2.894774931,3.550774473,EIF4A1,2
4411,aminoglycan biosynthetic process (GO:0006023),0.293283652,1,0,0,2.894774931,3.550774473,SDC4,2
4412,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.293283652,1,0,0,2.894774931,3.550774473,NDUFA4,2
4413,positive regulation of programmed cell death (GO:0043068),0.294975429,1,0,0,1.58202816,1.93143999,UBB;C1QBP;HMGB1,2
4414,positive regulation of organelle assembly (GO:1902117),0.298490245,1,0,0,2.83446712,3.426921846,SDC4,2
4415,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.298490245,1,0,0,2.83446712,3.426921846,PLAUR,2
4416,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.298490245,1,0,0,2.83446712,3.426921846,JAML,2
4417,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.298490245,1,0,0,2.83446712,3.426921846,DAB2,2
4418,"mRNA splicing, via spliceosome (GO:0000398)",0.302995325,1,0,0,1.557875058,1.860161866,HNRNPK;ALYREF;YBX1,2
4419,negative regulation of mitotic cell cycle (GO:0045930),0.303658738,1,0,0,2.776620852,3.309317731,RGCC,2
4420,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.303658738,1,0,0,2.776620852,3.309317731,CRIP1,2
4421,cytoplasmic microtubule organization (GO:0031122),0.303658738,1,0,0,2.776620852,3.309317731,EZR,2
4422,positive regulation of chemotaxis (GO:0050921),0.303658738,1,0,0,2.776620852,3.309317731,PF4,2
4423,regulation of epithelial cell migration (GO:0010632),0.303658738,1,0,0,2.776620852,3.309317731,PFN1,2
4424,glycoprotein metabolic process (GO:0009100),0.303658738,1,0,0,2.776620852,3.309317731,PARK7,2
4425,interstrand cross-link repair (GO:0036297),0.303658738,1,0,0,2.776620852,3.309317731,UBB,2
4426,regulation of mitochondrion organization (GO:0010821),0.303658738,1,0,0,2.776620852,3.309317731,PID1,2
4427,non-recombinational repair (GO:0000726),0.308789408,1,0,0,2.721088435,3.197539486,UBE2N,2
4428,regulation of megakaryocyte differentiation (GO:0045652),0.308789408,1,0,0,2.721088435,3.197539486,PF4,2
4429,organic hydroxy compound biosynthetic process (GO:1901617),0.308789408,1,0,0,2.721088435,3.197539486,PARK7,2
4430,positive regulation of response to DNA damage stimulus (GO:2001022),0.308789408,1,0,0,2.721088435,3.197539486,UBE2N,2
4431,regulation of reactive oxygen species metabolic process (GO:2000377),0.308789408,1,0,0,2.721088435,3.197539486,PID1,2
4432,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.308789408,1,0,0,2.721088435,3.197539486,CALM2,2
4433,positive regulation of nucleic acid-templated transcription (GO:1903508),0.311211718,1,0,0,1.35242964,1.578666548,CD74;DAB2;CNBP;RAN;YWHAH,2
4434,regulation of cellular protein metabolic process (GO:0032268),0.313882531,1,0,0,2.66773376,3.091200396,RBM3,2
4435,receptor internalization (GO:0031623),0.313882531,1,0,0,2.66773376,3.091200396,CD81,2
4436,wound healing (GO:0042060),0.313882531,1,0,0,2.66773376,3.091200396,JAML,2
4437,double-strand break repair via nonhomologous end joining (GO:0006303),0.313882531,1,0,0,2.66773376,3.091200396,UBE2N,2
4438,negative regulation of protein ubiquitination (GO:0031397),0.313882531,1,0,0,2.66773376,3.091200396,PARK7,2
4439,regulation of cellular amine metabolic process (GO:0033238),0.318938379,1,0,0,2.616431188,2.989946011,PSMB2,2
4440,regulation of telomere maintenance via telomerase (GO:0032210),0.318938379,1,0,0,2.616431188,2.989946011,CCT3,2
4441,regulation of cellular amino acid metabolic process (GO:0006521),0.318938379,1,0,0,2.616431188,2.989946011,PSMB2,2
4442,positive regulation of proteolysis (GO:0045862),0.323957222,1,0,0,2.567064562,2.893450909,CTSC,2
4443,positive regulation of ossification (GO:0045778),0.323957222,1,0,0,2.567064562,2.893450909,TMEM119,2
4444,axon guidance (GO:0007411),0.326471209,1,0,0,1.711376374,1.915737841,DOK2;EZR,2
4445,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),0.328939331,1,0,0,2.519526329,2.801415844,UBB,2
4446,positive regulation of protein import into nucleus (GO:0042307),0.328939331,1,0,0,2.519526329,2.801415844,DAB2,2
4447,protein localization to membrane (GO:0072657),0.331847749,1,0,0,1.690117041,1.86433262,EZR;S100A10,2
4448,sensory perception (GO:0007600),0.333884972,1,0,0,2.473716759,2.713565218,C5AR1,2
4449,action potential (GO:0001508),0.333884972,1,0,0,2.473716759,2.713565218,YWHAH,2
4450,negative regulation of supramolecular fiber organization (GO:1902904),0.333884972,1,0,0,2.473716759,2.713565218,PFN1,2
4451,cytoplasmic translation (GO:0002181),0.333884972,1,0,0,2.473716759,2.713565218,RPLP0,2
4452,positive regulation of immune response (GO:0050778),0.333884972,1,0,0,2.473716759,2.713565218,FCGR2B,2
4453,positive regulation of response to stimulus (GO:0048584),0.333884972,1,0,0,2.473716759,2.713565218,FCGR2B,2
4454,MAPK cascade (GO:0000165),0.337157271,1,0,0,1.462950772,1.59052853,UBB;PSMB2;CCL2,2
4455,regulation of cellular catabolic process (GO:0031329),0.338794411,1,0,0,2.429543246,2.629644834,HMGB1,2
4456,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.338794411,1,0,0,2.429543246,2.629644834,HMGB1,2
4457,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.338794411,1,0,0,2.429543246,2.629644834,UBB,2
4458,regulation of gene silencing by RNA (GO:0060966),0.338794411,1,0,0,2.429543246,2.629644834,RAN,2
4459,DNA recombination (GO:0006310),0.338794411,1,0,0,2.429543246,2.629644834,HMGB1,2
4460,regulation of posttranscriptional gene silencing (GO:0060147),0.338794411,1,0,0,2.429543246,2.629644834,RAN,2
4461,regulation of protein kinase B signaling (GO:0051896),0.339890052,1,0,0,1.659200265,1.790497909,C1QBP;PARK7,2
4462,chromosome organization (GO:0051276),0.343667909,1,0,0,2.38691968,2.5494199,UBB,2
4463,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.343667909,1,0,0,2.38691968,2.5494199,UBB,2
4464,cellular iron ion homeostasis (GO:0006879),0.343667909,1,0,0,2.38691968,2.5494199,UBB,2
4465,glycosaminoglycan catabolic process (GO:0006027),0.343667909,1,0,0,2.38691968,2.5494199,SDC4,2
4466,mRNA processing (GO:0006397),0.347202062,1,0,0,1.437194596,1.520333945,HNRNPK;ALYREF;YBX1,2
4467,protein polyubiquitination (GO:0000209),0.347202062,1,0,0,1.437194596,1.520333945,UBB;PSMB2;UBE2N,2
4468,negative regulation of signal transduction (GO:0009968),0.347202062,1,0,0,1.437194596,1.520333945,PID1;UBB;LGMN,2
4469,IRE1-mediated unfolded protein response (GO:0036498),0.34850573,1,0,0,2.345765893,2.472673251,LMNA,2
4470,regulation of neurogenesis (GO:0050767),0.34850573,1,0,0,2.345765893,2.472673251,YWHAH,2
4471,positive regulation of cell death (GO:0010942),0.34850573,1,0,0,2.345765893,2.472673251,FCGR2B,2
4472,protein homotetramerization (GO:0051289),0.34850573,1,0,0,2.345765893,2.472673251,ALDOA,2
4473,neuron projection development (GO:0031175),0.350566965,1,0,0,1.619695497,1.697770546,UBB;HMGB1,2
4474,response to light stimulus (GO:0009416),0.353308132,1,0,0,2.306007149,2.399203755,CIRBP,2
4475,vesicle-mediated transport (GO:0016192),0.357478267,1,0,0,1.324130625,1.362107633,SNX2;ANXA2;NCF4;S100A10,2
4476,regulation of protein metabolic process (GO:0051246),0.358075372,1,0,0,2.267573696,2.328824893,PLAUR,2
4477,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.358075372,1,0,0,2.267573696,2.328824893,PARK7,2
4478,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.358075372,1,0,0,2.267573696,2.328824893,DAB2,2
4479,ion transport (GO:0006811),0.359237835,1,0,0,1.407459536,1.440915717,UBB;TSC22D3;PLP2,2
4480,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.362807707,1,0,0,2.230400357,2.261363482,C1QBP,2
4481,cell chemotaxis (GO:0060326),0.362807707,1,0,0,2.230400357,2.261363482,C5AR1,2
4482,striated muscle contraction (GO:0006941),0.36750539,1,0,0,2.194426158,2.196658532,ALDOA,2
4483,regulation of vesicle fusion (GO:0031338),0.36750539,1,0,0,2.194426158,2.196658532,ANXA2,2
4484,positive regulation of T cell proliferation (GO:0042102),0.36750539,1,0,0,2.194426158,2.196658532,HMGB1,2
4485,regulation of DNA replication (GO:0006275),0.36750539,1,0,0,2.194426158,2.196658532,S100A11,2
4486,glycosaminoglycan metabolic process (GO:0030203),0.36750539,1,0,0,2.194426158,2.196658532,SDC4,2
4487,regulation of cellular ketone metabolic process (GO:0010565),0.36750539,1,0,0,2.194426158,2.196658532,PSMB2,2
4488,negative regulation of viral life cycle (GO:1903901),0.36750539,1,0,0,2.194426158,2.196658532,GSN,2
4489,RNA 3'-end processing (GO:0031123),0.36750539,1,0,0,2.194426158,2.196658532,ALYREF,2
4490,diterpenoid metabolic process (GO:0016101),0.372168674,1,0,0,2.159593996,2.134560206,SDC4,2
4491,regulation of translational initiation (GO:0006446),0.372168674,1,0,0,2.159593996,2.134560206,EIF4EBP1,2
4492,vesicle coating (GO:0006901),0.376797808,1,0,0,2.12585034,2.074928901,CTSC,2
4493,COPII vesicle coating (GO:0048208),0.376797808,1,0,0,2.12585034,2.074928901,CTSC,2
4494,carbohydrate homeostasis (GO:0033500),0.376797808,1,0,0,2.12585034,2.074928901,PARK7,2
4495,iron ion homeostasis (GO:0055072),0.376797808,1,0,0,2.12585034,2.074928901,UBB,2
4496,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.376797808,1,0,0,2.12585034,2.074928901,CTSC,2
4497,regulation of viral genome replication (GO:0045069),0.376797808,1,0,0,2.12585034,2.074928901,PPIA,2
4498,regulation of proteolysis (GO:0030162),0.376797808,1,0,0,2.12585034,2.074928901,PLAUR,2
4499,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.376797808,1,0,0,2.12585034,2.074928901,EIF4A1,2
4500,positive regulation of cell adhesion (GO:0045785),0.38139304,1,0,0,2.09314495,2.017634398,C1QBP,2
4501,positive regulation of cell motility (GO:2000147),0.382226105,1,0,0,1.511715797,1.453882009,DAB2;CCL7,2
4502,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.385954618,1,0,0,2.061430633,1.962555113,UBB,2
4503,DNA synthesis involved in DNA repair (GO:0000731),0.385954618,1,0,0,2.061430633,1.962555113,UBB,2
4504,regulation of myeloid cell differentiation (GO:0045637),0.385954618,1,0,0,2.061430633,1.962555113,PF4,2
4505,regulation of cell division (GO:0051302),0.385954618,1,0,0,2.061430633,1.962555113,CALM2,2
4506,cellular response to reactive oxygen species (GO:0034614),0.385954618,1,0,0,2.061430633,1.962555113,PARK7,2
4507,negative regulation of cell adhesion (GO:0007162),0.385954618,1,0,0,2.061430633,1.962555113,TGFBI,2
4508,cellular response to light stimulus (GO:0071482),0.390482787,1,0,0,2.030663011,1.909577401,GNB1,2
4509,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.390482787,1,0,0,2.030663011,1.909577401,RAN,2
4510,negative regulation of epithelial cell proliferation (GO:0050680),0.390482787,1,0,0,2.030663011,1.909577401,RGCC,2
4511,positive regulation of cellular protein localization (GO:1903829),0.390482787,1,0,0,2.030663011,1.909577401,PARK7,2
4512,phosphate-containing compound metabolic process (GO:0006796),0.392637751,1,0,0,1.478852411,1.382531567,ALDOA;PPP1CA,2
4513,regulation of gene silencing by miRNA (GO:0060964),0.394977788,1,0,0,2.00080032,1.858594934,RAN,2
4514,positive regulation of autophagy (GO:0010508),0.394977788,1,0,0,2.00080032,1.858594934,PARK7,2
4515,regulation of cardiac conduction (GO:1903779),0.394977788,1,0,0,2.00080032,1.858594934,CALM2,2
4516,cellular response to UV (GO:0034644),0.394977788,1,0,0,2.00080032,1.858594934,CRIP1,2
4517,positive regulation of apoptotic process (GO:0043065),0.395126654,1,0,0,1.325205407,1.230518052,UBB;C1QBP;HMGB1,2
4518,protein sumoylation (GO:0016925),0.399439864,1,0,0,1.971803214,1.809508138,SUMO2,2
4519,monocarboxylic acid biosynthetic process (GO:0072330),0.399439864,1,0,0,1.971803214,1.809508138,PARK7,2
4520,positive regulation of T cell activation (GO:0050870),0.399439864,1,0,0,1.971803214,1.809508138,CCL2,2
4521,COPII-coated vesicle budding (GO:0090114),0.399439864,1,0,0,1.971803214,1.809508138,CTSC,2
4522,regulation of actin filament polymerization (GO:0030833),0.399439864,1,0,0,1.971803214,1.809508138,PFN1,2
4523,termination of RNA polymerase II transcription (GO:0006369),0.399439864,1,0,0,1.971803214,1.809508138,ALYREF,2
4524,cholesterol metabolic process (GO:0008203),0.399439864,1,0,0,1.971803214,1.809508138,CNBP,2
4525,response to organic cyclic compound (GO:0014070),0.403869254,1,0,0,1.943634597,1.762223675,CCL2,2
4526,regulation of endocytosis (GO:0030100),0.403869254,1,0,0,1.943634597,1.762223675,DAB2,2
4527,regulation of innate immune response (GO:0045088),0.403869254,1,0,0,1.943634597,1.762223675,FCGR2B,2
4528,regulation of osteoblast differentiation (GO:0045667),0.403869254,1,0,0,1.943634597,1.762223675,TMEM119,2
4529,protein complex assembly (GO:0006461),0.408106535,1,0,0,1.432151808,1.283533153,SNX2;CTSC,2
4530,regulation of Notch signaling pathway (GO:0008593),0.408266196,1,0,0,1.916259462,1.716653971,UBB,2
4531,stress-activated protein kinase signaling cascade (GO:0031098),0.408266196,1,0,0,1.916259462,1.716653971,UBB,2
4532,interferon-gamma-mediated signaling pathway (GO:0060333),0.408266196,1,0,0,1.916259462,1.716653971,IFNGR1,2
4533,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.408266196,1,0,0,1.916259462,1.716653971,NCF4,2
4534,protein homooligomerization (GO:0051260),0.410666473,1,0,0,1.424653631,1.267904541,MIF;ALDOA,2
4535,recombinational repair (GO:0000725),0.412630926,1,0,0,1.889644747,1.672716792,UBE2N,2
4536,defense response to Gram-negative bacterium (GO:0050829),0.412630926,1,0,0,1.889644747,1.672716792,IGHM,2
4537,response to insulin (GO:0032868),0.412630926,1,0,0,1.889644747,1.672716792,PKM,2
4538,regulation of cell migration (GO:0030334),0.412888537,1,0,0,1.287581279,1.138965569,DAB2;CCL7;LMNA,2
4539,negative regulation of nucleic acid-templated transcription (GO:1903507),0.414065264,1,0,0,1.222961095,1.078323533,EID1;DAB2;ENO1;PA2G4,2
4540,cilium organization (GO:0044782),0.415770199,1,0,0,1.409890381,1.237351631,ACTR3;GSN,2
4541,RNA processing (GO:0006396),0.418313868,1,0,0,1.402622905,1.222418469,RBM3;HNRNPK,2
4542,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.421264686,1,0,0,1.838573267,1.589435438,UBB,2
4543,transcription-coupled nucleotide-excision repair (GO:0006283),0.421264686,1,0,0,1.838573267,1.589435438,UBB,2
4544,canonical Wnt signaling pathway (GO:0060070),0.421264686,1,0,0,1.838573267,1.589435438,PPP1CA,2
4545,regulation of protein complex assembly (GO:0043254),0.421264686,1,0,0,1.838573267,1.589435438,GSN,2
4546,chloride transport (GO:0006821),0.421264686,1,0,0,1.838573267,1.589435438,CLIC1,2
4547,positive regulation of epithelial cell migration (GO:0010634),0.425534179,1,0,0,1.814058957,1.549950125,PFN1,2
4548,glucose homeostasis (GO:0042593),0.425534179,1,0,0,1.814058957,1.549950125,PARK7,2
4549,mRNA 3'-end processing (GO:0031124),0.425534179,1,0,0,1.814058957,1.549950125,ALYREF,2
4550,mitotic spindle organization (GO:0007052),0.425534179,1,0,0,1.814058957,1.549950125,RAN,2
4551,mitotic nuclear division (GO:0140014),0.425534179,1,0,0,1.814058957,1.549950125,RAN,2
4552,retinoid metabolic process (GO:0001523),0.429772388,1,0,0,1.79018976,1.511814429,SDC4,2
4553,negative regulation of cellular amide metabolic process (GO:0034249),0.429772388,1,0,0,1.79018976,1.511814429,GAPDH,2
4554,protein transport (GO:0015031),0.432433774,1,0,0,1.248205704,1.046403406,CD74;TMED9;YWHAH,2
4555,double-strand break repair via homologous recombination (GO:0000724),0.43397954,1,0,0,1.766940542,1.474967557,UBE2N,2
4556,transforming growth factor beta receptor signaling pathway (GO:0007179),0.43397954,1,0,0,1.766940542,1.474967557,UBB,2
4557,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.438155861,1,0,0,1.744287459,1.439352146,UBB,2
4558,response to ionizing radiation (GO:0010212),0.438155861,1,0,0,1.744287459,1.439352146,EEF1D,2
4559,positive regulation of cytoskeleton organization (GO:0051495),0.438155861,1,0,0,1.744287459,1.439352146,PFN1,2
4560,regulation of cytokinesis (GO:0032465),0.438155861,1,0,0,1.744287459,1.439352146,CALM2,2
4561,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),0.442301575,1,0,0,1.72220787,1.404914032,GNB1,2
4562,fibroblast growth factor receptor signaling pathway (GO:0008543),0.442301575,1,0,0,1.72220787,1.404914032,UBB,2
4563,visual perception (GO:0007601),0.442301575,1,0,0,1.72220787,1.404914032,PITPNA,2
4564,extracellular matrix disassembly (GO:0022617),0.442301575,1,0,0,1.72220787,1.404914032,CAPN2,2
4565,regulation of autophagy (GO:0010506),0.443437004,1,0,0,1.33386688,1.084699919,HMGB1;GAPDH,2
4566,regulation of MAPK cascade (GO:0043408),0.443437004,1,0,0,1.33386688,1.084699919,CD74;HMGB1,2
4567,response to calcium ion (GO:0051592),0.446416906,1,0,0,1.700680272,1.371602036,CALM2,2
4568,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",0.450502074,1,0,0,1.679684219,1.339367765,TMED9,2
4569,regulation of protein serine/threonine kinase activity (GO:0071900),0.450502074,1,0,0,1.679684219,1.339367765,CALM2,2
4570,ERBB signaling pathway (GO:0038127),0.450502074,1,0,0,1.679684219,1.339367765,UBB,2
4571,negative regulation of MAPK cascade (GO:0043409),0.450502074,1,0,0,1.679684219,1.339367765,EZR,2
4572,negative regulation of defense response (GO:0031348),0.450502074,1,0,0,1.679684219,1.339367765,C1QBP,2
4573,protein catabolic process (GO:0030163),0.454557299,1,0,0,1.659200265,1.308165428,PSMB2,2
4574,epidermis development (GO:0008544),0.454557299,1,0,0,1.659200265,1.308165428,EMP1,2
4575,positive regulation of protein catabolic process (GO:0045732),0.454557299,1,0,0,1.659200265,1.308165428,EZR,2
4576,sensory perception of light stimulus (GO:0050953),0.454557299,1,0,0,1.659200265,1.308165428,PITPNA,2
4577,negative regulation of cell death (GO:0060548),0.454557299,1,0,0,1.659200265,1.308165428,PARK7,2
4578,negative regulation of cell cycle process (GO:0010948),0.454557299,1,0,0,1.659200265,1.308165428,MIF,2
4579,cellular protein modification process (GO:0006464),0.457004553,1,0,0,1.086262848,0.850611078,LGALS1;PSMB2;UBE2N;PLAUR;CCL2;GLRX;PARK7;PPP1CA,2
4580,regulation of anatomical structure morphogenesis (GO:0022603),0.458582799,1,0,0,1.639209901,1.277951672,PID1,2
4581,mitotic sister chromatid segregation (GO:0000070),0.458582799,1,0,0,1.639209901,1.277951672,RAN,2
4582,"retrograde transport, endosome to Golgi (GO:0042147)",0.458582799,1,0,0,1.639209901,1.277951672,SNX2,2
4583,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.458582799,1,0,0,1.639209901,1.277951672,DAB2,2
4584,ubiquitin-dependent protein catabolic process (GO:0006511),0.461300346,1,0,0,1.19345984,0.923386965,RANBP1;UBB;PSMB2,2
4585,negative regulation of endopeptidase activity (GO:0010951),0.46257879,1,0,0,1.619695497,1.248685423,GAPDH,2
4586,protein maturation (GO:0051604),0.46257879,1,0,0,1.619695497,1.248685423,SRGN,2
4587,regulation of neuron differentiation (GO:0045664),0.466545487,1,0,0,1.600640256,1.22032774,YWHAH,2
4588,positive regulation of supramolecular fiber organization (GO:1902905),0.466545487,1,0,0,1.600640256,1.22032774,PFN1,2
4589,protein modification process (GO:0036211),0.466545487,1,0,0,1.600640256,1.22032774,UBE2N,2
4590,regulation of mitotic nuclear division (GO:0007088),0.466545487,1,0,0,1.600640256,1.22032774,RGCC,2
4591,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.470483104,1,0,0,1.58202816,1.192841687,NDUFA4,2
4592,regulation of type I interferon production (GO:0032479),0.470483104,1,0,0,1.58202816,1.192841687,UBB,2
4593,calcium ion homeostasis (GO:0055074),0.478271942,1,0,0,1.546072975,1.140345997,CCL7,2
4594,organic substance transport (GO:0071702),0.478271942,1,0,0,1.546072975,1.140345997,PLTP,2
4595,T cell activation (GO:0042110),0.482123582,1,0,0,1.528701368,1.115271425,JAML,2
4596,positive regulation of protein complex assembly (GO:0031334),0.482123582,1,0,0,1.528701368,1.115271425,TPPP3,2
4597,ion transmembrane transport (GO:0034220),0.482359234,1,0,0,1.23685838,0.901751568,UBB;TSC22D3,2
4598,negative regulation of cellular protein metabolic process (GO:0032269),0.48594698,1,0,0,1.511715797,1.090938408,GAPDH,2
4599,regulation of cell cycle process (GO:0010564),0.48974234,1,0,0,1.495103536,1.067318328,CALM2,2
4600,Ras protein signal transduction (GO:0007265),0.49182862,1,0,0,1.214771623,0.86203226,GNB1;PARK7,2
4601,axonogenesis (GO:0007409),0.49182862,1,0,0,1.214771623,0.86203226,DOK2;EZR,2
4602,protein-DNA complex assembly (GO:0065004),0.493509867,1,0,0,1.478852411,1.044383949,UBB,2
4603,negative regulation of kinase activity (GO:0033673),0.493509867,1,0,0,1.478852411,1.044383949,PARK7,2
4604,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.497574859,1,0,0,1.076379919,0.751323155,RBM3;TSC22D3;CNBP;YBX1;HMGB1,2
4605,cellular transition metal ion homeostasis (GO:0046916),0.500962233,1,0,0,1.447387466,1.00046977,UBB,2
4606,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.500962233,1,0,0,1.447387466,1.00046977,HMGB1,2
4607,respiratory electron transport chain (GO:0022904),0.504647473,1,0,0,1.432151808,0.979441701,NDUFA4,2
4608,endosomal transport (GO:0016197),0.505828468,1,0,0,1.183081928,0.806338555,SNX2;UBB,2
4609,extracellular matrix organization (GO:0030198),0.505828468,1,0,0,1.183081928,0.806338555,CAPN2;TGFBI,2
4610,positive regulation of protein localization to membrane (GO:1905477),0.508305681,1,0,0,1.41723356,0.959002661,YWHAH,2
4611,regulation of heart contraction (GO:0008016),0.508305681,1,0,0,1.41723356,0.959002661,CALM2,2
4612,regulation of cytoskeleton organization (GO:0051493),0.508305681,1,0,0,1.41723356,0.959002661,CAPN2,2
4613,positive regulation of protein metabolic process (GO:0051247),0.511937056,1,0,0,1.402622905,0.939131213,HNRNPK,2
4614,cellular metal ion homeostasis (GO:0006875),0.511937056,1,0,0,1.402622905,0.939131213,CCL7,2
4615,"regulation of transcription, DNA-templated (GO:0006355)",0.513803645,1,0,0,1.021046317,0.679929139,EID1;CD74;DAB2;TSC22D3;CNBP;ENO1;PARK7;PA2G4;YBX1;HMGB1;RAN;YWHAH,2
4616,histone modification (GO:0016570),0.519120086,1,0,0,1.374287089,0.90101016,UBE2N,2
4617,response to UV (GO:0009411),0.519120086,1,0,0,1.374287089,0.90101016,CIRBP,2
4618,glycosaminoglycan biosynthetic process (GO:0006024),0.522672127,1,0,0,1.360544218,0.882722339,SDC4,2
4619,proteasomal protein catabolic process (GO:0010498),0.524105164,1,0,0,1.143314469,0.738653084,UBB;PSMB2,2
4620,organelle assembly (GO:0070925),0.526028975,1,0,0,1.082661181,0.69550044,ACTR3;GSN;CIRBP,2
4621,cellular response to transforming growth factor beta stimulus (GO:0071560),0.526198108,1,0,0,1.347073483,0.864925582,UBB,2
4622,transmembrane transport (GO:0055085),0.529600828,1,0,0,1.07694793,0.684542254,UBB;PSMB2;TSC22D3,2
4623,cellular divalent inorganic cation homeostasis (GO:0072503),0.529698219,1,0,0,1.33386688,0.847602819,CCL7,2
4624,regulation of kinase activity (GO:0043549),0.529698219,1,0,0,1.33386688,0.847602819,CD74,2
4625,intrinsic apoptotic signaling pathway (GO:0097193),0.529698219,1,0,0,1.33386688,0.847602819,CRIP1,2
4626,positive regulation of angiogenesis (GO:0045766),0.536621582,1,0,0,1.308215594,0.814314655,ECM1,2
4627,positive regulation of vasculature development (GO:1904018),0.540045207,1,0,0,1.295756398,0.798318661,ECM1,2
4628,"DNA-templated transcription, termination (GO:0006353)",0.546817268,1,0,0,1.271536652,0.767551141,ALYREF,2
4629,positive regulation of cellular catabolic process (GO:0031331),0.546817268,1,0,0,1.271536652,0.767551141,EZR,2
4630,negative regulation of response to external stimulus (GO:0032102),0.550166068,1,0,0,1.259763165,0.752752715,C1QBP,2
4631,regulation of response to external stimulus (GO:0032101),0.550166068,1,0,0,1.259763165,0.752752715,PARK7,2
4632,positive regulation of cell cycle process (GO:0090068),0.550166068,1,0,0,1.259763165,0.752752715,RGCC,2
4633,monocarboxylic acid metabolic process (GO:0032787),0.553490289,1,0,0,1.248205704,0.738327494,LDHA,2
4634,regulation of cytokine production (GO:0001817),0.553490289,1,0,0,1.248205704,0.738327494,UBB,2
4635,negative regulation of hydrolase activity (GO:0051346),0.553490289,1,0,0,1.248205704,0.738327494,ECM1,2
4636,circulatory system development (GO:0072359),0.55679011,1,0,0,1.23685838,0.724263366,CRIP1,2
4637,regulation of cell motility (GO:2000145),0.55679011,1,0,0,1.23685838,0.724263366,LMNA,2
4638,Wnt signaling pathway (GO:0016055),0.55679011,1,0,0,1.23685838,0.724263366,UBB,2
4639,regulation of Wnt signaling pathway (GO:0030111),0.55679011,1,0,0,1.23685838,0.724263366,PPP1CA,2
4640,negative regulation of protein kinase activity (GO:0006469),0.55679011,1,0,0,1.23685838,0.724263366,PARK7,2
4641,macroautophagy (GO:0016236),0.56006571,1,0,0,1.225715511,0.710548708,UBB,2
4642,cellular response to insulin stimulus (GO:0032869),0.56006571,1,0,0,1.225715511,0.710548708,PKM,2
4643,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.56006571,1,0,0,1.225715511,0.710548708,YWHAH,2
4644,protein modification by small protein conjugation (GO:0032446),0.564483825,1,0,0,1.022965577,0.584976267,UBB;SUMO2;UBE2N,2
4645,protein deubiquitination (GO:0016579),0.567788189,1,0,0,1.05468544,0.596959169,UBB;PSMB2,2
4646,positive regulation of kinase activity (GO:0033674),0.569748936,1,0,0,1.19345984,0.671392145,CD74,2
4647,protein O-linked glycosylation (GO:0006493),0.576086514,1,0,0,1.172882946,0.646841932,CFP,2
4648,negative regulation of cell growth (GO:0030308),0.576086514,1,0,0,1.172882946,0.646841932,ENO1,2
4649,epithelium development (GO:0060429),0.576086514,1,0,0,1.172882946,0.646841932,TAGLN2,2
4650,protein modification by small protein removal (GO:0070646),0.576173786,1,0,0,1.038583372,0.572618739,UBB;PSMB2,2
4651,regulation of macroautophagy (GO:0016241),0.579220446,1,0,0,1.162858306,0.635004522,GAPDH,2
4652,chromatin remodeling (GO:0006338),0.579220446,1,0,0,1.162858306,0.635004522,HMGB1,2
4653,cytosolic transport (GO:0016482),0.58541944,1,0,0,1.143314469,0.61216109,SNX2,2
4654,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.58541944,1,0,0,1.143314469,0.61216109,CALM2,2
4655,plasma membrane bounded cell projection organization (GO:0120036),0.58541944,1,0,0,1.143314469,0.61216109,HMGB1,2
4656,regulation of phosphorylation (GO:0042325),0.588484837,1,0,0,1.133786848,0.601138456,MIF,2
4657,negative regulation of growth (GO:0045926),0.591527722,1,0,0,1.124416709,0.590371316,ENO1,2
4658,Golgi organization (GO:0007030),0.594548258,1,0,0,1.115200178,0.579852116,TMED9,2
4659,regulation of cell differentiation (GO:0045595),0.594548258,1,0,0,1.115200178,0.579852116,PA2G4,2
4660,cellular calcium ion homeostasis (GO:0006874),0.600522936,1,0,0,1.097213079,0.559528685,CCL7,2
4661,dephosphorylation (GO:0016311),0.603477401,1,0,0,1.088435374,0.549710678,PPP1CA,2
4662,protein dephosphorylation (GO:0006470),0.606410162,1,0,0,1.079796998,0.54011304,PPP1CA,2
4663,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.606410162,1,0,0,1.079796998,0.54011304,CCL2,2
4664,negative regulation of response to stimulus (GO:0048585),0.612211208,1,0,0,1.06292517,0.521553938,FCGR2B,2
4665,protein targeting (GO:0006605),0.629109699,1,0,0,1.015331506,0.470555015,SPCS1,2
4666,mitochondrial transport (GO:0006839),0.634578372,1,0,0,1.00040016,0.454976472,ATP5B,2
4667,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.635290337,1,0,0,0.931879601,0.422768765,UBB;PSMB2,2
4668,regulation of signal transduction by p53 class mediator (GO:1901796),0.642631571,1,0,0,0.97880879,0.432813296,UBB,2
4669,response to cytokine (GO:0034097),0.642631571,1,0,0,0.97880879,0.432813296,PID1,2
4670,cellular response to growth factor stimulus (GO:0071363),0.645276602,1,0,0,0.971817298,0.425730043,CCL2,2
4671,regulation of primary metabolic process (GO:0080090),0.645276602,1,0,0,0.971817298,0.425730043,PSMB2,2
4672,response to lipid (GO:0033993),0.647902188,1,0,0,0.964924977,0.418792433,PF4,2
4673,regulation of small GTPase mediated signal transduction (GO:0051056),0.647902188,1,0,0,0.964924977,0.418792433,GDI2,2
4674,inorganic cation transmembrane transport (GO:0098662),0.647902188,1,0,0,0.964924977,0.418792433,ATP5B,2
4675,double-strand break repair (GO:0006302),0.650508472,1,0,0,0.958129731,0.411996702,UBE2N,2
4676,modification-dependent protein catabolic process (GO:0019941),0.650508472,1,0,0,0.958129731,0.411996702,RANBP1,2
4677,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.653095593,1,0,0,0.951429523,0.405339204,JAML,2
4678,regulation of nucleic acid-templated transcription (GO:1903506),0.657195584,1,0,0,0.89509488,0.375737211,TSC22D3;CNBP;YBX1;HMGB1,2
4679,neuron development (GO:0048666),0.658212909,1,0,0,0.938306357,0.392424894,HMGB1,2
4680,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.658212909,1,0,0,0.938306357,0.392424894,UBB,2
4681,regulation of protein kinase activity (GO:0045859),0.665748633,1,0,0,0.919286634,0.37400543,PARK7,2
4682,heart development (GO:0007507),0.670680536,1,0,0,0.907029478,0.362324133,CRIP1,2
4683,spermatogenesis (GO:0007283),0.680328543,1,0,0,0.883470271,0.340294589,TMEM119,2
4684,male gamete generation (GO:0048232),0.682696351,1,0,0,0.877770463,0.335049462,TMEM119,2
4685,transcription from RNA polymerase II promoter (GO:0006366),0.696778393,1,0,0,0.83984211,0.303424761,ALYREF;C5AR1;YBX1,2
4686,negative regulation of intracellular signal transduction (GO:1902532),0.698790304,1,0,0,0.83984211,0.301003255,PLAUR,2
4687,cellular response to DNA damage stimulus (GO:0006974),0.700730895,1,0,0,0.824572253,0.293243746,PARK7;CRIP1,2
4688,neuron projection morphogenesis (GO:0048812),0.703237797,1,0,0,0.829600133,0.292069176,UBB,2
4689,regulation of mitotic cell cycle (GO:0007346),0.70762006,1,0,0,0.81960495,0.283458707,EIF4EBP1,2
4690,regulation of inflammatory response (GO:0050727),0.709787028,1,0,0,0.814697136,0.279270288,PARK7,2
4691,positive regulation of protein kinase activity (GO:0045860),0.722457895,1,0,0,0.786441744,0.255669174,CALM2,2
4692,protein ubiquitination (GO:0016567),0.723773592,1,0,0,0.80505575,0.260255729,UBB;PSMB2;UBE2N,2
4693,organonitrogen compound biosynthetic process (GO:1901566),0.740441096,1,0,0,0.747551768,0.22464618,ARG1,2
4694,post-translational protein modification (GO:0043687),0.742518575,1,0,0,0.760080569,0.226281604,LGALS1;PSMB2,2
4695,regulation of cell growth (GO:0001558),0.776366178,1,0,0,0.673536741,0.170493023,ENO1,2
4696,positive regulation of signal transduction (GO:0009967),0.784546954,1,0,0,0.657267738,0.159485265,CD74,2
4697,protein oligomerization (GO:0051259),0.80151324,1,0,0,0.624102852,0.13808512,SNX2,2
4698,regulation of intracellular signal transduction (GO:1902531),0.820743019,1,0,0,0.643283318,0.12707755,UBB;GDI2,2
4699,sensory perception of chemical stimulus (GO:0007606),0.91281828,1,0,0,0.414800066,0.037837421,C5AR1,2
4700,"transcription, DNA-templated (GO:0006351)",0.929871658,1,0,0,0.381104823,0.027709638,YBX1,2
4701,phosphorylation (GO:0016310),0.944030013,1,0,0,0.351561813,0.020249018,CCL2,2
4702,protein phosphorylation (GO:0006468),0.970288002,1,0,0,0.288862891,0.008712781,CCL2,2
4703,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),1.56E-81,7.97E-78,0,0,32.04623063,5962.620329,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS4X;RPS15;RPL7A;RPS14;RPS16;RPL18A;RPS19;RPS18;SEC61B;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4704,protein targeting to ER (GO:0045047),5.52E-78,1.41E-74,0,0,29.4302118,5235.43435,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;SEC61G;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4705,cotranslational protein targeting to membrane (GO:0006613),1.05E-77,1.78E-74,0,0,30.17956843,5349.376819,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS4X;RPS15;RPL7A;RPS14;RPS16;RPL18A;RPS19;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4706,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",2.65E-74,3.38E-71,0,0,25.94196531,4395.039616,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;PABPC1;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;EIF3E;RPS24;RPS23,3
4707,viral gene expression (GO:0019080),2.38E-71,2.43E-68,0,0,25.55747237,4156.018503,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4708,viral transcription (GO:0019083),2.19E-70,1.86E-67,0,0,24.8849073,3991.465451,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4709,nuclear-transcribed mRNA catabolic process (GO:0000956),1.01E-60,7.37E-58,0,0,17.0212766,2351.387398,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;ZFP36;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;PABPC1;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;EIF3E;RPS24;RPS23,3
4710,viral process (GO:0016032),1.87E-57,1.19E-54,0,0,14.12021437,1844.382939,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;AP2A2;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;AP1S2;RPL37;RAC1;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;HCK;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;PCBP2;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;EIF3F;RPS24;RPS23,3
4711,peptide biosynthetic process (GO:0043043),2.54E-56,1.44E-53,0,0,16.21073961,2075.188164,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;EEF1A1;RPL24;RPL27;RPL26;RPL29;RPL28;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4712,rRNA metabolic process (GO:0016072),3.44E-52,1.76E-49,0,0,14.11382802,1672.46478,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4713,rRNA processing (GO:0006364),6.70E-52,3.11E-49,0,0,13.97477553,1646.672957,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4714,translation (GO:0006412),1.65E-50,7.04E-48,0,0,12.58129648,1442.138659,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;EEF1B2;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;EEF1A1;RPL24;RPL27;RPL26;RPL29;RPL28;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;EEF2;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4715,ribosome biogenesis (GO:0042254),1.10E-48,4.34E-46,0,0,12.49726622,1380.006253,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4716,ncRNA processing (GO:0034470),1.47E-48,5.37E-46,0,0,12.44245365,1370.380022,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;RPS23,3
4717,cellular macromolecule biosynthetic process (GO:0034645),5.65E-42,1.92E-39,0,0,8.479802652,805.3783664,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;EEF1B2;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;EEF1A1;RPL24;RPL27;RPL26;RPL29;RPL28;RPL10;RPL11;RPS15A;ST3GAL4;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;NFE2;RPL35A;RPL23A;EEF2;RPS26;FAM111A;RPS25;RPS28;RPS27;RPS29;RPL27A;BCL3;RPS24;RPS23,3
4718,gene expression (GO:0010467),8.52E-40,2.72E-37,0,0,7.688953155,691.7039455,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;RPL8;RPL10A;RPL9;RPL6;RPL7;DUSP11;RPS15;RPS4X;RBM3;RPL7A;RPS14;RPS16;RPS19;RPL18A;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;EEF1A1;SNRPG;RPL24;RPL27;RPL26;SRSF5;RPL29;RPL28;RPL10;RPL11;RPS15A;RPS3;RPL13;RPL15;RPL18;RPS27A;RPL17;RPL19;NFE2;RPL35A;RPL23A;SORL1;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;BCL3;RPS24;RPS23,3
4719,cellular protein metabolic process (GO:0044267),4.68E-39,1.40E-36,0,0,6.921595867,610.8887402,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP0;UBE2D3;RPL8;RPL10A;RPL9;RPL6;RPL7;RPS15;RPS4X;RPL7A;RPS14;RPS16;SERP1;RPL18A;RPS19;RPS18;RPL37;RPS11;RPL39;RPS10;RPS13;ATG3;RPS9;RPL21;RPS7;RPS5;RPL22;RPS6;RPL13A;RPSA;EEF1A1;VCAN;RPL24;RPL27;RPL26;RPL29;UBA52;RPL28;RPL10;RPL11;C3;RPS15A;RPS3;RPL13;RPL15;IGFBP6;RPS27A;RPL18;RPL17;RPL19;NAPSA;H3F3A;RPL35A;RPL23A;SORL1;RPS26;RPS25;RPS28;RPS27;RPS29;RPL27A;RPS24;MSRB1;RPS23,3
4720,cytoplasmic translation (GO:0002181),3.90E-36,1.10E-33,0,0,25.78981302,2102.72833,RPL4;RPL30;RPL32;RPL31;RPLP0;RPL11;RPL10A;RPL8;RPL9;RPL6;RPL7;RPL18A;RPS3;RPL15;RPL18;RPL39;RPL17;RPL19;RPS7;RPL22;RPL35A;RPS26;RPS28;EIF3M;RPS29;RPL27A;RPL24;RPL26;RPL29;RPS23,3
4721,neutrophil degranulation (GO:0043312),1.33E-15,3.57E-13,0,0,4.235618597,145.0920666,SLC44A2;GMFG;MGST1;FPR2;ITGAL;AP2A2;PLAC8;C3;RAP1B;CNN2;RAP1A;ADGRE5;RAC1;PGLYRP1;S100A11;CD33;CD177;CD53;HSPA8;HGSNAT;FCER1G;CD300A;NFAM1;MCEMP1;EEF2;MMP8;SVIP;EEF1A1;FGR;CEACAM1;LRG1;PTPRC;TYROBP;BIN2;SLPI;SELL;TARM1;LCN2;PTPN6;PRTN3;CD47;HSPA1B;HSPA1A,3
4722,neutrophil activation involved in immune response (GO:0002283),1.79E-15,4.56E-13,0,0,4.200613485,142.64534,SLC44A2;GMFG;MGST1;FPR2;ITGAL;AP2A2;PLAC8;C3;RAP1B;CNN2;RAP1A;ADGRE5;RAC1;PGLYRP1;S100A11;CD33;CD177;CD53;HSPA8;HGSNAT;FCER1G;CD300A;NFAM1;MCEMP1;EEF2;MMP8;SVIP;EEF1A1;FGR;CEACAM1;LRG1;PTPRC;TYROBP;BIN2;SLPI;SELL;TARM1;LCN2;PTPN6;PRTN3;CD47;HSPA1B;HSPA1A,3
4723,neutrophil mediated immunity (GO:0002446),2.40E-15,5.83E-13,0,0,4.166182227,140.2521688,SLC44A2;GMFG;MGST1;FPR2;ITGAL;AP2A2;PLAC8;C3;RAP1B;CNN2;RAP1A;ADGRE5;RAC1;PGLYRP1;S100A11;CD33;CD177;CD53;HSPA8;HGSNAT;FCER1G;CD300A;NFAM1;MCEMP1;EEF2;MMP8;SVIP;EEF1A1;FGR;CEACAM1;LRG1;PTPRC;TYROBP;BIN2;SLPI;SELL;TARM1;LCN2;PTPN6;PRTN3;CD47;HSPA1B;HSPA1A,3
4724,ribosome assembly (GO:0042255),3.17E-14,7.35E-12,0,0,13.27195056,412.5309788,RPL5;RPL3;RPL10;RPS5;RPL11;RPSA;RPL23A;RPL6;RPS15;RPS14;RPS28;RPS27;RPS19;RPL24;RPS10;NOP53,3
4725,ribonucleoprotein complex assembly (GO:0022618),1.86E-11,4.12E-09,0,0,6.324253512,156.2722694,RPL5;RPL3;RPL10;RPS5;RPL11;RPSA;RPL23A;RPL6;RPS15;RPS14;RPS28;RPS27;RPS19;SNRPG;RPL24;SRSF5;RPS10;SF3B1;NOP53;SNRPB;RPS23,3
4726,ribosomal small subunit biogenesis (GO:0042274),1.05E-10,2.23E-08,0,0,12.60835303,289.7046064,RPS15;RPS14;RPS28;RPS16;RPS27;RPS19;RPS7;RPS5;RPS6;RPSA;RPS10;RPS24,3
4727,ribosomal large subunit biogenesis (GO:0042273),6.96E-10,1.42E-07,0,0,9.604018913,202.5009836,RPL5;RPL3;RPL10;RPL11;RPL35A;RPL23A;RPL10A;RPL6;RPL7;RPL7A;RPL24;RPL26;NOP53,3
4728,ribosomal small subunit assembly (GO:0000028),2.31E-09,4.53E-07,0,0,19.90792584,395.8889366,RPS15;RPS14;RPS28;RPS27;RPS19;RPS5;RPSA;RPS10,3
4729,positive regulation of cellular amide metabolic process (GO:0034250),6.42E-08,1.21E-05,0,0,8.388621978,138.9320057,RPS4X;RBM3;RPL5;BCL3;RACK1;FAM129A;EIF3E;RPL26;EEF2;THBS1;TNFRSF1A,3
4730,ribosomal large subunit assembly (GO:0000027),1.93E-07,3.52E-05,0,0,12.20163197,188.645899,RPL5;RPL3;RPL10;RPL11;RPL24;RPL23A;NOP53;RPL6,3
4731,cytokine-mediated signaling pathway (GO:0019221),2.55E-07,4.49E-05,0,0,2.610167722,39.62324001,IFITM3;SP100;CSF3R;IFITM2;CEBPD;RPLP0;F13A1;ADIPOR1;SAMHD1;PSMA7;IKBKB;RAP1B;CNN2;SOCS3;RPS27A;JUNB;CCR2;HSPA8;TGFB1;IFNGR1;IL1R2;TALDO1;FOS;TNFRSF1A;IL17RA;HCK;CEACAM1;IL1B;LCN2;PTPN6;PRTN3;IRF5;PLCB1;UBA52;MYD88,3
4732,cellular response to cytokine stimulus (GO:0071345),5.49E-07,9.34E-05,0,0,2.896886364,41.75995244,CSF3R;CEBPD;F13A1;CIB1;ZFP36L2;IKBKB;SOCS3;ZFP36;SBNO2;RPS3;RPS27A;JUNB;CCR2;PTPN18;HSPA8;XBP1;TGFB1;IFNGR1;IL1R2;RPL13A;FOS;TNFRSF1A;HCK;IL1B;LCN2;PTPN6;PRTN3;UBA52,3
4733,positive regulation of translation (GO:0045727),8.26E-07,0.000136036,0,0,6.583475477,92.20940536,RPS4X;RBM3;RPL5;RPS9;TGFB1;BCL3;FAM129A;EIF3E;RPL26;EEF2;THBS1,3
4734,regulation of translation (GO:0006417),3.31E-06,0.000528446,0,0,3.755993018,47.39093653,RPL5;BTG2;RPL10;H3F3A;FAM129A;RPL13A;EEF2;THBS1;EIF1;RPS4X;RBM3;BCL3;RACK1;RPS3;EIF3H;EIF3E;RPL26,3
4735,transforming growth factor beta receptor signaling pathway (GO:0007179),4.99E-06,0.000771935,0,0,6.140431672,74.96046178,KLF10;DUSP22;JUN;TGFB1;HPGD;GCNT2;ZYX;FOS;RPS27A;UBA52,3
4736,positive regulation of cytokine production (GO:0001819),5.11E-06,0.000767276,0,0,3.637024914,44.31310109,FAM49B;CEBPB;TGFB1;NFAM1;IL17RA;C3;FGR;IL1B;RARA;RPS3;FLOT1;IRF5;PLCB1;HSPA1B;MYD88;CCR2;HSPA1A,3
4737,positive regulation of cellular biosynthetic process (GO:0031328),8.07E-06,0.001175958,0,0,4.137115839,48.51971467,RPL5;SCARB1;FAM129A;EEF2;THBS1;KLF2;RPS4X;RBM3;IL1B;BCL3;EIF3E;RPL26;LDLR;CD244,3
4738,regulation of cell proliferation (GO:0042127),8.65E-06,0.001226148,0,0,2.233260912,26.03522818,BTG2;BTG1;HMGB2;SLA;CIB1;THBS1;RPS4X;RPS15A;GCNT2;HES1;IGFBP6;JUNB;IER5;S100A11;CD33;LYN;CDKN2D;KLF10;JUN;RPS9;XBP1;JUND;TGFB1;TNFRSF1A;DUSP22;FGR;HCK;IL1B;RARA;PTPN6;PRTN3;CD47;SLC25A5;HSPA1B;HSPA1A,3
4739,cellular response to transforming growth factor beta stimulus (GO:0071560),9.59E-06,0.001322187,0,0,5.149451115,59.50259678,KLF10;DUSP22;JUN;TGFB1;HPGD;GCNT2;ZYX;FOS;RPS27A;UBA52;ZFP36L2,3
4740,positive regulation of protein modification process (GO:0031401),1.07E-05,0.001438728,0,0,4.036210575,46.19036888,LYN;TGFB1;FAM129A;PPP2R5A;CIB1;FPR2;SVIP;C3;CCND3;IL1B;FLOT1;RACK1;RAC1;RAMP1,3
4741,regulation of cytokine-mediated signaling pathway (GO:0001959),2.25E-05,0.002942245,0,0,5.195749877,55.608056,IKBKB;SOCS3;PTPN1;PTPRC;IFNGR1;RACK1;PTPN6;RPS27A;UBA52;TNFRSF1A,3
4742,positive regulation of cellular protein metabolic process (GO:0032270),2.48E-05,0.003158737,0,0,5.139274334,54.50862096,RPS4X;RBM3;RPL5;TGFB1;BCL3;FAM129A;EIF3E;RPL26;EEF2;THBS1,3
4743,regulation of phagocytosis (GO:0050764),2.56E-05,0.003191156,0,0,7.880220646,83.30483614,FGR;SCARB1;HCK;FCER1G;IL1B;RACK1;PRTN3,3
4744,negative regulation of lipid metabolic process (GO:0045833),3.76E-05,0.004570873,0,0,12.44245365,126.7632857,BSCL2;CEACAM1;IL1B;APOC1;PPP2R5A,3
4745,positive regulation of cellular process (GO:0048522),5.01E-05,0.005939663,0,0,2.364066194,23.41013381,CIB1;THBS1;RPS4X;RPS15A;RPS19;RACK1;GCNT2;FLOT1;HES1;JUNB;IER5;LYN;JUN;RPS9;XBP1;JUND;TGFB1;H3F3A;SORL1;HCK;IL1B;RARA;PTPN6;PRTN3;CD47;SLC25A5,3
4746,positive regulation of macromolecule biosynthetic process (GO:0010557),5.37E-05,0.006229849,0,0,3.967663542,39.0092639,RPS4X;RBM3;RPL5;XBP1;TGFB1;BCL3;FAM129A;EIF3E;RPL26;EEF2;THBS1;SVIP,3
4747,regulation of erythrocyte differentiation (GO:0045646),5.90E-05,0.006685397,0,0,8.596604341,83.72019021,LYN;ZFP36;SPI1;HMGB2;HSPA1B;HSPA1A,3
4748,regulation of DNA binding (GO:0051101),0.000119951,0.013306694,0,0,6.244703154,56.37986856,SP100;JUN;TGFB1;BCL3;HMGB2;ID3;HES1,3
4749,negative regulation of gene expression (GO:0010629),0.00014476,0.015717243,0,0,2.138735167,18.90734537,BTG2;SPI1;HMGB2;AHR;ZFP36L2;ZFP36;SBNO2;RACK1;RPS3;HES1;JARID2;XDH;RPS13;KLF10;HSPA8;JUN;TGFB1;H3F3A;ARID5A;RPL13A;RPS26;BCL3;RARA;ID3;PLCB1;PFDN5;HSPA1B;HSPA1A,3
4750,regulation of endothelial cell development (GO:1901550),0.000179167,0.01904773,0,0,23.64066194,203.9524876,IKBKB;IL1B;TNFRSF1A,3
4751,negative regulation of leukocyte degranulation (GO:0043301),0.000179167,0.018659001,0,0,23.64066194,203.9524876,CEACAM1;CD300A;CCR2,3
4752,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.000191346,0.019528763,0,0,5.806478371,49.71174503,IKBKB;RACK1;RPS27A;UBA52;HSPA1B;TNFRSF1A;HSPA1A,3
4753,ATP metabolic process (GO:0046034),0.000191346,0.019145846,0,0,5.806478371,49.71174503,HSPA8;TGFB1;ATP5C1;UQCRH;NADK;HSPA1B;HSPA1A,3
4754,response to cAMP (GO:0051591),0.000207504,0.020363366,0,0,6.919218128,58.67744633,RAP1B;JUN;RAP1A;JUND;AHR;JUNB,3
4755,apoptotic cell clearance (GO:0043277),0.000227204,0.021875928,0,0,8.755800718,73.45819432,SCARB1;RAC2;RARA;RAC1;THBS1,3
4756,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.000266427,0.025177381,0,0,3.586859053,29.52131746,KLF10;DUSP22;JUN;TGFB1;HPGD;UBE2D3;GCNT2;ZYX;FOS;RPS27A;UBA52,3
4757,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.000293413,0.027223395,0,0,11.82033097,96.14573597,LYN;HCK;TGFB1;IL1B,3
4758,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.000293413,0.026737263,0,0,11.82033097,96.14573597,BTG2;ZFP36;PABPC1;ZFP36L2,3
4759,negative regulation of nitrogen compound metabolic process (GO:0051172),0.00030862,0.027629648,0,0,20.26342452,163.7973353,TGFB1;APOC1;LDLR,3
4760,regulation of interleukin-23 production (GO:0032667),0.00030862,0.027153275,0,0,20.26342452,163.7973353,RAC1;MYD88;IL17RA,3
4761,negative regulation of MAP kinase activity (GO:0043407),0.000325124,0.028120473,0,0,5.338213986,42.8728185,DUSP22;LYN;PTPN1;CD300A;DUSP1;IL1B;SORL1,3
4762,dephosphorylation (GO:0016311),0.000328586,0.027946208,0,0,3.78250591,30.33839459,DUSP11;DUSP22;PTPN1;PTPN18;PTPRC;DUSP1;PTPRO;PPP2R5A;PTPN6;SSH2,3
4763,inflammatory response (GO:0006954),0.000341049,0.028530668,0,0,2.803240546,22.37963088,LYN;CEBPB;TGFB1;NFAM1;FPR2;FOS;MEFV;ITGAL;THBS1;TNFRSF1A;IKBKB;PRDX5;ADGRE5;IL1B;RAC1,3
4764,protein dephosphorylation (GO:0006470),0.000350319,0.028833533,0,0,3.752486022,29.85727689,DUSP11;DUSP22;PTPN1;PTPN18;PTPRC;DUSP1;PTPRO;PPP2R5A;PTPN6;SSH2,3
4765,negative regulation of protein phosphorylation (GO:0001933),0.000443951,0.035959996,0,0,3.16969769,24.46942378,LYN;CEACAM1;TGFB1;PTPRC;DUSP1;DDIT4;RACK1;FAM129A;CIB1;PTPN6;SAMSN1;XDH,3
4766,regulation of protein phosphorylation (GO:0001932),0.000492561,0.039274013,0,0,2.706946023,20.61581133,LYN;TGFB1;FAM129A;CIB1;FPR2;C3;FGR;CCND3;IL1B;CCDC88C;RACK1;FLOT1;RAC1;XDH;NOP53,3
4767,positive regulation of gene expression (GO:0010628),0.000516889,0.040579801,0,0,1.898602384,14.36801805,RPL5;SP100;SPI1;RPL11;FAM129A;HMGB2;AHR;THBS1;IKBKB;RPS4X;RBM3;LYL1;RPS3;SF3B1;NFE2;JUN;TGFB1;RPS7;H3F3A;FOS;EEF2;KLF2;IL1B;BCL3;RARA;EIF3E;RPL26;PLCB1;HSPA1B;MYD88;HSPA1A,3
4768,positive regulation of phosphorylation (GO:0042327),0.000532728,0.041189547,0,0,2.94094359,22.16736204,LYN;TGFB1;LMO4;FAM129A;CIB1;FPR2;THBS1;C3;CCND3;IL1B;RACK1;FLOT1;RAC1,3
4769,cellular response to organic substance (GO:0071310),0.000571243,0.043508239,0,0,3.528457006,26.34944505,PTPN18;JUN;TGFB1;JUND;IL1B;RACK1;CIB1;PTPN6;JUNB;RAMP1,3
4770,negative regulation of cytokine production (GO:0001818),0.000586935,0.044045999,0,0,3.833620855,28.52442759,SRGN;CEACAM1;PCBP2;RARA;RAC1;MEFV;RPS27A;UBA52;THBS1,3
4771,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),0.000594246,0.043948349,0,0,9.953962921,73.94020259,JUN;TGFB1;SPI1;FOS,3
4772,regulation of endocytosis (GO:0030100),0.000685841,0.049997836,0,0,4.728132388,34.44380236,FGR;SCARB1;HCK;PTPN1;FLOT1;LDLR;CD177,3
4773,negative regulation of protein ubiquitination (GO:0031397),0.000695763,0.050006739,0,0,5.562508691,40.44222784,RPL5;RPS7;RPL11;RPS3;HSPA1B;HSPA1A,3
4774,negative regulation of phagocytosis (GO:0050765),0.000717649,0.050863353,0,0,15.76044129,114.0981932,CD300A;RACK1;PRTN3,3
4775,regulation of endothelial cell differentiation (GO:0045601),0.000717649,0.050166595,0,0,15.76044129,114.0981932,CEACAM1;BTG1;XDH,3
4776,engulfment of apoptotic cell (GO:0043652),0.000717649,0.049488668,0,0,15.76044129,114.0981932,RAC2;RAC1;THBS1,3
4777,regulation of cell cycle (GO:0051726),0.000725237,0.04934512,0,0,2.845635233,20.57113171,JUN;JUND;TGFB1;HPGD;NR4A1;RPS15A;PTPRC;STK24;RACK1;RARA;ID3;JUNB;NOP53,3
4778,cellular response to lipopolysaccharide (GO:0071222),0.000740689,0.049733359,0,0,4.111419468,29.63482331,LYN;HCK;ZFP36;SBNO2;XBP1;TGFB1;IL1B;HMGB2,3
4779,response to cytokine (GO:0034097),0.000760363,0.050391321,0,0,3.401534092,24.42884768,IFITM3;PTPN18;JUN;SP100;IFITM2;JUND;PTPN6;MEFV;JUNB;MYD88,3
4780,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.000907623,0.059379487,0,0,6.566850538,45.99869656,RPS14;RPS16;RPS19;RPSA;RPS24,3
4781,positive regulation of cell differentiation (GO:0045597),0.000947131,0.061179845,0,0,2.909619931,20.25698782,XBP1;JUN;CEACAM1;ZFP36;CEBPB;JUND;RAP1A;TGFB1;GLIPR2;IL1B;GCNT2;JUNB,3
4782,regulation of protein complex assembly (GO:0043254),0.00095792,0.061103323,0,0,4.472557664,31.08761352,HCK;HSPA8;TGFB1;RPS3;STXBP6;SVIP;NOP53,3
4783,interleukin-1-mediated signaling pathway (GO:0070498),0.000980841,0.061792953,0,0,3.940110323,27.29354091,IKBKB;IL1R2;IL1B;PLCB1;RPS27A;UBA52;PSMA7;MYD88,3
4784,negative regulation of inclusion body assembly (GO:0090084),0.001009166,0.062802102,0,0,14.18439716,97.85292726,SORL1;HSPA1B;HSPA1A,3
4785,positive regulation of nuclease activity (GO:0032075),0.001009166,0.06204545,0,0,14.18439716,97.85292726,PTPN1;HMGB2;HSPA1A,3
4786,negative regulation of cellular component organization (GO:0051129),0.001043302,0.063380621,0,0,5.157962605,35.41129187,HSPA8;RPL13A;SVIP;NOP53;HSPA1B;HSPA1A,3
4787,regulation of monocyte chemotaxis (GO:0090025),0.001066639,0.064036002,0,0,8.596604341,58.82864773,LYN;FPR2;PLA2G7;CCR2,3
4788,mRNA metabolic process (GO:0016071),0.001122315,0.066595045,0,0,3.859699908,26.21647777,ZFP36;PCBP2;SNRPG;SRSF5;ZFP36L2;HSPA1B;SNRPB;HSPA1A,3
4789,"negative regulation of transcription, DNA-templated (GO:0045892)",0.001220145,0.071567824,0,0,1.800640099,12.0801081,CEBPB;SP100;SPI1;RPL10;UBE2D3;HMGB2;AHR;RPS14;PRDX5;ZFP36;SBNO2;NFIL3;HES1;JARID2;RPS27A;JUNB;KLF10;HSPA8;JUN;JUND;TGFB1;ARID5A;KLF2;DUSP22;BCL3;RARA;ID3;PLCB1;UBA52;NOP53;PFDN5,3
4790,positive regulation of superoxide anion generation (GO:0032930),0.001365906,0.079207043,0,0,12.89490651,85.05399253,TGFB1;FPR2;CD177,3
4791,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),0.001365906,0.078317076,0,0,12.89490651,85.05399253,RPL5;RPS7;RPL11,3
4792,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.001365906,0.077446887,0,0,12.89490651,85.05399253,BTG2;ZFP36;PABPC1,3
4793,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.001365906,0.076595822,0,0,12.89490651,85.05399253,BTG2;ZFP36;PABPC1,3
4794,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.001478328,0.081999014,0,0,5.910165485,38.51562267,TGFB1;FPR2;THBS1;XDH;CD177,3
4795,integrin-mediated signaling pathway (GO:0007229),0.001510745,0.082896035,0,0,4.808270225,31.23044806,FGR;HCK;CEACAM1;ZYX;ITGB7;CD47,3
4796,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.001708265,0.092736981,0,0,3.298697015,21.0202113,IKBKB;IL1B;RPS3;CIB1;RPS27A;UBA52;MYD88;HSPA1B;HSPA1A,3
4797,positive regulation of microtubule polymerization (GO:0031116),0.001754535,0.094246233,0,0,7.56501182,48.00417144,RPS3;RAC1;HSPA1B;HSPA1A,3
4798,regulation of vasculogenesis (GO:2001212),0.001792762,0.095296498,0,0,11.82033097,74.75174833,CEACAM1;RAP1A;XDH,3
4799,regulation of establishment of endothelial barrier (GO:1903140),0.001792762,0.09431406,0,0,11.82033097,74.75174833,IKBKB;IL1B;TNFRSF1A,3
4800,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.001792762,0.093351671,0,0,11.82033097,74.75174833,IL1B;GCNT2;FLOT1,3
4801,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.001792762,0.092408725,0,0,11.82033097,74.75174833,LYN;PTPRC;CD300A,3
4802,response to lipopolysaccharide (GO:0032496),0.001824141,0.093085893,0,0,3.030854095,19.11452484,SCARB1;ZFP36;SBNO2;XBP1;JUN;JUND;SLPI;HMGB2;JUNB;TNFRSF1A,3
4803,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.001879632,0.094967941,0,0,3.987581532,25.02877033,BTG2;SP100;BCL3;RPL26;RPS27A;UBA52;NDRG1,3
4804,positive regulation of cell proliferation (GO:0008284),0.001888358,0.094473419,0,0,2.113753303,13.25756181,LYN;RPS9;XBP1;TGFB1;CIB1;THBS1;RPS4X;HCK;RPS15A;PTPRC;IL1B;RARA;GCNT2;S100A6;PTPN6;PRTN3;HES1;CD47;SLC25A5,3
4805,peptidyl-tyrosine dephosphorylation (GO:0035335),0.002039292,0.101034054,0,0,7.274049827,45.06384829,PTPN1;DUSP1;PTPRO;PTPN6,3
4806,RNA catabolic process (GO:0006401),0.002277217,0.111736898,0,0,5.372877713,32.6928932,ZFP36;RNASE6;ZFP36L2;HSPA1B;HSPA1A,3
4807,cellular response to oxygen-containing compound (GO:1901701),0.002278962,0.110757553,0,0,2.407049216,14.64457216,LYN;XBP1;JUN;H2AFZ;HMGB2;FOS;AHR;RAP1B;PRDX5;ZFP36;SBNO2;RAP1A;RARA;LAMTOR4,3
4808,regulation of superoxide anion generation (GO:0032928),0.002294226,0.1104475,0,0,10.91107474,66.31052665,TGFB1;FPR2;CD177,3
4809,regulation of triglyceride biosynthetic process (GO:0010866),0.002294226,0.109415281,0,0,10.91107474,66.31052665,C3;SCARB1;LDLR,3
4810,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.002294226,0.108402176,0,0,10.91107474,66.31052665,RPL5;RPS7;RPL11,3
4811,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),0.002354439,0.110226629,0,0,7.004640574,42.38825158,JUN;SPI1;TGFB1;FOS,3
4812,regulation of MAP kinase activity (GO:0043405),0.002627261,0.121881022,0,0,3.761014399,22.34724595,LYN;PTPN1;TGFB1;CD300A;DUSP1;IL1B;SORL1,3
4813,cellular response to type I interferon (GO:0071357),0.002692262,0.123771301,0,0,4.298302171,25.43465912,IFITM3;SP100;IFITM2;IRF5;SAMHD1;MYD88,3
4814,type I interferon signaling pathway (GO:0060337),0.002692262,0.1226662,0,0,4.298302171,25.43465912,IFITM3;SP100;IFITM2;IRF5;SAMHD1;MYD88,3
4815,defense response to Gram-positive bacterium (GO:0050830),0.002692262,0.121580658,0,0,4.298302171,25.43465912,FGR;HMGB2;RNASE6;PGLYRP1;RPL39;MYD88,3
4816,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.002701542,0.12092955,0,0,6.75447484,39.94550871,SOCS3;CD300A;PTPN6;SAMSN1,3
4817,regulation of vascular endothelial growth factor production (GO:0010574),0.002701542,0.119877989,0,0,6.75447484,39.94550871,C3;TGFB1;IL1B;CCR2,3
4818,regulation of stem cell differentiation (GO:2000736),0.00280086,0.123213695,0,0,3.718755811,21.85820987,SPI1;H3F3A;HES1;RPS27A;UBA52;ZFP36L2;PSMA7,3
4819,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.002874412,0.125368604,0,0,10.13171226,59.28983783,ZFP36;PABPC1;ZFP36L2,3
4820,regulation of immune response (GO:0050776),0.002878612,0.124487771,0,0,2.439115914,14.26991851,LYN;ITGA4;CD300A;ITGAL;SAMHD1;C3;FGR;TYROBP;SELL;ITGB7;HCST;CD300LG;CD33,3
4821,interleukin-12-mediated signaling pathway (GO:0035722),0.003054546,0.130986115,0,0,5.029928072,29.1289389,CNN2;RAP1B;RPLP0;TALDO1;PLCB1,3
4822,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.003054546,0.129894564,0,0,5.029928072,29.1289389,RPL5;RPL11;RPS3;HSPA1B;HSPA1A,3
4823,cellular response to interleukin-12 (GO:0071349),0.003054546,0.128821055,0,0,5.029928072,29.1289389,CNN2;RAP1B;RPLP0;TALDO1;PLCB1,3
4824,maturation of SSU-rRNA (GO:0030490),0.003054546,0.127765145,0,0,5.029928072,29.1289389,RPS14;RPS28;RPS16;RPS19;RPS24,3
4825,negative regulation of endocytosis (GO:0045806),0.003082142,0.127871291,0,0,6.521561914,37.70852262,APOC1;RACK1;PRTN3;RAC1,3
4826,regulation of defense response to virus by virus (GO:0050690),0.003082142,0.126840071,0,0,6.521561914,37.70852262,HCK;AP1S2;RAC1;AP2A2,3
4827,response to lipid (GO:0033993),0.003128102,0.127701618,0,0,3.017956843,17.40554999,CDKN2D;JUN;TGFB1;JUND;SLPI;HMGB2;RARA;JUNB;TNFRSF1A,3
4828,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.003130935,0.126802878,0,0,4.171881519,24.05683567,LYN;PTPN1;CD300A;DUSP1;IL1B;SORL1,3
4829,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.00320513,0.128785648,0,0,1.93549279,11.11554031,KLF10;HSPA8;JUN;BTG2;SPI1;TGFB1;ARID5A;HMGB2;RPL13A;AHR;SBNO2;BCL3;RACK1;RARA;RPS3;ID3;HES1;JARID2;PLCB1;PFDN5;S100A11,3
4830,cellular response to heat (GO:0034605),0.003351585,0.133618259,0,0,4.925137904,28.06502154,HSPA8;THBS1;IER5;HSPA1B;HSPA1A,3
4831,positive regulation of T cell activation (GO:0050870),0.003369263,0.133281786,0,0,4.111419468,23.40656256,FAM49B;XBP1;PTPRC;IL1B;CD47;CCR2,3
4832,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.00349775,0.137300155,0,0,6.304176517,35.65412305,IKBKB;UBE2D3;RPS27A;UBA52,3
4833,protein alkylation (GO:0008213),0.00349775,0.136252062,0,0,6.304176517,35.65412305,EEF1A1;HSPA8;EEF2;SNRPB,3
4834,negative regulation of lymphocyte proliferation (GO:0050672),0.00349775,0.135219849,0,0,6.304176517,35.65412305,LYN;CEBPB;CD300A;LST1,3
4835,regulation of mast cell degranulation (GO:0043304),0.003537073,0.135711898,0,0,9.456264775,53.37546849,LYN;FGR;CD300A,3
4836,negative regulation of lipid catabolic process (GO:0050995),0.003537073,0.134699122,0,0,9.456264775,53.37546849,BSCL2;IL1B;APOC1,3
4837,negative regulation of RNA metabolic process (GO:0051253),0.003537073,0.133701351,0,0,9.456264775,53.37546849,RPS26;TGFB1;RPS13,3
4838,regulation of T cell mediated cytotoxicity (GO:0001914),0.003537073,0.132718253,0,0,9.456264775,53.37546849,FAM49B;CEACAM1;PTPRC,3
4839,regulation of cell junction assembly (GO:1901888),0.003537073,0.131749506,0,0,9.456264775,53.37546849,RAP1B;RAP1A;FLOT1,3
4840,negative regulation of mitotic cell cycle (GO:0045930),0.003668839,0.13566727,0,0,4.824624885,27.05591803,BTG2;BTG1;TGFB1;DUSP1;ZFP36L2,3
4841,regulation of cell growth (GO:0001558),0.003938571,0.144593725,0,0,2.574725558,14.25609401,CDKN2D;CEACAM1;BTG1;TGFB1;H3F3A;PPT1;RACK1;CIB1;RASGRP2;HSPA1B;HSPA1A,3
4842,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.003949849,0.143972,0,0,6.100815984,33.76239092,IKBKB;UBE2D3;RPS27A;UBA52,3
4843,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.004007055,0.145021293,0,0,4.728132388,26.09786616,RPL30;RPS19;RNASE6;PGLYRP1;RPL39,3
4844,regulation of megakaryocyte differentiation (GO:0045652),0.004007055,0.144000016,0,0,4.728132388,26.09786616,NFE2;H3F3A;HMGB2;CIB1;THBS1,3
4845,leukocyte tethering or rolling (GO:0050901),0.004285613,0.152933437,0,0,8.865248227,48.33769289,ITGA4;SELL;ITGB7,3
4846,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.004285613,0.151871399,0,0,8.865248227,48.33769289,ITGA4;SELL;ITGB7,3
4847,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.004285613,0.15082401,0,0,8.865248227,48.33769289,CDKN2D;RPS3;TPT1,3
4848,negative regulation of cell cycle (GO:0045786),0.004459415,0.155865702,0,0,3.886136209,21.03463631,NR4A1;BTG2;BTG1;TGFB1;HPGD;DUSP1,3
4849,regulation of apoptotic process (GO:0042981),0.004664202,0.161914424,0,0,1.680341167,9.019800223,RPL10;CIB1;NDRG1;THBS1;IKBKB;PRDX5;CASP6;RACK1;RPS3;RAC1;RPS27A;JUN;XBP1;TGFB1;DUSP1;RPS6;TNFRSF1A;HIGD2A;HCK;STK24;BCL3;PPT1;IRF5;UBA52;NOP53;HSPA1B;MYD88;TPT1;HSPA1A,3
4850,negative regulation of cell proliferation (GO:0008285),0.00491106,0.169332012,0,0,2.078299951,11.04879439,LYN;CDKN2D;KLF10;BTG2;BTG1;TGFB1;CD300A;CIB1;IL1B;HES1;PTPN6;IGFBP6;S100A11;CD33;HSPA1B;HSPA1A,3
4851,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.004969267,0.170189072,0,0,5.731069561,30.40036017,HSPA8;NADK;HSPA1B;HSPA1A,3
4852,response to molecule of bacterial origin (GO:0002237),0.005059845,0.17213594,0,0,3.34312391,17.67315493,JUN;JUND;SLPI;HMGB2;IRF5;JUNB;TNFRSF1A,3
4853,negative regulation of immune effector process (GO:0002698),0.005123108,0.173133912,0,0,8.343763037,44.00495596,RPS19;CD300A;PCBP2,3
4854,positive regulation of monocyte chemotaxis (GO:0090026),0.005123108,0.171994873,0,0,8.343763037,44.00495596,FPR2;PLA2G7;CCR2,3
4855,negative regulation of B cell activation (GO:0050869),0.005123108,0.170870723,0,0,8.343763037,44.00495596,LYN;CD300A;SAMSN1,3
4856,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.005123108,0.169761173,0,0,8.343763037,44.00495596,PTPRC;NFAM1;RPS3,3
4857,negative regulation of intracellular transport (GO:0032387),0.005123108,0.16866594,0,0,8.343763037,44.00495596,CD300A;SLC25A5;HSPA1A,3
4858,response to purine-containing compound (GO:0014074),0.005123108,0.167584748,0,0,8.343763037,44.00495596,JUN;JUND;JUNB,3
4859,nucleotide catabolic process (GO:0009166),0.005123108,0.166517329,0,0,8.343763037,44.00495596,GDA;SAMHD1;XDH,3
4860,regulation of B cell receptor signaling pathway (GO:0050855),0.005123108,0.165463422,0,0,8.343763037,44.00495596,LYN;CD300A;NFAM1,3
4861,negative regulation of cellular process (GO:0048523),0.005163701,0.165725564,0,0,1.855902433,9.773371076,LYN;CDKN2D;KLF10;BTG2;SP100;BTG1;TGFB1;HPGD;CIB1;HOPX;NR4A1;IL1B;ARHGDIB;PPT1;RACK1;PTPN6;IGFBP6;S100A11;HSPA1B;CD33;HSPA1A,3
4862,negative regulation of phosphorylation (GO:0042326),0.005433089,0.173281588,0,0,3.732736096,19.4671422,LYN;CDKN2D;TGFB1;FAM129A;CIB1;XDH,3
4863,positive regulation of cell-cell adhesion (GO:0022409),0.005539369,0.175573911,0,0,5.562508691,28.90209816,IL1B;GCNT2;FLOT1;CD47,3
4864,regulation of cell-substrate adhesion (GO:0010810),0.005539369,0.174490121,0,0,5.562508691,28.90209816,PTPRO;GCNT2;RAC2;RAC1,3
4865,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.005539369,0.17341963,0,0,5.562508691,28.90209816,FIS1;RPS7;RPS3;RACK1,3
4866,regulation of interleukin-12 production (GO:0032655),0.005539369,0.172362193,0,0,5.562508691,28.90209816,IRF5;MEFV;PLCB1;THBS1,3
4867,hemopoiesis (GO:0030097),0.005789739,0.179060828,0,0,3.684259003,18.98007963,LYL1;TGFB1;PTPRC;PLD4;ZFP36L2;RASGRP4,3
4868,regulation of lipid catabolic process (GO:0050994),0.006052321,0.186054177,0,0,7.880220646,40.24675701,BSCL2;IL1B;APOC1,3
4869,glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.006052321,0.18494008,0,0,7.880220646,40.24675701,TALDO1;RBKS;KHK,3
4870,response to organophosphorus (GO:0046683),0.006052321,0.183839247,0,0,7.880220646,40.24675701,JUN;JUND;JUNB,3
4871,macromolecule catabolic process (GO:0009057),0.00615152,0.185746785,0,0,5.403579872,27.50992811,NAPSA;TGFB1;PPT1;USE1,3
4872,negative regulation of ubiquitin protein ligase activity (GO:1904667),0.006163172,0.185003934,0,0,3.637024914,18.50941493,RPL5;RPS7;RPL11;RPS27A;UBA52;PSMA7,3
4873,regulation of mRNA stability (GO:0043488),0.006190935,0.184750536,0,0,2.932175124,14.90914038,HSPA8;ZFP36;PABPC1;RPS27A;UBA52;ZFP36L2;PSMA7;HSPA1A,3
4874,polyamine biosynthetic process (GO:0006596),0.006327197,0.1877191,0,0,15.76044129,79.7935065,SMOX;SAT1,3
4875,response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.006327197,0.186634018,0,0,15.76044129,79.7935065,ZFP36;ZFP36L2,3
4876,regulation of hydrogen peroxide metabolic process (GO:0010310),0.006327197,0.185561409,0,0,15.76044129,79.7935065,RAC2;RAC1,3
4877,lipoxin biosynthetic process (GO:2001301),0.006327197,0.184501058,0,0,15.76044129,79.7935065,HPGD;ALOX5AP,3
4878,positive regulation of fibroblast migration (GO:0010763),0.006327197,0.183452757,0,0,15.76044129,79.7935065,TGFB1;THBS1,3
4879,regulation of blood vessel remodeling (GO:0060312),0.006327197,0.1824163,0,0,15.76044129,79.7935065,CEACAM1;TGFB1,3
4880,definitive hemopoiesis (GO:0060216),0.006327197,0.18139149,0,0,15.76044129,79.7935065,LYL1;ZFP36L2,3
4881,sterol import (GO:0035376),0.006327197,0.180378129,0,0,15.76044129,79.7935065,SCARB1;LDLR,3
4882,cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.006327197,0.179376029,0,0,15.76044129,79.7935065,ZFP36;ZFP36L2,3
4883,neutrophil extravasation (GO:0072672),0.006327197,0.178385001,0,0,15.76044129,79.7935065,PRTN3;CD177,3
4884,positive regulation of fibroblast apoptotic process (GO:2000271),0.006327197,0.177404864,0,0,15.76044129,79.7935065,BTG1;STK17B,3
4885,cholesterol import (GO:0070508),0.006327197,0.176435438,0,0,15.76044129,79.7935065,SCARB1;LDLR,3
4886,regulation of microtubule nucleation (GO:0010968),0.006327197,0.17547655,0,0,15.76044129,79.7935065,HSPA1B;HSPA1A,3
4887,negative regulation of protein kinase B signaling (GO:0051898),0.006807009,0.187763066,0,0,5.253480431,26.21382954,RACK1;CIB1;XDH;NOP53,3
4888,negative regulation of protein complex assembly (GO:0031333),0.006807009,0.186753587,0,0,5.253480431,26.21382954,MEFV;SORL1;SVIP;NOP53,3
4889,positive regulation of intracellular signal transduction (GO:1902533),0.006982192,0.190535427,0,0,1.871552403,9.291120522,LYN;FIS1;TGFB1;SLC44A2;ADRB2;THBS1;TNFRSF1A;IKBKB;FGR;RACK1;RPS3;GCNT2;S100A4;PTPN6;RPS27A;LAMTOR4;UBA52;HCST;MYD88,3
4890,negative regulation of lymphocyte activation (GO:0051250),0.007075713,0.192060455,0,0,7.465472191,36.96220233,LST1;TNFAIP8L2;SAMSN1,3
4891,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.007075713,0.191044263,0,0,7.465472191,36.96220233,RPL5;RPS7;RPL11,3
4892,regulation of heterotypic cell-cell adhesion (GO:0034114),0.007075713,0.190038766,0,0,7.465472191,36.96220233,IL1B;GCNT2;FLOT1,3
4893,positive regulation of mononuclear cell migration (GO:0071677),0.007075713,0.189043799,0,0,7.465472191,36.96220233,FPR2;PLA2G7;CCR2,3
4894,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.007388587,0.196374783,0,0,3.502320287,17.18875334,FGR;CEACAM1;PTPN6;HCST;NOP53;IER3,3
4895,negative regulation of MAPK cascade (GO:0043409),0.007388587,0.195357297,0,0,3.502320287,17.18875334,LYN;PTPN1;CD300A;DUSP1;IL1B;SORL1,3
4896,regulation of receptor-mediated endocytosis (GO:0048259),0.00750708,0.197467171,0,0,5.111494473,25.00496405,APOC1;FLOT1;PPT1;RAC1,3
4897,mRNA catabolic process (GO:0006402),0.00750708,0.196454519,0,0,5.111494473,25.00496405,ZFP36;ZFP36L2;HSPA1B;HSPA1A,3
4898,IRE1-mediated unfolded protein response (GO:0036498),0.007555753,0.196719428,0,0,4.075976196,19.91296164,XBP1;SERP1;SEC61G;SEC61B;TLN1,3
4899,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.007555753,0.195720852,0,0,4.075976196,19.91296164,IKBKB;BCL3;RPS27A;UBA52;TNFRSF1A,3
4900,negative regulation of intracellular signal transduction (GO:1902532),0.007692904,0.198267109,0,0,2.626740215,12.78554497,LYN;DUSP1;DDIT4;RACK1;CIB1;ADIPOR1;THBS1;XDH;NOP53,3
4901,protein catabolic process (GO:0030163),0.007833556,0.200877581,0,0,3.459609064,16.77681599,HSPA8;CEACAM1;NAPSA;PPT1;USE1;PSMA7,3
4902,positive regulation of cell migration (GO:0030335),0.007874256,0.200911652,0,0,2.3427683,11.34873635,FGR;XBP1;TGFB1;PTPRC;GLIPR2;IL1B;RACK1;GCNT2;CIB1;THBS1;CCR2,3
4903,Fc-gamma receptor signaling pathway (GO:0038094),0.00807248,0.204944596,0,0,2.80185623,13.50297052,LYN;ACTR3;FGR;HCK;FCER1G;ARPC3;RAC1;ACTG1,3
4904,positive regulation of interleukin-2 production (GO:0032743),0.008195463,0.207036876,0,0,7.092198582,34.07215986,IL1B;RPS3;CCR2,3
4905,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.008195463,0.20601699,0,0,7.092198582,34.07215986,LYN;FCER1G;FPR2,3
4906,ephrin receptor signaling pathway (GO:0048013),0.0082975,0.207559514,0,0,3.417927027,16.37802633,ACTR3;LYN;ARPC3;RAC1;AP2A2;ACTG1,3
4907,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.008423679,0.20968796,0,0,2.781254346,13.28524172,LYN;ACTR3;FGR;HCK;FCER1G;ARPC3;RAC1;ACTG1,3
4908,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.008734637,0.216373078,0,0,13.50894968,64.03862018,SLC25A5;HSPA1A,3
4909,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.008734637,0.215327798,0,0,13.50894968,64.03862018,RACK1;TNFRSF1A,3
4910,leukocyte aggregation (GO:0070486),0.008734637,0.214292568,0,0,13.50894968,64.03862018,IL1B;RAC2,3
4911,negative regulation of T cell mediated immunity (GO:0002710),0.008734637,0.213267245,0,0,13.50894968,64.03862018,CEACAM1;PTPRC,3
4912,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.008734637,0.212251686,0,0,13.50894968,64.03862018,HSPA1B;HSPA1A,3
4913,negative regulation of alpha-beta T cell activation (GO:0046636),0.008734637,0.211245754,0,0,13.50894968,64.03862018,CD300A;TARM1,3
4914,positive regulation of ceramide biosynthetic process (GO:2000304),0.008734637,0.210249312,0,0,13.50894968,64.03862018,RACK1;TNFRSF1A,3
4915,chylomicron remnant clearance (GO:0034382),0.008734637,0.209262226,0,0,13.50894968,64.03862018,APOC1;LDLR,3
4916,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.009413477,0.224471829,0,0,6.75447484,31.51376514,FAM49B;CD47;CCR2,3
4917,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.009886542,0.234655916,0,0,4.728132388,21.82780557,HSPA8;NADK;HSPA1B;HSPA1A,3
4918,cellular response to growth factor stimulus (GO:0071363),0.009943857,0.234923624,0,0,2.701789936,12.45741384,EEF1A1;NR4A1;ZFP36;RAP1A;TGFB1;RACK1;CIB1;ZFP36L2,3
4919,hematopoietic progenitor cell differentiation (GO:0002244),0.010731402,0.252361038,0,0,6.447453256,29.23649938,TGFB1;PTPRC;PLD4,3
4920,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.010731402,0.251203418,0,0,6.447453256,29.23649938,XBP1;RACK1;HSPA1A,3
4921,positive regulation of erythrocyte differentiation (GO:0045648),0.010731402,0.250056371,0,0,6.447453256,29.23649938,HMGB2;HSPA1B;HSPA1A,3
4922,cellular response to unfolded protein (GO:0034620),0.010731402,0.248919751,0,0,6.447453256,29.23649938,HSPA8;HSPA1B;HSPA1A,3
4923,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.010776458,0.248833787,0,0,4.612812086,20.89784378,TGFB1;GLIPR2;IL1B;GCNT2,3
4924,JAK-STAT cascade (GO:0007259),0.010776458,0.247712914,0,0,4.612812086,20.89784378,LYN;PTPN1;HES1;CCR2,3
4925,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.010840696,0.24807206,0,0,1.905544539,8.621537406,LYN;ACTR3;NCF2;SLA;ADRB2;AP2A2;RASGRP4;ACTG1;FGR;HCK;ARPC3;DDIT4;RAC1;PLCB1;RPS27A;UBA52,3
4926,negative regulation of protein modification process (GO:0031400),0.011349023,0.258544933,0,0,3.693853428,16.54337916,LYN;TGFB1;FAM129A;CIB1;XDH,3
4927,regulation of viral genome replication (GO:0045069),0.011349023,0.257395845,0,0,3.693853428,16.54337916,IFITM3;FAM111A;IFITM2;SLPI;PABPC1,3
4928,positive regulation of multicellular organismal process (GO:0051240),0.011441132,0.258336709,0,0,2.329129255,10.41246632,XBP1;TGFB1;RPS19;GLIPR2;NFAM1;IL1B;GCNT2;FLOT1;PLCB1;LDLR,3
4929,regulation of fibroblast apoptotic process (GO:2000269),0.011484177,0.258166326,0,0,11.82033097,52.79887815,BTG1;STK17B,3
4930,negative regulation of interleukin-1 production (GO:0032692),0.011484177,0.257034017,0,0,11.82033097,52.79887815,CEACAM1;MEFV,3
4931,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.011484177,0.255911598,0,0,11.82033097,52.79887815,CEACAM1;PTPRC,3
4932,positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.011484177,0.254798939,0,0,11.82033097,52.79887815,PTPN1;HSPA1A,3
4933,positive regulation of tumor necrosis factor biosynthetic process (GO:0042535),0.011484177,0.253695913,0,0,11.82033097,52.79887815,THBS1;CCR2,3
4934,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.011484177,0.252602396,0,0,11.82033097,52.79887815,LYN;SORL1,3
4935,positive regulation of vasculogenesis (GO:2001214),0.011484177,0.251518266,0,0,11.82033097,52.79887815,CEACAM1;RAP1A,3
4936,regulation of nitrogen compound metabolic process (GO:0051171),0.011484177,0.250443402,0,0,11.82033097,52.79887815,SCARB1;LDLR,3
4937,negative regulation of cell growth (GO:0030308),0.011708483,0.254248468,0,0,2.853183337,12.68936637,CDKN2D;TGFB1;BTG1;PPT1;RACK1;HSPA1B;HSPA1A,3
4938,cellular response to oxidative stress (GO:0034599),0.011708483,0.253171144,0,0,2.853183337,12.68936637,PRDX5;JUN;NCF2;GSR;FOS;HSPA1B;HSPA1A,3
4939,positive regulation of endocytosis (GO:0045807),0.012087189,0.260257072,0,0,3.637024914,16.05968044,FCER1G;IL1B;FLOT1;PPT1;LDLR,3
4940,negative regulation of viral transcription (GO:0032897),0.012150643,0.260524085,0,0,6.167129201,27.19934119,IFITM3;JUN;ZFP36,3
4941,positive regulation of mRNA catabolic process (GO:0061014),0.012150643,0.259434026,0,0,6.167129201,27.19934119,ZFP36;PABPC1;ZFP36L2,3
4942,negative regulation of signal transduction in absence of ligand (GO:1901099),0.012150643,0.258353051,0,0,6.167129201,27.19934119,IL1B;HSPA1B;HSPA1A,3
4943,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.012150643,0.257281046,0,0,6.167129201,27.19934119,IL1B;HSPA1B;HSPA1A,3
4944,maturation of LSU-rRNA (GO:0000470),0.012150643,0.256217901,0,0,6.167129201,27.19934119,RPL7A;RPL10A;RPL7,3
4945,regulation of programmed cell death (GO:0043067),0.012421233,0.260845898,0,0,2.109204039,9.255921145,TGFB1;STK24;DUSP1;CASP6;BCL3;RPS3;RPS27A;UBA52;NDRG1;NOP53;TPT1;TNFRSF1A,3
4946,cell-matrix adhesion (GO:0007160),0.012742944,0.266505104,0,0,3.117449926,13.60074051,TIMM10B;ITGA4;ZYX;ITGB7;RAC1;ITGAL,3
4947,regulation of myeloid cell differentiation (GO:0045637),0.012857267,0.267798497,0,0,3.581918476,15.59512189,LYN;NFE2;SPI1;H3F3A;THBS1,3
4948,negative regulation of cell adhesion (GO:0007162),0.012857267,0.266709885,0,0,3.581918476,15.59512189,TGFB1;PTPRC;PTPRO;ARHGDIB;GCNT2,3
4949,cellular protein modification process (GO:0006464),0.013687879,0.282790482,0,0,1.509982399,6.479703736,GMFG;UBE2D3;PTPRO;F13A1;THBS1;PSMA7;C3;IKBKB;DUSP11;SOCS3;SERP1;ST3GAL4;GCNT2;LYN;ATG3;PTPN18;PTPN1;TGFB1;DUSP1;PPP2R5A;SSH2;DUSP22;FGR;HCK;VCAN;PTPRC;STK24;STK17B;RARA;PTPN6;UBA52;HCST,3
4950,positive regulation of interferon-gamma production (GO:0032729),0.013750583,0.282940431,0,0,4.298302171,18.42542029,FAM49B;IL1B;CD244;CCR2,3
4951,regulation of B cell proliferation (GO:0030888),0.013750583,0.281804124,0,0,4.298302171,18.42542029,LYN;PTPRC;CD300A;AHR,3
4952,regulation of interferon-gamma production (GO:0032649),0.013750583,0.280676907,0,0,4.298302171,18.42542029,FAM49B;IL1B;RARA;CCR2,3
4953,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),0.013897153,0.282538535,0,0,1.559336948,6.667835925,CEBPB;SPI1;HMGB2;AHR;IKBKB;SBNO2;HES1;RPS27A;JUNB;IER5;IER2;KDM6B;KLF10;JUN;XBP1;JUND;TGFB1;H2AFZ;FOS;PBX1;KLF2;FOSL2;TNFRSF1A;NR4A1;SUB1;RARA;IRF5;UBA52,3
4954,negative regulation of programmed cell death (GO:0043069),0.014044918,0.284409597,0,0,1.849636142,7.889613029,XBP1;RPL10;CIB1;THBS1;HIGD2A;IKBKB;HCK;PRDX5;BCL3;PPT1;RPS27A;UBA52;HSPA1B;MYD88;TPT1;HSPA1A,3
4955,defense response to bacterium (GO:0042742),0.014353709,0.289513736,0,0,2.149151085,9.120453314,FGR;RPL30;CEBPB;FCER1G;RPS19;SLPI;RNASE6;HMGB2;PGLYRP1;RPL39;MYD88,3
4956,negative regulation of growth (GO:0045926),0.014509845,0.291510788,0,0,2.735283199,11.57825651,CDKN2D;TGFB1;BTG1;PPT1;RACK1;HSPA1B;HSPA1A,3
4957,positive regulation of production of molecular mediator of immune response (GO:0002702),0.014560338,0.291378062,0,0,10.50696086,44.43870772,XBP1;CD244,3
4958,positive regulation of triglyceride biosynthetic process (GO:0010867),0.014560338,0.290239867,0,0,10.50696086,44.43870772,SCARB1;LDLR,3
4959,regulation of mast cell activation involved in immune response (GO:0033006),0.014560338,0.289110529,0,0,10.50696086,44.43870772,LYN;CD300A,3
4960,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.014560338,0.287989945,0,0,10.50696086,44.43870772,XBP1;RACK1,3
4961,cell junction maintenance (GO:0034331),0.014560338,0.286878015,0,0,10.50696086,44.43870772,PRTN3;CD177,3
4962,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.014560338,0.285774638,0,0,10.50696086,44.43870772,FGR;CD177,3
4963,mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.014560338,0.284679716,0,0,10.50696086,44.43870772,FIS1;ATG3,3
4964,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.014773376,0.287742509,0,0,3.017956843,12.72047274,UBE2D3;RPS27A;UBA52;PSMA7;KLF2;HSPA1A,3
4965,positive regulation of interleukin-8 production (GO:0032757),0.014846437,0.288066029,0,0,4.202784345,17.69370279,IL1B;CD244;HSPA1B;HSPA1A,3
4966,regulation of T cell activation (GO:0050863),0.014846437,0.286974869,0,0,4.202784345,17.69370279,FAM49B;TNFAIP8L2;CD47;CCR2,3
4967,negative regulation of immune response (GO:0050777),0.014846437,0.285891945,0,0,4.202784345,17.69370279,LYN;CD300A;SAMSN1;CCR2,3
4968,myeloid cell differentiation (GO:0030099),0.014846437,0.284817164,0,0,4.202784345,17.69370279,LYN;RPS14;RPS19;RASGRP4,3
4969,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.015122848,0.289033315,0,0,2.712862845,11.37109631,LYN;IKBKB;FCER1G;CLEC4E;RPS27A;UBA52;PSMA7,3
4970,cellular response to interleukin-1 (GO:0071347),0.015170776,0.28886742,0,0,2.504970801,10.49178051,IKBKB;IL1R2;IL1B;PLCB1;RPS27A;UBA52;MYD88;PSMA7,3
4971,positive regulation of immune effector process (GO:0002699),0.015297534,0.290198198,0,0,5.673758865,23.71667318,XBP1;RPS19;CCR2,3
4972,receptor clustering (GO:0043113),0.015297534,0.28912339,0,0,5.673758865,23.71667318,ITGA4;ITGB7;ITGAL,3
4973,positive regulation of vascular endothelial growth factor production (GO:0010575),0.015297534,0.288056514,0,0,5.673758865,23.71667318,C3;TGFB1;IL1B,3
4974,chaperone mediated protein folding requiring cofactor (GO:0051085),0.015297534,0.286997483,0,0,5.673758865,23.71667318,HSPA8;HSPA1B;HSPA1A,3
4975,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.015297534,0.28594621,0,0,5.673758865,23.71667318,RPL11;SVIP;NOP53,3
4976,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.015297534,0.284902611,0,0,5.673758865,23.71667318,IKBKB;RPS27A;UBA52,3
4977,positive regulation of macromolecule metabolic process (GO:0010604),0.015331763,0.284501766,0,0,2.048288399,8.557397859,RPL5;PTPN1;TGFB1;RPS7;IL1B;RPL11;RPS3;HMGB2;HSPA1B;MYD88;KLF2;HSPA1A,3
4978,regulation of epithelial to mesenchymal transition (GO:0010717),0.015364702,0.28407998,0,0,3.42618289,14.30665185,TGFB1;GLIPR2;IL1B;GCNT2;ADIPOR1,3
4979,response to interferon-gamma (GO:0034341),0.015364702,0.283054421,0,0,3.42618289,14.30665185,IFITM3;SP100;IFITM2;RPL13A;MEFV,3
4980,peptidyl-tyrosine autophosphorylation (GO:0038083),0.015995912,0.293622797,0,0,4.111419468,17.00245496,LYN;FGR;HCK;SLA,3
4981,Fc-epsilon receptor signaling pathway (GO:0038095),0.016148381,0.295359104,0,0,2.32531101,9.594083152,LYN;IKBKB;JUN;FCER1G;RAC1;FOS;RPS27A;UBA52;PSMA7,3
4982,positive regulation of intracellular protein transport (GO:0090316),0.016301585,0.297096379,0,0,2.472226085,10.17690128,FIS1;TGFB1;IL1B;UBE2D3;RAC2;CIB1;HES1;SORL1,3
4983,Fc receptor signaling pathway (GO:0038093),0.016673878,0.302799999,0,0,2.312673451,9.467881526,LYN;IKBKB;JUN;FCER1G;RAC1;FOS;RPS27A;UBA52;PSMA7,3
4984,regulation of ERK1 and ERK2 cascade (GO:0070372),0.016920303,0.306185483,0,0,2.097155495,8.554802711,LYN;PTPN1;CEACAM1;RAP1A;TGFB1;GLIPR2;IL1B;GCNT2;CIB1;PTPN6;FPR2,3
4985,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),0.017007788,0.306681063,0,0,2.188950179,8.917966767,IKBKB;NFAM1;IL1B;RPS3;CIB1;RPS27A;UBA52;HSPA1B;MYD88;HSPA1A,3
4986,regulation of cell death (GO:0010941),0.017018357,0.305791111,0,0,2.924617972,11.91332221,JUN;JUND;JUNB;HSPA1B;IER3;HSPA1A,3
4987,organophosphate ester transport (GO:0015748),0.017026874,0.304870657,0,0,5.45553737,22.22019841,SCARB1;SCP2;LDLR,3
4988,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.017026874,0.303804676,0,0,5.45553737,22.22019841,FGR;TGFB1;FPR2,3
4989,"protein import into nucleus, translocation (GO:0000060)",0.017026874,0.302746123,0,0,5.45553737,22.22019841,TGFB1;BCL3;SEC61B,3
4990,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.017026874,0.301694921,0,0,5.45553737,22.22019841,IKBKB;RPS27A;UBA52,3
4991,"negative regulation of gene expression, epigenetic (GO:0045814)",0.017026874,0.300650994,0,0,5.45553737,22.22019841,SPI1;H3F3A;JARID2,3
4992,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),0.017026874,0.299614266,0,0,5.45553737,22.22019841,RPL5;RPS7;RPL11,3
4993,regulation of lamellipodium assembly (GO:0010591),0.017026874,0.298584664,0,0,5.45553737,22.22019841,RAC2;RAC1;SSH2,3
4994,cellular response to epidermal growth factor stimulus (GO:0071364),0.017026874,0.297562114,0,0,5.45553737,22.22019841,EEF1A1;ZFP36;ZFP36L2,3
4995,negative regulation of insulin receptor signaling pathway (GO:0046627),0.017026874,0.296546543,0,0,5.45553737,22.22019841,SOCS3;PTPN1;IL1B,3
4996,positive regulation of embryonic development (GO:0040019),0.017026874,0.295537882,0,0,5.45553737,22.22019841,RACK1;HES1;PLCB1,3
4997,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.017072213,0.295320345,0,0,2.647754137,10.77716193,LYN;IKBKB;FCER1G;CLEC4E;RPS27A;UBA52;PSMA7,3
4998,platelet degranulation (GO:0002576),0.017072213,0.294322641,0,0,2.647754137,10.77716193,LYN;SRGN;FAM49B;TGFB1;F13A1;TLN1;THBS1,3
4999,protein methylation (GO:0006479),0.017199762,0.295523186,0,0,4.023942458,16.34871375,EEF1A1;HSPA8;EEF2;SNRPB,3
5000,stress-activated protein kinase signaling cascade (GO:0031098),0.017206109,0.294640186,0,0,3.329670696,13.52675647,IKBKB;STK24;CCDC88C;RPS27A;UBA52,3
5001,membrane raft organization (GO:0031579),0.017948141,0.306318949,0,0,9.456264775,38.01672541,PPT1;FLOT1,3
5002,3'-UTR-mediated mRNA destabilization (GO:0061158),0.017948141,0.305297885,0,0,9.456264775,38.01672541,ZFP36;ZFP36L2,3
5003,positive regulation of alcohol biosynthetic process (GO:1902932),0.017948141,0.304283607,0,0,9.456264775,38.01672541,IL1B;CD244,3
5004,regulation of respiratory burst (GO:0060263),0.017948141,0.303276045,0,0,9.456264775,38.01672541,RAC2;RAC1,3
5005,regulation of granulocyte differentiation (GO:0030852),0.017948141,0.302275134,0,0,9.456264775,38.01672541,CEACAM1;RARA,3
5006,negative regulation of B cell proliferation (GO:0030889),0.017948141,0.301280808,0,0,9.456264775,38.01672541,LYN;CD300A,3
5007,negative regulation of reproductive process (GO:2000242),0.017948141,0.300293002,0,0,9.456264775,38.01672541,DUSP1;ARHGDIB,3
5008,Rap protein signal transduction (GO:0032486),0.017948141,0.299311652,0,0,9.456264775,38.01672541,RAP1B;RAP1A,3
5009,IRES-dependent viral translational initiation (GO:0075522),0.017948141,0.298336696,0,0,9.456264775,38.01672541,PCBP2;EIF3F,3
5010,negative regulation of stem cell differentiation (GO:2000737),0.017948141,0.29736807,0,0,9.456264775,38.01672541,HES1;ZFP36L2,3
5011,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.017948141,0.296405714,0,0,9.456264775,38.01672541,JUN;HSPA1A,3
5012,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.017948141,0.295449566,0,0,9.456264775,38.01672541,PTPN1;RACK1,3
5013,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.017948141,0.294499568,0,0,9.456264775,38.01672541,IL1B;CCR2,3
5014,regulation of cell migration (GO:0030334),0.017979588,0.294069985,0,0,1.938981736,7.791833374,XBP1;TGFB1;LMO4;CIB1;THBS1;SORL1;FGR;CEACAM1;STK24;IL1B;RACK1;GCNT2;RAC1,3
5015,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),0.018130384,0.295588978,0,0,1.670718158,6.699857268,KLF10;JUN;CEBPB;SP100;JUND;RPL10;UBE2D3;ARID5A;KLF2;DUSP22;RPS14;ZFP36;NFIL3;RARA;HES1;RPS27A;JUNB;UBA52;NOP53;HSPA1A,3
5016,negative regulation of signal transduction (GO:0009968),0.018278938,0.297061845,0,0,1.997802417,7.99521691,LYN;SOCS3;PTPN1;PTPN18;PTPRC;IL1B;DDIT4;RACK1;RPS27A;UBA52;XDH;THBS1,3
5017,regulation of intracellular signal transduction (GO:1902531),0.018667741,0.302417406,0,0,1.78841887,7.119620978,LYN;RPL5;TGFB1;RPL11;ARHGAP15;ARHGAP26;CEACAM1;IL1B;DDIT4;ARHGDIB;RAC2;RAC1;RPS27A;UBA52;NOP53;IER3,3
5018,negative regulation of cellular response to insulin stimulus (GO:1900077),0.018860932,0.304580182,0,0,5.253480431,20.85979811,SOCS3;PTPN1;IL1B,3
5019,regulation of T cell receptor signaling pathway (GO:0050856),0.018860932,0.303619362,0,0,5.253480431,20.85979811,CEACAM1;CD300A;RPS3,3
5020,regulation of fat cell differentiation (GO:0045598),0.019188109,0.30791485,0,0,3.238446841,12.8030846,ZFP36;CEBPB;XBP1;TGFB1;ZFP36L2,3
5021,receptor-mediated endocytosis (GO:0006898),0.019490615,0.311788737,0,0,2.251491613,8.865973708,SCARB1;FCER1G;PPT1;FPR2;ADRB2;AP2A2;LDLR;SORL1;RAMP1,3
5022,cellular response to mechanical stimulus (GO:0071260),0.019773346,0.315323072,0,0,3.859699908,15.14322545,CNN2;IL1B;MYD88;TNFRSF1A,3
5023,positive regulation of inflammatory response (GO:0050729),0.02023302,0.321648286,0,0,3.194684046,12.46067142,RPS19;PLA2G7;MYD88;CCR2;TNFRSF1A,3
5024,B cell activation (GO:0042113),0.02023302,0.320649378,0,0,3.194684046,12.46067142,TPD52;LYL1;PTPRC;ITGA4;NFAM1,3
5025,lymphocyte differentiation (GO:0030098),0.02023302,0.319656656,0,0,3.194684046,12.46067142,TPD52;LYL1;PTPRC;ITGA4;NFAM1,3
5026,leukocyte cell-cell adhesion (GO:0007159),0.020800063,0.327600997,0,0,5.06585613,19.61904381,ITGA4;ITGAL;CD177,3
5027,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.020800063,0.326592994,0,0,5.06585613,19.61904381,IL1B;HSPA1B;HSPA1A,3
5028,cellular response to topologically incorrect protein (GO:0035967),0.020800063,0.325591175,0,0,5.06585613,19.61904381,HSPA8;HSPA1B;HSPA1A,3
5029,regulation of reactive oxygen species metabolic process (GO:2000377),0.02114433,0.329967939,0,0,3.78250591,14.58679336,RAC2;RAC1;THBS1;XDH,3
5030,regulation of tumor necrosis factor biosynthetic process (GO:0042534),0.021633092,0.33656607,0,0,8.596604341,32.9553499,THBS1;CCR2,3
5031,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.021633092,0.335543073,0,0,8.596604341,32.9553499,FGR;LYN,3
5032,positive regulation of leukocyte degranulation (GO:0043302),0.021633092,0.334526276,0,0,8.596604341,32.9553499,FGR;CD177,3
5033,negative regulation of fatty acid biosynthetic process (GO:0045717),0.021633092,0.333515622,0,0,8.596604341,32.9553499,CEACAM1;APOC1,3
5034,myeloid cell activation involved in immune response (GO:0002275),0.021633092,0.332511057,0,0,8.596604341,32.9553499,SBNO2;FCER1G,3
5035,cell-cell junction maintenance (GO:0045217),0.021633092,0.331512525,0,0,8.596604341,32.9553499,PRTN3;CD177,3
5036,positive regulation of myoblast fusion (GO:1901741),0.021633092,0.330519973,0,0,8.596604341,32.9553499,CD53;FLOT1,3
5037,regulation of ceramide biosynthetic process (GO:2000303),0.021633092,0.329533346,0,0,8.596604341,32.9553499,RACK1;TNFRSF1A,3
5038,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.021633092,0.328552592,0,0,8.596604341,32.9553499,PLCB1;RAMP1,3
5039,icosanoid biosynthetic process (GO:0046456),0.021633092,0.327577659,0,0,8.596604341,32.9553499,HPGD;ALOX5AP,3
5040,oxidative phosphorylation (GO:0006119),0.021633092,0.326608494,0,0,8.596604341,32.9553499,ATP5C1;UQCRH,3
5041,negative regulation of cellular amide metabolic process (GO:0034249),0.022432876,0.337684263,0,0,3.110613413,11.8117075,BTG2;RACK1;RPS3;RPL13A;SORL1,3
5042,regulation of defense response (GO:0031347),0.022432876,0.336691074,0,0,3.110613413,11.8117075,FGR;HCK;SBNO2;SAMHD1;MYD88,3
5043,negative regulation of viral genome replication (GO:0045071),0.022572192,0.337788553,0,0,3.708339128,14.05844923,IFITM3;FAM111A;IFITM2;SLPI,3
5044,negative regulation of response to DNA damage stimulus (GO:2001021),0.022844443,0.340863138,0,0,4.891171436,18.48396861,CDKN2D;RPS3;TPT1,3
5045,regulation of lipid biosynthetic process (GO:0046890),0.022844443,0.339869368,0,0,4.891171436,18.48396861,C3;CEACAM1;ADIPOR1,3
5046,regulation of fatty acid biosynthetic process (GO:0042304),0.022844443,0.338881375,0,0,4.891171436,18.48396861,CEACAM1;APOC1;ADIPOR1,3
5047,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.022844443,0.337899111,0,0,4.891171436,18.48396861,IKBKB;RPS27A;UBA52,3
5048,cellular response to tumor necrosis factor (GO:0071356),0.023307289,0.343748835,0,0,2.182214948,8.202922261,IKBKB;ZFP36;RPS3;CIB1;RPS27A;UBA52;PSMA7;ZFP36L2;TNFRSF1A,3
5049,regulation of hematopoietic stem cell differentiation (GO:1902036),0.023588651,0.346895925,0,0,3.070215836,11.50406673,SPI1;H3F3A;RPS27A;UBA52;PSMA7,3
5050,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.02362899,0.34649062,0,0,2.306406043,8.638138577,IKBKB;SLC44A2;IL1B;S100A4;RPS27A;UBA52;MYD88;TNFRSF1A,3
5051,protein targeting (GO:0006605),0.023973527,0.350535552,0,0,2.469919904,9.214789783,TIMM10B;ATG3;FIS1;SYS1;SEC61G;RPL11;SORL1,3
5052,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.023973527,0.349534022,0,0,2.469919904,9.214789783,LYN;ACTR3;FGR;HCK;ARPC3;RAC1;ACTG1,3
5053,peptidyl-tyrosine modification (GO:0018212),0.024057431,0.349758041,0,0,3.637024914,13.55632418,FGR;LYN;HCK;PTPN6,3
5054,positive regulation of vasculature development (GO:1904018),0.024126138,0.349760454,0,0,2.701789936,10.06270715,XBP1;CEACAM1;RAP1A;BTG1;IL1B;THBS1,3
5055,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.024782179,0.358253422,0,0,3.030854095,11.20697849,SPI1;H3F3A;RPS27A;UBA52;PSMA7,3
5056,positive regulation of myeloid cell differentiation (GO:0045639),0.02499408,0.360296015,0,0,4.728132388,17.44263021,HMGB2;HSPA1B;HSPA1A,3
5057,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.02499408,0.359281097,0,0,4.728132388,17.44263021,RPS27A;UBA52;MYD88,3
5058,regulation of myoblast differentiation (GO:0045661),0.02499408,0.35827188,0,0,4.728132388,17.44263021,BTG1;TGFB1;PLCB1,3
5059,translational elongation (GO:0006414),0.025135077,0.359283744,0,0,2.676301352,9.85813175,EEF1B2;EEF1A1;MRPL30;RACK1;EEF2;MRPL33,3
5060,endocytosis (GO:0006897),0.025431498,0.362505403,0,0,1.970055162,7.233583124,SCARB1;PPT1;RAC2;PLD4;PRTN3;FPR2;RAC1;ADRB2;LDLR;CORO1A;SORL1,3
5061,B cell differentiation (GO:0030183),0.025600497,0.363897873,0,0,3.568401802,13.07870472,TPD52;LYL1;ITGA4;NFAM1,3
5062,regulation of myoblast fusion (GO:1901739),0.025601168,0.362896562,0,0,7.880220646,28.88193292,CD53;FLOT1,3
5063,regulation of inclusion body assembly (GO:0090083),0.025601168,0.361891309,0,0,7.880220646,28.88193292,HSPA1B;HSPA1A,3
5064,ribose phosphate metabolic process (GO:0019693),0.025601168,0.360891609,0,0,7.880220646,28.88193292,TALDO1;RBKS,3
5065,negative regulation of metabolic process (GO:0009892),0.025601168,0.359897417,0,0,7.880220646,28.88193292,IL1B;APOC1,3
5066,pentose-phosphate shunt (GO:0006098),0.025601168,0.358908688,0,0,7.880220646,28.88193292,TALDO1;RBKS,3
5067,modification-dependent macromolecule catabolic process (GO:0043632),0.025601168,0.357925376,0,0,7.880220646,28.88193292,RPS27A;UBA52,3
5068,entry of bacterium into host cell (GO:0035635),0.025601168,0.356947438,0,0,7.880220646,28.88193292,RPS27A;UBA52,3
5069,regulation of interleukin-2 biosynthetic process (GO:0045076),0.025601168,0.355974829,0,0,7.880220646,28.88193292,ZFP36;IL1B,3
5070,polyamine metabolic process (GO:0006595),0.025601168,0.355007507,0,0,7.880220646,28.88193292,SMOX;SAT1,3
5071,regulation of skeletal muscle tissue development (GO:0048641),0.025601168,0.354045427,0,0,7.880220646,28.88193292,TGFB1;FLOT1,3
5072,regulation of mononuclear cell migration (GO:0071675),0.025601168,0.353088547,0,0,7.880220646,28.88193292,LYN;THBS1,3
5073,ribosomal subunit export from nucleus (GO:0000054),0.025601168,0.352136826,0,0,7.880220646,28.88193292,RPS15;NOP53,3
5074,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.025601168,0.351190222,0,0,7.880220646,28.88193292,PTPN1;XBP1,3
5075,negative regulation of interleukin-12 production (GO:0032695),0.025601168,0.350248693,0,0,7.880220646,28.88193292,MEFV;THBS1,3
5076,negative regulation of fatty acid metabolic process (GO:0045922),0.025601168,0.349312199,0,0,7.880220646,28.88193292,CEACAM1;APOC1,3
5077,cellular response to organic cyclic compound (GO:0071407),0.025734095,0.350189563,0,0,2.433597552,8.906817416,RAP1B;RAP1A;TGFB1;CASP6;H2AFZ;IL1B;AHR,3
5078,regulation of inflammatory response (GO:0050727),0.025973902,0.352512827,0,0,2.264973599,8.268655331,HCK;SBNO2;TNFAIP8L2;MEFV;PLA2G7;MYD88;CCR2;TNFRSF1A,3
5079,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),0.027201789,0.36819822,0,0,3.502320287,12.6240173,TGFB1;RPS27A;UBA52;HSPA1A,3
5080,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.027201789,0.36722415,0,0,3.502320287,12.6240173,LYN;SOCS3;HES1;TNFRSF1A,3
5081,cellular response to cAMP (GO:0071320),0.027248823,0.366888507,0,0,4.575611988,16.48476298,RAP1B;RAP1A;AHR,3
5082,'de novo' posttranslational protein folding (GO:0051084),0.027248823,0.365923011,0,0,4.575611988,16.48476298,HSPA8;HSPA1B;HSPA1A,3
5083,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.027283939,0.36543291,0,0,2.955082742,10.64260366,CDK2AP2;RPS27A;UBA52;ZFP36L2;PSMA7,3
5084,peptidyl-tyrosine phosphorylation (GO:0018108),0.027283939,0.36447628,0,0,2.955082742,10.64260366,FGR;LYN;HCK;SLA;PTPN6,3
5085,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.027283939,0.363524644,0,0,2.955082742,10.64260366,TGFB1;RPS27A;UBA52;THBS1;HSPA1A,3
5086,negative regulation of nucleic acid-templated transcription (GO:1903507),0.028181564,0.374506562,0,0,1.700002656,6.06745786,KLF10;HSPA8;JUN;SPI1;TGFB1;ARID5A;HMGB2;AHR;SBNO2;BCL3;RARA;ID3;HES1;JARID2;PLCB1;PFDN5,3
5087,regulation of cytokine production (GO:0001817),0.028329477,0.375494334,0,0,2.602641681,9.275430913,LYN;NFAM1;FLOT1;RPS27A;UBA52;CCR2,3
5088,cellular response to hormone stimulus (GO:0032870),0.028592845,0.378003339,0,0,2.918600239,10.37445279,JUN;XBP1;JUND;JUNB;RAMP1,3
5089,cellular response to nutrient levels (GO:0031669),0.028861658,0.380571166,0,0,3.438641737,12.19081461,KLF10;HSPA8;XBP1;STK24,3
5090,negative regulation of supramolecular fiber organization (GO:1902904),0.028861658,0.379590313,0,0,3.438641737,12.19081461,HSPA8;CIB1;CORO1A;LDLR,3
5091,positive regulation of protein dephosphorylation (GO:0035307),0.029608373,0.388410091,0,0,4.432624113,15.60149866,TGFB1;CD300A;PPP2R5A,3
5092,liver development (GO:0001889),0.029608373,0.387414168,0,0,4.432624113,15.60149866,CEBPB;XBP1;RARA,3
5093,viral translation (GO:0019081),0.029838804,0.389430733,0,0,7.274049827,25.54606719,PCBP2;EIF3F,3
5094,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.029838804,0.388437287,0,0,7.274049827,25.54606719,FCER1G;LDLR,3
5095,regulation of necrotic cell death (GO:0010939),0.029838804,0.387448897,0,0,7.274049827,25.54606719,RPS27A;UBA52,3
5096,positive regulation of lamellipodium assembly (GO:0010592),0.029838804,0.386465524,0,0,7.274049827,25.54606719,RAC2;RAC1,3
5097,positive regulation of interleukin-17 production (GO:0032740),0.029838804,0.38548713,0,0,7.274049827,25.54606719,TGFB1;MYD88,3
5098,positive regulation of binding (GO:0051099),0.029940853,0.385828716,0,0,2.883007553,10.11512258,RPL11;HMGB2;FLOT1;RARA;HES1,3
5099,negative regulation of apoptotic process (GO:0043066),0.030344374,0.390043673,0,0,1.653873469,5.780526204,CDKN2D;XBP1;RPL10;CIB1;THBS1;HIGD2A;IKBKB;HCK;PRDX5;BCL3;PPT1;RPS27A;UBA52;HSPA1B;MYD88;TPT1;HSPA1A,3
5100,positive regulation of protein phosphorylation (GO:0001934),0.030480521,0.390809295,0,0,1.717239366,5.99431156,LYN;TGFB1;FAM129A;CIB1;FPR2;ADRB2;TNFRSF1A;C3;CCND3;RAP1A;PTPRC;IL1B;RACK1;FLOT1;RAC1,3
5101,regulation of cellular component organization (GO:0051128),0.030517094,0.390297564,0,0,2.347299767,8.19082815,RAP1B;HSPA8;PTPN1;CEACAM1;RAP1A;RASGRP2;CD177,3
5102,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.030580407,0.390129547,0,0,3.37723742,11.77776345,TGFB1;RPS27A;UBA52;HSPA1A,3
5103,Notch signaling pathway (GO:0007219),0.030580407,0.389156656,0,0,3.37723742,11.77776345,HES1;RPS27A;UBA52;PBX1,3
5104,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.030808166,0.391079773,0,0,2.075765439,7.22361289,IKBKB;SLC44A2;IL1B;BCL3;S100A4;RPS27A;UBA52;MYD88;TNFRSF1A,3
5105,negative regulation of binding (GO:0051100),0.031328249,0.396694925,0,0,2.848272523,9.86423727,SP100;JUN;SLPI;ID3;SORL1,3
5106,regulation of cell-cell adhesion (GO:0022407),0.032072287,0.405111095,0,0,4.298302171,14.78514053,CEACAM1;TGFB1;CD47,3
5107,substrate adhesion-dependent cell spreading (GO:0034446),0.032072287,0.404110821,0,0,4.298302171,14.78514053,ITGA4;ITGB7;RAC1,3
5108,positive regulation of developmental process (GO:0051094),0.034227108,0.430199345,0,0,2.48849073,8.398002501,FIS1;XBP1;JUN;JUND;PLCB1;JUNB,3
5109,regulation of fibroblast migration (GO:0010762),0.034332879,0.430468499,0,0,6.75447484,22.77373742,TGFB1;THBS1,3
5110,negative regulation of receptor-mediated endocytosis (GO:0048261),0.034332879,0.429413429,0,0,6.75447484,22.77373742,APOC1;RAC1,3
5111,positive regulation of myoblast differentiation (GO:0045663),0.034332879,0.428363519,0,0,6.75447484,22.77373742,BTG1;PLCB1,3
5112,regulation of platelet aggregation (GO:0090330),0.034332879,0.42731873,0,0,6.75447484,22.77373742,LYN;CEACAM1,3
5113,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.034332879,0.426279025,0,0,6.75447484,22.77373742,UQCRFS1;UQCRH,3
5114,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.034332879,0.425244367,0,0,6.75447484,22.77373742,XBP1;HSPA1A,3
5115,purine nucleotide catabolic process (GO:0006195),0.034332879,0.42421472,0,0,6.75447484,22.77373742,GDA;XDH,3
5116,nucleoside triphosphate metabolic process (GO:0009141),0.034332879,0.423190046,0,0,6.75447484,22.77373742,CMPK1;SMPDL3A,3
5117,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.034332879,0.422170311,0,0,6.75447484,22.77373742,HSPA1B;HSPA1A,3
5118,regulation of response to interferon-gamma (GO:0060330),0.034332879,0.421155479,0,0,6.75447484,22.77373742,SOCS3;IFNGR1,3
5119,purine-containing compound catabolic process (GO:0072523),0.034332879,0.420145514,0,0,6.75447484,22.77373742,GDA;XDH,3
5120,mRNA stabilization (GO:0048255),0.034639993,0.422889679,0,0,4.171881519,14.02897951,ZFP36;PABPC1;MYD88,3
5121,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.035729347,0.435147628,0,0,2.748914179,9.158785231,COX7A2L;NDUFA6;NDUFA4;UQCRFS1;UQCRH,3
5122,phospholipid transport (GO:0015914),0.036092252,0.438520867,0,0,3.205513483,10.64768058,SCARB1;SCP2;APOC1;LDLR,3
5123,phosphorylation (GO:0016310),0.036778182,0.445793498,0,0,1.710435489,5.649312695,LYN;TGFB1;GMFG;ATP5C1;UQCRH;IKBKB;FGR;HCK;STK24;STK17B;RARA;HCST;NADK;RBKS,3
5124,cellular response to lipid (GO:0071396),0.036971236,0.4470716,0,0,2.113131793,6.968295279,LYN;ZFP36;SBNO2;XBP1;H2AFZ;HMGB2;RARA;AHR,3
5125,toll-like receptor signaling pathway (GO:0002224),0.037276774,0.449700662,0,0,2.717317464,8.938302806,IKBKB;UBE2D3;RPS27A;UBA52;MYD88,3
5126,regulation of interleukin-8 production (GO:0032677),0.037310792,0.44904946,0,0,4.052684904,13.32714354,IL1B;HSPA1B;HSPA1A,3
5127,negative regulation of DNA binding (GO:0043392),0.037310792,0.447992873,0,0,4.052684904,13.32714354,SP100;JUN;ID3,3
5128,positive regulation of DNA binding (GO:0043388),0.037310792,0.446941246,0,0,4.052684904,13.32714354,TGFB1;HMGB2;HES1,3
5129,negative regulation of T cell activation (GO:0050868),0.037310792,0.445894546,0,0,4.052684904,13.32714354,CEBPB;CEACAM1;TNFAIP8L2,3
5130,regulation of insulin receptor signaling pathway (GO:0046626),0.037310792,0.444852736,0,0,4.052684904,13.32714354,SOCS3;PTPN1;IL1B,3
5131,negative regulation of endothelial cell migration (GO:0010596),0.037310792,0.443815783,0,0,4.052684904,13.32714354,SP100;TGFB1;THBS1,3
5132,positive regulation of cell motility (GO:2000147),0.038009677,0.451077638,0,0,2.101392172,6.871372694,FGR;XBP1;TGFB1;IL1B;RACK1;GCNT2;CIB1;THBS1,3
5133,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.038119585,0.45133235,0,0,2.424683276,7.921505933,LYN;SOCS3;PTPN1;TGFB1;HES1;TNFRSF1A,3
5134,regulation of B cell differentiation (GO:0045577),0.039070704,0.461522691,0,0,6.304176517,20.44055068,XBP1;ZFP36L2,3
5135,lipoxygenase pathway (GO:0019372),0.039070704,0.460456818,0,0,6.304176517,20.44055068,HPGD;ALOX5AP,3
5136,regulation of interleukin-4 production (GO:0032673),0.039070704,0.459395858,0,0,6.304176517,20.44055068,CEBPB;RARA,3
5137,regulation of establishment of cell polarity (GO:2000114),0.039070704,0.458339775,0,0,6.304176517,20.44055068,RAP1B;RACK1,3
5138,unsaturated fatty acid biosynthetic process (GO:0006636),0.039070704,0.457288537,0,0,6.304176517,20.44055068,HPGD;ALOX5AP,3
5139,cellular biogenic amine biosynthetic process (GO:0042401),0.039070704,0.456242111,0,0,6.304176517,20.44055068,SMOX;SAT1,3
5140,regulation of macrophage chemotaxis (GO:0010758),0.039070704,0.455200462,0,0,6.304176517,20.44055068,MTUS1;THBS1,3
5141,negative regulation of viral entry into host cell (GO:0046597),0.039070704,0.454163559,0,0,6.304176517,20.44055068,IFITM3;IFITM2,3
5142,positive regulation of interleukin-4 production (GO:0032753),0.039070704,0.453131369,0,0,6.304176517,20.44055068,CEBPB;RARA,3
5143,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.039070704,0.45210386,0,0,6.304176517,20.44055068,CD53;FLOT1,3
5144,JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),0.039070704,0.451081001,0,0,6.304176517,20.44055068,LYN;PTPN1,3
5145,regulation of lymphocyte proliferation (GO:0050670),0.039070704,0.450062759,0,0,6.304176517,20.44055068,LST1;AHR,3
5146,cellular response to corticosteroid stimulus (GO:0071384),0.039070704,0.449049104,0,0,6.304176517,20.44055068,ZFP36;ZFP36L2,3
5147,regulated exocytosis (GO:0045055),0.039352893,0.451275984,0,0,2.221270249,7.18622194,LYN;SRGN;FAM49B;TGFB1;F13A1;TLN1;THBS1,3
5148,cell chemotaxis (GO:0060326),0.040064655,0.45840793,0,0,3.10041468,9.97484244,NR4A1;BIN2;HMGB2;FPR2,3
5149,response to reactive oxygen species (GO:0000302),0.040064655,0.457382409,0,0,3.10041468,9.97484244,PRDX5;JUN;STK24;FOS,3
5150,antibacterial humoral response (GO:0019731),0.040083867,0.4565803,0,0,3.940110323,12.67447336,SLPI;RNASE6;RPL39,3
5151,negative regulation of cell-substrate adhesion (GO:0010812),0.040083867,0.455563417,0,0,3.940110323,12.67447336,PTPRO;GCNT2;THBS1,3
5152,erythrocyte differentiation (GO:0030218),0.040083867,0.454551054,0,0,3.940110323,12.67447336,LYN;RPS14;RPS19,3
5153,negative regulation of epithelial cell migration (GO:0010633),0.040083867,0.45354318,0,0,3.940110323,12.67447336,SP100;ADIPOR1;THBS1,3
5154,membrane protein proteolysis (GO:0033619),0.040083867,0.452539766,0,0,3.940110323,12.67447336,NAPSA;TGFB1;PRTN3,3
5155,protein kinase B signaling (GO:0043491),0.040083867,0.451540782,0,0,3.940110323,12.67447336,NR4A1;TGFB1;IL1B,3
5156,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.040493379,0.455149144,0,0,2.65625415,8.517589203,RPL11;RACK1;NOP53;HSPA1B;HSPA1A,3
5157,negative regulation of translation (GO:0017148),0.040493379,0.454148817,0,0,2.65625415,8.517589203,BTG2;RACK1;RPS3;RPL13A;EIF3E,3
5158,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.040493379,0.453152876,0,0,2.65625415,8.517589203,RAC1;RPS27A;AP2A2;UBA52;PSMA7,3
5159,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.042140426,0.470552718,0,0,3.050407992,9.659872703,LYN;SOCS3;HES1;TNFRSF1A,3
5160,positive regulation of T cell proliferation (GO:0042102),0.042140426,0.469525311,0,0,3.050407992,9.659872703,PTPRC;IL1B;RPS3;CCR2,3
5161,positive regulation of leukocyte chemotaxis (GO:0002690),0.042140426,0.46850238,0,0,3.050407992,9.659872703,FPR2;THBS1;PLA2G7;CCR2,3
5162,negative regulation of viral life cycle (GO:1903901),0.042140426,0.467483896,0,0,3.050407992,9.659872703,IFITM3;FAM111A;IFITM2;SLPI,3
5163,regulation of establishment of planar polarity (GO:0090175),0.042162871,0.466718285,0,0,2.626740215,8.316825018,RAC1;RPS27A;AP2A2;UBA52;PSMA7,3
5164,regulation of phosphorylation (GO:0042325),0.042283601,0.467041594,0,0,2.364066194,7.478382859,LYN;IKBKB;CDKN2D;CCDC88C;THBS1;NOP53,3
5165,endoderm formation (GO:0001706),0.042958294,0.473469055,0,0,3.833620855,12.06641958,ITGA4;DUSP1;MMP8,3
5166,plasma membrane organization (GO:0007009),0.042958294,0.472448648,0,0,3.833620855,12.06641958,SERP1;BIN2;DMKN,3
5167,regulation of ubiquitin protein ligase activity (GO:1904666),0.042958294,0.471432629,0,0,3.833620855,12.06641958,RPL5;RPS7;RPL11,3
5168,positive regulation of response to external stimulus (GO:0032103),0.043873333,0.480441246,0,0,2.597874938,8.122122416,TGFB1;THBS1;PLA2G7;CCR2;TNFRSF1A,3
5169,glucose 6-phosphate metabolic process (GO:0051156),0.044040012,0.481233788,0,0,5.910165485,18.45541787,TALDO1;RBKS,3
5170,positive regulation of myotube differentiation (GO:0010831),0.044040012,0.480205511,0,0,5.910165485,18.45541787,CD53;FLOT1,3
5171,negative regulation of DNA replication (GO:0008156),0.044040012,0.479181619,0,0,5.910165485,18.45541787,TGFB1;S100A11,3
5172,positive regulation of triglyceride metabolic process (GO:0090208),0.044040012,0.478162083,0,0,5.910165485,18.45541787,SCARB1;LDLR,3
5173,regulation of stem cell proliferation (GO:0072091),0.044040012,0.477146877,0,0,5.910165485,18.45541787,PTPRC;HMGB2,3
5174,regulation of necroptotic process (GO:0060544),0.044040012,0.476135973,0,0,5.910165485,18.45541787,RPS27A;UBA52,3
5175,regulation of glucose transport (GO:0010827),0.044040012,0.475129343,0,0,5.910165485,18.45541787,C3;IL1B,3
5176,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.044040012,0.47412696,0,0,5.910165485,18.45541787,JUN;SUB1,3
5177,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.044275903,0.475663018,0,0,3.001988818,9.358143865,CDKN2D;XBP1;TPT1;HSPA1A,3
5178,stress-activated MAPK cascade (GO:0051403),0.044275903,0.474663726,0,0,3.001988818,9.358143865,IKBKB;ZFP36;RPS27A;UBA52,3
5179,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.044275903,0.473668624,0,0,3.001988818,9.358143865,BTG2;RPL26;RPS27A;UBA52,3
5180,protein stabilization (GO:0050821),0.044338844,0.473349621,0,0,2.163197824,6.74029546,RPL5;RPS7;RPL11;FLOT1;NOP53;HSPA1B;HSPA1A,3
5181,cellular response to acid chemical (GO:0071229),0.045624875,0.486062082,0,0,2.569637167,7.933246493,LYN;XBP1;RARA;LAMTOR4;KLF2,3
5182,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),0.046471031,0.494045148,0,0,2.955082742,9.068930704,BTG2;RPL26;RPS27A;UBA52,3
5183,positive regulation of protein polymerization (GO:0032273),0.048725712,0.516938268,0,0,2.909619931,8.791557527,HCK;RAC2;RPS3;RAC1,3
5184,positive regulation of JAK-STAT cascade (GO:0046427),0.048725712,0.515865782,0,0,2.909619931,8.791557527,LYN;SOCS3;HES1;TNFRSF1A,3
5185,negative regulation of neuron differentiation (GO:0045665),0.048725712,0.514797736,0,0,2.909619931,8.791557527,PTPRO;ID3;CIB1;HES1,3
5186,T cell differentiation (GO:0030217),0.049006991,0.516699739,0,0,3.637024914,10.96851181,FCER1G;PTPRC;ZFP36L2,3
5187,regulation of cellular amide metabolic process (GO:0034248),0.049006991,0.515634379,0,0,3.637024914,10.96851181,RBM3;EEF1A1;RPL10,3
5188,high-density lipoprotein particle remodeling (GO:0034375),0.049228941,0.516903877,0,0,5.562508691,16.7502356,SCARB1;APOC1,3
5189,regulation of tissue remodeling (GO:0034103),0.049228941,0.515842472,0,0,5.562508691,16.7502356,CEACAM1;TGFB1,3
5190,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.049228941,0.514785418,0,0,5.562508691,16.7502356,CEACAM1;CD300A,3
5191,response to interferon-alpha (GO:0035455),0.049228941,0.513732687,0,0,5.562508691,16.7502356,IFITM3;IFITM2,3
5192,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.049228941,0.512684253,0,0,5.562508691,16.7502356,SLC25A5;HSPA1A,3
5193,negative regulation of lipid biosynthetic process (GO:0051055),0.049228941,0.51164009,0,0,5.562508691,16.7502356,CEACAM1;APOC1,3
5194,3'-UTR-mediated mRNA stabilization (GO:0070935),0.049228941,0.510600171,0,0,5.562508691,16.7502356,ZFP36;MYD88,3
5195,macrophage activation (GO:0042116),0.049228941,0.509564471,0,0,5.562508691,16.7502356,SBNO2;FPR2,3
5196,virion assembly (GO:0019068),0.049228941,0.508532964,0,0,5.562508691,16.7502356,RPS27A;UBA52,3
5197,neurotrophin signaling pathway (GO:0038179),0.049228941,0.507505624,0,0,5.562508691,16.7502356,RAP1A;DDIT4,3
5198,chaperone-mediated protein complex assembly (GO:0051131),0.049228941,0.506482427,0,0,5.562508691,16.7502356,HOPX;HSPA1A,3
5199,regulation of lamellipodium organization (GO:1902743),0.049228941,0.505463348,0,0,5.562508691,16.7502356,RAC1;SSH2,3
5200,positive chemotaxis (GO:0050918),0.049228941,0.504448361,0,0,5.562508691,16.7502356,FPR2;CORO1A,3
5201,regulation of establishment or maintenance of cell polarity (GO:0032878),0.049228941,0.503437443,0,0,5.562508691,16.7502356,RAP1B;RACK1,3
5202,cellular response to glucocorticoid stimulus (GO:0071385),0.049228941,0.502430568,0,0,5.562508691,16.7502356,ZFP36;ZFP36L2,3
5203,protein homooligomerization (GO:0051260),0.05073709,0.516789158,0,0,1.980369586,5.903675983,FIS1;FCER1G;CCDC88C;ALOX5AP;MGST1;FLOT1;TMCC1;SAMHD1,3
5204,regulation of JAK-STAT cascade (GO:0046425),0.051039807,0.518836927,0,0,2.86553478,8.52539412,SOCS3;BCL3;HES1;ADIPOR1,3
5205,cellular response to reactive oxygen species (GO:0034614),0.051039807,0.517805442,0,0,2.86553478,8.52539412,PRDX5;JUN;RPS3;FOS,3
5206,cellular response to fibroblast growth factor stimulus (GO:0044344),0.051126763,0.517658479,0,0,2.48849073,7.399395729,NR4A1;ZFP36;RPS27A;UBA52;ZFP36L2,3
5207,respiratory electron transport chain (GO:0022904),0.051126763,0.516633413,0,0,2.48849073,7.399395729,COX7A2L;NDUFA6;NDUFA4;UQCRFS1;UQCRH,3
5208,negative regulation of multicellular organismal process (GO:0051241),0.05144148,0.518786312,0,0,2.251491613,6.680874531,CEACAM1;RPS19;IL1B;ARHGDIB;PTPRO;ADIPOR1,3
5209,positive regulation of phagocytosis (GO:0050766),0.052178923,0.525185491,0,0,3.546099291,10.47190298,C3;FCER1G;IL1B,3
5210,ERBB2 signaling pathway (GO:0038128),0.052178923,0.524151662,0,0,3.546099291,10.47190298,PTPN18;RPS27A;UBA52,3
5211,positive regulation of fat cell differentiation (GO:0045600),0.052178923,0.523121894,0,0,3.546099291,10.47190298,CEBPB;ZFP36;XBP1,3
5212,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.052178923,0.522096165,0,0,3.546099291,10.47190298,ATG3;RAC1;SSH2,3
5213,"positive regulation of transcription, DNA-templated (GO:0045893)",0.05269329,0.526211071,0,0,1.349689888,3.972497926,CEBPB;SP100;SPI1;HMGB2;AHR;IKBKB;LYL1;SBNO2;HES1;RPS27A;JUNB;IER5;IER2;KDM6B;KLF10;NFE2;JUN;XBP1;JUND;TGFB1;H2AFZ;FOS;KLF2;FOSL2;TNFRSF1A;NR4A1;IL1B;BCL3;RARA;IRF5;PLCB1;UBA52,3
5214,purine ribonucleotide metabolic process (GO:0009150),0.053413141,0.532357931,0,0,2.822765605,8.269852072,HSPA8;NADK;HSPA1B;HSPA1A,3
5215,negative regulation of epithelial cell proliferation (GO:0050680),0.053413141,0.531320196,0,0,2.822765605,8.269852072,CEACAM1;TGFB1;THBS1;XDH,3
5216,actin filament polymerization (GO:0030041),0.054626026,0.54232804,0,0,5.253480431,15.27315385,RAC1;MSRB1,3
5217,glucan biosynthetic process (GO:0009250),0.054626026,0.541274976,0,0,5.253480431,15.27315385,RPS27A;UBA52,3
5218,negative regulation of RNA splicing (GO:0033119),0.054626026,0.540225994,0,0,5.253480431,15.27315385,RPS26;RPS13,3
5219,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.054626026,0.539181069,0,0,5.253480431,15.27315385,DDIT4;RACK1,3
5220,positive regulation of p38MAPK cascade (GO:1900745),0.054626026,0.538140179,0,0,5.253480431,15.27315385,IL1B;XDH,3
5221,acute-phase response (GO:0006953),0.054626026,0.5371033,0,0,5.253480431,15.27315385,CEBPB;IL1B,3
5222,glycogen biosynthetic process (GO:0005978),0.054626026,0.536070409,0,0,5.253480431,15.27315385,RPS27A;UBA52,3
5223,regulation of epithelial cell differentiation (GO:0030856),0.054626026,0.535041483,0,0,5.253480431,15.27315385,CEBPB;CEACAM1,3
5224,mRNA destabilization (GO:0061157),0.054626026,0.534016499,0,0,5.253480431,15.27315385,ZFP36;ZFP36L2,3
5225,non-canonical Wnt signaling pathway (GO:0035567),0.054743038,0.534137136,0,0,2.216312057,6.438619415,RAC1;PLCB1;RPS27A;UBA52;AP2A2;PSMA7,3
5226,negative regulation of catabolic process (GO:0009895),0.055447543,0.539978644,0,0,3.459609064,10.00628917,BSCL2;IL1B;APOC1,3
5227,positive regulation of cytokine biosynthetic process (GO:0042108),0.055447543,0.538950114,0,0,3.459609064,10.00628917,IL1B;THBS1;CCR2,3
5228,protein localization to membrane (GO:0072657),0.055486607,0.53830448,0,0,2.055709734,5.944318221,IKBKB;ITGA4;FLOT1;ITGB7;ITGAL;RAMP1;TNFRSF1A,3
5229,negative regulation of protein binding (GO:0032091),0.055845499,0.540758215,0,0,2.781254346,8.024381462,ITGA4;SLPI;ADRB2;SORL1,3
5230,extracellular matrix organization (GO:0030198),0.056526738,0.546318076,0,0,1.85013876,5.315525463,VCAN;TGFB1;ITGA4;FLOT1;ITGB7;CD47;ITGAL;MMP8;THBS1,3
5231,response to tumor necrosis factor (GO:0034612),0.057000396,0.549854482,0,0,2.412312443,6.910544368,IKBKB;ZFP36;RPS3;CIB1;ZFP36L2,3
5232,cellular response to organonitrogen compound (GO:0071417),0.057000396,0.548817021,0,0,2.412312443,6.910544368,RAP1B;XBP1;RAP1A;AHR;LAMTOR4,3
5233,peptide transport (GO:0015833),0.058811475,0.56518824,0,0,3.37723742,9.569126293,RAP1A;PPT1;RAMP1,3
5234,cellular response to peptide (GO:1901653),0.058811475,0.564125856,0,0,3.37723742,9.569126293,XBP1;FPR2;ADRB2,3
5235,spliceosomal complex assembly (GO:0000245),0.058811475,0.563067458,0,0,3.37723742,9.569126293,SNRPG;SRSF5;SF3B1,3
5236,negative regulation of STAT cascade (GO:1904893),0.058811475,0.562013025,0,0,3.37723742,9.569126293,SOCS3;BCL3;ADIPOR1,3
5237,apoptotic process (GO:0006915),0.059046346,0.563202807,0,0,1.834189288,5.189715012,DUSP22;FIS1;CASP6;IL1B;CIB1;PTPN6;AHR;MYD88;IER3,3
5238,regulation of protein kinase B signaling (GO:0051896),0.060078462,0.571978347,0,0,2.018105287,5.675121674,TGFB1;RACK1;GCNT2;CIB1;THBS1;XDH;NOP53,3
5239,regulation of mitotic spindle assembly (GO:1901673),0.060220189,0.572260007,0,0,4.976981461,13.98406181,HSPA1B;HSPA1A,3
5240,error-free translesion synthesis (GO:0070987),0.060220189,0.571196327,0,0,4.976981461,13.98406181,RPS27A;UBA52,3
5241,regulation of sprouting angiogenesis (GO:1903670),0.060220189,0.570136593,0,0,4.976981461,13.98406181,CEACAM1;KLF2,3
5242,negative regulation of cell junction assembly (GO:1901889),0.060220189,0.569080785,0,0,4.976981461,13.98406181,IKBKB;THBS1,3
5243,negative regulation of protein localization to plasma membrane (GO:1903077),0.060220189,0.568028879,0,0,4.976981461,13.98406181,TGFB1;PPP2R5A,3
5244,protein targeting to lysosome (GO:0006622),0.060220189,0.566980856,0,0,4.976981461,13.98406181,HSPA8;SORL1,3
5245,NADP metabolic process (GO:0006739),0.060220189,0.565936692,0,0,4.976981461,13.98406181,TALDO1;RBKS,3
5246,endothelial cell development (GO:0001885),0.060220189,0.564896367,0,0,4.976981461,13.98406181,RAP1B;RAP1A,3
5247,Rac protein signal transduction (GO:0016601),0.060220189,0.56385986,0,0,4.976981461,13.98406181,RAC2;RAC1,3
5248,positive regulation of lipid storage (GO:0010884),0.060220189,0.56282715,0,0,4.976981461,13.98406181,C3;SCARB1,3
5249,macromolecule biosynthetic process (GO:0009059),0.060220189,0.561798215,0,0,4.976981461,13.98406181,PTPRC;RPS23,3
5250,negative regulation of protein localization to cell periphery (GO:1904376),0.060220189,0.560773036,0,0,4.976981461,13.98406181,TGFB1;PPP2R5A,3
5251,regulation of platelet activation (GO:0010543),0.060220189,0.559751591,0,0,4.976981461,13.98406181,LYN;FCER1G,3
5252,response to interferon-beta (GO:0035456),0.060220189,0.558733861,0,0,4.976981461,13.98406181,IFITM3;IFITM2,3
5253,regulation of endothelial cell migration (GO:0010594),0.060886238,0.563888339,0,0,2.701789936,7.561629446,SCARB1;CEACAM1;SP100;THBS1,3
5254,regulation of innate immune response (GO:0045088),0.060886238,0.562866803,0,0,2.701789936,7.561629446,FGR;PTPN1;PTPN6;SAMHD1,3
5255,regulation of protein modification process (GO:0031399),0.062269273,0.574611392,0,0,3.298697015,9.15813025,LYN;CCDC88C;NOP53,3
5256,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.06349401,0.584855473,0,0,2.663736556,7.343414807,RACK1;NOP53;HSPA1B;HSPA1A,3
5257,interferon-gamma-mediated signaling pathway (GO:0060333),0.06349401,0.583801679,0,0,2.663736556,7.343414807,HCK;SP100;IFNGR1;IRF5,3
5258,negative regulation of developmental process (GO:0051093),0.06349401,0.582751676,0,0,2.663736556,7.343414807,CEACAM1;TGFB1;ARHGDIB;HOPX,3
5259,cellular response to hypoxia (GO:0071456),0.063546139,0.582183032,0,0,2.132992055,5.878502712,UBE2D3;RPS27A;UBA52;NDRG1;NOP53;PSMA7,3
5260,positive regulation of apoptotic process (GO:0043065),0.064040577,0.58566141,0,0,1.68861871,4.640726737,FIS1;JUN;BTG1;STK17B;RPS6;RACK1;RPS3;IRF5;RAC1;RPS27A;UBA52,3
5261,regulation of transcription from RNA polymerase II promoter (GO:0006357),0.065132915,0.594585449,0,0,1.27873763,3.492648375,CEBPB;SP100;SPI1;RPL10;UBE2D3;HMGB2;AHR;IKBKB;RPS14;LYL1;ZFP36;SBNO2;NFIL3;HES1;RPS27A;JUNB;IER5;IER2;KDM6B;KLF10;NFE2;JUN;XBP1;JUND;TGFB1;KLF13;H2AFZ;ARID5A;FOS;HOPX;KLF2;FOSL2;TNFRSF1A;DUSP22;NR4A1;SUB1;RARA;IRF5;UBA52;NOP53,3
5262,negative regulation of ERBB signaling pathway (GO:1901185),0.065819425,0.599779508,0,0,3.223726628,8.771245246,PTPN18;RPS27A;UBA52,3
5263,response to unfolded protein (GO:0006986),0.065819425,0.598710382,0,0,3.223726628,8.771245246,HSPA8;HSPA1B;HSPA1A,3
5264,negative regulation of DNA metabolic process (GO:0051053),0.065819425,0.597645061,0,0,3.223726628,8.771245246,TGFB1;RPS3;S100A11,3
5265,positive regulation of interleukin-6 production (GO:0032755),0.065819425,0.596583525,0,0,3.223726628,8.771245246,XBP1;IL1B;MYD88,3
5266,cell projection assembly (GO:0030031),0.066000722,0.597166103,0,0,4.728132388,12.85148749,RAC2;RAC1,3
5267,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.066000722,0.596109172,0,0,4.728132388,12.85148749,XBP1;HSPA1A,3
5268,natural killer cell activation involved in immune response (GO:0002323),0.066000722,0.595055976,0,0,4.728132388,12.85148749,CORO1A;CD244,3
5269,endoplasmic reticulum mannose trimming (GO:1904380),0.066000722,0.594006494,0,0,4.728132388,12.85148749,RPS27A;UBA52,3
5270,response to progesterone (GO:0032570),0.066000722,0.592960708,0,0,4.728132388,12.85148749,TGFB1;THBS1,3
5271,error-prone translesion synthesis (GO:0042276),0.066000722,0.591918598,0,0,4.728132388,12.85148749,RPS27A;UBA52,3
5272,purine nucleotide metabolic process (GO:0006163),0.066000722,0.590880144,0,0,4.728132388,12.85148749,GDA;XDH,3
5273,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.066000722,0.589845328,0,0,4.728132388,12.85148749,ACTR3;ARPC3,3
5274,regulation of cell development (GO:0060284),0.066000722,0.58881413,0,0,4.728132388,12.85148749,RPS19;HMGB2,3
5275,positive regulation of gene silencing by miRNA (GO:2000637),0.066000722,0.587786531,0,0,4.728132388,12.85148749,ZFP36;TGFB1,3
5276,growth hormone receptor signaling pathway (GO:0060396),0.066000722,0.586762513,0,0,4.728132388,12.85148749,LYN;PTPN1,3
5277,inactivation of MAPK activity (GO:0000188),0.066000722,0.585742056,0,0,4.728132388,12.85148749,DUSP22;DUSP1,3
5278,defense response to Gram-negative bacterium (GO:0050829),0.066159584,0.586132562,0,0,2.626740215,7.133400366,RPL30;RPS19;HMGB2;RNASE6,3
5279,cell-cell junction organization (GO:0045216),0.06888257,0.609198883,0,0,2.590757473,6.931188461,TGFB1;PRTN3;TLN1;CD177,3
5280,lysosomal transport (GO:0007041),0.06888257,0.608144906,0,0,2.590757473,6.931188461,HGSNAT;ADRB2;USE1;SORL1,3
5281,regulation of MAPK cascade (GO:0043408),0.068976004,0.607918042,0,0,1.854169564,4.958043125,LYN;CEACAM1;TGFB1;DUSP1;IL1B;PTPN6;ADRB2;TNFRSF1A,3
5282,phagocytosis (GO:0006909),0.069205378,0.60888801,0,0,2.085940759,5.570873376,C3;BIN2;RARA;PLD4;PRTN3;CORO1A,3
5283,cholesterol transport (GO:0030301),0.069460356,0.610079513,0,0,3.152088258,8.406616563,SCARB1;APOC1;LDLR,3
5284,negative regulation of type I interferon production (GO:0032480),0.069460356,0.609031267,0,0,3.152088258,8.406616563,PCBP2;RPS27A;UBA52,3
5285,positive regulation of transport (GO:0051050),0.069460356,0.607986616,0,0,3.152088258,8.406616563,C3;FLOT1;LDLR,3
5286,posttranscriptional regulation of gene expression (GO:0010608),0.069460356,0.606945543,0,0,3.152088258,8.406616563,RBM3;RPL10;GCNT2,3
5287,positive regulation of proteasomal protein catabolic process (GO:1901800),0.071662547,0.625117908,0,0,2.555747237,6.736405412,RACK1;NOP53;HSPA1B;HSPA1A,3
5288,hyaluronan metabolic process (GO:0030212),0.071957281,0.626617756,0,0,4.502983226,11.85042285,TGFB1;IL1B,3
5289,positive regulation of cellular component movement (GO:0051272),0.071957281,0.625550264,0,0,4.502983226,11.85042285,LYN;RPS19,3
5290,dendritic cell differentiation (GO:0097028),0.071957281,0.624486403,0,0,4.502983226,11.85042285,LYN;PRTN3,3
5291,regulation of interleukin-17 production (GO:0032660),0.071957281,0.623426155,0,0,4.502983226,11.85042285,TGFB1;MYD88,3
5292,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.071957281,0.6223695,0,0,4.502983226,11.85042285,COX7A2L;NDUFA4,3
5293,histone lysine demethylation (GO:0070076),0.071957281,0.621316422,0,0,4.502983226,11.85042285,KDM6B;KDM7A,3
5294,positive regulation of T cell mediated immunity (GO:0002711),0.071957281,0.620266901,0,0,4.502983226,11.85042285,FAM49B;IL1B,3
5295,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.071957281,0.619220919,0,0,4.502983226,11.85042285,DDIT4;BCL3,3
5296,positive regulation of lamellipodium organization (GO:1902745),0.071957281,0.61817846,0,0,4.502983226,11.85042285,RAC2;RAC1,3
5297,negative regulation of cytokine biosynthetic process (GO:0042036),0.071957281,0.617139505,0,0,4.502983226,11.85042285,ZFP36;BCL3,3
5298,establishment of endothelial barrier (GO:0061028),0.071957281,0.616104036,0,0,4.502983226,11.85042285,RAP1B;RAP1A,3
5299,regulation of interleukin-2 production (GO:0032663),0.071957281,0.615072036,0,0,4.502983226,11.85042285,RPS3;CCR2,3
5300,negative regulation of viral process (GO:0048525),0.071957281,0.614043487,0,0,4.502983226,11.85042285,IFITM3;ZFP36,3
5301,hepaticobiliary system development (GO:0061008),0.071957281,0.613018373,0,0,4.502983226,11.85042285,XBP1;RARA,3
5302,"phagocytosis, engulfment (GO:0006911)",0.072147399,0.613613629,0,0,2.251491613,5.919270615,C3;BIN2;RAC2;RAC1;THBS1,3
5303,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.073190437,0.62144892,0,0,3.083564601,8.062567084,TGFB1;CIB1;THBS1,3
5304,MAPK cascade (GO:0000165),0.073686737,0.624623616,0,0,1.694671107,4.419587791,IKBKB;ZFP36;TGFB1;STK24;IL1B;RPS27A;UBA52;PSMA7;ZFP36L2;RASGRP4,3
5305,"regulation of gene expression, epigenetic (GO:0040029)",0.074499061,0.6304622,0,0,2.521670607,6.548699796,SPI1;H3F3A;JARID2;SF3B1,3
5306,response to endoplasmic reticulum stress (GO:0034976),0.076842538,0.649217668,0,0,2.209407658,5.669333228,JUN;CEBPB;FLOT1;FAM129A;THBS1,3
5307,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.077007987,0.649540093,0,0,3.017956843,7.737576998,CDK2AP2;PTPN6;PLCB1,3
5308,regulation of cellular component movement (GO:0051270),0.077007987,0.648468245,0,0,3.017956843,7.737576998,LYN;SP100;RPS19,3
5309,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.078079876,0.656411214,0,0,4.298302171,10.96076907,SOCS3;IFNGR1,3
5310,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.078079876,0.655331591,0,0,4.298302171,10.96076907,PTPN1;IL1B,3
5311,cellular response to nerve growth factor stimulus (GO:1990090),0.078079876,0.654255513,0,0,4.298302171,10.96076907,RAP1A;CIB1,3
5312,protein homotrimerization (GO:0070207),0.078079876,0.653182963,0,0,4.298302171,10.96076907,ALOX5AP;MGST1,3
5313,positive regulation of protein targeting to membrane (GO:0090314),0.078079876,0.652113923,0,0,4.298302171,10.96076907,FIS1;CIB1,3
5314,cellular response to hexose stimulus (GO:0071331),0.078079876,0.651048378,0,0,4.298302171,10.96076907,XBP1;RACK1,3
5315,negative regulation of myeloid cell differentiation (GO:0045638),0.078079876,0.649986309,0,0,4.298302171,10.96076907,ZFP36;CIB1,3
5316,negative regulation of sprouting angiogenesis (GO:1903671),0.078079876,0.648927699,0,0,4.298302171,10.96076907,THBS1;KLF2,3
5317,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.078079876,0.647872532,0,0,4.298302171,10.96076907,RPS27A;UBA52,3
5318,regulation of cytokine production involved in inflammatory response (GO:1900015),0.078079876,0.646820791,0,0,4.298302171,10.96076907,MEFV;MYD88,3
5319,regulation of ERBB signaling pathway (GO:1901184),0.078079876,0.645772459,0,0,4.298302171,10.96076907,PTPN18;CEACAM1,3
5320,negative regulation of Wnt signaling pathway (GO:0030178),0.078860973,0.651177258,0,0,1.891252955,4.803912646,PTPRO;RACK1;IGFBP6;RPS27A;UBA52;PFDN5;PSMA7,3
5321,positive regulation of JNK cascade (GO:0046330),0.080339739,0.662316138,0,0,2.456172669,6.193217021,DUSP22;IL1B;RPS3;PLCB1,3
5322,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.080339739,0.661247887,0,0,2.456172669,6.193217021,IL1B;THBS1;HSPA1B;HSPA1A,3
5323,response to glucose (GO:0009749),0.080911277,0.664879621,0,0,2.955082742,7.430266178,XBP1;RACK1;THBS1,3
5324,negative regulation of cellular biosynthetic process (GO:0031327),0.080911277,0.663810683,0,0,2.955082742,7.430266178,CEACAM1;TGFB1;APOC1,3
5325,negative regulation of JAK-STAT cascade (GO:0046426),0.080911277,0.662745176,0,0,2.955082742,7.430266178,SOCS3;BCL3;ADIPOR1,3
5326,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.083342853,0.681568235,0,0,2.424683276,6.024834628,TGFB1;RPS27A;UBA52;HSPA1A,3
5327,cholesterol efflux (GO:0033344),0.084358857,0.688773198,0,0,4.111419468,10.16620606,SCARB1;APOC1,3
5328,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.084358857,0.687672921,0,0,4.111419468,10.16620606,RPS27A;UBA52,3
5329,positive regulation of ERBB signaling pathway (GO:1901186),0.084358857,0.686576154,0,0,4.111419468,10.16620606,RPS27A;UBA52,3
5330,lamellipodium assembly (GO:0030032),0.084358857,0.68548288,0,0,4.111419468,10.16620606,PTPRO;RAC1,3
5331,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.084358857,0.684393082,0,0,4.111419468,10.16620606,RPS27A;UBA52,3
5332,membrane assembly (GO:0071709),0.084358857,0.683306744,0,0,4.111419468,10.16620606,FLOT1;DMKN,3
5333,cellular response to interleukin-6 (GO:0071354),0.084358857,0.682223849,0,0,4.111419468,10.16620606,SOCS3;SBNO2,3
5334,cellular response to amyloid-beta (GO:1904646),0.084358857,0.681144381,0,0,4.111419468,10.16620606,FPR2;ADRB2,3
5335,positive regulation of monooxygenase activity (GO:0032770),0.084358857,0.680068323,0,0,4.111419468,10.16620606,SCARB1;IL1B,3
5336,regulation of cell size (GO:0008361),0.084358857,0.67899566,0,0,4.111419468,10.16620606,RAC1;LAMTOR4,3
5337,positive regulation of cell junction assembly (GO:1901890),0.084358857,0.677926376,0,0,4.111419468,10.16620606,FLOT1;RAC1,3
5338,positive regulation of MAP kinase activity (GO:0043406),0.084514665,0.678110591,0,0,1.859377905,4.594207099,RAP1A;TGFB1;IL1B;RPS3;RPS27A;UBA52;THBS1,3
5339,regulation of angiogenesis (GO:0045765),0.084514665,0.677046053,0,0,1.859377905,4.594207099,XBP1;CEACAM1;SP100;BTG1;IL1B;THBS1;CCR2,3
5340,regulation of epithelial cell migration (GO:0010632),0.084898536,0.679055221,0,0,2.894774931,7.139378855,CEACAM1;GLIPR2;ADIPOR1,3
5341,positive regulation of chemotaxis (GO:0050921),0.084898536,0.677992537,0,0,2.894774931,7.139378855,TGFB1;THBS1;CCR2,3
5342,regulation of cellular response to heat (GO:1900034),0.086400403,0.688908215,0,0,2.393991082,5.862316633,HSPA8;IER5;HSPA1B;HSPA1A,3
5343,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.086400403,0.687833475,0,0,2.393991082,5.862316633,IKBKB;FCER1G;NCF2;PSMA7,3
5344,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.086400403,0.686762083,0,0,2.393991082,5.862316633,UBE2D3;RPS27A;UBA52;PSMA7,3
5345,negative regulation of inflammatory response (GO:0050728),0.086400403,0.685694024,0,0,2.393991082,5.862316633,RPS19;TNFAIP8L2;MEFV;TNFRSF1A,3
5346,glutathione metabolic process (GO:0006749),0.088967957,0.704974355,0,0,2.836879433,6.863770233,ETHE1;GSR;MGST1,3
5347,regulation of endothelial cell proliferation (GO:0001936),0.089511798,0.70818404,0,0,2.364066194,5.705401511,NR4A1;HMGB2;THBS1;XDH,3
5348,ERBB signaling pathway (GO:0038127),0.092676421,0.732086343,0,0,2.334880191,5.553842209,PTPN18;TGFB1;RPS27A;UBA52,3
5349,positive regulation of stress-activated MAPK cascade (GO:0032874),0.092676421,0.730954833,0,0,2.334880191,5.553842209,DUSP22;IL1B;PLCB1;XDH,3
5350,negative regulation of defense response (GO:0031348),0.092676421,0.729826817,0,0,2.334880191,5.553842209,PCBP2;TNFAIP8L2;MEFV;TNFRSF1A,3
5351,regulation of cellular protein metabolic process (GO:0032268),0.093117696,0.732171957,0,0,2.781254346,6.602394778,RBM3;TGFB1;RPL10,3
5352,receptor internalization (GO:0031623),0.093117696,0.731045539,0,0,2.781254346,6.602394778,CEACAM1;FCER1G;RAMP1,3
5353,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.096970784,0.76012582,0,0,1.903945928,4.44256375,PTPRO;IGFBP6;RPS27A;UBA52;PFDN5;PSMA7,3
5354,positive regulation of actin filament polymerization (GO:0030838),0.097345878,0.76189573,0,0,2.727768685,6.354295935,HCK;RAC2;RAC1,3
5355,positive regulation of neutrophil chemotaxis (GO:0090023),0.097349034,0.760753626,0,0,3.78250591,8.811167755,RAC2;RAC1,3
5356,negative regulation of protein localization to membrane (GO:1905476),0.097349034,0.759590394,0,0,3.78250591,8.811167755,TGFB1;PPP2R5A,3
5357,response to glucocorticoid (GO:0051384),0.097349034,0.758430714,0,0,3.78250591,8.811167755,ZFP36;ZFP36L2,3
5358,histone mRNA metabolic process (GO:0008334),0.097349034,0.75727457,0,0,3.78250591,8.811167755,SNRPG;SNRPB,3
5359,receptor catabolic process (GO:0032801),0.097349034,0.756121945,0,0,3.78250591,8.811167755,TGFB1;AP2A2,3
5360,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.097349034,0.754972824,0,0,3.78250591,8.811167755,RPS3;RAC1,3
5361,positive regulation of endopeptidase activity (GO:0010950),0.097349034,0.75382719,0,0,3.78250591,8.811167755,LYN;MEFV,3
5362,regulation of chemotaxis (GO:0050920),0.097349034,0.752685027,0,0,3.78250591,8.811167755,TGFB1;THBS1,3
5363,positive regulation of dephosphorylation (GO:0035306),0.097349034,0.751546321,0,0,3.78250591,8.811167755,TGFB1;PPP2R5A,3
5364,"protein alpha-1,2-demannosylation (GO:0036508)",0.097349034,0.750411054,0,0,3.78250591,8.811167755,RPS27A;UBA52,3
5365,actin nucleation (GO:0045010),0.097349034,0.749279213,0,0,3.78250591,8.811167755,ACTR3;ARPC3,3
5366,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.097349034,0.74815078,0,0,3.78250591,8.811167755,CDKN2D;TPT1,3
5367,positive regulation of cell cycle arrest (GO:0071158),0.099162767,0.760943761,0,0,2.278618018,5.265869529,BTG2;RPL26;RPS27A;UBA52,3
5368,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.101650604,0.778863411,0,0,2.676301352,6.118597077,STK24;RAC2;RAC1,3
5369,negative regulation of cell differentiation (GO:0045596),0.101701383,0.778084194,0,0,1.878728101,4.294235832,TGFB1;HES1;ADIPOR1;XDH;ZFP36L2;HOPX,3
5370,cellular response to interferon-gamma (GO:0071346),0.102697499,0.784528951,0,0,2.020569396,4.5987503,HCK;SP100;IFNGR1;RPL13A;IRF5,3
5371,heterotypic cell-cell adhesion (GO:0034113),0.104042553,0.793616063,0,0,3.637024914,8.230424819,ITGA4;ITGB7,3
5372,regulation of spindle assembly (GO:0090169),0.104042553,0.792431561,0,0,3.637024914,8.230424819,HSPA1B;HSPA1A,3
5373,lamellipodium organization (GO:0097581),0.104042553,0.79125059,0,0,3.637024914,8.230424819,PTPRO;RAC1,3
5374,positive regulation of interleukin-12 production (GO:0032735),0.104042553,0.790073134,0,0,3.637024914,8.230424819,IRF5;PLCB1,3
5375,prostaglandin metabolic process (GO:0006693),0.104042553,0.788899177,0,0,3.637024914,8.230424819,HPGD;MGST1,3
5376,response to amyloid-beta (GO:1904645),0.104042553,0.787728703,0,0,3.637024914,8.230424819,FPR2;ADRB2,3
5377,positive regulation of neutrophil migration (GO:1902624),0.104042553,0.786561698,0,0,3.637024914,8.230424819,RAC2;RAC1,3
5378,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.104042553,0.785398145,0,0,3.637024914,8.230424819,IL1B;KLF2,3
5379,signal transduction in response to DNA damage (GO:0042770),0.104042553,0.784238029,0,0,3.637024914,8.230424819,BCL3;NDRG1,3
5380,positive regulation of nitric oxide metabolic process (GO:1904407),0.104042553,0.783081336,0,0,3.637024914,8.230424819,IL1B;KLF2,3
5381,positive regulation of supramolecular fiber organization (GO:1902905),0.105854052,0.795542309,0,0,2.225003477,4.996676958,HCK;RAC2;RPS3;RAC1,3
5382,protein modification process (GO:0036211),0.105854052,0.794372394,0,0,2.225003477,4.996676958,ATG3;SERP1;UBE2D3;UBA52,3
5383,cellular response to molecule of bacterial origin (GO:0071219),0.105854052,0.793205915,0,0,2.225003477,4.996676958,ZFP36;SBNO2;XBP1;HMGB2,3
5384,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.106029949,0.793358987,0,0,2.626740215,5.894493534,FGR;PTPN6;HCST,3
5385,embryonic organ development (GO:0048568),0.106029949,0.792197407,0,0,2.626740215,5.894493534,TGFB1;RPL10;RARA,3
5386,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.108329496,0.808195059,0,0,1.986610247,4.41539584,CCND3;TGFB1;IL1B;CIB1;ADRB2,3
5387,regulation of type I interferon production (GO:0032479),0.109274771,0.814057165,0,0,2.199131343,4.868634297,PCBP2;RPS27A;UBA52;MYD88,3
5388,cell morphogenesis involved in differentiation (GO:0000904),0.110481968,0.821850561,0,0,2.578981302,5.681245526,ITGA4;ITGB7;RAC1,3
5389,positive regulation of immune response (GO:0050778),0.110481968,0.820654272,0,0,2.578981302,5.681245526,XBP1;PTPRC;CD177,3
5390,positive regulation of response to stimulus (GO:0048584),0.110481968,0.819461461,0,0,2.578981302,5.681245526,TGFB1;IER5;YPEL3,3
5391,response to growth factor (GO:0070848),0.110857088,0.82105039,0,0,3.502320287,7.703400422,RACK1;CIB1,3
5392,positive regulation of interferon-beta production (GO:0032728),0.110857088,0.819860462,0,0,3.502320287,7.703400422,FLOT1;IRF5,3
5393,regulation of p38MAPK cascade (GO:1900744),0.110857088,0.818673978,0,0,3.502320287,7.703400422,IL1B;XDH,3
5394,regulation of NF-kappaB import into nucleus (GO:0042345),0.110857088,0.817490923,0,0,3.502320287,7.703400422,IL1B;BCL3,3
5395,positive regulation of granulocyte chemotaxis (GO:0071624),0.110857088,0.816311282,0,0,3.502320287,7.703400422,RAC2;RAC1,3
5396,positive regulation of wound healing (GO:0090303),0.110857088,0.815135041,0,0,3.502320287,7.703400422,XBP1;THBS1,3
5397,response to ketone (GO:1901654),0.110857088,0.813962185,0,0,3.502320287,7.703400422,TGFB1;THBS1,3
5398,regulation of supramolecular fiber organization (GO:1902903),0.110857088,0.812792699,0,0,3.502320287,7.703400422,HSPA8;SSH2,3
5399,positive regulation of cAMP metabolic process (GO:0030816),0.110857088,0.811626569,0,0,3.502320287,7.703400422,RACK1;RAMP1,3
5400,regulation of viral entry into host cell (GO:0046596),0.110857088,0.81046378,0,0,3.502320287,7.703400422,IFITM3;IFITM2,3
5401,T cell activation involved in immune response (GO:0002286),0.110857088,0.809304318,0,0,3.502320287,7.703400422,FCER1G;ITGAL,3
5402,regulation of neuron projection development (GO:0010975),0.111201058,0.810655716,0,0,1.970055162,4.327059454,LYN;RAP1A;PTPRO;CIB1;SSH2,3
5403,enzyme linked receptor protein signaling pathway (GO:0007167),0.11410918,0.830669252,0,0,1.953773714,4.240860382,LYN;FGR;HCK;SLA;RASGRP4,3
5404,positive regulation of nucleic acid-templated transcription (GO:1903508),0.115804667,0.841810851,0,0,1.409979837,3.03970561,NFE2;JUN;SP100;SPI1;TGFB1;HMGB2;FOS;AHR;KLF2;IKBKB;LYL1;IL1B;BCL3;RARA;PLCB1,3
5405,regulation of cell differentiation (GO:0045595),0.117053484,0.849678422,0,0,1.937759175,4.156734327,JUN;TGFB1;JUND;JUNB;HOPX,3
5406,positive regulation of lipid kinase activity (GO:0090218),0.117784556,0.853770725,0,0,3.37723742,7.223566759,FGR;TGFB1,3
5407,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.117784556,0.852559703,0,0,3.37723742,7.223566759,CEACAM1;RARA,3
5408,regulation of protein transport (GO:0051223),0.117784556,0.851352112,0,0,3.37723742,7.223566759,PTPN1;HSPA8,3
5409,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),0.117784556,0.850147936,0,0,3.37723742,7.223566759,TGFB1;ATP5C1,3
5410,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.117784556,0.848947162,0,0,3.37723742,7.223566759,CIB1;RAC1,3
5411,regulation of protein targeting to membrane (GO:0090313),0.117784556,0.847749775,0,0,3.37723742,7.223566759,FIS1;CIB1,3
5412,cellular response to glucose stimulus (GO:0071333),0.117784556,0.846555762,0,0,3.37723742,7.223566759,XBP1;RACK1,3
5413,chromosome organization (GO:0051276),0.119596171,0.858367454,0,0,2.48849073,5.284644654,H3F3A;RPS27A;UBA52,3
5414,cellular defense response (GO:0006968),0.119596171,0.857161882,0,0,2.48849073,5.284644654,TYROBP;NCF2;LSP1,3
5415,organonitrogen compound catabolic process (GO:1901565),0.119596171,0.855959691,0,0,2.48849073,5.284644654,NAPSA;PPT1;USE1,3
5416,cellular iron ion homeostasis (GO:0006879),0.119596171,0.854760868,0,0,2.48849073,5.284644654,LCN2;RPS27A;UBA52,3
5417,glycosaminoglycan catabolic process (GO:0006027),0.119596171,0.853565398,0,0,2.48849073,5.284644654,HGSNAT;VCAN;TGFB1,3
5418,regulation of protein localization to early endosome (GO:1902965),0.120390322,0.858033258,0,0,7.880220646,16.68255423,SORL1,3
5419,regulation of glomerular filtration (GO:0003093),0.120390322,0.856836559,0,0,7.880220646,16.68255423,PTPRO,3
5420,positive regulation of protein glycosylation (GO:0060050),0.120390322,0.855643193,0,0,7.880220646,16.68255423,RAMP1,3
5421,protein repair (GO:0030091),0.120390322,0.854453147,0,0,7.880220646,16.68255423,MSRB1,3
5422,positive regulation of interferon-gamma secretion (GO:1902715),0.120390322,0.853266407,0,0,7.880220646,16.68255423,CD244,3
5423,granzyme-mediated apoptotic signaling pathway (GO:0008626),0.120390322,0.852082958,0,0,7.880220646,16.68255423,SRGN,3
5424,positive regulation of cellular extravasation (GO:0002693),0.120390322,0.850902788,0,0,7.880220646,16.68255423,CCR2,3
5425,negative regulation of mRNA catabolic process (GO:1902373),0.120390322,0.849725882,0,0,7.880220646,16.68255423,PABPC1,3
5426,positive regulation of RNA binding (GO:1905216),0.120390322,0.848552228,0,0,7.880220646,16.68255423,EIF3E,3
5427,regulation of lymphocyte apoptotic process (GO:0070228),0.120390322,0.847381811,0,0,7.880220646,16.68255423,LYN,3
5428,amylin receptor signaling pathway (GO:0097647),0.120390322,0.846214618,0,0,7.880220646,16.68255423,RAMP1,3
5429,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.120390322,0.845050637,0,0,7.880220646,16.68255423,RPS7,3
5430,positive regulation of aspartic-type peptidase activity (GO:1905247),0.120390322,0.843889853,0,0,7.880220646,16.68255423,LYN,3
5431,"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.120390322,0.842732254,0,0,7.880220646,16.68255423,SEC61B,3
5432,vascular smooth muscle cell differentiation (GO:0035886),0.120390322,0.841577826,0,0,7.880220646,16.68255423,HES1,3
5433,positive regulation of icosanoid secretion (GO:0032305),0.120390322,0.840426557,0,0,7.880220646,16.68255423,IL1B,3
5434,positive regulation of protein localization to early endosome (GO:1902966),0.120390322,0.839278433,0,0,7.880220646,16.68255423,SORL1,3
5435,"regulation of phagocytosis, engulfment (GO:0060099)",0.120390322,0.838133442,0,0,7.880220646,16.68255423,CD300A,3
5436,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),0.120390322,0.836991571,0,0,7.880220646,16.68255423,ADRB2,3
5437,regulation of nuclease activity (GO:0032069),0.120390322,0.835852807,0,0,7.880220646,16.68255423,HMGB2,3
5438,positive regulation of amyloid-beta clearance (GO:1900223),0.120390322,0.834717137,0,0,7.880220646,16.68255423,LDLR,3
5439,negative regulation of oligodendrocyte differentiation (GO:0048715),0.120390322,0.833584549,0,0,7.880220646,16.68255423,HES1,3
5440,cellular triglyceride homeostasis (GO:0035356),0.120390322,0.832455031,0,0,7.880220646,16.68255423,XBP1,3
5441,negative regulation of meiotic cell cycle (GO:0051447),0.120390322,0.831328569,0,0,7.880220646,16.68255423,DUSP1,3
5442,regulation of adiponectin secretion (GO:0070163),0.120390322,0.830205152,0,0,7.880220646,16.68255423,IL1B,3
5443,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.120390322,0.829084768,0,0,7.880220646,16.68255423,THBS1,3
5444,negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),0.120390322,0.827967403,0,0,7.880220646,16.68255423,FIS1,3
5445,renal system process involved in regulation of blood volume (GO:0001977),0.120390322,0.826853046,0,0,7.880220646,16.68255423,PTPRO,3
5446,positive regulation of cardiac muscle tissue development (GO:0055025),0.120390322,0.825741684,0,0,7.880220646,16.68255423,TGFB1,3
5447,vascular smooth muscle cell development (GO:0097084),0.120390322,0.824633306,0,0,7.880220646,16.68255423,HES1,3
5448,rRNA transport (GO:0051029),0.120390322,0.823527899,0,0,7.880220646,16.68255423,RPSA,3
5449,negative regulation of sterol transport (GO:0032372),0.120390322,0.822425452,0,0,7.880220646,16.68255423,APOC1,3
5450,glomerular epithelial cell differentiation (GO:0072311),0.120390322,0.821325953,0,0,7.880220646,16.68255423,PTPRO,3
5451,negative regulation of phospholipid metabolic process (GO:1903726),0.120390322,0.82022939,0,0,7.880220646,16.68255423,APOC1,3
5452,renal filtration cell differentiation (GO:0061318),0.120390322,0.81913575,0,0,7.880220646,16.68255423,PTPRO,3
5453,spermine metabolic process (GO:0008215),0.120390322,0.818045024,0,0,7.880220646,16.68255423,SAT1,3
5454,membrane raft assembly (GO:0001765),0.120390322,0.816957198,0,0,7.880220646,16.68255423,FLOT1,3
5455,rescue of stalled ribosome (GO:0072344),0.120390322,0.815872261,0,0,7.880220646,16.68255423,RACK1,3
5456,immune response-inhibiting cell surface receptor signaling pathway (GO:0002767),0.120390322,0.814790203,0,0,7.880220646,16.68255423,LYN,3
5457,positive regulation of T-helper 2 cell differentiation (GO:0045630),0.120390322,0.81371101,0,0,7.880220646,16.68255423,RARA,3
5458,regulation of NK T cell activation (GO:0051133),0.120390322,0.812634673,0,0,7.880220646,16.68255423,CD300A,3
5459,chemical homeostasis within a tissue (GO:0048875),0.120390322,0.811561179,0,0,7.880220646,16.68255423,NAPSA,3
5460,negative regulation of cellular extravasation (GO:0002692),0.120390322,0.810490518,0,0,7.880220646,16.68255423,PLCB1,3
5461,regulation of hyaluronan biosynthetic process (GO:1900125),0.120390322,0.809422678,0,0,7.880220646,16.68255423,TGFB1,3
5462,macrophage derived foam cell differentiation (GO:0010742),0.120390322,0.808357648,0,0,7.880220646,16.68255423,TGFB1,3
5463,regulation of response to wounding (GO:1903034),0.120390322,0.807295418,0,0,7.880220646,16.68255423,STK24,3
5464,ribosomal small subunit export from nucleus (GO:0000056),0.120390322,0.806235975,0,0,7.880220646,16.68255423,RPS15,3
5465,regulation of mitotic spindle checkpoint (GO:1903504),0.120390322,0.805179309,0,0,7.880220646,16.68255423,DUSP1,3
5466,regulation of keratinocyte apoptotic process (GO:1902172),0.120390322,0.804125409,0,0,7.880220646,16.68255423,ZFP36,3
5467,positive regulation of histone phosphorylation (GO:0033129),0.120390322,0.803074265,0,0,7.880220646,16.68255423,IL1B,3
5468,gland morphogenesis (GO:0022612),0.120390322,0.802025865,0,0,7.880220646,16.68255423,TGFB1,3
5469,positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),0.120390322,0.800980199,0,0,7.880220646,16.68255423,FLOT1,3
5470,positive regulation of protein localization to endosome (GO:1905668),0.120390322,0.799937256,0,0,7.880220646,16.68255423,SORL1,3
5471,negative regulation of erythrocyte differentiation (GO:0045647),0.120390322,0.798897026,0,0,7.880220646,16.68255423,ZFP36,3
5472,positive regulation of cholesterol storage (GO:0010886),0.120390322,0.797859497,0,0,7.880220646,16.68255423,SCARB1,3
5473,negative regulation of systemic arterial blood pressure (GO:0003085),0.120390322,0.79682466,0,0,7.880220646,16.68255423,ADRB2,3
5474,lipoprotein catabolic process (GO:0042159),0.120390322,0.795792504,0,0,7.880220646,16.68255423,PPT1,3
5475,regulation of inositol phosphate biosynthetic process (GO:0010919),0.120390322,0.794763018,0,0,7.880220646,16.68255423,CD244,3
5476,positive regulation of autophagosome maturation (GO:1901098),0.120390322,0.793736192,0,0,7.880220646,16.68255423,ADRB2,3
5477,negative regulation of DNA repair (GO:0045738),0.120390322,0.792712017,0,0,7.880220646,16.68255423,RPS3,3
5478,positive regulation of megakaryocyte differentiation (GO:0045654),0.120390322,0.79169048,0,0,7.880220646,16.68255423,HMGB2,3
5479,positive regulation of fever generation (GO:0031622),0.120390322,0.790671574,0,0,7.880220646,16.68255423,IL1B,3
5480,surfactant homeostasis (GO:0043129),0.120390322,0.789655286,0,0,7.880220646,16.68255423,NAPSA,3
5481,regulation of lysosomal protein catabolic process (GO:1905165),0.120390322,0.788641608,0,0,7.880220646,16.68255423,LDLR,3
5482,negative regulation of cell cycle phase transition (GO:1901988),0.120390322,0.787630529,0,0,7.880220646,16.68255423,ZFP36L2,3
5483,negative regulation of mononuclear cell migration (GO:0071676),0.120390322,0.786622039,0,0,7.880220646,16.68255423,PLCB1,3
5484,negative regulation of glial cell proliferation (GO:0060253),0.120390322,0.785616129,0,0,7.880220646,16.68255423,HES1,3
5485,nucleoside phosphate catabolic process (GO:1901292),0.120390322,0.784612788,0,0,7.880220646,16.68255423,SMPDL3A,3
5486,astrocyte activation (GO:0048143),0.120390322,0.783612006,0,0,7.880220646,16.68255423,FPR2,3
5487,foam cell differentiation (GO:0090077),0.120390322,0.782613774,0,0,7.880220646,16.68255423,TGFB1,3
5488,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.120390322,0.781618082,0,0,7.880220646,16.68255423,LYN,3
5489,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.123049078,0.797864606,0,0,1.906504995,3.994455875,IKBKB;RPS27A;UBA52;PSMA7;TNFRSF1A,3
5490,negative regulation of cellular protein metabolic process (GO:0032269),0.123440604,0.799387569,0,0,2.101392172,4.396102283,BTG2;RACK1;RPS3;RPL13A,3
5491,response to retinoic acid (GO:0032526),0.124254391,0.803637713,0,0,2.445585718,5.100083827,LYN;CDKN2D;RARA,3
5492,negative regulation of homeostatic process (GO:0032845),0.124817162,0.806255669,0,0,3.260780957,6.785376426,ZFP36;TSC22D3,3
5493,negative regulation of proteasomal protein catabolic process (GO:1901799),0.124817162,0.805236382,0,0,3.260780957,6.785376426,RPL11;NOP53,3
5494,positive regulation of phosphate metabolic process (GO:0045937),0.124817162,0.80421967,0,0,3.260780957,6.785376426,THBS1;CD244,3
5495,positive regulation of phospholipid metabolic process (GO:1903727),0.124817162,0.803205521,0,0,3.260780957,6.785376426,FGR;TGFB1,3
5496,regulation of NIK/NF-kappaB signaling (GO:1901222),0.124817162,0.802193927,0,0,3.260780957,6.785376426,RPS3;ADIPOR1,3
5497,triglyceride homeostasis (GO:0070328),0.124817162,0.801184878,0,0,3.260780957,6.785376426,SCARB1;XBP1,3
5498,positive regulation of lipid biosynthetic process (GO:0046889),0.124817162,0.800178365,0,0,3.260780957,6.785376426,SCARB1;LDLR,3
5499,primary neural tube formation (GO:0014020),0.124817162,0.799174377,0,0,3.260780957,6.785376426,TGFB1;LMO4,3
5500,receptor metabolic process (GO:0043112),0.128977365,0.824776307,0,0,2.404135112,4.923953255,FCER1G;TGFB1;RAMP1,3
5501,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.128977365,0.823744046,0,0,2.404135112,4.923953255,CEACAM1;RPS27A;UBA52,3
5502,cholesterol homeostasis (GO:0042632),0.128977365,0.822714366,0,0,2.404135112,4.923953255,SCARB1;XBP1;LDLR,3
5503,neutrophil migration (GO:1990266),0.128977365,0.821687257,0,0,2.404135112,4.923953255,FCER1G;PRTN3;CD177,3
5504,sterol homeostasis (GO:0055092),0.128977365,0.820662709,0,0,2.404135112,4.923953255,SCARB1;XBP1;LDLR,3
5505,post-Golgi vesicle-mediated transport (GO:0006892),0.128977365,0.819640713,0,0,2.404135112,4.923953255,SYS1;STXBP6;SORL1,3
5506,lipid transport (GO:0006869),0.130802237,0.830203747,0,0,2.055709734,4.181454911,SCARB1;CEACAM1;SCP2;LDLR,3
5507,protein-DNA complex assembly (GO:0065004),0.130802237,0.829172438,0,0,2.055709734,4.181454911,H3F3A;HMGB2;RPS27A;UBA52,3
5508,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.131188848,0.830591428,0,0,1.595994055,3.241651306,HSPA8;SYF2;PCBP2;SNRPG;PABPC1;SRSF5;SF3B1;SNRPB,3
5509,cellular response to cadmium ion (GO:0071276),0.131947387,0.834358755,0,0,3.152088258,6.384088322,JUN;FOS,3
5510,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.131947387,0.833326133,0,0,3.152088258,6.384088322,RPS27A;UBA52,3
5511,tube closure (GO:0060606),0.131947387,0.832296063,0,0,3.152088258,6.384088322,TGFB1;LMO4,3
5512,vacuolar transport (GO:0007034),0.131947387,0.831268537,0,0,3.152088258,6.384088322,HGSNAT;USE1,3
5513,negative regulation of Notch signaling pathway (GO:0045746),0.131947387,0.830243545,0,0,3.152088258,6.384088322,RPS27A;UBA52,3
5514,regulation of neutrophil chemotaxis (GO:0090022),0.131947387,0.829221078,0,0,3.152088258,6.384088322,RAC2;RAC1,3
5515,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.131947387,0.828201126,0,0,3.152088258,6.384088322,CEBPB;KLF2,3
5516,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.131947387,0.82718368,0,0,3.152088258,6.384088322,ZFP36;PABPC1,3
5517,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.131947387,0.82616873,0,0,3.152088258,6.384088322,RPS27A;UBA52,3
5518,regulation of cellular biosynthetic process (GO:0031326),0.131947387,0.825156269,0,0,3.152088258,6.384088322,C3;ADIPOR1,3
5519,cell morphogenesis (GO:0000902),0.133763091,0.835487215,0,0,2.364066194,4.755756547,PTPRO;RAC2;RAC1,3
5520,positive regulation of cellular metabolic process (GO:0031325),0.134549863,0.839374022,0,0,2.033605328,4.079047096,TGFB1;APOC1;THBS1;XDH,3
5521,regulation of cyclic nucleotide metabolic process (GO:0030799),0.138999621,0.866074565,0,0,6.75447484,13.32849759,THBS1,3
5522,regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),0.138999621,0.865018376,0,0,6.75447484,13.32849759,RACK1,3
5523,cellular divalent inorganic anion homeostasis (GO:0072501),0.138999621,0.863964761,0,0,6.75447484,13.32849759,GPCPD1,3
5524,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.138999621,0.862913709,0,0,6.75447484,13.32849759,TGFB1,3
5525,regulation of interleukin-13 production (GO:0032656),0.138999621,0.861865211,0,0,6.75447484,13.32849759,RARA,3
5526,negative regulation of leukocyte migration (GO:0002686),0.138999621,0.860819258,0,0,6.75447484,13.32849759,CD300A,3
5527,regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.138999621,0.859775841,0,0,6.75447484,13.32849759,IKBKB,3
5528,regulation of monocyte chemotactic protein-1 production (GO:0071637),0.138999621,0.85873495,0,0,6.75447484,13.32849759,IL1B,3
5529,rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.138999621,0.857696576,0,0,6.75447484,13.32849759,RPSA,3
5530,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.138999621,0.856660711,0,0,6.75447484,13.32849759,CIB1,3
5531,positive regulation of glutamate receptor signaling pathway (GO:1900451),0.138999621,0.855627344,0,0,6.75447484,13.32849759,ADRB2,3
5532,cellular trivalent inorganic anion homeostasis (GO:0072502),0.138999621,0.854596468,0,0,6.75447484,13.32849759,GPCPD1,3
5533,regulation of endocytic recycling (GO:2001135),0.138999621,0.853568073,0,0,6.75447484,13.32849759,SORL1,3
5534,hemostasis (GO:0007599),0.138999621,0.85254215,0,0,6.75447484,13.32849759,NFE2,3
5535,positive regulation of histone H3-K9 methylation (GO:0051574),0.138999621,0.85151869,0,0,6.75447484,13.32849759,JARID2,3
5536,radial glial cell differentiation (GO:0060019),0.138999621,0.850497684,0,0,6.75447484,13.32849759,HES1,3
5537,regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.138999621,0.849479124,0,0,6.75447484,13.32849759,SORL1,3
5538,positive regulation of mast cell degranulation (GO:0043306),0.138999621,0.848463001,0,0,6.75447484,13.32849759,FGR,3
5539,cellular response to laminar fluid shear stress (GO:0071499),0.138999621,0.847449305,0,0,6.75447484,13.32849759,KLF2,3
5540,positive regulation of cellular senescence (GO:2000774),0.138999621,0.846438029,0,0,6.75447484,13.32849759,YPEL3,3
5541,pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),0.138999621,0.845429164,0,0,6.75447484,13.32849759,SPI1,3
5542,nucleoside diphosphate metabolic process (GO:0009132),0.138999621,0.844422701,0,0,6.75447484,13.32849759,CMPK1,3
5543,negative regulation of type 2 immune response (GO:0002829),0.138999621,0.843418631,0,0,6.75447484,13.32849759,CCR2,3
5544,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.138999621,0.842416946,0,0,6.75447484,13.32849759,SEC61B,3
5545,death-inducing signaling complex assembly (GO:0071550),0.138999621,0.841417638,0,0,6.75447484,13.32849759,TNFRSF1A,3
5546,positive regulation of apoptotic cell clearance (GO:2000427),0.138999621,0.840420697,0,0,6.75447484,13.32849759,C3,3
5547,negative regulation of striated muscle tissue development (GO:0045843),0.138999621,0.839426117,0,0,6.75447484,13.32849759,TGFB1,3
5548,regulation of sterol transport (GO:0032371),0.138999621,0.838433887,0,0,6.75447484,13.32849759,APOC1,3
5549,retinoic acid receptor signaling pathway (GO:0048384),0.138999621,0.837444001,0,0,6.75447484,13.32849759,RARA,3
5550,positive regulation of B cell differentiation (GO:0045579),0.138999621,0.836456449,0,0,6.75447484,13.32849759,XBP1,3
5551,positive regulation of protein deubiquitination (GO:1903003),0.138999621,0.835471223,0,0,6.75447484,13.32849759,NOP53,3
5552,response to type I interferon (GO:0034340),0.138999621,0.834488316,0,0,6.75447484,13.32849759,SP100,3
5553,positive regulation of killing of cells of other organism (GO:0051712),0.138999621,0.833507719,0,0,6.75447484,13.32849759,PGLYRP1,3
5554,positive regulation of macrophage migration (GO:1905523),0.138999621,0.832529423,0,0,6.75447484,13.32849759,THBS1,3
5555,lysosomal lumen acidification (GO:0007042),0.138999621,0.831553421,0,0,6.75447484,13.32849759,PPT1,3
5556,positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.138999621,0.830579706,0,0,6.75447484,13.32849759,CD244,3
5557,positive regulation of protein kinase A signaling (GO:0010739),0.138999621,0.829608267,0,0,6.75447484,13.32849759,ADRB2,3
5558,granulocyte migration (GO:0097530),0.138999621,0.828639099,0,0,6.75447484,13.32849759,CD177,3
5559,negative regulation of macrophage activation (GO:0043031),0.138999621,0.827672192,0,0,6.75447484,13.32849759,LDLR,3
5560,"retrograde transport, vesicle recycling within Golgi (GO:0000301)",0.138999621,0.826707539,0,0,6.75447484,13.32849759,SYS1,3
5561,regulation of pinocytosis (GO:0048548),0.138999621,0.825745132,0,0,6.75447484,13.32849759,PPT1,3
5562,regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.138999621,0.824784963,0,0,6.75447484,13.32849759,FLOT1,3
5563,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.138999621,0.823827025,0,0,6.75447484,13.32849759,RPSA,3
5564,positive regulation of mRNA binding (GO:1902416),0.138999621,0.822871309,0,0,6.75447484,13.32849759,EIF3E,3
5565,V(D)J recombination (GO:0033151),0.138999621,0.821917808,0,0,6.75447484,13.32849759,HMGB2,3
5566,activation of signaling protein activity involved in unfolded protein response (GO:0006987),0.138999621,0.820966514,0,0,6.75447484,13.32849759,PTPN1,3
5567,pharyngeal arch artery morphogenesis (GO:0061626),0.138999621,0.82001742,0,0,6.75447484,13.32849759,HES1,3
5568,hyaluronan biosynthetic process (GO:0030213),0.138999621,0.819070518,0,0,6.75447484,13.32849759,IL1B,3
5569,positive regulation of interleukin-5 production (GO:0032754),0.138999621,0.8181258,0,0,6.75447484,13.32849759,RARA,3
5570,regulation of activation of Janus kinase activity (GO:0010533),0.138999621,0.817183259,0,0,6.75447484,13.32849759,CD300A,3
5571,regulation of calcidiol 1-monooxygenase activity (GO:0060558),0.138999621,0.816242887,0,0,6.75447484,13.32849759,IL1B,3
5572,positive regulation of membrane depolarization (GO:1904181),0.138999621,0.815304676,0,0,6.75447484,13.32849759,RACK1,3
5573,positive regulation of macrophage chemotaxis (GO:0010759),0.138999621,0.814368621,0,0,6.75447484,13.32849759,THBS1,3
5574,regulation of microglial cell activation (GO:1903978),0.138999621,0.813434712,0,0,6.75447484,13.32849759,LDLR,3
5575,spermidine metabolic process (GO:0008216),0.138999621,0.812502942,0,0,6.75447484,13.32849759,SAT1,3
5576,store-operated calcium entry (GO:0002115),0.138999621,0.811573305,0,0,6.75447484,13.32849759,ORAI1,3
5577,detection of molecule of bacterial origin (GO:0032490),0.138999621,0.810645793,0,0,6.75447484,13.32849759,SCARB1,3
5578,regulation of transcription involved in cell fate commitment (GO:0060850),0.138999621,0.809720398,0,0,6.75447484,13.32849759,CEBPB,3
5579,calcitonin family receptor signaling pathway (GO:0097646),0.138999621,0.808797113,0,0,6.75447484,13.32849759,RAMP1,3
5580,cellular phosphate ion homeostasis (GO:0030643),0.138999621,0.807875932,0,0,6.75447484,13.32849759,GPCPD1,3
5581,microglial cell activation (GO:0001774),0.138999621,0.806956847,0,0,6.75447484,13.32849759,FPR2,3
5582,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031658),0.138999621,0.806039851,0,0,6.75447484,13.32849759,CDKN2D,3
5583,positive regulation of gastrulation (GO:2000543),0.138999621,0.805124936,0,0,6.75447484,13.32849759,RACK1,3
5584,regulation of actin cytoskeleton reorganization (GO:2000249),0.139167982,0.80518618,0,0,3.050407992,6.01562899,HCK;ARHGDIB,3
5585,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.139167982,0.804274305,0,0,3.050407992,6.01562899,CIB1;THBS1,3
5586,negative regulation of endothelial cell proliferation (GO:0001937),0.139167982,0.803364492,0,0,3.050407992,6.01562899,THBS1;XDH,3
5587,regulation of leukocyte chemotaxis (GO:0002688),0.139167982,0.802456736,0,0,3.050407992,6.01562899,LYN;MTUS1,3
5588,regulation of cell adhesion mediated by integrin (GO:0033628),0.139167982,0.801551028,0,0,3.050407992,6.01562899,LYN;CIB1,3
5589,protein localization to lysosome (GO:0061462),0.139167982,0.800647363,0,0,3.050407992,6.01562899,LAMTOR4;SORL1,3
5590,artery morphogenesis (GO:0048844),0.139167982,0.799745733,0,0,3.050407992,6.01562899,HPGD;HES1,3
5591,response to estradiol (GO:0032355),0.139167982,0.798846132,0,0,3.050407992,6.01562899,TGFB1;H2AFZ,3
5592,regulation of blood coagulation (GO:0030193),0.139167982,0.797948552,0,0,3.050407992,6.01562899,FCER1G;THBS1,3
5593,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.139167982,0.797052987,0,0,3.050407992,6.01562899,IL1B;KLF2,3
5594,actin cytoskeleton reorganization (GO:0031532),0.143514777,0.821026801,0,0,2.287805994,4.441357296,PTPN1;RAC2;RAC1,3
5595,glycosaminoglycan metabolic process (GO:0030203),0.143514777,0.820107398,0,0,2.287805994,4.441357296,HGSNAT;VCAN;GCNT2,3
5596,protein localization to plasma membrane (GO:0072659),0.145112935,0.828312422,0,0,1.804630682,3.483375706,IKBKB;SYS1;FLOT1;RAMP1;TNFRSF1A,3
5597,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.14647196,0.835135654,0,0,2.955082742,5.676481294,LYN;CD300A,3
5598,negative regulation of cell-cell adhesion (GO:0022408),0.14647196,0.834203583,0,0,2.955082742,5.676481294,TGFB1;FXYD5,3
5599,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.14647196,0.83327359,0,0,2.955082742,5.676481294,TGFB1;THBS1,3
5600,regulation of protein export from nucleus (GO:0046825),0.14647196,0.832345669,0,0,2.955082742,5.676481294,SP100;IL1B,3
5601,response to cadmium ion (GO:0046686),0.14647196,0.831419811,0,0,2.955082742,5.676481294,JUN;FOS,3
5602,nucleobase-containing small molecule interconversion (GO:0015949),0.14647196,0.830496012,0,0,2.955082742,5.676481294,GSR;CMPK1,3
5603,regulation of cytokine secretion (GO:0050707),0.14647196,0.829574263,0,0,2.955082742,5.676481294,SRGN;FGR,3
5604,positive regulation of type I interferon production (GO:0032481),0.148476723,0.839996359,0,0,2.251491613,4.294330931,FLOT1;IRF5;MYD88,3
5605,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.148476723,0.83906613,0,0,2.251491613,4.294330931,RPS27A;UBA52;PSMA7,3
5606,regulation of T cell proliferation (GO:0042129),0.148476723,0.83813796,0,0,2.251491613,4.294330931,CEBPB;PTPRC;IL1B,3
5607,regulation of translational initiation (GO:0006446),0.148476723,0.837211841,0,0,2.251491613,4.294330931,EIF3H;EIF3E;EIF1,3
5608,transcription from RNA polymerase II promoter (GO:0006366),0.151734477,0.854636906,0,0,1.362013445,2.568244077,BTF3;CEBPB;XBP1;SPI1;KLF13;CEBPD;LMO4;AHR;POU2F2;NR4A1;RARA;SNRPG;SRSF5;SNRPB,3
5609,iron ion homeostasis (GO:0055072),0.153493398,0.863590749,0,0,2.216312057,4.153585379,LCN2;RPS27A;UBA52,3
5610,cellular response to amino acid stimulus (GO:0071230),0.153852587,0.864658319,0,0,2.86553478,5.36359441,XBP1;LAMTOR4,3
5611,protein trimerization (GO:0070206),0.153852587,0.8637071,0,0,2.86553478,5.36359441,ALOX5AP;MGST1,3
5612,ATP biosynthetic process (GO:0006754),0.153852587,0.862757971,0,0,2.86553478,5.36359441,TGFB1;ATP5C1,3
5613,endodermal cell differentiation (GO:0035987),0.153852587,0.861810926,0,0,2.86553478,5.36359441,ITGA4;MMP8,3
5614,negative regulation of fat cell differentiation (GO:0045599),0.153852587,0.860865958,0,0,2.86553478,5.36359441,TGFB1;ZFP36L2,3
5615,regulation of nitric oxide biosynthetic process (GO:0045428),0.153852587,0.85992306,0,0,2.86553478,5.36359441,IL1B;KLF2,3
5616,global genome nucleotide-excision repair (GO:0070911),0.153852587,0.858982225,0,0,2.86553478,5.36359441,RPS27A;UBA52,3
5617,exocyst localization (GO:0051601),0.157216129,0.876802083,0,0,5.910165485,10.93459695,STXBP6,3
5618,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.157216129,0.875844875,0,0,5.910165485,10.93459695,LYN,3
5619,positive regulation of extracellular matrix assembly (GO:1901203),0.157216129,0.874889755,0,0,5.910165485,10.93459695,TGFB1,3
5620,"regulation of synaptic transmission, dopaminergic (GO:0032225)",0.157216129,0.873936716,0,0,5.910165485,10.93459695,FLOT1,3
5621,positive regulation of cell aging (GO:0090343),0.157216129,0.872985751,0,0,5.910165485,10.93459695,YPEL3,3
5622,positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.157216129,0.872036854,0,0,5.910165485,10.93459695,FIS1,3
5623,ribosomal large subunit export from nucleus (GO:0000055),0.157216129,0.871090017,0,0,5.910165485,10.93459695,NOP53,3
5624,positive regulation of isotype switching (GO:0045830),0.157216129,0.870145234,0,0,5.910165485,10.93459695,TGFB1,3
5625,regulation of chaperone-mediated autophagy (GO:1904714),0.157216129,0.869202498,0,0,5.910165485,10.93459695,EEF1A1,3
5626,negative regulation of glial cell differentiation (GO:0045686),0.157216129,0.868261803,0,0,5.910165485,10.93459695,HES1,3
5627,nucleoside diphosphate phosphorylation (GO:0006165),0.157216129,0.867323141,0,0,5.910165485,10.93459695,CMPK1,3
5628,cellular response to forskolin (GO:1904322),0.157216129,0.866386507,0,0,5.910165485,10.93459695,AHR,3
5629,response to magnesium ion (GO:0032026),0.157216129,0.865451894,0,0,5.910165485,10.93459695,THBS1,3
5630,negative regulation of anion transmembrane transport (GO:1903960),0.157216129,0.864519295,0,0,5.910165485,10.93459695,THBS1,3
5631,negative regulation of platelet aggregation (GO:0090331),0.157216129,0.863588703,0,0,5.910165485,10.93459695,CEACAM1,3
5632,negative regulation of lipase activity (GO:0060192),0.157216129,0.862660113,0,0,5.910165485,10.93459695,APOC1,3
5633,microvillus organization (GO:0032528),0.157216129,0.861733518,0,0,5.910165485,10.93459695,FXYD5,3
5634,regulation of histone H4 acetylation (GO:0090239),0.157216129,0.860808912,0,0,5.910165485,10.93459695,SPI1,3
5635,intestinal cholesterol absorption (GO:0030299),0.157216129,0.859886287,0,0,5.910165485,10.93459695,LDLR,3
5636,positive regulation of transforming growth factor beta production (GO:0071636),0.157216129,0.858965638,0,0,5.910165485,10.93459695,THBS1,3
5637,SMAD protein complex assembly (GO:0007183),0.157216129,0.858046958,0,0,5.910165485,10.93459695,TGFB1,3
5638,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.157216129,0.857130241,0,0,5.910165485,10.93459695,ZFP36,3
5639,regulation of PERK-mediated unfolded protein response (GO:1903897),0.157216129,0.856215481,0,0,5.910165485,10.93459695,PTPN1,3
5640,regulation of muscle organ development (GO:0048634),0.157216129,0.855302671,0,0,5.910165485,10.93459695,TGFB1,3
5641,regulation of T cell mediated immunity (GO:0002709),0.157216129,0.854391806,0,0,5.910165485,10.93459695,IL1B,3
5642,microvillus assembly (GO:0030033),0.157216129,0.853482878,0,0,5.910165485,10.93459695,FXYD5,3
5643,regulation of endodeoxyribonuclease activity (GO:0032071),0.157216129,0.852575883,0,0,5.910165485,10.93459695,RPS3,3
5644,response to forskolin (GO:1904321),0.157216129,0.851670813,0,0,5.910165485,10.93459695,AHR,3
5645,desensitization of G-protein coupled receptor protein signaling pathway (GO:0002029),0.157216129,0.850767662,0,0,5.910165485,10.93459695,ADRB2,3
5646,positive regulation of spindle checkpoint (GO:0090232),0.157216129,0.849866425,0,0,5.910165485,10.93459695,NDRG1,3
5647,insulin metabolic process (GO:1901142),0.157216129,0.848967096,0,0,5.910165485,10.93459695,CEACAM1,3
5648,"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.157216129,0.848069668,0,0,5.910165485,10.93459695,SVIP,3
5649,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.157216129,0.847174135,0,0,5.910165485,10.93459695,LYN,3
5650,dimeric G-protein coupled receptor signaling pathway (GO:0038042),0.157216129,0.846280491,0,0,5.910165485,10.93459695,RAMP1,3
5651,negative regulation of biosynthetic process (GO:0009890),0.157216129,0.845388731,0,0,5.910165485,10.93459695,CEACAM1,3
5652,B cell mediated immunity (GO:0019724),0.157216129,0.844498848,0,0,5.910165485,10.93459695,FCER1G,3
5653,cellular biogenic amine catabolic process (GO:0042402),0.157216129,0.843610837,0,0,5.910165485,10.93459695,SMOX,3
5654,negative regulation of exocytosis (GO:0045920),0.157216129,0.842724691,0,0,5.910165485,10.93459695,STXBP6,3
5655,membrane lipid catabolic process (GO:0046466),0.157216129,0.841840405,0,0,5.910165485,10.93459695,PPT1,3
5656,positive regulation of interleukin-2 biosynthetic process (GO:0045086),0.157216129,0.840957972,0,0,5.910165485,10.93459695,IL1B,3
5657,regulation of MHC class II biosynthetic process (GO:0045346),0.157216129,0.840077388,0,0,5.910165485,10.93459695,XBP1,3
5658,peptidyl-diphthamide metabolic process (GO:0017182),0.157216129,0.839198646,0,0,5.910165485,10.93459695,EEF2,3
5659,positive regulation of respiratory burst (GO:0060267),0.157216129,0.83832174,0,0,5.910165485,10.93459695,RPS19,3
5660,negative regulation of vascular permeability (GO:0043116),0.157216129,0.837446665,0,0,5.910165485,10.93459695,CEACAM1,3
5661,nucleotide phosphorylation (GO:0046939),0.157216129,0.836573416,0,0,5.910165485,10.93459695,CMPK1,3
5662,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.157216129,0.835701985,0,0,5.910165485,10.93459695,TGFB1,3
5663,regulation of dendritic cell antigen processing and presentation (GO:0002604),0.157216129,0.834832368,0,0,5.910165485,10.93459695,THBS1,3
5664,regulation of T-helper 2 cell differentiation (GO:0045628),0.157216129,0.833964559,0,0,5.910165485,10.93459695,RARA,3
5665,regulation of amyloid fibril formation (GO:1905906),0.157216129,0.833098552,0,0,5.910165485,10.93459695,LDLR,3
5666,peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.157216129,0.832234342,0,0,5.910165485,10.93459695,EEF2,3
5667,immunoglobulin mediated immune response (GO:0016064),0.157216129,0.831371923,0,0,5.910165485,10.93459695,FCER1G,3
5668,histone H3-K36 demethylation (GO:0070544),0.157216129,0.830511289,0,0,5.910165485,10.93459695,KDM7A,3
5669,cellular response to interleukin-17 (GO:0097398),0.157216129,0.829652436,0,0,5.910165485,10.93459695,IL17RA,3
5670,response to vitamin D (GO:0033280),0.157216129,0.828795357,0,0,5.910165485,10.93459695,CDKN2D,3
5671,cellular monovalent inorganic anion homeostasis (GO:0030320),0.157216129,0.827940047,0,0,5.910165485,10.93459695,GPCPD1,3
5672,regulation of apoptotic cell clearance (GO:2000425),0.157216129,0.827086501,0,0,5.910165485,10.93459695,C3,3
5673,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.157916794,0.829916993,0,0,1.91035652,3.525920203,MARCH1;FCER1G;AP1S2;AP2A2,3
5674,glycerophospholipid metabolic process (GO:0006650),0.158562804,0.832454721,0,0,2.182214948,4.018776922,GPCPD1;PLCB1;PLA2G7,3
5675,positive regulation of cell adhesion (GO:0045785),0.158562804,0.831599166,0,0,2.182214948,4.018776922,CIB1;RAC1;CD47,3
5676,positive regulation of hydrolase activity (GO:0051345),0.16122047,0.844669462,0,0,1.639814701,2.992633091,RAP1A;HMGB2;RACK1;RPS3;PRTN3;RASGRP2,3
5677,positive regulation of protein kinase activity (GO:0045860),0.16122047,0.843803134,0,0,1.639814701,2.992633091,PTPN1;RAP1A;PTPRC;STK24;CIB1;ADRB2,3
5678,glycogen metabolic process (GO:0005977),0.161303378,0.843372068,0,0,2.781254346,5.07431053,RPS27A;UBA52,3
5679,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.161303378,0.842508842,0,0,2.781254346,5.07431053,HSPA1B;HSPA1A,3
5680,negative regulation of neurogenesis (GO:0050768),0.161303378,0.841647381,0,0,2.781254346,5.07431053,ID3;SORL1,3
5681,entry into host cell (GO:0030260),0.161303378,0.84078768,0,0,2.781254346,5.07431053,RPS27A;UBA52,3
5682,negative regulation of mitochondrion organization (GO:0010823),0.161303378,0.839929733,0,0,2.781254346,5.07431053,SLC25A5;HSPA1A,3
5683,neural tube closure (GO:0001843),0.161303378,0.839073536,0,0,2.781254346,5.07431053,TGFB1;LMO4,3
5684,stem cell differentiation (GO:0048863),0.161303378,0.838219082,0,0,2.781254346,5.07431053,PTPRC;JARID2,3
5685,positive regulation of cell-matrix adhesion (GO:0001954),0.161303378,0.837366367,0,0,2.781254346,5.07431053,CIB1;RAC1,3
5686,platelet aggregation (GO:0070527),0.161303378,0.836515385,0,0,2.781254346,5.07431053,TLN1;ACTG1,3
5687,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.161303378,0.83566613,0,0,2.781254346,5.07431053,FGR;TGFB1,3
5688,positive regulation of nucleocytoplasmic transport (GO:0046824),0.161303378,0.834818599,0,0,2.781254346,5.07431053,TGFB1;IL1B,3
5689,negative regulation of multi-organism process (GO:0043901),0.161303378,0.833972785,0,0,2.781254346,5.07431053,ARHGDIB;PCBP2,3
5690,positive regulation of locomotion (GO:0040017),0.161303378,0.833128683,0,0,2.781254346,5.07431053,TGFB1;THBS1,3
5691,cellular glucose homeostasis (GO:0001678),0.161303378,0.832286288,0,0,2.781254346,5.07431053,XBP1;RACK1,3
5692,regulation of intracellular protein transport (GO:0033157),0.161303378,0.831445594,0,0,2.781254346,5.07431053,PTPN1;TGFB1,3
5693,glycosaminoglycan biosynthetic process (GO:0006024),0.161949885,0.833935683,0,0,1.891252955,3.442966137,VCAN;IL1B;ST3GAL4;GCNT2,3
5694,negative regulation of blood vessel morphogenesis (GO:2000181),0.163682948,0.842010167,0,0,2.149151085,3.889585135,THBS1;XDH;CCR2,3
5695,DNA synthesis involved in DNA repair (GO:0000731),0.163682948,0.841162221,0,0,2.149151085,3.889585135,CDKN2D;RPS27A;UBA52,3
5696,regulation of cell division (GO:0051302),0.163682948,0.840315982,0,0,2.149151085,3.889585135,RACK1;CDK2AP2;CIB1,3
5697,negative regulation of apoptotic signaling pathway (GO:2001234),0.163682948,0.839471443,0,0,2.149151085,3.889585135,SLC25A5;THBS1;HSPA1A,3
5698,cellular response to metal ion (GO:0071248),0.166020166,0.850603321,0,0,1.872527678,3.362396864,JUN;ALOX5AP;FOS;RASGRP2,3
5699,apoptotic mitochondrial changes (GO:0008637),0.168818083,0.864070893,0,0,2.701789936,4.806304824,FIS1;ATG3,3
5700,response to amino acid (GO:0043200),0.168818083,0.86320509,0,0,2.701789936,4.806304824,XBP1;LAMTOR4,3
5701,positive regulation of muscle cell differentiation (GO:0051149),0.168818083,0.862341021,0,0,2.701789936,4.806304824,BTG1;PLCB1,3
5702,bone development (GO:0060348),0.168818083,0.86147868,0,0,2.701789936,4.806304824,PTPRC;RARA,3
5703,regulation of interferon-beta production (GO:0032648),0.168818083,0.860618062,0,0,2.701789936,4.806304824,FLOT1;IRF5,3
5704,regulation of protein ubiquitination (GO:0031396),0.170126719,0.8664238,0,0,1.854169564,3.284126849,RPS3;ADRB2;HSPA1B;HSPA1A,3
5705,protein autophosphorylation (GO:0046777),0.170312421,0.866504772,0,0,1.611863314,2.853192708,LYN;FGR;HCK;STK24;STK17B;SLA,3
5706,regulation of signal transduction by p53 class mediator (GO:1901796),0.172227918,0.875377557,0,0,1.700767046,2.991541358,RPL5;RPL11;RPS27A;UBA52;NOP53,3
5707,regulation of gene silencing by miRNA (GO:0060964),0.174067526,0.883847351,0,0,2.085940759,3.646875202,ZFP36;TGFB1;H3F3A,3
5708,extrinsic apoptotic signaling pathway (GO:0097191),0.174067526,0.882968775,0,0,2.085940759,3.646875202,TGFB1;CIB1;TNFRSF1A,3
5709,regulation of protein localization to plasma membrane (GO:1903076),0.174067526,0.882091944,0,0,2.085940759,3.646875202,TGFB1;PPP2R5A;CIB1,3
5710,secretory granule organization (GO:0033363),0.175048115,0.886181083,0,0,5.253480431,9.155210924,SRGN,3
5711,regulation of immunoglobulin secretion (GO:0051023),0.175048115,0.885302806,0,0,5.253480431,9.155210924,XBP1,3
5712,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.175048115,0.884426269,0,0,5.253480431,9.155210924,ADIPOR1,3
5713,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.175048115,0.883551465,0,0,5.253480431,9.155210924,MEFV,3
5714,response to UV-C (GO:0010225),0.175048115,0.882678391,0,0,5.253480431,9.155210924,BCL3,3
5715,regulation of macrophage cytokine production (GO:0010935),0.175048115,0.88180704,0,0,5.253480431,9.155210924,TGFB1,3
5716,ATF6-mediated unfolded protein response (GO:0036500),0.175048115,0.880937408,0,0,5.253480431,9.155210924,XBP1,3
5717,interleukin-17-mediated signaling pathway (GO:0097400),0.175048115,0.880069489,0,0,5.253480431,9.155210924,IL17RA,3
5718,cellular response to interleukin-4 (GO:0071353),0.175048115,0.879203279,0,0,5.253480431,9.155210924,XBP1,3
5719,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.175048115,0.878338772,0,0,5.253480431,9.155210924,LYN,3
5720,negative regulation of T cell apoptotic process (GO:0070233),0.175048115,0.877475964,0,0,5.253480431,9.155210924,TSC22D3,3
5721,regulation of T-helper 1 type immune response (GO:0002825),0.175048115,0.876614849,0,0,5.253480431,9.155210924,CCR2,3
5722,positive regulation of coagulation (GO:0050820),0.175048115,0.875755423,0,0,5.253480431,9.155210924,THBS1,3
5723,regulation of SNARE complex assembly (GO:0035542),0.175048115,0.87489768,0,0,5.253480431,9.155210924,STXBP6,3
5724,regulation of interferon-gamma secretion (GO:1902713),0.175048115,0.874041616,0,0,5.253480431,9.155210924,CD244,3
5725,vasodilation (GO:0042311),0.175048115,0.873187225,0,0,5.253480431,9.155210924,ADRB2,3
5726,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.175048115,0.872334503,0,0,5.253480431,9.155210924,SVIP,3
5727,neurotrophin TRK receptor signaling pathway (GO:0048011),0.175048115,0.871483445,0,0,5.253480431,9.155210924,DDIT4,3
5728,phagolysosome assembly (GO:0001845),0.175048115,0.870634046,0,0,5.253480431,9.155210924,CORO1A,3
5729,adipose tissue development (GO:0060612),0.175048115,0.869786301,0,0,5.253480431,9.155210924,XBP1,3
5730,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.175048115,0.868940206,0,0,5.253480431,9.155210924,CEACAM1,3
5731,positive regulation of cholesterol esterification (GO:0010873),0.175048115,0.868095755,0,0,5.253480431,9.155210924,APOC1,3
5732,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.175048115,0.867252943,0,0,5.253480431,9.155210924,SOCS3,3
5733,mitochondrion morphogenesis (GO:0070584),0.175048115,0.866411767,0,0,5.253480431,9.155210924,FIS1,3
5734,positive regulation of immunoglobulin secretion (GO:0051024),0.175048115,0.86557222,0,0,5.253480431,9.155210924,XBP1,3
5735,positive regulation of leukocyte apoptotic process (GO:2000108),0.175048115,0.8647343,0,0,5.253480431,9.155210924,LYN,3
5736,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.175048115,0.863897999,0,0,5.253480431,9.155210924,SVIP,3
5737,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.175048115,0.863063315,0,0,5.253480431,9.155210924,RPL7,3
5738,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.175048115,0.862230243,0,0,5.253480431,9.155210924,NOP53,3
5739,nucleoside phosphate biosynthetic process (GO:1901293),0.175048115,0.861398777,0,0,5.253480431,9.155210924,CMPK1,3
5740,negative regulation of fibrinolysis (GO:0051918),0.175048115,0.860568913,0,0,5.253480431,9.155210924,THBS1,3
5741,positive regulation of T cell chemotaxis (GO:0010820),0.175048115,0.859740646,0,0,5.253480431,9.155210924,CCR2,3
5742,positive regulation of astrocyte differentiation (GO:0048711),0.175048115,0.858913972,0,0,5.253480431,9.155210924,HES1,3
5743,negative regulation of histone methylation (GO:0031061),0.175048115,0.858088887,0,0,5.253480431,9.155210924,JARID2,3
5744,protein localization to vacuole (GO:0072665),0.175048115,0.857265385,0,0,5.253480431,9.155210924,LAMTOR4,3
5745,regulation of striated muscle tissue development (GO:0016202),0.175048115,0.856443463,0,0,5.253480431,9.155210924,TGFB1,3
5746,podosome assembly (GO:0071800),0.175048115,0.855623114,0,0,5.253480431,9.155210924,BIN2,3
5747,nucleoside triphosphate biosynthetic process (GO:0009142),0.175048115,0.854804336,0,0,5.253480431,9.155210924,CMPK1,3
5748,intestinal lipid absorption (GO:0098856),0.175048115,0.853987124,0,0,5.253480431,9.155210924,LDLR,3
5749,pinocytosis (GO:0006907),0.175048115,0.853171472,0,0,5.253480431,9.155210924,PPT1,3
5750,positive regulation of hemostasis (GO:1900048),0.175048115,0.852357377,0,0,5.253480431,9.155210924,THBS1,3
5751,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.175048115,0.851544834,0,0,5.253480431,9.155210924,PTPN1,3
5752,endothelial cell chemotaxis (GO:0035767),0.175048115,0.850733839,0,0,5.253480431,9.155210924,NR4A1,3
5753,peroxisome fission (GO:0016559),0.175048115,0.849924388,0,0,5.253480431,9.155210924,FIS1,3
5754,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.175048115,0.849116475,0,0,5.253480431,9.155210924,FLOT1,3
5755,regulation of leukocyte activation (GO:0002694),0.175048115,0.848310096,0,0,5.253480431,9.155210924,LYN,3
5756,response to interleukin-4 (GO:0070670),0.175048115,0.847505248,0,0,5.253480431,9.155210924,XBP1,3
5757,regulation of leukocyte degranulation (GO:0043300),0.175048115,0.846701925,0,0,5.253480431,9.155210924,LYN,3
5758,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.175048115,0.845900124,0,0,5.253480431,9.155210924,MYD88,3
5759,B cell homeostasis (GO:0001782),0.175048115,0.84509984,0,0,5.253480431,9.155210924,LYN,3
5760,regulation of homotypic cell-cell adhesion (GO:0034110),0.175048115,0.844301069,0,0,5.253480431,9.155210924,LYN,3
5761,negative regulation of amyloid-beta formation (GO:1902430),0.175048115,0.843503807,0,0,5.253480431,9.155210924,SORL1,3
5762,positive regulation of protein homooligomerization (GO:0032464),0.175048115,0.842708048,0,0,5.253480431,9.155210924,RACK1,3
5763,mesodermal cell differentiation (GO:0048333),0.175048115,0.84191379,0,0,5.253480431,9.155210924,KDM6B,3
5764,fatty acid homeostasis (GO:0055089),0.175048115,0.841121028,0,0,5.253480431,9.155210924,XBP1,3
5765,cytoskeletal anchoring at plasma membrane (GO:0007016),0.175048115,0.840329757,0,0,5.253480431,9.155210924,TLN1,3
5766,DNA topological change (GO:0006265),0.175048115,0.839539973,0,0,5.253480431,9.155210924,HMGB2,3
5767,response to vitamin (GO:0033273),0.175048115,0.838751673,0,0,5.253480431,9.155210924,CDKN2D,3
5768,vitamin transmembrane transport (GO:0035461),0.175048115,0.837964851,0,0,5.253480431,9.155210924,SCARB1,3
5769,neuron differentiation (GO:0030182),0.175747828,0.840525931,0,0,1.68861871,2.936009971,XBP1;DDIT4;PPT1;ID3;IER2,3
5770,positive regulation of RNA metabolic process (GO:0051254),0.176390687,0.84281056,0,0,2.626740215,4.557535932,TGFB1;HSPA1A,3
5771,regulation of microtubule polymerization (GO:0031113),0.176390687,0.842022149,0,0,2.626740215,4.557535932,RPS3;RAC1,3
5772,regulation of mitotic spindle organization (GO:0060236),0.176390687,0.841235213,0,0,2.626740215,4.557535932,HSPA1B;HSPA1A,3
5773,positive regulation of angiogenesis (GO:0045766),0.178444939,0.850237649,0,0,1.818512457,3.134161107,XBP1;BTG1;IL1B;THBS1,3
5774,protein import into nucleus (GO:0006606),0.178444939,0.849444516,0,0,1.818512457,3.134161107,TGFB1;BCL3;HES1;SEC61B,3
5775,regulation of small GTPase mediated signal transduction (GO:0051056),0.179295002,0.852695613,0,0,1.676642691,2.88168398,ARHGDIB;RAC2;RAC1;ARHGAP15;ARHGAP26,3
5776,monocarboxylic acid biosynthetic process (GO:0072330),0.179328023,0.852058569,0,0,2.055709734,3.532816564,VCAN;XBP1;SCP2,3
5777,regulation of actin filament polymerization (GO:0030833),0.179328023,0.851265957,0,0,2.055709734,3.532816564,HCK;RAC2;RAC1,3
5778,termination of RNA polymerase II transcription (GO:0006369),0.179328023,0.850474817,0,0,2.055709734,3.532816564,SNRPG;SRSF5;SNRPB,3
5779,protein oligomerization (GO:0051259),0.180371333,0.854628516,0,0,1.518207647,2.600291311,FIS1;HGSNAT;FCER1G;RPS19;CCDC88C;FLOT1;TMCC1,3
5780,regulation of cellular response to stress (GO:0080135),0.182654743,0.864644855,0,0,1.801193291,3.062312386,HSPA8;HSPA1B;IER3;HSPA1A,3
5781,peptide metabolic process (GO:0006518),0.182654743,0.863843516,0,0,1.801193291,3.062312386,HSPA8;ETHE1;GSR;MGST1,3
5782,actin polymerization or depolymerization (GO:0008154),0.184015398,0.869472757,0,0,2.555747237,4.326204942,RAC1;MSRB1,3
5783,regulation of nitric-oxide synthase activity (GO:0050999),0.184015398,0.868668434,0,0,2.555747237,4.326204942,SCARB1;IL1B,3
5784,negative regulation of angiogenesis (GO:0016525),0.184631388,0.870770771,0,0,2.026342452,3.423290654,THBS1;KLF2;CCR2,3
5785,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.184631388,0.869966735,0,0,2.026342452,3.423290654,RPS27A;UBA52;PSMA7,3
5786,response to organic cyclic compound (GO:0014070),0.184631388,0.869164183,0,0,2.026342452,3.423290654,CDKN2D;TGFB1;IL1B,3
5787,positive regulation of endothelial cell migration (GO:0010595),0.189975686,0.893498547,0,0,1.997802417,3.318068495,SCARB1;TGFB1;THBS1,3
5788,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.189975686,0.892675805,0,0,1.997802417,3.318068495,NCF2;RAC1;ACTG1,3
5789,positive regulation of cellular catabolic process (GO:0031331),0.191171061,0.897466352,0,0,1.767526126,2.924525121,PTPN1;IL1B;MEFV;SVIP,3
5790,fatty acid metabolic process (GO:0006631),0.191171061,0.896641475,0,0,1.767526126,2.924525121,XBP1;HPGD;ALOX5AP;ADIPOR1,3
5791,positive regulation of cellular component organization (GO:0051130),0.191171061,0.895818113,0,0,1.767526126,2.924525121,TGFB1;FLOT1;RPS3;LDLR,3
5792,epithelial to mesenchymal transition (GO:0001837),0.191686643,0.897410035,0,0,2.48849073,4.110721188,TGFB1;S100A4,3
5793,spliceosomal snRNP assembly (GO:0000387),0.191686643,0.896587477,0,0,2.48849073,4.110721188,SNRPG;SNRPB,3
5794,positive regulation of smooth muscle cell proliferation (GO:0048661),0.191686643,0.895766427,0,0,2.48849073,4.110721188,JUN;THBS1,3
5795,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.191686643,0.894946878,0,0,2.48849073,4.110721188,TGFB1;DDIT4,3
5796,response to steroid hormone (GO:0048545),0.191686643,0.894128828,0,0,2.48849073,4.110721188,TGFB1;THBS1,3
5797,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.191686643,0.893312272,0,0,2.48849073,4.110721188,RPS27A;UBA52,3
5798,"mRNA splicing, via spliceosome (GO:0000398)",0.19245397,0.896069899,0,0,1.443704546,2.379078224,HSPA8;SYF2;PCBP2;SNRPG;PABPC1;SRSF5;SF3B1;SNRPB,3
5799,negative regulation of response to cytokine stimulus (GO:0060761),0.192503678,0.895484292,0,0,4.728132388,7.790260141,PTPRC,3
5800,regulation of B cell apoptotic process (GO:0002902),0.192503678,0.894668732,0,0,4.728132388,7.790260141,LYN,3
5801,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.192503678,0.893854657,0,0,4.728132388,7.790260141,AP2A2,3
5802,negative regulation of cholesterol transport (GO:0032375),0.192503678,0.893042062,0,0,4.728132388,7.790260141,APOC1,3
5803,regulation of myeloid leukocyte differentiation (GO:0002761),0.192503678,0.892230943,0,0,4.728132388,7.790260141,CEBPB,3
5804,regulation of cellular respiration (GO:0043457),0.192503678,0.891421296,0,0,4.728132388,7.790260141,NOP53,3
5805,positive regulation of steroid metabolic process (GO:0045940),0.192503678,0.890613117,0,0,4.728132388,7.790260141,APOC1,3
5806,superoxide anion generation (GO:0042554),0.192503678,0.889806402,0,0,4.728132388,7.790260141,NCF2,3
5807,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.192503678,0.889001148,0,0,4.728132388,7.790260141,RACK1,3
5808,positive regulation of cytoplasmic transport (GO:1903651),0.192503678,0.888197349,0,0,4.728132388,7.790260141,SORL1,3
5809,regulation of actin filament length (GO:0030832),0.192503678,0.887395003,0,0,4.728132388,7.790260141,SSH2,3
5810,regulation of cytoplasmic translational elongation (GO:1900247),0.192503678,0.886594105,0,0,4.728132388,7.790260141,EEF2,3
5811,contractile actin filament bundle assembly (GO:0030038),0.192503678,0.885794651,0,0,4.728132388,7.790260141,ZYX,3
5812,response to laminar fluid shear stress (GO:0034616),0.192503678,0.884996638,0,0,4.728132388,7.790260141,KLF2,3
5813,nerve growth factor signaling pathway (GO:0038180),0.192503678,0.884200061,0,0,4.728132388,7.790260141,RAP1A,3
5814,regulation of mast cell activation (GO:0033003),0.192503678,0.883404917,0,0,4.728132388,7.790260141,LYN,3
5815,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.192503678,0.882611202,0,0,4.728132388,7.790260141,MEFV,3
5816,positive regulation of glial cell differentiation (GO:0045687),0.192503678,0.881818912,0,0,4.728132388,7.790260141,HES1,3
5817,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.192503678,0.881028043,0,0,4.728132388,7.790260141,SORL1,3
5818,regulation of amyloid-beta clearance (GO:1900221),0.192503678,0.880238591,0,0,4.728132388,7.790260141,LDLR,3
5819,positive regulation of acrosome reaction (GO:2000344),0.192503678,0.879450553,0,0,4.728132388,7.790260141,PLCB1,3
5820,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.192503678,0.878663925,0,0,4.728132388,7.790260141,JUN,3
5821,astrocyte development (GO:0014002),0.192503678,0.877878702,0,0,4.728132388,7.790260141,FPR2,3
5822,positive regulation of cardiac muscle cell differentiation (GO:2000727),0.192503678,0.877094882,0,0,4.728132388,7.790260141,TGFB1,3
5823,negative regulation of gene silencing by miRNA (GO:0060965),0.192503678,0.87631246,0,0,4.728132388,7.790260141,TGFB1,3
5824,positive regulation of fertilization (GO:1905516),0.192503678,0.875531433,0,0,4.728132388,7.790260141,PLCB1,3
5825,negative regulation of cell activation (GO:0050866),0.192503678,0.874751797,0,0,4.728132388,7.790260141,LDLR,3
5826,regulation of histone phosphorylation (GO:0033127),0.192503678,0.873973548,0,0,4.728132388,7.790260141,IL1B,3
5827,response to muramyl dipeptide (GO:0032495),0.192503678,0.873196683,0,0,4.728132388,7.790260141,IRF5,3
5828,insulin-like growth factor receptor signaling pathway (GO:0048009),0.192503678,0.872421197,0,0,4.728132388,7.790260141,PLCB1,3
5829,detection of bacterium (GO:0016045),0.192503678,0.871647088,0,0,4.728132388,7.790260141,PGLYRP1,3
5830,complement receptor mediated signaling pathway (GO:0002430),0.192503678,0.870874351,0,0,4.728132388,7.790260141,FPR2,3
5831,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.192503678,0.870102983,0,0,4.728132388,7.790260141,SORL1,3
5832,regulation of podosome assembly (GO:0071801),0.192503678,0.869332981,0,0,4.728132388,7.790260141,HCK,3
5833,regulation of mitochondrial depolarization (GO:0051900),0.192503678,0.86856434,0,0,4.728132388,7.790260141,RACK1,3
5834,stress fiber assembly (GO:0043149),0.192503678,0.867797057,0,0,4.728132388,7.790260141,ZYX,3
5835,regulation of astrocyte differentiation (GO:0048710),0.192503678,0.867031128,0,0,4.728132388,7.790260141,HES1,3
5836,positive regulation of interleukin-13 production (GO:0032736),0.192503678,0.86626655,0,0,4.728132388,7.790260141,RARA,3
5837,positive regulation of lipid localization (GO:1905954),0.192503678,0.86550332,0,0,4.728132388,7.790260141,C3,3
5838,chaperone-mediated protein transport (GO:0072321),0.192503678,0.864741433,0,0,4.728132388,7.790260141,HSPA8,3
5839,regulation of immunoglobulin production (GO:0002637),0.192503678,0.863980887,0,0,4.728132388,7.790260141,XBP1,3
5840,very-low-density lipoprotein particle assembly (GO:0034379),0.192503678,0.863221677,0,0,4.728132388,7.790260141,APOC1,3
5841,positive regulation of execution phase of apoptosis (GO:1900119),0.192503678,0.8624638,0,0,4.728132388,7.790260141,RPS3,3
5842,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.192503678,0.861707253,0,0,4.728132388,7.790260141,CEACAM1,3
5843,sequestering of actin monomers (GO:0042989),0.192503678,0.860952032,0,0,4.728132388,7.790260141,TMSB10,3
5844,regulation of dendritic cell apoptotic process (GO:2000668),0.192503678,0.860198133,0,0,4.728132388,7.790260141,LYN,3
5845,regulation of lysosomal lumen pH (GO:0035751),0.192503678,0.859445554,0,0,4.728132388,7.790260141,PPT1,3
5846,regulation of plasminogen activation (GO:0010755),0.192503678,0.85869429,0,0,4.728132388,7.790260141,THBS1,3
5847,intracellular cholesterol transport (GO:0032367),0.192503678,0.857944339,0,0,4.728132388,7.790260141,LDLR,3
5848,regulation of axon regeneration (GO:0048679),0.192503678,0.857195696,0,0,4.728132388,7.790260141,STK24,3
5849,negative regulation of glucose transport (GO:0010829),0.192503678,0.856448359,0,0,4.728132388,7.790260141,IL1B,3
5850,positive regulation of type 2 immune response (GO:0002830),0.192503678,0.855702324,0,0,4.728132388,7.790260141,RARA,3
5851,regulation of T cell chemotaxis (GO:0010819),0.192503678,0.854957587,0,0,4.728132388,7.790260141,CCR2,3
5852,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),0.195358996,0.866884308,0,0,1.970055162,3.216935402,RPS27A;UBA52;PSMA7,3
5853,positive regulation of growth (GO:0045927),0.195358996,0.866131151,0,0,1.970055162,3.216935402,H3F3A;CIB1;PLCB1,3
5854,regulation of response to external stimulus (GO:0032101),0.195475695,0.865896243,0,0,1.751160144,2.858452377,HCK;SBNO2;STK24;MYD88,3
5855,cellular response to starvation (GO:0009267),0.195475695,0.865145248,0,0,1.751160144,2.858452377,KLF10;HSPA8;XBP1;STK24,3
5856,negative regulation of response to external stimulus (GO:0032102),0.195475695,0.864395556,0,0,1.751160144,2.858452377,PCBP2;TNFAIP8L2;MEFV;TNFRSF1A,3
5857,regulation of protein secretion (GO:0050708),0.195475695,0.863647161,0,0,1.751160144,2.858452377,RAP1A;TGFB1;IL1B;SLC25A5,3
5858,phosphate-containing compound metabolic process (GO:0006796),0.195552102,0.86323735,0,0,1.5417823,2.516078367,TGFB1;PTPRC;PLBD1;PLD4;PLCB1;NADK,3
5859,positive regulation of neuron death (GO:1901216),0.199399059,0.879458423,0,0,2.424683276,3.909673621,DDIT4;FOS,3
5860,mitochondrion disassembly (GO:0061726),0.199399059,0.87869896,0,0,2.424683276,3.909673621,FIS1;ATG3,3
5861,homotypic cell-cell adhesion (GO:0034109),0.199399059,0.877940807,0,0,2.424683276,3.909673621,TLN1;ACTG1,3
5862,glycoprotein biosynthetic process (GO:0009101),0.200779415,0.88325634,0,0,1.943068105,3.119689909,SERP1;ST3GAL4;GCNT2,3
5863,regulation of neuron death (GO:1901214),0.200779415,0.882495568,0,0,1.943068105,3.119689909,DDIT4;FOS;SORL1,3
5864,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.200779415,0.881736105,0,0,1.943068105,3.119689909,RPS27A;UBA52;PSMA7,3
5865,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),0.200779415,0.880977949,0,0,1.943068105,3.119689909,RPS27A;UBA52;PSMA7,3
5866,regulation of epithelial cell proliferation (GO:0050678),0.200779415,0.880221095,0,0,1.943068105,3.119689909,NR4A1;ZFP36;TGFB1,3
5867,regulation of cell motility (GO:2000145),0.204173201,0.894331199,0,0,1.719320868,2.731633989,CEACAM1;TGFB1;LMO4;RAC1,3
5868,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.204173201,0.893564191,0,0,1.719320868,2.731633989,FIS1;RACK1;RPS3;XDH,3
5869,negative regulation of protein kinase activity (GO:0006469),0.204173201,0.892798498,0,0,1.719320868,2.731633989,PTPN1;CEACAM1;PTPRC;SORL1,3
5870,regulation of peptide hormone secretion (GO:0090276),0.206235058,0.901042382,0,0,1.916810427,3.026142805,RAP1A;IL1B;SLC25A5,3
5871,positive regulation of cytokine secretion (GO:0050715),0.206235058,0.900271601,0,0,1.916810427,3.026142805,FGR;XBP1;CD244,3
5872,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.206235058,0.899502138,0,0,1.916810427,3.026142805,RNASE6;RPS27A;UBA52,3
5873,signal transduction by p53 class mediator (GO:0072331),0.207147489,0.902710192,0,0,2.364066194,3.721806699,BCL3;NDRG1,3
5874,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.207147489,0.901939962,0,0,2.364066194,3.721806699,SP100;THBS1,3
5875,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.207147489,0.901171044,0,0,2.364066194,3.721806699,PTPN1;PTPN6,3
5876,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.207147489,0.900403437,0,0,2.364066194,3.721806699,TGFB1;ATP5C1,3
5877,Golgi to plasma membrane transport (GO:0006893),0.207147489,0.899637136,0,0,2.364066194,3.721806699,SYS1;STXBP6,3
5878,macroautophagy (GO:0016236),0.208564188,0.9050196,0,0,1.703831491,2.670770227,ATG3;ATG101;RPS27A;UBA52,3
5879,cellular response to peptide hormone stimulus (GO:0071375),0.208564188,0.904250679,0,0,1.703831491,2.670770227,NR4A1;XBP1;CEACAM1;GNB2,3
5880,positive regulation of posttranscriptional gene silencing (GO:0060148),0.209590744,0.907930025,0,0,4.298302171,6.716520462,ZFP36,3
5881,positive regulation of endothelial cell apoptotic process (GO:2000353),0.209590744,0.90715994,0,0,4.298302171,6.716520462,THBS1,3
5882,regulation of histone H3-K9 methylation (GO:0051570),0.209590744,0.90639116,0,0,4.298302171,6.716520462,JARID2,3
5883,negative regulation of defense response to virus (GO:0050687),0.209590744,0.905623683,0,0,4.298302171,6.716520462,PCBP2,3
5884,negative regulation of leukocyte activation (GO:0002695),0.209590744,0.904857503,0,0,4.298302171,6.716520462,CD300A,3
5885,endothelium development (GO:0003158),0.209590744,0.90409262,0,0,4.298302171,6.716520462,KDM6B,3
5886,regulation of myeloid leukocyte mediated immunity (GO:0002886),0.209590744,0.903329028,0,0,4.298302171,6.716520462,LYN,3
5887,regulation of lipid kinase activity (GO:0043550),0.209590744,0.902566725,0,0,4.298302171,6.716520462,PPP2R5A,3
5888,regulation of trophoblast cell migration (GO:1901163),0.209590744,0.901805708,0,0,4.298302171,6.716520462,ARHGDIB,3
5889,intracellular protein transmembrane transport (GO:0065002),0.209590744,0.901045972,0,0,4.298302171,6.716520462,SEC61B,3
5890,positive regulation of extracellular matrix organization (GO:1903055),0.209590744,0.900287516,0,0,4.298302171,6.716520462,TGFB1,3
5891,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.209590744,0.899530336,0,0,4.298302171,6.716520462,TNFAIP8L2,3
5892,negative regulation of bone mineralization (GO:0030502),0.209590744,0.898774428,0,0,4.298302171,6.716520462,SRGN,3
5893,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.209590744,0.898019789,0,0,4.298302171,6.716520462,XDH,3
5894,T cell differentiation in thymus (GO:0033077),0.209590744,0.897266417,0,0,4.298302171,6.716520462,ZFP36L2,3
5895,chromatin silencing at rDNA (GO:0000183),0.209590744,0.896514308,0,0,4.298302171,6.716520462,H3F3A,3
5896,positive regulation of cytolysis (GO:0045919),0.209590744,0.895763458,0,0,4.298302171,6.716520462,PGLYRP1,3
5897,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.209590744,0.895013865,0,0,4.298302171,6.716520462,STK24,3
5898,low-density lipoprotein particle remodeling (GO:0034374),0.209590744,0.894265526,0,0,4.298302171,6.716520462,PLA2G7,3
5899,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.209590744,0.893518437,0,0,4.298302171,6.716520462,RPSA,3
5900,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.209590744,0.892772595,0,0,4.298302171,6.716520462,CEBPB,3
5901,purine nucleobase metabolic process (GO:0006144),0.209590744,0.892027998,0,0,4.298302171,6.716520462,GDA,3
5902,regulation of integrin-mediated signaling pathway (GO:2001044),0.209590744,0.891284641,0,0,4.298302171,6.716520462,CD177,3
5903,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.209590744,0.890542522,0,0,4.298302171,6.716520462,SORL1,3
5904,negative regulation of myotube differentiation (GO:0010832),0.209590744,0.889801638,0,0,4.298302171,6.716520462,XBP1,3
5905,stress granule assembly (GO:0034063),0.209590744,0.889061986,0,0,4.298302171,6.716520462,RPS23,3
5906,sphingolipid catabolic process (GO:0030149),0.209590744,0.888323562,0,0,4.298302171,6.716520462,PPT1,3
5907,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),0.209590744,0.887586364,0,0,4.298302171,6.716520462,CEACAM1,3
5908,negative regulation of histone acetylation (GO:0035067),0.209590744,0.886850389,0,0,4.298302171,6.716520462,SPI1,3
5909,response to sterol (GO:0036314),0.209590744,0.886115633,0,0,4.298302171,6.716520462,TGFB1,3
5910,negative regulation of nucleocytoplasmic transport (GO:0046823),0.209590744,0.885382094,0,0,4.298302171,6.716520462,SP100,3
5911,positive regulation of T cell receptor signaling pathway (GO:0050862),0.209590744,0.884649768,0,0,4.298302171,6.716520462,RPS3,3
5912,protein kinase C signaling (GO:0070528),0.209590744,0.883918652,0,0,4.298302171,6.716520462,FLOT1,3
5913,regulation of cholesterol esterification (GO:0010872),0.209590744,0.883188744,0,0,4.298302171,6.716520462,APOC1,3
5914,cell part morphogenesis (GO:0032990),0.209590744,0.882460041,0,0,4.298302171,6.716520462,FIS1,3
5915,phosphate ion homeostasis (GO:0055062),0.209590744,0.881732538,0,0,4.298302171,6.716520462,GPCPD1,3
5916,negative regulation of chemotaxis (GO:0050922),0.209590744,0.881006235,0,0,4.298302171,6.716520462,THBS1,3
5917,carbohydrate phosphorylation (GO:0046835),0.209590744,0.880281127,0,0,4.298302171,6.716520462,RBKS,3
5918,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.209590744,0.879557211,0,0,4.298302171,6.716520462,AP2A2,3
5919,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.209590744,0.878834486,0,0,4.298302171,6.716520462,ZFP36,3
5920,regulation of cardiac muscle cell differentiation (GO:2000725),0.209590744,0.878112947,0,0,4.298302171,6.716520462,TGFB1,3
5921,carbohydrate derivative catabolic process (GO:1901136),0.209590744,0.877392592,0,0,4.298302171,6.716520462,SAMHD1,3
5922,regulation of autophagosome maturation (GO:1901096),0.209590744,0.876673417,0,0,4.298302171,6.716520462,ADRB2,3
5923,miRNA mediated inhibition of translation (GO:0035278),0.209590744,0.875955421,0,0,4.298302171,6.716520462,ZFP36,3
5924,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.209590744,0.8752386,0,0,4.298302171,6.716520462,THBS1,3
5925,positive regulation of T-helper cell differentiation (GO:0045624),0.209590744,0.874522951,0,0,4.298302171,6.716520462,RARA,3
5926,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.209590744,0.873808471,0,0,4.298302171,6.716520462,RAC1,3
5927,positive regulation of epithelial cell migration (GO:0010634),0.211724059,0.881981937,0,0,1.891252955,2.936116238,SCARB1;GLIPR2;THBS1,3
5928,positive regulation of defense response (GO:0031349),0.211724059,0.881262539,0,0,1.891252955,2.936116238,PLA2G7;CCR2;TNFRSF1A,3
5929,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),0.211724059,0.880544314,0,0,1.891252955,2.936116238,C3;PLCB1;RASGRP4,3
5930,regulation of protein binding (GO:0043393),0.212982072,0.885054977,0,0,1.68861871,2.611528686,SLPI;RPL11;FLOT1;SORL1,3
5931,"nucleotide-excision repair, DNA incision (GO:0033683)",0.214926975,0.892410377,0,0,2.306406043,3.546000023,RPS27A;UBA52,3
5932,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.214926975,0.89168484,0,0,2.306406043,3.546000023,RPS27A;UBA52,3
5933,regulation of protein dephosphorylation (GO:0035304),0.214926975,0.890960482,0,0,2.306406043,3.546000023,TGFB1;PPP2R5A,3
5934,autophagy of mitochondrion (GO:0000422),0.214926975,0.890237299,0,0,2.306406043,3.546000023,FIS1;ATG3,3
5935,ameboidal-type cell migration (GO:0001667),0.214926975,0.88951529,0,0,2.306406043,3.546000023,ITGA4;ITGB7,3
5936,positive regulation of Ras protein signal transduction (GO:0046579),0.214926975,0.888794451,0,0,2.306406043,3.546000023,RAC1;RASGRP4,3
5937,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.214926975,0.88807478,0,0,2.306406043,3.546000023,LYN;PTPN1,3
5938,regulation of intracellular transport (GO:0032386),0.214926975,0.887356273,0,0,2.306406043,3.546000023,LYN;PTPN1,3
5939,regulation of viral transcription (GO:0046782),0.214926975,0.886638927,0,0,2.306406043,3.546000023,IFITM3;ZFP36,3
5940,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.217244571,0.895475803,0,0,1.866368048,2.849442901,IKBKB;NCF2;PSMA7,3
5941,gland development (GO:0048732),0.217244571,0.894753062,0,0,1.866368048,2.849442901,XBP1;RARA;HES1,3
5942,mesenchymal cell differentiation (GO:0048762),0.222732751,0.916617121,0,0,2.251491613,3.381251042,TGFB1;S100A4,3
5943,DNA duplex unwinding (GO:0032508),0.222732751,0.91587851,0,0,2.251491613,3.381251042,RPS27A;UBA52,3
5944,telomere organization (GO:0032200),0.222732751,0.915141087,0,0,2.251491613,3.381251042,SP100;H3F3A,3
5945,negative regulation of cell projection organization (GO:0031345),0.222732751,0.914404852,0,0,2.251491613,3.381251042,PTPRO;CIB1,3
5946,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.222732751,0.913669799,0,0,2.251491613,3.381251042,CIB1;RAC1,3
5947,monocyte chemotaxis (GO:0002548),0.222732751,0.912935928,0,0,2.251491613,3.381251042,RPS19;PTPRO,3
5948,positive regulation of apoptotic signaling pathway (GO:2001235),0.222794767,0.912457221,0,0,1.842129502,2.76596529,FIS1;RACK1;RPS3,3
5949,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),0.222794767,0.911725499,0,0,1.842129502,2.76596529,RPS27A;UBA52;PSMA7,3
5950,"transcription, DNA-templated (GO:0006351)",0.226053664,0.924320389,0,0,1.324406831,1.969370256,BTF3;NFE2;XBP1;CEBPB;KLF13;CEBPD;LMO4;BCL3;AHR;POU2F2,3
5951,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.226317076,0.924656556,0,0,3.940110323,5.854287911,SVIP,3
5952,rRNA 3'-end processing (GO:0031125),0.226317076,0.923916831,0,0,3.940110323,5.854287911,RPSA,3
5953,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836),0.226317076,0.923178289,0,0,3.940110323,5.854287911,NOP53,3
5954,histone H3-K9 demethylation (GO:0033169),0.226317076,0.922440926,0,0,3.940110323,5.854287911,KDM7A,3
5955,peptidyl-arginine modification (GO:0018195),0.226317076,0.92170474,0,0,3.940110323,5.854287911,KRTCAP2,3
5956,negative regulation of protein oligomerization (GO:0032460),0.226317076,0.920969728,0,0,3.940110323,5.854287911,SORL1,3
5957,regulation of protein glycosylation (GO:0060049),0.226317076,0.920235888,0,0,3.940110323,5.854287911,RAMP1,3
5958,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.226317076,0.919503216,0,0,3.940110323,5.854287911,PTPN1,3
5959,negative regulation of ERAD pathway (GO:1904293),0.226317076,0.91877171,0,0,3.940110323,5.854287911,SVIP,3
5960,carbohydrate derivative transport (GO:1901264),0.226317076,0.918041366,0,0,3.940110323,5.854287911,SCARB1,3
5961,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.226317076,0.917312183,0,0,3.940110323,5.854287911,RPL26,3
5962,viral RNA genome replication (GO:0039694),0.226317076,0.916584158,0,0,3.940110323,5.854287911,PCBP2,3
5963,regulation of cholesterol storage (GO:0010885),0.226317076,0.915857287,0,0,3.940110323,5.854287911,SCARB1,3
5964,regulation of actomyosin structure organization (GO:0110020),0.226317076,0.915131568,0,0,3.940110323,5.854287911,RAC1,3
5965,phospholipid efflux (GO:0033700),0.226317076,0.914406998,0,0,3.940110323,5.854287911,APOC1,3
5966,positive regulation of T-helper 1 type immune response (GO:0002827),0.226317076,0.913683575,0,0,3.940110323,5.854287911,CCR2,3
5967,regulation of histone methylation (GO:0031060),0.226317076,0.912961296,0,0,3.940110323,5.854287911,JARID2,3
5968,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.226317076,0.912240157,0,0,3.940110323,5.854287911,LYN,3
5969,DNA ligation involved in DNA repair (GO:0051103),0.226317076,0.911520157,0,0,3.940110323,5.854287911,HMGB2,3
5970,positive regulation of cardiocyte differentiation (GO:1905209),0.226317076,0.910801293,0,0,3.940110323,5.854287911,TGFB1,3
5971,regulation of interleukin-8 biosynthetic process (GO:0045414),0.226317076,0.910083561,0,0,3.940110323,5.854287911,BCL3,3
5972,negative regulation by host of viral transcription (GO:0043922),0.226317076,0.90936696,0,0,3.940110323,5.854287911,JUN,3
5973,cellular response to fluid shear stress (GO:0071498),0.226317076,0.908651486,0,0,3.940110323,5.854287911,KLF2,3
5974,cytoplasmic translational initiation (GO:0002183),0.226317076,0.907937138,0,0,3.940110323,5.854287911,EIF3M,3
5975,negative regulation of histone modification (GO:0031057),0.226317076,0.907223911,0,0,3.940110323,5.854287911,JARID2,3
5976,response to interleukin-6 (GO:0070741),0.226317076,0.906511805,0,0,3.940110323,5.854287911,SBNO2,3
5977,negative regulation of epithelial cell differentiation (GO:0030857),0.226317076,0.905800815,0,0,3.940110323,5.854287911,XDH,3
5978,L-serine metabolic process (GO:0006563),0.226317076,0.90509094,0,0,3.940110323,5.854287911,SERINC3,3
5979,prostanoid metabolic process (GO:0006692),0.226317076,0.904382176,0,0,3.940110323,5.854287911,HPGD,3
5980,plasma membrane tubulation (GO:0097320),0.226317076,0.903674522,0,0,3.940110323,5.854287911,BIN2,3
5981,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.226317076,0.902967974,0,0,3.940110323,5.854287911,THBS1,3
5982,dermatan sulfate biosynthetic process (GO:0030208),0.226317076,0.90226253,0,0,3.940110323,5.854287911,VCAN,3
5983,negative regulation of myoblast differentiation (GO:0045662),0.226317076,0.901558188,0,0,3.940110323,5.854287911,TGFB1,3
5984,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.226317076,0.900854945,0,0,3.940110323,5.854287911,IL1B,3
5985,positive regulation of SMAD protein import into nucleus (GO:0060391),0.226317076,0.900152797,0,0,3.940110323,5.854287911,TGFB1,3
5986,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.226317076,0.899451744,0,0,3.940110323,5.854287911,IL1B,3
5987,regulation of signal transduction (GO:0009966),0.227849533,0.904837483,0,0,1.414398578,2.091994239,PTPN1;SP100;IGFBP6;PLCB1;SAMSN1;RASGRP4;CD177,3
5988,activation of protein kinase activity (GO:0032147),0.227849533,0.904133877,0,0,1.414398578,2.091994239,RAP1A;STK24;IL1B;ADRB2;RPS27A;UBA52;THBS1,3
5989,positive regulation of cytoskeleton organization (GO:0051495),0.228372844,0.905506313,0,0,1.818512457,2.685535012,HCK;RAC2;RAC1,3
5990,regulation of interleukin-6 production (GO:0032675),0.23056024,0.913469645,0,0,2.199131343,3.226660306,IL1B;MYD88,3
5991,cellular response to calcium ion (GO:0071277),0.23056024,0.912760979,0,0,2.199131343,3.226660306,ALOX5AP;RASGRP2,3
5992,negative regulation of protein secretion (GO:0050709),0.23056024,0.912053413,0,0,2.199131343,3.226660306,SRGN;IL1B,3
5993,cellular response to retinoic acid (GO:0071300),0.23056024,0.911346942,0,0,2.199131343,3.226660306,LYN;RARA,3
5994,translesion synthesis (GO:0019985),0.23056024,0.910641565,0,0,2.199131343,3.226660306,RPS27A;UBA52,3
5995,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.238405041,0.940897855,0,0,2.149151085,3.081418864,DDIT4;BCL3,3
5996,response to hydrogen peroxide (GO:0042542),0.238405041,0.940170731,0,0,2.149151085,3.081418864,STK24;RPS3,3
5997,positive regulation of protein localization to plasma membrane (GO:1903078),0.238405041,0.939444731,0,0,2.149151085,3.081418864,RACK1;CIB1,3
5998,nucleosome organization (GO:0034728),0.239605536,0.943446798,0,0,1.773049645,2.533264731,NFE2;H3F3A;HMGB2,3
5999,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.239605536,0.942719391,0,0,1.773049645,2.533264731,RPS27A;UBA52;PSMA7,3
6000,response to calcium ion (GO:0051592),0.239605536,0.941993105,0,0,1.773049645,2.533264731,ALOX5AP;RASGRP2;THBS1,3
6001,protein localization to cell periphery (GO:1990778),0.240001591,0.942823802,0,0,1.602756742,2.287309736,IKBKB;FLOT1;RAMP1;TNFRSF1A,3
6002,activation of MAPK activity (GO:0000187),0.240001591,0.942098553,0,0,1.602756742,2.287309736,IL1B;RPS27A;UBA52;THBS1,3
6003,dermatan sulfate metabolic process (GO:0030205),0.24269027,0.951920407,0,0,3.637024914,5.149915462,VCAN,3
6004,regulation of interleukin-1 beta production (GO:0032651),0.24269027,0.951189285,0,0,3.637024914,5.149915462,MEFV,3
6005,regulation of granulocyte chemotaxis (GO:0071622),0.24269027,0.950459286,0,0,3.637024914,5.149915462,THBS1,3
6006,cellular response to exogenous dsRNA (GO:0071360),0.24269027,0.949730406,0,0,3.637024914,5.149915462,FLOT1,3
6007,regulation of oligodendrocyte differentiation (GO:0048713),0.24269027,0.949002643,0,0,3.637024914,5.149915462,HES1,3
6008,glycerolipid catabolic process (GO:0046503),0.24269027,0.948275995,0,0,3.637024914,5.149915462,GPCPD1,3
6009,DNA replication-independent nucleosome organization (GO:0034724),0.24269027,0.947550459,0,0,3.637024914,5.149915462,H3F3A,3
6010,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.24269027,0.946826032,0,0,3.637024914,5.149915462,CD244,3
6011,muscle cell development (GO:0055001),0.24269027,0.946102712,0,0,3.637024914,5.149915462,HES1,3
6012,positive regulation of skeletal muscle tissue development (GO:0048643),0.24269027,0.945380496,0,0,3.637024914,5.149915462,FLOT1,3
6013,serine family amino acid biosynthetic process (GO:0009070),0.24269027,0.944659382,0,0,3.637024914,5.149915462,SERINC3,3
6014,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.24269027,0.943939367,0,0,3.637024914,5.149915462,TGFB1,3
6015,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.24269027,0.943220449,0,0,3.637024914,5.149915462,IL1B,3
6016,positive regulation of protein complex disassembly (GO:0043243),0.24269027,0.942502625,0,0,3.637024914,5.149915462,ADRB2,3
6017,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.24269027,0.941785893,0,0,3.637024914,5.149915462,TGFB1,3
6018,alpha-linolenic acid metabolic process (GO:0036109),0.24269027,0.94107025,0,0,3.637024914,5.149915462,SCP2,3
6019,regulation of cAMP metabolic process (GO:0030814),0.24269027,0.940355694,0,0,3.637024914,5.149915462,RAMP1,3
6020,cardiocyte differentiation (GO:0035051),0.24269027,0.939642223,0,0,3.637024914,5.149915462,KDM6B,3
6021,cellular response to interleukin-15 (GO:0071350),0.24269027,0.938929833,0,0,3.637024914,5.149915462,PLCB1,3
6022,leukocyte differentiation (GO:0002521),0.24269027,0.938218522,0,0,3.637024914,5.149915462,LYN,3
6023,toll-like receptor 9 signaling pathway (GO:0034162),0.24269027,0.937508289,0,0,3.637024914,5.149915462,MYD88,3
6024,regulation of endothelial cell chemotaxis (GO:2001026),0.24269027,0.93679913,0,0,3.637024914,5.149915462,THBS1,3
6025,prostanoid biosynthetic process (GO:0046457),0.24269027,0.936091043,0,0,3.637024914,5.149915462,MGST1,3
6026,negative regulation of hormone secretion (GO:0046888),0.24269027,0.935384025,0,0,3.637024914,5.149915462,IL1B,3
6027,secretion (GO:0046903),0.24269027,0.934678075,0,0,3.637024914,5.149915462,TPD52,3
6028,regulation of fibrinolysis (GO:0051917),0.24269027,0.93397319,0,0,3.637024914,5.149915462,THBS1,3
6029,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.24269027,0.933269367,0,0,3.637024914,5.149915462,ADRB2,3
6030,chondroitin sulfate catabolic process (GO:0030207),0.24269027,0.932566604,0,0,3.637024914,5.149915462,VCAN,3
6031,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.24269027,0.931864898,0,0,3.637024914,5.149915462,CCR2,3
6032,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.24269027,0.931164248,0,0,3.637024914,5.149915462,SUB1,3
6033,interleukin-15-mediated signaling pathway (GO:0035723),0.24269027,0.93046465,0,0,3.637024914,5.149915462,PLCB1,3
6034,glomerular visceral epithelial cell differentiation (GO:0072112),0.24269027,0.929766103,0,0,3.637024914,5.149915462,PTPRO,3
6035,regulation of leukocyte migration (GO:0002685),0.24269027,0.929068604,0,0,3.637024914,5.149915462,RAC2,3
6036,negative regulation of chemokine production (GO:0032682),0.24269027,0.928372151,0,0,3.637024914,5.149915462,MEFV,3
6037,endothelial cell differentiation (GO:0045446),0.24269027,0.927676741,0,0,3.637024914,5.149915462,KDM6B,3
6038,regulation of cellular carbohydrate metabolic process (GO:0010675),0.24269027,0.926982372,0,0,3.637024914,5.149915462,ADIPOR1,3
6039,RNA transport (GO:0050658),0.245256656,0.936084305,0,0,1.751160144,2.461168095,ZFP36;FLOT1;SRSF5,3
6040,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",0.245256656,0.935384691,0,0,1.751160144,2.461168095,USE1;ARF5;COPE,3
6041,NIK/NF-kappaB signaling (GO:0038061),0.245256656,0.934686121,0,0,1.751160144,2.461168095,RPS27A;UBA52;PSMA7,3
6042,regulation of protein serine/threonine kinase activity (GO:0071900),0.245256656,0.933988594,0,0,1.751160144,2.461168095,CDKN2D;CIB1;ADRB2,3
6043,regulation of focal adhesion assembly (GO:0051893),0.246262935,0.937121369,0,0,2.101392172,2.944797424,RAC1;THBS1,3
6044,sprouting angiogenesis (GO:0002040),0.246262935,0.936423067,0,0,2.101392172,2.944797424,NR4A1;THBS1,3
6045,negative regulation of immune system process (GO:0002683),0.246262935,0.935725804,0,0,2.101392172,2.944797424,LYN;TSC22D3,3
6046,positive regulation of intracellular transport (GO:0032388),0.246262935,0.93502958,0,0,2.101392172,2.944797424,FGR;SORL1,3
6047,positive regulation of protein targeting to mitochondrion (GO:1903955),0.25092867,0.952036433,0,0,1.729804532,2.391604504,UBE2D3;RAC2;HES1,3
6048,negative regulation of cell death (GO:0060548),0.25092867,0.951329125,0,0,1.729804532,2.391604504,SORL1;HSPA1B;HSPA1A,3
6049,protein polymerization (GO:0051258),0.254129867,0.962750343,0,0,2.055709734,2.816137023,RAC1;MSRB1,3
6050,mRNA processing (GO:0006397),0.254438919,0.963206086,0,0,1.331868278,1.822920754,HSPA8;SYF2;PCBP2;SNRPG;PABPC1;SRSF5;SF3B1;SNRPB,3
6051,regulation of anatomical structure morphogenesis (GO:0022603),0.256619892,0.970742258,0,0,1.708963514,2.324462634,CEACAM1;SP100;TGFB1,3
6052,positive regulation of cell cycle (GO:0045787),0.256619892,0.97002319,0,0,1.708963514,2.324462634,CCND3;RPS15A;RARA,3
6053,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.256619892,0.969305186,0,0,1.708963514,2.324462634,RPS27A;UBA52;PSMA7,3
6054,positive regulation of protein secretion (GO:0050714),0.256619892,0.968588244,0,0,1.708963514,2.324462634,FGR;XBP1;TGFB1,3
6055,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.256805163,0.968571136,0,0,1.404395759,1.909188402,RAP1A;TGFB1;GLIPR2;GCNT2;CIB1;FPR2,3
6056,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.258717766,0.975064076,0,0,3.37723742,4.566084157,RACK1,3
6057,mitotic cell cycle arrest (GO:0071850),0.258717766,0.974344471,0,0,3.37723742,4.566084157,DUSP1,3
6058,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.258717766,0.973625928,0,0,3.37723742,4.566084157,CIB1,3
6059,lipid particle organization (GO:0034389),0.258717766,0.972908444,0,0,3.37723742,4.566084157,BSCL2,3
6060,stem cell development (GO:0048864),0.258717766,0.972192017,0,0,3.37723742,4.566084157,PTPRC,3
6061,regulation of nucleocytoplasmic transport (GO:0046822),0.258717766,0.971476644,0,0,3.37723742,4.566084157,TGFB1,3
6062,regulation of phosphate metabolic process (GO:0019220),0.258717766,0.970762323,0,0,3.37723742,4.566084157,IKBKB,3
6063,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.258717766,0.970049051,0,0,3.37723742,4.566084157,FAM49B,3
6064,regulation of extracellular matrix disassembly (GO:0010715),0.258717766,0.969336827,0,0,3.37723742,4.566084157,TGFB1,3
6065,negative regulation of interleukin-1 beta production (GO:0032691),0.258717766,0.968625648,0,0,3.37723742,4.566084157,MEFV,3
6066,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.258717766,0.967915512,0,0,3.37723742,4.566084157,CIB1,3
6067,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.258717766,0.967206417,0,0,3.37723742,4.566084157,SP100,3
6068,acyl-CoA biosynthetic process (GO:0071616),0.258717766,0.966498359,0,0,3.37723742,4.566084157,PPT1,3
6069,negative regulation of focal adhesion assembly (GO:0051895),0.258717766,0.965791338,0,0,3.37723742,4.566084157,THBS1,3
6070,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.258717766,0.96508535,0,0,3.37723742,4.566084157,TGFB1,3
6071,thymus development (GO:0048538),0.258717766,0.964380393,0,0,3.37723742,4.566084157,HES1,3
6072,regulation of lymphocyte differentiation (GO:0045619),0.258717766,0.963676466,0,0,3.37723742,4.566084157,ZFP36L2,3
6073,positive regulation of mitochondrial fission (GO:0090141),0.258717766,0.962973566,0,0,3.37723742,4.566084157,FIS1,3
6074,regulation of defense response to virus (GO:0050688),0.258717766,0.96227169,0,0,3.37723742,4.566084157,PCBP2,3
6075,hydrogen peroxide catabolic process (GO:0042744),0.258717766,0.961570837,0,0,3.37723742,4.566084157,PRDX5,3
6076,negative regulation of biomineral tissue development (GO:0070168),0.258717766,0.960871003,0,0,3.37723742,4.566084157,SRGN,3
6077,cell migration involved in sprouting angiogenesis (GO:0002042),0.258717766,0.960172188,0,0,3.37723742,4.566084157,NR4A1,3
6078,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),0.258717766,0.959474389,0,0,3.37723742,4.566084157,CDKN2D,3
6079,neutrophil activation (GO:0042119),0.258717766,0.958777603,0,0,3.37723742,4.566084157,FCER1G,3
6080,regulation of fatty acid metabolic process (GO:0019217),0.258717766,0.958081828,0,0,3.37723742,4.566084157,ADIPOR1,3
6081,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.258717766,0.957387062,0,0,3.37723742,4.566084157,RPL26,3
6082,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.258717766,0.956693303,0,0,3.37723742,4.566084157,THBS1,3
6083,epiboly involved in wound healing (GO:0090505),0.258717766,0.956000549,0,0,3.37723742,4.566084157,CEACAM1,3
6084,positive regulation of vascular smooth muscle cell proliferation (GO:1904707),0.258717766,0.955308798,0,0,3.37723742,4.566084157,JUN,3
6085,regulation of gastrulation (GO:0010470),0.258717766,0.954618047,0,0,3.37723742,4.566084157,RACK1,3
6086,positive regulation of purine nucleotide metabolic process (GO:1900544),0.258717766,0.953928294,0,0,3.37723742,4.566084157,RAMP1,3
6087,interleukin-6-mediated signaling pathway (GO:0070102),0.258717766,0.953239537,0,0,3.37723742,4.566084157,SOCS3,3
6088,regulation of adaptive immune response (GO:0002819),0.258717766,0.952551774,0,0,3.37723742,4.566084157,SAMSN1,3
6089,negative regulation of T cell receptor signaling pathway (GO:0050860),0.258717766,0.951865003,0,0,3.37723742,4.566084157,CEACAM1,3
6090,positive regulation of interleukin-8 secretion (GO:2000484),0.258717766,0.951179221,0,0,3.37723742,4.566084157,CD244,3
6091,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.258717766,0.950494427,0,0,3.37723742,4.566084157,DUSP1,3
6092,nucleocytoplasmic transport (GO:0006913),0.262001951,0.961867595,0,0,2.011971229,2.69484096,SNRPG;SNRPB,3
6093,regulation of fibroblast proliferation (GO:0048145),0.262001951,0.961176101,0,0,2.011971229,2.69484096,CD300A;S100A6,3
6094,icosanoid metabolic process (GO:0006690),0.262001951,0.960485601,0,0,2.011971229,2.69484096,HPGD;ALOX5AP,3
6095,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.262001951,0.959796092,0,0,2.011971229,2.69484096,NDUFA6;NDUFA4,3
6096,positive regulation of homeostatic process (GO:0032846),0.26232866,0.960303553,0,0,1.68861871,2.259637172,HMGB2;HSPA1B;HSPA1A,3
6097,T cell receptor signaling pathway (GO:0050852),0.26712469,0.977159349,0,0,1.441503777,1.902842251,IKBKB;PTPRC;RPS27A;UBA52;PSMA7,3
6098,regulation of mitotic nuclear division (GO:0007088),0.268053341,0.979854011,0,0,1.668752607,2.197028427,IL1B;HSPA1B;HSPA1A,3
6099,DNA repair (GO:0006281),0.269344871,0.983870349,0,0,1.308825574,1.716868532,CDKN2D;BTG2;RPS3;HMGB2;CIB1;RPS27A;UBA52;NOP53,3
6100,peptide cross-linking (GO:0018149),0.269875459,0.985103339,0,0,1.970055162,2.580367788,F13A1;THBS1,3
6101,polyol metabolic process (GO:0019751),0.269875459,0.984399191,0,0,1.970055162,2.580367788,PLD4;PLCB1,3
6102,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.269875459,0.983696048,0,0,1.970055162,2.580367788,FIS1;RACK1,3
6103,positive regulation of tumor necrosis factor production (GO:0032760),0.269875459,0.98299391,0,0,1.970055162,2.580367788,THBS1;CCR2,3
6104,regulation of organelle assembly (GO:1902115),0.269875459,0.982292773,0,0,1.970055162,2.580367788,ATG3;HCK,3
6105,postreplication repair (GO:0006301),0.269875459,0.981592636,0,0,1.970055162,2.580367788,RPS27A;UBA52,3
6106,"positive regulation of gene expression, epigenetic (GO:0045815)",0.269875459,0.980893496,0,0,1.970055162,2.580367788,H3F3A;SF3B1,3
6107,inositol phosphate metabolic process (GO:0043647),0.269875459,0.980195351,0,0,1.970055162,2.580367788,PLD4;PLCB1,3
6108,positive regulation of MAPK cascade (GO:0043410),0.272356206,0.988501934,0,0,1.304312383,1.696446712,RAP1A;TGFB1;GLIPR2;GCNT2;CIB1;FPR2;ADRB2;TNFRSF1A,3
6109,negative regulation of macromolecule metabolic process (GO:0010605),0.272436894,0.98809202,0,0,1.513002364,1.967430009,TGFB1;RACK1;LDLR;XDH,3
6110,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.273792325,0.992302725,0,0,1.649348507,2.13654197,TGFB1;PTPN6;SAMSN1,3
6111,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.274406844,0.993824078,0,0,3.152088258,4.076102256,IL1B,3
6112,positive regulation of alpha-beta T cell activation (GO:0046635),0.274406844,0.993119239,0,0,3.152088258,4.076102256,CCR2,3
6113,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.274406844,0.992415398,0,0,3.152088258,4.076102256,SCP2,3
6114,apoptotic DNA fragmentation (GO:0006309),0.274406844,0.991712554,0,0,3.152088258,4.076102256,HMGB2,3
6115,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.274406844,0.991010705,0,0,3.152088258,4.076102256,DDIT4,3
6116,maintenance of protein location in nucleus (GO:0051457),0.274406844,0.990309849,0,0,3.152088258,4.076102256,BCL3,3
6117,negative regulation of adherens junction organization (GO:1903392),0.274406844,0.989609983,0,0,3.152088258,4.076102256,THBS1,3
6118,regulation of protein homooligomerization (GO:0032462),0.274406844,0.988911106,0,0,3.152088258,4.076102256,RACK1,3
6119,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.274406844,0.988213215,0,0,3.152088258,4.076102256,RASGRP4,3
6120,substrate-dependent cell migration (GO:0006929),0.274406844,0.987516309,0,0,3.152088258,4.076102256,PTPRC,3
6121,transport along microtubule (GO:0010970),0.274406844,0.986820385,0,0,3.152088258,4.076102256,HSPA8,3
6122,positive regulation of protein import (GO:1904591),0.274406844,0.986125441,0,0,3.152088258,4.076102256,TGFB1,3
6123,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.274406844,0.985431475,0,0,3.152088258,4.076102256,LYN,3
6124,cardiac muscle cell differentiation (GO:0055007),0.274406844,0.984738485,0,0,3.152088258,4.076102256,KDM6B,3
6125,glycerophospholipid catabolic process (GO:0046475),0.274406844,0.98404647,0,0,3.152088258,4.076102256,GPCPD1,3
6126,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.274406844,0.983355426,0,0,3.152088258,4.076102256,VCAN,3
6127,negative regulation of interleukin-2 production (GO:0032703),0.274406844,0.982665352,0,0,3.152088258,4.076102256,ZFP36,3
6128,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.274406844,0.981976246,0,0,3.152088258,4.076102256,CD300A,3
6129,negative regulation of cellular component movement (GO:0051271),0.274406844,0.981288105,0,0,3.152088258,4.076102256,SP100,3
6130,positive regulation of acute inflammatory response (GO:0002675),0.274406844,0.980600929,0,0,3.152088258,4.076102256,IL1B,3
6131,response to cholesterol (GO:0070723),0.274406844,0.979914714,0,0,3.152088258,4.076102256,TGFB1,3
6132,negative regulation of muscle cell differentiation (GO:0051148),0.274406844,0.979229459,0,0,3.152088258,4.076102256,TGFB1,3
6133,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.274406844,0.978545162,0,0,3.152088258,4.076102256,SP100,3
6134,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.274406844,0.97786182,0,0,3.152088258,4.076102256,IL1B,3
6135,cofactor transport (GO:0051181),0.274406844,0.977179432,0,0,3.152088258,4.076102256,PPT1,3
6136,negative regulation of platelet activation (GO:0010544),0.274406844,0.976497996,0,0,3.152088258,4.076102256,CEACAM1,3
6137,negative regulation of cytokine production involved in immune response (GO:0002719),0.274406844,0.97581751,0,0,3.152088258,4.076102256,TGFB1,3
6138,positive regulation of collagen metabolic process (GO:0010714),0.274406844,0.975137971,0,0,3.152088258,4.076102256,TGFB1,3
6139,positive regulation of NF-kappaB import into nucleus (GO:0042346),0.274406844,0.974459378,0,0,3.152088258,4.076102256,IL1B,3
6140,protein O-linked fucosylation (GO:0036066),0.274406844,0.973781729,0,0,3.152088258,4.076102256,THBS1,3
6141,positive regulation of collagen biosynthetic process (GO:0032967),0.274406844,0.973105022,0,0,3.152088258,4.076102256,TGFB1,3
6142,negative regulation of protein processing (GO:0010955),0.274406844,0.972429254,0,0,3.152088258,4.076102256,THBS1,3
6143,regulation of fertilization (GO:0080154),0.274406844,0.971754425,0,0,3.152088258,4.076102256,PLCB1,3
6144,positive regulation of protein export from nucleus (GO:0046827),0.274406844,0.971080531,0,0,3.152088258,4.076102256,IL1B,3
6145,endoderm development (GO:0007492),0.274406844,0.970407572,0,0,3.152088258,4.076102256,DUSP1,3
6146,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.274406844,0.969735545,0,0,3.152088258,4.076102256,SEC61G,3
6147,cytoplasmic microtubule organization (GO:0031122),0.277746818,0.980859523,0,0,1.929849954,2.472225229,CCDC88C;CIB1,3
6148,interstrand cross-link repair (GO:0036297),0.277746818,0.980181197,0,0,1.929849954,2.472225229,RPS27A;UBA52,3
6149,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.277746818,0.979503808,0,0,1.929849954,2.472225229,DDIT4;BCL3,3
6150,regulation of peptidyl-serine phosphorylation (GO:0033135),0.279544031,0.985161044,0,0,1.630390479,2.078088307,TGFB1;DDIT4;RACK1,3
6151,neuron projection development (GO:0031175),0.283333877,0.997828,0,0,1.407182258,1.774638777,LYN;BTG2;STK24;RAC2;RAC1,3
6152,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),0.285306904,1,0,0,1.611863314,2.021582566,RPS27A;UBA52;PSMA7,3
6153,positive regulation of cellular component biogenesis (GO:0044089),0.285306904,1,0,0,1.611863314,2.021582566,TGFB1;FLOT1;RPS3,3
6154,organic hydroxy compound biosynthetic process (GO:1901617),0.285612604,1,0,0,1.891252955,2.369964859,SCP2;LBR,3
6155,establishment of protein localization to mitochondrion (GO:0072655),0.285612604,1,0,0,1.891252955,2.369964859,TIMM10B;FIS1,3
6156,peptidyl-threonine dephosphorylation (GO:0035970),0.289764635,1,0,0,2.955082742,3.660420477,DUSP1,3
6157,neural tube development (GO:0021915),0.289764635,1,0,0,2.955082742,3.660420477,TGFB1,3
6158,positive regulation of epithelial cell apoptotic process (GO:1904037),0.289764635,1,0,0,2.955082742,3.660420477,THBS1,3
6159,regulation of actin nucleation (GO:0051125),0.289764635,1,0,0,2.955082742,3.660420477,CORO1A,3
6160,dendritic cell chemotaxis (GO:0002407),0.289764635,1,0,0,2.955082742,3.660420477,CCR2,3
6161,positive regulation of secretion (GO:0051047),0.289764635,1,0,0,2.955082742,3.660420477,XBP1,3
6162,cellular response to dsRNA (GO:0071359),0.289764635,1,0,0,2.955082742,3.660420477,FLOT1,3
6163,DNA alkylation (GO:0006305),0.289764635,1,0,0,2.955082742,3.660420477,FOS,3
6164,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.289764635,1,0,0,2.955082742,3.660420477,PLBD1,3
6165,hyaluronan catabolic process (GO:0030214),0.289764635,1,0,0,2.955082742,3.660420477,TGFB1,3
6166,regulation of RIG-I signaling pathway (GO:0039535),0.289764635,1,0,0,2.955082742,3.660420477,NOP53,3
6167,cardiac ventricle development (GO:0003231),0.289764635,1,0,0,2.955082742,3.660420477,HES1,3
6168,protein deacylation (GO:0035601),0.289764635,1,0,0,2.955082742,3.660420477,PPT1,3
6169,negative regulation of striated muscle cell differentiation (GO:0051154),0.289764635,1,0,0,2.955082742,3.660420477,XBP1,3
6170,positive regulation of mRNA processing (GO:0050685),0.289764635,1,0,0,2.955082742,3.660420477,HSPA1A,3
6171,positive regulation of lymphocyte differentiation (GO:0045621),0.289764635,1,0,0,2.955082742,3.660420477,XBP1,3
6172,regulation of bicellular tight junction assembly (GO:2000810),0.289764635,1,0,0,2.955082742,3.660420477,IKBKB,3
6173,extracellular matrix assembly (GO:0085029),0.289764635,1,0,0,2.955082742,3.660420477,TGFB1,3
6174,DNA methylation or demethylation (GO:0044728),0.289764635,1,0,0,2.955082742,3.660420477,FOS,3
6175,negative regulation of translational initiation (GO:0045947),0.289764635,1,0,0,2.955082742,3.660420477,EIF3E,3
6176,bone morphogenesis (GO:0060349),0.289764635,1,0,0,2.955082742,3.660420477,RARA,3
6177,regulation of SMAD protein import into nucleus (GO:0060390),0.289764635,1,0,0,2.955082742,3.660420477,TGFB1,3
6178,positive regulation of cyclic nucleotide metabolic process (GO:0030801),0.289764635,1,0,0,2.955082742,3.660420477,RAMP1,3
6179,positive regulation of nitric-oxide synthase activity (GO:0051000),0.289764635,1,0,0,2.955082742,3.660420477,SCARB1,3
6180,regulation of protein homodimerization activity (GO:0043496),0.289764635,1,0,0,2.955082742,3.660420477,ITGA4,3
6181,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.289764635,0.999776154,0,0,2.955082742,3.660420477,CIB1,3
6182,G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),0.289764635,0.999100629,0,0,2.955082742,3.660420477,PLCB1,3
6183,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.289764635,0.998426017,0,0,2.955082742,3.660420477,PLCB1,3
6184,artery development (GO:0060840),0.289764635,0.997752316,0,0,2.955082742,3.660420477,HES1,3
6185,regulation of acrosome reaction (GO:0060046),0.289764635,0.997079522,0,0,2.955082742,3.660420477,PLCB1,3
6186,embryonic heart tube development (GO:0035050),0.289764635,0.996407636,0,0,2.955082742,3.660420477,HES1,3
6187,mitochondrial fusion (GO:0008053),0.289764635,0.995736654,0,0,2.955082742,3.660420477,FIS1,3
6188,endoplasmic reticulum to cytosol transport (GO:1903513),0.289764635,0.995066576,0,0,2.955082742,3.660420477,SEC61B,3
6189,ruffle organization (GO:0031529),0.289764635,0.994397399,0,0,2.955082742,3.660420477,RAC1,3
6190,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.289764635,0.993729121,0,0,2.955082742,3.660420477,XBP1,3
6191,regulation of interferon-alpha production (GO:0032647),0.289764635,0.99306174,0,0,2.955082742,3.660420477,IRF5,3
6192,regulation of protein targeting to mitochondrion (GO:1903214),0.291079414,0.996898154,0,0,1.59375249,1.966944216,UBE2D3;RAC2;HES1,3
6193,positive regulation of protein complex assembly (GO:0031334),0.291079414,0.996229544,0,0,1.59375249,1.966944216,JUN;TGFB1;RPS3,3
6194,positive regulation of mitochondrion organization (GO:0010822),0.2912993,0.996313894,0,0,1.466087562,1.808278288,FIS1;UBE2D3;RAC2;HES1,3
6195,regulation of bone mineralization (GO:0030500),0.293469538,1,0,0,1.854169564,2.273177458,SRGN;TGFB1,3
6196,myeloid leukocyte differentiation (GO:0002573),0.293469538,1,0,0,1.854169564,2.273177458,SBNO2;PRTN3,3
6197,regulation of blood vessel endothelial cell migration (GO:0043535),0.293469538,1,0,0,1.854169564,2.273177458,TGFB1;THBS1,3
6198,regulation of canonical Wnt signaling pathway (GO:0060828),0.30019064,1,0,0,1.325644595,1.595197906,PTPRO;IGFBP6;RPS27A;UBA52;PFDN5;PSMA7,3
6199,generation of neurons (GO:0048699),0.300797064,1,0,0,1.443704546,1.734350346,DDIT4;HMGB2;ID3;IER2,3
6200,protein glycosylation (GO:0006486),0.300797064,1,0,0,1.443704546,1.734350346,C1GALT1C1;SERP1;ST3GAL4;GCNT2,3
6201,negative regulation of neuron projection development (GO:0010977),0.301314485,1,0,0,1.818512457,2.181488926,PTPRO;CIB1,3
6202,regulation of JNK cascade (GO:0046328),0.302647375,1,0,0,1.558724963,1.862967702,DUSP22;IL1B;PLCB1,3
6203,positive regulation of cholesterol transport (GO:0032376),0.304798117,1,0,0,2.781254346,3.304423959,SCP2,3
6204,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.304798117,1,0,0,2.781254346,3.304423959,SUB1,3
6205,reverse cholesterol transport (GO:0043691),0.304798117,1,0,0,2.781254346,3.304423959,SCARB1,3
6206,positive regulation of focal adhesion assembly (GO:0051894),0.304798117,1,0,0,2.781254346,3.304423959,RAC1,3
6207,negative regulation of axon guidance (GO:1902668),0.304798117,1,0,0,2.781254346,3.304423959,PTPRO,3
6208,sialylation (GO:0097503),0.304798117,1,0,0,2.781254346,3.304423959,ST3GAL4,3
6209,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.304798117,1,0,0,2.781254346,3.304423959,LYN,3
6210,positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),0.304798117,1,0,0,2.781254346,3.304423959,C3,3
6211,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.304798117,1,0,0,2.781254346,3.304423959,IGFBP6,3
6212,positive regulation of nitrogen compound metabolic process (GO:0051173),0.304798117,1,0,0,2.781254346,3.304423959,KLF2,3
6213,positive regulation of interleukin-6 secretion (GO:2000778),0.304798117,1,0,0,2.781254346,3.304423959,XBP1,3
6214,RNA stabilization (GO:0043489),0.304798117,1,0,0,2.781254346,3.304423959,PABPC1,3
6215,positive regulation of striated muscle cell differentiation (GO:0051155),0.304798117,1,0,0,2.781254346,3.304423959,TGFB1,3
6216,negative regulation of cell development (GO:0010721),0.304798117,1,0,0,2.781254346,3.304423959,SORL1,3
6217,negative regulation of interleukin-8 production (GO:0032717),0.304798117,1,0,0,2.781254346,3.304423959,BCL3,3
6218,positive regulation of stem cell proliferation (GO:2000648),0.304798117,1,0,0,2.781254346,3.304423959,PTPRC,3
6219,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.304798117,1,0,0,2.781254346,3.304423959,IKBKB,3
6220,regulation of collagen biosynthetic process (GO:0032965),0.304798117,1,0,0,2.781254346,3.304423959,TGFB1,3
6221,pharyngeal system development (GO:0060037),0.304798117,1,0,0,2.781254346,3.304423959,HES1,3
6222,phospholipid catabolic process (GO:0009395),0.304798117,1,0,0,2.781254346,3.304423959,GPCPD1,3
6223,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.304798117,1,0,0,2.781254346,3.304423959,RPS7,3
6224,positive regulation of macrophage activation (GO:0043032),0.304798117,1,0,0,2.781254346,3.304423959,THBS1,3
6225,long-term memory (GO:0007616),0.304798117,1,0,0,2.781254346,3.304423959,LDLR,3
6226,positive regulation by host of viral transcription (GO:0043923),0.304798117,1,0,0,2.781254346,3.304423959,JUN,3
6227,positive regulation of leukocyte activation (GO:0002696),0.304798117,1,0,0,2.781254346,3.304423959,THBS1,3
6228,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.304798117,1,0,0,2.781254346,3.304423959,PTPN1,3
6229,positive regulation of transcription of Notch receptor target (GO:0007221),0.304798117,1,0,0,2.781254346,3.304423959,PBX1,3
6230,mitotic G2 DNA damage checkpoint (GO:0007095),0.304798117,1,0,0,2.781254346,3.304423959,NOP53,3
6231,positive regulation of programmed cell death (GO:0043068),0.30567081,1,0,0,1.282826617,1.52046581,JUN;RPS6;RACK1;IRF5;RAC1;RPS27A;UBA52,3
6232,negative regulation of kinase activity (GO:0033673),0.308439907,1,0,0,1.5417823,1.813487888,CEACAM1;PTPRC;PPP2R5A,3
6233,chemokine-mediated signaling pathway (GO:0070098),0.30914444,1,0,0,1.784200901,2.094556702,CIB1;CCR2,3
6234,regulation of calcium ion transport (GO:0051924),0.30914444,1,0,0,1.784200901,2.094556702,TSPAN13;ORAI1,3
6235,regulation of cell-matrix adhesion (GO:0001952),0.30914444,1,0,0,1.784200901,2.094556702,CIB1;THBS1,3
6236,positive regulation of cell-substrate adhesion (GO:0010811),0.30914444,1,0,0,1.784200901,2.094556702,CIB1;RAC1,3
6237,positive regulation of mitotic cell cycle (GO:0045931),0.30914444,1,0,0,1.784200901,2.094556702,IL1B;HES1,3
6238,central nervous system development (GO:0007417),0.314961805,1,0,0,1.301320841,1.503421046,LYN;VCAN;DDIT4;PPT1;RARA;JARID2,3
6239,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.315107783,1,0,0,1.411382802,1.629922066,FIS1;CD52;FPR2;CCR2,3
6240,membrane protein ectodomain proteolysis (GO:0006509),0.319514122,1,0,0,2.626740215,2.996989245,PRTN3,3
6241,regulation of amyloid-beta formation (GO:1902003),0.319514122,1,0,0,2.626740215,2.996989245,SORL1,3
6242,cellular response to gamma radiation (GO:0071480),0.319514122,1,0,0,2.626740215,2.996989245,RPL26,3
6243,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.319514122,1,0,0,2.626740215,2.996989245,TGFB1,3
6244,regulation of keratinocyte proliferation (GO:0010837),0.319514122,1,0,0,2.626740215,2.996989245,ZFP36,3
6245,release of cytochrome c from mitochondria (GO:0001836),0.319514122,1,0,0,2.626740215,2.996989245,FIS1,3
6246,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.319514122,1,0,0,2.626740215,2.996989245,FIS1,3
6247,positive regulation of lipid catabolic process (GO:0050996),0.319514122,1,0,0,2.626740215,2.996989245,IL1B,3
6248,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.319514122,1,0,0,2.626740215,2.996989245,FIS1,3
6249,maintenance of protein localization in organelle (GO:0072595),0.319514122,1,0,0,2.626740215,2.996989245,BCL3,3
6250,leukotriene biosynthetic process (GO:0019370),0.319514122,1,0,0,2.626740215,2.996989245,ALOX5AP,3
6251,positive regulation of cyclic nucleotide biosynthetic process (GO:0030804),0.319514122,1,0,0,2.626740215,2.996989245,RAMP1,3
6252,negative regulation of fibroblast proliferation (GO:0048147),0.319514122,1,0,0,2.626740215,2.996989245,CD300A,3
6253,anion homeostasis (GO:0055081),0.319514122,1,0,0,2.626740215,2.996989245,XBP1,3
6254,prostaglandin biosynthetic process (GO:0001516),0.319514122,1,0,0,2.626740215,2.996989245,MGST1,3
6255,modulation by virus of host morphology or physiology (GO:0019048),0.319514122,1,0,0,2.626740215,2.996989245,TGFB1,3
6256,negative regulation of microtubule depolymerization (GO:0007026),0.319514122,1,0,0,2.626740215,2.996989245,CIB1,3
6257,"retrograde protein transport, ER to cytosol (GO:0030970)",0.319514122,1,0,0,2.626740215,2.996989245,SEC61B,3
6258,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.319514122,1,0,0,2.626740215,2.996989245,HCK,3
6259,DNA conformation change (GO:0071103),0.319514122,1,0,0,2.626740215,2.996989245,HMGB2,3
6260,blood vessel endothelial cell migration (GO:0043534),0.319514122,1,0,0,2.626740215,2.996989245,NR4A1,3
6261,DNA methylation (GO:0006306),0.319514122,1,0,0,2.626740215,2.996989245,FOS,3
6262,regulation of smooth muscle cell migration (GO:0014910),0.319514122,1,0,0,2.626740215,2.996989245,SORL1,3
6263,DNA ligation (GO:0006266),0.319514122,1,0,0,2.626740215,2.996989245,HMGB2,3
6264,cellular transition metal ion homeostasis (GO:0046916),0.320034989,1,0,0,1.508978422,1.719216765,LCN2;RPS27A;UBA52,3
6265,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.320034989,1,0,0,1.508978422,1.719216765,CDKN2D;FIS1;THBS1,3
6266,proteolysis involved in cellular protein catabolic process (GO:0051603),0.320034989,1,0,0,1.508978422,1.719216765,RPS27A;UBA52;PSMA7,3
6267,mitochondrial transport (GO:0006839),0.324681327,1,0,0,1.390627173,1.564331957,TIMM10B;FIS1;ATP5C1;SLC25A5,3
6268,protein targeting to mitochondrion (GO:0006626),0.324748028,1,0,0,1.719320868,1.933729975,TIMM10B;FIS1,3
6269,intracellular transport of virus (GO:0075733),0.324748028,1,0,0,1.719320868,1.933729975,RPS27A;UBA52,3
6270,transport of virus (GO:0046794),0.324748028,1,0,0,1.719320868,1.933729975,RPS27A;UBA52,3
6271,regulation of B cell activation (GO:0050864),0.331634303,1,0,0,1.477541371,1.63079553,AHR;SAMSN1;ZFP36L2,3
6272,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.332516298,1,0,0,1.68861871,1.859281329,FIS1;MEFV,3
6273,regulation of RNA splicing (GO:0043484),0.332516298,1,0,0,1.68861871,1.859281329,RPS26;RPS13,3
6274,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.332516298,1,0,0,1.68861871,1.859281329,PTPN1;THBS1,3
6275,fat cell differentiation (GO:0045444),0.332516298,1,0,0,1.68861871,1.859281329,BSCL2;NR4A1,3
6276,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.33391934,1,0,0,2.48849073,2.729515521,THBS1,3
6277,regulation of protein kinase A signaling (GO:0010738),0.33391934,1,0,0,2.48849073,2.729515521,ADRB2,3
6278,organelle fusion (GO:0048284),0.33391934,1,0,0,2.48849073,2.729515521,FIS1,3
6279,acetylcholine receptor signaling pathway (GO:0095500),0.33391934,1,0,0,2.48849073,2.729515521,PLCB1,3
6280,positive regulation of STAT cascade (GO:1904894),0.33391934,1,0,0,2.48849073,2.729515521,HES1,3
6281,protein exit from endoplasmic reticulum (GO:0032527),0.33391934,1,0,0,2.48849073,2.729515521,SEC61B,3
6282,positive regulation of activated T cell proliferation (GO:0042104),0.33391934,1,0,0,2.48849073,2.729515521,RPS3,3
6283,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.33391934,1,0,0,2.48849073,2.729515521,RPSA,3
6284,regulation of myotube differentiation (GO:0010830),0.33391934,1,0,0,2.48849073,2.729515521,XBP1,3
6285,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.33391934,1,0,0,2.48849073,2.729515521,FLOT1,3
6286,regulation of mitochondrial fission (GO:0090140),0.33391934,1,0,0,2.48849073,2.729515521,FIS1,3
6287,osteoclast differentiation (GO:0030316),0.33391934,1,0,0,2.48849073,2.729515521,SBNO2,3
6288,nucleosome disassembly (GO:0006337),0.33391934,1,0,0,2.48849073,2.729515521,NFE2,3
6289,regulation of transcription factor import into nucleus (GO:0042990),0.33391934,1,0,0,2.48849073,2.729515521,BCL3,3
6290,chromatin disassembly (GO:0031498),0.33391934,1,0,0,2.48849073,2.729515521,NFE2,3
6291,leukotriene metabolic process (GO:0006691),0.33391934,1,0,0,2.48849073,2.729515521,ALOX5AP,3
6292,striated muscle cell differentiation (GO:0051146),0.33391934,1,0,0,2.48849073,2.729515521,KDM6B,3
6293,fatty-acyl-CoA metabolic process (GO:0035337),0.33391934,1,0,0,2.48849073,2.729515521,PPT1,3
6294,positive regulation of immunoglobulin production (GO:0002639),0.33391934,1,0,0,2.48849073,2.729515521,XBP1,3
6295,positive regulation of blood coagulation (GO:0030194),0.33391934,1,0,0,2.48849073,2.729515521,THBS1,3
6296,positive regulation of adherens junction organization (GO:1903393),0.33391934,1,0,0,2.48849073,2.729515521,RAC1,3
6297,positive regulation of epithelial cell differentiation (GO:0030858),0.33391934,1,0,0,2.48849073,2.729515521,BTG1,3
6298,innate immune response in mucosa (GO:0002227),0.33391934,1,0,0,2.48849073,2.729515521,RPL39,3
6299,mitochondrial calcium ion homeostasis (GO:0051560),0.33391934,1,0,0,2.48849073,2.729515521,FIS1,3
6300,regulation of cAMP biosynthetic process (GO:0030817),0.33391934,1,0,0,2.48849073,2.729515521,RAMP1,3
6301,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.33391934,1,0,0,2.48849073,2.729515521,TGFB1,3
6302,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.33391934,1,0,0,2.48849073,2.729515521,THBS1,3
6303,regulation of cytosolic calcium ion concentration (GO:0051480),0.334273793,1,0,0,1.370473156,1.50175747,FIS1;CD52;FPR2;CCR2,3
6304,Ras protein signal transduction (GO:0007265),0.337321955,1,0,0,1.266464032,1.376288561,RAP1B;JUN;RAP1A;RAC2;RAC1;RASGRP2,3
6305,positive regulation of protein metabolic process (GO:0051247),0.337432232,1,0,0,1.462308986,1.588638712,TGFB1;SORL1;KLF2,3
6306,protein localization to nucleus (GO:0034504),0.337432232,1,0,0,1.462308986,1.588638712,BCL3;RPL11;NOP53,3
6307,epithelial cell differentiation (GO:0030855),0.337432232,1,0,0,1.462308986,1.588638712,KDM6B;CASP6;RARA,3
6308,positive regulation of protein transport (GO:0051222),0.340258847,1,0,0,1.65899382,1.788476025,TGFB1;RACK1,3
6309,autophagosome organization (GO:1905037),0.340258847,1,0,0,1.65899382,1.788476025,ATG3;ATG101,3
6310,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.343227297,1,0,0,1.447387466,1.547781702,FCER1G;AP1S2;AP2A2,3
6311,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.343227297,1,0,0,1.447387466,1.547781702,FCER1G;AP1S2;AP2A2,3
6312,positive regulation of cell death (GO:0010942),0.347973291,1,0,0,1.630390479,1.721088371,DDIT4;FOS,3
6313,regulation of Rho protein signal transduction (GO:0035023),0.347973291,1,0,0,1.630390479,1.721088371,ARHGDIB;RAC1,3
6314,regulation of neurogenesis (GO:0050767),0.347973291,1,0,0,1.630390479,1.721088371,HMGB2;SORL1,3
6315,vacuolar acidification (GO:0007035),0.348020319,1,0,0,2.364066194,2.495258661,PPT1,3
6316,negative regulation of innate immune response (GO:0045824),0.348020319,1,0,0,2.364066194,2.495258661,RPS19,3
6317,Golgi to endosome transport (GO:0006895),0.348020319,1,0,0,2.364066194,2.495258661,SYS1,3
6318,mesoderm formation (GO:0001707),0.348020319,1,0,0,2.364066194,2.495258661,KDM6B,3
6319,hydrogen peroxide metabolic process (GO:0042743),0.348020319,1,0,0,2.364066194,2.495258661,PRDX5,3
6320,negative regulation of intracellular protein transport (GO:0090317),0.348020319,1,0,0,2.364066194,2.495258661,SP100,3
6321,negative regulation of phosphate metabolic process (GO:0045936),0.348020319,1,0,0,2.364066194,2.495258661,CDKN2D,3
6322,regulation of epidermal cell differentiation (GO:0045604),0.348020319,1,0,0,2.364066194,2.495258661,ZFP36,3
6323,negative regulation of macromolecule biosynthetic process (GO:0010558),0.348020319,1,0,0,2.364066194,2.495258661,TGFB1,3
6324,"wound healing, spreading of cells (GO:0044319)",0.348020319,1,0,0,2.364066194,2.495258661,CEACAM1,3
6325,regulation of lipoprotein lipase activity (GO:0051004),0.348020319,1,0,0,2.364066194,2.495258661,APOC1,3
6326,negative regulation of cyclase activity (GO:0031280),0.348020319,1,0,0,2.364066194,2.495258661,CCR2,3
6327,regulation of cholesterol transport (GO:0032374),0.348020319,1,0,0,2.364066194,2.495258661,APOC1,3
6328,regulation of calcium ion transmembrane transport (GO:1903169),0.348020319,1,0,0,2.364066194,2.495258661,TSPAN13,3
6329,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.348020319,1,0,0,2.364066194,2.495258661,ADRB2,3
6330,negative regulation of response to biotic stimulus (GO:0002832),0.348020319,1,0,0,2.364066194,2.495258661,PCBP2,3
6331,autophagy of nucleus (GO:0044804),0.348020319,1,0,0,2.364066194,2.495258661,ATG3,3
6332,negative regulation of protein depolymerization (GO:1901880),0.348020319,1,0,0,2.364066194,2.495258661,CIB1,3
6333,positive regulation of interferon-alpha production (GO:0032727),0.348020319,1,0,0,2.364066194,2.495258661,IRF5,3
6334,positive regulation of T cell migration (GO:2000406),0.348020319,1,0,0,2.364066194,2.495258661,CCR2,3
6335,adrenergic receptor signaling pathway (GO:0071875),0.348020319,1,0,0,2.364066194,2.495258661,ADRB2,3
6336,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.348020319,1,0,0,2.364066194,2.495258661,THBS1,3
6337,negative regulation of adenylate cyclase activity (GO:0007194),0.348020319,1,0,0,2.364066194,2.495258661,CCR2,3
6338,negative regulation of interferon-gamma production (GO:0032689),0.348020319,1,0,0,2.364066194,2.495258661,RARA,3
6339,chondroitin sulfate biosynthetic process (GO:0030206),0.348020319,1,0,0,2.364066194,2.495258661,VCAN,3
6340,cellular response to estradiol stimulus (GO:0071392),0.348020319,1,0,0,2.364066194,2.495258661,H2AFZ,3
6341,positive regulation of cAMP biosynthetic process (GO:0030819),0.348020319,1,0,0,2.364066194,2.495258661,RAMP1,3
6342,regulation of insulin secretion (GO:0050796),0.349018249,1,0,0,1.43276739,1.508175468,RAP1A;IL1B;SLC25A5,3
6343,response to UV (GO:0009411),0.349018249,1,0,0,1.43276739,1.508175468,CDKN2D;BCL3;RPL26,3
6344,DNA metabolic process (GO:0006259),0.350126775,1,0,0,1.200795527,1.260186845,FAM111A;BTG2;SP100;RPS3;HMGB2;RPS27A;UBA52;NOP53,3
6345,modification-dependent protein catabolic process (GO:0019941),0.353490505,1,0,0,1.331868278,1.385008028,XBP1;UBE2D3;RPS27A;UBA52,3
6346,regulation of mitotic cell cycle phase transition (GO:1901990),0.353830108,1,0,0,1.277873618,1.327631975,PTPN6;RPS27A;UBA52;ZFP36L2;PSMA7,3
6347,regulation of gene expression (GO:0010468),0.355540729,1,0,0,1.093209801,1.130505166,RPL5;CEBPB;SP100;BTG1;TGFB1;RPS7;TSC22D3;RPL11;HMGB2;AHR;RPL6;SAP30;LYL1;SBNO2;NFIL3;IL1B;RACK1;RPS3;GCNT2;XDH;PFDN5;HSPA1B;MYD88;HSPA1A,3
6348,autophagosome assembly (GO:0000045),0.355657357,1,0,0,1.602756742,1.656909871,ATG3;ATG101,3
6349,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.355657357,1,0,0,1.602756742,1.656909871,CIB1;RAC1,3
6350,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.358296879,1,0,0,1.322554514,1.357461177,CEACAM1;SELL;ITGAL;CD177,3
6351,regulation of lipid metabolic process (GO:0019216),0.360582959,1,0,0,1.404395759,1.432530336,IL1B;APOC1;ADIPOR1,3
6352,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.361823469,1,0,0,2.251491613,2.288863764,XBP1,3
6353,cortical actin cytoskeleton organization (GO:0030866),0.361823469,1,0,0,2.251491613,2.288863764,IKBKB,3
6354,mesoderm development (GO:0007498),0.361823469,1,0,0,2.251491613,2.288863764,HCK,3
6355,cellular protein complex localization (GO:0034629),0.361823469,1,0,0,2.251491613,2.288863764,STXBP6,3
6356,ventricular cardiac muscle tissue development (GO:0003229),0.361823469,1,0,0,2.251491613,2.288863764,TGFB1,3
6357,mitochondrial fission (GO:0000266),0.361823469,1,0,0,2.251491613,2.288863764,FIS1,3
6358,positive regulation of histone acetylation (GO:0035066),0.361823469,1,0,0,2.251491613,2.288863764,IL1B,3
6359,regulation of macrophage activation (GO:0043030),0.361823469,1,0,0,2.251491613,2.288863764,THBS1,3
6360,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.361823469,1,0,0,2.251491613,2.288863764,ATP5C1,3
6361,ventricular septum morphogenesis (GO:0060412),0.361823469,1,0,0,2.251491613,2.288863764,HES1,3
6362,protein-DNA complex disassembly (GO:0032986),0.361823469,1,0,0,2.251491613,2.288863764,NFE2,3
6363,cellular response to alkaloid (GO:0071312),0.361823469,1,0,0,2.251491613,2.288863764,CASP6,3
6364,negative regulation of cAMP biosynthetic process (GO:0030818),0.361823469,1,0,0,2.251491613,2.288863764,CCR2,3
6365,positive regulation of lipid metabolic process (GO:0045834),0.361823469,1,0,0,2.251491613,2.288863764,IL1B,3
6366,lipid catabolic process (GO:0016042),0.361823469,1,0,0,2.251491613,2.288863764,PPT1,3
6367,ERK1 and ERK2 cascade (GO:0070371),0.361823469,1,0,0,2.251491613,2.288863764,ZFP36L2,3
6368,regulation of protein metabolic process (GO:0051246),0.363308882,1,0,0,1.576044129,1.595747662,LDLR;KLF2,3
6369,cell junction assembly (GO:0034329),0.363308882,1,0,0,1.576044129,1.595747662,TLN1;ACTG1,3
6370,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.363308882,1,0,0,1.576044129,1.595747662,SP100;THBS1,3
6371,cellular protein complex assembly (GO:0043623),0.367907112,1,0,0,1.304312383,1.304214278,TGFB1;ADRB2;HOPX;HSPA1A,3
6372,neuron development (GO:0048666),0.367907112,1,0,0,1.304312383,1.304214278,LYN;XBP1;BTG2;PPT1,3
6373,nucleosome assembly (GO:0006334),0.370925807,1,0,0,1.55020734,1.537423119,H3F3A;HMGB2,3
6374,positive regulation of protein binding (GO:0032092),0.370925807,1,0,0,1.55020734,1.537423119,RPL11;FLOT1,3
6375,acylglycerol homeostasis (GO:0055090),0.375335067,1,0,0,2.149151085,2.106030821,SCARB1,3
6376,glutathione derivative biosynthetic process (GO:1901687),0.375335067,1,0,0,2.149151085,2.106030821,MGST1,3
6377,sterol transport (GO:0015918),0.375335067,1,0,0,2.149151085,2.106030821,LDLR,3
6378,lymphocyte activation involved in immune response (GO:0002285),0.375335067,1,0,0,2.149151085,2.106030821,CD244,3
6379,activation of phospholipase C activity (GO:0007202),0.375335067,1,0,0,2.149151085,2.106030821,RASGRP4,3
6380,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.375335067,1,0,0,2.149151085,2.106030821,CDK2AP2,3
6381,regulation of transcription from RNA polymerase III promoter (GO:0006359),0.375335067,1,0,0,2.149151085,2.106030821,PRDX5,3
6382,"DNA catabolic process, endonucleolytic (GO:0000737)",0.375335067,1,0,0,2.149151085,2.106030821,HMGB2,3
6383,negative regulation of actin filament polymerization (GO:0030837),0.375335067,1,0,0,2.149151085,2.106030821,TMSB10,3
6384,protein localization to cell surface (GO:0034394),0.375335067,1,0,0,2.149151085,2.106030821,CD177,3
6385,STAT cascade (GO:0097696),0.375335067,1,0,0,2.149151085,2.106030821,CCR2,3
6386,regulation of microtubule depolymerization (GO:0031114),0.375335067,1,0,0,2.149151085,2.106030821,CIB1,3
6387,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.375335067,1,0,0,2.149151085,2.106030821,IL1B,3
6388,viral genome replication (GO:0019079),0.375335067,1,0,0,2.149151085,2.106030821,PCBP2,3
6389,negative regulation of nervous system development (GO:0051961),0.375335067,1,0,0,2.149151085,2.106030821,SORL1,3
6390,positive regulation of RNA splicing (GO:0033120),0.375335067,1,0,0,2.149151085,2.106030821,HSPA1A,3
6391,negative regulation of lyase activity (GO:0051350),0.375335067,1,0,0,2.149151085,2.106030821,CCR2,3
6392,glutathione derivative metabolic process (GO:1901685),0.375335067,1,0,0,2.149151085,2.106030821,MGST1,3
6393,positive regulation of phosphatase activity (GO:0010922),0.375335067,1,0,0,2.149151085,2.106030821,CD300A,3
6394,regulation of tumor necrosis factor production (GO:0032680),0.378506173,1,0,0,1.525203996,1.481770607,ZFP36;RARA,3
6395,regulation of DNA replication (GO:0006275),0.378506173,1,0,0,1.525203996,1.481770607,TGFB1;S100A11,3
6396,regulation of protein kinase activity (GO:0045859),0.382305533,1,0,0,1.277873618,1.228720421,FGR;CEACAM1;RAP1A;PTPRC,3
6397,RNA metabolic process (GO:0016070),0.383195039,1,0,0,1.231284476,1.181061833,DUSP11;RBM3;PCBP2;RNASE6;SNRPG,3
6398,positive regulation of lymphocyte activation (GO:0051251),0.383611173,1,0,0,1.350894968,1.294327334,FAM49B;CD47;CCR2,3
6399,positive regulation of catabolic process (GO:0009896),0.38604812,1,0,0,1.500994409,1.428636353,IL1B;SORL1,3
6400,regulation of actin filament-based process (GO:0032970),0.38604812,1,0,0,1.500994409,1.428636353,CNN2;CORO1A,3
6401,mitotic G2/M transition checkpoint (GO:0044818),0.388561255,1,0,0,2.055709734,1.94327156,NOP53,3
6402,regulation of protein oligomerization (GO:0032459),0.388561255,1,0,0,2.055709734,1.94327156,SORL1,3
6403,positive regulation of protein oligomerization (GO:0032461),0.388561255,1,0,0,2.055709734,1.94327156,RACK1,3
6404,TOR signaling (GO:0031929),0.388561255,1,0,0,2.055709734,1.94327156,RPS6,3
6405,vitamin transport (GO:0051180),0.388561255,1,0,0,2.055709734,1.94327156,SCARB1,3
6406,peroxisome organization (GO:0007031),0.388561255,1,0,0,2.055709734,1.94327156,FIS1,3
6407,cellular response to ammonium ion (GO:0071242),0.388561255,1,0,0,2.055709734,1.94327156,CASP6,3
6408,regulation of smooth muscle contraction (GO:0006940),0.388561255,1,0,0,2.055709734,1.94327156,ADRB2,3
6409,apoptotic nuclear changes (GO:0030262),0.388561255,1,0,0,2.055709734,1.94327156,HMGB2,3
6410,regulation of interleukin-8 secretion (GO:2000482),0.388561255,1,0,0,2.055709734,1.94327156,CD244,3
6411,protein localization to Golgi apparatus (GO:0034067),0.388561255,1,0,0,2.055709734,1.94327156,SORL1,3
6412,regulation of monooxygenase activity (GO:0032768),0.388561255,1,0,0,2.055709734,1.94327156,IL1B,3
6413,regulation of microtubule cytoskeleton organization (GO:0070507),0.388561255,1,0,0,2.055709734,1.94327156,CDK2AP2,3
6414,NAD metabolic process (GO:0019674),0.388561255,1,0,0,2.055709734,1.94327156,NADK,3
6415,RNA processing (GO:0006396),0.391581821,1,0,0,1.218590822,1.142502976,DUSP11;RBM3;SNRPG;SRSF5;SNRPB,3
6416,carbohydrate homeostasis (GO:0033500),0.393549883,1,0,0,1.477541371,1.377877439,RPS6;ADIPOR1,3
6417,positive regulation of cell projection organization (GO:0031346),0.393549883,1,0,0,1.477541371,1.377877439,LYN;RAP1A,3
6418,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.393549883,1,0,0,1.477541371,1.377877439,ZFP36;PABPC1,3
6419,"DNA-templated transcription, termination (GO:0006353)",0.395057139,1,0,0,1.325644595,1.231159103,SNRPG;SRSF5;SNRPB,3
6420,RNA splicing (GO:0008380),0.395057139,1,0,0,1.325644595,1.231159103,SNRPG;SF3B1;SNRPB,3
6421,positive regulation of epithelial cell proliferation (GO:0050679),0.400759464,1,0,0,1.313370108,1.200937578,NR4A1;XBP1;HMGB2,3
6422,cellular response to decreased oxygen levels (GO:0036294),0.401009789,1,0,0,1.454809965,1.32936089,NDRG1;NOP53,3
6423,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.40150805,1,0,0,1.970055162,1.797729897,PLCB1,3
6424,ammonium transport (GO:0015696),0.40150805,1,0,0,1.970055162,1.797729897,SLC44A2,3
6425,O-glycan processing (GO:0016266),0.40842625,1,0,0,1.43276739,1.282962847,C1GALT1C1;ST3GAL4,3
6426,chromatin assembly (GO:0031497),0.40842625,1,0,0,1.43276739,1.282962847,H3F3A;HMGB2,3
6427,protein phosphorylation (GO:0006468),0.412008536,1,0,0,1.10423474,0.979137324,LYN;IKBKB;FGR;HCK;TGFB1;STK24;GMFG;STK17B;RARA;PTPN6;HCST,3
6428,positive regulation of histone methylation (GO:0031062),0.414181339,1,0,0,1.891252955,1.667047534,JARID2,3
6429,membrane protein intracellular domain proteolysis (GO:0031293),0.414181339,1,0,0,1.891252955,1.667047534,TGFB1,3
6430,negative regulation of cytoskeleton organization (GO:0051494),0.414181339,1,0,0,1.891252955,1.667047534,CORO1A,3
6431,Golgi to plasma membrane protein transport (GO:0043001),0.414181339,1,0,0,1.891252955,1.667047534,SYS1,3
6432,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.414181339,1,0,0,1.891252955,1.667047534,RAMP1,3
6433,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.414181339,1,0,0,1.891252955,1.667047534,CDK2AP2,3
6434,negative regulation of sequestering of calcium ion (GO:0051283),0.414181339,1,0,0,1.891252955,1.667047534,PTPRC,3
6435,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.414181339,1,0,0,1.891252955,1.667047534,PSMA7,3
6436,regulation of actin filament bundle assembly (GO:0032231),0.414181339,1,0,0,1.891252955,1.667047534,RAC1,3
6437,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.414181339,1,0,0,1.891252955,1.667047534,CEBPB,3
6438,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.414181339,1,0,0,1.891252955,1.667047534,CDKN2D,3
6439,macromolecule modification (GO:0043412),0.414181339,1,0,0,1.891252955,1.667047534,ST3GAL4,3
6440,DNA geometric change (GO:0032392),0.414181339,1,0,0,1.891252955,1.667047534,HMGB2,3
6441,regulation of AMPA receptor activity (GO:2000311),0.414181339,1,0,0,1.891252955,1.667047534,ADRB2,3
6442,mucosal immune response (GO:0002385),0.414181339,1,0,0,1.891252955,1.667047534,RPL39,3
6443,mRNA splice site selection (GO:0006376),0.414181339,1,0,0,1.891252955,1.667047534,SRSF5,3
6444,fatty acid derivative biosynthetic process (GO:1901570),0.414181339,1,0,0,1.891252955,1.667047534,PPT1,3
6445,negative regulation of T cell proliferation (GO:0042130),0.414181339,1,0,0,1.891252955,1.667047534,CEBPB,3
6446,regulation of cell cycle G1/S phase transition (GO:1902806),0.414181339,1,0,0,1.891252955,1.667047534,PTPN6,3
6447,regulation of cellular senescence (GO:2000772),0.414181339,1,0,0,1.891252955,1.667047534,YPEL3,3
6448,organic cation transport (GO:0015695),0.414181339,1,0,0,1.891252955,1.667047534,SLC44A2,3
6449,JNK cascade (GO:0007254),0.415797768,1,0,0,1.411382802,1.23856783,RPS27A;UBA52,3
6450,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.417772197,1,0,0,1.277873618,1.115352346,UBE2D3;RAC2;HES1,3
6451,positive regulation of endothelial cell proliferation (GO:0001938),0.423122925,1,0,0,1.390627173,1.196068058,NR4A1;HMGB2,3
6452,regulation of TOR signaling (GO:0032006),0.423122925,1,0,0,1.390627173,1.196068058,DDIT4;LAMTOR4,3
6453,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.423122925,1,0,0,1.390627173,1.196068058,CDKN2D;CCND3,3
6454,positive regulation of autophagy (GO:0010508),0.423122925,1,0,0,1.390627173,1.196068058,MEFV;SVIP,3
6455,positive regulation of nuclear division (GO:0051785),0.426586887,1,0,0,1.818512457,1.549262069,IL1B,3
6456,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.426586887,1,0,0,1.818512457,1.549262069,VCAN,3
6457,"RNA splicing, via transesterification reactions (GO:0000375)",0.426586887,1,0,0,1.818512457,1.549262069,SF3B1,3
6458,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.426586887,1,0,0,1.818512457,1.549262069,FAM49B,3
6459,response to alcohol (GO:0097305),0.426586887,1,0,0,1.818512457,1.549262069,TGFB1,3
6460,positive regulation of glucose transport (GO:0010828),0.426586887,1,0,0,1.818512457,1.549262069,C3,3
6461,regulation of glucose metabolic process (GO:0010906),0.426586887,1,0,0,1.818512457,1.549262069,ADIPOR1,3
6462,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.426586887,1,0,0,1.818512457,1.549262069,NR4A1,3
6463,regulation of apoptotic signaling pathway (GO:2001233),0.426586887,1,0,0,1.818512457,1.549262069,RPS3,3
6464,positive regulation of Rho protein signal transduction (GO:0035025),0.426586887,1,0,0,1.818512457,1.549262069,RAC1,3
6465,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.426586887,1,0,0,1.818512457,1.549262069,ADIPOR1,3
6466,regulation of nervous system development (GO:0051960),0.426586887,1,0,0,1.818512457,1.549262069,HMGB2,3
6467,regulation of vascular smooth muscle cell proliferation (GO:1904705),0.426586887,1,0,0,1.818512457,1.549262069,JUN,3
6468,regulation of cellular protein localization (GO:1903827),0.426586887,1,0,0,1.818512457,1.549262069,PTPN1,3
6469,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.426586887,1,0,0,1.818512457,1.549262069,TGFB1,3
6470,regulation of protein import into nucleus (GO:0042306),0.426586887,1,0,0,1.818512457,1.549262069,TGFB1,3
6471,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.430400382,1,0,0,1.370473156,1.155362844,CDKN2D;THBS1,3
6472,regulation of autophagy (GO:0010506),0.433319816,1,0,0,1.158855977,0.969127172,EEF1A1;ATG101;MEFV;LAMTOR4;SVIP,3
6473,positive regulation of kinase activity (GO:0033674),0.434624478,1,0,0,1.244245365,1.036795932,RAP1A;PTPRC;LMO4,3
6474,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.434624478,1,0,0,1.244245365,1.036795932,RPS27A;UBA52;PSMA7,3
6475,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.437628879,1,0,0,1.350894968,1.116358035,RAC2;RAC1,3
6476,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.438730337,1,0,0,1.751160144,1.442728869,CCND3,3
6477,bile acid biosynthetic process (GO:0006699),0.438730337,1,0,0,1.751160144,1.442728869,SCP2,3
6478,cytoskeleton-dependent intracellular transport (GO:0030705),0.438730337,1,0,0,1.751160144,1.442728869,CCDC88C,3
6479,response to gamma radiation (GO:0010332),0.438730337,1,0,0,1.751160144,1.442728869,RPL26,3
6480,regulation of transcription regulatory region DNA binding (GO:2000677),0.438730337,1,0,0,1.751160144,1.442728869,TGFB1,3
6481,regulation of microtubule-based process (GO:0032886),0.438730337,1,0,0,1.751160144,1.442728869,CDK2AP2,3
6482,regulation of histone acetylation (GO:0035065),0.438730337,1,0,0,1.751160144,1.442728869,IL1B,3
6483,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.438730337,1,0,0,1.751160144,1.442728869,PLBD1,3
6484,"regulation of transcription, DNA-templated (GO:0006355)",0.44142781,1,0,0,1.034925788,0.846301024,CEBPB;SP100;SPI1;BTG1;HMGB2;AHR;RPL6;IKBKB;LYL1;SBNO2;NFIL3;HES1;JARID2;JUNB;KLF10;NFE2;HSPA8;JUN;JUND;TGFB1;KLF13;TSC22D3;ARID5A;FOS;HOPX;KLF2;FOSL2;SAP30;SUB1;IL1B;BCL3;RARA;ID3;PLCB1;PFDN5,3
6485,regulation of Notch signaling pathway (GO:0008593),0.44480723,1,0,0,1.331868278,1.078965513,RPS27A;UBA52,3
6486,calcium-mediated signaling (GO:0019722),0.44480723,1,0,0,1.331868278,1.078965513,FIS1;FPR2,3
6487,positive regulation of signal transduction (GO:0009967),0.445735725,1,0,0,1.142060963,0.922818433,C3;XBP1;PTPRC;IL1B;RPS3,3
6488,protein O-linked glycosylation (GO:0006493),0.445758841,1,0,0,1.222792859,0.987988735,C1GALT1C1;ST3GAL4;THBS1,3
6489,epithelium development (GO:0060429),0.445758841,1,0,0,1.222792859,0.987988735,TGFB1;CASP6;RARA,3
6490,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.450617214,1,0,0,1.68861871,1.346060537,PLBD1,3
6491,ATP synthesis coupled proton transport (GO:0015986),0.450617214,1,0,0,1.68861871,1.346060537,ATP5C1,3
6492,mRNA polyadenylation (GO:0006378),0.450617214,1,0,0,1.68861871,1.346060537,PABPC1,3
6493,regulation of cilium assembly (GO:1902017),0.450617214,1,0,0,1.68861871,1.346060537,ATG3,3
6494,response to hexose (GO:0009746),0.450617214,1,0,0,1.68861871,1.346060537,THBS1,3
6495,negative regulation of synaptic transmission (GO:0050805),0.450617214,1,0,0,1.68861871,1.346060537,IL1B,3
6496,cristae formation (GO:0042407),0.450617214,1,0,0,1.68861871,1.346060537,ATP5C1,3
6497,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.450617214,1,0,0,1.68861871,1.346060537,CIB1,3
6498,modulation by host of viral transcription (GO:0043921),0.450617214,1,0,0,1.68861871,1.346060537,JUN,3
6499,regulation of protein localization to nucleus (GO:1900180),0.450617214,1,0,0,1.68861871,1.346060537,TGFB1,3
6500,release of sequestered calcium ion into cytosol (GO:0051209),0.450617214,1,0,0,1.68861871,1.346060537,PTPRC,3
6501,negative regulation of cell-matrix adhesion (GO:0001953),0.450617214,1,0,0,1.68861871,1.346060537,THBS1,3
6502,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.450617214,1,0,0,1.68861871,1.346060537,TNFRSF1A,3
6503,protein targeting to vacuole (GO:0006623),0.450617214,1,0,0,1.68861871,1.346060537,SORL1,3
6504,chromatin remodeling (GO:0006338),0.451293492,1,0,0,1.212341638,0.96458434,KDM6B;SP100;HMGB2,3
6505,regulation of cell communication (GO:0010646),0.45193432,1,0,0,1.313370108,1.043102732,PTPN1;SAMSN1,3
6506,phosphatidylcholine metabolic process (GO:0046470),0.45193432,1,0,0,1.313370108,1.043102732,SLC44A2;PLBD1,3
6507,positive regulation of lymphocyte proliferation (GO:0050671),0.45193432,1,0,0,1.313370108,1.043102732,PTPRC;IL1B,3
6508,nuclear import (GO:0051170),0.45193432,1,0,0,1.313370108,1.043102732,SNRPG;SNRPB,3
6509,response to insulin (GO:0032868),0.45193432,1,0,0,1.313370108,1.043102732,CEACAM1;XBP1,3
6510,neuron projection morphogenesis (GO:0048812),0.458062649,1,0,0,1.153203021,0.90036247,STK24;S100A6;RAC2;RAC1,3
6511,lipid biosynthetic process (GO:0008610),0.459009103,1,0,0,1.295378736,1.008692298,XBP1;SCP2,3
6512,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.459009103,1,0,0,1.295378736,1.008692298,CDKN2D;THBS1,3
6513,response to metal ion (GO:0010038),0.459009103,1,0,0,1.295378736,1.008692298,NDRG1;THBS1,3
6514,Rho protein signal transduction (GO:0007266),0.459009103,1,0,0,1.295378736,1.008692298,RAC2;RAC1,3
6515,regulation of vasculature development (GO:1901342),0.462252926,1,0,0,1.630390479,1.25807953,SP100,3
6516,RNA polyadenylation (GO:0043631),0.462252926,1,0,0,1.630390479,1.25807953,PABPC1,3
6517,cellular response to ketone (GO:1901655),0.462252926,1,0,0,1.630390479,1.25807953,AHR,3
6518,cellular response to hydrogen peroxide (GO:0070301),0.462252926,1,0,0,1.630390479,1.25807953,RPS3,3
6519,carboxylic acid catabolic process (GO:0046395),0.462252926,1,0,0,1.630390479,1.25807953,TGFB1,3
6520,RNA phosphodiester bond hydrolysis (GO:0090501),0.462252926,1,0,0,1.630390479,1.25807953,RNASE6,3
6521,acute inflammatory response (GO:0002526),0.462252926,1,0,0,1.630390479,1.25807953,CEBPB,3
6522,regulation of receptor internalization (GO:0002090),0.462252926,1,0,0,1.630390479,1.25807953,FLOT1,3
6523,aerobic respiration (GO:0009060),0.462252926,1,0,0,1.630390479,1.25807953,UQCRH,3
6524,positive regulation of sprouting angiogenesis (GO:1903672),0.462252926,1,0,0,1.630390479,1.25807953,CIB1,3
6525,chondrocyte differentiation (GO:0002062),0.462252926,1,0,0,1.630390479,1.25807953,TGFB1,3
6526,positive regulation of protein tyrosine kinase activity (GO:0061098),0.462252926,1,0,0,1.630390479,1.25807953,PTPN1,3
6527,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.462252926,1,0,0,1.630390479,1.25807953,THBS1,3
6528,organelle fission (GO:0048285),0.462252926,1,0,0,1.630390479,1.25807953,FIS1,3
6529,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.462252926,1,0,0,1.630390479,1.25807953,TGFB1,3
6530,protein K11-linked ubiquitination (GO:0070979),0.462252926,1,0,0,1.630390479,1.25807953,UBE2D3,3
6531,positive regulation of calcium-mediated signaling (GO:0050850),0.462252926,1,0,0,1.630390479,1.25807953,CIB1,3
6532,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.462252926,1,0,0,1.630390479,1.25807953,FCER1G,3
6533,ventricular septum development (GO:0003281),0.462252926,1,0,0,1.630390479,1.25807953,HES1,3
6534,regulation of adenylate cyclase activity (GO:0045761),0.462252926,1,0,0,1.630390479,1.25807953,CCR2,3
6535,protein export from nucleus (GO:0006611),0.462252926,1,0,0,1.630390479,1.25807953,TGFB1,3
6536,regulation of actin polymerization or depolymerization (GO:0008064),0.462252926,1,0,0,1.630390479,1.25807953,SSH2,3
6537,positive regulation of fibroblast proliferation (GO:0048146),0.462252926,1,0,0,1.630390479,1.25807953,S100A6,3
6538,plasma membrane bounded cell projection organization (GO:0120036),0.462294001,1,0,0,1.191966148,0.919666517,LYN;BTG2;RAC1,3
6539,calcium ion transport (GO:0006816),0.462294001,1,0,0,1.191966148,0.919666517,ORAI1;RAMP1;TPT1,3
6540,protein N-linked glycosylation (GO:0006487),0.466030601,1,0,0,1.277873618,0.975661592,KRTCAP2;ST3GAL4,3
6541,transcription-coupled nucleotide-excision repair (GO:0006283),0.466030601,1,0,0,1.277873618,0.975661592,RPS27A;UBA52,3
6542,regulation of mitotic cell cycle (GO:0007346),0.467335921,1,0,0,1.139309009,0.866680296,BTG2;TGFB1;BTG1;STK24,3
6543,brain development (GO:0007420),0.46775844,1,0,0,1.182033097,0.898112614,DDIT4;PPT1;RARA,3
6544,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.468247705,1,0,0,1.047371099,0.794701031,CEBPB;SP100;BTG1;RPL10;TSC22D3;HMGB2;AHR;RPL6;SAP30;RBM3;LYL1;SBNO2;NFIL3;PFDN5,3
6545,glucose homeostasis (GO:0042593),0.472997901,1,0,0,1.260835303,0.943942415,RPS6;ADIPOR1,3
6546,mRNA 3'-end processing (GO:0031124),0.472997901,1,0,0,1.260835303,0.943942415,PABPC1;SRSF5,3
6547,keratan sulfate biosynthetic process (GO:0018146),0.473642767,1,0,0,1.576044129,1.177780768,ST3GAL4,3
6548,superoxide metabolic process (GO:0006801),0.473642767,1,0,0,1.576044129,1.177780768,NCF2,3
6549,cortical cytoskeleton organization (GO:0030865),0.473642767,1,0,0,1.576044129,1.177780768,IKBKB,3
6550,positive regulation of histone modification (GO:0031058),0.473642767,1,0,0,1.576044129,1.177780768,IL1B,3
6551,regulation of embryonic development (GO:0045995),0.473642767,1,0,0,1.576044129,1.177780768,PLCB1,3
6552,lysosome localization (GO:0032418),0.473642767,1,0,0,1.576044129,1.177780768,KXD1,3
6553,regulation of keratinocyte differentiation (GO:0045616),0.473642767,1,0,0,1.576044129,1.177780768,ZFP36,3
6554,B cell proliferation (GO:0042100),0.473642767,1,0,0,1.576044129,1.177780768,PTPRC,3
6555,regulation of activated T cell proliferation (GO:0046006),0.473642767,1,0,0,1.576044129,1.177780768,RPS3,3
6556,semaphorin-plexin signaling pathway (GO:0071526),0.473642767,1,0,0,1.576044129,1.177780768,RAC1,3
6557,carbohydrate derivative biosynthetic process (GO:1901137),0.473642767,1,0,0,1.576044129,1.177780768,ST3GAL4,3
6558,negative regulation of cell migration (GO:0030336),0.47861231,1,0,0,1.162655505,0.856719433,STK24;ARHGDIB;ADIPOR1,3
6559,C-terminal protein lipidation (GO:0006501),0.47991015,1,0,0,1.244245365,0.913470673,CD52;LY6E,3
6560,regulation of actin cytoskeleton organization (GO:0032956),0.47991015,1,0,0,1.244245365,0.913470673,ARHGDIB;CORO1A,3
6561,purine ribonucleotide biosynthetic process (GO:0009152),0.47991015,1,0,0,1.244245365,0.913470673,TGFB1;ATP5C1,3
6562,cAMP-mediated signaling (GO:0019933),0.47991015,1,0,0,1.244245365,0.913470673,AHR;RAMP1,3
6563,sulfur compound biosynthetic process (GO:0044272),0.48400046,1,0,0,1.153203021,0.83684417,VCAN;MGST1;ST3GAL4,3
6564,connective tissue development (GO:0061448),0.484791922,1,0,0,1.525203996,1.104301849,XBP1,3
6565,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.484791922,1,0,0,1.525203996,1.104301849,CCND3,3
6566,bile acid and bile salt transport (GO:0015721),0.484791922,1,0,0,1.525203996,1.104301849,CEACAM1,3
6567,cellular response to drug (GO:0035690),0.484791922,1,0,0,1.525203996,1.104301849,IL1B,3
6568,negative regulation of transferase activity (GO:0051348),0.484791922,1,0,0,1.525203996,1.104301849,ZFP36,3
6569,negative regulation of secretion by cell (GO:1903531),0.484791922,1,0,0,1.525203996,1.104301849,STXBP6,3
6570,fatty-acyl-CoA biosynthetic process (GO:0046949),0.484791922,1,0,0,1.525203996,1.104301849,PPT1,3
6571,regulation of cation transmembrane transport (GO:1904062),0.484791922,1,0,0,1.525203996,1.104301849,TSPAN13,3
6572,positive regulation of cation channel activity (GO:2001259),0.484791922,1,0,0,1.525203996,1.104301849,ADRB2,3
6573,regulation of developmental growth (GO:0048638),0.484791922,1,0,0,1.525203996,1.104301849,PLCB1,3
6574,positive regulation of phospholipase C activity (GO:0010863),0.484791922,1,0,0,1.525203996,1.104301849,RASGRP4,3
6575,aminoglycan metabolic process (GO:0006022),0.484791922,1,0,0,1.525203996,1.104301849,VCAN,3
6576,positive regulation of B cell proliferation (GO:0030890),0.484791922,1,0,0,1.525203996,1.104301849,PTPRC,3
6577,bile acid metabolic process (GO:0008206),0.484791922,1,0,0,1.525203996,1.104301849,SCP2,3
6578,regulation of sodium ion transmembrane transport (GO:1902305),0.484791922,1,0,0,1.525203996,1.104301849,FXYD5,3
6579,chondroitin sulfate metabolic process (GO:0030204),0.484791922,1,0,0,1.525203996,1.104301849,VCAN,3
6580,nucleic acid-templated transcription (GO:0097659),0.486766557,1,0,0,1.228086334,0.884186079,NFE2;BCL3,3
6581,organic anion transport (GO:0015711),0.494696158,1,0,0,1.134751773,0.798651379,SCARB1;SCP2;LDLR,3
6582,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.495705464,1,0,0,1.477541371,1.03689916,RARA,3
6583,regulation of protein tyrosine kinase activity (GO:0061097),0.495705464,1,0,0,1.477541371,1.03689916,PTPN1,3
6584,skeletal system morphogenesis (GO:0048705),0.495705464,1,0,0,1.477541371,1.03689916,RARA,3
6585,positive regulation of viral genome replication (GO:0045070),0.495705464,1,0,0,1.477541371,1.03689916,PABPC1,3
6586,lysosome organization (GO:0007040),0.495705464,1,0,0,1.477541371,1.03689916,CORO1A,3
6587,positive regulation of bone mineralization (GO:0030501),0.495705464,1,0,0,1.477541371,1.03689916,TGFB1,3
6588,protein destabilization (GO:0031648),0.495705464,1,0,0,1.477541371,1.03689916,CCDC88C,3
6589,gene silencing by miRNA (GO:0035195),0.495705464,1,0,0,1.477541371,1.03689916,ZFP36,3
6590,vesicle-mediated transport to the plasma membrane (GO:0098876),0.495705464,1,0,0,1.477541371,1.03689916,STXBP6,3
6591,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),0.500308967,1,0,0,1.196995541,0.82895465,ADRB2;RAMP1,3
6592,negative regulation of cell communication (GO:0010648),0.500308967,1,0,0,1.196995541,0.82895465,PTPN1;IL1B,3
6593,extracellular matrix disassembly (GO:0022617),0.500308967,1,0,0,1.196995541,0.82895465,FLOT1;MMP8,3
6594,fibroblast growth factor receptor signaling pathway (GO:0008543),0.500308967,1,0,0,1.196995541,0.82895465,RPS27A;UBA52,3
6595,G2/M transition of mitotic cell cycle (GO:0000086),0.505280593,1,0,0,1.116881666,0.762429635,PLCB1;RPS27A;UBA52,3
6596,phosphatidylcholine biosynthetic process (GO:0006656),0.506388361,1,0,0,1.43276739,0.974928565,SLC44A2,3
6597,cellular response to glucagon stimulus (GO:0071377),0.506388361,1,0,0,1.43276739,0.974928565,GNB2,3
6598,cyclic-nucleotide-mediated signaling (GO:0019935),0.506388361,1,0,0,1.43276739,0.974928565,AHR,3
6599,phagosome maturation (GO:0090382),0.506388361,1,0,0,1.43276739,0.974928565,CORO1A,3
6600,positive regulation of TOR signaling (GO:0032008),0.506388361,1,0,0,1.43276739,0.974928565,LAMTOR4,3
6601,activation of adenylate cyclase activity (GO:0007190),0.506388361,1,0,0,1.43276739,0.974928565,ADRB2,3
6602,G2 DNA damage checkpoint (GO:0031572),0.506388361,1,0,0,1.43276739,0.974928565,NOP53,3
6603,positive regulation of T cell differentiation (GO:0045582),0.506388361,1,0,0,1.43276739,0.974928565,XBP1,3
6604,positive regulation of transcription factor import into nucleus (GO:0042993),0.506388361,1,0,0,1.43276739,0.974928565,IL1B,3
6605,aminoglycan catabolic process (GO:0006026),0.506388361,1,0,0,1.43276739,0.974928565,HGSNAT,3
6606,vasculogenesis (GO:0001570),0.506388361,1,0,0,1.43276739,0.974928565,TGFB1,3
6607,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.506993667,1,0,0,1.182033097,0.80290398,RACK1;XDH,3
6608,steroid biosynthetic process (GO:0006694),0.506993667,1,0,0,1.182033097,0.80290398,SCP2;LBR,3
6609,positive regulation of protein kinase B signaling (GO:0051897),0.510529747,1,0,0,1.108156028,0.745020361,TGFB1;GCNT2;THBS1,3
6610,negative regulation of response to stimulus (GO:0048585),0.510529747,1,0,0,1.108156028,0.745020361,LYN;PTPN1;TGFB1,3
6611,cell cycle G2/M phase transition (GO:0044839),0.510529747,1,0,0,1.108156028,0.745020361,PLCB1;RPS27A;UBA52,3
6612,nucleic acid metabolic process (GO:0090304),0.513619917,1,0,0,1.167440096,0.777832354,DUSP11;PCBP2,3
6613,positive regulation of adenylate cyclase activity (GO:0045762),0.516845477,1,0,0,1.390627173,0.917829695,ADRB2,3
6614,activation of MAPKK activity (GO:0000186),0.516845477,1,0,0,1.390627173,0.917829695,RAP1A,3
6615,regulation of T cell differentiation (GO:0045580),0.516845477,1,0,0,1.390627173,0.917829695,XBP1,3
6616,oligosaccharide biosynthetic process (GO:0009312),0.516845477,1,0,0,1.390627173,0.917829695,ST3GAL4,3
6617,positive regulation of calcium ion transport (GO:0051928),0.516845477,1,0,0,1.390627173,0.917829695,ORAI1,3
6618,response to exogenous dsRNA (GO:0043330),0.516845477,1,0,0,1.390627173,0.917829695,FLOT1,3
6619,intra-Golgi vesicle-mediated transport (GO:0006891),0.516845477,1,0,0,1.390627173,0.917829695,COPE,3
6620,cellular response to glucose starvation (GO:0042149),0.516845477,1,0,0,1.390627173,0.917829695,XBP1,3
6621,embryonic organ morphogenesis (GO:0048562),0.516845477,1,0,0,1.390627173,0.917829695,HES1,3
6622,positive regulation of catalytic activity (GO:0043085),0.516845477,1,0,0,1.390627173,0.917829695,CIB1,3
6623,positive regulation of biomineral tissue development (GO:0070169),0.516845477,1,0,0,1.390627173,0.917829695,TGFB1,3
6624,positive regulation of organelle organization (GO:0010638),0.516845477,1,0,0,1.390627173,0.917829695,ADRB2,3
6625,BMP signaling pathway (GO:0030509),0.520187194,1,0,0,1.153203021,0.753694912,TGFB1;UBE2D3,3
6626,positive regulation of protein catabolic process (GO:0045732),0.520187194,1,0,0,1.153203021,0.753694912,IL1B;SORL1,3
6627,regulation of macromolecule metabolic process (GO:0060255),0.520939423,1,0,0,1.091107474,0.711534658,FLOT1;AHR;LDLR,3
6628,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.526695026,1,0,0,1.139309009,0.730449283,TGFB1;THBS1,3
6629,C-terminal protein amino acid modification (GO:0018410),0.526695026,1,0,0,1.139309009,0.730449283,CD52;LY6E,3
6630,epithelial tube morphogenesis (GO:0060562),0.527081571,1,0,0,1.350894968,0.865113082,HES1,3
6631,keratan sulfate metabolic process (GO:0042339),0.527081571,1,0,0,1.350894968,0.865113082,ST3GAL4,3
6632,regulation of JUN kinase activity (GO:0043506),0.527081571,1,0,0,1.350894968,0.865113082,RPS3,3
6633,response to peptide (GO:1901652),0.527081571,1,0,0,1.350894968,0.865113082,IRF5,3
6634,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.527081571,1,0,0,1.350894968,0.865113082,TGFB1,3
6635,endoplasmic reticulum organization (GO:0007029),0.527081571,1,0,0,1.350894968,0.865113082,TMCC1,3
6636,positive regulation of chemokine production (GO:0032722),0.527081571,1,0,0,1.350894968,0.865113082,IL1B,3
6637,response to glucagon (GO:0033762),0.527081571,1,0,0,1.350894968,0.865113082,GNB2,3
6638,negative regulation of signaling (GO:0023057),0.533142982,1,0,0,1.125745807,0.708055422,PTPN1;IL1B,3
6639,establishment of protein localization to membrane (GO:0090150),0.533142982,1,0,0,1.125745807,0.708055422,ATG3;SYS1,3
6640,negative regulation of neuron death (GO:1901215),0.533142982,1,0,0,1.125745807,0.708055422,PPT1;SORL1,3
6641,protein maturation (GO:0051604),0.533142982,1,0,0,1.125745807,0.708055422,SRGN;SORL1,3
6642,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.537101305,1,0,0,1.313370108,0.816349557,CDKN2D,3
6643,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.537101305,1,0,0,1.313370108,0.816349557,RPS3,3
6644,positive regulation of peptide secretion (GO:0002793),0.537101305,1,0,0,1.313370108,0.816349557,TGFB1,3
6645,regulation of endothelial cell apoptotic process (GO:2000351),0.537101305,1,0,0,1.313370108,0.816349557,THBS1,3
6646,anatomical structure homeostasis (GO:0060249),0.537101305,1,0,0,1.313370108,0.816349557,SP100,3
6647,endothelial cell migration (GO:0043542),0.537101305,1,0,0,1.313370108,0.816349557,NR4A1,3
6648,cholesterol biosynthetic process (GO:0006695),0.537101305,1,0,0,1.313370108,0.816349557,LBR,3
6649,regulation of phosphoprotein phosphatase activity (GO:0043666),0.537101305,1,0,0,1.313370108,0.816349557,CD300A,3
6650,negative regulation of tumor necrosis factor production (GO:0032720),0.537101305,1,0,0,1.313370108,0.816349557,RARA,3
6651,sulfur compound catabolic process (GO:0044273),0.537101305,1,0,0,1.313370108,0.816349557,VCAN,3
6652,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),0.546425598,1,0,0,1.050696086,0.634995665,FPR2;ADRB2;RAMP1,3
6653,organic hydroxy compound transport (GO:0015850),0.546909241,1,0,0,1.277873618,0.771161474,CEACAM1,3
6654,carbohydrate biosynthetic process (GO:0016051),0.546909241,1,0,0,1.277873618,0.771161474,ST3GAL4,3
6655,lymphocyte proliferation (GO:0046651),0.546909241,1,0,0,1.277873618,0.771161474,PTPRC,3
6656,natural killer cell activation (GO:0030101),0.546909241,1,0,0,1.277873618,0.771161474,CD244,3
6657,regulation of response to DNA damage stimulus (GO:2001020),0.546909241,1,0,0,1.277873618,0.771161474,IER3,3
6658,calcium ion transmembrane import into cytosol (GO:0097553),0.546909241,1,0,0,1.277873618,0.771161474,PTPRC,3
6659,regulation of cell morphogenesis involved in differentiation (GO:0010769),0.546909241,1,0,0,1.277873618,0.771161474,SSH2,3
6660,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.546909241,1,0,0,1.277873618,0.771161474,PLCB1,3
6661,cardiac muscle tissue morphogenesis (GO:0055008),0.546909241,1,0,0,1.277873618,0.771161474,TGFB1,3
6662,inner mitochondrial membrane organization (GO:0007007),0.546909241,1,0,0,1.277873618,0.771161474,ATP5C1,3
6663,glutamate receptor signaling pathway (GO:0007215),0.546909241,1,0,0,1.277873618,0.771161474,PLCB1,3
6664,cardiac muscle tissue development (GO:0048738),0.546909241,1,0,0,1.277873618,0.771161474,KDM6B,3
6665,regulation of cysteine-type endopeptidase activity (GO:2000116),0.546909241,1,0,0,1.277873618,0.771161474,MEFV,3
6666,spermatid development (GO:0007286),0.546909241,1,0,0,1.277873618,0.771161474,CIB1,3
6667,secondary alcohol biosynthetic process (GO:1902653),0.546909241,1,0,0,1.277873618,0.771161474,LBR,3
6668,protein monoubiquitination (GO:0006513),0.556509846,1,0,0,1.244245365,0.729215398,UBE2D3,3
6669,regulation of DNA repair (GO:0006282),0.556509846,1,0,0,1.244245365,0.729215398,RPS3,3
6670,positive regulation of receptor activity (GO:2000273),0.556509846,1,0,0,1.244245365,0.729215398,ADRB2,3
6671,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.556509846,1,0,0,1.244245365,0.729215398,FXYD5,3
6672,regulation of osteoclast differentiation (GO:0045670),0.556509846,1,0,0,1.244245365,0.729215398,CEBPB,3
6673,positive regulation of stress fiber assembly (GO:0051496),0.556509846,1,0,0,1.244245365,0.729215398,RAC1,3
6674,regulation of metal ion transport (GO:0010959),0.556509846,1,0,0,1.244245365,0.729215398,ORAI1,3
6675,organic cyclic compound biosynthetic process (GO:1901362),0.556509846,1,0,0,1.244245365,0.729215398,SCP2,3
6676,mitochondrial translational elongation (GO:0070125),0.558329027,1,0,0,1.074575543,0.626269972,MRPL30;MRPL33,3
6677,cellular response to BMP stimulus (GO:0071773),0.558329027,1,0,0,1.074575543,0.626269972,TGFB1;UBE2D3,3
6678,calcium ion homeostasis (GO:0055074),0.558329027,1,0,0,1.074575543,0.626269972,TPT1;CCR2,3
6679,positive regulation of transferase activity (GO:0051347),0.561332467,1,0,0,1.027854867,0.593526484,TGFB1;LMO4;SORL1,3
6680,divalent metal ion transport (GO:0070838),0.564472693,1,0,0,1.06250166,0.607605675,RAMP1;TPT1,3
6681,positive regulation of innate immune response (GO:0045089),0.565907492,1,0,0,1.212341638,0.690215985,RPS19,3
6682,positive regulation of DNA repair (GO:0045739),0.565907492,1,0,0,1.212341638,0.690215985,RPS3,3
6683,retina homeostasis (GO:0001895),0.565907492,1,0,0,1.212341638,0.690215985,ACTG1,3
6684,proteasomal protein catabolic process (GO:0010498),0.568394219,1,0,0,0.993305123,0.56115785,PCBP2;UBE2D3;RPS27A;UBA52;PSMA7,3
6685,regulation of GTPase activity (GO:0043087),0.569012622,1,0,0,1.000662939,0.564226462,RAP1A;RACK1;PRTN3;RASGRP2,3
6686,mitochondrial translational termination (GO:0070126),0.570554794,1,0,0,1.050696086,0.589593978,MRPL30;MRPL33,3
6687,regulation of primary metabolic process (GO:0080090),0.571104312,1,0,0,1.013171226,0.567561706,ADIPOR1;LDLR;PSMA7,3
6688,clathrin-dependent endocytosis (GO:0072583),0.575106461,1,0,0,1.182033097,0.653900835,AP2A2,3
6689,DNA replication-independent nucleosome assembly (GO:0006336),0.575106461,1,0,0,1.182033097,0.653900835,H3F3A,3
6690,mitotic DNA damage checkpoint (GO:0044773),0.575106461,1,0,0,1.182033097,0.653900835,NOP53,3
6691,DNA biosynthetic process (GO:0071897),0.575106461,1,0,0,1.182033097,0.653900835,CDKN2D,3
6692,positive regulation of Wnt signaling pathway (GO:0030177),0.575939527,1,0,0,1.005985614,0.55505519,RPS27A;UBA52;PSMA7,3
6693,protein tetramerization (GO:0051262),0.576575182,1,0,0,1.039149975,0.572207453,RPS19;SAMHD1,3
6694,regulation of Ras protein signal transduction (GO:0046578),0.576575182,1,0,0,1.039149975,0.572207453,ARHGDIB;RASGRP4,3
6695,regulation of protein catabolic process (GO:0042176),0.582533739,1,0,0,1.027854867,0.555420057,EEF1A1;SORL1,3
6696,negative regulation of transport (GO:0051051),0.584110942,1,0,0,1.153203021,0.620036147,IL1B,3
6697,embryonic heart tube morphogenesis (GO:0003143),0.584110942,1,0,0,1.153203021,0.620036147,HES1,3
6698,negative regulation of TOR signaling (GO:0032007),0.584110942,1,0,0,1.153203021,0.620036147,DDIT4,3
6699,cognition (GO:0050890),0.584110942,1,0,0,1.153203021,0.620036147,ST3GAL4,3
6700,positive regulation of mitotic nuclear division (GO:0045840),0.584110942,1,0,0,1.153203021,0.620036147,IL1B,3
6701,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.584110942,1,0,0,1.153203021,0.620036147,PLCB1,3
6702,sterol biosynthetic process (GO:0016126),0.584110942,1,0,0,1.153203021,0.620036147,LBR,3
6703,negative regulation of cytokine secretion (GO:0050710),0.584110942,1,0,0,1.153203021,0.620036147,SRGN,3
6704,response to peptide hormone (GO:0043434),0.584110942,1,0,0,1.153203021,0.620036147,XBP1,3
6705,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.584110942,1,0,0,1.153203021,0.620036147,PTPRC,3
6706,neuron migration (GO:0001764),0.584110942,1,0,0,1.153203021,0.620036147,DDIT4,3
6707,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.585422723,1,0,0,0.971534052,0.520179821,PCBP2;UBE2D3;SEC61B;RPS27A;UBA52;PSMA7,3
6708,positive regulation of GTPase activity (GO:0043547),0.58558135,1,0,0,0.979923811,0.524406389,RAP1A;RACK1;PRTN3;RASGRP2,3
6709,nuclear export (GO:0051168),0.588430384,1,0,0,1.016802664,0.539207051,TGFB1;SRSF5,3
6710,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.592925038,1,0,0,1.125745807,0.588413036,SELL,3
6711,positive regulation of receptor-mediated endocytosis (GO:0048260),0.592925038,1,0,0,1.125745807,0.588413036,PPT1,3
6712,positive regulation of viral transcription (GO:0050434),0.592925038,1,0,0,1.125745807,0.588413036,JUN,3
6713,regulation of cellular metabolic process (GO:0031323),0.592925038,1,0,0,1.125745807,0.588413036,FLOT1,3
6714,regulation of protein localization (GO:0032880),0.592925038,1,0,0,1.125745807,0.588413036,RACK1,3
6715,positive regulation of protein localization to nucleus (GO:1900182),0.601552765,1,0,0,1.099565672,0.558844384,TGFB1,3
6716,glycolipid biosynthetic process (GO:0009247),0.601552765,1,0,0,1.099565672,0.558844384,ST3GAL4,3
6717,regulation of ion transmembrane transporter activity (GO:0032412),0.601552765,1,0,0,1.099565672,0.558844384,FXYD5,3
6718,positive regulation of protein localization to membrane (GO:1905477),0.605748459,1,0,0,0.985027581,0.493784932,FIS1;CIB1,3
6719,regulation of cytoskeleton organization (GO:0051493),0.605748459,1,0,0,0.985027581,0.493784932,CDK2AP2;CORO1A,3
6720,cardiac ventricle morphogenesis (GO:0003208),0.609998054,1,0,0,1.074575543,0.531162166,TGFB1,3
6721,negative regulation of protein metabolic process (GO:0051248),0.609998054,1,0,0,1.074575543,0.531162166,LDLR,3
6722,histone H3 acetylation (GO:0043966),0.609998054,1,0,0,1.074575543,0.531162166,SPI1,3
6723,nucleobase-containing compound catabolic process (GO:0034655),0.609998054,1,0,0,1.074575543,0.531162166,RNASE6,3
6724,translational termination (GO:0006415),0.611397218,1,0,0,0.974872657,0.479645556,MRPL30;MRPL33,3
6725,cellular metal ion homeostasis (GO:0006875),0.611397218,1,0,0,0.974872657,0.479645556,TPT1;CCR2,3
6726,positive regulation of neuron projection development (GO:0010976),0.616984087,1,0,0,0.964924977,0.465973895,LYN;RAP1A,3
6727,protein localization to organelle (GO:0033365),0.616984087,1,0,0,0.964924977,0.465973895,RPL11;SORL1,3
6728,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.617892806,1,0,0,0.945626478,0.455262685,RPS27A;UBA52;PSMA7,3
6729,positive regulation of viral life cycle (GO:1903902),0.618264755,1,0,0,1.050696086,0.505215137,PABPC1,3
6730,unsaturated fatty acid metabolic process (GO:0033559),0.618264755,1,0,0,1.050696086,0.505215137,SCP2,3
6731,positive regulation of macroautophagy (GO:0016239),0.618264755,1,0,0,1.050696086,0.505215137,ADRB2,3
6732,regulation of smooth muscle cell proliferation (GO:0048660),0.618264755,1,0,0,1.050696086,0.505215137,THBS1,3
6733,protein N-linked glycosylation via asparagine (GO:0018279),0.618264755,1,0,0,1.050696086,0.505215137,ST3GAL4,3
6734,carboxylic acid biosynthetic process (GO:0046394),0.618264755,1,0,0,1.050696086,0.505215137,IL1B,3
6735,positive regulation of actin filament bundle assembly (GO:0032233),0.618264755,1,0,0,1.050696086,0.505215137,RAC1,3
6736,positive regulation of neuron differentiation (GO:0045666),0.622509151,1,0,0,0.95517826,0.452751582,LYN;RAP1A,3
6737,positive regulation of cell growth (GO:0030307),0.622509151,1,0,0,0.95517826,0.452751582,H3F3A;CIB1,3
6738,nicotinamide nucleotide metabolic process (GO:0046496),0.626356635,1,0,0,1.027854867,0.480866857,NADK,3
6739,peptidyl-asparagine modification (GO:0018196),0.626356635,1,0,0,1.027854867,0.480866857,ST3GAL4,3
6740,nucleus organization (GO:0006997),0.626356635,1,0,0,1.027854867,0.480866857,RPS19,3
6741,negative regulation of ossification (GO:0030279),0.626356635,1,0,0,1.027854867,0.480866857,SRGN,3
6742,small GTPase mediated signal transduction (GO:0007264),0.62797252,1,0,0,0.945626478,0.439961107,JUN;RASGRP2,3
6743,cellular response to ionizing radiation (GO:0071479),0.634277382,1,0,0,1.005985614,0.457993973,RPL26,3
6744,positive regulation of protein localization to cell periphery (GO:1904377),0.634277382,1,0,0,1.005985614,0.457993973,CIB1,3
6745,cartilage development (GO:0051216),0.634277382,1,0,0,1.005985614,0.457993973,TGFB1,3
6746,positive regulation of ion transport (GO:0043270),0.634277382,1,0,0,1.005985614,0.457993973,ORAI1,3
6747,aminoglycan biosynthetic process (GO:0006023),0.634277382,1,0,0,1.005985614,0.457993973,GCNT2,3
6748,regulation of nucleic acid-templated transcription (GO:1903506),0.63743178,1,0,0,0.933184024,0.42022025,LYL1;SBNO2;CEBPB;SP100;BTG1;NFIL3;TSC22D3;HMGB2;AHR;PFDN5;RPL6;SAP30,3
6749,cellular divalent inorganic cation homeostasis (GO:0072503),0.63871472,1,0,0,0.927084782,0.415609671,TPT1;CCR2,3
6750,regulation of kinase activity (GO:0043549),0.63871472,1,0,0,0.927084782,0.415609671,FGR;LMO4,3
6751,intrinsic apoptotic signaling pathway (GO:0097193),0.63871472,1,0,0,0.927084782,0.415609671,CEBPB;STK24,3
6752,protein deubiquitination (GO:0016579),0.639634705,1,0,0,0.916304726,0.409458133,ADRB2;EIF3F;RPS27A;UBA52;PSMA7,3
6753,antigen receptor-mediated signaling pathway (GO:0050851),0.639634705,1,0,0,0.916304726,0.409458133,IKBKB;PTPRC;RPS27A;UBA52;PSMA7,3
6754,fatty acid biosynthetic process (GO:0006633),0.642030608,1,0,0,0.985027581,0.436484732,XBP1,3
6755,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.642030608,1,0,0,0.985027581,0.436484732,ITGAL,3
6756,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.642030608,1,0,0,0.985027581,0.436484732,TGFB1,3
6757,plasma membrane invagination (GO:0099024),0.649211999,1,0,0,0.909256228,0.392795018,C3;BIN2,3
6758,endosome to lysosome transport (GO:0008333),0.649619847,1,0,0,0.964924977,0.416237697,ADRB2,3
6759,protein K48-linked ubiquitination (GO:0070936),0.649619847,1,0,0,0.964924977,0.416237697,UBE2D3,3
6760,glycoprotein metabolic process (GO:0009100),0.649619847,1,0,0,0.964924977,0.416237697,ST3GAL4,3
6761,regulation of mitochondrion organization (GO:0010821),0.649619847,1,0,0,0.964924977,0.416237697,FIS1,3
6762,pattern recognition receptor signaling pathway (GO:0002221),0.649619847,1,0,0,0.964924977,0.416237697,MYD88,3
6763,cellular macromolecule catabolic process (GO:0044265),0.649619847,1,0,0,0.964924977,0.416237697,RNASE6,3
6764,protein modification by small protein removal (GO:0070646),0.652978486,1,0,0,0.902315341,0.384576811,ADRB2;EIF3F;RPS27A;UBA52;PSMA7,3
6765,mRNA transport (GO:0051028),0.654369292,1,0,0,0.900596645,0.381928105,ZFP36;SRSF5,3
6766,protein heterooligomerization (GO:0051291),0.65704856,1,0,0,0.945626478,0.397160617,TMCC1,3
6767,protein autoubiquitination (GO:0051865),0.65704856,1,0,0,0.945626478,0.397160617,UBE2D3,3
6768,positive regulation of response to DNA damage stimulus (GO:2001022),0.65704856,1,0,0,0.945626478,0.397160617,RPS3,3
6769,lipid homeostasis (GO:0055088),0.65704856,1,0,0,0.945626478,0.397160617,XBP1,3
6770,fatty acid oxidation (GO:0019395),0.664320133,1,0,0,0.927084782,0.379169441,ADIPOR1,3
6771,positive regulation of JUN kinase activity (GO:0043507),0.664320133,1,0,0,0.927084782,0.379169441,RPS3,3
6772,blood circulation (GO:0008015),0.664320133,1,0,0,0.927084782,0.379169441,NFE2,3
6773,wound healing (GO:0042060),0.664320133,1,0,0,0.927084782,0.379169441,SCARB1,3
6774,heart morphogenesis (GO:0003007),0.664320133,1,0,0,0.927084782,0.379169441,HES1,3
6775,fatty acid beta-oxidation (GO:0006635),0.664320133,1,0,0,0.927084782,0.379169441,SCP2,3
6776,viral life cycle (GO:0019058),0.669478622,1,0,0,0.875580072,0.351331798,RPS27A;UBA52,3
6777,mitochondrial translation (GO:0032543),0.669478622,1,0,0,0.875580072,0.351331798,MRPL30;MRPL33,3
6778,regulation of exocytosis (GO:0017157),0.671437884,1,0,0,0.909256228,0.362187462,STXBP6,3
6779,response to organonitrogen compound (GO:0010243),0.671437884,1,0,0,0.909256228,0.362187462,IRF5,3
6780,regulation of cellular amine metabolic process (GO:0033238),0.671437884,1,0,0,0.909256228,0.362187462,PSMA7,3
6781,telomere maintenance (GO:0000723),0.671437884,1,0,0,0.909256228,0.362187462,SP100,3
6782,regulation of cellular amino acid metabolic process (GO:0006521),0.671437884,1,0,0,0.909256228,0.362187462,PSMA7,3
6783,positive regulation of developmental growth (GO:0048639),0.671437884,1,0,0,0.909256228,0.362187462,PLCB1,3
6784,nucleotide-excision repair (GO:0006289),0.674395101,1,0,0,0.867547227,0.341760805,RPS27A;UBA52,3
6785,positive regulation of proteolysis (GO:0045862),0.678405059,1,0,0,0.892100451,0.346144554,IL1B,3
6786,positive regulation of ossification (GO:0045778),0.678405059,1,0,0,0.892100451,0.346144554,TGFB1,3
6787,positive regulation of secretion by cell (GO:1903532),0.678405059,1,0,0,0.892100451,0.346144554,TGFB1,3
6788,circulatory system development (GO:0072359),0.679252081,1,0,0,0.859660434,0.33248482,TGFB1;RARA,3
6789,Wnt signaling pathway (GO:0016055),0.679252081,1,0,0,0.859660434,0.33248482,RPS27A;UBA52,3
6790,cellular response to insulin stimulus (GO:0032869),0.684049873,1,0,0,0.851915746,0.323493239,XBP1;CEACAM1,3
6791,neutrophil chemotaxis (GO:0030593),0.685224835,1,0,0,0.875580072,0.330976506,FCER1G,3
6792,monocarboxylic acid transport (GO:0015718),0.685224835,1,0,0,0.875580072,0.330976506,CEACAM1,3
6793,positive regulation of protein import into nucleus (GO:0042307),0.685224835,1,0,0,0.875580072,0.330976506,TGFB1,3
6794,organelle assembly (GO:0070925),0.688282777,1,0,0,0.877902565,0.327945342,ACTR3;ATG3;BIN2;ATG101;RPS3;CORO1A;RPS23,3
6795,membrane fusion (GO:0061025),0.691900325,1,0,0,0.859660434,0.316624434,FIS1,3
6796,phosphatidylinositol metabolic process (GO:0046488),0.6934692,1,0,0,0.836837591,0.306323105,PLBD1;PLCB1,3
6797,transmembrane transport (GO:0055085),0.693520836,1,0,0,0.873269834,0.31959405,SCARB1;SLC44A2;TSC22D3;RPS27A;ADD3;UBA52;PSMA7,3
6798,mitotic cell cycle phase transition (GO:0044772),0.693916212,1,0,0,0.851915746,0.311293471,CDKN2D;PLCB1;RPS27A;UBA52,3
6799,long-chain fatty acid metabolic process (GO:0001676),0.698434573,1,0,0,0.844309355,0.303034256,SCP2,3
6800,regulation of axonogenesis (GO:0050770),0.698434573,1,0,0,0.844309355,0.303034256,SSH2,3
6801,regulation of gene silencing by RNA (GO:0060966),0.698434573,1,0,0,0.844309355,0.303034256,H3F3A,3
6802,regulation of posttranscriptional gene silencing (GO:0060147),0.698434573,1,0,0,0.844309355,0.303034256,H3F3A,3
6803,cellular response to DNA damage stimulus (GO:0006974),0.701493348,1,0,0,0.859660434,0.30478733,LYN;BTG2;BCL3;RPS3;CIB1;NOP53,3
6804,granulocyte chemotaxis (GO:0071621),0.704830561,1,0,0,0.82949691,0.290156231,FCER1G,3
6805,chordate embryonic development (GO:0043009),0.704830561,1,0,0,0.82949691,0.290156231,TGFB1,3
6806,negative regulation of cellular catabolic process (GO:0031330),0.704830561,1,0,0,0.82949691,0.290156231,APOC1,3
6807,epidermal growth factor receptor signaling pathway (GO:0007173),0.711091207,1,0,0,0.815195239,0.277944548,TGFB1,3
6808,cellular respiration (GO:0045333),0.711091207,1,0,0,0.815195239,0.277944548,UQCRH,3
6809,protein homotetramerization (GO:0051289),0.711091207,1,0,0,0.815195239,0.277944548,SAMHD1,3
6810,regulation of macroautophagy (GO:0016241),0.711612683,1,0,0,0.808227759,0.27497646,ATG101;LAMTOR4,3
6811,response to light stimulus (GO:0009416),0.71721937,1,0,0,0.801378371,0.266356958,CDKN2D,3
6812,ubiquitin-dependent ERAD pathway (GO:0030433),0.71721937,1,0,0,0.801378371,0.266356958,SEC61B,3
6813,endosomal transport (GO:0016197),0.71997215,1,0,0,0.822283894,0.27015541,SYS1;ADRB2;RPS27A;UBA52,3
6814,protein polyubiquitination (GO:0000209),0.720598153,1,0,0,0.832417674,0.272761332,MARCH1;UBE2D3;RPS27A;UBA52;PSMA7,3
6815,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.723217846,1,0,0,0.788022065,0.255354448,TGFB1,3
6816,sterol metabolic process (GO:0016125),0.723217846,1,0,0,0.788022065,0.255354448,LBR,3
6817,positive regulation of B cell activation (GO:0050871),0.724623944,1,0,0,0.788022065,0.253823843,XBP1;PTPRC,3
6818,RNA export from nucleus (GO:0006405),0.724623944,1,0,0,0.788022065,0.253823843,RPSA;SRSF5,3
6819,actin filament organization (GO:0007015),0.728849583,1,0,0,0.781509486,0.247181995,RAC2;RAC1,3
6820,regulation of stress fiber assembly (GO:0051492),0.729089372,1,0,0,0.77510367,0.244900948,RAC1,3
6821,membrane lipid biosynthetic process (GO:0046467),0.729089372,1,0,0,0.77510367,0.244900948,ST3GAL4,3
6822,ubiquitin-dependent protein catabolic process (GO:0006511),0.733221403,1,0,0,0.82949691,0.257399173,XBP1;PCBP2;UBE2D3;RPS27A;UBA52;PSMA7,3
6823,regulation of vesicle fusion (GO:0031338),0.734836631,1,0,0,0.762601998,0.234963071,STXBP6,3
6824,regulation of cellular ketone metabolic process (GO:0010565),0.734836631,1,0,0,0.762601998,0.234963071,PSMA7,3
6825,RNA 3'-end processing (GO:0031123),0.734836631,1,0,0,0.762601998,0.234963071,SRSF5,3
6826,protein targeting to membrane (GO:0006612),0.734836631,1,0,0,0.762601998,0.234963071,ATG3,3
6827,cellular protein catabolic process (GO:0044257),0.740462245,1,0,0,0.750497204,0.225509875,AP2A2,3
6828,second-messenger-mediated signaling (GO:0019932),0.740462245,1,0,0,0.750497204,0.225509875,FPR2,3
6829,cellular calcium ion homeostasis (GO:0006874),0.741198092,1,0,0,0.762601998,0.228389658,TPT1;CCR2,3
6830,proteolysis (GO:0006508),0.742722054,1,0,0,0.80961171,0.240805555,SRGN;NAPSA;CASP6;PRTN3;MMP8,3
6831,organonitrogen compound biosynthetic process (GO:1901566),0.743412091,1,0,0,0.779362481,0.231084683,SLC44A2;MGST1;ST3GAL4,3
6832,oligosaccharide metabolic process (GO:0009311),0.745968783,1,0,0,0.738770686,0.216512652,ST3GAL4,3
6833,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),0.745968783,1,0,0,0.738770686,0.216512652,FPR2,3
6834,negative regulation of neuron apoptotic process (GO:0043524),0.745968783,1,0,0,0.738770686,0.216512652,PPT1,3
6835,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.75135876,1,0,0,0.727404983,0.207944741,CEACAM1,3
6836,NADH dehydrogenase complex assembly (GO:0010257),0.75135876,1,0,0,0.727404983,0.207944741,NDUFA6,3
6837,mitochondrial respiratory chain complex I biogenesis (GO:0097031),0.75135876,1,0,0,0.727404983,0.207944741,NDUFA6,3
6838,mitochondrial respiratory chain complex I assembly (GO:0032981),0.75135876,1,0,0,0.727404983,0.207944741,NDUFA6,3
6839,nervous system development (GO:0007399),0.751881457,1,0,0,0.82949691,0.236553112,LYN;VCAN;TGFB1;GDA;PPT1;HES1;JARID2;ARHGAP26,3
6840,cytoskeleton organization (GO:0007010),0.753063225,1,0,0,0.744587778,0.211169629,CNN2;TLN1,3
6841,plasma membrane bounded cell projection assembly (GO:0120031),0.755929258,1,0,0,0.781509486,0.218672201,ACTR3;PTPRO;FXYD5;RAC1,3
6842,glycolipid metabolic process (GO:0006664),0.756634637,1,0,0,0.716383695,0.199781351,ST3GAL4,3
6843,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.756634637,1,0,0,0.716383695,0.199781351,ADRB2,3
6844,vesicle organization (GO:0016050),0.756912958,1,0,0,0.738770686,0.205752819,SRGN;CORO1A,3
6845,protein lipidation (GO:0006497),0.756912958,1,0,0,0.738770686,0.205752819,CD52;LY6E,3
6846,cellular response to light stimulus (GO:0071482),0.761798824,1,0,0,0.705691401,0.191999413,RPL26,3
6847,positive regulation of synaptic transmission (GO:0050806),0.766853681,1,0,0,0.695313586,0.184577432,FLOT1,3
6848,cellular response to UV (GO:0034644),0.766853681,1,0,0,0.695313586,0.184577432,RPL26,3
6849,protein complex assembly (GO:0006461),0.769109367,1,0,0,0.746547219,0.195985144,HGSNAT;BIN2;TNFRSF1A,3
6850,cholesterol metabolic process (GO:0008203),0.771801516,1,0,0,0.685236578,0.177495368,LBR,3
6851,phospholipid metabolic process (GO:0006644),0.781385117,1,0,0,0.665934139,0.16427739,PLBD1,3
6852,snRNA transcription (GO:0009301),0.781385117,1,0,0,0.665934139,0.16427739,POU2F2,3
6853,snRNA transcription from RNA polymerase II promoter (GO:0042795),0.781385117,1,0,0,0.665934139,0.16427739,POU2F2,3
6854,actomyosin structure organization (GO:0031032),0.786025261,1,0,0,0.656685054,0.158107662,ZYX,3
6855,histone acetylation (GO:0016573),0.786025261,1,0,0,0.656685054,0.158107662,SPI1,3
6856,muscle contraction (GO:0006936),0.792634418,1,0,0,0.685236578,0.159244304,TLN1;MYL12B,3
6857,regulation of vesicle-mediated transport (GO:0060627),0.795939511,1,0,0,0.680306818,0.155267845,PTPN1;CD177,3
6858,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),0.802410334,1,0,0,0.670657076,0.147635206,SP100;ID3,3
6859,response to interleukin-1 (GO:0070555),0.807792938,1,0,0,0.614043167,0.131067218,MYD88,3
6860,ERAD pathway (GO:0036503),0.811873794,1,0,0,0.606170819,0.126332289,SEC61B,3
6861,cell-cell junction assembly (GO:0007043),0.819778004,1,0,0,0.591016548,0.117447814,TLN1,3
6862,skeletal system development (GO:0001501),0.820743019,1,0,0,0.643283318,0.12707755,KLF10;VCAN,3
6863,spindle assembly (GO:0051225),0.823604973,1,0,0,0.583720048,0.113279203,RPS3,3
6864,heart development (GO:0007507),0.829326075,1,0,0,0.630417652,0.117977536,TGFB1;RARA,3
6865,Golgi vesicle transport (GO:0048193),0.830171303,1,0,0,0.695313586,0.129413997,USE1;SORL1;ARF5;COPE,3
6866,modulation of chemical synaptic transmission (GO:0050804),0.831017391,1,0,0,0.569654505,0.105445645,IL1B,3
6867,positive regulation of DNA metabolic process (GO:0051054),0.831017391,1,0,0,0.569654505,0.105445645,RPS3,3
6868,positive regulation of protein ubiquitination (GO:0031398),0.834606231,1,0,0,0.562872903,0.101764744,ADRB2,3
6869,negative regulation of endopeptidase activity (GO:0010951),0.834606231,1,0,0,0.562872903,0.101764744,SORL1,3
6870,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.834606231,1,0,0,0.562872903,0.101764744,TGFB1,3
6871,regulation of neuron differentiation (GO:0045664),0.838119028,1,0,0,0.556250869,0.098231206,ID3,3
6872,ion transmembrane transport (GO:0034220),0.847325037,1,0,0,0.644745326,0.106815543,TSC22D3;RPS27A;UBA52,3
6873,organic substance transport (GO:0071702),0.848217059,1,0,0,0.537287771,0.08844762,SCP2,3
6874,T cell activation (GO:0042110),0.851441419,1,0,0,0.53125083,0.085438191,PTPRC,3
6875,regulation of neuron apoptotic process (GO:0043523),0.854597441,1,0,0,0.525348043,0.08254518,PPT1,3
6876,transcription initiation from RNA polymerase II promoter (GO:0006367),0.857716815,1,0,0,0.587345638,0.090146564,NR4A1;RARA,3
6877,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),0.86071022,1,0,0,0.513927433,0.077087776,FPR2,3
6878,intracellular protein transport (GO:0006886),0.862455337,1,0,0,0.679329366,0.100521667,TGFB1;RPL11;BCL3;SEC61B;SORL1,3
6879,cell cycle G1/S phase transition (GO:0044843),0.863669775,1,0,0,0.508401332,0.074513733,CDKN2D,3
6880,axon development (GO:0061564),0.869401998,1,0,0,0.497698146,0.069652687,S100A6,3
6881,vesicle-mediated transport (GO:0016192),0.869685554,1,0,0,0.690238305,0.096373532,HSPA8;RAC2;KXD1;RAC1;ADRB2;LDLR,3
6882,mitochondrion organization (GO:0007005),0.873468873,1,0,0,0.562872903,0.076147014,TIMM10B;FIS1,3
6883,cell morphogenesis involved in neuron differentiation (GO:0048667),0.877552597,1,0,0,0.482462489,0.063018472,S100A6,3
6884,negative regulation of cell motility (GO:2000146),0.877552597,1,0,0,0.482462489,0.063018472,STK24,3
6885,mitochondrial respiratory chain complex assembly (GO:0033108),0.877552597,1,0,0,0.482462489,0.063018472,NDUFA6,3
6886,steroid metabolic process (GO:0008202),0.882702364,1,0,0,0.472813239,0.058991588,SCP2,3
6887,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.885195637,1,0,0,0.46813192,0.057087096,SRSF5,3
6888,protein processing (GO:0016485),0.887636034,1,0,0,0.463542391,0.055251236,SRGN,3
6889,B cell receptor signaling pathway (GO:0050853),0.894651045,1,0,0,0.450298323,0.050127899,PTPRC,3
6890,G1/S transition of mitotic cell cycle (GO:0000082),0.896890895,1,0,0,0.446050225,0.048539657,CDKN2D,3
6891,mRNA export from nucleus (GO:0006406),0.896890895,1,0,0,0.446050225,0.048539657,SRSF5,3
6892,positive regulation of cell cycle process (GO:0090068),0.901229062,1,0,0,0.437790036,0.045528335,IL1B,3
6893,regulation of protein activation cascade (GO:2000257),0.903329369,1,0,0,0.433773614,0.044100914,C3,3
6894,regulation of complement activation (GO:0030449),0.905385116,1,0,0,0.429830217,0.042722924,C3,3
6895,regulation of Wnt signaling pathway (GO:0030111),0.905385116,1,0,0,0.429830217,0.042722924,RACK1,3
6896,"DNA-templated transcription, initiation (GO:0006352)",0.908479688,1,0,0,0.505682608,0.048536807,NR4A1;RARA,3
6897,regulation of organelle organization (GO:0033043),0.913181078,1,0,0,0.414748455,0.037667905,FIS1,3
6898,regulation of humoral immune response (GO:0002920),0.913181078,1,0,0,0.414748455,0.037667905,C3,3
6899,protein ubiquitination (GO:0016567),0.914358757,1,0,0,0.652799343,0.058446608,ATG3;MARCH1;UBE2D3;RACK1;RPS27A;UBA52;PSMA7,3
6900,regulation of immune effector process (GO:0002697),0.915027783,1,0,0,0.411141947,0.036509755,C3,3
6901,protein transport (GO:0015031),0.917752346,1,0,0,0.578364818,0.049639723,SYS1;RAP1A;PPT1;RAMP1,3
6902,sphingolipid metabolic process (GO:0006665),0.91860445,1,0,0,0.404113879,0.034309132,PPT1,3
6903,cytosolic transport (GO:0016482),0.922030904,1,0,0,0.397322049,0.032253228,SYS1,3
6904,macromolecular complex assembly (GO:0065003),0.925313439,1,0,0,0.390754743,0.030331456,HES1,3
6905,DNA replication (GO:0006260),0.925313439,1,0,0,0.390754743,0.030331456,FAM111A,3
6906,regulation of acute inflammatory response (GO:0002673),0.926902632,1,0,0,0.387551835,0.029417802,C3,3
6907,protein modification by small protein conjugation (GO:0032446),0.927033502,1,0,0,0.592497793,0.044890935,ATG3;UBE2D3;RACK1;RPS27A;UBA52,3
6908,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.932929095,1,0,0,0.375248602,0.026052039,ADRB2,3
6909,regulation of protein processing (GO:0070613),0.937121297,1,0,0,0.366521891,0.023802867,C3,3
6910,ion transport (GO:0006811),0.946711014,1,0,0,0.489117144,0.026784736,TSC22D3;RPS27A;UBA52,3
6911,post-translational protein modification (GO:0043687),0.946879048,1,0,0,0.528282948,0.028835752,C3;SOCS3;VCAN;PSMA7,3
6912,axonogenesis (GO:0007409),0.952228766,1,0,0,0.422154677,0.02066446,PTPRO;S100A6,3
6913,double-strand break repair (GO:0006302),0.952467671,1,0,0,0.33296707,0.016215201,CIB1,3
6914,peptidyl-serine phosphorylation (GO:0018105),0.956390191,1,0,0,0.323844684,0.014440008,IKBKB,3
6915,axon guidance (GO:0007411),0.967041534,1,0,0,0.297366817,0.009965902,PTPRO,3
6916,glycerophospholipid biosynthetic process (GO:0046474),0.97103926,1,0,0,0.286553478,0.008421342,SLC44A2,3
6917,peptidyl-serine modification (GO:0018209),0.974553045,1,0,0,0.27649897,0.007127128,IKBKB,3
6918,ER to Golgi vesicle-mediated transport (GO:0006888),0.979489498,1,0,0,0.261222784,0.005413519,COPE,3
6919,cilium organization (GO:0044782),0.98416838,1,0,0,0.244980953,0.003909474,ACTR3,3
6920,anterograde trans-synaptic signaling (GO:0098916),0.994388209,1,0,0,0.196188066,0.001104067,PPT1,3
6921,cilium assembly (GO:0060271),0.998014642,1,0,0,0.163603197,0.000325134,ACTR3,3
6922,chemical synaptic transmission (GO:0007268),0.998057185,1,0,0,0.163039048,0.000317063,PPT1,3
6923,cellular protein localization (GO:0034613),0.999147075,1,0,0,0.144150378,0.000123002,CD177,3
6924,cytokine-mediated signaling pathway (GO:0019221),4.40E-28,2.25E-24,0,0,5.845536731,368.2130073,IFITM3;CD86;CD40;CDKN1A;IFI35;IFIT1;IFIT3;IFIT2;CCND1;JAK2;CCR5;B2M;IL15RA;RSAD2;IL18;PSMA5;HCK;PSMA4;OAS2;OAS3;IRF1;PSME1;PELI1;IRF7;PSME2;IRF5;IFNAR1;SP100;CAMK2D;PSMD11;PTAFR;SAMHD1;IL2RG;PSMB10;RAP1B;CDC42;SOCS1;PSMB2;UBB;CCL7;UBC;IL21R;CCL2;CD300LF;GBP2;STAT1;STAT2;IL10RA;MX1;ISG15;PSMB8;PSMB9;BST2;ISG20;CXCL10;PTPN6;XAF1;MYD88,4
6925,cellular response to type I interferon (GO:0071357),6.62E-27,1.69E-23,0,0,23.23555039,1400.629015,IFITM3;SP100;RSAD2;STAT1;STAT2;MX1;ISG15;IFI35;IFIT1;SAMHD1;IFIT3;PSMB8;IFIT2;BST2;ISG20;OAS2;IRF1;OAS3;IRF7;IRF5;GBP2;XAF1;MYD88;IFNAR1,4
6926,type I interferon signaling pathway (GO:0060337),6.62E-27,1.13E-23,0,0,23.23555039,1400.629015,IFITM3;SP100;RSAD2;STAT1;STAT2;MX1;ISG15;IFI35;IFIT1;SAMHD1;IFIT3;PSMB8;IFIT2;BST2;ISG20;OAS2;IRF1;OAS3;IRF7;IRF5;GBP2;XAF1;MYD88;IFNAR1,4
6927,cellular response to interferon-gamma (GO:0071346),3.20E-13,4.08E-10,0,0,9.830425166,282.8357234,SP100;CAMK2D;STAT1;PTAFR;ACOD1;AIF1;HCK;CCL7;OAS2;IRF1;OAS3;IRF7;CCL2;IRF5;LGALS9;JAK2;GBP2;B2M,4
6928,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),1.30E-12,1.32E-09,0,0,12.13248676,332.0928627,FCER1G;PSMD11;NCF4;TAP1;PSMB10;PSMB8;TAPBP;PSMB9;PSMA5;PSMA4;PSMB2;PSME1;PSME2;CALR;B2M,4
6929,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",1.14E-11,9.67E-09,0,0,11.77064066,296.6240068,PSMD11;NCF4;TAP1;PSMB10;PSMB8;TAPBP;PSMB9;PSMA5;PSMA4;PSMB2;PSME1;PSME2;CALR;B2M,4
6930,negative regulation of viral genome replication (GO:0045071),1.61E-11,1.17E-08,0,0,15.0347679,373.6561121,IFITM3;BST2;ISG20;PARP10;RSAD2;OAS2;OAS3;MX1;EIF2AK2;ISG15;ZC3HAV1;IFIT1,4
6931,response to cytokine (GO:0034097),6.43E-11,4.10E-08,0,0,7.814834394,183.3917245,IFITM3;CD274;SP100;GCH1;STAT1;MX1;TRAFD1;EIF2AK2;ISG15;BST2;CASP8;HCLS1;PTPN6;LGALS9;XAF1;JAK2;MYD88,4
6932,regulation of type I interferon production (GO:0032479),6.52E-11,3.70E-08,0,0,10.40196151,243.9583267,ZBP1;UBA7;DDX58;NLRC5;ACOD1;UBE2L6;ISG15;IFIH1;UBB;IRF1;DHX58;UBC;IRF7;MYD88,4
6933,interferon-gamma-mediated signaling pathway (GO:0060333),6.78E-11,3.46E-08,0,0,11.69959051,273.9317184,SP100;CAMK2D;STAT1;PTAFR;HCK;OAS2;IRF1;OAS3;IRF7;IRF5;JAK2;GBP2;B2M,4
6934,negative regulation of viral life cycle (GO:1903901),1.88E-10,8.71E-08,0,0,12.36730908,276.9765735,IFITM3;BST2;ISG20;PARP10;RSAD2;OAS2;OAS3;MX1;EIF2AK2;ISG15;ZC3HAV1;IFIT1,4
6935,regulation of viral genome replication (GO:0045069),2.78E-10,1.18E-07,0,0,11.98083067,263.6363152,IFITM3;BST2;ISG20;PARP10;RSAD2;OAS2;OAS3;MX1;EIF2AK2;ISG15;ZC3HAV1;IFIT1,4
6936,regulation of innate immune response (GO:0045088),8.27E-10,3.25E-07,0,0,10.95390233,229.0814633,GBP5;STAT1;IRF1;STAT2;DHX58;ACOD1;TRAFD1;PTPN6;PARP9;SAMHD1;USP18;IFNAR1,4
6937,negative regulation of type I interferon production (GO:0032480),1.50E-09,5.47E-07,0,0,14.19950302,288.5016038,IFIH1;UBA7;UBB;DDX58;UBC;DHX58;NLRC5;ACOD1;UBE2L6;ISG15,4
6938,cellular response to interleukin-1 (GO:0071347),2.02E-09,6.87E-07,0,0,6.770623955,135.5500272,PSMD11;ACOD1;PSMB10;PSMB8;PSMB9;PSMA5;PSMA4;UBB;CCL7;PSMB2;UBC;PSME1;PELI1;PSME2;CCL2;MYD88,4
6939,regulation of hematopoietic stem cell differentiation (GO:1902036),2.59E-09,8.26E-07,0,0,9.958093025,196.8847957,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;EIF2AK2;PSMB10;PSMB8;PSMB9,4
6940,regulation of hematopoietic progenitor cell differentiation (GO:1901532),3.02E-09,9.06E-07,0,0,9.830425166,192.8556119,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;EIF2AK2;PSMB10;PSMB8;PSMB9,4
6941,interleukin-1-mediated signaling pathway (GO:0070498),3.32E-09,9.42E-07,0,0,8.652822151,168.9290271,PSMD11;PSMB10;PSMB8;PSMB9;PSMA5;PSMA4;UBB;PSMB2;UBC;PELI1;PSME1;PSME2;MYD88,4
6942,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),3.46E-09,9.28E-07,0,0,11.15675237,217.3700288,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6943,cellular response to cytokine stimulus (GO:0071345),3.86E-09,9.85E-07,0,0,3.775141393,73.13423437,CD86;CDKN1A;PTAFR;IFIT1;IL2RG;AIF1;SOCS1;CCND1;UBB;CCL7;UBC;CCL2;LGALS9;JAK2;CCR5;PNPT1;STAT1;STAT2;IL10RA;IL18;ACOD1;HCK;CXCL10;IRF1;HCLS1;PTPN6;IFNAR1,4
6944,negative regulation of mitotic cell cycle phase transition (GO:1901991),4.07E-09,9.90E-07,0,0,9.584664537,185.1649168,PSMA5;CDKN1A;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6945,anaphase-promoting complex-dependent catabolic process (GO:0031145),4.07E-09,9.45E-07,0,0,9.584664537,185.1649168,PSMA5;PSMA4;PSMD11;PTTG1;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6946,tumor necrosis factor-mediated signaling pathway (GO:0033209),9.17E-09,2.04E-06,0,0,7.21426363,133.5140843,CD40;PSMD11;STAT1;PSMB10;PSMB8;PSMB9;PSMA5;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;JAK2,4
6947,response to interferon-beta (GO:0035456),9.22E-09,1.96E-06,0,0,23.54128132,435.5559975,IFITM3;BST2;PNPT1;STAT1;IRF1;ACOD1;XAF1,4
6948,negative regulation of cell cycle G2/M phase transition (GO:1902750),1.10E-08,2.25E-06,0,0,10.04107713,183.99095,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6949,cellular response to tumor necrosis factor (GO:0071356),1.25E-08,2.45E-06,0,0,5.570574261,101.3798444,CD40;PSMD11;STAT1;ACOD1;PSMB8;PSMB10;PSMB9;PSMA5;PSMA4;PSMB2;UBB;CCL7;UBC;PSME1;PSME2;CCL2;JAK2,4
6950,regulation of stem cell differentiation (GO:2000736),1.42E-08,2.68E-06,0,0,8.615428797,155.7086235,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;EIF2AK2;PSMB10;PSMB8;PSMB9,4
6951,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1.42E-08,2.58E-06,0,0,8.615428797,155.7086235,PSMA5;CDC42;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6952,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),1.50E-08,2.63E-06,0,0,9.762158324,175.8895705,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6953,regulation of establishment of planar polarity (GO:0090175),1.61E-08,2.74E-06,0,0,8.51970181,152.8781853,PSMA5;CDC42;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6954,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),1.74E-08,2.86E-06,0,0,9.628430128,172.0413333,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6955,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),1.74E-08,2.77E-06,0,0,9.628430128,172.0413333,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6956,negative regulation of cytokine production (GO:0001818),2.00E-08,3.10E-06,0,0,7.483521861,132.6524549,SRGN;CD274;UBA7;DDX58;NLRC5;ACOD1;UBE2L6;ISG15;IFIH1;UBB;DHX58;UBC;LGALS9,4
6957,proteolysis involved in cellular protein catabolic process (GO:0051603),2.66E-08,3.99E-06,0,0,8.157161308,142.2932228,PSMA5;CASP8;PSMA4;PSMB2;UBC;CHMP4B;ISG15;CTSC;PSMB10;PSMB8;PSMB9;LGMN,4
6958,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),3.00E-08,4.37E-06,0,0,20.33110659,352.1935653,SOCS1;STAT1;NLRC5;NR1H3;PARP14;PARP9;JAK2,4
6959,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),3.09E-08,4.38E-06,0,0,9.12825194,157.860245,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6960,negative regulation of ubiquitin protein ligase activity (GO:1904667),3.54E-08,4.89E-06,0,0,9.011223069,154.5917024,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6961,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),4.06E-08,5.45E-06,0,0,8.897156954,151.4243709,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6962,NIK/NF-kappaB signaling (GO:0038061),5.30E-08,6.93E-06,0,0,8.677474066,145.3764211,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6963,positive regulation of ubiquitin protein ligase activity (GO:1904668),6.86E-08,8.75E-06,0,0,8.468378306,139.6847778,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6964,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),8.12E-08,1.01E-05,0,0,17.8913738,292.1117461,PSMA5;PSMA4;PSMB2;KEAP1;PSMB10;PSMB8;PSMB9,4
6965,regulation of cellular amine metabolic process (GO:0033238),1.02E-07,1.24E-05,0,0,11.05922831,178.0022252,PSMA5;PSMA4;PSMD11;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6966,regulation of cellular amino acid metabolic process (GO:0006521),1.02E-07,1.21E-05,0,0,11.05922831,178.0022252,PSMA5;PSMA4;PSMD11;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6967,response to interferon-gamma (GO:0034341),1.15E-07,1.33E-05,0,0,9.260545446,147.9881858,IFITM3;BST2;SP100;CCL7;GCH1;STAT1;ACOD1;CCL2;LGALS9;AIF1,4
6968,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),1.27E-07,1.44E-05,0,0,7.987220447,126.8352127,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6969,neutrophil degranulation (GO:0043312),1.71E-07,1.90E-05,0,0,3.32800852,51.85878491,CSTB;GRN;RAB5C;PSMD11;BRI3;MVP;PTAFR;FGL2;PLAC8;RAP1B;SDCBP;PNP;C3AR1;B2M;SNAP29;HMOX2;CTSC;CD53;FCER1G;BST2;RAP2C;PSMA5;NPC2;PTPN6;CD47,4
6970,regulation of cytokine-mediated signaling pathway (GO:0001959),1.80E-07,1.95E-05,0,0,7.723905487,119.9544251,CASP8;SOCS1;UBB;STAT1;STAT2;SPPL2A;UBC;PTPN6;JAK2;USP18;IFNAR1,4
6971,neutrophil activation involved in immune response (GO:0002283),2.00E-07,2.12E-05,0,0,3.300504317,50.91385934,CSTB;GRN;RAB5C;PSMD11;BRI3;MVP;PTAFR;FGL2;PLAC8;RAP1B;SDCBP;PNP;C3AR1;B2M;SNAP29;HMOX2;CTSC;CD53;FCER1G;BST2;RAP2C;PSMA5;NPC2;PTPN6;CD47,4
6972,neutrophil mediated immunity (GO:0002446),2.33E-07,2.43E-05,0,0,3.273451003,49.99031511,CSTB;GRN;RAB5C;PSMD11;BRI3;MVP;PTAFR;FGL2;PLAC8;RAP1B;SDCBP;PNP;C3AR1;B2M;SNAP29;HMOX2;CTSC;CD53;FCER1G;BST2;RAP2C;PSMA5;NPC2;PTPN6;CD47,4
6973,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),2.52E-07,2.57E-05,0,0,7.477397866,113.6133323,PSMA5;PSMA4;PSMD11;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6974,positive regulation of interferon-alpha production (GO:0032727),4.51E-07,4.51E-05,0,0,19.16932907,280.0890706,IFIH1;DDX58;STAT1;IRF7;IRF5;TLR7,4
6975,MAPK cascade (GO:0000165),4.60E-07,4.51E-05,0,0,4.12243636,60.15880443,CAMK2D;PSMD11;IL18;IL2RG;PSMB8;PSMB10;PSMB9;PSMA5;PSMA4;PSMB2;UBB;UBC;PSME1;PSME2;CCL2;LGALS9;CCR5;JAK2,4
6976,stimulatory C-type lectin receptor signaling pathway (GO:0002223),4.89E-07,4.70E-05,0,0,6.285025926,91.33152355,PSMA5;PSMD11;FCER1G;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6977,regulation of cellular ketone metabolic process (GO:0010565),4.92E-07,4.65E-05,0,0,9.27548181,134.7279192,PSMA5;PSMA4;PSMD11;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6978,positive regulation of type I interferon production (GO:0032481),5.66E-07,5.25E-05,0,0,9.12825194,131.3073363,IFIH1;ZBP1;DDX58;STAT1;IRF1;DHX58;IRF7;IRF5;MYD88,4
6979,protein polyubiquitination (GO:0000209),5.96E-07,5.43E-05,0,0,4.049858255,58.04916812,PSMD11;RNF34;DTX3L;MARCH5;PSMB8;PSMB10;PSMB9;PSMA5;RNF114;RNF213;PSMA4;PSMB2;UBB;UBC;PSME1;PELI1;PSME2;HERC6,4
6980,innate immune response activating cell surface receptor signaling pathway (GO:0002220),6.36E-07,5.69E-05,0,0,6.134185304,87.52263474,PSMA5;PSMD11;FCER1G;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6981,regulation of G2/M transition of mitotic cell cycle (GO:0010389),7.08E-07,6.23E-05,0,0,5.537806177,78.4214223,DYNC1I2;PSMD11;PSMB10;PSMB8;PSMB9;PSMA5;PSMA4;CCND1;UBB;PSMB2;UBC;PSME1;PSME2,4
6982,protein deubiquitination (GO:0016579),7.18E-07,6.21E-05,0,0,4.210317755,59.56445536,USP25;PSMD11;DDX58;KEAP1;USP18;ACTB;PSMB8;PSMB10;PSMB9;IFIH1;PSMA5;PSMA4;PSMB2;UBB;UBC;PSME1;PSME2,4
6983,non-canonical Wnt signaling pathway (GO:0035567),8.22E-07,6.99E-05,0,0,5.990415335,83.93767726,PSMA5;CDC42;PSMD11;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6984,STAT cascade (GO:0097696),8.46E-07,7.08E-05,0,0,17.42666279,243.6732474,STAT1;STAT2;CCL2;NMI;JAK2;IFNAR1,4
6985,protein modification by small protein removal (GO:0070646),8.89E-07,7.31E-05,0,0,4.146038095,57.7691428,USP25;PSMD11;DDX58;KEAP1;USP18;ACTB;PSMB8;PSMB10;PSMB9;IFIH1;PSMA5;PSMA4;PSMB2;UBB;UBC;PSME1;PSME2,4
6986,regulation of mRNA stability (GO:0043488),8.93E-07,7.24E-05,0,0,5.943978007,82.78937096,PSMA5;PSMD11;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;DCP2;PSMB10;PSMB8;PSMB9,4
6987,positive regulation of canonical Wnt signaling pathway (GO:0090263),1.78E-06,0.00014186,0,0,6.165573679,81.62833015,PSMA5;PSMD11;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6988,response to type I interferon (GO:0034340),1.98E-06,0.000155803,0,0,36.51300776,479.419956,SP100;MX1;ISG15;IFIT1,4
6989,regulation of type I interferon-mediated signaling pathway (GO:0060338),2.57E-06,0.00019898,0,0,11.18210863,143.9163543,ZBP1;STAT1;STAT2;NLRC5;PTPN6;USP18;IFNAR1,4
6990,positive regulation of interferon-beta production (GO:0032728),3.14E-06,0.00023931,0,0,14.19950302,179.9168165,IFIH1;DDX58;IRF1;IRF7;IRF5;TLR7,4
6991,regulation of interferon-alpha production (GO:0032647),3.45E-06,0.000258699,0,0,19.96805112,251.1565545,IFIH1;STAT1;DDX58;IRF7;IRF5,4
6992,positive regulation of response to biotic stimulus (GO:0002833),4.82E-06,0.000356561,0,0,18.79345988,230.0785854,CD180;DHX58;LY86;ACOD1;DDX60,4
6993,response to lipopolysaccharide (GO:0032496),6.59E-06,0.000480595,0,0,4.915212583,58.63639336,CD86;CD274;CXCL10;CD40;GCH1;ACOD1;CCL2;NR1H3;LGALS9;CCR5;JAK2;IFNAR1,4
6994,regulation of mitotic cell cycle phase transition (GO:1901990),7.36E-06,0.000528972,0,0,4.490113116,53.07079538,DYNC1I2;PSMD11;PSMB10;PSMB8;PSMB9;PSMA5;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PTPN6,4
6995,cellular response to hypoxia (GO:0071456),8.02E-06,0.000568385,0,0,5.284777439,62.00961852,PSMA5;PSMD11;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
6996,negative regulation of protein binding (GO:0032091),1.08E-05,0.000752381,0,0,7.51738395,85.99430489,HSPA5;BAX;TMBIM6;MITD1;IFIT1;B2M;ACTB;IFIT2,4
6997,T cell receptor signaling pathway (GO:0050852),1.10E-05,0.000757581,0,0,4.675446115,53.38844451,PSMA5;PSMD11;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;CSK;PSMB10;PSMB8;PSMB9,4
6998,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1.30E-05,0.000885781,0,0,11.27607593,126.8461125,ZBP1;CASP4;NLRC5;CD300LF;PARP14;PARP9,4
6999,cellular response to lipopolysaccharide (GO:0071222),1.40E-05,0.00093814,0,0,6.250868176,69.87509095,CD86;HCK;CD274;CXCL10;IL18;ACOD1;CCL2;NR1H3;CCR5,4
7000,positive regulation of Wnt signaling pathway (GO:0030177),1.40E-05,0.000927304,0,0,4.98493191,55.71662332,PSMA5;PSMD11;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
7001,cellular response to interferon-beta (GO:0035458),1.78E-05,0.001164901,0,0,23.23555039,254.1038417,PNPT1;STAT1;IRF1;ACOD1,4
7002,negative regulation of Wnt signaling pathway (GO:0030178),2.11E-05,0.00136318,0,0,4.381560931,47.17219577,PSMA5;PSMD11;RNF213;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
7003,negative regulation of canonical Wnt signaling pathway (GO:0090090),2.35E-05,0.001499016,0,0,4.717284559,50.27919511,PSMA5;PSMD11;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
7004,regulation of defense response (GO:0031347),2.46E-05,0.001552215,0,0,6.726080377,71.37183128,HCK;IRF1;CASP4;DHX58;JAK2;SAMHD1;USP18;MYD88,4
7005,Fc-epsilon receptor signaling pathway (GO:0038095),3.29E-05,0.00204458,0,0,4.190017284,43.25533996,PSMA5;PSMD11;FCER1G;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
7006,Fc receptor signaling pathway (GO:0038093),3.47E-05,0.00213111,0,0,4.167245451,42.79700803,PSMA5;PSMD11;FCER1G;PSMA4;UBB;PSMB2;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9,4
7007,JAK-STAT cascade (GO:0007259),3.97E-05,0.002411674,0,0,9.350892231,94.76382506,STAT1;STAT2;CCL2;NMI;JAK2;IFNAR1,4
7008,negative regulation of binding (GO:0051100),4.69E-05,0.002814882,0,0,6.158820586,61.38969233,SP100;BAX;TMBIM6;MITD1;IFIT1;JAK2;ACTB;IFIT2,4
7009,positive regulation of cytokine production (GO:0001819),4.83E-05,0.0028671,0,0,3.758691975,37.35271815,ZBP1;GBP5;DDX58;IL18;EIF2AK2;DDX60;IRF1;DHX58;IRF7;TLR7;IRF5;LGALS9;MYD88,4
7010,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),5.06E-05,0.002967016,0,0,7.21426363,71.36258969,CD40;SOCS1;IL18;HCLS1;JAK2;PARP9;PARP14,4
7011,regulation of response to interferon-gamma (GO:0060330),5.20E-05,0.003017739,0,0,18.25650388,180.0729229,SOCS1;STAT1;PARP9;JAK2,4
7012,protein ubiquitination (GO:0016567),5.40E-05,0.003097253,0,0,2.646652929,26.0065069,PSMD11;RNF34;UBA7;DTX3L;KEAP1;ISG15;MARCH5;PSMB8;PSMB10;PSMB9;PSMA5;RNF114;RNF213;PSMA4;PSMB2;UBB;UBC;PSME1;PELI1;PSME2;HERC6,4
7013,regulation of cytokine production (GO:0001817),5.44E-05,0.003083126,0,0,5.27596213,51.80776174,ZBP1;IFIH1;UBB;DDX58;UBC;IRF7;EIF2AK2;ISG15;CSK,4
7014,regulation of protein binding (GO:0043393),6.73E-05,0.003772404,0,0,5.134641716,49.32730698,DTX3L;BAX;TMBIM6;MITD1;AIDA;IFIT1;B2M;ACTB;IFIT2,4
7015,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),7.01E-05,0.003887768,0,0,17.03940362,162.9940845,PARP10;PNP;NAMPT;PARP9,4
7016,regulation of primary metabolic process (GO:0080090),7.29E-05,0.003997762,0,0,4.56412597,43.48245034,PSMA5;PSMD11;PSMA4;PSMB2;PSME1;PSME2;PLIN2;PSMB10;PSMB8;PSMB9,4
7017,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),7.33E-05,0.003980315,0,0,31.94888179,304.1751853,TAP1;CALR;TAPBP,4
7018,positive regulation of intracellular signal transduction (GO:1902533),7.50E-05,0.00402737,0,0,2.662406816,25.28846835,CD86;CD40;IL18;SHISA5;EIF2AK2;DDX60;MERTK;BST2;CXCL10;CASP8;UBB;DHX58;UBC;PELI1;HCLS1;BAX;PTPN6;LGALS9;JAK2;MYD88,4
7019,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),7.93E-05,0.004215951,0,0,11.01685579,104.0224277,FCER1G;TAP1;CALR;B2M;TAPBP,4
7020,regulation of G1/S transition of mitotic cell cycle (GO:2000045),8.76E-05,0.0046097,0,0,8.157161308,76.2079976,CDKN1A;CCND2;PSME1;PSME2;PTPN6;AIF1,4
7021,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),9.40E-05,0.004892805,0,0,10.64962726,98.74979733,CASP8;UBB;UBC;IRF7;CD300LF,4
7022,positive regulation of T cell activation (GO:0050870),0.000101082,0.005210294,0,0,6.482381812,59.63520994,CD86;CD274;PNP;CCL2;LGALS9;CD47;AIF1,4
7023,proteasomal protein catabolic process (GO:0010498),0.000102618,0.005236596,0,0,3.490213977,32.055861,PSMD11;RNF34;KEAP1;PSMB8;PSMB10;PSMB9;PSMA5;PSMA4;PSMB2;UBB;UBC;PSME1;PSME2,4
7024,ubiquitin-dependent protein catabolic process (GO:0006511),0.000105719,0.005341443,0,0,2.989369056,27.36684515,RANBP2;PSMD11;RNF34;UBA7;DTX3L;PSMB8;PSMB10;PSMB9;PSMA5;RNF213;PSMA4;PSMB2;UBB;UBC;PSME1;PSME2,4
7025,regulation of defense response to virus by host (GO:0050691),0.000110608,0.005533629,0,0,10.3060909,93.88356729,DTX3L;DDX58;STAT1;IFIT1;PARP9,4
7026,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.000110608,0.005479904,0,0,10.3060909,93.88356729,CASP8;UBB;UBC;IRF7;CD300LF,4
7027,response to interferon-alpha (GO:0035455),0.000119224,0.00585002,0,0,15.0347679,135.8316597,IFITM3;BST2;EIF2AK2;IFNAR1,4
7028,regulation of natural killer cell chemotaxis (GO:2000501),0.000126821,0.006163517,0,0,27.38475582,245.7160565,KLRK1;CCL7;CCL2,4
7029,response to molecule of bacterial origin (GO:0002237),0.000164006,0.007895481,0,0,5.163455643,45.00266294,CXCL10;CD40;GCH1;ACOD1;IRF5;LGALS9;JAK2;IFNAR1,4
7030,protein ADP-ribosylation (GO:0006471),0.000189426,0.009034047,0,0,13.45216075,115.3053292,PARP10;ARF4;PARP14;PARP9,4
7031,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.000192293,0.009085846,0,0,7.099751509,60.74895332,CD40;IL18;HCLS1;JAK2;PARP9;PARP14,4
7032,cellular response to interleukin-21 (GO:0098757),0.000200563,0.009389646,0,0,23.96166134,204.0187782,STAT1;IL21R;IL2RG,4
7033,interleukin-21-mediated signaling pathway (GO:0038114),0.000200563,0.009304286,0,0,23.96166134,204.0187782,STAT1;IL21R;IL2RG,4
7034,regulation of interferon-beta production (GO:0032648),0.000200783,0.009230569,0,0,9.12825194,77.71144054,IFIH1;DDX58;IRF1;IRF7;IRF5,4
7035,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.000220551,0.010048843,0,0,3.063591404,25.79354865,PSMD11;RNF34;HSPA5;PSMB8;PSMB10;PSMB9;PSMA5;PSMA4;PSMB2;PTTG1;UBB;UBC;PSME1;PSME2,4
7036,negative regulation of innate immune response (GO:0045824),0.000233878,0.010561752,0,0,12.77955272,106.8461613,DHX58;NLRC5;ACOD1;TRAFD1,4
7037,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.000268044,0.011998497,0,0,3.896205096,32.04379081,BST2;CD40;CASP8;UBB;UBC;SHISA5;PELI1;TLR7;LGALS9;MYD88,4
7038,positive regulation of defense response to virus by host (GO:0002230),0.000285365,0.012662747,0,0,12.17100259,99.33659063,DTX3L;STAT1;DDX58;PARP9,4
7039,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.00029736,0.013081285,0,0,21.29925453,172.9620099,NAMPT;CCL2;JAK2,4
7040,positive regulation of multi-organism process (GO:0043902),0.00029877,0.01303099,0,0,8.407600471,68.23469724,DHX58;CD180;LY86;ACOD1;DDX60,4
7041,apoptotic process (GO:0006915),0.000311038,0.013451069,0,0,3.305056737,26.69030283,DAXX;CASP8;IRF1;CASP4;MX1;LY86;TSPO;BAX;PTPN6;JAK2;MYD88;IFIT2,4
7042,positive regulation of innate immune response (GO:0045089),0.000338359,0.014509616,0,0,8.192020972,65.46574975,ZBP1;GBP5;DHX58;NLRC5;DDX60,4
7043,NAD biosynthetic process (GO:0009435),0.000344504,0.014650026,0,0,11.6177752,92.63323073,PARP10;PNP;NAMPT;PARP9,4
7044,cellular response to molecule of bacterial origin (GO:0071219),0.000373786,0.015763904,0,0,5.262168765,41.52811932,CD86;CD274;CXCL10;ACOD1;CCL2;NR1H3;CCR5,4
7045,positive regulation of phagocytosis (GO:0050766),0.000381791,0.015969487,0,0,7.987220447,62.86452304,FCER1G;CCL2;CALR;CD300LF;MERTK,4
7046,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.000411922,0.017089727,0,0,11.11265454,86.61955575,UBB;PSME1;PSME2;CTSC,4
7047,positive regulation of type 2 immune response (GO:0002830),0.000419885,0.017279603,0,0,19.16932907,149.0517093,CD86;RSAD2;IL18,4
7048,toll-like receptor signaling pathway (GO:0002224),0.000430917,0.017591736,0,0,5.141199368,39.84221894,CASP8;UBB;CD180;UBC;TLR7;MYD88;LGMN,4
7049,positive regulation of JAK-STAT cascade (GO:0046427),0.000532639,0.021571861,0,0,5.8982551,44.45908586,CD40;IL18;HCLS1;JAK2;PARP9;PARP14,4
7050,translesion synthesis (GO:0019985),0.00053755,0.021599369,0,0,7.429972509,55.93645852,UBA7;UBB;UBC;UBE2L6;ISG15,4
7051,positive regulation of response to external stimulus (GO:0032103),0.00056604,0.022566406,0,0,4.915212583,36.75029032,DHX58;CD180;IL18;LY86;ACOD1;TLR7;DDX60,4
7052,positive regulation of tumor necrosis factor secretion (GO:1904469),0.000570665,0.022574451,0,0,17.42666279,130.1546554,IFIH1;DDX58;LGALS9,4
7053,regulation of canonical Wnt signaling pathway (GO:0060828),0.000578721,0.022717011,0,0,3.284464483,24.48466679,PSMA5;PSMA4;PSMD11;PSMB2;UBB;UBC;PSME1;PSME2;PSMB8;PSMB10;PSMB9,4
7054,regulation of immune response (GO:0050776),0.000651615,0.025383158,0,0,3.042750647,22.321789,CD40;KLRK1;IRF1;DHX58;TREML2;SPPL2A;IRF7;CSK;CD300LF;SAMHD1;B2M;CLEC2D,4
7055,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.000670228,0.025910418,0,0,9.830425166,71.83968636,RNF34;CASP8;UBB;UBC,4
7056,inflammatory response (GO:0006954),0.000674692,0.025886861,0,0,3.030723964,22.128087,TPST1;CXCL10;CD40;CCL7;CD180;C3AR1;IL18;CCL2;LGALS9;NMI;SIGLEC1;AIF1,4
7057,vesicle fusion (GO:0006906),0.000732865,0.027909025,0,0,4.708256264,33.98677979,SAMD9L;STX16;STX6;TAP1;CALR;SNAP29;TAPBP,4
7058,negative regulation of leukocyte apoptotic process (GO:2000107),0.000752095,0.028429185,0,0,15.97444089,114.8985325,IRF7;HCLS1;MERTK,4
7059,antigen receptor-mediated signaling pathway (GO:0050851),0.00080061,0.030040519,0,0,2.971989004,21.19068931,PSMA5;PSMA4;PSMD11;PSMB2;UBB;UBC;PSME1;PSME2;CSK;PSMB8;PSMB10;PSMB9,4
7060,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.000895618,0.033360144,0,0,9.12825194,64.06203863,SOCS1;MVP;PTPN6;PARP14,4
7061,postreplication repair (GO:0006301),0.000897216,0.033177486,0,0,6.656017039,46.7000396,UBA7;UBB;UBC;UBE2L6;ISG15,4
7062,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.000966434,0.035479954,0,0,14.74563775,102.362704,NAMPT;CCL2;JAK2,4
7063,cellular response to exogenous dsRNA (GO:0071360),0.000966434,0.035226525,0,0,14.74563775,102.362704,IFIH1;DDX58;IFIT1,4
7064,regulation of necrotic cell death (GO:0010939),0.000966434,0.034976692,0,0,14.74563775,102.362704,CASP8;UBB;UBC,4
7065,cellular response to mechanical stimulus (GO:0071260),0.000986541,0.035452942,0,0,6.520179957,45.1281597,CD40;CASP8;IRF1;TLR7;MYD88,4
7066,regulation of inflammatory response (GO:0050727),0.001297987,0.046319082,0,0,3.443592049,22.88935149,HCK;CASP4;IL18;ACOD1;NR1H3;TLR7;JAK2;USP18;MYD88,4
7067,regulation of tumor necrosis factor secretion (GO:1904467),0.001502248,0.05323593,0,0,12.77955272,83.07721811,IFIH1;DDX58;LGALS9,4
7068,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.001502248,0.052868786,0,0,12.77955272,83.07721811,CASP8;LGALS9;JAK2,4
7069,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.001510405,0.052791764,0,0,3.116964077,20.24585785,BST2;CD40;CASP8;UBB;STAT1;UBC;PELI1;SHISA5;LGALS9;MYD88,4
7070,positive regulation of transcription factor import into nucleus (GO:0042993),0.00168336,0.058436631,0,0,7.745183464,49.46820521,DDX58;HCLS1;TLR7;LGALS9,4
7071,response to lipid (GO:0033993),0.001725802,0.059505172,0,0,3.625405026,23.06505754,CXCL10;CD40;GCH1;NR1H3;LGALS9;JAK2;ABCG1;IFNAR1,4
7072,modification-dependent protein catabolic process (GO:0019941),0.001804554,0.061802945,0,0,3.599874004,22.74199465,RANBP2;PSMD11;RNF213;RNF34;UBA7;DTX3L;UBC;ISG15,4
7073,protein catabolic process (GO:0030163),0.001809816,0.061569954,0,0,4.675446115,29.52324415,PSMA5;PSMA4;PSMB2;PSMB10;PSMB8;PSMB9,4
7074,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.001827621,0.061763924,0,0,11.98083067,75.53602106,HCK;IL18;CCL2,4
7075,cellular response to dsRNA (GO:0071359),0.001827621,0.061357582,0,0,11.98083067,75.53602106,IFIH1;DDX58;IFIT1,4
7076,regulation of protein homodimerization activity (GO:0043496),0.001827621,0.060956552,0,0,11.98083067,75.53602106,HSPA5;BAX;AIDA,4
7077,regulation of necroptotic process (GO:0060544),0.001827621,0.06056073,0,0,11.98083067,75.53602106,CASP8;UBB;UBC,4
7078,response to exogenous dsRNA (GO:0043330),0.001884567,0.062044797,0,0,7.51738395,47.16449832,IFIH1;DDX58;SLC3A2;IFIT1,4
7079,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.001956945,0.064014685,0,0,5.605066981,34.9552752,CASP8;UBB;SPPL2A;CASP4;UBC,4
7080,positive regulation of lymphocyte migration (GO:2000403),0.002193708,0.071302507,0,0,11.27607593,69.03396198,CXCL10;CCL7;AIF1,4
7081,positive regulation of interleukin-6 secretion (GO:2000778),0.002193708,0.070851226,0,0,11.27607593,69.03396198,IFIH1;DDX58;LGALS9,4
7082,virion assembly (GO:0019068),0.002193708,0.07040562,0,0,11.27607593,69.03396198,UBB;UBC;CHMP4B,4
7083,protein oligomerization (GO:0051259),0.002372666,0.075673204,0,0,2.931090072,17.71474989,KHDRBS1;CAMK2D;RNF213;SNX2;FCER1G;PNPT1;GCH1;CHMP2A;CHMP4B;BAX,4
7084,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.002602171,0.082477498,0,0,10.64962726,63.38029067,CAMK2D;BAX;TGM2,4
7085,regulation of chemokine production (GO:0032642),0.002602171,0.081968377,0,0,10.64962726,63.38029067,EIF2AK2;TLR7;LGALS9,4
7086,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.002602171,0.081465504,0,0,10.64962726,63.38029067,CDC42;HCK;HCLS1,4
7087,mitotic cell cycle phase transition (GO:0044772),0.002705697,0.084190085,0,0,2.878277639,17.01751597,RANBP2;DYNC1I2;KHDRBS1;CDKN1A;CDK7;CCND1;UBB;UBC;CHMP2A;CHMP4B,4
7088,positive regulation of T cell proliferation (GO:0042102),0.002838753,0.087794893,0,0,5.15304545,30.21947001,CD86;CD274;PNP;IL18;AIF1,4
7089,positive regulation of leukocyte chemotaxis (GO:0002690),0.002838753,0.087266008,0,0,5.15304545,30.21947001,CXCL10;CCL7;LGALS9;CALR;AIF1,4
7090,protein homooligomerization (GO:0051260),0.003233907,0.098818125,0,0,3.010889383,17.26463335,GBP5;RNF213;PNPT1;FCER1G;GCH1;CHMP2A;CHMP4B;BAX;SAMHD1,4
7091,negative regulation of cholesterol storage (GO:0010887),0.003512976,0.106706654,0,0,21.29925453,120.3682995,NR1H3;ABCG1,4
7092,arginine biosynthetic process (GO:0006526),0.003512976,0.106075254,0,0,21.29925453,120.3682995,ACOD1;ASS1,4
7093,regulation of nuclease activity (GO:0032069),0.003512976,0.105451282,0,0,21.29925453,120.3682995,OAS2;OAS3,4
7094,negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.003512976,0.104834608,0,0,21.29925453,120.3682995,NR1H3;PARP14,4
7095,negative regulation of response to interferon-gamma (GO:0060331),0.003512976,0.104225104,0,0,21.29925453,120.3682995,NR1H3;PARP14,4
7096,positive regulation of T-helper 2 cell differentiation (GO:0045630),0.003512976,0.103622647,0,0,21.29925453,120.3682995,CD86;IL18,4
7097,antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.003512976,0.103027114,0,0,21.29925453,120.3682995,TAP1;B2M,4
7098,regulation of interferon-alpha secretion (GO:1902739),0.003512976,0.102438388,0,0,21.29925453,120.3682995,IFIH1;DDX58,4
7099,regulation of interleukin-10 secretion (GO:2001179),0.003512976,0.101856352,0,0,21.29925453,120.3682995,CD274;LGALS9,4
7100,positive regulation of interferon-alpha secretion (GO:1902741),0.003512976,0.101280892,0,0,21.29925453,120.3682995,IFIH1;DDX58,4
7101,regulation of dendritic cell chemotaxis (GO:2000508),0.003512976,0.100711898,0,0,21.29925453,120.3682995,CALR;LGALS9,4
7102,regulation of response to cytokine stimulus (GO:0060759),0.003552332,0.101271235,0,0,9.584664537,54.05895475,IFIH1;DDX58;PARP9,4
7103,DNA synthesis involved in DNA repair (GO:0000731),0.003727152,0.105664754,0,0,4.840739665,27.06995317,UBA7;UBB;UBC;UBE2L6;ISG15,4
7104,regulation of phagocytosis (GO:0050764),0.00412461,0.116286646,0,0,6.085501293,33.4141725,HCK;FCER1G;CALR;MERTK,4
7105,regulation of cellular metabolic process (GO:0031323),0.00412461,0.115647709,0,0,6.085501293,33.4141725,ARF4;RNF34;NPC2;ABCG1,4
7106,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.00423895,0.118204157,0,0,4.698364969,25.66923385,CDKN1A;CDK7;CCND2;CCND1;SERTAD1,4
7107,response to tumor necrosis factor (GO:0034612),0.004422287,0.122646351,0,0,3.912107974,21.20792222,CASP8;CCL7;GCH1;ACOD1;CCL2;JAK2,4
7108,sterol transport (GO:0015918),0.004689304,0.129348735,0,0,8.713331397,46.72498874,STARD3;NPC2;ABCG1,4
7109,intracellular sterol transport (GO:0032366),0.004867445,0.133540707,0,0,18.25650388,97.21928133,NPC2;ABCG1,4
7110,positive regulation of dendritic cell chemotaxis (GO:2000510),0.004867445,0.132826585,0,0,18.25650388,97.21928133,CALR;LGALS9,4
7111,regulation of MDA-5 signaling pathway (GO:0039533),0.004867445,0.132120061,0,0,18.25650388,97.21928133,DHX58;DDX60,4
7112,positive regulation of apoptotic cell clearance (GO:2000427),0.004867445,0.131421013,0,0,18.25650388,97.21928133,CCL2;CD300LF,4
7113,regulation by virus of viral protein levels in host cell (GO:0046719),0.004867445,0.130729324,0,0,18.25650388,97.21928133,STAT1;IFIT1,4
7114,positive regulation of RIG-I signaling pathway (GO:1900246),0.004867445,0.130044877,0,0,18.25650388,97.21928133,DHX58;DDX60,4
7115,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.004867445,0.12936756,0,0,18.25650388,97.21928133,BAX;CYCS,4
7116,positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.004867445,0.128697262,0,0,18.25650388,97.21928133,ZBP1;NLRC5,4
7117,negative regulation of ERBB signaling pathway (GO:1901185),0.004881888,0.128413798,0,0,5.808887598,30.91619606,CDC42;UBB;UBC;LGMN,4
7118,positive regulation of interleukin-6 production (GO:0032755),0.004881888,0.127755266,0,0,5.808887598,30.91619606,IFIH1;DDX58;LGALS9;MYD88,4
7119,substantia nigra development (GO:0021762),0.004881888,0.127103453,0,0,5.808887598,30.91619606,CDC42;CNP;HSPA5;ACTB,4
7120,regulation of interferon-gamma production (GO:0032649),0.004881888,0.126458258,0,0,5.808887598,30.91619606,CD274;IL18;ISG15;LGALS9,4
7121,positive regulation of viral life cycle (GO:1903902),0.005293283,0.136422346,0,0,5.679801207,29.76963619,CHMP2A;CHMP4B;LGALS9;IFIT1,4
7122,positive regulation of lymphocyte proliferation (GO:0050671),0.005409668,0.138721274,0,0,4.437344693,23.16102075,CD86;CD274;PNP;IL18;AIF1,4
7123,interleukin-12-mediated signaling pathway (GO:0035722),0.00618428,0.157791907,0,0,5.438107539,27.65682643,CDC42;RAP1B;PSME2;JAK2,4
7124,cellular response to interleukin-12 (GO:0071349),0.00618428,0.157006873,0,0,5.438107539,27.65682643,CDC42;RAP1B;PSME2;JAK2,4
7125,positive regulation of chromatin binding (GO:0035563),0.006423079,0.162262244,0,0,15.97444089,80.63670358,DTX3L;PARP9,4
7126,negative regulation of activated T cell proliferation (GO:0046007),0.006423079,0.161462923,0,0,15.97444089,80.63670358,CD274;LGALS9,4
7127,regulation of T-helper 2 cell differentiation (GO:0045628),0.006423079,0.160671438,0,0,15.97444089,80.63670358,CD86;IL18,4
7128,regulation of apoptotic cell clearance (GO:2000425),0.006423079,0.159887675,0,0,15.97444089,80.63670358,CCL2;CD300LF,4
7129,positive regulation of tumor necrosis factor production (GO:0032760),0.006664924,0.165102455,0,0,5.324813632,26.68209144,IFIH1;DDX58;LGALS9;JAK2,4
7130,positive regulation of immune effector process (GO:0002699),0.006765715,0.166789593,0,0,7.667731629,38.30712283,DHX58;LGALS9;DDX60,4
7131,negative regulation of T cell proliferation (GO:0042130),0.006765715,0.16598772,0,0,7.667731629,38.30712283,CD86;CD274;LGALS9,4
7132,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.006765715,0.165193521,0,0,7.667731629,38.30712283,CASP8;UBB;UBC,4
7133,regulation of cell cycle G1/S phase transition (GO:1902806),0.006765715,0.164406885,0,0,7.667731629,38.30712283,PSME1;PSME2;PTPN6,4
7134,transmembrane transport (GO:0055085),0.0070179,0.169726748,0,0,2.191743869,10.86949619,PSMD11;TAP1;PSMB8;PSMB10;PSMB9;PSMA5;PSMA4;PSMB2;UBB;UBC;PSME1;PSME2;ABCG1,4
7135,viral life cycle (GO:0019058),0.007066507,0.17009616,0,0,3.549875754,17.58036551,RANBP2;UBB;UBC;CHMP2A;CHMP4B;CCL2,4
7136,pattern recognition receptor signaling pathway (GO:0002221),0.00716967,0.171769143,0,0,5.216143966,25.75677439,CD180;TLR7;MYD88;LGMN,4
7137,response to interleukin-1 (GO:0070555),0.007173036,0.171046735,0,0,4.149205427,20.48639609,CCL7;ACOD1;CCL2;LGALS9;MYD88,4
7138,positive regulation of cell proliferation (GO:0008284),0.007389861,0.17539748,0,0,2.104867506,10.32994547,CD86;CDKN1A;STAT1;IL18;AIF1;HCK;SDCBP;CCND2;SERTAD1;NAMPT;HCLS1;PTPN6;CALR;CD47,4
7139,regulation of spindle assembly (GO:0090169),0.007560782,0.178623463,0,0,7.372818874,36.01460348,GPSM2;CHMP2A;CHMP4B,4
7140,positive regulation of cytoskeleton organization (GO:0051495),0.007568563,0.177983314,0,0,4.096010486,20.00389942,CDC42;GPSM2;HCK;HCLS1;PFDN2,4
7141,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.007708556,0.180443862,0,0,3.485332559,16.957622,CASP8;CASP4;CYCS;BAX;LGALS9;JAK2,4
7142,macroautophagy (GO:0016236),0.008044875,0.187456614,0,0,3.453933166,16.65735257,PLEKHF2;UBB;UBC;CHMP2A;CHMP4B;SNAP29,4
7143,ATF6-mediated unfolded protein response (GO:0036500),0.008173292,0.189583217,0,0,14.19950302,68.25535743,HSPA5;CALR,4
7144,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.008173292,0.188725374,0,0,14.19950302,68.25535743,SOCS1;PARP14,4
7145,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.008173292,0.18787526,0,0,14.19950302,68.25535743,HSPA5;BAX,4
7146,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.008173292,0.18703277,0,0,14.19950302,68.25535743,GBP5;MYD88,4
7147,viral process (GO:0016032),0.008251382,0.187976798,0,0,2.602171367,12.48359074,RANBP2;HCK;UBB;UBC;CHMP2A;IRF7;CHMP4B;CCL2;B2M,4
7148,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.008404694,0.190618469,0,0,3.993610224,19.08532297,CASP8;CASP4;BAX;CYCS;JAK2,4
7149,apoptotic cell clearance (GO:0043277),0.008408736,0.189866273,0,0,7.099751509,33.92605014,NR1H3;PDIA6;TGM2,4
7150,peptidyl-tyrosine modification (GO:0018212),0.008833341,0.198575052,0,0,4.915212583,23.24513158,HCK;TPST1;PTPN6;JAK2,4
7151,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.009310312,0.208379491,0,0,6.846188955,32.01711071,DAXX;CASP8;BAX,4
7152,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.009775613,0.217838224,0,0,3.849262866,17.81386682,CDKN1A;SP100;UBB;UBC;BAX,4
7153,ephrin receptor signaling pathway (GO:0048013),0.009775613,0.216891101,0,0,3.849262866,17.81386682,ACTR3;CDC42;SDCBP;ACTB;MYL12A,4
7154,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.01007155,0.222489694,0,0,4.733167672,21.76329745,IL18;HCLS1;PTPN6;JAK2,4
7155,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.010111651,0.22241273,0,0,12.77955272,58.71012124,GBP5;EIF2AK2,4
7156,positive regulation of T cell apoptotic process (GO:0070234),0.010111651,0.221458169,0,0,12.77955272,58.71012124,CD274;LGALS9,4
7157,Rap protein signal transduction (GO:0032486),0.010111651,0.220511767,0,0,12.77955272,58.71012124,RAP2C;RAP1B,4
7158,intracellular cholesterol transport (GO:0032367),0.010111651,0.219573419,0,0,12.77955272,58.71012124,NPC2;ABCG1,4
7159,regulation of defense response to virus by virus (GO:0050690),0.010266171,0.221984198,0,0,6.610113474,30.26705623,HCK;EIF2AK2;B2M,4
7160,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.010266171,0.221047556,0,0,6.610113474,30.26705623,CASP8;UBB;UBC,4
7161,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.01028778,0.220582115,0,0,3.276808389,14.99729158,CD40;IL18;HCLS1;PARP14;JAK2;PARP9,4
7162,post-translational protein modification (GO:0043687),0.011140425,0.237864382,0,0,2.141824477,9.632159325,PSMA5;PSMA4;PSMD11;PSMB2;PSME1;SHISA5;KEAP1;PSME2;PDIA6;PSMB8;PSMB10;PSMB9,4
7163,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.011276898,0.239775043,0,0,6.389776358,28.65814106,CDK7;UBB;UBC,4
7164,regulation of macrophage derived foam cell differentiation (GO:0010743),0.011276898,0.238780125,0,0,6.389776358,28.65814106,IL18;NR1H3;ABCG1,4
7165,negative regulation of Notch signaling pathway (GO:0045746),0.011276898,0.237793431,0,0,6.389776358,28.65814106,MMP14;UBB;UBC,4
7166,negative regulation of lymphocyte proliferation (GO:0050672),0.011276898,0.236814857,0,0,6.389776358,28.65814106,CD86;CD274;LST1,4
7167,regulation of activated T cell proliferation (GO:0046006),0.011276898,0.235844304,0,0,6.389776358,28.65814106,CD274;IL18;LGALS9,4
7168,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.011276898,0.234881674,0,0,6.389776358,28.65814106,UBB;UBC;MYD88,4
7169,regulation of phosphorylation (GO:0042325),0.011561484,0.239830299,0,0,3.194888179,14.24944421,RANBP2;SDCBP;CDKN1A;SOCS1;STAT2;NLRC5,4
7170,interleukin-27-mediated signaling pathway (GO:0070106),0.012231877,0.252709587,0,0,11.6177752,51.16131133,STAT1;JAK2,4
7171,negative regulation of leukocyte activation (GO:0002695),0.012231877,0.251690596,0,0,11.6177752,51.16131133,NR1H3;CD300LF,4
7172,Golgi ribbon formation (GO:0090161),0.012231877,0.250679791,0,0,11.6177752,51.16131133,STX16;STX6,4
7173,urea cycle (GO:0000050),0.012231877,0.249677072,0,0,11.6177752,51.16131133,ACOD1;ASS1,4
7174,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),0.012231877,0.248682342,0,0,11.6177752,51.16131133,CASP8;JAK2,4
7175,relaxation of cardiac muscle (GO:0055119),0.012231877,0.247695508,0,0,11.6177752,51.16131133,CAMK2D;RGS2,4
7176,regulation of chromatin binding (GO:0035561),0.012231877,0.246716474,0,0,11.6177752,51.16131133,DTX3L;PARP9,4
7177,relaxation of muscle (GO:0090075),0.012231877,0.245745149,0,0,11.6177752,51.16131133,CAMK2D;RGS2,4
7178,macrophage differentiation (GO:0030225),0.012231877,0.244781443,0,0,11.6177752,51.16131133,CDC42;CASP8,4
7179,arginine metabolic process (GO:0006525),0.012231877,0.243825265,0,0,11.6177752,51.16131133,ACOD1;ASS1,4
7180,"regulation of symbiosis, encompassing mutualism through parasitism (GO:0043903)",0.012231877,0.242876529,0,0,11.6177752,51.16131133,CHMP2A;CHMP4B,4
7181,interleukin-35-mediated signaling pathway (GO:0070757),0.012231877,0.241935147,0,0,11.6177752,51.16131133,STAT1;JAK2,4
7182,positive regulation of T-helper cell differentiation (GO:0045624),0.012231877,0.241001034,0,0,11.6177752,51.16131133,CD86;IL18,4
7183,regulation of actin cytoskeleton reorganization (GO:2000249),0.012343009,0.242255297,0,0,6.18365454,27.17509272,CDC42;HCK;HCLS1,4
7184,nuclear envelope organization (GO:0006998),0.012343009,0.241327116,0,0,6.18365454,27.17509272,CHMP2A;TOR1AIP2;CHMP4B,4
7185,cholesterol homeostasis (GO:0042632),0.013643272,0.265731363,0,0,4.332051768,18.60403432,NPC2;IL18;NR1H3;ABCG1,4
7186,sterol homeostasis (GO:0055092),0.013643272,0.264720977,0,0,4.332051768,18.60403432,NPC2;IL18;NR1H3;ABCG1,4
7187,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.014527841,0.280816555,0,0,10.64962726,45.06590448,DTX3L;PARP9,4
7188,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.014527841,0.27975687,0,0,10.64962726,45.06590448,HSPA5;BAX,4
7189,carbohydrate derivative transport (GO:1901264),0.014527841,0.278705152,0,0,10.64962726,45.06590448,NPC2;ABCG1,4
7190,modification-dependent macromolecule catabolic process (GO:0043632),0.014527841,0.277661313,0,0,10.64962726,45.06590448,UBC;ISG15,4
7191,entry of bacterium into host cell (GO:0035635),0.014527841,0.276625263,0,0,10.64962726,45.06590448,UBB;UBC,4
7192,regulation of cholesterol storage (GO:0010885),0.014527841,0.275596916,0,0,10.64962726,45.06590448,NR1H3;ABCG1,4
7193,exit from mitosis (GO:0010458),0.014527841,0.274576187,0,0,10.64962726,45.06590448,CHMP2A;CHMP4B,4
7194,positive regulation of peptidase activity (GO:0010952),0.014527841,0.273562991,0,0,10.64962726,45.06590448,PSME1;PSME2,4
7195,PERK-mediated unfolded protein response (GO:0036499),0.014527841,0.272557244,0,0,10.64962726,45.06590448,HSPA5;CCL2,4
7196,positive regulation of mRNA metabolic process (GO:1903313),0.014527841,0.271558866,0,0,10.64962726,45.06590448,PNPT1;ZC3HAV1,4
7197,positive regulation of T cell cytokine production (GO:0002726),0.014527841,0.270567775,0,0,10.64962726,45.06590448,RSAD2;B2M,4
7198,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.014527841,0.269583893,0,0,10.64962726,45.06590448,DDX58;IL18,4
7199,cellular protein modification process (GO:0006464),0.014871889,0.27496829,0,0,1.594255578,6.709077872,CAMK2D;PSMD11;UBA7;KEAP1;UBE2L6;PSMB10;PSMB2;CCL2;CSK;JAK2;USP25;SHISA5;EIF2AK2;ISG15;MERTK;PDIA6;PSMB8;PSMB9;PSMA5;HCK;CDK7;PSMA4;PSME1;PSME2;PTPN6,4
7200,G2/M transition of mitotic cell cycle (GO:0000086),0.014958689,0.275574701,0,0,3.01879198,12.68636135,KHDRBS1;DYNC1I2;CDK7;CDKN1A;UBB;UBC,4
7201,cell cycle G2/M phase transition (GO:0044839),0.015494898,0.28442614,0,0,2.995207668,12.4817625,KHDRBS1;DYNC1I2;CDK7;CDKN1A;UBB;UBC,4
7202,entry into host cell (GO:0030260),0.015877818,0.290410417,0,0,5.638037963,23.35744536,UBB;UBC;CCR5,4
7203,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.016044284,0.292407079,0,0,2.971989004,12.28145514,CD40;UBB;UBC;EIF2AK2;LGALS9;MYD88,4
7204,protein targeting to membrane (GO:0006612),0.016127633,0.292880116,0,0,4.12243636,17.01420644,RTP4;SDCBP;ARL6IP1;CHMP4B,4
7205,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.016993558,0.307511088,0,0,9.830425166,40.05820539,NR1H3;ABCG1,4
7206,regulation of cell aging (GO:0090342),0.016993558,0.306424476,0,0,9.830425166,40.05820539,PNPT1;MARCH5,4
7207,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.016993558,0.305345517,0,0,9.830425166,40.05820539,DDX58;IL18,4
7208,glutamine family amino acid biosynthetic process (GO:0009084),0.016993558,0.304274129,0,0,9.830425166,40.05820539,ACOD1;ASS1,4
7209,cellular response to interleukin-15 (GO:0071350),0.016993558,0.303210234,0,0,9.830425166,40.05820539,IL15RA;IL2RG,4
7210,toll-like receptor 9 signaling pathway (GO:0034162),0.016993558,0.302153752,0,0,9.830425166,40.05820539,TLR7;MYD88,4
7211,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.016993558,0.301104607,0,0,9.830425166,40.05820539,IL18;LGALS9,4
7212,positive regulation of interleukin-17 production (GO:0032740),0.016993558,0.300062723,0,0,9.830425166,40.05820539,IL18;MYD88,4
7213,interleukin-15-mediated signaling pathway (GO:0035723),0.016993558,0.299028024,0,0,9.830425166,40.05820539,IL15RA;IL2RG,4
7214,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.017014613,0.298369662,0,0,4.057000862,16.52693422,CDKN1A;UBB;UBC;BAX,4
7215,regulation of T cell proliferation (GO:0042129),0.017014613,0.297347848,0,0,4.057000862,16.52693422,CD86;CD274;PNP;AIF1,4
7216,positive regulation of chemokine production (GO:0032722),0.01716932,0.299027442,0,0,5.476951164,22.2617866,EIF2AK2;TLR7;LGALS9,4
7217,iron ion homeostasis (GO:0055072),0.017931508,0.311239746,0,0,3.993610224,16.05908902,UBB;UBC;B2M;HMOX2,4
7218,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),0.017931508,0.310184696,0,0,3.993610224,16.05908902,CDKN1A;UBB;UBC;BAX,4
7219,regulation of apoptotic process (GO:0042981),0.01811346,0.3122736,0,0,1.644427739,6.595964072,ARF4;CD40;ARL6IP1;GADD45B;HSPA5;STAT1;MERTK;IFIT3;IFIT2;HCK;CCND2;UBB;UBC;TMEM219;BAX;TMBIM6;IRF5;CALR;JAK2;MYD88;TGM2,4
7220,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.018517826,0.318169926,0,0,5.324813632,21.24079565,CDKN1A;CDK7;SERTAD1,4
7221,regulation of mitotic spindle organization (GO:0060236),0.018517826,0.317102242,0,0,5.324813632,21.24079565,GPSM2;CHMP2A;CHMP4B,4
7222,positive regulation of ATPase activity (GO:0032781),0.018517826,0.316041699,0,0,5.324813632,21.24079565,DYNC1I2;TOR1AIP2;TOR1AIP1,4
7223,positive regulation of endocytosis (GO:0045807),0.018878586,0.321124741,0,0,3.932170066,15.60964183,FCER1G;CALR;MERTK;B2M,4
7224,positive regulation of response to cytokine stimulus (GO:0060760),0.019623189,0.332681507,0,0,9.12825194,35.88355363,IFIH1;DDX58,4
7225,purine-containing compound salvage (GO:0043101),0.019623189,0.331579912,0,0,9.12825194,35.88355363,PNP;DCK,4
7226,interleukin-6-mediated signaling pathway (GO:0070102),0.019623189,0.330485589,0,0,9.12825194,35.88355363,STAT1;JAK2,4
7227,regulation of mRNA catabolic process (GO:0061013),0.019623189,0.329398465,0,0,9.12825194,35.88355363,PNPT1;ZC3HAV1,4
7228,regulation of adaptive immune response (GO:0002819),0.019623189,0.32831847,0,0,9.12825194,35.88355363,IRF1;IRF7,4
7229,actin polymerization or depolymerization (GO:0008154),0.019923486,0.332253421,0,0,5.18089975,20.2876577,EVL;JAK2;AIF1,4
7230,natural killer cell activation (GO:0030101),0.019923486,0.331171162,0,0,5.18089975,20.2876577,CASP8;KLRK1;IL21R,4
7231,phagocytosis (GO:0006909),0.020270921,0.335852304,0,0,2.819018981,10.99013687,CDC42;NR1H3;MERTK;PDIA6;AIF1;TGM2,4
7232,positive regulation of smooth muscle cell proliferation (GO:0048661),0.021386393,0.353186937,0,0,5.044560282,19.3963363,STAT1;IL18;AIF1,4
7233,negative regulation of apoptotic process (GO:0043066),0.021476618,0.353532843,0,0,1.840676317,7.069652066,ARF4;ARL6IP1;HSPA5;MERTK;IFIT3;HCK;CCND2;UBB;UBC;HCLS1;CCL2;TMBIM6;MYD88;LGMN,4
7234,extrinsic apoptotic signaling pathway (GO:0097191),0.021903373,0.359398426,0,0,3.758691975,14.36239298,DAXX;CASP8;BAX;JAK2,4
7235,negative regulation of cellular process (GO:0048523),0.021913327,0.358409313,0,0,1.791526082,6.844812586,CD164;CDKN1A;SP100;EIF2AK2;MARCH5;IFIT3;BST2;IRF1;CHMP2A;CHMP4B;LPXN;TMBIM6;CSK;PTPN6;JAK2,4
7236,pyrimidine nucleoside biosynthetic process (GO:0046134),0.022411033,0.365378601,0,0,8.51970181,32.35954751,ACOD1;DCK,4
7237,transport along microtubule (GO:0010970),0.022411033,0.364214975,0,0,8.51970181,32.35954751,CDC42;DYNC1I2,4
7238,L-alpha-amino acid transmembrane transport (GO:1902475),0.022411033,0.363058737,0,0,8.51970181,32.35954751,SLC3A2;SLC25A22,4
7239,regulation of establishment of cell polarity (GO:2000114),0.022411033,0.361909817,0,0,8.51970181,32.35954751,RAP1B;RUFY3,4
7240,positive regulation of viral release from host cell (GO:1902188),0.022411033,0.360768146,0,0,8.51970181,32.35954751,CHMP2A;CHMP4B,4
7241,positive regulation of interleukin-4 production (GO:0032753),0.022411033,0.359633655,0,0,8.51970181,32.35954751,CD86;LGALS9,4
7242,positive regulation of NF-kappaB import into nucleus (GO:0042346),0.022411033,0.358506277,0,0,8.51970181,32.35954751,TLR7;LGALS9,4
7243,positive regulation of double-strand break repair (GO:2000781),0.022411033,0.357385944,0,0,8.51970181,32.35954751,DTX3L;PARP9,4
7244,positive regulation of exosomal secretion (GO:1903543),0.022411033,0.356272593,0,0,8.51970181,32.35954751,SDCBP;CHMP2A,4
7245,negative regulation of mRNA processing (GO:0050686),0.022411033,0.355166156,0,0,8.51970181,32.35954751,TMBIM6;SRSF7,4
7246,cellular response to lipid (GO:0071396),0.022875765,0.361408759,0,0,2.498795224,9.439641798,CD86;CD274;CXCL10;ACOD1;CCL2;NR1H3;CCR5,4
7247,regulation of endopeptidase activity (GO:0052548),0.022973564,0.361833631,0,0,3.704218178,13.97753807,PSME1;PSME2;PSMB8;PSMB9,4
7248,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.023094289,0.36261587,0,0,1.931418546,7.277913255,ACTR3;CDC42;HCK;SDCBP;UBB;MVP;NCF4;UBC;CSK;JAK2;ACTB;MYL12A,4
7249,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.024484081,0.383258482,0,0,4.792332268,17.77826899,SP100;RNF34;CASP8,4
7250,regulation of proteasomal protein catabolic process (GO:0061136),0.024484081,0.382086438,0,0,4.792332268,17.77826899,UBB;PSME1;PSME2,4
7251,regulation of cell proliferation (GO:0042127),0.024689062,0.384110625,0,0,1.638404194,6.06438102,CD86;CD164;CD40;CDKN1A;EIF2AK2;IFIT3;HCK;SDCBP;CXCL10;CCND2;SERTAD1;IRF1;NAMPT;HCLS1;CSK;PTPN6;CALR;CD47;JAK2,4
7252,Ras protein signal transduction (GO:0007265),0.025153124,0.390141003,0,0,2.282062985,8.404320375,RAP2C;RAP1B;CDC42;GPSM2;CDKN1A;RAB5C;G3BP2;AIF1,4
7253,positive regulation of macromolecule biosynthetic process (GO:0010557),0.02519691,0.389635849,0,0,2.681025045,9.868944143,NAMPT;NLRC5;CCL2;NR1H3;CALR;JAK2,4
7254,C21-steroid hormone biosynthetic process (GO:0006700),0.025351528,0.390842434,0,0,7.987220447,29.35236653,STARD3;TSPO,4
7255,regulation of RIG-I signaling pathway (GO:0039535),0.025351528,0.389665197,0,0,7.987220447,29.35236653,DHX58;DDX60,4
7256,cytoplasmic sequestering of transcription factor (GO:0042994),0.025351528,0.388495032,0,0,7.987220447,29.35236653,G3BP2;KEAP1,4
7257,regulation of exosomal secretion (GO:1903541),0.025351528,0.387331873,0,0,7.987220447,29.35236653,SDCBP;CHMP2A,4
7258,positive regulation of myotube differentiation (GO:0010831),0.025351528,0.386175658,0,0,7.987220447,29.35236653,CD53;MMP14,4
7259,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.025351528,0.385026326,0,0,7.987220447,29.35236653,CCND2;AIF1,4
7260,negative regulation of lipid storage (GO:0010888),0.025351528,0.383883815,0,0,7.987220447,29.35236653,NR1H3;ABCG1,4
7261,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.026118805,0.39433214,0,0,4.675446115,17.0424673,CDC42;UBB;UBC,4
7262,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.026118805,0.393168919,0,0,4.675446115,17.0424673,CCND2;CCND1;AIF1,4
7263,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.026118805,0.39201254,0,0,4.675446115,17.0424673,NLRC5;NR1H3;PARP14,4
7264,regulation of programmed cell death (GO:0043067),0.02630403,0.393634792,0,0,2.137843391,7.77754508,CD40;CASP8;UBB;STAT1;UBC;TMEM219;BAX;CALR;JAK2,4
7265,regulation of response to external stimulus (GO:0032101),0.027474243,0.409944628,0,0,2.958229795,10.63337571,HCK;CASP4;JAK2;USP18;MYD88,4
7266,DNA duplex unwinding (GO:0032508),0.02781067,0.413754656,0,0,4.56412597,16.35023064,UBB;UBC;ASCC3,4
7267,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.028439244,0.421876341,0,0,7.51738395,26.76177607,NR1H3;ACOD1,4
7268,positive regulation of monocyte chemotaxis (GO:0090026),0.028439244,0.420653511,0,0,7.51738395,26.76177607,CXCL10;AIF1,4
7269,nucleotide catabolic process (GO:0009166),0.028439244,0.41943775,0,0,7.51738395,26.76177607,PNP;SAMHD1,4
7270,regulation of T cell migration (GO:2000404),0.028439244,0.418228996,0,0,7.51738395,26.76177607,CXCL10;AIF1,4
7271,regulation of establishment or maintenance of cell polarity (GO:0032878),0.028439244,0.417027188,0,0,7.51738395,26.76177607,RAP1B;RUFY3,4
7272,nucleobase-containing compound biosynthetic process (GO:0034654),0.028439244,0.415832268,0,0,7.51738395,26.76177607,PNP;DCK,4
7273,positive regulation of inflammatory response (GO:0050729),0.028797368,0.41986562,0,0,3.453933166,12.25272877,GBP5;IL18;TLR7;MYD88,4
7274,positive regulation of cytokine secretion (GO:0050715),0.028797368,0.418669421,0,0,3.453933166,12.25272877,IFIH1;CD274;DDX58;LGALS9,4
7275,endosomal transport (GO:0016197),0.02882171,0.417832915,0,0,2.222530907,7.882486694,SNX2;UBB;DTX3L;STX16;UBC;STX6;CHMP2A;CHMP4B,4
7276,negative regulation of protein secretion (GO:0050709),0.029559534,0.427315308,0,0,4.457983505,15.69811548,SRGN;RSAD2;NR1H3,4
7277,cellular response to oxygen-containing compound (GO:1901701),0.029718692,0.428402498,0,0,2.091199535,7.352613814,CD86;RAP1B;CD274;CXCL10;ACOD1;NR1H3;CCL2;CCR5;ACTB,4
7278,positive regulation of interferon-gamma production (GO:0032729),0.031365219,0.450863976,0,0,4.356665699,15.08301923,IL18;TLR7;LGALS9,4
7279,RNA catabolic process (GO:0006401),0.031365219,0.449597504,0,0,4.356665699,15.08301923,ISG20;PNPT1;DCP2,4
7280,regulation of viral process (GO:0050792),0.031668885,0.452678767,0,0,7.099751509,24.51132857,CHMP2A;CHMP4B,4
7281,nuclear envelope reassembly (GO:0031468),0.031668885,0.451414301,0,0,7.099751509,24.51132857,CHMP2A;CHMP4B,4
7282,actin filament polymerization (GO:0030041),0.031668885,0.450156879,0,0,7.099751509,24.51132857,JAK2;AIF1,4
7283,glucan biosynthetic process (GO:0009250),0.031668885,0.448906444,0,0,7.099751509,24.51132857,UBB;UBC,4
7284,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.031668885,0.447662935,0,0,7.099751509,24.51132857,CD180;LY86,4
7285,negative regulation of RNA splicing (GO:0033119),0.031668885,0.446426298,0,0,7.099751509,24.51132857,TMBIM6;SRSF7,4
7286,glycogen biosynthetic process (GO:0005978),0.031668885,0.445196473,0,0,7.099751509,24.51132857,UBB;UBC,4
7287,negative regulation of protein transport (GO:0051224),0.031668885,0.443973406,0,0,7.099751509,24.51132857,RSAD2;CSK,4
7288,regulation of peptidase activity (GO:0052547),0.031668885,0.44275704,0,0,7.099751509,24.51132857,CSTB;PSMB8,4
7289,cholesterol transport (GO:0030301),0.033227503,0.463278546,0,0,4.259850905,14.5021399,STARD3;NPC2;ABCG1,4
7290,lymphocyte chemotaxis (GO:0048247),0.033227503,0.462016207,0,0,4.259850905,14.5021399,CXCL10;CCL7;CCL2,4
7291,positive regulation of interleukin-8 production (GO:0032757),0.033227503,0.460760728,0,0,4.259850905,14.5021399,DDX58;TLR7;LGALS9,4
7292,regulation of smooth muscle cell proliferation (GO:0048660),0.033227503,0.459512054,0,0,4.259850905,14.5021399,STAT1;IL18;AIF1,4
7293,negative regulation of immune response (GO:0050777),0.033227503,0.458270129,0,0,4.259850905,14.5021399,DHX58;ACOD1;TRAFD1,4
7294,regulation of mitotic spindle assembly (GO:1901673),0.035035283,0.481900396,0,0,6.726080377,22.54178343,CHMP2A;CHMP4B,4
7295,error-free translesion synthesis (GO:0070987),0.035035283,0.480604965,0,0,6.726080377,22.54178343,UBB;UBC,4
7296,positive regulation of mononuclear cell migration (GO:0071677),0.035035283,0.47931648,0,0,6.726080377,22.54178343,CXCL10;AIF1,4
7297,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.035035283,0.478034885,0,0,6.726080377,22.54178343,RSAD2;NR1H3,4
7298,regulation of mitochondrial fission (GO:0090140),0.035035283,0.476760125,0,0,6.726080377,22.54178343,STAT2;MARCH5,4
7299,regulation of transcription factor import into nucleus (GO:0042990),0.035035283,0.475492146,0,0,6.726080377,22.54178343,DDX58;HCLS1,4
7300,cellular response to interleukin-7 (GO:0098761),0.035035283,0.474230894,0,0,6.726080377,22.54178343,SOCS1;IL2RG,4
7301,interleukin-7-mediated signaling pathway (GO:0038111),0.035035283,0.472976315,0,0,6.726080377,22.54178343,SOCS1;IL2RG,4
7302,protein polymerization (GO:0051258),0.035146129,0.473220837,0,0,4.167245451,13.9529412,CHMP2A;JAK2;AIF1,4
7303,peptidyl-tyrosine autophosphorylation (GO:0038083),0.035146129,0.471975519,0,0,4.167245451,13.9529412,HCK;CSK;JAK2,4
7304,negative regulation of signal transduction (GO:0009968),0.035404591,0.474198504,0,0,2.024929127,6.765113597,MMP14;RGS2;SOCS1;UBB;UBC;TMBIM6;CALR;MERTK;LGMN,4
7305,peptidyl-tyrosine phosphorylation (GO:0018108),0.036843624,0.492180667,0,0,3.194888179,10.54655813,HCK;CSK;PTPN6;JAK2,4
7306,chromatin remodeling (GO:0006338),0.036942761,0.492216479,0,0,2.730673657,9.006814539,DAXX;SP100;SP110;SP140;ACTB,4
7307,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.038298057,0.508945268,0,0,3.155445115,10.2941857,IL18;HCLS1;PTPN6;JAK2,4
7308,ERBB signaling pathway (GO:0038127),0.038298057,0.507623332,0,0,3.155445115,10.2941857,UBB;MVP;UBC;CSK,4
7309,negative regulation of defense response (GO:0031348),0.038298057,0.506308245,0,0,3.155445115,10.2941857,DHX58;ACOD1;TRAFD1;NR1H3,4
7310,regulation of regulatory T cell differentiation (GO:0045589),0.038533395,0.508103137,0,0,6.389776358,20.80658157,SOCS1;IRF1,4
7311,endoplasmic reticulum mannose trimming (GO:1904380),0.038533395,0.506793592,0,0,6.389776358,20.80658157,UBB;UBC,4
7312,response to progesterone (GO:0032570),0.038533395,0.505490781,0,0,6.389776358,20.80658157,NR1H3;ACOD1,4
7313,error-prone translesion synthesis (GO:0042276),0.038533395,0.504194651,0,0,6.389776358,20.80658157,UBB;UBC,4
7314,regulation of cholesterol transport (GO:0032374),0.038533395,0.502905151,0,0,6.389776358,20.80658157,NR1H3;TSPO,4
7315,regulation of toll-like receptor signaling pathway (GO:0034121),0.038533395,0.501622229,0,0,6.389776358,20.80658157,IRF1;IRF7,4
7316,positive regulation of T cell migration (GO:2000406),0.038533395,0.500345837,0,0,6.389776358,20.80658157,CXCL10;AIF1,4
7317,negative regulation of interferon-gamma production (GO:0032689),0.038533395,0.499075924,0,0,6.389776358,20.80658157,CD274;LGALS9,4
7318,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.038533395,0.49781244,0,0,6.389776358,20.80658157,FCER1G;C3AR1,4
7319,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.039151199,0.504516585,0,0,3.993610224,12.94059199,CASP8;STAT1;G3BP2,4
7320,regulation of cell growth (GO:0001558),0.040162641,0.516246737,0,0,2.214278936,7.118503904,BST2;OGFR;CDC42;SDCBP;CDKN1A;MMP14;CAMK2D,4
7321,protein K48-linked ubiquitination (GO:0070936),0.041236954,0.528724057,0,0,3.912107974,12.47344522,RNF34;DTX3L;PELI1,4
7322,positive regulation of cell cycle arrest (GO:0071158),0.041304463,0.528262343,0,0,3.079410293,9.813417671,CDKN1A;UBB;UBC;BAX,4
7323,regulation of interleukin-17 production (GO:0032660),0.042158303,0.537834551,0,0,6.085501293,19.26866652,IL18;MYD88,4
7324,viral budding via host ESCRT complex (GO:0039702),0.042158303,0.536493318,0,0,6.085501293,19.26866652,CHMP2A;CHMP4B,4
7325,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.042158303,0.535158757,0,0,6.085501293,19.26866652,CCL2;CD47,4
7326,mesoderm development (GO:0007498),0.042158303,0.53383082,0,0,6.085501293,19.26866652,HCK;JAK2,4
7327,regulation of cardiac muscle hypertrophy (GO:0010611),0.042158303,0.532509456,0,0,6.085501293,19.26866652,CAMK2D;RGS2,4
7328,establishment of endothelial barrier (GO:0061028),0.042158303,0.531194618,0,0,6.085501293,19.26866652,RAP2C;RAP1B,4
7329,vesicle docking (GO:0048278),0.042158303,0.529886257,0,0,6.085501293,19.26866652,STX16;STX6,4
7330,negative regulation of viral process (GO:0048525),0.042158303,0.528584325,0,0,6.085501293,19.26866652,IFITM3;STAT1,4
7331,meiosis I (GO:0007127),0.042158303,0.527288775,0,0,6.085501293,19.26866652,PTTG1;SCIMP,4
7332,negative regulation of cell cycle arrest (GO:0071157),0.042158303,0.525999561,0,0,6.085501293,19.26866652,CCND1;CALR,4
7333,regulation of reactive oxygen species metabolic process (GO:2000377),0.043377677,0.539893376,0,0,3.833865815,12.02994377,ARF4;CDKN1A;ACOD1,4
7334,protein autoubiquitination (GO:0051865),0.043377677,0.538579767,0,0,3.833865815,12.02994377,RNF213;DTX3L;MARCH5,4
7335,cellular calcium ion homeostasis (GO:0006874),0.045537512,0.564024085,0,0,2.576522725,7.959442584,CD40;CAMK2D;CCL7;BAX;CALR,4
7336,myeloid leukocyte differentiation (GO:0002573),0.045572946,0.563096234,0,0,3.758691975,11.60849849,CDC42;BATF2;CASP8,4
7337,blood circulation (GO:0008015),0.045572946,0.561736098,0,0,3.758691975,11.60849849,CXCL10;STAT1;C3AR1,4
7338,acylglycerol homeostasis (GO:0055090),0.045905209,0.564468153,0,0,5.808887598,17.89820897,IL18;NR1H3,4
7339,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.045905209,0.563111258,0,0,5.808887598,17.89820897,USP25;TMBIM6,4
7340,positive regulation of interleukin-10 production (GO:0032733),0.045905209,0.561760871,0,0,5.808887598,17.89820897,CD274;LGALS9,4
7341,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.045905209,0.560416946,0,0,5.808887598,17.89820897,UBB;UBC,4
7342,regulation of cytokine production involved in inflammatory response (GO:1900015),0.045905209,0.559079435,0,0,5.808887598,17.89820897,GBP5;MYD88,4
7343,purine-containing compound biosynthetic process (GO:0072522),0.045905209,0.557748294,0,0,5.808887598,17.89820897,PNP;DCK,4
7344,C21-steroid hormone metabolic process (GO:0008207),0.045905209,0.556423476,0,0,5.808887598,17.89820897,STARD3;TSPO,4
7345,cellular response to unfolded protein (GO:0034620),0.045905209,0.555104937,0,0,5.808887598,17.89820897,DAXX;HSPA5,4
7346,viral genome replication (GO:0019079),0.045905209,0.553792632,0,0,5.808887598,17.89820897,CDC42;CCL2,4
7347,regulation of monocyte chemotaxis (GO:0090025),0.045905209,0.552486517,0,0,5.808887598,17.89820897,CXCL10;AIF1,4
7348,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.046057929,0.553020262,0,0,2.971989004,9.147352257,RAP2C;HCLS1;PTPN6;JAK2,4
7349,negative regulation of macromolecule metabolic process (GO:0010605),0.046854693,0.561266424,0,0,2.555910543,7.82288591,PARP10;SDCBP;LGALS9;PARP14;PARP9,4
7350,mitochondrion organization (GO:0007005),0.049055523,0.586253714,0,0,2.282062985,6.879969172,PNPT1;MX1;CYCS;TSPO;BAX;IFIT2,4
7351,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.049769434,0.593395848,0,0,5.556327268,16.67095015,KLRK1;LGALS9,4
7352,cholesterol efflux (GO:0033344),0.049769434,0.592012641,0,0,5.556327268,16.67095015,NPC2;ABCG1,4
7353,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.049769434,0.590635868,0,0,5.556327268,16.67095015,UBB;UBC,4
7354,positive regulation of ERBB signaling pathway (GO:1901186),0.049769434,0.589265483,0,0,5.556327268,16.67095015,UBB;UBC,4
7355,positive regulation of mRNA catabolic process (GO:0061014),0.049769434,0.587901442,0,0,5.556327268,16.67095015,PNPT1;ZC3HAV1,4
7356,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.049769434,0.586543702,0,0,5.556327268,16.67095015,UBB;UBC,4
7357,cellular response to interleukin-6 (GO:0071354),0.049769434,0.585192219,0,0,5.556327268,16.67095015,STAT1;JAK2,4
7358,viral budding (GO:0046755),0.049769434,0.58384695,0,0,5.556327268,16.67095015,CHMP2A;CHMP4B,4
7359,chemokine-mediated signaling pathway (GO:0070098),0.0501253,0.586672949,0,0,3.616854542,10.82607538,CXCL10;CCL7;CCL2,4
7360,positive regulation of cell-substrate adhesion (GO:0010811),0.0501253,0.585330448,0,0,3.616854542,10.82607538,CDC42;CALR;JAK2,4
7361,vesicle organization (GO:0016050),0.050941065,0.593498294,0,0,2.49600639,7.430825456,SRGN;SNX2;STX16;STX6;SNAP29,4
7362,neutrophil chemotaxis (GO:0030593),0.052481406,0.610051513,0,0,3.549875754,10.46253584,FCER1G;CCL7;CCL2,4
7363,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.053746414,0.623336251,0,0,5.324813632,15.56697727,CCND2;AIF1,4
7364,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),0.05401108,0.624985352,0,0,2.070760857,6.043652379,CD40;UBB;DDX58;UBC;EIF2AK2;LGALS9;MYD88,4
7365,intracellular transport of virus (GO:0075733),0.054890104,0.633719916,0,0,3.485332559,10.11590657,RANBP2;UBB;UBC,4
7366,membrane fusion (GO:0061025),0.054890104,0.632289397,0,0,3.485332559,10.11590657,MX1;BAX;SNAP29,4
7367,transport of virus (GO:0046794),0.054890104,0.630865322,0,0,3.485332559,10.11590657,RANBP2;UBB;UBC,4
7368,protein-DNA complex assembly (GO:0065004),0.056439114,0.647210779,0,0,2.778163634,7.986089338,DAXX;CDK7;UBB;UBC,4
7369,Notch signaling pathway (GO:0007219),0.057350847,0.656191418,0,0,3.423094477,9.785147192,UBB;STAT1;UBC,4
7370,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.057831698,0.660212875,0,0,5.111821086,14.56980572,CASP4;BAX,4
7371,positive regulation of endopeptidase activity (GO:0010950),0.057831698,0.658739185,0,0,5.111821086,14.56980572,PSME1;PSME2,4
7372,eosinophil chemotaxis (GO:0048245),0.057831698,0.65727206,0,0,5.111821086,14.56980572,CCL7;CCL2,4
7373,cellular senescence (GO:0090398),0.057831698,0.655811456,0,0,5.111821086,14.56980572,CDKN1A;CALR,4
7374,eosinophil migration (GO:0072677),0.057831698,0.654357328,0,0,5.111821086,14.56980572,CCL7;CCL2,4
7375,"protein alpha-1,2-demannosylation (GO:0036508)",0.057831698,0.652909635,0,0,5.111821086,14.56980572,UBB;UBC,4
7376,transition metal ion homeostasis (GO:0055076),0.057831698,0.651468333,0,0,5.111821086,14.56980572,B2M;HMOX2,4
7377,negative regulation of programmed cell death (GO:0043069),0.058018166,0.652129293,0,0,1.718521759,4.892629931,ARF4;HCK;CCND2;ARL6IP1;UBB;HSPA5;UBC;TMBIM6;MERTK;IFIT3;MYD88,4
7378,cell cycle G1/S phase transition (GO:0044843),0.058281802,0.653652831,0,0,2.748290907,7.81192173,RANBP2;CDKN1A;CDK7;CCND1,4
7379,protein autophosphorylation (GO:0046777),0.058886101,0.658981962,0,0,2.178332849,6.169365789,HCK;CAMK2D;ACOD1;EIF2AK2;CSK;JAK2,4
7380,granulocyte chemotaxis (GO:0071621),0.059863063,0.66844904,0,0,3.363040188,9.46929748,FCER1G;CCL7;CCL2,4
7381,cellular iron ion homeostasis (GO:0006879),0.059863063,0.666989544,0,0,3.363040188,9.46929748,UBB;UBC;HMOX2,4
7382,Fc-gamma receptor signaling pathway (GO:0038094),0.061263758,0.681108834,0,0,2.366583836,6.60884355,ACTR3;CDC42;HCK;FCER1G;ACTB,4
7383,regulation of centrosome duplication (GO:0010824),0.062020947,0.688028025,0,0,4.915212583,13.66568247,CHMP2A;CHMP4B,4
7384,positive regulation of interleukin-12 production (GO:0032735),0.062020947,0.686535557,0,0,4.915212583,13.66568247,IRF5;LGALS9,4
7385,regulation of viral release from host cell (GO:1902186),0.062020947,0.685049549,0,0,4.915212583,13.66568247,CHMP2A;CHMP4B,4
7386,L-amino acid transport (GO:0015807),0.062020947,0.68356996,0,0,4.915212583,13.66568247,SLC3A2;SLC25A22,4
7387,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.062426162,0.686553245,0,0,3.305056737,9.167469956,UBB;UBC;TLR7,4
7388,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.062828371,0.689490703,0,0,2.349182484,6.501006722,ACTR3;CDC42;HCK;FCER1G;ACTB,4
7389,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.065039534,0.712224768,0,0,3.249038826,8.878843272,CDC42;UBB;UBC,4
7390,integrin-mediated signaling pathway (GO:0007229),0.065039534,0.710699662,0,0,3.249038826,8.878843272,CDC42;HCK;CD47,4
7391,neutrophil migration (GO:1990266),0.065039534,0.709181073,0,0,3.249038826,8.878843272,FCER1G;CCL7;CCL2,4
7392,protein localization to nucleus (GO:0034504),0.065969914,0.717792053,0,0,2.634959323,7.163285753,RANBP2;TOR1AIP2;CALR;TOR1AIP1,4
7393,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.066309929,0.71995653,0,0,4.733167672,12.84305114,CCND2;CCND1,4
7394,regulation of centrosome cycle (GO:0046605),0.066309929,0.71842796,0,0,4.733167672,12.84305114,CHMP2A;CHMP4B,4
7395,regulation of NF-kappaB import into nucleus (GO:0042345),0.066309929,0.716905867,0,0,4.733167672,12.84305114,TLR7;LGALS9,4
7396,regulation of viral entry into host cell (GO:0046596),0.066309929,0.71539021,0,0,4.733167672,12.84305114,IFITM3;LGALS9,4
7397,positive regulation of cellular process (GO:0048522),0.066510264,0.716037715,0,0,1.597444089,4.329710861,CD86;CDC42;HCK;SDCBP;MMP14;CCND2;SERTAD1;CCND1;NAMPT;HCLS1;PTPN6;CALR;CD47,4
7398,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.067970574,0.730218609,0,0,2.608071983,7.012272028,DYNC1I2;FCER1G;CAPZA2;LGMN,4
7399,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.067970574,0.728684536,0,0,2.608071983,7.012272028,DYNC1I2;FCER1G;CAPZA2;LGMN,4
7400,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.070002369,0.748893271,0,0,2.581727821,6.865398241,DYNC1I2;FCER1G;CAPZA2;LGMN,4
7401,positive regulation of cell growth (GO:0030307),0.070002369,0.747326549,0,0,2.581727821,6.865398241,CDC42;SDCBP;MMP14;RUFY3,4
7402,regulation of protein localization to nucleus (GO:1900180),0.070694521,0.753140165,0,0,4.56412597,12.09213697,DTX3L;PARP9,4
7403,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.070694521,0.751571123,0,0,4.56412597,12.09213697,CDC42;CALR,4
7404,cellular response to topologically incorrect protein (GO:0035967),0.070694521,0.750008605,0,0,4.56412597,12.09213697,DAXX;HSPA5,4
7405,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),0.0709869,0.751548033,0,0,2.265878141,5.993836636,PARP10;SP100;NLRC5;KEAP1;ACOD1,4
7406,negative regulation of proteasomal protein catabolic process (GO:1901799),0.0751707,0.794194786,0,0,4.406742316,11.40462158,SDCBP;USP25,4
7407,triglyceride homeostasis (GO:0070328),0.0751707,0.792553888,0,0,4.406742316,11.40462158,IL18;NR1H3,4
7408,cellular protein catabolic process (GO:0044257),0.07598294,0.799465865,0,0,3.042750647,7.841918249,CASP8;CTSC;LGMN,4
7409,stress-activated MAPK cascade (GO:0051403),0.07598294,0.797820874,0,0,3.042750647,7.841918249,UBB;UBC;LGALS9,4
7410,protein processing (GO:0016485),0.076282772,0.799324409,0,0,2.50579465,6.448181807,SRGN;MMP14;SPPL2A;LGMN,4
7411,intrinsic apoptotic signaling pathway (GO:0097193),0.076282772,0.797686449,0,0,2.50579465,6.448181807,CDKN1A;CASP4;CYCS;BAX,4
7412,protein complex assembly (GO:0006461),0.078726398,0.82155585,0,0,2.017824113,5.128858416,KHDRBS1;CAMK2D;SNX2;CASP8;BAX;CTSC,4
7413,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.079734548,0.830378364,0,0,4.259850905,10.77338578,UBB;UBC,4
7414,amino acid transmembrane transport (GO:0003333),0.079734548,0.828687166,0,0,4.259850905,10.77338578,SLC7A8;SLC3A2,4
7415,positive regulation of cell adhesion (GO:0045785),0.081739193,0.847794918,0,0,2.94912755,7.385269144,CD47;JAK2;TGM2,4
7416,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.084382245,0.873433261,0,0,4.12243636,10.1923045,CCND2;CCND1,4
7417,multivesicular body assembly (GO:0036258),0.084382245,0.871665177,0,0,4.12243636,10.1923045,CHMP2A;CHMP4B,4
7418,G1/S transition of mitotic cell cycle (GO:0000082),0.085080913,0.877106866,0,0,2.411236361,5.94165425,RANBP2;CDK7;CDKN1A;CCND1,4
7419,response to endoplasmic reticulum stress (GO:0034976),0.087354758,0.898732521,0,0,2.388701442,5.82312328,HSPA5;CASP4;BAX;PDIA6,4
7420,JNK cascade (GO:0007254),0.087677655,0.900239581,0,0,2.861093892,6.964154896,DAXX;UBB;UBC,4
7421,positive regulation of cellular protein localization (GO:1903829),0.087677655,0.898431871,0,0,2.861093892,6.964154896,DTX3L;RUFY3;PARP9,4
7422,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.089110069,0.911279928,0,0,3.993610224,9.656082024,ACOD1;CD300LF,4
7423,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.089110069,0.909457368,0,0,3.993610224,9.656082024,CD274;LGALS9,4
7424,organelle transport along microtubule (GO:0072384),0.089110069,0.907642084,0,0,3.993610224,9.656082024,CDC42;UBB,4
7425,regulation of protein tyrosine kinase activity (GO:0061097),0.089110069,0.905834032,0,0,3.993610224,9.656082024,RAP2C;MVP,4
7426,secondary alcohol metabolic process (GO:1902652),0.089110069,0.904033169,0,0,3.993610224,9.656082024,STARD3;ABCG1,4
7427,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.089110069,0.902239452,0,0,3.993610224,9.656082024,RNF34;CASP8,4
7428,multivesicular body organization (GO:0036257),0.089110069,0.90045284,0,0,3.993610224,9.656082024,CHMP2A;CHMP4B,4
7429,regulation of protein autophosphorylation (GO:0031952),0.089110069,0.898673289,0,0,3.993610224,9.656082024,RAP2C;MVP,4
7430,cellular response to starvation (GO:0009267),0.089657856,0.902414282,0,0,2.366583836,5.707619095,PLEKHF2;CDKN1A;HSPA5;EIF2AK2,4
7431,regulation of protein localization to early endosome (GO:1902965),0.090312475,0.907213702,0,0,10.64962726,25.60681232,DTX3L,4
7432,positive regulation of nucleobase-containing compound transport (GO:0032241),0.090312475,0.905431356,0,0,10.64962726,25.60681232,KHDRBS1,4
7433,pyrimidine-containing compound biosynthetic process (GO:0072528),0.090312475,0.903656001,0,0,10.64962726,25.60681232,ACOD1,4
7434,protein sulfation (GO:0006477),0.090312475,0.901887594,0,0,10.64962726,25.60681232,TPST1,4
7435,positive regulation of interferon-gamma secretion (GO:1902715),0.090312475,0.900126095,0,0,10.64962726,25.60681232,LGALS9,4
7436,granzyme-mediated apoptotic signaling pathway (GO:0008626),0.090312475,0.898371463,0,0,10.64962726,25.60681232,SRGN,4
7437,regulation of macrophage apoptotic process (GO:2000109),0.090312475,0.896623658,0,0,10.64962726,25.60681232,IRF7,4
7438,protein localization to nuclear envelope (GO:0090435),0.090312475,0.894882642,0,0,10.64962726,25.60681232,TOR1AIP2,4
7439,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.090312475,0.893148373,0,0,10.64962726,25.60681232,UBB,4
7440,cellular response to iron ion (GO:0071281),0.090312475,0.891420813,0,0,10.64962726,25.60681232,B2M,4
7441,regulation of superoxide metabolic process (GO:0090322),0.090312475,0.889699924,0,0,10.64962726,25.60681232,GCH1,4
7442,positive regulation of protein localization to early endosome (GO:1902966),0.090312475,0.887985666,0,0,10.64962726,25.60681232,DTX3L,4
7443,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.090312475,0.886278001,0,0,10.64962726,25.60681232,UBB,4
7444,negative regulation of cellular response to hypoxia (GO:1900038),0.090312475,0.884576891,0,0,10.64962726,25.60681232,TMBIM6,4
7445,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.090312475,0.8828823,0,0,10.64962726,25.60681232,NLRC5,4
7446,establishment of endothelial intestinal barrier (GO:0090557),0.090312475,0.881194188,0,0,10.64962726,25.60681232,RAP2C,4
7447,positive regulation of receptor binding (GO:1900122),0.090312475,0.87951252,0,0,10.64962726,25.60681232,B2M,4
7448,positive regulation of humoral immune response (GO:0002922),0.090312475,0.877837258,0,0,10.64962726,25.60681232,ACOD1,4
7449,negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),0.090312475,0.876168366,0,0,10.64962726,25.60681232,TGM2,4
7450,regulation of cardiac muscle cell apoptotic process (GO:0010665),0.090312475,0.874505807,0,0,10.64962726,25.60681232,CAMK2D,4
7451,regulation of MHC class I biosynthetic process (GO:0045343),0.090312475,0.872849546,0,0,10.64962726,25.60681232,NLRC5,4
7452,rRNA transport (GO:0051029),0.090312475,0.871199547,0,0,10.64962726,25.60681232,PNPT1,4
7453,negative regulation of digestive system process (GO:0060457),0.090312475,0.869555774,0,0,10.64962726,25.60681232,NR1H3,4
7454,positive regulation of granulocyte differentiation (GO:0030854),0.090312475,0.867918193,0,0,10.64962726,25.60681232,HCLS1,4
7455,regulation of histone deacetylase activity (GO:1901725),0.090312475,0.866286768,0,0,10.64962726,25.60681232,CAMK2D,4
7456,regulation of relaxation of cardiac muscle (GO:1901897),0.090312475,0.864661464,0,0,10.64962726,25.60681232,CAMK2D,4
7457,citrulline metabolic process (GO:0000052),0.090312475,0.863042248,0,0,10.64962726,25.60681232,ASS1,4
7458,regulation of cellular response to oxidative stress (GO:1900407),0.090312475,0.861429085,0,0,10.64962726,25.60681232,GCH1,4
7459,regulation of glial cell apoptotic process (GO:0034350),0.090312475,0.859821941,0,0,10.64962726,25.60681232,CCL2,4
7460,regulation of protein K63-linked ubiquitination (GO:1900044),0.090312475,0.858220783,0,0,10.64962726,25.60681232,PARP10,4
7461,regulation of protein localization to cell cortex (GO:1904776),0.090312475,0.856625577,0,0,10.64962726,25.60681232,GPSM2,4
7462,negative regulation of leukocyte degranulation (GO:0043301),0.090312475,0.85503629,0,0,10.64962726,25.60681232,LGALS9,4
7463,alpha-beta T cell activation (GO:0046631),0.090312475,0.85345289,0,0,10.64962726,25.60681232,RSAD2,4
7464,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.090312475,0.851875343,0,0,10.64962726,25.60681232,CMPK2,4
7465,regulation of interleukin-12 secretion (GO:2001182),0.090312475,0.850303617,0,0,10.64962726,25.60681232,LGALS9,4
7466,response to UV-A (GO:0070141),0.090312475,0.84873768,0,0,10.64962726,25.60681232,CCND1,4
7467,positive regulation of RNA export from nucleus (GO:0046833),0.090312475,0.847177501,0,0,10.64962726,25.60681232,KHDRBS1,4
7468,positive regulation of microtubule motor activity (GO:2000576),0.090312475,0.845623047,0,0,10.64962726,25.60681232,DYNC1I2,4
7469,macrophage derived foam cell differentiation (GO:0010742),0.090312475,0.844074286,0,0,10.64962726,25.60681232,STAT1,4
7470,corticosteroid receptor signaling pathway (GO:0031958),0.090312475,0.842531189,0,0,10.64962726,25.60681232,CALR,4
7471,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),0.090312475,0.840993723,0,0,10.64962726,25.60681232,CCR5,4
7472,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),0.090312475,0.839461859,0,0,10.64962726,25.60681232,BAX,4
7473,positive regulation of protein localization to endosome (GO:1905668),0.090312475,0.837935564,0,0,10.64962726,25.60681232,DTX3L,4
7474,dosage compensation by inactivation of X chromosome (GO:0009048),0.090312475,0.83641481,0,0,10.64962726,25.60681232,PCGF5,4
7475,positive regulation of cardiac muscle contraction (GO:0060452),0.090312475,0.834899566,0,0,10.64962726,25.60681232,RGS2,4
7476,GDP-mannose metabolic process (GO:0019673),0.090312475,0.833389802,0,0,10.64962726,25.60681232,GMPPB,4
7477,negative regulation of phospholipase activity (GO:0010519),0.090312475,0.831885488,0,0,10.64962726,25.60681232,RGS2,4
7478,mesenchymal cell differentiation involved in kidney development (GO:0072161),0.090312475,0.830386595,0,0,10.64962726,25.60681232,STAT1,4
7479,positive regulation of centrosome cycle (GO:0046607),0.090312475,0.828893094,0,0,10.64962726,25.60681232,RANBP2,4
7480,regulation of natural killer cell proliferation (GO:0032817),0.090312475,0.827404956,0,0,10.64962726,25.60681232,IL18,4
7481,mitochondrial RNA processing (GO:0000963),0.090312475,0.825922151,0,0,10.64962726,25.60681232,PNPT1,4
7482,regulation of extracellular exosome assembly (GO:1903551),0.090312475,0.824444652,0,0,10.64962726,25.60681232,SDCBP,4
7483,negative regulation of myeloid cell apoptotic process (GO:0033033),0.090312475,0.822972429,0,0,10.64962726,25.60681232,IRF7,4
7484,regulation of interleukin-13 secretion (GO:2000665),0.090312475,0.821505455,0,0,10.64962726,25.60681232,LGALS9,4
7485,L-amino acid import (GO:0043092),0.090312475,0.820043702,0,0,10.64962726,25.60681232,SLC3A2,4
7486,glucocorticoid receptor signaling pathway (GO:0042921),0.090312475,0.818587141,0,0,10.64962726,25.60681232,CALR,4
7487,endoplasmic reticulum membrane organization (GO:0090158),0.090312475,0.817135745,0,0,10.64962726,25.60681232,ARL6IP1,4
7488,foam cell differentiation (GO:0090077),0.090312475,0.815689487,0,0,10.64962726,25.60681232,STAT1,4
7489,negative regulation of hydrolase activity (GO:0051346),0.091989959,0.829372372,0,0,2.344872058,5.595042578,PLEKHF2;CSTB;KLRK1;IFIT1,4
7490,positive regulation of T cell differentiation (GO:0045582),0.093914393,0.845229541,0,0,3.872591732,9.160118576,PNP;SOCS1,4
7491,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.093914393,0.843741461,0,0,3.872591732,9.160118576,CASP8;HCLS1,4
7492,global genome nucleotide-excision repair (GO:0070911),0.093914393,0.842258611,0,0,3.872591732,9.160118576,UBB;UBC,4
7493,protein modification by small protein conjugation (GO:0032446),0.097942657,0.876844528,0,0,1.601447709,3.720760527,IFIH1;RANBP2;RNF213;RNF34;UBA7;UBB;UBC;KEAP1;ISG15;HERC6,4
7494,glycogen metabolic process (GO:0005977),0.098791684,0.882896607,0,0,3.758691975,8.700401615,UBB;UBC,4
7495,platelet aggregation (GO:0070527),0.098791684,0.881353081,0,0,3.758691975,8.700401615,MYL12A;ACTB,4
7496,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.098791684,0.879814943,0,0,3.758691975,8.700401615,UBB;BAX,4
7497,positive regulation of locomotion (GO:0040017),0.098791684,0.878282165,0,0,3.758691975,8.700401615,CHMP2A;CHMP4B,4
7498,regulation of Notch signaling pathway (GO:0008593),0.100077665,0.888167518,0,0,2.699905503,6.214666106,MMP14;UBB;UBC,4
7499,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.100077665,0.88662556,0,0,2.699905503,6.214666106,CDC42;NCF4;ACTB,4
7500,cytoskeleton-dependent cytokinesis (GO:0061640),0.100077665,0.885088948,0,0,2.699905503,6.214666106,BIN3;CHMP4B;MITD1,4
7501,positive regulation of growth (GO:0045927),0.103282233,0.911849891,0,0,2.662406816,6.044435326,CDC42;SDCBP;MMP14,4
7502,organelle membrane fusion (GO:0090174),0.103282233,0.91027502,0,0,2.662406816,6.044435326,STX16;STX6;SNAP29,4
7503,apoptotic mitochondrial changes (GO:0008637),0.103738498,0.912719923,0,0,3.651300776,8.273416663,BAX;IFIT2,4
7504,regulation of interleukin-8 production (GO:0032677),0.103738498,0.911148976,0,0,3.651300776,8.273416663,DDX58;TLR7,4
7505,negative regulation of DNA binding (GO:0043392),0.103738498,0.909583428,0,0,3.651300776,8.273416663,SP100;JAK2,4
7506,positive regulation of exocytosis (GO:0045921),0.103738498,0.908023251,0,0,3.651300776,8.273416663,SDCBP;CHMP2A,4
7507,response to peptide (GO:1901652),0.103738498,0.906468417,0,0,3.651300776,8.273416663,STAT1;IRF5,4
7508,negative regulation of T cell activation (GO:0050868),0.103738498,0.904918898,0,0,3.651300776,8.273416663,CD86;CD274,4
7509,"substrate-dependent cell migration, cell extension (GO:0006930)",0.104553333,0.910470408,0,0,9.12825194,20.61212207,SDCBP,4
7510,negative regulation of muscle hypertrophy (GO:0014741),0.104553333,0.908919351,0,0,9.12825194,20.61212207,RGS2,4
7511,cellular response to interleukin-18 (GO:0071351),0.104553333,0.90737357,0,0,9.12825194,20.61212207,IL18,4
7512,regulation of chromatin assembly or disassembly (GO:0001672),0.104553333,0.905833038,0,0,9.12825194,20.61212207,PARP10,4
7513,cellular response to interferon-alpha (GO:0035457),0.104553333,0.904297728,0,0,9.12825194,20.61212207,IFNAR1,4
7514,regulation of monocyte chemotactic protein-1 production (GO:0071637),0.104553333,0.902767613,0,0,9.12825194,20.61212207,LGALS9,4
7515,negative regulation of glial cell apoptotic process (GO:0034351),0.104553333,0.901242668,0,0,9.12825194,20.61212207,CCL2,4
7516,cellular response to laminar fluid shear stress (GO:0071499),0.104553333,0.899722866,0,0,9.12825194,20.61212207,ASS1,4
7517,positive regulation of protein kinase C signaling (GO:0090037),0.104553333,0.898208181,0,0,9.12825194,20.61212207,CD40,4
7518,nucleoside diphosphate metabolic process (GO:0009132),0.104553333,0.896698587,0,0,9.12825194,20.61212207,CMPK2,4
7519,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.104553333,0.895194059,0,0,9.12825194,20.61212207,CHMP4B,4
7520,cytoplasmic sequestering of NF-kappaB (GO:0007253),0.104553333,0.893694572,0,0,9.12825194,20.61212207,G3BP2,4
7521,death-inducing signaling complex assembly (GO:0071550),0.104553333,0.892200099,0,0,9.12825194,20.61212207,CASP8,4
7522,release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),0.104553333,0.890710617,0,0,9.12825194,20.61212207,CCR5,4
7523,pteridine-containing compound biosynthetic process (GO:0042559),0.104553333,0.889226099,0,0,9.12825194,20.61212207,GCH1,4
7524,negative regulation of osteoblast proliferation (GO:0033689),0.104553333,0.887746521,0,0,9.12825194,20.61212207,EIF2AK2,4
7525,regulation of sterol transport (GO:0032371),0.104553333,0.886271859,0,0,9.12825194,20.61212207,TSPO,4
7526,regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.104553333,0.884802088,0,0,9.12825194,20.61212207,RSAD2,4
7527,activation of MAPKKK activity (GO:0000185),0.104553333,0.883337184,0,0,9.12825194,20.61212207,GADD45B,4
7528,positive regulation of B cell differentiation (GO:0045579),0.104553333,0.881877123,0,0,9.12825194,20.61212207,MMP14,4
7529,heme catabolic process (GO:0042167),0.104553333,0.88042188,0,0,9.12825194,20.61212207,HMOX2,4
7530,porphyrin-containing compound catabolic process (GO:0006787),0.104553333,0.878971432,0,0,9.12825194,20.61212207,HMOX2,4
7531,positive regulation of NK T cell activation (GO:0051135),0.104553333,0.877525755,0,0,9.12825194,20.61212207,IL18,4
7532,regulation of interleukin-23 production (GO:0032667),0.104553333,0.876084826,0,0,9.12825194,20.61212207,MYD88,4
7533,negative regulation of macrophage activation (GO:0043031),0.104553333,0.874648622,0,0,9.12825194,20.61212207,NR1H3,4
7534,regulation of alpha-beta T cell differentiation (GO:0046637),0.104553333,0.873217118,0,0,9.12825194,20.61212207,PNP,4
7535,regulation of dendritic cell differentiation (GO:2001198),0.104553333,0.871790293,0,0,9.12825194,20.61212207,LGALS9,4
7536,negative regulation of receptor internalization (GO:0002091),0.104553333,0.870368123,0,0,9.12825194,20.61212207,SDCBP,4
7537,regulation of pinocytosis (GO:0048548),0.104553333,0.868950585,0,0,9.12825194,20.61212207,NR1H3,4
7538,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.104553333,0.867537657,0,0,9.12825194,20.61212207,CASP4,4
7539,positive regulation of striated muscle contraction (GO:0045989),0.104553333,0.866129317,0,0,9.12825194,20.61212207,RGS2,4
7540,activation of signaling protein activity involved in unfolded protein response (GO:0006987),0.104553333,0.864725542,0,0,9.12825194,20.61212207,BAX,4
7541,negative regulation of RIG-I signaling pathway (GO:0039536),0.104553333,0.86332631,0,0,9.12825194,20.61212207,DHX58,4
7542,negative regulation of retinoic acid receptor signaling pathway (GO:0048387),0.104553333,0.861931598,0,0,9.12825194,20.61212207,CALR,4
7543,regulation of protein heterodimerization activity (GO:0043497),0.104553333,0.860541386,0,0,9.12825194,20.61212207,BAX,4
7544,T-helper 1 type immune response (GO:0042088),0.104553333,0.859155651,0,0,9.12825194,20.61212207,IL18,4
7545,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.104553333,0.857774372,0,0,9.12825194,20.61212207,LGALS9,4
7546,regulation of relaxation of muscle (GO:1901077),0.104553333,0.856397527,0,0,9.12825194,20.61212207,CAMK2D,4
7547,membrane invagination (GO:0010324),0.104553333,0.855025095,0,0,9.12825194,20.61212207,CHMP2A,4
7548,microglial cell activation (GO:0001774),0.104553333,0.853657055,0,0,9.12825194,20.61212207,AIF1,4
7549,regulation of neuron death (GO:1901214),0.106527087,0.868382945,0,0,2.62593549,5.880404369,DAXX;UBB;CHMP4B,4
7550,erythrocyte differentiation (GO:0030218),0.108751483,0.885101781,0,0,3.549875754,7.876073747,HCLS1;JAK2,4
7551,negative regulation of epithelial cell migration (GO:0010633),0.108751483,0.883692383,0,0,3.549875754,7.876073747,SP100;EVL,4
7552,regulation of mitochondrial membrane potential (GO:0051881),0.108751483,0.882287467,0,0,3.549875754,7.876073747,UBB;BAX,4
7553,protein kinase B signaling (GO:0043491),0.108751483,0.88088701,0,0,3.549875754,7.876073747,CDKN1A;CCL2,4
7554,transcription initiation from RNA polymerase II promoter (GO:0006367),0.109061777,0.882000393,0,0,1.984402596,4.397120228,CDK7;CDKN1A;CCND1;NR1H3;BAX,4
7555,transcription-coupled nucleotide-excision repair (GO:0006283),0.109811443,0.886657903,0,0,2.590449875,5.722279261,CDK7;UBB;UBC,4
7556,regulation of protein complex assembly (GO:0043254),0.109811443,0.885257179,0,0,2.590449875,5.722279261,CDC42;HCK;EIF2AK2,4
7557,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.109811443,0.883860874,0,0,2.590449875,5.722279261,ISG20;UBB;UBC,4
7558,positive regulation of phosphorylation (GO:0042327),0.110937584,0.891518883,0,0,1.834385557,4.033424113,SDCBP;DAXX;CD40;CCND2;CCND1;MERTK,4
7559,positive regulation of programmed cell death (GO:0043068),0.111629987,0.89567268,0,0,1.733660252,3.801163767,GADD45B;UBB;UBC;BAX;IRF5;IFIT2;TGM2,4
7560,positive regulation of apoptotic process (GO:0043065),0.111965463,0.896954096,0,0,1.659682171,3.633981692,GADD45B;UBB;UBC;CYCS;BAX;IRF5;IFIT2;TGM2,4
7561,positive regulation of defense response (GO:0031349),0.113134516,0.9048988,0,0,2.555910543,5.569783418,GBP5;IL18;TLR7,4
7562,mRNA catabolic process (GO:0006402),0.113827372,0.909015775,0,0,3.453933166,7.505646341,PNPT1;DCP2,4
7563,positive regulation of protein phosphorylation (GO:0001934),0.115554365,0.921365504,0,0,1.547161346,3.338796108,RAP2C;SDCBP;DAXX;CD40;CDKN1A;CCND2;CCND1;HCLS1;JAK2;MERTK,4
7564,protein insertion into mitochondrial membrane (GO:0051204),0.118571958,0.943951171,0,0,7.987220447,17.0306331,BAX,4
7565,positive regulation of macrophage differentiation (GO:0045651),0.118571958,0.942480842,0,0,7.987220447,17.0306331,CASP8,4
7566,histone H2A-K119 monoubiquitination (GO:0036353),0.118571958,0.941015086,0,0,7.987220447,17.0306331,PCGF5,4
7567,positive regulation of tissue remodeling (GO:0034105),0.118571958,0.939553883,0,0,7.987220447,17.0306331,IL18,4
7568,positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.118571958,0.93809721,0,0,7.987220447,17.0306331,TGM2,4
7569,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.118571958,0.936645047,0,0,7.987220447,17.0306331,CAMK2D,4
7570,stress-induced premature senescence (GO:0090400),0.118571958,0.935197373,0,0,7.987220447,17.0306331,CDKN1A,4
7571,defense response to protozoan (GO:0042832),0.118571958,0.933754167,0,0,7.987220447,17.0306331,BATF2,4
7572,interleukin-18-mediated signaling pathway (GO:0035655),0.118571958,0.932315409,0,0,7.987220447,17.0306331,IL18,4
7573,nucleoside diphosphate phosphorylation (GO:0006165),0.118571958,0.930881078,0,0,7.987220447,17.0306331,CMPK2,4
7574,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.118571958,0.929451153,0,0,7.987220447,17.0306331,LGALS9,4
7575,negative regulation of lipase activity (GO:0060192),0.118571958,0.928025614,0,0,7.987220447,17.0306331,RGS2,4
7576,positive regulation of interleukin-8 biosynthetic process (GO:0045416),0.118571958,0.926604442,0,0,7.987220447,17.0306331,TLR7,4
7577,positive regulation of steroid biosynthetic process (GO:0010893),0.118571958,0.925187615,0,0,7.987220447,17.0306331,ABCG1,4
7578,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.118571958,0.923775115,0,0,7.987220447,17.0306331,PNP,4
7579,positive regulation of transforming growth factor beta production (GO:0071636),0.118571958,0.922366921,0,0,7.987220447,17.0306331,LGALS9,4
7580,regulation of PERK-mediated unfolded protein response (GO:1903897),0.118571958,0.920963014,0,0,7.987220447,17.0306331,HSPA5,4
7581,negative regulation of execution phase of apoptosis (GO:1900118),0.118571958,0.919563375,0,0,7.987220447,17.0306331,RNF34,4
7582,cellular response to UV-B (GO:0071493),0.118571958,0.918167982,0,0,7.987220447,17.0306331,CDKN1A,4
7583,regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.118571958,0.916776819,0,0,7.987220447,17.0306331,IRF7,4
7584,plasma membrane to endosome transport (GO:0048227),0.118571958,0.915389865,0,0,7.987220447,17.0306331,RAB5C,4
7585,positive regulation of cAMP-mediated signaling (GO:0043950),0.118571958,0.9140071,0,0,7.987220447,17.0306331,CXCL10,4
7586,deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.118571958,0.912628507,0,0,7.987220447,17.0306331,DCP2,4
7587,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.118571958,0.911254067,0,0,7.987220447,17.0306331,ACOD1,4
7588,positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.118571958,0.90988376,0,0,7.987220447,17.0306331,BAX,4
7589,negative regulation of centriole replication (GO:0046600),0.118571958,0.908517568,0,0,7.987220447,17.0306331,CHMP2A,4
7590,amyloid precursor protein catabolic process (GO:0042987),0.118571958,0.907155473,0,0,7.987220447,17.0306331,ABCG1,4
7591,B cell mediated immunity (GO:0019724),0.118571958,0.905797456,0,0,7.987220447,17.0306331,FCER1G,4
7592,positive regulation of regulatory T cell differentiation (GO:0045591),0.118571958,0.904443498,0,0,7.987220447,17.0306331,SOCS1,4
7593,membrane fusion involved in viral entry into host cell (GO:0039663),0.118571958,0.903093583,0,0,7.987220447,17.0306331,CCR5,4
7594,exocrine system development (GO:0035272),0.118571958,0.901747691,0,0,7.987220447,17.0306331,PPDPF,4
7595,phospholipid homeostasis (GO:0055091),0.118571958,0.900405804,0,0,7.987220447,17.0306331,ABCG1,4
7596,regulation of lipid transport (GO:0032368),0.118571958,0.899067906,0,0,7.987220447,17.0306331,NR1H3,4
7597,positive regulation of interleukin-2 biosynthetic process (GO:0045086),0.118571958,0.897733977,0,0,7.987220447,17.0306331,CD86,4
7598,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.118571958,0.896404001,0,0,7.987220447,17.0306331,NR1H3,4
7599,fusion of virus membrane with host plasma membrane (GO:0019064),0.118571958,0.895077959,0,0,7.987220447,17.0306331,CCR5,4
7600,regulation of ERAD pathway (GO:1904292),0.118571958,0.893755835,0,0,7.987220447,17.0306331,USP25,4
7601,nucleotide phosphorylation (GO:0046939),0.118571958,0.892437611,0,0,7.987220447,17.0306331,CMPK2,4
7602,positive regulation of lipoprotein lipase activity (GO:0051006),0.118571958,0.89112327,0,0,7.987220447,17.0306331,NR1H3,4
7603,positive regulation of viral entry into host cell (GO:0046598),0.118571958,0.889812795,0,0,7.987220447,17.0306331,LGALS9,4
7604,immunoglobulin mediated immune response (GO:0016064),0.118571958,0.888506168,0,0,7.987220447,17.0306331,FCER1G,4
7605,response to leptin (GO:0044321),0.118571958,0.887203373,0,0,7.987220447,17.0306331,CCND1,4
7606,interleukin-1 beta secretion (GO:0050702),0.118571958,0.885904393,0,0,7.987220447,17.0306331,GBP5,4
7607,regulation of T-helper 2 cell cytokine production (GO:2000551),0.118571958,0.884609211,0,0,7.987220447,17.0306331,RSAD2,4
7608,regulation of receptor binding (GO:1900120),0.118571958,0.883317811,0,0,7.987220447,17.0306331,B2M,4
7609,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.118571958,0.882030176,0,0,7.987220447,17.0306331,CAMK2D,4
7610,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.118962986,0.883650826,0,0,3.363040188,7.159720454,CASP8;BAX,4
7611,positive regulation of stress fiber assembly (GO:0051496),0.118962986,0.882366449,0,0,3.363040188,7.159720454,CDC42;EVL,4
7612,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.118962986,0.881085801,0,0,3.363040188,7.159720454,UBB;UBC,4
7613,negative regulation of cell proliferation (GO:0008285),0.119418946,0.883180989,0,0,1.579889759,3.357451235,PARP10;CD164;CDKN1A;IRF1;EIF2AK2;PTPN6;JAK2;AIF1;IFIT3,4
7614,macromolecular complex assembly (GO:0065003),0.122138197,0.901984399,0,0,2.112322763,4.441374304,CD40;CAPZA2;LPXN;TAPBP,4
7615,actin filament organization (GO:0007015),0.122138197,0.900680953,0,0,2.112322763,4.441374304,CDC42;BIN3;RUFY3;EVL,4
7616,protein phosphorylation (GO:0006468),0.122647697,0.903133039,0,0,1.492304457,3.131510304,HCK;CDK7;CAMK2D;ACOD1;EIF2AK2;CCL2;TLR7;CSK;PTPN6;JAK2;MERTK,4
7617,positive regulation of neuron death (GO:1901216),0.124155227,0.912916604,0,0,3.276808389,6.836151932,DAXX;BAX,4
7618,homotypic cell-cell adhesion (GO:0034109),0.124155227,0.911603055,0,0,3.276808389,6.836151932,MYL12A;ACTB,4
7619,retina homeostasis (GO:0001895),0.124155227,0.91029328,0,0,3.276808389,6.836151932,B2M;ACTB,4
7620,negative regulation of cell migration (GO:0030336),0.124821853,0.913867882,0,0,2.095008642,4.359435892,BST2;RAP2C;EVL;CALR,4
7621,regulation of cell migration (GO:0030334),0.125987813,0.921082823,0,0,1.612561857,3.340534923,BST2;RAP2C;SDCBP;MMP14;HSPA5;CCL7;DDX58;RUFY3,4
7622,ERBB2 signaling pathway (GO:0038128),0.12940108,0.944683422,0,0,3.194888179,6.533030509,UBB;UBC,4
7623,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.12940108,0.943333875,0,0,3.194888179,6.533030509,CDKN1A;ACOD1,4
7624,regulation of RNA metabolic process (GO:0051252),0.12940108,0.941988177,0,0,3.194888179,6.533030509,OAS2;OAS3,4
7625,cellular response to amino acid starvation (GO:0034198),0.12940108,0.940646314,0,0,3.194888179,6.533030509,CDKN1A;EIF2AK2,4
7626,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.130302817,0.945853873,0,0,2.396166134,4.883133017,SDCBP;UBB;UBC,4
7627,secretory granule organization (GO:0033363),0.132371805,0.959507562,0,0,7.099751509,14.35669583,SRGN,4
7628,negative regulation of phagocytosis (GO:0050765),0.132371805,0.958146558,0,0,7.099751509,14.35669583,CD300LF,4
7629,acidic amino acid transport (GO:0015800),0.132371805,0.95678941,0,0,7.099751509,14.35669583,SLC25A22,4
7630,positive regulation of triglyceride biosynthetic process (GO:0010867),0.132371805,0.955436101,0,0,7.099751509,14.35669583,NR1H3,4
7631,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.132371805,0.954086615,0,0,7.099751509,14.35669583,ACOD1,4
7632,sarcoplasmic reticulum calcium ion transport (GO:0070296),0.132371805,0.952740936,0,0,7.099751509,14.35669583,CCR5,4
7633,regulation of interferon-gamma secretion (GO:1902713),0.132371805,0.951399047,0,0,7.099751509,14.35669583,LGALS9,4
7634,establishment of Golgi localization (GO:0051683),0.132371805,0.950060933,0,0,7.099751509,14.35669583,CDC42,4
7635,regulation of morphogenesis of an epithelium (GO:1905330),0.132371805,0.948726578,0,0,7.099751509,14.35669583,CXCL10,4
7636,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.132371805,0.947395965,0,0,7.099751509,14.35669583,LGALS9,4
7637,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.132371805,0.94606908,0,0,7.099751509,14.35669583,LGALS9,4
7638,Cdc42 protein signal transduction (GO:0032488),0.132371805,0.944745907,0,0,7.099751509,14.35669583,CDC42,4
7639,mitochondrion morphogenesis (GO:0070584),0.132371805,0.943426429,0,0,7.099751509,14.35669583,PNPT1,4
7640,interleukin-1 beta production (GO:0032611),0.132371805,0.942110632,0,0,7.099751509,14.35669583,GBP5,4
7641,positive regulation of leukocyte apoptotic process (GO:2000108),0.132371805,0.940798501,0,0,7.099751509,14.35669583,LGALS9,4
7642,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.132371805,0.939490019,0,0,7.099751509,14.35669583,HSPA5,4
7643,establishment of viral latency (GO:0019043),0.132371805,0.938185171,0,0,7.099751509,14.35669583,IRF7,4
7644,nucleoside phosphate biosynthetic process (GO:1901293),0.132371805,0.936883944,0,0,7.099751509,14.35669583,CMPK2,4
7645,interleukin-1 secretion (GO:0050701),0.132371805,0.93558632,0,0,7.099751509,14.35669583,GBP5,4
7646,tyrosine phosphorylation of STAT protein (GO:0007260),0.132371805,0.934292287,0,0,7.099751509,14.35669583,JAK2,4
7647,early endosome to Golgi transport (GO:0034498),0.132371805,0.933001828,0,0,7.099751509,14.35669583,SNX2,4
7648,nucleoside triphosphate biosynthetic process (GO:0009142),0.132371805,0.931714929,0,0,7.099751509,14.35669583,CMPK2,4
7649,interleukin-23-mediated signaling pathway (GO:0038155),0.132371805,0.930431575,0,0,7.099751509,14.35669583,JAK2,4
7650,regulation of methylation-dependent chromatin silencing (GO:0090308),0.132371805,0.929151752,0,0,7.099751509,14.35669583,APOBEC1,4
7651,toll-like receptor 3 signaling pathway (GO:0034138),0.132371805,0.927875444,0,0,7.099751509,14.35669583,CASP8,4
7652,ether lipid metabolic process (GO:0046485),0.132371805,0.926602638,0,0,7.099751509,14.35669583,TMEM86A,4
7653,negative regulation of chromatin silencing (GO:0031936),0.132371805,0.92533332,0,0,7.099751509,14.35669583,APOBEC1,4
7654,negative regulation of lipid localization (GO:1905953),0.132371805,0.924067474,0,0,7.099751509,14.35669583,NR1H3,4
7655,regulation of helicase activity (GO:0051095),0.132371805,0.922805087,0,0,7.099751509,14.35669583,IFIT1,4
7656,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.132371805,0.921546144,0,0,7.099751509,14.35669583,CAMK2D,4
7657,dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.132371805,0.920290631,0,0,7.099751509,14.35669583,MX1,4
7658,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.132371805,0.919038535,0,0,7.099751509,14.35669583,B2M,4
7659,mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.132371805,0.917789842,0,0,7.099751509,14.35669583,BAX,4
7660,establishment of epithelial cell apical/basal polarity (GO:0045198),0.132371805,0.916544536,0,0,7.099751509,14.35669583,CDC42,4
7661,positive regulation of triglyceride lipase activity (GO:0061365),0.132371805,0.915302606,0,0,7.099751509,14.35669583,NR1H3,4
7662,RNA transport (GO:0050658),0.133841463,0.924212429,0,0,2.366583836,4.759435078,RANBP2;PNPT1;SRSF7,4
7663,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",0.133841463,0.922963494,0,0,2.366583836,4.759435078,ARF4;COPE;TAPBP,4
7664,positive regulation of stress-activated MAPK cascade (GO:0032874),0.133841463,0.921717929,0,0,2.366583836,4.759435078,SDCBP;GADD45B;EIF2AK2,4
7665,regulation of protein serine/threonine kinase activity (GO:0071900),0.133841463,0.920475721,0,0,2.366583836,4.759435078,CDKN1A;CDK7;SERTAD1,4
7666,negative regulation of transport (GO:0051051),0.13469761,0.925116966,0,0,3.116964077,6.248649376,BST2;NR1H3,4
7667,"nucleotide-excision repair, DNA incision (GO:0033683)",0.13469761,0.923873529,0,0,3.116964077,6.248649376,UBB;UBC,4
7668,response to cAMP (GO:0051591),0.13469761,0.922633431,0,0,3.116964077,6.248649376,RAP1B;STAT1,4
7669,androgen receptor signaling pathway (GO:0030521),0.13469761,0.921396657,0,0,3.116964077,6.248649376,DAXX;CDK7,4
7670,positive regulation of cytokine biosynthetic process (GO:0042108),0.13469761,0.920163194,0,0,3.116964077,6.248649376,CD86;TLR7,4
7671,regulation of ATPase activity (GO:0043462),0.13469761,0.918933029,0,0,3.116964077,6.248649376,TOR1AIP2;TOR1AIP1,4
7672,positive regulation of hydrolase activity (GO:0051345),0.135821613,0.92536407,0,0,1.846756173,3.686887896,CD40;CCL7;TOR1AIP2;CCL2;TOR1AIP1,4
7673,Golgi vesicle transport (GO:0048193),0.136078837,0.925880407,0,0,1.644427739,3.279845457,ARF4;DYNC1I2;SNX2;CAPZA2;CTSC;COPE;TAPBP,4
7674,positive regulation of binding (GO:0051099),0.137413229,0.933714657,0,0,2.337723058,4.639825347,DTX3L;PARP9;B2M,4
7675,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.140041961,0.950311336,0,0,3.042750647,5.981479334,CDC42;CALR,4
7676,monocyte chemotaxis (GO:0002548),0.140041961,0.949049302,0,0,3.042750647,5.981479334,CCL7;CCL2,4
7677,regulation of anatomical structure morphogenesis (GO:0022603),0.141017309,0.954391684,0,0,2.30955772,4.524129415,SP100;STAT2;MARCH5,4
7678,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.141017309,0.953127589,0,0,2.30955772,4.524129415,PARP10;NLRC5;ACOD1,4
7679,positive regulation of cell cycle (GO:0045787),0.141017309,0.951866838,0,0,2.30955772,4.524129415,CCND2;CCND1;CALR,4
7680,"retrograde transport, endosome to Golgi (GO:0042147)",0.141017309,0.950609418,0,0,2.30955772,4.524129415,SNX2;STX16;STX6,4
7681,negative regulation of neuron death (GO:1901215),0.144652898,0.973830792,0,0,2.282062985,4.412182134,CHMP4B;CCL2;LGMN,4
7682,positive regulation of homeostatic process (GO:0032846),0.144652898,0.972547747,0,0,2.282062985,4.412182134,STAT1;NR1H3;LGALS9,4
7683,regulation of interleukin-6 production (GO:0032675),0.14543135,0.976494974,0,0,2.971989004,5.730146739,DDX58;MYD88,4
7684,regulation of protein modification process (GO:0031399),0.14543135,0.9752118,0,0,2.971989004,5.730146739,SOCS1;STAT2,4
7685,positive regulation of protein localization to nucleus (GO:1900182),0.14543135,0.973931995,0,0,2.971989004,5.730146739,DTX3L;PARP9,4
7686,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.14595628,0.97616631,0,0,6.389776358,12.29679334,DHX58,4
7687,negative regulation of sodium ion transmembrane transport (GO:1902306),0.14595628,0.974888606,0,0,6.389776358,12.29679334,CAMK2D,4
7688,dynamin family protein polymerization involved in membrane fission (GO:0003373),0.14595628,0.973614241,0,0,6.389776358,12.29679334,MX1,4
7689,positive regulation of calcium ion import (GO:0090280),0.14595628,0.972343205,0,0,6.389776358,12.29679334,CCL2,4
7690,cellular response to growth hormone stimulus (GO:0071378),0.14595628,0.971075482,0,0,6.389776358,12.29679334,JAK2,4
7691,regulation of myeloid leukocyte differentiation (GO:0002761),0.14595628,0.969811061,0,0,6.389776358,12.29679334,IRF7,4
7692,regulation of cellular respiration (GO:0043457),0.14595628,0.968549928,0,0,6.389776358,12.29679334,PNPT1,4
7693,macrophage chemotaxis (GO:0048246),0.14595628,0.967292071,0,0,6.389776358,12.29679334,CCL2,4
7694,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.14595628,0.966037477,0,0,6.389776358,12.29679334,CDC42,4
7695,positive regulation of alcohol biosynthetic process (GO:1902932),0.14595628,0.964786133,0,0,6.389776358,12.29679334,ABCG1,4
7696,response to laminar fluid shear stress (GO:0034616),0.14595628,0.963538027,0,0,6.389776358,12.29679334,ASS1,4
7697,regulation of mast cell activation (GO:0033003),0.14595628,0.962293146,0,0,6.389776358,12.29679334,CD300LF,4
7698,L-glutamate transport (GO:0015813),0.14595628,0.961051477,0,0,6.389776358,12.29679334,SLC25A22,4
7699,aspartate family amino acid metabolic process (GO:0009066),0.14595628,0.959813009,0,0,6.389776358,12.29679334,ASS1,4
7700,glutamine metabolic process (GO:0006541),0.14595628,0.958577728,0,0,6.389776358,12.29679334,ACOD1,4
7701,ESCRT III complex disassembly (GO:1904903),0.14595628,0.957345623,0,0,6.389776358,12.29679334,CHMP2A,4
7702,regulation of transforming growth factor beta production (GO:0071634),0.14595628,0.956116681,0,0,6.389776358,12.29679334,LGALS9,4
7703,cell differentiation involved in metanephros development (GO:0072202),0.14595628,0.954890891,0,0,6.389776358,12.29679334,STAT1,4
7704,mitotic G1 DNA damage checkpoint (GO:0031571),0.14595628,0.953668239,0,0,6.389776358,12.29679334,CCND1,4
7705,DNA dealkylation involved in DNA repair (GO:0006307),0.14595628,0.952448714,0,0,6.389776358,12.29679334,ASCC3,4
7706,T cell chemotaxis (GO:0010818),0.14595628,0.951232305,0,0,6.389776358,12.29679334,CXCL10,4
7707,regulation of granulocyte differentiation (GO:0030852),0.14595628,0.950018998,0,0,6.389776358,12.29679334,HCLS1,4
7708,positive regulation of natural killer cell activation (GO:0032816),0.14595628,0.948808783,0,0,6.389776358,12.29679334,IL18,4
7709,negative regulation of autophagosome assembly (GO:1902902),0.14595628,0.947601647,0,0,6.389776358,12.29679334,CHMP4B,4
7710,negative regulation of reproductive process (GO:2000242),0.14595628,0.946397579,0,0,6.389776358,12.29679334,CALR,4
7711,macrophage migration (GO:1905517),0.14595628,0.945196567,0,0,6.389776358,12.29679334,CCL2,4
7712,G1 DNA damage checkpoint (GO:0044783),0.14595628,0.943998599,0,0,6.389776358,12.29679334,CCND1,4
7713,endosomal vesicle fusion (GO:0034058),0.14595628,0.942803664,0,0,6.389776358,12.29679334,SAMD9L,4
7714,response to muramyl dipeptide (GO:0032495),0.14595628,0.941611751,0,0,6.389776358,12.29679334,IRF5,4
7715,myeloid dendritic cell differentiation (GO:0043011),0.14595628,0.940422847,0,0,6.389776358,12.29679334,BATF2,4
7716,DNA dealkylation (GO:0035510),0.14595628,0.939236942,0,0,6.389776358,12.29679334,ASCC3,4
7717,complement receptor mediated signaling pathway (GO:0002430),0.14595628,0.938054023,0,0,6.389776358,12.29679334,C3AR1,4
7718,positive regulation of smooth muscle cell migration (GO:0014911),0.14595628,0.936874081,0,0,6.389776358,12.29679334,AIF1,4
7719,regulation of gene expression by genetic imprinting (GO:0006349),0.14595628,0.935697104,0,0,6.389776358,12.29679334,PCGF5,4
7720,regulation of podosome assembly (GO:0071801),0.14595628,0.93452308,0,0,6.389776358,12.29679334,HCK,4
7721,polarized epithelial cell differentiation (GO:0030859),0.14595628,0.933351998,0,0,6.389776358,12.29679334,CDC42,4
7722,regulation of phospholipase activity (GO:0010517),0.14595628,0.932183848,0,0,6.389776358,12.29679334,RGS2,4
7723,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.14595628,0.931018618,0,0,6.389776358,12.29679334,CAMK2D,4
7724,ESCRT complex disassembly (GO:1904896),0.14595628,0.929856298,0,0,6.389776358,12.29679334,CHMP2A,4
7725,negative regulation of protein autophosphorylation (GO:0031953),0.14595628,0.928696876,0,0,6.389776358,12.29679334,MVP,4
7726,positive regulation of interleukin-13 production (GO:0032736),0.14595628,0.927540342,0,0,6.389776358,12.29679334,LGALS9,4
7727,mitotic G1/S transition checkpoint (GO:0044819),0.14595628,0.926386685,0,0,6.389776358,12.29679334,CCND1,4
7728,positive regulation of execution phase of apoptosis (GO:1900119),0.14595628,0.925235894,0,0,6.389776358,12.29679334,BAX,4
7729,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.14595628,0.924087959,0,0,6.389776358,12.29679334,HSPA5,4
7730,regulation of dendritic cell apoptotic process (GO:2000668),0.14595628,0.922942868,0,0,6.389776358,12.29679334,LGALS9,4
7731,histone H2B ubiquitination (GO:0033523),0.14595628,0.921800612,0,0,6.389776358,12.29679334,DTX3L,4
7732,positive regulation of nuclease activity (GO:0032075),0.14595628,0.92066118,0,0,6.389776358,12.29679334,BAX,4
7733,regulation of T cell chemotaxis (GO:0010819),0.14595628,0.919524561,0,0,6.389776358,12.29679334,CXCL10,4
7734,positive regulation of MAP kinase activity (GO:0043406),0.147758882,0.929733135,0,0,1.794880999,3.432123906,CD40;UBB;GADD45B;UBC;EIF2AK2,4
7735,protein modification process (GO:0036211),0.148319191,0.932109397,0,0,2.255215185,4.303827025,USP25;UBA7;UBE2L6,4
7736,protein glycosylation (GO:0006486),0.150054085,0.941852396,0,0,1.95107675,3.700723324,PARP10;ARF4;PARP14;PARP9,4
7737,mitotic metaphase plate congression (GO:0007080),0.150863074,0.945766909,0,0,2.904443799,5.493414613,CHMP2A;CHMP4B,4
7738,response to unfolded protein (GO:0006986),0.150863074,0.944606459,0,0,2.904443799,5.493414613,DAXX;HSPA5,4
7739,nucleobase-containing compound catabolic process (GO:0034655),0.150863074,0.943448853,0,0,2.904443799,5.493414613,ISG20;PNPT1,4
7740,regulation of multicellular organismal development (GO:2000026),0.150863074,0.942294081,0,0,2.904443799,5.493414613,CXCL10;OAS2,4
7741,positive regulation of cell motility (GO:2000147),0.15265541,0.952323421,0,0,1.774937877,3.336123746,SDCBP;MMP14;HSPA5;CCL7;RUFY3,4
7742,ER to Golgi vesicle-mediated transport (GO:0006888),0.155128959,0.966572742,0,0,1.765131591,3.289320101,ARF4;DYNC1I2;CAPZA2;COPE;CTSC,4
7743,amide biosynthetic process (GO:0043604),0.156334498,0.972896273,0,0,2.839900603,5.270166415,ACOD1;ASS1,4
7744,regulation of T cell activation (GO:0050863),0.156334498,0.971711259,0,0,2.839900603,5.270166415,CCL2;CD47,4
7745,positive regulation of intracellular transport (GO:0032388),0.156334498,0.970529129,0,0,2.839900603,5.270166415,RUFY3;BAX,4
7746,metaphase plate congression (GO:0051310),0.156334498,0.969349871,0,0,2.839900603,5.270166415,CHMP2A;CHMP4B,4
7747,positive regulation of actin filament bundle assembly (GO:0032233),0.156334498,0.968173475,0,0,2.839900603,5.270166415,CDC42;EVL,4
7748,myeloid cell differentiation (GO:0030099),0.156334498,0.966999932,0,0,2.839900603,5.270166415,HCLS1;JAK2,4
7749,cellular response to organic substance (GO:0071310),0.158869479,0.981490258,0,0,1.907395928,3.50898345,IL18;HCLS1;CCL2;PTPN6,4
7750,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.158869479,0.98030345,0,0,1.907395928,3.50898345,ACTR3;CDC42;HCK;ACTB,4
7751,positive regulation of endothelial cell apoptotic process (GO:2000353),0.159328731,0.981949894,0,0,5.808887598,10.66968181,CD40,4
7752,negative regulation of morphogenesis of an epithelium (GO:1905331),0.159328731,0.980765395,0,0,5.808887598,10.66968181,STAT1,4
7753,negative regulation of defense response to virus (GO:0050687),0.159328731,0.97958375,0,0,5.808887598,10.66968181,IFIT1,4
7754,nitric oxide biosynthetic process (GO:0006809),0.159328731,0.978404948,0,0,5.808887598,10.66968181,GCH1,4
7755,regulation of histone deacetylation (GO:0031063),0.159328731,0.977228981,0,0,5.808887598,10.66968181,CAMK2D,4
7756,regulation of trophoblast cell migration (GO:1901163),0.159328731,0.976055837,0,0,5.808887598,10.66968181,CALR,4
7757,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.159328731,0.974885506,0,0,5.808887598,10.66968181,ASS1,4
7758,negative regulation of JUN kinase activity (GO:0043508),0.159328731,0.973717979,0,0,5.808887598,10.66968181,AIDA,4
7759,negative regulation of bone mineralization (GO:0030502),0.159328731,0.972553244,0,0,5.808887598,10.66968181,SRGN,4
7760,proteasome assembly (GO:0043248),0.159328731,0.971391293,0,0,5.808887598,10.66968181,PSMD11,4
7761,positive regulation of receptor biosynthetic process (GO:0010870),0.159328731,0.970232115,0,0,5.808887598,10.66968181,NR1H3,4
7762,I-kappaB phosphorylation (GO:0007252),0.159328731,0.9690757,0,0,5.808887598,10.66968181,TLR7,4
7763,low-density lipoprotein particle remodeling (GO:0034374),0.159328731,0.967922038,0,0,5.808887598,10.66968181,ABCG1,4
7764,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.159328731,0.96677112,0,0,5.808887598,10.66968181,RNF213,4
7765,regulation of mitotic centrosome separation (GO:0046602),0.159328731,0.965622936,0,0,5.808887598,10.66968181,RANBP2,4
7766,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.159328731,0.964477476,0,0,5.808887598,10.66968181,HSPA5,4
7767,myeloid cell activation involved in immune response (GO:0002275),0.159328731,0.96333473,0,0,5.808887598,10.66968181,FCER1G,4
7768,regulation of protein kinase C signaling (GO:0090036),0.159328731,0.962194689,0,0,5.808887598,10.66968181,CD40,4
7769,positive regulation of myoblast fusion (GO:1901741),0.159328731,0.961057343,0,0,5.808887598,10.66968181,CD53,4
7770,regulation of hemopoiesis (GO:1903706),0.159328731,0.959922683,0,0,5.808887598,10.66968181,EIF2AK2,4
7771,negative regulation of peptide secretion (GO:0002792),0.159328731,0.958790698,0,0,5.808887598,10.66968181,RSAD2,4
7772,positive regulation of mesenchymal cell proliferation (GO:0002053),0.159328731,0.957661381,0,0,5.808887598,10.66968181,STAT1,4
7773,cytidine to uridine editing (GO:0016554),0.159328731,0.95653472,0,0,5.808887598,10.66968181,APOBEC1,4
7774,cellular response to interleukin-2 (GO:0071352),0.159328731,0.955410708,0,0,5.808887598,10.66968181,IL2RG,4
7775,response to sterol (GO:0036314),0.159328731,0.954289333,0,0,5.808887598,10.66968181,CCR5,4
7776,negative regulation of nucleocytoplasmic transport (GO:0046823),0.159328731,0.953170589,0,0,5.808887598,10.66968181,SP100,4
7777,histone mRNA catabolic process (GO:0071044),0.159328731,0.952054464,0,0,5.808887598,10.66968181,DCP2,4
7778,negative regulation of receptor binding (GO:1900121),0.159328731,0.95094095,0,0,5.808887598,10.66968181,B2M,4
7779,positive regulation of fatty acid biosynthetic process (GO:0045723),0.159328731,0.949830037,0,0,5.808887598,10.66968181,NR1H3,4
7780,regulation of cholesterol esterification (GO:0010872),0.159328731,0.948721718,0,0,5.808887598,10.66968181,ABCG1,4
7781,cell part morphogenesis (GO:0032990),0.159328731,0.947615981,0,0,5.808887598,10.66968181,PNPT1,4
7782,protein localization to mitochondrion (GO:0070585),0.159328731,0.94651282,0,0,5.808887598,10.66968181,5-Mar,4
7783,metanephric mesenchyme development (GO:0072075),0.159328731,0.945412223,0,0,5.808887598,10.66968181,STAT1,4
7784,negative regulation of T cell differentiation (GO:0045581),0.159328731,0.944314184,0,0,5.808887598,10.66968181,IRF1,4
7785,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.159328731,0.943218692,0,0,5.808887598,10.66968181,RGS2,4
7786,negative regulation of chemotaxis (GO:0050922),0.159328731,0.942125738,0,0,5.808887598,10.66968181,AIF1,4
7787,carbohydrate derivative catabolic process (GO:1901136),0.159328731,0.941035315,0,0,5.808887598,10.66968181,SAMHD1,4
7788,regulation of receptor biosynthetic process (GO:0010869),0.159328731,0.939947413,0,0,5.808887598,10.66968181,NR1H3,4
7789,urate metabolic process (GO:0046415),0.159328731,0.938862023,0,0,5.808887598,10.66968181,PNP,4
7790,positive regulation of interferon-gamma biosynthetic process (GO:0045078),0.159328731,0.937779137,0,0,5.808887598,10.66968181,TLR7,4
7791,calcium ion homeostasis (GO:0055074),0.159494253,0.937671861,0,0,2.178332849,3.998868834,CD40;CCL7;CALR,4
7792,nucleus organization (GO:0006997),0.161843063,0.950385673,0,0,2.778163634,5.05939203,CHMP2A;CHMP4B,4
7793,activation of protein kinase activity (GO:0032147),0.161909726,0.949684289,0,0,1.638404194,2.983069298,GADD45B;UBB;UBC;IL18;EIF2AK2;JAK2,4
7794,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.163275333,0.956594744,0,0,2.153857199,3.903472765,SDCBP;RNF114;KEAP1,4
7795,cellular response to organic cyclic compound (GO:0071407),0.164850458,0.964715467,0,0,1.879345988,3.387928079,RAP1B;IL18;CCL2;ACTB,4
7796,mitochondrial transport (GO:0006839),0.164850458,0.96361041,0,0,1.879345988,3.387928079,STARD3;PNPT1;TSPO;SLC25A22,4
7797,negative regulation of cellular protein metabolic process (GO:0032269),0.167083111,0.975543611,0,0,2.129925453,3.810998763,CSTB;EIF2AK2;CALR,4
7798,regulation of neuron apoptotic process (GO:0043523),0.167083111,0.974428704,0,0,2.129925453,3.810998763,CCL2;BAX;LGMN,4
7799,regulation of generation of precursor metabolites and energy (GO:0043467),0.167386277,0.975082386,0,0,2.719053769,4.860175659,RANBP2;PNPT1,4
7800,regulation of fibroblast proliferation (GO:0048145),0.167386277,0.973970548,0,0,2.719053769,4.860175659,PARP10;CDKN1A,4
7801,"DNA-templated transcription, initiation (GO:0006352)",0.170311507,0.989862894,0,0,1.708496352,3.024254026,CDK7;CDKN1A;CCND1;NR1H3;BAX,4
7802,regulation of JNK cascade (GO:0046328),0.170916795,0.992250747,0,0,2.106519678,3.721332201,SDCBP;GADD45B;AIDA,4
7803,positive regulation of MAPK cascade (GO:0043410),0.171001841,0.991616356,0,0,1.542359811,2.723932292,CD40;CCL7;EIF2AK2;CCL2;LGALS9;MERTK;SCIMP,4
7804,regulation of mesenchymal cell proliferation (GO:0010464),0.172492457,0.999124868,0,0,5.324813632,9.357836904,STAT1,4
7805,regulation of myoblast fusion (GO:1901739),0.172492457,0.997992073,0,0,5.324813632,9.357836904,CD53,4
7806,regulation of leukocyte cell-cell adhesion (GO:1903037),0.172492457,0.996861844,0,0,5.324813632,9.357836904,ASS1,4
7807,establishment of apical/basal cell polarity (GO:0035089),0.172492457,0.995734172,0,0,5.324813632,9.357836904,CDC42,4
7808,interleukin-2-mediated signaling pathway (GO:0038110),0.172492457,0.994609049,0,0,5.324813632,9.357836904,IL2RG,4
7809,negative regulation of ERAD pathway (GO:1904293),0.172492457,0.993486466,0,0,5.324813632,9.357836904,USP25,4
7810,pyrimidine nucleoside salvage (GO:0043097),0.172492457,0.992366413,0,0,5.324813632,9.357836904,DCK,4
7811,mitochondrial outer membrane permeabilization (GO:0097345),0.172492457,0.991248883,0,0,5.324813632,9.357836904,BAX,4
7812,viral RNA genome replication (GO:0039694),0.172492457,0.990133868,0,0,5.324813632,9.357836904,CDC42,4
7813,protein insertion into membrane (GO:0051205),0.172492457,0.989021358,0,0,5.324813632,9.357836904,RTP4,4
7814,Golgi localization (GO:0051645),0.172492457,0.987911345,0,0,5.324813632,9.357836904,CDC42,4
7815,cellular response to arsenic-containing substance (GO:0071243),0.172492457,0.986803821,0,0,5.324813632,9.357836904,DAXX,4
7816,regulation of actomyosin structure organization (GO:0110020),0.172492457,0.985698778,0,0,5.324813632,9.357836904,CDC42,4
7817,phospholipid efflux (GO:0033700),0.172492457,0.984596206,0,0,5.324813632,9.357836904,ABCG1,4
7818,mitochondrion transport along microtubule (GO:0047497),0.172492457,0.983496099,0,0,5.324813632,9.357836904,UBB,4
7819,regulation of cholesterol homeostasis (GO:2000188),0.172492457,0.982398447,0,0,5.324813632,9.357836904,NR1H3,4
7820,regulation of interleukin-2 biosynthetic process (GO:0045076),0.172492457,0.981303242,0,0,5.324813632,9.357836904,CD86,4
7821,regulation of cell communication by electrical coupling (GO:0010649),0.172492457,0.980210477,0,0,5.324813632,9.357836904,CAMK2D,4
7822,regulation of interleukin-8 biosynthetic process (GO:0045414),0.172492457,0.979120143,0,0,5.324813632,9.357836904,TLR7,4
7823,nitric oxide metabolic process (GO:0046209),0.172492457,0.978032232,0,0,5.324813632,9.357836904,GCH1,4
7824,positive regulation of pseudopodium assembly (GO:0031274),0.172492457,0.976946735,0,0,5.324813632,9.357836904,CDC42,4
7825,cellular response to fluid shear stress (GO:0071498),0.172492457,0.975863646,0,0,5.324813632,9.357836904,ASS1,4
7826,activation of cysteine-type endopeptidase activity (GO:0097202),0.172492457,0.974782955,0,0,5.324813632,9.357836904,CASP8,4
7827,regulation of pseudopodium assembly (GO:0031272),0.172492457,0.973704655,0,0,5.324813632,9.357836904,CDC42,4
7828,"regulation of protein import into nucleus, translocation (GO:0033158)",0.172492457,0.972628739,0,0,5.324813632,9.357836904,PARP10,4
7829,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.172492457,0.971555197,0,0,5.324813632,9.357836904,BAX,4
7830,aromatic compound biosynthetic process (GO:0019438),0.172492457,0.970484023,0,0,5.324813632,9.357836904,GCH1,4
7831,pyrimidine-containing compound salvage (GO:0008655),0.172492457,0.969415208,0,0,5.324813632,9.357836904,DCK,4
7832,negative regulation of JAK-STAT cascade (GO:0046426),0.172961717,0.970983105,0,0,2.662406816,4.671685296,SOCS1;PARP14,4
7833,positive regulation of organelle assembly (GO:1902117),0.172961717,0.969916091,0,0,2.662406816,4.671685296,GPSM2;SDCBP,4
7834,cellular response to heat (GO:0034605),0.172961717,0.968851419,0,0,2.662406816,4.671685296,DAXX;HSPA5,4
7835,proteolysis (GO:0006508),0.175106417,0.979789522,0,0,1.531795702,2.668941697,SRGN;USP25;MMP14;CASP8;SPPL2A;CTSC;LGMN,4
7836,regulation of cell cycle arrest (GO:0071156),0.178567028,0.998058648,0,0,2.608071983,4.493163564,CCND1;CALR,4
7837,interstrand cross-link repair (GO:0036297),0.178567028,0.99696668,0,0,2.608071983,4.493163564,UBB;UBC,4
7838,regulation of mitochondrion organization (GO:0010821),0.178567028,0.995877099,0,0,2.608071983,4.493163564,STAT2;MARCH5,4
7839,positive regulation of chemotaxis (GO:0050921),0.178567028,0.994789897,0,0,2.608071983,4.493163564,CXCL10;AIF1,4
7840,cellular macromolecule catabolic process (GO:0044265),0.178567028,0.993705066,0,0,2.608071983,4.493163564,ISG20;PNPT1,4
7841,amino acid transport (GO:0006865),0.178567028,0.992622599,0,0,2.608071983,4.493163564,SLC7A8;SLC3A2,4
7842,positive regulation of cellular metabolic process (GO:0031325),0.178658722,0.992051643,0,0,2.06121818,3.549990462,CDKN1A;ACOD1;NR1H3,4
7843,nuclear export (GO:0051168),0.178658722,0.990973326,0,0,2.06121818,3.549990462,RANBP2;CALR;SRSF7,4
7844,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),0.179579223,0.994997585,0,0,1.279460519,2.197011318,ARF4;CD40;STAT1;PCGF5;DDX58;IL18;NLRC5;NR1H3;CXCL10;CDK7;UBB;IRF1;NAMPT;UBC;IRF7;HCLS1;IRF5,4
7845,regulation of cellular component organization (GO:0051128),0.180145586,0.997053066,0,0,1.812702513,3.106953876,RAP1B;OGFR;CAMK2D;RAB5C,4
7846,cellular transition metal ion homeostasis (GO:0046916),0.182565395,1,0,0,2.039290327,3.468112658,UBB;UBC;HMOX2,4
7847,lipid homeostasis (GO:0055088),0.18419992,1,0,0,2.555910543,4.323919718,NR1H3;ABCG1,4
7848,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.18419992,1,0,0,2.555910543,4.323919718,CXCL10;CAMK2D,4
7849,response to iron ion (GO:0010039),0.185450707,1,0,0,4.915212583,8.281966895,B2M,4
7850,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.185450707,1,0,0,4.915212583,8.281966895,SRSF7,4
7851,regulation of triglyceride biosynthetic process (GO:0010866),0.185450707,1,0,0,4.915212583,8.281966895,NR1H3,4
7852,tricarboxylic acid metabolic process (GO:0072350),0.185450707,1,0,0,4.915212583,8.281966895,ASS1,4
7853,positive regulation of cholesterol efflux (GO:0010875),0.185450707,1,0,0,4.915212583,8.281966895,NR1H3,4
7854,regulation of macrophage differentiation (GO:0045649),0.185450707,1,0,0,4.915212583,8.281966895,CASP8,4
7855,regulation of cAMP metabolic process (GO:0030814),0.185450707,1,0,0,4.915212583,8.281966895,CXCL10,4
7856,catecholamine biosynthetic process (GO:0042423),0.185450707,1,0,0,4.915212583,8.281966895,GCH1,4
7857,response to UV-B (GO:0010224),0.185450707,1,0,0,4.915212583,8.281966895,CDKN1A,4
7858,protein localization to endoplasmic reticulum (GO:0070972),0.185450707,1,0,0,4.915212583,8.281966895,HSPA5,4
7859,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.185450707,1,0,0,4.915212583,8.281966895,FCER1G,4
7860,positive regulation of lamellipodium assembly (GO:0010592),0.185450707,1,0,0,4.915212583,8.281966895,CDC42,4
7861,mammary gland epithelium development (GO:0061180),0.185450707,1,0,0,4.915212583,8.281966895,JAK2,4
7862,nucleotide metabolic process (GO:0009117),0.185450707,1,0,0,4.915212583,8.281966895,DCK,4
7863,regulation of T cell cytokine production (GO:0002724),0.185450707,1,0,0,4.915212583,8.281966895,B2M,4
7864,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.185450707,1,0,0,4.915212583,8.281966895,CALR,4
7865,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.185450707,1,0,0,4.915212583,8.281966895,DTX3L,4
7866,negative regulation of chemokine production (GO:0032682),0.185450707,1,0,0,4.915212583,8.281966895,LGALS9,4
7867,amyloid precursor protein metabolic process (GO:0042982),0.185450707,1,0,0,4.915212583,8.281966895,ABCG1,4
7868,negative regulation of interleukin-10 production (GO:0032693),0.185450707,1,0,0,4.915212583,8.281966895,CD274,4
7869,cellular response to fibroblast growth factor stimulus (GO:0044344),0.186494833,1,0,0,2.017824113,3.388636449,UBB;UBC;CCL2,4
7870,regulation of bone mineralization (GO:0030500),0.189858166,1,0,0,2.50579465,4.163322639,SRGN;ISG15,4
7871,negative regulation of protein ubiquitination (GO:0031397),0.189858166,1,0,0,2.50579465,4.163322639,DTX3L;ISG15,4
7872,regulation of cytoskeleton organization (GO:0051493),0.190446262,1,0,0,1.996805112,3.311472072,CDC42;BST2;PFDN2,4
7873,regulation of ERK1 and ERK2 cascade (GO:0070372),0.194164194,1,0,0,1.545913635,2.533831468,CCL7;CCL2;PTPN6;LGALS9;MERTK;SCIMP,4
7874,regulation of cell death (GO:0010941),0.194418912,1,0,0,1.976219492,3.236533921,UBB;CHMP2A;CHMP4B,4
7875,cellular metal ion homeostasis (GO:0006875),0.194418912,1,0,0,1.976219492,3.236533921,CD40;CCL7;CALR,4
7876,carboxylic acid transport (GO:0046942),0.195539601,1,0,0,2.457606291,4.010794679,SLC7A8;SLC3A2,4
7877,nucleoside salvage (GO:0043174),0.198206676,1,0,0,4.56412597,7.386786732,DCK,4
7878,mitotic cell cycle arrest (GO:0071850),0.198206676,1,0,0,4.56412597,7.386786732,PNPT1,4
7879,negative regulation of receptor-mediated endocytosis (GO:0048261),0.198206676,1,0,0,4.56412597,7.386786732,SDCBP,4
7880,myeloid dendritic cell activation (GO:0001773),0.198206676,1,0,0,4.56412597,7.386786732,BATF2,4
7881,establishment of mitotic spindle orientation (GO:0000132),0.198206676,1,0,0,4.56412597,7.386786732,GPSM2,4
7882,regulation of nucleocytoplasmic transport (GO:0046822),0.198206676,1,0,0,4.56412597,7.386786732,KHDRBS1,4
7883,endoplasmic reticulum tubular network organization (GO:0071786),0.198206676,1,0,0,4.56412597,7.386786732,ARL6IP1,4
7884,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.198206676,1,0,0,4.56412597,7.386786732,CYCS,4
7885,regulation of secretion (GO:0051046),0.198206676,1,0,0,4.56412597,7.386786732,OAS2,4
7886,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.198206676,1,0,0,4.56412597,7.386786732,SP100,4
7887,regulation of monocyte differentiation (GO:0045655),0.198206676,1,0,0,4.56412597,7.386786732,IRF7,4
7888,pancreas development (GO:0031016),0.198206676,1,0,0,4.56412597,7.386786732,PPDPF,4
7889,negative regulation of secretion (GO:0051048),0.198206676,1,0,0,4.56412597,7.386786732,NR1H3,4
7890,copper ion transport (GO:0006825),0.198206676,1,0,0,4.56412597,7.386786732,SLC31A2,4
7891,positive regulation of mitochondrial fission (GO:0090141),0.198206676,1,0,0,4.56412597,7.386786732,5-Mar,4
7892,negative regulation of biomineral tissue development (GO:0070168),0.198206676,1,0,0,4.56412597,7.386786732,SRGN,4
7893,neutrophil activation (GO:0042119),0.198206676,1,0,0,4.56412597,7.386786732,FCER1G,4
7894,metallo-sulfur cluster assembly (GO:0031163),0.198206676,1,0,0,4.56412597,7.386786732,FAM96B,4
7895,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.198206676,1,0,0,4.56412597,7.386786732,TMBIM6,4
7896,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.198206676,1,0,0,4.56412597,7.386786732,IL18,4
7897,regulation of transferase activity (GO:0051338),0.198206676,1,0,0,4.56412597,7.386786732,NLRC5,4
7898,cellular response to nitrogen compound (GO:1901699),0.198206676,1,0,0,4.56412597,7.386786732,DAXX,4
7899,negative regulation of smooth muscle cell migration (GO:0014912),0.198206676,1,0,0,4.56412597,7.386786732,AIF1,4
7900,purine nucleotide catabolic process (GO:0006195),0.198206676,1,0,0,4.56412597,7.386786732,PNP,4
7901,nucleoside triphosphate metabolic process (GO:0009141),0.198206676,1,0,0,4.56412597,7.386786732,CMPK2,4
7902,positive regulation of purine nucleotide metabolic process (GO:1900544),0.198206676,1,0,0,4.56412597,7.386786732,CXCL10,4
7903,positive regulation of muscle hypertrophy (GO:0014742),0.198206676,1,0,0,4.56412597,7.386786732,CAMK2D,4
7904,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.198206676,1,0,0,4.56412597,7.386786732,DAXX,4
7905,regulation of interferon-gamma biosynthetic process (GO:0045072),0.198206676,1,0,0,4.56412597,7.386786732,TLR7,4
7906,negative regulation of cation transmembrane transport (GO:1904063),0.198206676,1,0,0,4.56412597,7.386786732,CAMK2D,4
7907,positive regulation of interleukin-8 secretion (GO:2000484),0.198206676,1,0,0,4.56412597,7.386786732,LGALS9,4
7908,purine-containing compound catabolic process (GO:0072523),0.198206676,1,0,0,4.56412597,7.386786732,PNP,4
7909,mRNA metabolic process (GO:0016071),0.198412019,1,0,0,1.956053987,3.163740319,PNPT1;SRSF7;DCP2,4
7910,protein localization to organelle (GO:0033365),0.198412019,1,0,0,1.956053987,3.163740319,CALR;MARCH5;TOR1AIP1,4
7911,positive regulation of proteolysis (GO:0045862),0.201242125,1,0,0,2.411236361,3.865806246,CASP8;CTSC,4
7912,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.201242125,1,0,0,2.411236361,3.865806246,SNX2;UBB,4
7913,regulation of DNA binding (GO:0051101),0.201242125,1,0,0,2.411236361,3.865806246,SP100;JAK2,4
7914,steroid metabolic process (GO:0008202),0.206456565,1,0,0,1.916932907,3.024278394,STARD3;TSPO;LGMN,4
7915,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),0.206963692,1,0,0,2.366583836,3.727871023,UBB;UBC,4
7916,positive regulation of protein import into nucleus (GO:0042307),0.206963692,1,0,0,2.366583836,3.727871023,DDX58;HCLS1,4
7917,cellular response to metal ion (GO:0071248),0.210506501,1,0,0,1.897953374,2.957464475,DAXX;CAMK2D;B2M,4
7918,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.210582211,1,0,0,1.581627811,2.463984994,CCL7;CCL2;LGALS9;MERTK;SCIMP,4
7919,positive regulation of alpha-beta T cell activation (GO:0046635),0.210763514,1,0,0,4.259850905,6.632666931,PNP,4
7920,regulation of mast cell degranulation (GO:0043304),0.210763514,1,0,0,4.259850905,6.632666931,LGALS9,4
7921,vitamin D metabolic process (GO:0042359),0.210763514,1,0,0,4.259850905,6.632666931,LGMN,4
7922,phosphatidylethanolamine biosynthetic process (GO:0006646),0.210763514,1,0,0,4.259850905,6.632666931,ETNK1,4
7923,regulation of B cell differentiation (GO:0045577),0.210763514,1,0,0,4.259850905,6.632666931,MMP14,4
7924,substrate-dependent cell migration (GO:0006929),0.210763514,1,0,0,4.259850905,6.632666931,SDCBP,4
7925,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.210763514,1,0,0,4.259850905,6.632666931,EIF2AK2,4
7926,positive regulation of cytokine production involved in immune response (GO:0002720),0.210763514,1,0,0,4.259850905,6.632666931,B2M,4
7927,regulation of interleukin-4 production (GO:0032673),0.210763514,1,0,0,4.259850905,6.632666931,LGALS9,4
7928,anterograde synaptic vesicle transport (GO:0048490),0.210763514,1,0,0,4.259850905,6.632666931,AP3B1,4
7929,intracellular lipid transport (GO:0032365),0.210763514,1,0,0,4.259850905,6.632666931,NPC2,4
7930,negative regulation of cell aging (GO:0090344),0.210763514,1,0,0,4.259850905,6.632666931,5-Mar,4
7931,pyrimidine nucleoside metabolic process (GO:0006213),0.210763514,1,0,0,4.259850905,6.632666931,ACOD1,4
7932,cellular response to virus (GO:0098586),0.210763514,1,0,0,4.259850905,6.632666931,LGALS9,4
7933,negative regulation of cellular component movement (GO:0051271),0.210763514,1,0,0,4.259850905,6.632666931,SP100,4
7934,response to cholesterol (GO:0070723),0.210763514,1,0,0,4.259850905,6.632666931,CCR5,4
7935,regulation of mitotic sister chromatid separation (GO:0010965),0.210763514,1,0,0,4.259850905,6.632666931,PTTG1,4
7936,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.210763514,1,0,0,4.259850905,6.632666931,SP100,4
7937,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.210763514,1,0,0,4.259850905,6.632666931,RNF34,4
7938,negative regulation of viral entry into host cell (GO:0046597),0.210763514,1,0,0,4.259850905,6.632666931,IFITM3,4
7939,amide transport (GO:0042886),0.210763514,1,0,0,4.259850905,6.632666931,TAP1,4
7940,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.210763514,1,0,0,4.259850905,6.632666931,CD53,4
7941,protein O-linked fucosylation (GO:0036066),0.210763514,1,0,0,4.259850905,6.632666931,SPON1,4
7942,JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),0.210763514,1,0,0,4.259850905,6.632666931,JAK2,4
7943,regulation of RNA export from nucleus (GO:0046831),0.210763514,1,0,0,4.259850905,6.632666931,KHDRBS1,4
7944,regulation of lymphocyte proliferation (GO:0050670),0.210763514,1,0,0,4.259850905,6.632666931,LST1,4
7945,synaptic vesicle transport along microtubule (GO:0099517),0.210763514,1,0,0,4.259850905,6.632666931,AP3B1,4
7946,cytoplasmic sequestering of protein (GO:0051220),0.210763514,1,0,0,4.259850905,6.632666931,KEAP1,4
7947,base conversion or substitution editing (GO:0016553),0.210763514,1,0,0,4.259850905,6.632666931,APOBEC1,4
7948,regulation of cell junction assembly (GO:1901888),0.210763514,1,0,0,4.259850905,6.632666931,RAP1B,4
7949,positive regulation of immune response (GO:0050778),0.21270232,1,0,0,2.323555039,3.59654174,GBP5;LGALS9,4
7950,positive regulation of response to stimulus (GO:0048584),0.21270232,1,0,0,2.323555039,3.59654174,IFIH1;DDX58,4
7951,cellular divalent inorganic cation homeostasis (GO:0072503),0.214573888,1,0,0,1.879345988,2.892503542,CD40;CCL7;CALR,4
7952,regulation of protein ubiquitination (GO:0031396),0.214573888,1,0,0,1.879345988,2.892503542,DAXX;UBB;ISG15,4
7953,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.218456079,1,0,0,2.282062985,3.471406426,CASP8;CYCS,4
7954,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.218456079,1,0,0,2.282062985,3.471406426,UBB;UBC,4
7955,positive regulation of epithelial cell apoptotic process (GO:1904037),0.223124318,1,0,0,3.993610224,5.990519905,CD40,4
7956,negative regulation of NF-kappaB import into nucleus (GO:0042347),0.223124318,1,0,0,3.993610224,5.990519905,G3BP2,4
7957,dendritic cell chemotaxis (GO:0002407),0.223124318,1,0,0,3.993610224,5.990519905,CCR5,4
7958,neuromuscular process (GO:0050905),0.223124318,1,0,0,3.993610224,5.990519905,GCH1,4
7959,positive regulation of lymphocyte differentiation (GO:0045621),0.223124318,1,0,0,3.993610224,5.990519905,MMP14,4
7960,heme biosynthetic process (GO:0006783),0.223124318,1,0,0,3.993610224,5.990519905,TSPO,4
7961,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.223124318,1,0,0,3.993610224,5.990519905,CAMK2D,4
7962,positive regulation of immune system process (GO:0002684),0.223124318,1,0,0,3.993610224,5.990519905,LGALS9,4
7963,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.223124318,1,0,0,3.993610224,5.990519905,IL18,4
7964,dendritic spine morphogenesis (GO:0060997),0.223124318,1,0,0,3.993610224,5.990519905,CDC42,4
7965,pyrimidine-containing compound metabolic process (GO:0072527),0.223124318,1,0,0,3.993610224,5.990519905,DCK,4
7966,T cell migration (GO:0072678),0.223124318,1,0,0,3.993610224,5.990519905,CXCL10,4
7967,regulation of osteoblast proliferation (GO:0033688),0.223124318,1,0,0,3.993610224,5.990519905,EIF2AK2,4
7968,regulation of steroid metabolic process (GO:0019218),0.223124318,1,0,0,3.993610224,5.990519905,ABCG1,4
7969,positive regulation of triglyceride metabolic process (GO:0090208),0.223124318,1,0,0,3.993610224,5.990519905,NR1H3,4
7970,positive regulation of cyclic nucleotide metabolic process (GO:0030801),0.223124318,1,0,0,3.993610224,5.990519905,CXCL10,4
7971,positive regulation of nitric-oxide synthase activity (GO:0051000),0.223124318,1,0,0,3.993610224,5.990519905,GCH1,4
7972,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.223124318,1,0,0,3.993610224,5.990519905,CCND1,4
7973,regulation of stem cell proliferation (GO:0072091),0.223124318,1,0,0,3.993610224,5.990519905,EIF2AK2,4
7974,mitochondrial fusion (GO:0008053),0.223124318,1,0,0,3.993610224,5.990519905,BAX,4
7975,ruffle organization (GO:0031529),0.223124318,1,0,0,3.993610224,5.990519905,AIF1,4
7976,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.223124318,1,0,0,3.993610224,5.990519905,BAX,4
7977,chromosome organization (GO:0051276),0.224223099,1,0,0,2.242026792,3.352085075,UBB;UBC,4
7978,cellular defense response (GO:0006968),0.224223099,1,0,0,2.242026792,3.352085075,LGALS3BP;CCR5,4
7979,regulation of cellular response to stress (GO:0080135),0.226873407,1,0,0,1.825650388,2.708102411,RANBP2;CAMK2D;PNPT1,4
7980,"positive regulation of transcription, DNA-templated (GO:0045893)",0.226906446,1,0,0,1.197014304,1.775432537,CD86;ARF4;CD40;SP100;DTX3L;STAT1;PCGF5;DDX58;IL18;NLRC5;NR1H3;PARP9;CXCL10;CDK7;UBB;IRF1;NAMPT;UBC;IRF7;HCLS1;IRF5,4
7981,regulation of protein phosphorylation (GO:0001932),0.22861581,1,0,0,1.463307563,2.159421069,DAXX;CD40;CCND2;SOCS1;CCND1;STAT2,4
7982,IRE1-mediated unfolded protein response (GO:0036498),0.230001562,1,0,0,2.203371158,3.238226681,HSPA5;PDIA6,4
7983,protein homotetramerization (GO:0051289),0.230001562,1,0,0,2.203371158,3.238226681,GBP5;SAMHD1,4
7984,cellular protein metabolic process (GO:0044267),0.230646518,1,0,0,1.317479661,1.932570028,USP25;UBA7;UBB;SPPL2A;UBC;SHISA5;UBE2L6;B2M;PDIA6;LGMN,4
7985,transcription from RNA polymerase II promoter (GO:0006366),0.23249443,1,0,0,1.314768798,1.918101751,CDKN1A;CDK7;PTTG1;CCND1;IRF1;IRF7;ELOA;NR1H3;BAX;SRSF7,4
7986,positive regulation of cellular catabolic process (GO:0031331),0.235146994,1,0,0,1.791526082,2.593313645,PNPT1;DTX3L;ZC3HAV1,4
7987,high-density lipoprotein particle remodeling (GO:0034375),0.235292139,1,0,0,3.758691975,5.438554379,ABCG1,4
7988,positive regulation of cholesterol transport (GO:0032376),0.235292139,1,0,0,3.758691975,5.438554379,NR1H3,4
7989,regulation of tissue remodeling (GO:0034103),0.235292139,1,0,0,3.758691975,5.438554379,IL18,4
7990,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.235292139,1,0,0,3.758691975,5.438554379,CCND1,4
7991,reverse cholesterol transport (GO:0043691),0.235292139,1,0,0,3.758691975,5.438554379,ABCG1,4
7992,regulation of membrane depolarization (GO:0003254),0.235292139,1,0,0,3.758691975,5.438554379,CAMK2D,4
7993,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.235292139,1,0,0,3.758691975,5.438554379,LPXN,4
7994,DNA catabolic process (GO:0006308),0.235292139,1,0,0,3.758691975,5.438554379,ISG20,4
7995,positive regulation of fatty acid metabolic process (GO:0045923),0.235292139,1,0,0,3.758691975,5.438554379,NR1H3,4
7996,histone H2A ubiquitination (GO:0033522),0.235292139,1,0,0,3.758691975,5.438554379,DTX3L,4
7997,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.235292139,1,0,0,3.758691975,5.438554379,BAX,4
7998,positive regulation of striated muscle cell differentiation (GO:0051155),0.235292139,1,0,0,3.758691975,5.438554379,MMP14,4
7999,histone H2A monoubiquitination (GO:0035518),0.235292139,1,0,0,3.758691975,5.438554379,PCGF5,4
8000,negative regulation of intracellular transport (GO:0032387),0.235292139,1,0,0,3.758691975,5.438554379,LGALS9,4
8001,positive regulation of cellular protein catabolic process (GO:1903364),0.235292139,1,0,0,3.758691975,5.438554379,CTSC,4
8002,3'-UTR-mediated mRNA stabilization (GO:0070935),0.235292139,1,0,0,3.758691975,5.438554379,MYD88,4
8003,response to purine-containing compound (GO:0014074),0.235292139,1,0,0,3.758691975,5.438554379,STAT1,4
8004,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.235292139,1,0,0,3.758691975,5.438554379,UBB,4
8005,macrophage activation (GO:0042116),0.235292139,1,0,0,3.758691975,5.438554379,AIF1,4
8006,heterocycle biosynthetic process (GO:0018130),0.235292139,1,0,0,3.758691975,5.438554379,GCH1,4
8007,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.235292139,1,0,0,3.758691975,5.438554379,CAMK2D,4
8008,regulation of lamellipodium organization (GO:1902743),0.235292139,1,0,0,3.758691975,5.438554379,CDC42,4
8009,regulation of B cell receptor signaling pathway (GO:0050855),0.235292139,1,0,0,3.758691975,5.438554379,LPXN,4
8010,positive regulation of transcription of Notch receptor target (GO:0007221),0.235292139,1,0,0,3.758691975,5.438554379,STAT1,4
8011,phospholipid transport (GO:0015914),0.235789704,1,0,0,2.166025884,3.129506591,NPC2;ABCG1,4
8012,receptor metabolic process (GO:0043112),0.235789704,1,0,0,2.166025884,3.129506591,FCER1G;LGMN,4
8013,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.235789704,1,0,0,2.166025884,3.129506591,CDC42;CALR,4
8014,mitotic cytokinesis (GO:0000281),0.241585814,1,0,0,2.129925453,3.025624139,CHMP4B;MITD1,4
8015,cell junction assembly (GO:0034329),0.241585814,1,0,0,2.129925453,3.025624139,CDC42;ACTB,4
8016,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.241585814,1,0,0,2.129925453,3.025624139,SP100;CASP8,4
8017,sterol metabolic process (GO:0016125),0.241585814,1,0,0,2.129925453,3.025624139,STARD3;ABCG1,4
8018,nucleotide-excision repair (GO:0006289),0.243473087,1,0,0,1.758654043,2.484536507,CDK7;UBB;UBC,4
8019,porphyrin-containing compound biosynthetic process (GO:0006779),0.247269981,1,0,0,3.549875754,4.960150869,TSPO,4
8020,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.247269981,1,0,0,3.549875754,4.960150869,DCP2,4
8021,membrane protein ectodomain proteolysis (GO:0006509),0.247269981,1,0,0,3.549875754,4.960150869,SPPL2A,4
8022,homologous chromosome segregation (GO:0045143),0.247269981,1,0,0,3.549875754,4.960150869,PTTG1,4
8023,iron-sulfur cluster assembly (GO:0016226),0.247269981,1,0,0,3.549875754,4.960150869,FAM96B,4
8024,regulation of spindle organization (GO:0090224),0.247269981,1,0,0,3.549875754,4.960150869,GPSM2,4
8025,cardiac muscle cell contraction (GO:0086003),0.247269981,1,0,0,3.549875754,4.960150869,CAMK2D,4
8026,release of cytochrome c from mitochondria (GO:0001836),0.247269981,1,0,0,3.549875754,4.960150869,BAX,4
8027,maintenance of protein localization in organelle (GO:0072595),0.247269981,1,0,0,3.549875754,4.960150869,HSPA5,4
8028,negative regulation of fibroblast proliferation (GO:0048147),0.247269981,1,0,0,3.549875754,4.960150869,PARP10,4
8029,establishment of mitotic spindle localization (GO:0040001),0.247269981,1,0,0,3.549875754,4.960150869,GPSM2,4
8030,anion homeostasis (GO:0055081),0.247269981,1,0,0,3.549875754,4.960150869,ABCG1,4
8031,regulation of cholesterol efflux (GO:0010874),0.247269981,1,0,0,3.549875754,4.960150869,NR1H3,4
8032,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.247269981,1,0,0,3.549875754,4.960150869,KLRK1,4
8033,positive regulation of p38MAPK cascade (GO:1900745),0.247269981,1,0,0,3.549875754,4.960150869,GADD45B,4
8034,regulation of cAMP-mediated signaling (GO:0043949),0.247269981,1,0,0,3.549875754,4.960150869,CXCL10,4
8035,establishment of epithelial cell polarity (GO:0090162),0.247269981,1,0,0,3.549875754,4.960150869,CDC42,4
8036,response to organophosphorus (GO:0046683),0.247269981,1,0,0,3.549875754,4.960150869,STAT1,4
8037,positive regulation of natural killer cell mediated immunity (GO:0002717),0.247269981,1,0,0,3.549875754,4.960150869,KLRK1,4
8038,positive regulation of protein binding (GO:0032092),0.247388229,1,0,0,2.095008642,2.926300523,DTX3L;B2M,4
8039,regulation of stress fiber assembly (GO:0051492),0.247388229,1,0,0,2.095008642,2.926300523,CDC42;EVL,4
8040,regulation of cell cycle (GO:0051726),0.250622923,1,0,0,1.479114898,2.04680773,SDCBP;GADD45B;CCND1;IRF1;CALR,4
8041,regulation of tumor necrosis factor production (GO:0032680),0.25319534,1,0,0,2.06121818,2.831276909,LGALS9;JAK2,4
8042,RNA 3'-end processing (GO:0031123),0.25319534,1,0,0,2.06121818,2.831276909,PNPT1;SRSF7,4
8043,negative regulation of MAP kinase activity (GO:0043407),0.25319534,1,0,0,2.06121818,2.831276909,RGS2;AIDA,4
8044,positive regulation of protein modification process (GO:0031401),0.255597359,1,0,0,1.558482038,2.126006216,DAXX;CD40;CCND2;CCND1,4
8045,regulation of actin filament-based process (GO:0032970),0.259005583,1,0,0,2.028500431,2.740312714,CDC42;BST2,4
8046,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.2590608,1,0,0,3.363040188,4.542433144,SDCBP,4
8047,negative regulation of lymphocyte activation (GO:0051250),0.2590608,1,0,0,3.363040188,4.542433144,LST1,4
8048,negative regulation of protein localization to plasma membrane (GO:1903077),0.2590608,1,0,0,3.363040188,4.542433144,CSK,4
8049,organelle fusion (GO:0048284),0.2590608,1,0,0,3.363040188,4.542433144,BAX,4
8050,positive regulation of heart contraction (GO:0045823),0.2590608,1,0,0,3.363040188,4.542433144,RGS2,4
8051,positive regulation of activated T cell proliferation (GO:0042104),0.2590608,1,0,0,3.363040188,4.542433144,IL18,4
8052,endothelial cell development (GO:0001885),0.2590608,1,0,0,3.363040188,4.542433144,RAP1B,4
8053,regulation of myotube differentiation (GO:0010830),0.2590608,1,0,0,3.363040188,4.542433144,MMP14,4
8054,Rac protein signal transduction (GO:0016601),0.2590608,1,0,0,3.363040188,4.542433144,AIF1,4
8055,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.2590608,1,0,0,3.363040188,4.542433144,TPST1,4
8056,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.2590608,1,0,0,3.363040188,4.542433144,BAX,4
8057,nucleotide-sugar biosynthetic process (GO:0009226),0.2590608,1,0,0,3.363040188,4.542433144,GMPPB,4
8058,regulation of platelet activation (GO:0010543),0.2590608,1,0,0,3.363040188,4.542433144,FCER1G,4
8059,positive regulation of phospholipase activity (GO:0010518),0.2590608,1,0,0,3.363040188,4.542433144,ARF4,4
8060,negative regulation of calcium ion transport (GO:0051926),0.2590608,1,0,0,3.363040188,4.542433144,TMBIM6,4
8061,mitochondrial calcium ion homeostasis (GO:0051560),0.2590608,1,0,0,3.363040188,4.542433144,TGM2,4
8062,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.2590608,1,0,0,3.363040188,4.542433144,SDCBP,4
8063,positive regulation of neuron apoptotic process (GO:0043525),0.2590608,1,0,0,3.363040188,4.542433144,BAX,4
8064,positive regulation of axon extension (GO:0045773),0.2590608,1,0,0,3.363040188,4.542433144,RUFY3,4
8065,phosphorylation (GO:0016310),0.261480199,1,0,0,1.320884002,1.771829466,HCK;CDK7;CAMK2D;EIF2AK2;CCL2;CSK;JAK2;MERTK,4
8066,positive regulation of kinase activity (GO:0033674),0.264481919,1,0,0,1.681520094,2.236392111,DAXX;CDKN1A;MERTK,4
8067,regulation of proteolysis (GO:0030162),0.264817443,1,0,0,1.996805112,2.653184072,CSTB;CASP8,4
8068,negative regulation of neuron apoptotic process (GO:0043524),0.264817443,1,0,0,1.996805112,2.653184072,CCL2;LGMN,4
8069,positive regulation of cell migration (GO:0030335),0.268347845,1,0,0,1.439138819,1.893145687,SDCBP;MMP14;HSPA5;CCL7;RUFY3,4
8070,positive regulation of interleukin-2 production (GO:0032743),0.270667508,1,0,0,3.194888179,4.175284729,CD86,4
8071,cell projection assembly (GO:0030031),0.270667508,1,0,0,3.194888179,4.175284729,CDC42,4
8072,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.270667508,1,0,0,3.194888179,4.175284729,TMBIM6,4
8073,negative regulation of intracellular protein transport (GO:0090317),0.270667508,1,0,0,3.194888179,4.175284729,SP100,4
8074,negative regulation of phosphate metabolic process (GO:0045936),0.270667508,1,0,0,3.194888179,4.175284729,CDKN1A,4
8075,regulation of lipoprotein lipase activity (GO:0051004),0.270667508,1,0,0,3.194888179,4.175284729,NR1H3,4
8076,phosphatidylethanolamine metabolic process (GO:0046337),0.270667508,1,0,0,3.194888179,4.175284729,ETNK1,4
8077,purine nucleotide metabolic process (GO:0006163),0.270667508,1,0,0,3.194888179,4.175284729,PNP,4
8078,regulation of calcium ion transmembrane transport (GO:1903169),0.270667508,1,0,0,3.194888179,4.175284729,CAMK2D,4
8079,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.270667508,1,0,0,3.194888179,4.175284729,ACTR3,4
8080,negative regulation of telomere maintenance via telomerase (GO:0032211),0.270667508,1,0,0,3.194888179,4.175284729,DCP2,4
8081,growth hormone receptor signaling pathway (GO:0060396),0.270667508,1,0,0,3.194888179,4.175284729,JAK2,4
8082,dorsal/ventral pattern formation (GO:0009953),0.270667508,1,0,0,3.194888179,4.175284729,AIDA,4
8083,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.270667508,1,0,0,3.194888179,4.175284729,EVL,4
8084,cellular response to steroid hormone stimulus (GO:0071383),0.270667508,1,0,0,3.194888179,4.175284729,ACOD1,4
8085,mitochondrial RNA metabolic process (GO:0000959),0.270667508,1,0,0,3.194888179,4.175284729,PNPT1,4
8086,cellular response to oxidative stress (GO:0034599),0.272948872,1,0,0,1.652528368,2.145759808,PNPT1;NCF4;CYCS,4
8087,negative regulation of cell adhesion (GO:0007162),0.276440184,1,0,0,1.936295866,2.489613346,CD164;LPXN,4
8088,activation of MAPK activity (GO:0000187),0.281444306,1,0,0,1.624519413,2.059599338,DAXX;UBB;UBC,4
8089,dendritic cell differentiation (GO:0097028),0.28209297,1,0,0,3.042750647,3.850657487,BATF2,4
8090,regulation of ruffle assembly (GO:1900027),0.28209297,1,0,0,3.042750647,3.850657487,EVL,4
8091,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.28209297,1,0,0,3.042750647,3.850657487,CYCS,4
8092,establishment of spindle orientation (GO:0051294),0.28209297,1,0,0,3.042750647,3.850657487,GPSM2,4
8093,histone ubiquitination (GO:0016574),0.28209297,1,0,0,3.042750647,3.850657487,DTX3L,4
8094,negative regulation of ion transmembrane transporter activity (GO:0032413),0.28209297,1,0,0,3.042750647,3.850657487,CAMK2D,4
8095,negative regulation of macroautophagy (GO:0016242),0.28209297,1,0,0,3.042750647,3.850657487,CHMP4B,4
8096,positive regulation of T cell mediated immunity (GO:0002711),0.28209297,1,0,0,3.042750647,3.850657487,B2M,4
8097,mitochondrial fission (GO:0000266),0.28209297,1,0,0,3.042750647,3.850657487,MX1,4
8098,dopamine metabolic process (GO:0042417),0.28209297,1,0,0,3.042750647,3.850657487,GCH1,4
8099,positive regulation of translational initiation (GO:0045948),0.28209297,1,0,0,3.042750647,3.850657487,KHDRBS1,4
8100,positive regulation of lamellipodium organization (GO:1902745),0.28209297,1,0,0,3.042750647,3.850657487,CDC42,4
8101,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),0.28209297,1,0,0,3.042750647,3.850657487,RGS2,4
8102,regulation of macrophage activation (GO:0043030),0.28209297,1,0,0,3.042750647,3.850657487,NR1H3,4
8103,negative regulation of protein tyrosine kinase activity (GO:0061099),0.28209297,1,0,0,3.042750647,3.850657487,MVP,4
8104,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.28209297,1,0,0,3.042750647,3.850657487,CDKN1A,4
8105,cellular response to copper ion (GO:0071280),0.28209297,1,0,0,3.042750647,3.850657487,DAXX,4
8106,ERK1 and ERK2 cascade (GO:0070371),0.28209297,1,0,0,3.042750647,3.850657487,LGALS9,4
8107,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.282248262,1,0,0,1.907395928,2.412795256,DAXX;CDK7,4
8108,cytosolic transport (GO:0016482),0.285701136,1,0,0,1.610867989,2.018109903,SNX2;STX16;STX6,4
8109,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.285701136,1,0,0,1.610867989,2.018109903,CD40;CCND2;CCND1,4
8110,regulation of calcium ion transport into cytosol (GO:0010522),0.293340007,1,0,0,2.904443799,3.562076415,TMBIM6,4
8111,regulation of calcium ion import (GO:0090279),0.293340007,1,0,0,2.904443799,3.562076415,CCL2,4
8112,positive regulation of protein autophosphorylation (GO:0031954),0.293340007,1,0,0,2.904443799,3.562076415,RAP2C,4
8113,protein homotrimerization (GO:0070207),0.293340007,1,0,0,2.904443799,3.562076415,PNPT1,4
8114,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.293340007,1,0,0,2.904443799,3.562076415,CTSC,4
8115,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.293340007,1,0,0,2.904443799,3.562076415,CAMK2D,4
8116,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.293340007,1,0,0,2.904443799,3.562076415,CDKN1A,4
8117,positive regulation of erythrocyte differentiation (GO:0045648),0.293340007,1,0,0,2.904443799,3.562076415,STAT1,4
8118,negative regulation of protein import into nucleus (GO:0042308),0.293340007,1,0,0,2.904443799,3.562076415,PARP10,4
8119,regulation of ERBB signaling pathway (GO:1901184),0.293340007,1,0,0,2.904443799,3.562076415,LGMN,4
8120,negative regulation of GTPase activity (GO:0034260),0.293340007,1,0,0,2.904443799,3.562076415,KLRK1,4
8121,NLS-bearing protein import into nucleus (GO:0006607),0.293340007,1,0,0,2.904443799,3.562076415,RANBP2,4
8122,digestive system development (GO:0055123),0.293340007,1,0,0,2.904443799,3.562076415,PPDPF,4
8123,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.293851151,1,0,0,1.852109089,2.268244531,RNF34;ARL6IP1,4
8124,protein sumoylation (GO:0016925),0.293851151,1,0,0,1.852109089,2.268244531,IFIH1;RANBP2,4
8125,regulation of actin filament polymerization (GO:0030833),0.293851151,1,0,0,1.852109089,2.268244531,HCK;HCLS1,4
8126,cholesterol metabolic process (GO:0008203),0.293851151,1,0,0,1.852109089,2.268244531,STARD3;ABCG1,4
8127,peptidyl-threonine phosphorylation (GO:0018107),0.293851151,1,0,0,1.852109089,2.268244531,CAMK2D;ACOD1,4
8128,enzyme linked receptor protein signaling pathway (GO:0007167),0.29422996,1,0,0,1.584242072,1.938151674,HCK;CSK;JAK2,4
8129,negative regulation of growth (GO:0045926),0.29422996,1,0,0,1.584242072,1.938151674,BST2;CDKN1A;PNPT1,4
8130,regulation of transcription from RNA polymerase II promoter (GO:0006357),0.296542886,1,0,0,1.123287257,1.365426909,ARF4;CD40;CDKN1A;SP100;CAMK2D;NLRC5;CCND1;UBB;NAMPT;UBC;BATF2;STAT1;PCGF5;DDX58;STAT2;IL18;NR1H3;PARP9;CXCL10;CDK7;IRF1;IRF7;HCLS1;IRF5;CALR;MXD1,4
8131,Golgi organization (GO:0007030),0.298500753,1,0,0,1.571256481,1.899622098,CDC42;STX16;STX6,4
8132,regulation of endothelial cell migration (GO:0010594),0.299643416,1,0,0,1.825650388,2.200204703,SP100;CALR,4
8133,regulation of endocytosis (GO:0030100),0.299643416,1,0,0,1.825650388,2.200204703,HCK;RAB5C,4
8134,response to organic cyclic compound (GO:0014070),0.299643416,1,0,0,1.825650388,2.200204703,IL18;CCL2,4
8135,regulation of protein oligomerization (GO:0032459),0.304411397,1,0,0,2.778163634,3.304278962,BAX,4
8136,negative regulation of viral transcription (GO:0032897),0.304411397,1,0,0,2.778163634,3.304278962,IFITM3,4
8137,melanosome organization (GO:0032438),0.304411397,1,0,0,2.778163634,3.304278962,AP3B1,4
8138,positive regulation of protein oligomerization (GO:0032461),0.304411397,1,0,0,2.778163634,3.304278962,BAX,4
8139,glutamine family amino acid metabolic process (GO:0009064),0.304411397,1,0,0,2.778163634,3.304278962,ACOD1,4
8140,protein K48-linked deubiquitination (GO:0071108),0.304411397,1,0,0,2.778163634,3.304278962,USP25,4
8141,cellular nitrogen compound biosynthetic process (GO:0044271),0.304411397,1,0,0,2.778163634,3.304278962,GCH1,4
8142,regulation of interleukin-8 secretion (GO:2000482),0.304411397,1,0,0,2.778163634,3.304278962,LGALS9,4
8143,autophagosome maturation (GO:0097352),0.304411397,1,0,0,2.778163634,3.304278962,SNAP29,4
8144,negative regulation of axonogenesis (GO:0050771),0.304411397,1,0,0,2.778163634,3.304278962,RUFY3,4
8145,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.304411397,1,0,0,2.778163634,3.304278962,CAMK2D,4
8146,negative regulation of transcription factor import into nucleus (GO:0042992),0.304411397,1,0,0,2.778163634,3.304278962,KEAP1,4
8147,cellular response to amyloid-beta (GO:1904646),0.304411397,1,0,0,2.778163634,3.304278962,CASP4,4
8148,positive regulation of monooxygenase activity (GO:0032770),0.304411397,1,0,0,2.778163634,3.304278962,GCH1,4
8149,regulation of ion homeostasis (GO:2000021),0.304411397,1,0,0,2.778163634,3.304278962,CAMK2D,4
8150,positive regulation of endothelial cell migration (GO:0010595),0.30542793,1,0,0,1.799937002,2.134799869,CD40;CALR,4
8151,stress-activated protein kinase signaling cascade (GO:0031098),0.30542793,1,0,0,1.799937002,2.134799869,UBB;UBC,4
8152,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.30542793,1,0,0,1.799937002,2.134799869,RNF114;KEAP1,4
8153,negative regulation of developmental process (GO:0051093),0.30542793,1,0,0,1.799937002,2.134799869,CALR;MARCH5,4
8154,vesicle-mediated transport (GO:0016192),0.3157921,1,0,0,1.243752089,1.433637206,CDC42;SNX2;RAB5C;DTX3L;STX16;NCF4;STX6;SNAP29,4
8155,organonitrogen compound biosynthetic process (GO:1901566),0.31837765,1,0,0,1.404346452,1.607298421,GCH1;IL18;ACOD1;ASS1,4
8156,cytoskeleton organization (GO:0007010),0.31989523,1,0,0,1.50939599,1.720351807,CDC42;CCL7;CCL2,4
8157,B cell activation (GO:0042113),0.322723431,1,0,0,1.726966583,1.953129389,CD40;CASP8,4
8158,positive regulation of proteasomal protein catabolic process (GO:1901800),0.322723431,1,0,0,1.726966583,1.953129389,RNF114;KEAP1,4
8159,positive regulation of protein kinase B signaling (GO:0051897),0.324178283,1,0,0,1.497603834,1.6869933,CD86;IL18;HCLS1,4
8160,dendritic spine organization (GO:0097061),0.326038132,1,0,0,2.555910543,2.864513571,CDC42,4
8161,membrane protein intracellular domain proteolysis (GO:0031293),0.326038132,1,0,0,2.555910543,2.864513571,SPPL2A,4
8162,histone monoubiquitination (GO:0010390),0.326038132,1,0,0,2.555910543,2.864513571,DTX3L,4
8163,histone mRNA metabolic process (GO:0008334),0.326038132,1,0,0,2.555910543,2.864513571,DCP2,4
8164,response to dsRNA (GO:0043331),0.326038132,1,0,0,2.555910543,2.864513571,SLC3A2,4
8165,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.326038132,1,0,0,2.555910543,2.864513571,CDKN1A,4
8166,regulation of actin filament bundle assembly (GO:0032231),0.326038132,1,0,0,2.555910543,2.864513571,CDC42,4
8167,receptor catabolic process (GO:0032801),0.326038132,1,0,0,2.555910543,2.864513571,LGMN,4
8168,DNA geometric change (GO:0032392),0.326038132,1,0,0,2.555910543,2.864513571,ASCC3,4
8169,chaperone mediated protein folding requiring cofactor (GO:0051085),0.326038132,1,0,0,2.555910543,2.864513571,HSPA5,4
8170,mammary gland development (GO:0030879),0.326038132,1,0,0,2.555910543,2.864513571,JAK2,4
8171,actin nucleation (GO:0045010),0.326038132,1,0,0,2.555910543,2.864513571,ACTR3,4
8172,regulation of cardiac muscle cell action potential (GO:0098901),0.326038132,1,0,0,2.555910543,2.864513571,CAMK2D,4
8173,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.326038132,1,0,0,2.555910543,2.864513571,SDCBP,4
8174,regulation of cellular senescence (GO:2000772),0.326038132,1,0,0,2.555910543,2.864513571,PNPT1,4
8175,mitotic nuclear division (GO:0140014),0.328465593,1,0,0,1.703940362,1.897036315,CHMP2A;CHMP4B,4
8176,nitrogen compound transport (GO:0071705),0.328465593,1,0,0,1.703940362,1.897036315,SLC7A8;SLC3A2,4
8177,negative regulation of cellular amide metabolic process (GO:0034249),0.334194513,1,0,0,1.681520094,1.842999968,EIF2AK2;CALR,4
8178,C-terminal protein lipidation (GO:0006501),0.334194513,1,0,0,1.681520094,1.842999968,CD52;LY6E,4
8179,regulation of actin cytoskeleton organization (GO:0032956),0.334194513,1,0,0,1.681520094,1.842999968,CDC42;BST2,4
8180,signal peptide processing (GO:0006465),0.336598819,1,0,0,2.457606291,2.675997802,SPPL2A,4
8181,organophosphate ester transport (GO:0015748),0.336598819,1,0,0,2.457606291,2.675997802,NPC2,4
8182,response to copper ion (GO:0046688),0.336598819,1,0,0,2.457606291,2.675997802,DAXX,4
8183,lamellipodium organization (GO:0097581),0.336598819,1,0,0,2.457606291,2.675997802,SNX2,4
8184,neutral amino acid transport (GO:0015804),0.336598819,1,0,0,2.457606291,2.675997802,SLC7A8,4
8185,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.336598819,1,0,0,2.457606291,2.675997802,CAMK2D,4
8186,response to amyloid-beta (GO:1904645),0.336598819,1,0,0,2.457606291,2.675997802,CASP4,4
8187,regulation of interleukin-10 production (GO:0032653),0.336598819,1,0,0,2.457606291,2.675997802,CD274,4
8188,positive regulation of filopodium assembly (GO:0051491),0.336598819,1,0,0,2.457606291,2.675997802,CDC42,4
8189,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.336598819,1,0,0,2.457606291,2.675997802,KLRK1,4
8190,response to alcohol (GO:0097305),0.336598819,1,0,0,2.457606291,2.675997802,CCR5,4
8191,regulation of lamellipodium assembly (GO:0010591),0.336598819,1,0,0,2.457606291,2.675997802,CDC42,4
8192,positive regulation of interleukin-1 beta secretion (GO:0050718),0.336598819,1,0,0,2.457606291,2.675997802,LGALS9,4
8193,regulation of apoptotic signaling pathway (GO:2001233),0.336598819,1,0,0,2.457606291,2.675997802,TMBIM6,4
8194,negative regulation of insulin receptor signaling pathway (GO:0046627),0.336598819,1,0,0,2.457606291,2.675997802,SOCS1,4
8195,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.336598819,1,0,0,2.457606291,2.675997802,TPST1,4
8196,peptidyl-tyrosine dephosphorylation (GO:0035335),0.336598819,1,0,0,2.457606291,2.675997802,PTPN6,4
8197,positive regulation of calcium ion transmembrane transport (GO:1904427),0.336598819,1,0,0,2.457606291,2.675997802,CXCL10,4
8198,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.336598819,1,0,0,2.457606291,2.675997802,ASS1,4
8199,positive regulation of nitric oxide metabolic process (GO:1904407),0.336598819,1,0,0,2.457606291,2.675997802,ASS1,4
8200,transforming growth factor beta receptor signaling pathway (GO:0007179),0.339909202,1,0,0,1.659682171,1.790924442,UBB;UBC,4
8201,positive regulation of JNK cascade (GO:0046330),0.339909202,1,0,0,1.659682171,1.790924442,SDCBP;GADD45B,4
8202,positive regulation of apoptotic signaling pathway (GO:2001235),0.339909202,1,0,0,1.659682171,1.790924442,BAX;LGALS9,4
8203,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.339909202,1,0,0,1.659682171,1.790924442,CASP8;RNF34,4
8204,regulation of GTPase activity (GO:0043087),0.343181466,1,0,0,1.352333621,1.446315285,CD40;KLRK1;CCL7;CCL2,4
8205,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.345608704,1,0,0,1.638404194,1.740719354,UBB;UBC,4
8206,cytoskeleton-dependent intracellular transport (GO:0030705),0.346994545,1,0,0,2.366583836,2.504901715,DYNC1I2,4
8207,regulation of p38MAPK cascade (GO:1900744),0.346994545,1,0,0,2.366583836,2.504901715,GADD45B,4
8208,response to ketone (GO:1901654),0.346994545,1,0,0,2.366583836,2.504901715,NR1H3,4
8209,negative regulation of catalytic activity (GO:0043086),0.346994545,1,0,0,2.366583836,2.504901715,PARP9,4
8210,positive regulation of cAMP metabolic process (GO:0030816),0.346994545,1,0,0,2.366583836,2.504901715,CXCL10,4
8211,negative regulation of cellular response to insulin stimulus (GO:1900077),0.346994545,1,0,0,2.366583836,2.504901715,SOCS1,4
8212,regulation of cardiac muscle cell contraction (GO:0086004),0.346994545,1,0,0,2.366583836,2.504901715,CAMK2D,4
8213,fat-soluble vitamin metabolic process (GO:0006775),0.346994545,1,0,0,2.366583836,2.504901715,LGMN,4
8214,T cell activation involved in immune response (GO:0002286),0.346994545,1,0,0,2.366583836,2.504901715,FCER1G,4
8215,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.346994545,1,0,0,2.366583836,2.504901715,BAX,4
8216,snRNA 3'-end processing (GO:0034472),0.346994545,1,0,0,2.366583836,2.504901715,USB1,4
8217,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.346994545,1,0,0,2.366583836,2.504901715,DCP2,4
8218,protein targeting (GO:0006605),0.349860627,1,0,0,1.430546946,1.502389602,RTP4;SDCBP;TSPO,4
8219,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.349860627,1,0,0,1.430546946,1.502389602,CD52;C3AR1;CCR5,4
8220,regulation of cellular response to heat (GO:1900034),0.351292095,1,0,0,1.617664901,1.692299463,RANBP2;CAMK2D,4
8221,fibroblast growth factor receptor signaling pathway (GO:0008543),0.351292095,1,0,0,1.617664901,1.692299463,UBB;UBC,4
8222,negative regulation of inflammatory response (GO:0050728),0.351292095,1,0,0,1.617664901,1.692299463,ACOD1;NR1H3,4
8223,steroid biosynthetic process (GO:0006694),0.356958486,1,0,0,1.597444089,1.645584327,STARD3;TSPO,4
8224,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.357227878,1,0,0,2.282062985,2.34911316,CAMK2D,4
8225,mRNA polyadenylation (GO:0006378),0.357227878,1,0,0,2.282062985,2.34911316,PNPT1,4
8226,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.357227878,1,0,0,2.282062985,2.34911316,CALR,4
8227,negative regulation of smooth muscle cell proliferation (GO:0048662),0.357227878,1,0,0,2.282062985,2.34911316,AIF1,4
8228,endocytic recycling (GO:0032456),0.357227878,1,0,0,2.282062985,2.34911316,STX6,4
8229,transition metal ion transport (GO:0000041),0.357227878,1,0,0,2.282062985,2.34911316,SLC31A2,4
8230,negative regulation of organelle assembly (GO:1902116),0.357227878,1,0,0,2.282062985,2.34911316,CHMP4B,4
8231,RNA processing (GO:0006396),0.360934685,1,0,0,1.317479661,1.342588539,APOBEC1;PNPT1;USB1;SRSF7,4
8232,regulation of cytosolic calcium ion concentration (GO:0051480),0.366930064,1,0,0,1.389081817,1.392671219,CD52;C3AR1;CCR5,4
8233,regulation of vasculature development (GO:1901342),0.367301347,1,0,0,2.203371158,2.206836307,SP100,4
8234,negative regulation of endocytosis (GO:0045806),0.367301347,1,0,0,2.203371158,2.206836307,NR1H3,4
8235,RNA polyadenylation (GO:0043631),0.367301347,1,0,0,2.203371158,2.206836307,PNPT1,4
8236,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.367301347,1,0,0,2.203371158,2.206836307,CALR,4
8237,cellular response to ketone (GO:1901655),0.367301347,1,0,0,2.203371158,2.206836307,ACOD1,4
8238,negative regulation of homeostatic process (GO:0032845),0.367301347,1,0,0,2.203371158,2.206836307,TMBIM6,4
8239,regulation of receptor internalization (GO:0002090),0.367301347,1,0,0,2.203371158,2.206836307,SDCBP,4
8240,positive regulation of phosphate metabolic process (GO:0045937),0.367301347,1,0,0,2.203371158,2.206836307,SDCBP,4
8241,organelle fission (GO:0048285),0.367301347,1,0,0,2.203371158,2.206836307,MX1,4
8242,regulation of NIK/NF-kappaB signaling (GO:1901222),0.367301347,1,0,0,2.203371158,2.206836307,EIF2AK2,4
8243,negative regulation of JNK cascade (GO:0046329),0.367301347,1,0,0,2.203371158,2.206836307,AIDA,4
8244,regulation of fatty acid biosynthetic process (GO:0042304),0.367301347,1,0,0,2.203371158,2.206836307,NR1H3,4
8245,positive regulation of lipid biosynthetic process (GO:0046889),0.367301347,1,0,0,2.203371158,2.206836307,NR1H3,4
8246,protein K63-linked deubiquitination (GO:0070536),0.367301347,1,0,0,2.203371158,2.206836307,USP25,4
8247,protein export from nucleus (GO:0006611),0.367301347,1,0,0,2.203371158,2.206836307,CALR,4
8248,regulation of actin polymerization or depolymerization (GO:0008064),0.367301347,1,0,0,2.203371158,2.206836307,HCLS1,4
8249,positive regulation of fibroblast proliferation (GO:0048146),0.367301347,1,0,0,2.203371158,2.206836307,CDKN1A,4
8250,transcription elongation from RNA polymerase I promoter (GO:0006362),0.367301347,1,0,0,2.203371158,2.206836307,CDK7,4
8251,negative regulation of cell death (GO:0060548),0.368236861,1,0,0,1.558482038,1.556968602,CHMP2A;CHMP4B,4
8252,negative regulation of cell cycle process (GO:0010948),0.368236861,1,0,0,1.558482038,1.556968602,CCND1;CALR,4
8253,regulation of signal transduction by p53 class mediator (GO:1901796),0.371186521,1,0,0,1.379088423,1.366746397,RNF34;UBB;UBC,4
8254,mitotic sister chromatid segregation (GO:0000070),0.373847219,1,0,0,1.539705146,1.514928319,CHMP2A;CHMP4B,4
8255,C-terminal protein amino acid modification (GO:0018410),0.373847219,1,0,0,1.539705146,1.514928319,CD52;LY6E,4
8256,negative regulation of gene expression (GO:0010629),0.376934149,1,0,0,1.135501453,1.107891482,PARP10;KHDRBS1;DAXX;PNPT1;IRF1;EIF2AK2;LGALS9;CALR;PARP14;PARP9;DCP2,4
8257,dicarboxylic acid transport (GO:0006835),0.377217442,1,0,0,2.129925453,2.07653565,SLC25A22,4
8258,cellular response to cadmium ion (GO:0071276),0.377217442,1,0,0,2.129925453,2.07653565,DAXX,4
8259,cortical cytoskeleton organization (GO:0030865),0.377217442,1,0,0,2.129925453,2.07653565,CDC42,4
8260,positive regulation of myeloid cell differentiation (GO:0045639),0.377217442,1,0,0,2.129925453,2.07653565,STAT1,4
8261,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.377217442,1,0,0,2.129925453,2.07653565,HSPA5,4
8262,positive regulation of interleukin-1 secretion (GO:0050716),0.377217442,1,0,0,2.129925453,2.07653565,LGALS9,4
8263,regulation of chromosome segregation (GO:0051983),0.377217442,1,0,0,2.129925453,2.07653565,CDC42,4
8264,coenzyme biosynthetic process (GO:0009108),0.377217442,1,0,0,2.129925453,2.07653565,GCH1,4
8265,B cell proliferation (GO:0042100),0.377217442,1,0,0,2.129925453,2.07653565,CD40,4
8266,negative regulation of signaling (GO:0023057),0.379437323,1,0,0,1.521375323,1.474312873,MVP;MERTK,4
8267,establishment of protein localization to membrane (GO:0090150),0.379437323,1,0,0,1.521375323,1.474312873,RTP4;SDCBP,4
8268,protein maturation (GO:0051604),0.379437323,1,0,0,1.521375323,1.474312873,SRGN;MMP14,4
8269,regulation of mitotic nuclear division (GO:0007088),0.385006434,1,0,0,1.50347679,1.435061431,CHMP2A;CHMP4B,4
8270,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.386978614,1,0,0,2.06121818,1.956891372,CASP8,4
8271,negative regulation of stress-activated MAPK cascade (GO:0032873),0.386978614,1,0,0,2.06121818,1.956891372,AIDA,4
8272,negative regulation of endothelial cell proliferation (GO:0001937),0.386978614,1,0,0,2.06121818,1.956891372,STAT1,4
8273,cellular response to cAMP (GO:0071320),0.386978614,1,0,0,2.06121818,1.956891372,RAP1B,4
8274,negative regulation of transferase activity (GO:0051348),0.386978614,1,0,0,2.06121818,1.956891372,DTX3L,4
8275,regulation of leukocyte chemotaxis (GO:0002688),0.386978614,1,0,0,2.06121818,1.956891372,CXCL10,4
8276,negative regulation of secretion by cell (GO:1903531),0.386978614,1,0,0,2.06121818,1.956891372,RSAD2,4
8277,activation of protein kinase B activity (GO:0032148),0.386978614,1,0,0,2.06121818,1.956891372,IL18,4
8278,negative regulation of DNA biosynthetic process (GO:2000279),0.386978614,1,0,0,2.06121818,1.956891372,DCP2,4
8279,activation of JUN kinase activity (GO:0007257),0.386978614,1,0,0,2.06121818,1.956891372,DAXX,4
8280,'de novo' posttranslational protein folding (GO:0051084),0.386978614,1,0,0,2.06121818,1.956891372,HSPA5,4
8281,aminoglycan metabolic process (GO:0006022),0.386978614,1,0,0,2.06121818,1.956891372,SDC3,4
8282,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.386978614,1,0,0,2.06121818,1.956891372,CASP8,4
8283,ATP-dependent chromatin remodeling (GO:0043044),0.386978614,1,0,0,2.06121818,1.956891372,ACTB,4
8284,regulation of blood coagulation (GO:0030193),0.386978614,1,0,0,2.06121818,1.956891372,FCER1G,4
8285,regulation of protein polymerization (GO:0032271),0.386978614,1,0,0,2.06121818,1.956891372,HCLS1,4
8286,regulation of sodium ion transmembrane transport (GO:1902305),0.386978614,1,0,0,2.06121818,1.956891372,CAMK2D,4
8287,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.386978614,1,0,0,2.06121818,1.956891372,RUFY3,4
8288,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.386978614,1,0,0,2.06121818,1.956891372,ASS1,4
8289,positive regulation of nucleic acid-templated transcription (GO:1903508),0.389172689,1,0,0,1.143299945,1.078968862,CD86;SP100;CDK7;DTX3L;STAT1;IRF1;IRF7;NR1H3;PARP9,4
8290,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),0.393412531,1,0,0,1.128935752,1.053180235,SP100;CCND1;UBB;STAT1;UBC;IRF7;NR1H3;CALR;PARP9;MXD1,4
8291,negative regulation of cell-cell adhesion (GO:0022408),0.396587274,1,0,0,1.996805112,1.846763478,ASS1,4
8292,regulation of ubiquitin-protein transferase activity (GO:0051438),0.396587274,1,0,0,1.996805112,1.846763478,DTX3L,4
8293,alpha-amino acid metabolic process (GO:1901605),0.396587274,1,0,0,1.996805112,1.846763478,ASS1,4
8294,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.396587274,1,0,0,1.996805112,1.846763478,CXCL10,4
8295,regulation of protein export from nucleus (GO:0046825),0.396587274,1,0,0,1.996805112,1.846763478,SP100,4
8296,anterograde axonal transport (GO:0008089),0.396587274,1,0,0,1.996805112,1.846763478,AP3B1,4
8297,positive regulation of viral genome replication (GO:0045070),0.396587274,1,0,0,1.996805112,1.846763478,IFIT1,4
8298,cofactor biosynthetic process (GO:0051188),0.396587274,1,0,0,1.996805112,1.846763478,FAM96B,4
8299,positive regulation of interleukin-1 beta production (GO:0032731),0.396587274,1,0,0,1.996805112,1.846763478,LGALS9,4
8300,response to cadmium ion (GO:0046686),0.396587274,1,0,0,1.996805112,1.846763478,DAXX,4
8301,termination of RNA polymerase I transcription (GO:0006363),0.396587274,1,0,0,1.996805112,1.846763478,CDK7,4
8302,regulation of cytokine secretion (GO:0050707),0.396587274,1,0,0,1.996805112,1.846763478,SRGN,4
8303,positive regulation of bone mineralization (GO:0030501),0.396587274,1,0,0,1.996805112,1.846763478,ISG15,4
8304,positive regulation of cellular component biogenesis (GO:0044089),0.401580819,1,0,0,1.4522219,1.32492953,SDCBP;CHMP2A,4
8305,regulation of MAP kinase activity (GO:0043405),0.401580819,1,0,0,1.4522219,1.32492953,CD40;RGS2,4
8306,dendrite morphogenesis (GO:0048813),0.4060458,1,0,0,1.936295866,1.745162781,CDC42,4
8307,7-methylguanosine mRNA capping (GO:0006370),0.4060458,1,0,0,1.936295866,1.745162781,CDK7,4
8308,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4060458,1,0,0,1.936295866,1.745162781,CXCL10,4
8309,oxoacid metabolic process (GO:0043436),0.4060458,1,0,0,1.936295866,1.745162781,TPST1,4
8310,protein trimerization (GO:0070206),0.4060458,1,0,0,1.936295866,1.745162781,PNPT1,4
8311,7-methylguanosine RNA capping (GO:0009452),0.4060458,1,0,0,1.936295866,1.745162781,CDK7,4
8312,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4060458,1,0,0,1.936295866,1.745162781,JAK2,4
8313,endodermal cell differentiation (GO:0035987),0.4060458,1,0,0,1.936295866,1.745162781,MMP14,4
8314,regulation of cell-cell adhesion (GO:0022407),0.4060458,1,0,0,1.936295866,1.745162781,CD47,4
8315,regulation of erythrocyte differentiation (GO:0045646),0.4060458,1,0,0,1.936295866,1.745162781,STAT1,4
8316,regulation of nitric oxide biosynthetic process (GO:0045428),0.4060458,1,0,0,1.936295866,1.745162781,ASS1,4
8317,aminoglycan catabolic process (GO:0006026),0.4060458,1,0,0,1.936295866,1.745162781,SDC3,4
8318,positive regulation of signal transduction (GO:0009967),0.406948453,1,0,0,1.234739393,1.110115607,CD180;LY86;BAX;JAK2,4
8319,T cell activation (GO:0042110),0.407059104,1,0,0,1.4359048,1.290586761,CASP8;TREML2,4
8320,divalent metal ion transport (GO:0070838),0.407059104,1,0,0,1.4359048,1.290586761,SLC3A2;CCR5,4
8321,negative regulation of translation (GO:0017148),0.407059104,1,0,0,1.4359048,1.290586761,EIF2AK2;CALR,4
8322,positive regulation of protein complex assembly (GO:0031334),0.407059104,1,0,0,1.4359048,1.290586761,GBP5;BAX,4
8323,regulation of protein kinase activity (GO:0045859),0.409206487,1,0,0,1.295224937,1.157329323,RAP2C;DAXX;CDKN1A,4
8324,peptidyl-threonine modification (GO:0018210),0.412513102,1,0,0,1.419950302,1.257347974,CAMK2D;ACOD1,4
8325,cellular response to DNA damage stimulus (GO:0006974),0.413316787,1,0,0,1.16177752,1.026478005,CDKN1A;CCND1;UBA7;DTX3L;IRF7;BAX,4
8326,activation of MAPKK activity (GO:0000186),0.415356528,1,0,0,1.879345988,1.651227257,EIF2AK2,4
8327,positive regulation of cell-cell adhesion (GO:0022409),0.415356528,1,0,0,1.879345988,1.651227257,CD47,4
8328,negative regulation of neurogenesis (GO:0050768),0.415356528,1,0,0,1.879345988,1.651227257,CALR,4
8329,stem cell differentiation (GO:0048863),0.415356528,1,0,0,1.879345988,1.651227257,PSMD11,4
8330,positive regulation of calcium ion transport (GO:0051928),0.415356528,1,0,0,1.879345988,1.651227257,CCL2,4
8331,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.415356528,1,0,0,1.879345988,1.651227257,RANBP2,4
8332,regulation of cell-substrate adhesion (GO:0010810),0.415356528,1,0,0,1.879345988,1.651227257,JAK2,4
8333,tRNA export from nucleus (GO:0006409),0.415356528,1,0,0,1.879345988,1.651227257,RANBP2,4
8334,intra-Golgi vesicle-mediated transport (GO:0006891),0.415356528,1,0,0,1.879345988,1.651227257,COPE,4
8335,regulation of autophagosome assembly (GO:2000785),0.415356528,1,0,0,1.879345988,1.651227257,CHMP4B,4
8336,cellular response to glucose starvation (GO:0042149),0.415356528,1,0,0,1.879345988,1.651227257,HSPA5,4
8337,mRNA stabilization (GO:0048255),0.415356528,1,0,0,1.879345988,1.651227257,MYD88,4
8338,transcription initiation from RNA polymerase I promoter (GO:0006361),0.415356528,1,0,0,1.879345988,1.651227257,CDK7,4
8339,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.415356528,1,0,0,1.879345988,1.651227257,CDC42,4
8340,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),0.415356528,1,0,0,1.879345988,1.651227257,DCP2,4
8341,positive regulation of biomineral tissue development (GO:0070169),0.415356528,1,0,0,1.879345988,1.651227257,ISG15,4
8342,transcription from RNA polymerase I promoter (GO:0006360),0.415356528,1,0,0,1.879345988,1.651227257,CDK7,4
8343,positive regulation of nucleocytoplasmic transport (GO:0046824),0.415356528,1,0,0,1.879345988,1.651227257,KHDRBS1,4
8344,negative regulation of multi-organism process (GO:0043901),0.415356528,1,0,0,1.879345988,1.651227257,CALR,4
8345,regulation of intracellular protein transport (GO:0033157),0.415356528,1,0,0,1.879345988,1.651227257,RUFY3,4
8346,positive regulation of organelle organization (GO:0010638),0.415356528,1,0,0,1.879345988,1.651227257,PFDN2,4
8347,regulation of interleukin-12 production (GO:0032655),0.415356528,1,0,0,1.879345988,1.651227257,IRF5,4
8348,protein tetramerization (GO:0051262),0.417942231,1,0,0,1.404346452,1.22516878,GBP5;SAMHD1,4
8349,positive regulation of cellular protein metabolic process (GO:0032270),0.423345932,1,0,0,1.389081817,1.194006983,CASP8;NR1H3,4
8350,positive regulation of leukocyte migration (GO:0002687),0.424521762,1,0,0,1.825650388,1.564202666,CXCL10,4
8351,negative regulation of cellular metabolic process (GO:0031324),0.424521762,1,0,0,1.825650388,1.564202666,SDCBP,4
8352,response to amino acid (GO:0043200),0.424521762,1,0,0,1.825650388,1.564202666,TMBIM6,4
8353,positive regulation of muscle cell differentiation (GO:0051149),0.424521762,1,0,0,1.825650388,1.564202666,CDC42,4
8354,regulation of JUN kinase activity (GO:0043506),0.424521762,1,0,0,1.825650388,1.564202666,AIDA,4
8355,positive regulation of cytokinesis (GO:0032467),0.424521762,1,0,0,1.825650388,1.564202666,CDC42,4
8356,regulation of axon extension (GO:0030516),0.424521762,1,0,0,1.825650388,1.564202666,RUFY3,4
8357,regulation of insulin receptor signaling pathway (GO:0046626),0.424521762,1,0,0,1.825650388,1.564202666,SOCS1,4
8358,negative regulation of endothelial cell migration (GO:0010596),0.424521762,1,0,0,1.825650388,1.564202666,SP100,4
8359,endoplasmic reticulum organization (GO:0007029),0.424521762,1,0,0,1.825650388,1.564202666,TOR1AIP2,4
8360,regulation of interleukin-1 beta secretion (GO:0050706),0.424521762,1,0,0,1.825650388,1.564202666,LGALS9,4
8361,macromolecule catabolic process (GO:0009057),0.424521762,1,0,0,1.825650388,1.564202666,LGMN,4
8362,protein stabilization (GO:0050821),0.430034642,1,0,0,1.252897325,1.057306912,CDK7;CDKN1A;CALR,4
8363,positive regulation of RNA metabolic process (GO:0051254),0.433543767,1,0,0,1.774937877,1.483426563,PNPT1,4
8364,regulation of heart rate by cardiac conduction (GO:0086091),0.433543767,1,0,0,1.774937877,1.483426563,CAMK2D,4
8365,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.433543767,1,0,0,1.774937877,1.483426563,EIF2AK2,4
8366,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.433543767,1,0,0,1.774937877,1.483426563,DCP2,4
8367,regulation of endothelial cell apoptotic process (GO:2000351),0.433543767,1,0,0,1.774937877,1.483426563,CD40,4
8368,anatomical structure homeostasis (GO:0060249),0.433543767,1,0,0,1.774937877,1.483426563,SP100,4
8369,positive regulation of DNA replication (GO:0045740),0.433543767,1,0,0,1.774937877,1.483426563,CALR,4
8370,negative regulation of protein complex assembly (GO:0031333),0.433543767,1,0,0,1.774937877,1.483426563,CDC42,4
8371,tRNA transport (GO:0051031),0.433543767,1,0,0,1.774937877,1.483426563,RANBP2,4
8372,membrane protein proteolysis (GO:0033619),0.433543767,1,0,0,1.774937877,1.483426563,SPPL2A,4
8373,carboxylic acid transmembrane transport (GO:1905039),0.433543767,1,0,0,1.774937877,1.483426563,SLC7A8,4
8374,negative regulation of tumor necrosis factor production (GO:0032720),0.433543767,1,0,0,1.774937877,1.483426563,LGALS9,4
8375,regulation of cardiac muscle contraction (GO:0055117),0.433543767,1,0,0,1.774937877,1.483426563,RGS2,4
8376,actin filament bundle organization (GO:0061572),0.433543767,1,0,0,1.774937877,1.483426563,AIF1,4
8377,positive regulation of gene expression (GO:0010628),0.433596364,1,0,0,1.075998609,0.899148784,CD86;SP100;DTX3L;STAT1;DDX58;NR1H3;PARP9;ACTB;CDK7;IRF1;IRF7;LGALS9;MYD88,4
8378,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.434074937,1,0,0,1.359526885,1.134576976,ARL6IP1;CYCS,4
8379,regulation of receptor-mediated endocytosis (GO:0048259),0.442424775,1,0,0,1.726966583,1.408315048,B2M,4
8380,regulation of muscle cell differentiation (GO:0051147),0.442424775,1,0,0,1.726966583,1.408315048,CDC42,4
8381,regulation of nitric-oxide synthase activity (GO:0050999),0.442424775,1,0,0,1.726966583,1.408315048,GCH1,4
8382,lymphocyte proliferation (GO:0046651),0.442424775,1,0,0,1.726966583,1.408315048,CD40,4
8383,endoderm formation (GO:0001706),0.442424775,1,0,0,1.726966583,1.408315048,MMP14,4
8384,regulation of filopodium assembly (GO:0051489),0.442424775,1,0,0,1.726966583,1.408315048,CDC42,4
8385,regulation of blood circulation (GO:1903522),0.442424775,1,0,0,1.726966583,1.408315048,CAMK2D,4
8386,zymogen activation (GO:0031638),0.442424775,1,0,0,1.726966583,1.408315048,CASP8,4
8387,regulation of cell morphogenesis involved in differentiation (GO:0010769),0.442424775,1,0,0,1.726966583,1.408315048,RUFY3,4
8388,cardiac muscle contraction (GO:0060048),0.442424775,1,0,0,1.726966583,1.408315048,CAMK2D,4
8389,axonal transport (GO:0098930),0.442424775,1,0,0,1.726966583,1.408315048,AP3B1,4
8390,regulation of cysteine-type endopeptidase activity (GO:2000116),0.442424775,1,0,0,1.726966583,1.408315048,PSMB9,4
8391,transcription elongation from RNA polymerase II promoter (GO:0006368),0.444696108,1,0,0,1.331203408,1.078759496,CDK7;ELOA,4
8392,protein monoubiquitination (GO:0006513),0.451166983,1,0,0,1.681520094,1.338351704,DTX3L,4
8393,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.451166983,1,0,0,1.681520094,1.338351704,CAMK2D,4
8394,positive regulation of axonogenesis (GO:0050772),0.451166983,1,0,0,1.681520094,1.338351704,RUFY3,4
8395,regulation of carbohydrate catabolic process (GO:0043470),0.451166983,1,0,0,1.681520094,1.338351704,RANBP2,4
8396,actin filament bundle assembly (GO:0051017),0.451166983,1,0,0,1.681520094,1.338351704,AIF1,4
8397,response to steroid hormone (GO:0048545),0.451166983,1,0,0,1.681520094,1.338351704,NR1H3,4
8398,organic cyclic compound biosynthetic process (GO:1901362),0.451166983,1,0,0,1.681520094,1.338351704,GCH1,4
8399,cellular response to organonitrogen compound (GO:0071417),0.455205787,1,0,0,1.304035991,1.026283736,RAP1B;ACTB,4
8400,negative regulation of cell motility (GO:2000146),0.455205787,1,0,0,1.304035991,1.026283736,BST2;RAP2C,4
8401,positive regulation of cellular biosynthetic process (GO:0031328),0.458736238,1,0,0,1.198083067,0.933642027,NR1H3;CALR;ASS1,4
8402,T cell differentiation (GO:0030217),0.459772552,1,0,0,1.638404194,1.273078339,FCER1G,4
8403,chemical homeostasis (GO:0048878),0.459772552,1,0,0,1.638404194,1.273078339,NR1H3,4
8404,intracellular protein transport (GO:0006886),0.463096492,1,0,0,1.101685579,0.848099416,RANBP2;RAB5C;STX16;STX6;AP3B1;CALR,4
8405,small GTPase mediated signal transduction (GO:0007264),0.465600643,1,0,0,1.277955272,0.976903516,CDKN1A;G3BP2,4
8406,negative regulation of intracellular signal transduction (GO:1902532),0.466825401,1,0,0,1.183291918,0.901431741,CASP8;RNF34;STAT1,4
8407,inositol lipid-mediated signaling (GO:0048017),0.468243612,1,0,0,1.597444089,1.212087188,PTAFR,4
8408,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.468243612,1,0,0,1.597444089,1.212087188,CDC42,4
8409,mitotic DNA damage checkpoint (GO:0044773),0.468243612,1,0,0,1.597444089,1.212087188,CCND1,4
8410,regulation of coenzyme metabolic process (GO:0051196),0.468243612,1,0,0,1.597444089,1.212087188,RANBP2,4
8411,cellular response to transforming growth factor beta stimulus (GO:0071560),0.470754058,1,0,0,1.265302249,0.953303377,UBB;UBC,4
8412,regulation of lipid metabolic process (GO:0019216),0.470754058,1,0,0,1.265302249,0.953303377,NPC2;PLIN2,4
8413,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.470754058,1,0,0,1.265302249,0.953303377,RANBP2;SRSF7,4
8414,DNA repair (GO:0006281),0.47371069,1,0,0,1.10549764,0.82598196,UBB;DTX3L;UBC;ASCC3;PARP9,4
8415,regulation of protein kinase B signaling (GO:0051896),0.474860915,1,0,0,1.168861529,0.870490136,CD86;IL18;HCLS1,4
8416,regulation of kinase activity (GO:0043549),0.475877659,1,0,0,1.252897325,0.930394633,NLRC5;MERTK,4
8417,regulation of cellular localization (GO:0060341),0.476582259,1,0,0,1.558482038,1.155014322,CAMK2D,4
8418,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.476582259,1,0,0,1.558482038,1.155014322,SDCBP,4
8419,positive regulation of mitotic nuclear division (GO:0045840),0.476582259,1,0,0,1.558482038,1.155014322,RANBP2,4
8420,negative regulation of cytokine secretion (GO:0050710),0.476582259,1,0,0,1.558482038,1.155014322,SRGN,4
8421,response to peptide hormone (GO:0043434),0.476582259,1,0,0,1.558482038,1.155014322,STAT1,4
8422,detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.476582259,1,0,0,1.558482038,1.155014322,RTP4,4
8423,regulation of release of cytochrome c from mitochondria (GO:0090199),0.476582259,1,0,0,1.558482038,1.155014322,BAX,4
8424,regulation of cholesterol biosynthetic process (GO:0045540),0.476582259,1,0,0,1.558482038,1.155014322,ABCG1,4
8425,regulation of viral transcription (GO:0046782),0.476582259,1,0,0,1.558482038,1.155014322,IFITM3,4
8426,ion transport (GO:0006811),0.476715769,1,0,0,1.101685579,0.816167058,UBB;UBC;TSPO;SLC15A3;SLC25A22,4
8427,regulation of calcium-mediated signaling (GO:0050848),0.484790555,1,0,0,1.521375323,1.101534043,CAMK2D,4
8428,peptide transport (GO:0015833),0.484790555,1,0,0,1.521375323,1.101534043,TAP1,4
8429,regulation of stress-activated MAPK cascade (GO:0032872),0.484790555,1,0,0,1.521375323,1.101534043,EIF2AK2,4
8430,positive regulation of cell division (GO:0051781),0.484790555,1,0,0,1.521375323,1.101534043,CDC42,4
8431,telomere organization (GO:0032200),0.484790555,1,0,0,1.521375323,1.101534043,SP100,4
8432,positive regulation of receptor-mediated endocytosis (GO:0048260),0.484790555,1,0,0,1.521375323,1.101534043,B2M,4
8433,cellular response to peptide (GO:1901653),0.484790555,1,0,0,1.521375323,1.101534043,CASP4,4
8434,negative regulation of STAT cascade (GO:1904893),0.484790555,1,0,0,1.521375323,1.101534043,SOCS1,4
8435,sensory perception of bitter taste (GO:0050913),0.484790555,1,0,0,1.521375323,1.101534043,RTP4,4
8436,regulation of protein localization (GO:0032880),0.484790555,1,0,0,1.521375323,1.101534043,STX6,4
8437,negative regulation of proteolysis (GO:0045861),0.484790555,1,0,0,1.521375323,1.101534043,CSTB,4
8438,plasma membrane invagination (GO:0099024),0.486034115,1,0,0,1.228803146,0.886552547,CDC42;AIF1,4
8439,protein import into nucleus (GO:0006606),0.486034115,1,0,0,1.228803146,0.886552547,RANBP2;JAK2,4
8440,"transcription, DNA-templated (GO:0006351)",0.487606146,1,0,0,1.073911993,0.771334365,CDK7;PTTG1;IRF1;IRF7;ELOA;PTMA,4
8441,mRNA transport (GO:0051028),0.491066359,1,0,0,1.217100259,0.865572505,RANBP2;SRSF7,4
8442,positive regulation of lymphocyte activation (GO:0051251),0.491066359,1,0,0,1.217100259,0.865572505,CCL2;CD47,4
8443,"phagocytosis, engulfment (GO:0006911)",0.491066359,1,0,0,1.217100259,0.865572505,CDC42;AIF1,4
8444,cellular response to calcium ion (GO:0071277),0.492870533,1,0,0,1.485994502,1.051354114,CAMK2D,4
8445,cellular response to radiation (GO:0071478),0.492870533,1,0,0,1.485994502,1.051354114,CDKN1A,4
8446,mRNA export from nucleus (GO:0006406),0.49606757,1,0,0,1.205618181,0.845190346,RANBP2;SRSF7,4
8447,regulation of signal transduction (GO:0009966),0.499810849,1,0,0,1.092269463,0.757516785,SP100;RGS2;CSK;MERTK,4
8448,negative regulation of DNA metabolic process (GO:0051053),0.500824191,1,0,0,1.4522219,1.00421167,APOBEC1,4
8449,regulation of ATP metabolic process (GO:1903578),0.500824191,1,0,0,1.4522219,1.00421167,RANBP2,4
8450,"DNA-templated transcription, termination (GO:0006353)",0.501037483,1,0,0,1.194350721,0.825385165,CDK7;SRSF7,4
8451,RNA splicing (GO:0008380),0.501037483,1,0,0,1.194350721,0.825385165,USB1;SRSF7,4
8452,positive regulation of cell cycle process (GO:0090068),0.505975851,1,0,0,1.183291918,0.806136949,CDC42;GPSM2,4
8453,negative regulation of response to external stimulus (GO:0032102),0.505975851,1,0,0,1.183291918,0.806136949,ACOD1;NR1H3,4
8454,sprouting angiogenesis (GO:0002040),0.508653498,1,0,0,1.419950302,0.959869712,RNF213,4
8455,adherens junction organization (GO:0034332),0.508653498,1,0,0,1.419950302,0.959869712,CSK,4
8456,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.508653498,1,0,0,1.419950302,0.959869712,RTP4,4
8457,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.508653498,1,0,0,1.419950302,0.959869712,GPSM2,4
8458,mitotic nuclear envelope disassembly (GO:0007077),0.508653498,1,0,0,1.419950302,0.959869712,RANBP2,4
8459,posttranscriptional regulation of gene expression (GO:0010608),0.508653498,1,0,0,1.419950302,0.959869712,PARP9,4
8460,"negative regulation of transcription, DNA-templated (GO:0045892)",0.510293559,1,0,0,1.020480254,0.686547596,KHDRBS1;DAXX;SP100;STAT1;NR1H3;PARP9;CCND1;UBB;IRF1;UBC;IRF7;CALR;MXD1,4
8461,positive regulation of protein kinase activity (GO:0045860),0.510302934,1,0,0,1.108053704,0.745443952,DAXX;CDKN1A;BAX,4
8462,regulation of protein activation cascade (GO:2000257),0.510882443,1,0,0,1.172436029,0.787426525,C3AR1;CFB,4
8463,"DNA-templated transcription, elongation (GO:0006354)",0.510882443,1,0,0,1.172436029,0.787426525,CDK7;ELOA,4
8464,negative regulation of protein kinase activity (GO:0006469),0.515757039,1,0,0,1.16177752,0.769235525,CDKN1A;MVP,4
8465,regulation of complement activation (GO:0030449),0.515757039,1,0,0,1.16177752,0.769235525,C3AR1;CFB,4
8466,Wnt signaling pathway (GO:0016055),0.515757039,1,0,0,1.16177752,0.769235525,UBB;UBC,4
8467,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.516360393,1,0,0,1.389081817,0.918114074,CD40,4
8468,mitochondrial gene expression (GO:0140053),0.516360393,1,0,0,1.389081817,0.918114074,PNPT1,4
8469,metal ion homeostasis (GO:0055065),0.516360393,1,0,0,1.389081817,0.918114074,SLC7A8,4
8470,negative regulation of ossification (GO:0030279),0.516360393,1,0,0,1.389081817,0.918114074,SRGN,4
8471,protein complex disassembly (GO:0043241),0.523946783,1,0,0,1.359526885,0.878750812,SNAP29,4
8472,cellular response to ionizing radiation (GO:0071479),0.523946783,1,0,0,1.359526885,0.878750812,CDKN1A,4
8473,positive regulation of protein localization to cell periphery (GO:1904377),0.523946783,1,0,0,1.359526885,0.878750812,GPSM2,4
8474,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.523946783,1,0,0,1.359526885,0.878750812,ISG15,4
8475,nuclear envelope disassembly (GO:0051081),0.523946783,1,0,0,1.359526885,0.878750812,RANBP2,4
8476,regulation of cellular component movement (GO:0051270),0.523946783,1,0,0,1.359526885,0.878750812,SP100,4
8477,aminoglycan biosynthetic process (GO:0006023),0.523946783,1,0,0,1.359526885,0.878750812,SDC3,4
8478,plasma membrane bounded cell projection assembly (GO:0120031),0.526158116,1,0,0,1.056161381,0.678217739,ACTR3;SDCBP;AIF1;SNAP29,4
8479,regulation of angiogenesis (GO:0045765),0.52944394,1,0,0,1.0769286,0.684849043,CD40;SP100;STAT1,4
8480,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.531414546,1,0,0,1.331203408,0.841603931,BAX,4
8481,regulation of organelle assembly (GO:1902115),0.531414546,1,0,0,1.331203408,0.841603931,HCK,4
8482,"positive regulation of gene expression, epigenetic (GO:0045815)",0.531414546,1,0,0,1.331203408,0.841603931,ACTB,4
8483,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.531414546,1,0,0,1.331203408,0.841603931,CD164,4
8484,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.531414546,1,0,0,1.331203408,0.841603931,SDCBP,4
8485,regulation of humoral immune response (GO:0002920),0.534931633,1,0,0,1.121013396,0.701324285,C3AR1;CFB,4
8486,negative regulation of mitotic cell cycle (GO:0045930),0.538765532,1,0,0,1.304035991,0.80651341,PNPT1,4
8487,endosome to lysosome transport (GO:0008333),0.538765532,1,0,0,1.304035991,0.80651341,DTX3L,4
8488,regulation of epithelial cell migration (GO:0010632),0.538765532,1,0,0,1.304035991,0.80651341,EVL,4
8489,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.538765532,1,0,0,1.304035991,0.80651341,BAX,4
8490,regulation of immune effector process (GO:0002697),0.539643491,1,0,0,1.111265454,0.685480271,C3AR1;CFB,4
8491,peptidyl-lysine modification (GO:0018205),0.544322341,1,0,0,1.101685579,0.670060227,IFIH1;RANBP2,4
8492,epithelium development (GO:0060429),0.544322341,1,0,0,1.101685579,0.670060227,STAT1;JAK2,4
8493,negative regulation of cell growth (GO:0030308),0.544322341,1,0,0,1.101685579,0.670060227,BST2;CDKN1A,4
8494,protein heterooligomerization (GO:0051291),0.546001561,1,0,0,1.277955272,0.773333476,CHMP2A,4
8495,establishment of protein localization to mitochondrion (GO:0072655),0.546001561,1,0,0,1.277955272,0.773333476,TSPO,4
8496,regulation of cellular protein metabolic process (GO:0032268),0.553124424,1,0,0,1.252897325,0.741931096,NR1H3,4
8497,positive regulation of JUN kinase activity (GO:0043507),0.553124424,1,0,0,1.252897325,0.741931096,DAXX,4
8498,regulation of blood vessel endothelial cell migration (GO:0043535),0.553124424,1,0,0,1.252897325,0.741931096,CD40,4
8499,receptor internalization (GO:0031623),0.553124424,1,0,0,1.252897325,0.741931096,FCER1G,4
8500,calcium ion transport (GO:0006816),0.558159668,1,0,0,1.073911993,0.626209052,SLC3A2;CCR5,4
8501,negative regulation of neuron projection development (GO:0010977),0.560135887,1,0,0,1.228803146,0.712184651,RUFY3,4
8502,response to organonitrogen compound (GO:0010243),0.560135887,1,0,0,1.228803146,0.712184651,IRF5,4
8503,positive regulation of actin filament polymerization (GO:0030838),0.560135887,1,0,0,1.228803146,0.712184651,HCK,4
8504,regulation of telomere maintenance via telomerase (GO:0032210),0.560135887,1,0,0,1.228803146,0.712184651,DCP2,4
8505,telomere maintenance (GO:0000723),0.560135887,1,0,0,1.228803146,0.712184651,SP100,4
8506,positive regulation of developmental growth (GO:0048639),0.560135887,1,0,0,1.228803146,0.712184651,RUFY3,4
8507,RNA export from nucleus (GO:0006405),0.562705368,1,0,0,1.064962726,0.612352623,RANBP2;SRSF7,4
8508,positive regulation of ossification (GO:0045778),0.567037686,1,0,0,1.205618181,0.683982775,ISG15,4
8509,regulation of acute inflammatory response (GO:0002673),0.571696167,1,0,0,1.047504321,0.585709532,C3AR1;CFB,4
8510,protein targeting to mitochondrion (GO:0006626),0.580519104,1,0,0,1.16177752,0.631812453,TSPO,4
8511,cellular response to nutrient levels (GO:0031669),0.580519104,1,0,0,1.16177752,0.631812453,PLEKHF2,4
8512,negative regulation of cellular component organization (GO:0051129),0.580519104,1,0,0,1.16177752,0.631812453,CDC42,4
8513,RNA metabolic process (GO:0016070),0.580732501,1,0,0,0.998402556,0.542596884,ISG20;APOBEC1;PNPT1,4
8514,protein transport (GO:0015031),0.582962103,1,0,0,0.977030024,0.527237739,RAB5C;STX16;STX6;AP3B1;ABCG1,4
8515,positive regulation of GTPase activity (GO:0043547),0.584259056,1,0,0,0.993229486,0.533772257,CD40;CCL7;CCL2,4
8516,platelet degranulation (GO:0002576),0.584930006,1,0,0,1.022364217,0.548256192,LGALS3BP;SRGN,4
8517,cellular protein localization (GO:0034613),0.585674419,1,0,0,0.974051274,0.521108902,RTP4;RAB5C;STX16;STX6;AP3B1,4
8518,regulation of axonogenesis (GO:0050770),0.587102063,1,0,0,1.141031492,0.607663854,RUFY3,4
8519,regulation of gene silencing by RNA (GO:0060966),0.587102063,1,0,0,1.141031492,0.607663854,RANBP2,4
8520,regulation of posttranscriptional gene silencing (GO:0060147),0.587102063,1,0,0,1.141031492,0.607663854,RANBP2,4
8521,fat cell differentiation (GO:0045444),0.587102063,1,0,0,1.141031492,0.607663854,PSMB8,4
8522,negative regulation of multicellular organismal process (GO:0051241),0.589273828,1,0,0,1.014250216,0.53640073,EVL;CALR,4
8523,positive regulation of cell differentiation (GO:0045597),0.591255542,1,0,0,0.983042517,0.51659569,CDC42;SDCBP;IL18,4
8524,anion transport (GO:0006820),0.59358204,1,0,0,1.121013396,0.584697991,TSPO,4
8525,positive regulation of protein transport (GO:0051222),0.59358204,1,0,0,1.121013396,0.584697991,RUFY3,4
8526,protein import (GO:0017038),0.59358204,1,0,0,1.121013396,0.584697991,RANBP2,4
8527,phosphatidylinositol-mediated signaling (GO:0048015),0.59358204,1,0,0,1.121013396,0.584697991,PTAFR,4
8528,glycosaminoglycan catabolic process (GO:0006027),0.59358204,1,0,0,1.121013396,0.584697991,SDC3,4
8529,endocytosis (GO:0006897),0.594903582,1,0,0,0.968147933,0.502813373,CDC42;SNX2;CALR;MERTK,4
8530,protein lipidation (GO:0006497),0.597860159,1,0,0,0.998402556,0.513576677,CD52;LY6E,4
8531,regulation of glycolytic process (GO:0006110),0.599960641,1,0,0,1.101685579,0.562841495,RANBP2,4
8532,positive regulation of cell death (GO:0010942),0.599960641,1,0,0,1.101685579,0.562841495,DAXX,4
8533,epidermal growth factor receptor signaling pathway (GO:0007173),0.599960641,1,0,0,1.101685579,0.562841495,CSK,4
8534,cellular respiration (GO:0045333),0.599960641,1,0,0,1.101685579,0.562841495,CYCS,4
8535,positive regulation of mitochondrion organization (GO:0010822),0.602102655,1,0,0,0.990663001,0.50259041,BAX;MARCH5,4
8536,regulation of protein processing (GO:0070613),0.602102655,1,0,0,0.990663001,0.50259041,C3AR1;CFB,4
8537,ubiquitin-dependent ERAD pathway (GO:0030433),0.606239445,1,0,0,1.083012942,0.542026585,HSPA5,4
8538,renal system development (GO:0072001),0.61242001,1,0,0,1.064962726,0.522190565,STAT1,4
8539,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.61242001,1,0,0,1.064962726,0.522190565,SDCBP,4
8540,dicarboxylic acid metabolic process (GO:0043648),0.61242001,1,0,0,1.064962726,0.522190565,ASS1,4
8541,positive regulation of multicellular organismal process (GO:0051240),0.618474669,1,0,0,0.944301925,0.453736172,SDCBP;IL18;EIF2AK2,4
8542,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.618503869,1,0,0,1.047504321,0.50327537,SRSF7,4
8543,cell chemotaxis (GO:0060326),0.618503869,1,0,0,1.047504321,0.50327537,C3AR1,4
8544,nucleosome assembly (GO:0006334),0.618503869,1,0,0,1.047504321,0.50327537,DAXX,4
8545,muscle organ development (GO:0007517),0.618503869,1,0,0,1.047504321,0.50327537,CXCL10,4
8546,regulation of MAPK cascade (GO:0043408),0.621789675,1,0,0,0.939672994,0.446488806,CD40;PTPN6;MERTK,4
8547,glycosaminoglycan metabolic process (GO:0030203),0.624492528,1,0,0,1.03060909,0.48522716,SDC3,4
8548,regulation of DNA replication (GO:0006275),0.624492528,1,0,0,1.03060909,0.48522716,CALR,4
8549,diterpenoid metabolic process (GO:0016101),0.630387474,1,0,0,1.014250216,0.467995953,SDC3,4
8550,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.630387474,1,0,0,1.014250216,0.467995953,TMBIM6,4
8551,negative regulation of peptidase activity (GO:0010466),0.630387474,1,0,0,1.014250216,0.467995953,CSTB,4
8552,establishment of protein localization to organelle (GO:0072594),0.630387474,1,0,0,1.014250216,0.467995953,RANBP2,4
8553,second-messenger-mediated signaling (GO:0019932),0.630387474,1,0,0,1.014250216,0.467995953,CCR5,4
8554,regulation of translational initiation (GO:0006446),0.630387474,1,0,0,1.014250216,0.467995953,KHDRBS1,4
8555,positive regulation of macromolecule metabolic process (GO:0010604),0.632636244,1,0,0,0.922711387,0.422472337,DTX3L;DDX58;LGALS9;MYD88,4
8556,vesicle coating (GO:0006901),0.636190168,1,0,0,0.998402556,0.451535297,CTSC,4
8557,COPII vesicle coating (GO:0048208),0.636190168,1,0,0,0.998402556,0.451535297,CTSC,4
8558,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.636190168,1,0,0,0.998402556,0.451535297,CTSC,4
8559,negative regulation of dephosphorylation (GO:0035305),0.636190168,1,0,0,0.998402556,0.451535297,PLEKHF2,4
8560,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.636190168,1,0,0,0.998402556,0.451535297,DCP2,4
8561,positive regulation of transferase activity (GO:0051347),0.63876865,1,0,0,0.926054545,0.41506963,DTX3L;MERTK,4
8562,positive regulation of protein polymerization (GO:0032273),0.64190205,1,0,0,0.983042517,0.435801974,HCK,4
8563,negative regulation of neuron differentiation (GO:0045665),0.64190205,1,0,0,0.983042517,0.435801974,CALR,4
8564,chromatin assembly (GO:0031497),0.647524535,1,0,0,0.968147933,0.420755731,DAXX,4
8565,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.647524535,1,0,0,0.968147933,0.420755731,UBB,4
8566,regulation of JAK-STAT cascade (GO:0046425),0.647524535,1,0,0,0.968147933,0.420755731,SOCS1,4
8567,negative regulation of blood vessel morphogenesis (GO:2000181),0.647524535,1,0,0,0.968147933,0.420755731,STAT1,4
8568,negative regulation of apoptotic signaling pathway (GO:2001234),0.647524535,1,0,0,0.968147933,0.420755731,TMBIM6,4
8569,defense response to Gram-positive bacterium (GO:0050830),0.647524535,1,0,0,0.968147933,0.420755731,MYD88,4
8570,purine ribonucleotide metabolic process (GO:0009150),0.653059019,1,0,0,0.953697964,0.406359041,TPST1,4
8571,negative regulation of epithelial cell proliferation (GO:0050680),0.653059019,1,0,0,0.953697964,0.406359041,STAT1,4
8572,regulation of translation (GO:0006417),0.653855285,1,0,0,0.895763041,0.380582152,RANBP2;EIF2AK2;CALR,4
8573,double-strand break repair (GO:0006302),0.654194376,1,0,0,0.899968501,0.381902318,DTX3L;PARP9,4
8574,regulation of gene silencing by miRNA (GO:0060964),0.658506875,1,0,0,0.939672994,0.392576882,RANBP2,4
8575,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.658506875,1,0,0,0.939672994,0.392576882,RGS2,4
8576,regulation of cardiac conduction (GO:1903779),0.658506875,1,0,0,0.939672994,0.392576882,CAMK2D,4
8577,cellular response to UV (GO:0034644),0.658506875,1,0,0,0.939672994,0.392576882,CDKN1A,4
8578,regulation of gene expression (GO:0010468),0.661884817,1,0,0,0.923378086,0.381044646,DAXX;SP100;SP110;DDX58;SP140;PARP14;PARP9;SAP30;TAPBP;PARP10;HCLS1;LGALS9;CALR;ABCG1;MYD88,4
8579,regulation of epithelial to mesenchymal transition (GO:0010717),0.663869454,1,0,0,0.926054545,0.379376538,SDCBP,4
8580,negative regulation of phosphatase activity (GO:0010923),0.663869454,1,0,0,0.926054545,0.379376538,PLEKHF2,4
8581,COPII-coated vesicle budding (GO:0090114),0.663869454,1,0,0,0.926054545,0.379376538,CTSC,4
8582,termination of RNA polymerase II transcription (GO:0006369),0.663869454,1,0,0,0.926054545,0.379376538,SRSF7,4
8583,cellular protein complex assembly (GO:0043623),0.665416449,1,0,0,0.881348463,0.359010417,PSMD11;CHMP2A,4
8584,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.665416449,1,0,0,0.881348463,0.359010417,UBB;UBC,4
8585,negative regulation of angiogenesis (GO:0016525),0.669148087,1,0,0,0.912825194,0.366727419,STAT1,4
8586,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.669148087,1,0,0,0.912825194,0.366727419,CDC42,4
8587,ion transmembrane transport (GO:0034220),0.67214151,1,0,0,0.87133314,0.346168789,UBB;UBC;BAX,4
8588,Rab protein signal transduction (GO:0032482),0.674344084,1,0,0,0.899968501,0.354600898,RAB5C,4
8589,snRNA transcription (GO:0009301),0.674344084,1,0,0,0.899968501,0.354600898,CDK7,4
8590,snRNA transcription from RNA polymerase II promoter (GO:0042795),0.674344084,1,0,0,0.899968501,0.354600898,CDK7,4
8591,calcium-mediated signaling (GO:0019722),0.674344084,1,0,0,0.899968501,0.354600898,CCR5,4
8592,regulation of cell communication (GO:0010646),0.679458735,1,0,0,0.887468939,0.34297016,CAMK2D,4
8593,nuclear import (GO:0051170),0.679458735,1,0,0,0.887468939,0.34297016,RANBP2,4
8594,regulation of cation channel activity (GO:2001257),0.679458735,1,0,0,0.887468939,0.34297016,CAMK2D,4
8595,regulated exocytosis (GO:0045055),0.679921543,1,0,0,0.857688102,0.330877086,LGALS3BP;SRGN,4
8596,cell-cell junction organization (GO:0045216),0.684493309,1,0,0,0.87531183,0.331810066,CSK,4
8597,lysosomal transport (GO:0007041),0.684493309,1,0,0,0.87531183,0.331810066,DTX3L,4
8598,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.684493309,1,0,0,0.87531183,0.331810066,ARL6IP1,4
8599,regulation of phosphatase activity (GO:0010921),0.684493309,1,0,0,0.87531183,0.331810066,PLEKHF2,4
8600,Rho protein signal transduction (GO:0007266),0.684493309,1,0,0,0.87531183,0.331810066,CDC42,4
8601,negative regulation of cell differentiation (GO:0045596),0.686980071,1,0,0,0.846327994,0.317753842,NR1H3;ABCG1,4
8602,positive regulation of epithelial cell migration (GO:0010634),0.694327205,1,0,0,0.851970181,0.310808905,CALR,4
8603,mitotic spindle organization (GO:0007052),0.694327205,1,0,0,0.851970181,0.310808905,GPSM2,4
8604,"regulation of gene expression, epigenetic (GO:0040029)",0.694327205,1,0,0,0.851970181,0.310808905,ACTB,4
8605,mRNA 3'-end processing (GO:0031124),0.694327205,1,0,0,0.851970181,0.310808905,SRSF7,4
8606,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),0.694327205,1,0,0,0.851970181,0.310808905,RGS2,4
8607,retinoid metabolic process (GO:0001523),0.699128969,1,0,0,0.840760047,0.300924877,SDC3,4
8608,negative regulation of phosphorylation (GO:0042326),0.699128969,1,0,0,0.840760047,0.300924877,CDKN1A,4
8609,gland development (GO:0048732),0.699128969,1,0,0,0.840760047,0.300924877,PPDPF,4
8610,nucleic acid-templated transcription (GO:0097659),0.70385554,1,0,0,0.829841085,0.291425371,PTMA,4
8611,hemopoiesis (GO:0030097),0.70385554,1,0,0,0.829841085,0.291425371,CD164,4
8612,ERAD pathway (GO:0036503),0.708508091,1,0,0,0.819202097,0.282291964,HSPA5,4
8613,response to ionizing radiation (GO:0010212),0.708508091,1,0,0,0.819202097,0.282291964,CDKN1A,4
8614,regulation of cytokinesis (GO:0032465),0.708508091,1,0,0,0.819202097,0.282291964,CDC42,4
8615,positive regulation of translation (GO:0045727),0.713087778,1,0,0,0.80883245,0.273507304,KHDRBS1,4
8616,negative regulation of cell communication (GO:0010648),0.713087778,1,0,0,0.80883245,0.273507304,MERTK,4
8617,extracellular matrix disassembly (GO:0022617),0.713087778,1,0,0,0.80883245,0.273507304,MMP14,4
8618,nucleosome organization (GO:0034728),0.717595738,1,0,0,0.798722045,0.265055038,DAXX,4
8619,cation transport (GO:0006812),0.717595738,1,0,0,0.798722045,0.265055038,SLC3A2,4
8620,regulation of endothelial cell proliferation (GO:0001936),0.717595738,1,0,0,0.798722045,0.265055038,STAT1,4
8621,response to calcium ion (GO:0051592),0.717595738,1,0,0,0.798722045,0.265055038,CAMK2D,4
8622,regulation of hydrolase activity (GO:0051336),0.722033092,1,0,0,0.788861279,0.256919739,CAMK2D,4
8623,negative regulation of MAPK cascade (GO:0043409),0.722033092,1,0,0,0.788861279,0.256919739,RGS2,4
8624,neuron projection morphogenesis (GO:0048812),0.729793694,1,0,0,0.779241019,0.245455774,CDC42;UBB,4
8625,positive regulation of DNA metabolic process (GO:0051054),0.730700372,1,0,0,0.769852573,0.241542624,CALR,4
8626,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.730700372,1,0,0,0.769852573,0.241542624,SDCBP,4
8627,defense response to bacterium (GO:0042742),0.733092886,1,0,0,0.792121036,0.245940008,FCER1G;ISG15;MYD88,4
8628,positive regulation of protein ubiquitination (GO:0031398),0.734932451,1,0,0,0.760687662,0.234274066,UBB,4
8629,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.734932451,1,0,0,0.760687662,0.234274066,HCLS1,4
8630,regulation of mitotic cell cycle (GO:0007346),0.735921824,1,0,0,0.769852573,0.236060959,SDCBP;GPSM2,4
8631,regulation of nucleic acid-templated transcription (GO:1903506),0.738963328,1,0,0,0.840760047,0.254335785,DAXX;SP100;SP110;SP140;HCLS1;CALR;ABCG1;SAP30,4
8632,positive regulation of supramolecular fiber organization (GO:1902905),0.739098232,1,0,0,0.751738395,0.227268891,HCK,4
8633,regulation of cell cycle G2/M phase transition (GO:1902749),0.739098232,1,0,0,0.751738395,0.227268891,DYNC1I2,4
8634,regulation of neuron differentiation (GO:0045664),0.739098232,1,0,0,0.751738395,0.227268891,CALR,4
8635,neuron projection development (GO:0031175),0.741931471,1,0,0,0.760687662,0.227064048,CDC42;UBB,4
8636,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.743198749,1,0,0,0.742997251,0.220515473,CYCS,4
8637,regulation of peptidyl-serine phosphorylation (GO:0033135),0.747235021,1,0,0,0.734457053,0.214002808,HCLS1,4
8638,organic substance transport (GO:0071702),0.751208052,1,0,0,0.72611095,0.20772047,TAP1,4
8639,regulation of cell cycle process (GO:0010564),0.762757501,1,0,0,0.702173226,0.190159127,CDC42,4
8640,cell-matrix adhesion (GO:0007160),0.762757501,1,0,0,0.702173226,0.190159127,SIGLEC1,4
8641,lipid transport (GO:0006869),0.766487293,1,0,0,0.694540908,0.184704236,NPC2,4
8642,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),0.766487293,1,0,0,0.694540908,0.184704236,C3AR1,4
8643,negative regulation of protein phosphorylation (GO:0001933),0.772931362,1,0,0,0.713941492,0.183886361,MVP;PTPN6,4
8644,cotranslational protein targeting to membrane (GO:0006613),0.773772429,1,0,0,0.679763442,0.174344007,ARL6IP1,4
8645,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.77620517,1,0,0,0.80883245,0.204908319,DAXX;SP100;SP110;SP140;HCLS1;CALR;ABCG1;SAP30,4
8646,respiratory electron transport chain (GO:0022904),0.777329585,1,0,0,0.672608038,0.169423805,CYCS,4
8647,positive regulation of protein localization to membrane (GO:1905477),0.780830984,1,0,0,0.665601704,0.164667573,CASP8,4
8648,regulation of heart contraction (GO:0008016),0.780830984,1,0,0,0.665601704,0.164667573,CAMK2D,4
8649,positive regulation of protein metabolic process (GO:0051247),0.784277498,1,0,0,0.658739831,0.160068752,NR1H3,4
8650,ciliary basal body-plasma membrane docking (GO:0097711),0.784277498,1,0,0,0.658739831,0.160068752,DYNC1I2,4
8651,protein targeting to ER (GO:0045047),0.787669985,1,0,0,0.652017996,0.155621098,CHMP4B,4
8652,response to UV (GO:0009411),0.791009288,1,0,0,0.645431955,0.151318662,CCND1,4
8653,glycosaminoglycan biosynthetic process (GO:0006024),0.794296238,1,0,0,0.638977636,0.147155777,SDC3,4
8654,receptor-mediated endocytosis (GO:0006898),0.798249693,1,0,0,0.67616681,0.152363259,FCER1G;CALR,4
8655,positive regulation of angiogenesis (GO:0045766),0.806936689,1,0,0,0.614401573,0.131795322,CD40,4
8656,cilium organization (GO:0044782),0.807658613,1,0,0,0.66215299,0.141446353,ACTR3;SNAP29,4
8657,B cell receptor signaling pathway (GO:0050853),0.809973899,1,0,0,0.608550129,0.128253921,BAX,4
8658,peptide metabolic process (GO:0006518),0.809973899,1,0,0,0.608550129,0.128253921,SPPL2A,4
8659,positive regulation of vasculature development (GO:1904018),0.809973899,1,0,0,0.608550129,0.128253921,CD40,4
8660,positive regulation of cellular component organization (GO:0051130),0.81590617,1,0,0,0.597175361,0.121498862,BAX,4
8661,regulation of protein secretion (GO:0050708),0.818802709,1,0,0,0.591645959,0.118277196,RSAD2,4
8662,regulation of cell motility (GO:2000145),0.824460204,1,0,0,0.58088876,0.112126869,DDX58,4
8663,viral gene expression (GO:0019080),0.827222569,1,0,0,0.575655528,0.1091912,RANBP2,4
8664,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.827222569,1,0,0,0.575655528,0.1091912,CASP8,4
8665,"regulation of transcription, DNA-templated (GO:0006355)",0.828561094,1,0,0,0.839182636,0.157820635,CD86;BATF2;KHDRBS1;DAXX;CDKN1A;SP100;CAMK2D;DTX3L;SP110;STAT1;SP140;STAT2;NR1H3;PARP9;SAP30;CDK7;IRF1;IRF7;HCLS1;CALR;ABCG1,4
8666,cilium assembly (GO:0060271),0.833200947,1,0,0,0.663298584,0.121039013,ACTR3;DYNC1I2;SNAP29,4
8667,viral transcription (GO:0019083),0.835252362,1,0,0,0.560506698,0.100903183,RANBP2,4
8668,positive regulation of developmental process (GO:0051094),0.835252362,1,0,0,0.560506698,0.100903183,5-Mar,4
8669,protein O-linked glycosylation (GO:0006493),0.840397786,1,0,0,0.550842789,0.095780514,SPON1,4
8670,organelle assembly (GO:0070925),0.844354305,1,0,0,0.677960356,0.114699421,ACTR3;CHMP2A;CHMP4B;SNAP29,4
8671,positive regulation of B cell activation (GO:0050871),0.850212984,1,0,0,0.532481363,0.086404894,MMP14,4
8672,regulation of neuron projection development (GO:0010975),0.850212984,1,0,0,0.532481363,0.086404894,RUFY3,4
8673,regulation of cell differentiation (GO:0045595),0.85489255,1,0,0,0.52375216,0.082113597,EIF2AK2,4
8674,dephosphorylation (GO:0016311),0.861640044,1,0,0,0.511182109,0.076124053,PTPN6,4
8675,organic anion transport (GO:0015711),0.861640044,1,0,0,0.511182109,0.076124053,NPC2,4
8676,protein dephosphorylation (GO:0006470),0.863818968,1,0,0,0.507125108,0.074239089,PTPN6,4
8677,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.863818968,1,0,0,0.507125108,0.074239089,CCL2,4
8678,negative regulation of response to stimulus (GO:0048585),0.868074731,1,0,0,0.499201278,0.070625735,MERTK,4
8679,regulation of macromolecule metabolic process (GO:0060255),0.872197908,1,0,0,0.491521258,0.067210087,TAPBP,4
8680,DNA metabolic process (GO:0006259),0.873345238,1,0,0,0.608550129,0.082412499,SP100;UBB;UBC,4
8681,extracellular matrix organization (GO:0030198),0.877731349,1,0,0,0.555632727,0.072462683,MMP14;CD47,4
8682,muscle contraction (GO:0006936),0.887445218,1,0,0,0.463027272,0.055289386,MYL12A,4
8683,gene expression (GO:0010467),0.888927915,1,0,0,0.620366637,0.07304143,APOBEC1;RANBP2;PTMA;SRSF7,4
8684,regulation of vesicle-mediated transport (GO:0060627),0.889218909,1,0,0,0.459696141,0.053973766,RAB5C,4
8685,cellular response to growth factor stimulus (GO:0071363),0.890964738,1,0,0,0.456412597,0.05269303,CCL2,4
8686,regulation of small GTPase mediated signal transduction (GO:0051056),0.89268314,1,0,0,0.453175628,0.051446123,CDC42,4
8687,anterograde trans-synaptic signaling (GO:0098916),0.893511128,1,0,0,0.530271897,0.059706754,SDCBP;CNP,4
8688,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.896039373,1,0,0,0.446837508,0.049049766,CD164,4
8689,peptidyl-serine phosphorylation (GO:0018105),0.900878543,1,0,0,0.437655915,0.04568464,CAMK2D,4
8690,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.906672504,1,0,0,0.62278522,0.06101674,KHDRBS1;DAXX;IRF1;EIF2AK2;CALR,4
8691,positive regulation of intracellular protein transport (GO:0090316),0.911314488,1,0,0,0.417632442,0.038784368,RUFY3,4
8692,spermatogenesis (GO:0007283),0.912713085,1,0,0,0.414920543,0.03789623,PTTG1,4
8693,male gamete generation (GO:0048232),0.914089695,1,0,0,0.412243636,0.037030435,PTTG1,4
8694,axon guidance (GO:0007411),0.919383069,1,0,0,0.401872727,0.033778372,EVL,4
8695,negative regulation of nucleic acid-templated transcription (GO:1903507),0.920333089,1,0,0,0.57436192,0.047683309,KHDRBS1;DAXX;IRF1;CALR,4
8696,glycerophospholipid biosynthetic process (GO:0046474),0.926719685,1,0,0,0.387259173,0.02947203,ETNK1,4
8697,peptidyl-serine modification (GO:0018209),0.933390543,1,0,0,0.373671132,0.02575774,CAMK2D,4
8698,nuclear-transcribed mRNA catabolic process (GO:0000956),0.937497894,1,0,0,0.365130078,0.023565776,DCP2,4
8699,mRNA processing (GO:0006397),0.938736839,1,0,0,0.449984251,0.028448047,CDK7;SRSF7,4
8700,chemical synaptic transmission (GO:0007268),0.943366509,1,0,0,0.440674232,0.025691488,SDCBP;CNP,4
8701,rRNA metabolic process (GO:0016072),0.958686557,1,0,0,0.317899321,0.013412522,PNO1,4
8702,rRNA processing (GO:0006364),0.959982434,1,0,0,0.314767308,0.012855189,PNO1,4
8703,regulation of intracellular signal transduction (GO:1902531),0.963072557,1,0,0,0.453175628,0.017051424,CDC42;UBB;UBC,4
8704,central nervous system development (GO:0007417),0.968493413,1,0,0,0.293109007,0.009383474,CSK,4
8705,axonogenesis (GO:0007409),0.971368773,1,0,0,0.285257873,0.008286483,EVL,4
8706,ribosome biogenesis (GO:0042254),0.97270679,1,0,0,0.281487945,0.0077895,PNO1,4
8707,ncRNA processing (GO:0034470),0.973138795,1,0,0,0.280253349,0.007630895,PNO1,4
8708,nervous system development (GO:0007399),0.975232958,1,0,0,0.420380024,0.010542671,CAMK2D;EVL;CSK,4
8709,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.976732596,1,0,0,0.269610817,0.006347276,SRSF7,4
8710,"mRNA splicing, via spliceosome (GO:0000398)",0.98439253,1,0,0,0.243884594,0.003836439,SRSF7,4
8711,cellular macromolecule biosynthetic process (GO:0034645),0.997143551,1,0,0,0.173635227,0.00049669,PTMA,4
